{"id": "site_Study 1_Site 10", "study": "Study 1", "site": "Site 10", "type": "site_summary", "total_subjects": 3, "total_issues": 57, "document": "# Site Report: Site 10\n\n## Site Information\n- **Site ID**: Site 10\n- **Study**: Study 1\n- **Country**: DEU\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 57\n- **Average Issues per Subject**: 19.00\n- **Clean Subjects**: 1 (33.3%)\n\n## Risk Profile\n- Low Risk: 1 (33.3%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (33.3%)\n- Critical Risk: 1 (33.3%)\n\n## Issue Breakdown\n- Open EDRR Issues: 5\n- Safety Discrepancies: 52\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 18: High risk, 15 issues\n- Subject 19: Critical risk, 42 issues\n"}
{"id": "site_Study 1_Site 11", "study": "Study 1", "site": "Site 11", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 11\n\n## Site Information\n- **Site ID**: Site 11\n- **Study**: Study 1\n- **Country**: SGP\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 2\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 1_Site 12", "study": "Study 1", "site": "Site 12", "type": "site_summary", "total_subjects": 1, "total_issues": 12, "document": "# Site Report: Site 12\n\n## Site Information\n- **Site ID**: Site 12\n- **Study**: Study 1\n- **Country**: KOR\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 12\n- **Average Issues per Subject**: 12.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (100.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 2\n- Missing Labs: 4\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\n- Subject 22: High risk, 12 issues\n"}
{"id": "site_Study 1_Site 13", "study": "Study 1", "site": "Site 13", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 13\n\n## Site Information\n- **Site ID**: Site 13\n- **Study**: Study 1\n- **Country**: ESP\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 1_Site 14", "study": "Study 1", "site": "Site 14", "type": "site_summary", "total_subjects": 13, "total_issues": 51, "document": "# Site Report: Site 14\n\n## Site Information\n- **Site ID**: Site 14\n- **Study**: Study 1\n- **Country**: ESP\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 51\n- **Average Issues per Subject**: 3.92\n- **Clean Subjects**: 10 (76.9%)\n\n## Risk Profile\n- Low Risk: 10 (76.9%)\n- Medium Risk: 1 (7.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 2 (15.4%)\n\n## Issue Breakdown\n- Open EDRR Issues: 6\n- Safety Discrepancies: 38\n- Missing Pages: 4\n- Missing Labs: 2\n- Outstanding Visits: 4\n\n## Subjects Requiring Attention\n- Subject 32: Critical risk, 26 issues\n- Subject 36: Critical risk, 22 issues\n"}
{"id": "site_Study 1_Site 15", "study": "Study 1", "site": "Site 15", "type": "site_summary", "total_subjects": 12, "total_issues": 255, "document": "# Site Report: Site 15\n\n## Site Information\n- **Site ID**: Site 15\n- **Study**: Study 1\n- **Country**: ESP\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 255\n- **Average Issues per Subject**: 21.25\n- **Clean Subjects**: 4 (33.3%)\n\n## Risk Profile\n- Low Risk: 4 (33.3%)\n- Medium Risk: 1 (8.3%)\n- High Risk: 1 (8.3%)\n- Critical Risk: 6 (50.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 19\n- Safety Discrepancies: 211\n- Missing Pages: 25\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\n- Subject 39: Critical risk, 54 issues\n- Subject 42: Critical risk, 47 issues\n- Subject 44: Critical risk, 44 issues\n- Subject 45: Critical risk, 30 issues\n- Subject 46: Critical risk, 23 issues\n- Subject 47: Critical risk, 40 issues\n- Subject 52: High risk, 15 issues\n"}
{"id": "site_Study 1_Site 16", "study": "Study 1", "site": "Site 16", "type": "site_summary", "total_subjects": 5, "total_issues": 14, "document": "# Site Report: Site 16\n\n## Site Information\n- **Site ID**: Site 16\n- **Study**: Study 1\n- **Country**: ESP\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 14\n- **Average Issues per Subject**: 2.80\n- **Clean Subjects**: 3 (60.0%)\n\n## Risk Profile\n- Low Risk: 3 (60.0%)\n- Medium Risk: 1 (20.0%)\n- High Risk: 1 (20.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 13\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 57: High risk, 13 issues\n"}
{"id": "site_Study 1_Site 17", "study": "Study 1", "site": "Site 17", "type": "site_summary", "total_subjects": 3, "total_issues": 23, "document": "# Site Report: Site 17\n\n## Site Information\n- **Site ID**: Site 17\n- **Study**: Study 1\n- **Country**: ESP\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 23\n- **Average Issues per Subject**: 7.67\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (33.3%)\n- High Risk: 2 (66.7%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 8\n- Missing Pages: 8\n- Missing Labs: 1\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\n- Subject 61: High risk, 12 issues\n- Subject 62: High risk, 8 issues\n"}
{"id": "site_Study 1_Site 18", "study": "Study 1", "site": "Site 18", "type": "site_summary", "total_subjects": 14, "total_issues": 66, "document": "# Site Report: Site 18\n\n## Site Information\n- **Site ID**: Site 18\n- **Study**: Study 1\n- **Country**: USA\n- **Total Subjects**: 14\n\n## Performance Metrics\n- **Total Issues**: 66\n- **Average Issues per Subject**: 4.71\n- **Clean Subjects**: 7 (50.0%)\n\n## Risk Profile\n- Low Risk: 7 (50.0%)\n- Medium Risk: 4 (28.6%)\n- High Risk: 2 (14.3%)\n- Critical Risk: 1 (7.1%)\n\n## Issue Breakdown\n- Open EDRR Issues: 3\n- Safety Discrepancies: 59\n- Missing Pages: 3\n- Missing Labs: 0\n- Outstanding Visits: 4\n\n## Subjects Requiring Attention\n- Subject 67: Critical risk, 26 issues\n- Subject 74: High risk, 14 issues\n- Subject 75: High risk, 9 issues\n"}
{"id": "site_Study 1_Site 19", "study": "Study 1", "site": "Site 19", "type": "site_summary", "total_subjects": 5, "total_issues": 80, "document": "# Site Report: Site 19\n\n## Site Information\n- **Site ID**: Site 19\n- **Study**: Study 1\n- **Country**: USA\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 80\n- **Average Issues per Subject**: 16.00\n- **Clean Subjects**: 3 (60.0%)\n\n## Risk Profile\n- Low Risk: 3 (60.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 2 (40.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 6\n- Safety Discrepancies: 32\n- Missing Pages: 33\n- Missing Labs: 0\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\n- Subject 78: Critical risk, 54 issues\n- Subject 80: Critical risk, 26 issues\n"}
{"id": "site_Study 1_Site 2", "study": "Study 1", "site": "Site 2", "type": "site_summary", "total_subjects": 4, "total_issues": 20, "document": "# Site Report: Site 2\n\n## Site Information\n- **Site ID**: Site 2\n- **Study**: Study 1\n- **Country**: FRA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 20\n- **Average Issues per Subject**: 5.00\n- **Clean Subjects**: 2 (50.0%)\n\n## Risk Profile\n- Low Risk: 2 (50.0%)\n- Medium Risk: 1 (25.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (25.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 3\n- Missing Pages: 16\n- Missing Labs: 1\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 5: Critical risk, 17 issues\n"}
{"id": "site_Study 1_Site 21", "study": "Study 1", "site": "Site 21", "type": "site_summary", "total_subjects": 3, "total_issues": 35, "document": "# Site Report: Site 21\n\n## Site Information\n- **Site ID**: Site 21\n- **Study**: Study 1\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 35\n- **Average Issues per Subject**: 11.67\n- **Clean Subjects**: 2 (66.7%)\n\n## Risk Profile\n- Low Risk: 2 (66.7%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (33.3%)\n\n## Issue Breakdown\n- Open EDRR Issues: 3\n- Safety Discrepancies: 13\n- Missing Pages: 19\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 83: Critical risk, 35 issues\n"}
{"id": "site_Study 1_Site 22", "study": "Study 1", "site": "Site 22", "type": "site_summary", "total_subjects": 1, "total_issues": 22, "document": "# Site Report: Site 22\n\n## Site Information\n- **Site ID**: Site 22\n- **Study**: Study 1\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 22\n- **Average Issues per Subject**: 22.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 22\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 86: Critical risk, 22 issues\n"}
{"id": "site_Study 1_Site 23", "study": "Study 1", "site": "Site 23", "type": "site_summary", "total_subjects": 3, "total_issues": 56, "document": "# Site Report: Site 23\n\n## Site Information\n- **Site ID**: Site 23\n- **Study**: Study 1\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 56\n- **Average Issues per Subject**: 18.67\n- **Clean Subjects**: 1 (33.3%)\n\n## Risk Profile\n- Low Risk: 1 (33.3%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (33.3%)\n- Critical Risk: 1 (33.3%)\n\n## Issue Breakdown\n- Open EDRR Issues: 3\n- Safety Discrepancies: 43\n- Missing Pages: 9\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 87: Critical risk, 49 issues\n- Subject 88: High risk, 7 issues\n"}
{"id": "site_Study 1_Site 24", "study": "Study 1", "site": "Site 24", "type": "site_summary", "total_subjects": 1, "total_issues": 50, "document": "# Site Report: Site 24\n\n## Site Information\n- **Site ID**: Site 24\n- **Study**: Study 1\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 50\n- **Average Issues per Subject**: 50.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 4\n- Safety Discrepancies: 46\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 90: Critical risk, 50 issues\n"}
{"id": "site_Study 1_Site 25", "study": "Study 1", "site": "Site 25", "type": "site_summary", "total_subjects": 2, "total_issues": 3, "document": "# Site Report: Site 25\n\n## Site Information\n- **Site ID**: Site 25\n- **Study**: Study 1\n- **Country**: GBR\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 1.50\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 3\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 1_Site 26", "study": "Study 1", "site": "Site 26", "type": "site_summary", "total_subjects": 1, "total_issues": 5, "document": "# Site Report: Site 26\n\n## Site Information\n- **Site ID**: Site 26\n- **Study**: Study 1\n- **Country**: CHN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 5\n- **Average Issues per Subject**: 5.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 5\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 1_Site 27", "study": "Study 1", "site": "Site 27", "type": "site_summary", "total_subjects": 3, "total_issues": 100, "document": "# Site Report: Site 27\n\n## Site Information\n- **Site ID**: Site 27\n- **Study**: Study 1\n- **Country**: CHN\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 100\n- **Average Issues per Subject**: 33.33\n- **Clean Subjects**: 1 (33.3%)\n\n## Risk Profile\n- Low Risk: 1 (33.3%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 2 (66.7%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 92\n- Missing Pages: 2\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 96: Critical risk, 52 issues\n- Subject 97: Critical risk, 48 issues\n"}
{"id": "site_Study 1_Site 3", "study": "Study 1", "site": "Site 3", "type": "site_summary", "total_subjects": 3, "total_issues": 38, "document": "# Site Report: Site 3\n\n## Site Information\n- **Site ID**: Site 3\n- **Study**: Study 1\n- **Country**: FRA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 38\n- **Average Issues per Subject**: 12.67\n- **Clean Subjects**: 1 (33.3%)\n\n## Risk Profile\n- Low Risk: 1 (33.3%)\n- Medium Risk: 1 (33.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (33.3%)\n\n## Issue Breakdown\n- Open EDRR Issues: 4\n- Safety Discrepancies: 3\n- Missing Pages: 1\n- Missing Labs: 30\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 7: Critical risk, 35 issues\n"}
{"id": "site_Study 1_Site 4", "study": "Study 1", "site": "Site 4", "type": "site_summary", "total_subjects": 2, "total_issues": 76, "document": "# Site Report: Site 4\n\n## Site Information\n- **Site ID**: Site 4\n- **Study**: Study 1\n- **Country**: FRA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 76\n- **Average Issues per Subject**: 38.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 2 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 55\n- Missing Pages: 10\n- Missing Labs: 10\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 10: Critical risk, 37 issues\n- Subject 9: Critical risk, 39 issues\n"}
{"id": "site_Study 1_Site 5", "study": "Study 1", "site": "Site 5", "type": "site_summary", "total_subjects": 1, "total_issues": 2, "document": "# Site Report: Site 5\n\n## Site Information\n- **Site ID**: Site 5\n- **Study**: Study 1\n- **Country**: AUT\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 2\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 1_Site 6", "study": "Study 1", "site": "Site 6", "type": "site_summary", "total_subjects": 2, "total_issues": 111, "document": "# Site Report: Site 6\n\n## Site Information\n- **Site ID**: Site 6\n- **Study**: Study 1\n- **Country**: AUT\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 111\n- **Average Issues per Subject**: 55.50\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (50.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 3\n- Missing Pages: 28\n- Missing Labs: 80\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\n- Subject 12: Critical risk, 106 issues\n"}
{"id": "site_Study 1_Site 7", "study": "Study 1", "site": "Site 7", "type": "site_summary", "total_subjects": 1, "total_issues": 30, "document": "# Site Report: Site 7\n\n## Site Information\n- **Site ID**: Site 7\n- **Study**: Study 1\n- **Country**: ISR\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 30\n- **Average Issues per Subject**: 30.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 26\n- Missing Pages: 2\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 14: Critical risk, 30 issues\n"}
{"id": "site_Study 1_Site 8", "study": "Study 1", "site": "Site 8", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 8\n\n## Site Information\n- **Site ID**: Site 8\n- **Study**: Study 1\n- **Country**: ISR\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 10_Site 11", "study": "Study 10", "site": "Site 11", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 11\n\n## Site Information\n- **Site ID**: Site 11\n- **Study**: Study 10\n- **Country**: HUN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 10_Site 153", "study": "Study 10", "site": "Site 153", "type": "site_summary", "total_subjects": 1, "total_issues": 2, "document": "# Site Report: Site 153\n\n## Site Information\n- **Site ID**: Site 153\n- **Study**: Study 10\n- **Country**: ITA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 10_Site 28", "study": "Study 10", "site": "Site 28", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 28\n\n## Site Information\n- **Site ID**: Site 28\n- **Study**: Study 10\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 2\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 10_Site 29", "study": "Study 10", "site": "Site 29", "type": "site_summary", "total_subjects": 1, "total_issues": 2, "document": "# Site Report: Site 29\n\n## Site Information\n- **Site ID**: Site 29\n- **Study**: Study 10\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 2\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 10_Site 32", "study": "Study 10", "site": "Site 32", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 32\n\n## Site Information\n- **Site ID**: Site 32\n- **Study**: Study 10\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 10_Site 36", "study": "Study 10", "site": "Site 36", "type": "site_summary", "total_subjects": 2, "total_issues": 7, "document": "# Site Report: Site 36\n\n## Site Information\n- **Site ID**: Site 36\n- **Study**: Study 10\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 7\n- **Average Issues per Subject**: 3.50\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 6\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 10_Site 38", "study": "Study 10", "site": "Site 38", "type": "site_summary", "total_subjects": 4, "total_issues": 3, "document": "# Site Report: Site 38\n\n## Site Information\n- **Site ID**: Site 38\n- **Study**: Study 10\n- **Country**: USA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 0.75\n- **Clean Subjects**: 3 (75.0%)\n\n## Risk Profile\n- Low Risk: 3 (75.0%)\n- Medium Risk: 1 (25.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 2\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 10_Site 40", "study": "Study 10", "site": "Site 40", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 40\n\n## Site Information\n- **Site ID**: Site 40\n- **Study**: Study 10\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 2\n- Outstanding Visits: 3\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 10_Site 42", "study": "Study 10", "site": "Site 42", "type": "site_summary", "total_subjects": 1, "total_issues": 2, "document": "# Site Report: Site 42\n\n## Site Information\n- **Site ID**: Site 42\n- **Study**: Study 10\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 2\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 10_Site 451", "study": "Study 10", "site": "Site 451", "type": "site_summary", "total_subjects": 3, "total_issues": 8, "document": "# Site Report: Site 451\n\n## Site Information\n- **Site ID**: Site 451\n- **Study**: Study 10\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 8\n- **Average Issues per Subject**: 2.67\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 3 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 8\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 10_Site 452", "study": "Study 10", "site": "Site 452", "type": "site_summary", "total_subjects": 1, "total_issues": 3, "document": "# Site Report: Site 452\n\n## Site Information\n- **Site ID**: Site 452\n- **Study**: Study 10\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 3.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 2\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 10_Site 453", "study": "Study 10", "site": "Site 453", "type": "site_summary", "total_subjects": 6, "total_issues": 11, "document": "# Site Report: Site 453\n\n## Site Information\n- **Site ID**: Site 453\n- **Study**: Study 10\n- **Country**: USA\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 11\n- **Average Issues per Subject**: 1.83\n- **Clean Subjects**: 2 (33.3%)\n\n## Risk Profile\n- Low Risk: 2 (33.3%)\n- Medium Risk: 4 (66.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 8\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 10_Site 454", "study": "Study 10", "site": "Site 454", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 454\n\n## Site Information\n- **Site ID**: Site 454\n- **Study**: Study 10\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 10_Site 455", "study": "Study 10", "site": "Site 455", "type": "site_summary", "total_subjects": 6, "total_issues": 6, "document": "# Site Report: Site 455\n\n## Site Information\n- **Site ID**: Site 455\n- **Study**: Study 10\n- **Country**: USA\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 6\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 3 (50.0%)\n\n## Risk Profile\n- Low Risk: 3 (50.0%)\n- Medium Risk: 3 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 6\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 10_Site 457", "study": "Study 10", "site": "Site 457", "type": "site_summary", "total_subjects": 1, "total_issues": 4, "document": "# Site Report: Site 457\n\n## Site Information\n- **Site ID**: Site 457\n- **Study**: Study 10\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 4.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 4\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 10_Site 458", "study": "Study 10", "site": "Site 458", "type": "site_summary", "total_subjects": 2, "total_issues": 3, "document": "# Site Report: Site 458\n\n## Site Information\n- **Site ID**: Site 458\n- **Study**: Study 10\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 1.50\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 2\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 10_Site 459", "study": "Study 10", "site": "Site 459", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 459\n\n## Site Information\n- **Site ID**: Site 459\n- **Study**: Study 10\n- **Country**: CHN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 10_Site 460", "study": "Study 10", "site": "Site 460", "type": "site_summary", "total_subjects": 1, "total_issues": 8, "document": "# Site Report: Site 460\n\n## Site Information\n- **Site ID**: Site 460\n- **Study**: Study 10\n- **Country**: CHN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 8\n- **Average Issues per Subject**: 8.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (100.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 3509: High risk, 8 issues\n"}
{"id": "site_Study 10_Site 461", "study": "Study 10", "site": "Site 461", "type": "site_summary", "total_subjects": 2, "total_issues": 4, "document": "# Site Report: Site 461\n\n## Site Information\n- **Site ID**: Site 461\n- **Study**: Study 10\n- **Country**: JPN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 4\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 10_Site 462", "study": "Study 10", "site": "Site 462", "type": "site_summary", "total_subjects": 2, "total_issues": 16, "document": "# Site Report: Site 462\n\n## Site Information\n- **Site ID**: Site 462\n- **Study**: Study 10\n- **Country**: JPN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 16\n- **Average Issues per Subject**: 8.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 1 (50.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 2\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 3517: High risk, 14 issues\n"}
{"id": "site_Study 10_Site 463", "study": "Study 10", "site": "Site 463", "type": "site_summary", "total_subjects": 4, "total_issues": 43, "document": "# Site Report: Site 463\n\n## Site Information\n- **Site ID**: Site 463\n- **Study**: Study 10\n- **Country**: JPN\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 43\n- **Average Issues per Subject**: 10.75\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 3 (75.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (25.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 6\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\n- Subject 3521: Critical risk, 37 issues\n"}
{"id": "site_Study 10_Site 465", "study": "Study 10", "site": "Site 465", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 465\n\n## Site Information\n- **Site ID**: Site 465\n- **Study**: Study 10\n- **Country**: ESP\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 10_Site 50", "study": "Study 10", "site": "Site 50", "type": "site_summary", "total_subjects": 2, "total_issues": 5, "document": "# Site Report: Site 50\n\n## Site Information\n- **Site ID**: Site 50\n- **Study**: Study 10\n- **Country**: CAN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 5\n- **Average Issues per Subject**: 2.50\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 4\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 10_Site 51", "study": "Study 10", "site": "Site 51", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 51\n\n## Site Information\n- **Site ID**: Site 51\n- **Study**: Study 10\n- **Country**: CAN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 2\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 10_Site 79", "study": "Study 10", "site": "Site 79", "type": "site_summary", "total_subjects": 1, "total_issues": 6, "document": "# Site Report: Site 79\n\n## Site Information\n- **Site ID**: Site 79\n- **Study**: Study 10\n- **Country**: CHN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 6\n- **Average Issues per Subject**: 6.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (100.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 587: High risk, 6 issues\n"}
{"id": "site_Study 10_Site 8", "study": "Study 10", "site": "Site 8", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 8\n\n## Site Information\n- **Site ID**: Site 8\n- **Study**: Study 10\n- **Country**: CHN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 10_Site 9", "study": "Study 10", "site": "Site 9", "type": "site_summary", "total_subjects": 3, "total_issues": 4, "document": "# Site Report: Site 9\n\n## Site Information\n- **Site ID**: Site 9\n- **Study**: Study 10\n- **Country**: JPN\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 1.33\n- **Clean Subjects**: 1 (33.3%)\n\n## Risk Profile\n- Low Risk: 1 (33.3%)\n- Medium Risk: 2 (66.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 4\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 11_Site 128", "study": "Study 11", "site": "Site 128", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 128\n\n## Site Information\n- **Site ID**: Site 128\n- **Study**: Study 11\n- **Country**: NLD\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 11_Site 148", "study": "Study 11", "site": "Site 148", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 148\n\n## Site Information\n- **Site ID**: Site 148\n- **Study**: Study 11\n- **Country**: CHE\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 11_Site 155", "study": "Study 11", "site": "Site 155", "type": "site_summary", "total_subjects": 1, "total_issues": 2, "document": "# Site Report: Site 155\n\n## Site Information\n- **Site ID**: Site 155\n- **Study**: Study 11\n- **Country**: GBR\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 2\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 11_Site 186", "study": "Study 11", "site": "Site 186", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 186\n\n## Site Information\n- **Site ID**: Site 186\n- **Study**: Study 11\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 11_Site 189", "study": "Study 11", "site": "Site 189", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 189\n\n## Site Information\n- **Site ID**: Site 189\n- **Study**: Study 11\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 11_Site 20", "study": "Study 11", "site": "Site 20", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 20\n\n## Site Information\n- **Site ID**: Site 20\n- **Study**: Study 11\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 11_Site 35", "study": "Study 11", "site": "Site 35", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 35\n\n## Site Information\n- **Site ID**: Site 35\n- **Study**: Study 11\n- **Country**: JPN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 1\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 11_Site 353", "study": "Study 11", "site": "Site 353", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 353\n\n## Site Information\n- **Site ID**: Site 353\n- **Study**: Study 11\n- **Country**: ESP\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 11_Site 454", "study": "Study 11", "site": "Site 454", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 454\n\n## Site Information\n- **Site ID**: Site 454\n- **Study**: Study 11\n- **Country**: JPN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 11_Site 467", "study": "Study 11", "site": "Site 467", "type": "site_summary", "total_subjects": 1, "total_issues": 2, "document": "# Site Report: Site 467\n\n## Site Information\n- **Site ID**: Site 467\n- **Study**: Study 11\n- **Country**: AUS\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 11_Site 472", "study": "Study 11", "site": "Site 472", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 472\n\n## Site Information\n- **Site ID**: Site 472\n- **Study**: Study 11\n- **Country**: CZE\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 11_Site 474", "study": "Study 11", "site": "Site 474", "type": "site_summary", "total_subjects": 2, "total_issues": 4, "document": "# Site Report: Site 474\n\n## Site Information\n- **Site ID**: Site 474\n- **Study**: Study 11\n- **Country**: CZE\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 4\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 11_Site 476", "study": "Study 11", "site": "Site 476", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 476\n\n## Site Information\n- **Site ID**: Site 476\n- **Study**: Study 11\n- **Country**: DNK\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 1\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 11_Site 488", "study": "Study 11", "site": "Site 488", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 488\n\n## Site Information\n- **Site ID**: Site 488\n- **Study**: Study 11\n- **Country**: FRA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 11_Site 491", "study": "Study 11", "site": "Site 491", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 491\n\n## Site Information\n- **Site ID**: Site 491\n- **Study**: Study 11\n- **Country**: FRA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 11_Site 492", "study": "Study 11", "site": "Site 492", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 492\n\n## Site Information\n- **Site ID**: Site 492\n- **Study**: Study 11\n- **Country**: FRA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 11_Site 496", "study": "Study 11", "site": "Site 496", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 496\n\n## Site Information\n- **Site ID**: Site 496\n- **Study**: Study 11\n- **Country**: DEU\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 11_Site 499", "study": "Study 11", "site": "Site 499", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 499\n\n## Site Information\n- **Site ID**: Site 499\n- **Study**: Study 11\n- **Country**: DEU\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 11_Site 5", "study": "Study 11", "site": "Site 5", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 5\n\n## Site Information\n- **Site ID**: Site 5\n- **Study**: Study 11\n- **Country**: ZAF\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 11_Site 500", "study": "Study 11", "site": "Site 500", "type": "site_summary", "total_subjects": 1, "total_issues": 2, "document": "# Site Report: Site 500\n\n## Site Information\n- **Site ID**: Site 500\n- **Study**: Study 11\n- **Country**: DEU\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 2\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 11_Site 501", "study": "Study 11", "site": "Site 501", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 501\n\n## Site Information\n- **Site ID**: Site 501\n- **Study**: Study 11\n- **Country**: DEU\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 11_Site 505", "study": "Study 11", "site": "Site 505", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 505\n\n## Site Information\n- **Site ID**: Site 505\n- **Study**: Study 11\n- **Country**: ITA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 11_Site 506", "study": "Study 11", "site": "Site 506", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 506\n\n## Site Information\n- **Site ID**: Site 506\n- **Study**: Study 11\n- **Country**: ITA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 11_Site 507", "study": "Study 11", "site": "Site 507", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 507\n\n## Site Information\n- **Site ID**: Site 507\n- **Study**: Study 11\n- **Country**: ITA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 11_Site 516", "study": "Study 11", "site": "Site 516", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 516\n\n## Site Information\n- **Site ID**: Site 516\n- **Study**: Study 11\n- **Country**: ESP\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 11_Site 520", "study": "Study 11", "site": "Site 520", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 520\n\n## Site Information\n- **Site ID**: Site 520\n- **Study**: Study 11\n- **Country**: COL\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 11_Site 521", "study": "Study 11", "site": "Site 521", "type": "site_summary", "total_subjects": 1, "total_issues": 2, "document": "# Site Report: Site 521\n\n## Site Information\n- **Site ID**: Site 521\n- **Study**: Study 11\n- **Country**: COL\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 2\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 11_Site 524", "study": "Study 11", "site": "Site 524", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 524\n\n## Site Information\n- **Site ID**: Site 524\n- **Study**: Study 11\n- **Country**: ARG\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 11_Site 526", "study": "Study 11", "site": "Site 526", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 526\n\n## Site Information\n- **Site ID**: Site 526\n- **Study**: Study 11\n- **Country**: ARG\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 11_Site 528", "study": "Study 11", "site": "Site 528", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 528\n\n## Site Information\n- **Site ID**: Site 528\n- **Study**: Study 11\n- **Country**: MEX\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 2\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 11_Site 532", "study": "Study 11", "site": "Site 532", "type": "site_summary", "total_subjects": 1, "total_issues": 2, "document": "# Site Report: Site 532\n\n## Site Information\n- **Site ID**: Site 532\n- **Study**: Study 11\n- **Country**: CHL\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 2\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 11_Site 541", "study": "Study 11", "site": "Site 541", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 541\n\n## Site Information\n- **Site ID**: Site 541\n- **Study**: Study 11\n- **Country**: IRL\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 11_Site 545", "study": "Study 11", "site": "Site 545", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 545\n\n## Site Information\n- **Site ID**: Site 545\n- **Study**: Study 11\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 11_Site 63", "study": "Study 11", "site": "Site 63", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 63\n\n## Site Information\n- **Site ID**: Site 63\n- **Study**: Study 11\n- **Country**: BEL\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 11_Site 7", "study": "Study 11", "site": "Site 7", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 7\n\n## Site Information\n- **Site ID**: Site 7\n- **Study**: Study 11\n- **Country**: CZE\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 13_Site 109", "study": "Study 13", "site": "Site 109", "type": "site_summary", "total_subjects": 2, "total_issues": 3, "document": "# Site Report: Site 109\n\n## Site Information\n- **Site ID**: Site 109\n- **Study**: Study 13\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 1.50\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 13_Site 110", "study": "Study 13", "site": "Site 110", "type": "site_summary", "total_subjects": 1, "total_issues": 24, "document": "# Site Report: Site 110\n\n## Site Information\n- **Site ID**: Site 110\n- **Study**: Study 13\n- **Country**: AUS\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 24\n- **Average Issues per Subject**: 24.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 23\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 893: Critical risk, 24 issues\n"}
{"id": "site_Study 13_Site 125", "study": "Study 13", "site": "Site 125", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 125\n\n## Site Information\n- **Site ID**: Site 125\n- **Study**: Study 13\n- **Country**: KOR\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 13_Site 130", "study": "Study 13", "site": "Site 130", "type": "site_summary", "total_subjects": 5, "total_issues": 2, "document": "# Site Report: Site 130\n\n## Site Information\n- **Site ID**: Site 130\n- **Study**: Study 13\n- **Country**: SGP\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.40\n- **Clean Subjects**: 4 (80.0%)\n\n## Risk Profile\n- Low Risk: 4 (80.0%)\n- Medium Risk: 1 (20.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 13_Site 2", "study": "Study 13", "site": "Site 2", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 2\n\n## Site Information\n- **Site ID**: Site 2\n- **Study**: Study 13\n- **Country**: CAN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 13_Site 353", "study": "Study 13", "site": "Site 353", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 353\n\n## Site Information\n- **Site ID**: Site 353\n- **Study**: Study 13\n- **Country**: TWN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 13_Site 417", "study": "Study 13", "site": "Site 417", "type": "site_summary", "total_subjects": 3, "total_issues": 3, "document": "# Site Report: Site 417\n\n## Site Information\n- **Site ID**: Site 417\n- **Study**: Study 13\n- **Country**: JPN\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 2 (66.7%)\n\n## Risk Profile\n- Low Risk: 2 (66.7%)\n- Medium Risk: 1 (33.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 13_Site 588", "study": "Study 13", "site": "Site 588", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 588\n\n## Site Information\n- **Site ID**: Site 588\n- **Study**: Study 13\n- **Country**: ISR\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 13_Site 589", "study": "Study 13", "site": "Site 589", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 589\n\n## Site Information\n- **Site ID**: Site 589\n- **Study**: Study 13\n- **Country**: ISR\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 13_Site 597", "study": "Study 13", "site": "Site 597", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 597\n\n## Site Information\n- **Site ID**: Site 597\n- **Study**: Study 13\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 13_Site 87", "study": "Study 13", "site": "Site 87", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 87\n\n## Site Information\n- **Site ID**: Site 87\n- **Study**: Study 13\n- **Country**: AUS\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 14_Site 502", "study": "Study 14", "site": "Site 502", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 502\n\n## Site Information\n- **Site ID**: Site 502\n- **Study**: Study 14\n- **Country**: CAN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 14_Site 503", "study": "Study 14", "site": "Site 503", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 503\n\n## Site Information\n- **Site ID**: Site 503\n- **Study**: Study 14\n- **Country**: CAN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 15_Site 2", "study": "Study 15", "site": "Site 2", "type": "site_summary", "total_subjects": 12, "total_issues": 0, "document": "# Site Report: Site 2\n\n## Site Information\n- **Site ID**: Site 2\n- **Study**: Study 15\n- **Country**: USA\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 12 (100.0%)\n\n## Risk Profile\n- Low Risk: 12 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 15_Site 3", "study": "Study 15", "site": "Site 3", "type": "site_summary", "total_subjects": 43, "total_issues": 1, "document": "# Site Report: Site 3\n\n## Site Information\n- **Site ID**: Site 3\n- **Study**: Study 15\n- **Country**: USA\n- **Total Subjects**: 43\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.02\n- **Clean Subjects**: 42 (97.7%)\n\n## Risk Profile\n- Low Risk: 42 (97.7%)\n- Medium Risk: 1 (2.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 599", "study": "Study 16", "site": "Site 599", "type": "site_summary", "total_subjects": 1, "total_issues": 4, "document": "# Site Report: Site 599\n\n## Site Information\n- **Site ID**: Site 599\n- **Study**: Study 16\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 4.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 4\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 600", "study": "Study 16", "site": "Site 600", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 600\n\n## Site Information\n- **Site ID**: Site 600\n- **Study**: Study 16\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 601", "study": "Study 16", "site": "Site 601", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 601\n\n## Site Information\n- **Site ID**: Site 601\n- **Study**: Study 16\n- **Country**: USA\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 602", "study": "Study 16", "site": "Site 602", "type": "site_summary", "total_subjects": 22, "total_issues": 33, "document": "# Site Report: Site 602\n\n## Site Information\n- **Site ID**: Site 602\n- **Study**: Study 16\n- **Country**: USA\n- **Total Subjects**: 22\n\n## Performance Metrics\n- **Total Issues**: 33\n- **Average Issues per Subject**: 1.50\n- **Clean Subjects**: 11 (50.0%)\n\n## Risk Profile\n- Low Risk: 11 (50.0%)\n- Medium Risk: 10 (45.5%)\n- High Risk: 1 (4.5%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 22\n- Safety Discrepancies: 6\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 5\n\n## Subjects Requiring Attention\n- Subject 4092: High risk, 8 issues\n"}
{"id": "site_Study 16_Site 603", "study": "Study 16", "site": "Site 603", "type": "site_summary", "total_subjects": 4, "total_issues": 11, "document": "# Site Report: Site 603\n\n## Site Information\n- **Site ID**: Site 603\n- **Study**: Study 16\n- **Country**: USA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 11\n- **Average Issues per Subject**: 2.75\n- **Clean Subjects**: 2 (50.0%)\n\n## Risk Profile\n- Low Risk: 2 (50.0%)\n- Medium Risk: 1 (25.0%)\n- High Risk: 1 (25.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 3\n\n## Subjects Requiring Attention\n- Subject 4108: High risk, 7 issues\n"}
{"id": "site_Study 16_Site 604", "study": "Study 16", "site": "Site 604", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 604\n\n## Site Information\n- **Site ID**: Site 604\n- **Study**: Study 16\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 605", "study": "Study 16", "site": "Site 605", "type": "site_summary", "total_subjects": 3, "total_issues": 9, "document": "# Site Report: Site 605\n\n## Site Information\n- **Site ID**: Site 605\n- **Study**: Study 16\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 9\n- **Average Issues per Subject**: 3.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (66.7%)\n- High Risk: 1 (33.3%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 9\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 4\n\n## Subjects Requiring Attention\n- Subject 4112: High risk, 7 issues\n"}
{"id": "site_Study 16_Site 606", "study": "Study 16", "site": "Site 606", "type": "site_summary", "total_subjects": 6, "total_issues": 2, "document": "# Site Report: Site 606\n\n## Site Information\n- **Site ID**: Site 606\n- **Study**: Study 16\n- **Country**: USA\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.33\n- **Clean Subjects**: 5 (83.3%)\n\n## Risk Profile\n- Low Risk: 5 (83.3%)\n- Medium Risk: 1 (16.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 3\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 607", "study": "Study 16", "site": "Site 607", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 607\n\n## Site Information\n- **Site ID**: Site 607\n- **Study**: Study 16\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 608", "study": "Study 16", "site": "Site 608", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 608\n\n## Site Information\n- **Site ID**: Site 608\n- **Study**: Study 16\n- **Country**: USA\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 609", "study": "Study 16", "site": "Site 609", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 609\n\n## Site Information\n- **Site ID**: Site 609\n- **Study**: Study 16\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 610", "study": "Study 16", "site": "Site 610", "type": "site_summary", "total_subjects": 7, "total_issues": 1, "document": "# Site Report: Site 610\n\n## Site Information\n- **Site ID**: Site 610\n- **Study**: Study 16\n- **Country**: USA\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.14\n- **Clean Subjects**: 6 (85.7%)\n\n## Risk Profile\n- Low Risk: 6 (85.7%)\n- Medium Risk: 1 (14.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 611", "study": "Study 16", "site": "Site 611", "type": "site_summary", "total_subjects": 12, "total_issues": 2, "document": "# Site Report: Site 611\n\n## Site Information\n- **Site ID**: Site 611\n- **Study**: Study 16\n- **Country**: USA\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.17\n- **Clean Subjects**: 11 (91.7%)\n\n## Risk Profile\n- Low Risk: 11 (91.7%)\n- Medium Risk: 1 (8.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 612", "study": "Study 16", "site": "Site 612", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 612\n\n## Site Information\n- **Site ID**: Site 612\n- **Study**: Study 16\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 613", "study": "Study 16", "site": "Site 613", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 613\n\n## Site Information\n- **Site ID**: Site 613\n- **Study**: Study 16\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 614", "study": "Study 16", "site": "Site 614", "type": "site_summary", "total_subjects": 3, "total_issues": 6, "document": "# Site Report: Site 614\n\n## Site Information\n- **Site ID**: Site 614\n- **Study**: Study 16\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 6\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 2 (66.7%)\n\n## Risk Profile\n- Low Risk: 2 (66.7%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (33.3%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 6\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 4153: High risk, 6 issues\n"}
{"id": "site_Study 16_Site 615", "study": "Study 16", "site": "Site 615", "type": "site_summary", "total_subjects": 4, "total_issues": 2, "document": "# Site Report: Site 615\n\n## Site Information\n- **Site ID**: Site 615\n- **Study**: Study 16\n- **Country**: USA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.50\n- **Clean Subjects**: 2 (50.0%)\n\n## Risk Profile\n- Low Risk: 2 (50.0%)\n- Medium Risk: 2 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 5\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 616", "study": "Study 16", "site": "Site 616", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 616\n\n## Site Information\n- **Site ID**: Site 616\n- **Study**: Study 16\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 617", "study": "Study 16", "site": "Site 617", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 617\n\n## Site Information\n- **Site ID**: Site 617\n- **Study**: Study 16\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 618", "study": "Study 16", "site": "Site 618", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 618\n\n## Site Information\n- **Site ID**: Site 618\n- **Study**: Study 16\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 619", "study": "Study 16", "site": "Site 619", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 619\n\n## Site Information\n- **Site ID**: Site 619\n- **Study**: Study 16\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 620", "study": "Study 16", "site": "Site 620", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 620\n\n## Site Information\n- **Site ID**: Site 620\n- **Study**: Study 16\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 3\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 621", "study": "Study 16", "site": "Site 621", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 621\n\n## Site Information\n- **Site ID**: Site 621\n- **Study**: Study 16\n- **Country**: USA\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 622", "study": "Study 16", "site": "Site 622", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 622\n\n## Site Information\n- **Site ID**: Site 622\n- **Study**: Study 16\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 623", "study": "Study 16", "site": "Site 623", "type": "site_summary", "total_subjects": 2, "total_issues": 1, "document": "# Site Report: Site 623\n\n## Site Information\n- **Site ID**: Site 623\n- **Study**: Study 16\n- **Country**: CAN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.50\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 5\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 624", "study": "Study 16", "site": "Site 624", "type": "site_summary", "total_subjects": 11, "total_issues": 3, "document": "# Site Report: Site 624\n\n## Site Information\n- **Site ID**: Site 624\n- **Study**: Study 16\n- **Country**: CAN\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 0.27\n- **Clean Subjects**: 9 (81.8%)\n\n## Risk Profile\n- Low Risk: 9 (81.8%)\n- Medium Risk: 2 (18.2%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 2\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 625", "study": "Study 16", "site": "Site 625", "type": "site_summary", "total_subjects": 3, "total_issues": 3, "document": "# Site Report: Site 625\n\n## Site Information\n- **Site ID**: Site 625\n- **Study**: Study 16\n- **Country**: CAN\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 2 (66.7%)\n\n## Risk Profile\n- Low Risk: 2 (66.7%)\n- Medium Risk: 1 (33.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 3\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 10\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 626", "study": "Study 16", "site": "Site 626", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 626\n\n## Site Information\n- **Site ID**: Site 626\n- **Study**: Study 16\n- **Country**: CAN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 627", "study": "Study 16", "site": "Site 627", "type": "site_summary", "total_subjects": 4, "total_issues": 20, "document": "# Site Report: Site 627\n\n## Site Information\n- **Site ID**: Site 627\n- **Study**: Study 16\n- **Country**: CAN\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 20\n- **Average Issues per Subject**: 5.00\n- **Clean Subjects**: 1 (25.0%)\n\n## Risk Profile\n- Low Risk: 1 (25.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 3 (75.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 20\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\n- Subject 4194: High risk, 8 issues\n- Subject 4195: High risk, 6 issues\n- Subject 4196: High risk, 6 issues\n"}
{"id": "site_Study 16_Site 628", "study": "Study 16", "site": "Site 628", "type": "site_summary", "total_subjects": 1, "total_issues": 28, "document": "# Site Report: Site 628\n\n## Site Information\n- **Site ID**: Site 628\n- **Study**: Study 16\n- **Country**: CAN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 28\n- **Average Issues per Subject**: 28.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 10\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 18\n- Outstanding Visits: 3\n\n## Subjects Requiring Attention\n- Subject 4197: Critical risk, 28 issues\n"}
{"id": "site_Study 16_Site 629", "study": "Study 16", "site": "Site 629", "type": "site_summary", "total_subjects": 2, "total_issues": 8, "document": "# Site Report: Site 629\n\n## Site Information\n- **Site ID**: Site 629\n- **Study**: Study 16\n- **Country**: CAN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 8\n- **Average Issues per Subject**: 4.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 1 (50.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 7\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 1\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\n- Subject 4198: High risk, 7 issues\n"}
{"id": "site_Study 16_Site 630", "study": "Study 16", "site": "Site 630", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 630\n\n## Site Information\n- **Site ID**: Site 630\n- **Study**: Study 16\n- **Country**: GRC\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 631", "study": "Study 16", "site": "Site 631", "type": "site_summary", "total_subjects": 1, "total_issues": 4, "document": "# Site Report: Site 631\n\n## Site Information\n- **Site ID**: Site 631\n- **Study**: Study 16\n- **Country**: GRC\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 4.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 4\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 632", "study": "Study 16", "site": "Site 632", "type": "site_summary", "total_subjects": 3, "total_issues": 8, "document": "# Site Report: Site 632\n\n## Site Information\n- **Site ID**: Site 632\n- **Study**: Study 16\n- **Country**: GRC\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 8\n- **Average Issues per Subject**: 2.67\n- **Clean Subjects**: 1 (33.3%)\n\n## Risk Profile\n- Low Risk: 1 (33.3%)\n- Medium Risk: 2 (66.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 8\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 3\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 633", "study": "Study 16", "site": "Site 633", "type": "site_summary", "total_subjects": 2, "total_issues": 1, "document": "# Site Report: Site 633\n\n## Site Information\n- **Site ID**: Site 633\n- **Study**: Study 16\n- **Country**: GRC\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.50\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 634", "study": "Study 16", "site": "Site 634", "type": "site_summary", "total_subjects": 1, "total_issues": 4, "document": "# Site Report: Site 634\n\n## Site Information\n- **Site ID**: Site 634\n- **Study**: Study 16\n- **Country**: GRC\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 4.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 4\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 635", "study": "Study 16", "site": "Site 635", "type": "site_summary", "total_subjects": 1, "total_issues": 4, "document": "# Site Report: Site 635\n\n## Site Information\n- **Site ID**: Site 635\n- **Study**: Study 16\n- **Country**: GRC\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 4.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 4\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 636", "study": "Study 16", "site": "Site 636", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 636\n\n## Site Information\n- **Site ID**: Site 636\n- **Study**: Study 16\n- **Country**: BEL\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 637", "study": "Study 16", "site": "Site 637", "type": "site_summary", "total_subjects": 8, "total_issues": 73, "document": "# Site Report: Site 637\n\n## Site Information\n- **Site ID**: Site 637\n- **Study**: Study 16\n- **Country**: BEL\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 73\n- **Average Issues per Subject**: 9.12\n- **Clean Subjects**: 3 (37.5%)\n\n## Risk Profile\n- Low Risk: 3 (37.5%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 2 (25.0%)\n- Critical Risk: 3 (37.5%)\n\n## Issue Breakdown\n- Open EDRR Issues: 65\n- Safety Discrepancies: 7\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 7\n\n## Subjects Requiring Attention\n- Subject 4210: High risk, 12 issues\n- Subject 4211: Critical risk, 17 issues\n- Subject 4212: Critical risk, 16 issues\n- Subject 4215: Critical risk, 18 issues\n- Subject 4216: High risk, 10 issues\n"}
{"id": "site_Study 16_Site 638", "study": "Study 16", "site": "Site 638", "type": "site_summary", "total_subjects": 1, "total_issues": 5, "document": "# Site Report: Site 638\n\n## Site Information\n- **Site ID**: Site 638\n- **Study**: Study 16\n- **Country**: BEL\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 5\n- **Average Issues per Subject**: 5.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 5\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 4\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 639", "study": "Study 16", "site": "Site 639", "type": "site_summary", "total_subjects": 4, "total_issues": 10, "document": "# Site Report: Site 639\n\n## Site Information\n- **Site ID**: Site 639\n- **Study**: Study 16\n- **Country**: BEL\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 10\n- **Average Issues per Subject**: 2.50\n- **Clean Subjects**: 1 (25.0%)\n\n## Risk Profile\n- Low Risk: 1 (25.0%)\n- Medium Risk: 3 (75.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 10\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 3\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 640", "study": "Study 16", "site": "Site 640", "type": "site_summary", "total_subjects": 5, "total_issues": 63, "document": "# Site Report: Site 640\n\n## Site Information\n- **Site ID**: Site 640\n- **Study**: Study 16\n- **Country**: BEL\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 63\n- **Average Issues per Subject**: 12.60\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 4 (80.0%)\n- Critical Risk: 1 (20.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 63\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 6\n\n## Subjects Requiring Attention\n- Subject 4223: Critical risk, 17 issues\n- Subject 4224: High risk, 15 issues\n- Subject 4225: High risk, 11 issues\n- Subject 4226: High risk, 12 issues\n- Subject 4227: High risk, 8 issues\n"}
{"id": "site_Study 16_Site 641", "study": "Study 16", "site": "Site 641", "type": "site_summary", "total_subjects": 1, "total_issues": 11, "document": "# Site Report: Site 641\n\n## Site Information\n- **Site ID**: Site 641\n- **Study**: Study 16\n- **Country**: BEL\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 11\n- **Average Issues per Subject**: 11.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (100.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 11\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\n- Subject 4228: High risk, 11 issues\n"}
{"id": "site_Study 16_Site 642", "study": "Study 16", "site": "Site 642", "type": "site_summary", "total_subjects": 2, "total_issues": 4, "document": "# Site Report: Site 642\n\n## Site Information\n- **Site ID**: Site 642\n- **Study**: Study 16\n- **Country**: FRA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 4\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 5\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 643", "study": "Study 16", "site": "Site 643", "type": "site_summary", "total_subjects": 2, "total_issues": 9, "document": "# Site Report: Site 643\n\n## Site Information\n- **Site ID**: Site 643\n- **Study**: Study 16\n- **Country**: FRA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 9\n- **Average Issues per Subject**: 4.50\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 1 (50.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 9\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 4232: High risk, 8 issues\n"}
{"id": "site_Study 16_Site 644", "study": "Study 16", "site": "Site 644", "type": "site_summary", "total_subjects": 2, "total_issues": 3, "document": "# Site Report: Site 644\n\n## Site Information\n- **Site ID**: Site 644\n- **Study**: Study 16\n- **Country**: FRA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 1.50\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 645", "study": "Study 16", "site": "Site 645", "type": "site_summary", "total_subjects": 4, "total_issues": 7, "document": "# Site Report: Site 645\n\n## Site Information\n- **Site ID**: Site 645\n- **Study**: Study 16\n- **Country**: FRA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 7\n- **Average Issues per Subject**: 1.75\n- **Clean Subjects**: 3 (75.0%)\n\n## Risk Profile\n- Low Risk: 3 (75.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (25.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 7\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 4238: High risk, 7 issues\n"}
{"id": "site_Study 16_Site 646", "study": "Study 16", "site": "Site 646", "type": "site_summary", "total_subjects": 1, "total_issues": 3, "document": "# Site Report: Site 646\n\n## Site Information\n- **Site ID**: Site 646\n- **Study**: Study 16\n- **Country**: FRA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 3.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 3\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 5\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 647", "study": "Study 16", "site": "Site 647", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 647\n\n## Site Information\n- **Site ID**: Site 647\n- **Study**: Study 16\n- **Country**: FRA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 648", "study": "Study 16", "site": "Site 648", "type": "site_summary", "total_subjects": 6, "total_issues": 6, "document": "# Site Report: Site 648\n\n## Site Information\n- **Site ID**: Site 648\n- **Study**: Study 16\n- **Country**: ESP\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 6\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 5 (83.3%)\n\n## Risk Profile\n- Low Risk: 5 (83.3%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (16.7%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 6\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 4245: High risk, 6 issues\n"}
{"id": "site_Study 16_Site 649", "study": "Study 16", "site": "Site 649", "type": "site_summary", "total_subjects": 1, "total_issues": 6, "document": "# Site Report: Site 649\n\n## Site Information\n- **Site ID**: Site 649\n- **Study**: Study 16\n- **Country**: ESP\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 6\n- **Average Issues per Subject**: 6.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (100.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 6\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\n- Subject 4247: High risk, 6 issues\n"}
{"id": "site_Study 16_Site 650", "study": "Study 16", "site": "Site 650", "type": "site_summary", "total_subjects": 2, "total_issues": 48, "document": "# Site Report: Site 650\n\n## Site Information\n- **Site ID**: Site 650\n- **Study**: Study 16\n- **Country**: ESP\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 48\n- **Average Issues per Subject**: 24.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (50.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 6\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 42\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 4249: Critical risk, 44 issues\n"}
{"id": "site_Study 16_Site 651", "study": "Study 16", "site": "Site 651", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 651\n\n## Site Information\n- **Site ID**: Site 651\n- **Study**: Study 16\n- **Country**: ESP\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 652", "study": "Study 16", "site": "Site 652", "type": "site_summary", "total_subjects": 1, "total_issues": 2, "document": "# Site Report: Site 652\n\n## Site Information\n- **Site ID**: Site 652\n- **Study**: Study 16\n- **Country**: ESP\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 653", "study": "Study 16", "site": "Site 653", "type": "site_summary", "total_subjects": 4, "total_issues": 44, "document": "# Site Report: Site 653\n\n## Site Information\n- **Site ID**: Site 653\n- **Study**: Study 16\n- **Country**: ESP\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 44\n- **Average Issues per Subject**: 11.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 4 (100.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 44\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\n- Subject 4253: High risk, 8 issues\n- Subject 4254: High risk, 12 issues\n- Subject 4255: High risk, 15 issues\n- Subject 4256: High risk, 9 issues\n"}
{"id": "site_Study 16_Site 654", "study": "Study 16", "site": "Site 654", "type": "site_summary", "total_subjects": 4, "total_issues": 2, "document": "# Site Report: Site 654\n\n## Site Information\n- **Site ID**: Site 654\n- **Study**: Study 16\n- **Country**: HRV\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.50\n- **Clean Subjects**: 3 (75.0%)\n\n## Risk Profile\n- Low Risk: 3 (75.0%)\n- Medium Risk: 1 (25.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 6\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 655", "study": "Study 16", "site": "Site 655", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 655\n\n## Site Information\n- **Site ID**: Site 655\n- **Study**: Study 16\n- **Country**: HRV\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 656", "study": "Study 16", "site": "Site 656", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 656\n\n## Site Information\n- **Site ID**: Site 656\n- **Study**: Study 16\n- **Country**: HRV\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 657", "study": "Study 16", "site": "Site 657", "type": "site_summary", "total_subjects": 7, "total_issues": 10, "document": "# Site Report: Site 657\n\n## Site Information\n- **Site ID**: Site 657\n- **Study**: Study 16\n- **Country**: ITA\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 10\n- **Average Issues per Subject**: 1.43\n- **Clean Subjects**: 2 (28.6%)\n\n## Risk Profile\n- Low Risk: 2 (28.6%)\n- Medium Risk: 5 (71.4%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 10\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 4\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 658", "study": "Study 16", "site": "Site 658", "type": "site_summary", "total_subjects": 4, "total_issues": 5, "document": "# Site Report: Site 658\n\n## Site Information\n- **Site ID**: Site 658\n- **Study**: Study 16\n- **Country**: ITA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 5\n- **Average Issues per Subject**: 1.25\n- **Clean Subjects**: 1 (25.0%)\n\n## Risk Profile\n- Low Risk: 1 (25.0%)\n- Medium Risk: 3 (75.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 5\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 8\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 659", "study": "Study 16", "site": "Site 659", "type": "site_summary", "total_subjects": 2, "total_issues": 11, "document": "# Site Report: Site 659\n\n## Site Information\n- **Site ID**: Site 659\n- **Study**: Study 16\n- **Country**: ITA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 11\n- **Average Issues per Subject**: 5.50\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 1 (50.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 8\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 3\n\n## Subjects Requiring Attention\n- Subject 4274: High risk, 7 issues\n"}
{"id": "site_Study 16_Site 660", "study": "Study 16", "site": "Site 660", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 660\n\n## Site Information\n- **Site ID**: Site 660\n- **Study**: Study 16\n- **Country**: ITA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 661", "study": "Study 16", "site": "Site 661", "type": "site_summary", "total_subjects": 8, "total_issues": 31, "document": "# Site Report: Site 661\n\n## Site Information\n- **Site ID**: Site 661\n- **Study**: Study 16\n- **Country**: ITA\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 31\n- **Average Issues per Subject**: 3.88\n- **Clean Subjects**: 5 (62.5%)\n\n## Risk Profile\n- Low Risk: 5 (62.5%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 3 (37.5%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 29\n- Safety Discrepancies: 2\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 7\n\n## Subjects Requiring Attention\n- Subject 4280: High risk, 13 issues\n- Subject 4281: High risk, 10 issues\n- Subject 4283: High risk, 8 issues\n"}
{"id": "site_Study 16_Site 662", "study": "Study 16", "site": "Site 662", "type": "site_summary", "total_subjects": 1, "total_issues": 7, "document": "# Site Report: Site 662\n\n## Site Information\n- **Site ID**: Site 662\n- **Study**: Study 16\n- **Country**: ITA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 7\n- **Average Issues per Subject**: 7.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (100.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 7\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 3\n\n## Subjects Requiring Attention\n- Subject 4285: High risk, 7 issues\n"}
{"id": "site_Study 16_Site 663", "study": "Study 16", "site": "Site 663", "type": "site_summary", "total_subjects": 2, "total_issues": 6, "document": "# Site Report: Site 663\n\n## Site Information\n- **Site ID**: Site 663\n- **Study**: Study 16\n- **Country**: ITA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 6\n- **Average Issues per Subject**: 3.00\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (50.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 6\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 4286: High risk, 6 issues\n"}
{"id": "site_Study 16_Site 664", "study": "Study 16", "site": "Site 664", "type": "site_summary", "total_subjects": 4, "total_issues": 39, "document": "# Site Report: Site 664\n\n## Site Information\n- **Site ID**: Site 664\n- **Study**: Study 16\n- **Country**: CZE\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 39\n- **Average Issues per Subject**: 9.75\n- **Clean Subjects**: 1 (25.0%)\n\n## Risk Profile\n- Low Risk: 1 (25.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 3 (75.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 39\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 5\n\n## Subjects Requiring Attention\n- Subject 4288: High risk, 14 issues\n- Subject 4289: High risk, 14 issues\n- Subject 4291: High risk, 11 issues\n"}
{"id": "site_Study 16_Site 665", "study": "Study 16", "site": "Site 665", "type": "site_summary", "total_subjects": 1, "total_issues": 5, "document": "# Site Report: Site 665\n\n## Site Information\n- **Site ID**: Site 665\n- **Study**: Study 16\n- **Country**: GBR\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 5\n- **Average Issues per Subject**: 5.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 5\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 666", "study": "Study 16", "site": "Site 666", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 666\n\n## Site Information\n- **Site ID**: Site 666\n- **Study**: Study 16\n- **Country**: GBR\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 667", "study": "Study 16", "site": "Site 667", "type": "site_summary", "total_subjects": 3, "total_issues": 3, "document": "# Site Report: Site 667\n\n## Site Information\n- **Site ID**: Site 667\n- **Study**: Study 16\n- **Country**: GBR\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 1 (33.3%)\n\n## Risk Profile\n- Low Risk: 1 (33.3%)\n- Medium Risk: 2 (66.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 6\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 668", "study": "Study 16", "site": "Site 668", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 668\n\n## Site Information\n- **Site ID**: Site 668\n- **Study**: Study 16\n- **Country**: GBR\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 669", "study": "Study 16", "site": "Site 669", "type": "site_summary", "total_subjects": 5, "total_issues": 19, "document": "# Site Report: Site 669\n\n## Site Information\n- **Site ID**: Site 669\n- **Study**: Study 16\n- **Country**: DEU\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 19\n- **Average Issues per Subject**: 3.80\n- **Clean Subjects**: 1 (20.0%)\n\n## Risk Profile\n- Low Risk: 1 (20.0%)\n- Medium Risk: 3 (60.0%)\n- High Risk: 1 (20.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 19\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 3\n\n## Subjects Requiring Attention\n- Subject 4304: High risk, 8 issues\n"}
{"id": "site_Study 16_Site 670", "study": "Study 16", "site": "Site 670", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 670\n\n## Site Information\n- **Site ID**: Site 670\n- **Study**: Study 16\n- **Country**: DEU\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 671", "study": "Study 16", "site": "Site 671", "type": "site_summary", "total_subjects": 3, "total_issues": 10, "document": "# Site Report: Site 671\n\n## Site Information\n- **Site ID**: Site 671\n- **Study**: Study 16\n- **Country**: DEU\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 10\n- **Average Issues per Subject**: 3.33\n- **Clean Subjects**: 1 (33.3%)\n\n## Risk Profile\n- Low Risk: 1 (33.3%)\n- Medium Risk: 1 (33.3%)\n- High Risk: 1 (33.3%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 10\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 8\n\n## Subjects Requiring Attention\n- Subject 4308: High risk, 9 issues\n"}
{"id": "site_Study 16_Site 672", "study": "Study 16", "site": "Site 672", "type": "site_summary", "total_subjects": 1, "total_issues": 2, "document": "# Site Report: Site 672\n\n## Site Information\n- **Site ID**: Site 672\n- **Study**: Study 16\n- **Country**: DEU\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 5\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 673", "study": "Study 16", "site": "Site 673", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 673\n\n## Site Information\n- **Site ID**: Site 673\n- **Study**: Study 16\n- **Country**: DEU\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 674", "study": "Study 16", "site": "Site 674", "type": "site_summary", "total_subjects": 2, "total_issues": 4, "document": "# Site Report: Site 674\n\n## Site Information\n- **Site ID**: Site 674\n- **Study**: Study 16\n- **Country**: DEU\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 4\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 5\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 675", "study": "Study 16", "site": "Site 675", "type": "site_summary", "total_subjects": 5, "total_issues": 10, "document": "# Site Report: Site 675\n\n## Site Information\n- **Site ID**: Site 675\n- **Study**: Study 16\n- **Country**: MEX\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 10\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 2 (40.0%)\n\n## Risk Profile\n- Low Risk: 2 (40.0%)\n- Medium Risk: 3 (60.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 10\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 7\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 676", "study": "Study 16", "site": "Site 676", "type": "site_summary", "total_subjects": 7, "total_issues": 7, "document": "# Site Report: Site 676\n\n## Site Information\n- **Site ID**: Site 676\n- **Study**: Study 16\n- **Country**: MEX\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 7\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 5 (71.4%)\n\n## Risk Profile\n- Low Risk: 5 (71.4%)\n- Medium Risk: 1 (14.3%)\n- High Risk: 1 (14.3%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 7\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 4320: High risk, 6 issues\n"}
{"id": "site_Study 16_Site 677", "study": "Study 16", "site": "Site 677", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 677\n\n## Site Information\n- **Site ID**: Site 677\n- **Study**: Study 16\n- **Country**: MEX\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 678", "study": "Study 16", "site": "Site 678", "type": "site_summary", "total_subjects": 4, "total_issues": 11, "document": "# Site Report: Site 678\n\n## Site Information\n- **Site ID**: Site 678\n- **Study**: Study 16\n- **Country**: ARG\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 11\n- **Average Issues per Subject**: 2.75\n- **Clean Subjects**: 1 (25.0%)\n\n## Risk Profile\n- Low Risk: 1 (25.0%)\n- Medium Risk: 3 (75.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 11\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 11\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 679", "study": "Study 16", "site": "Site 679", "type": "site_summary", "total_subjects": 4, "total_issues": 26, "document": "# Site Report: Site 679\n\n## Site Information\n- **Site ID**: Site 679\n- **Study**: Study 16\n- **Country**: ARG\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 26\n- **Average Issues per Subject**: 6.50\n- **Clean Subjects**: 1 (25.0%)\n\n## Risk Profile\n- Low Risk: 1 (25.0%)\n- Medium Risk: 1 (25.0%)\n- High Risk: 2 (50.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 11\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 15\n- Outstanding Visits: 8\n\n## Subjects Requiring Attention\n- Subject 4332: High risk, 6 issues\n- Subject 4334: High risk, 15 issues\n"}
{"id": "site_Study 16_Site 680", "study": "Study 16", "site": "Site 680", "type": "site_summary", "total_subjects": 7, "total_issues": 7, "document": "# Site Report: Site 680\n\n## Site Information\n- **Site ID**: Site 680\n- **Study**: Study 16\n- **Country**: ARG\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 7\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 5 (71.4%)\n\n## Risk Profile\n- Low Risk: 5 (71.4%)\n- Medium Risk: 1 (14.3%)\n- High Risk: 1 (14.3%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 4\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\n- Subject 4336: High risk, 6 issues\n"}
{"id": "site_Study 16_Site 681", "study": "Study 16", "site": "Site 681", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 681\n\n## Site Information\n- **Site ID**: Site 681\n- **Study**: Study 16\n- **Country**: ARG\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 682", "study": "Study 16", "site": "Site 682", "type": "site_summary", "total_subjects": 8, "total_issues": 5, "document": "# Site Report: Site 682\n\n## Site Information\n- **Site ID**: Site 682\n- **Study**: Study 16\n- **Country**: ARG\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 5\n- **Average Issues per Subject**: 0.62\n- **Clean Subjects**: 6 (75.0%)\n\n## Risk Profile\n- Low Risk: 6 (75.0%)\n- Medium Risk: 2 (25.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 4\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 683", "study": "Study 16", "site": "Site 683", "type": "site_summary", "total_subjects": 2, "total_issues": 4, "document": "# Site Report: Site 683\n\n## Site Information\n- **Site ID**: Site 683\n- **Study**: Study 16\n- **Country**: ARG\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 4\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 684", "study": "Study 16", "site": "Site 684", "type": "site_summary", "total_subjects": 8, "total_issues": 2, "document": "# Site Report: Site 684\n\n## Site Information\n- **Site ID**: Site 684\n- **Study**: Study 16\n- **Country**: BRA\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.25\n- **Clean Subjects**: 6 (75.0%)\n\n## Risk Profile\n- Low Risk: 6 (75.0%)\n- Medium Risk: 2 (25.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 13\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 685", "study": "Study 16", "site": "Site 685", "type": "site_summary", "total_subjects": 11, "total_issues": 1, "document": "# Site Report: Site 685\n\n## Site Information\n- **Site ID**: Site 685\n- **Study**: Study 16\n- **Country**: BRA\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.09\n- **Clean Subjects**: 10 (90.9%)\n\n## Risk Profile\n- Low Risk: 10 (90.9%)\n- Medium Risk: 1 (9.1%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 686", "study": "Study 16", "site": "Site 686", "type": "site_summary", "total_subjects": 8, "total_issues": 27, "document": "# Site Report: Site 686\n\n## Site Information\n- **Site ID**: Site 686\n- **Study**: Study 16\n- **Country**: BRA\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 27\n- **Average Issues per Subject**: 3.38\n- **Clean Subjects**: 3 (37.5%)\n\n## Risk Profile\n- Low Risk: 3 (37.5%)\n- Medium Risk: 2 (25.0%)\n- High Risk: 3 (37.5%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 25\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\n- Subject 4373: High risk, 11 issues\n- Subject 4374: High risk, 7 issues\n- Subject 4375: High risk, 6 issues\n"}
{"id": "site_Study 16_Site 687", "study": "Study 16", "site": "Site 687", "type": "site_summary", "total_subjects": 6, "total_issues": 1, "document": "# Site Report: Site 687\n\n## Site Information\n- **Site ID**: Site 687\n- **Study**: Study 16\n- **Country**: BRA\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.17\n- **Clean Subjects**: 5 (83.3%)\n\n## Risk Profile\n- Low Risk: 5 (83.3%)\n- Medium Risk: 1 (16.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 688", "study": "Study 16", "site": "Site 688", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 688\n\n## Site Information\n- **Site ID**: Site 688\n- **Study**: Study 16\n- **Country**: BRA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 689", "study": "Study 16", "site": "Site 689", "type": "site_summary", "total_subjects": 11, "total_issues": 9, "document": "# Site Report: Site 689\n\n## Site Information\n- **Site ID**: Site 689\n- **Study**: Study 16\n- **Country**: BRA\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 9\n- **Average Issues per Subject**: 0.82\n- **Clean Subjects**: 9 (81.8%)\n\n## Risk Profile\n- Low Risk: 9 (81.8%)\n- Medium Risk: 1 (9.1%)\n- High Risk: 1 (9.1%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 8\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 4391: High risk, 8 issues\n"}
{"id": "site_Study 16_Site 690", "study": "Study 16", "site": "Site 690", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 690\n\n## Site Information\n- **Site ID**: Site 690\n- **Study**: Study 16\n- **Country**: BRA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 691", "study": "Study 16", "site": "Site 691", "type": "site_summary", "total_subjects": 6, "total_issues": 44, "document": "# Site Report: Site 691\n\n## Site Information\n- **Site ID**: Site 691\n- **Study**: Study 16\n- **Country**: MYS\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 44\n- **Average Issues per Subject**: 7.33\n- **Clean Subjects**: 4 (66.7%)\n\n## Risk Profile\n- Low Risk: 4 (66.7%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 2 (33.3%)\n\n## Issue Breakdown\n- Open EDRR Issues: 4\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 40\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\n- Subject 4408: Critical risk, 22 issues\n- Subject 4409: Critical risk, 22 issues\n"}
{"id": "site_Study 16_Site 692", "study": "Study 16", "site": "Site 692", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 692\n\n## Site Information\n- **Site ID**: Site 692\n- **Study**: Study 16\n- **Country**: MYS\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 693", "study": "Study 16", "site": "Site 693", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 693\n\n## Site Information\n- **Site ID**: Site 693\n- **Study**: Study 16\n- **Country**: MYS\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 2\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 694", "study": "Study 16", "site": "Site 694", "type": "site_summary", "total_subjects": 4, "total_issues": 14, "document": "# Site Report: Site 694\n\n## Site Information\n- **Site ID**: Site 694\n- **Study**: Study 16\n- **Country**: MYS\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 14\n- **Average Issues per Subject**: 3.50\n- **Clean Subjects**: 1 (25.0%)\n\n## Risk Profile\n- Low Risk: 1 (25.0%)\n- Medium Risk: 1 (25.0%)\n- High Risk: 2 (50.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 14\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 3\n\n## Subjects Requiring Attention\n- Subject 4416: High risk, 6 issues\n- Subject 4417: High risk, 6 issues\n"}
{"id": "site_Study 16_Site 695", "study": "Study 16", "site": "Site 695", "type": "site_summary", "total_subjects": 3, "total_issues": 2, "document": "# Site Report: Site 695\n\n## Site Information\n- **Site ID**: Site 695\n- **Study**: Study 16\n- **Country**: MYS\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.67\n- **Clean Subjects**: 2 (66.7%)\n\n## Risk Profile\n- Low Risk: 2 (66.7%)\n- Medium Risk: 1 (33.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 696", "study": "Study 16", "site": "Site 696", "type": "site_summary", "total_subjects": 4, "total_issues": 7, "document": "# Site Report: Site 696\n\n## Site Information\n- **Site ID**: Site 696\n- **Study**: Study 16\n- **Country**: AUS\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 7\n- **Average Issues per Subject**: 1.75\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 4 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 7\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 7\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 697", "study": "Study 16", "site": "Site 697", "type": "site_summary", "total_subjects": 5, "total_issues": 14, "document": "# Site Report: Site 697\n\n## Site Information\n- **Site ID**: Site 697\n- **Study**: Study 16\n- **Country**: AUS\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 14\n- **Average Issues per Subject**: 2.80\n- **Clean Subjects**: 4 (80.0%)\n\n## Risk Profile\n- Low Risk: 4 (80.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (20.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 14\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 4426: High risk, 14 issues\n"}
{"id": "site_Study 16_Site 698", "study": "Study 16", "site": "Site 698", "type": "site_summary", "total_subjects": 3, "total_issues": 10, "document": "# Site Report: Site 698\n\n## Site Information\n- **Site ID**: Site 698\n- **Study**: Study 16\n- **Country**: AUS\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 10\n- **Average Issues per Subject**: 3.33\n- **Clean Subjects**: 2 (66.7%)\n\n## Risk Profile\n- Low Risk: 2 (66.7%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (33.3%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 10\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 4432: High risk, 10 issues\n"}
{"id": "site_Study 16_Site 699", "study": "Study 16", "site": "Site 699", "type": "site_summary", "total_subjects": 7, "total_issues": 24, "document": "# Site Report: Site 699\n\n## Site Information\n- **Site ID**: Site 699\n- **Study**: Study 16\n- **Country**: AUS\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 24\n- **Average Issues per Subject**: 3.43\n- **Clean Subjects**: 4 (57.1%)\n\n## Risk Profile\n- Low Risk: 4 (57.1%)\n- Medium Risk: 1 (14.3%)\n- High Risk: 2 (28.6%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 24\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\n- Subject 4436: High risk, 8 issues\n- Subject 4437: High risk, 14 issues\n"}
{"id": "site_Study 16_Site 700", "study": "Study 16", "site": "Site 700", "type": "site_summary", "total_subjects": 3, "total_issues": 26, "document": "# Site Report: Site 700\n\n## Site Information\n- **Site ID**: Site 700\n- **Study**: Study 16\n- **Country**: AUS\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 26\n- **Average Issues per Subject**: 8.67\n- **Clean Subjects**: 1 (33.3%)\n\n## Risk Profile\n- Low Risk: 1 (33.3%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 2 (66.7%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 26\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 4442: High risk, 12 issues\n- Subject 4443: High risk, 14 issues\n"}
{"id": "site_Study 16_Site 701", "study": "Study 16", "site": "Site 701", "type": "site_summary", "total_subjects": 7, "total_issues": 29, "document": "# Site Report: Site 701\n\n## Site Information\n- **Site ID**: Site 701\n- **Study**: Study 16\n- **Country**: AUS\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 29\n- **Average Issues per Subject**: 4.14\n- **Clean Subjects**: 2 (28.6%)\n\n## Risk Profile\n- Low Risk: 2 (28.6%)\n- Medium Risk: 2 (28.6%)\n- High Risk: 3 (42.9%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 21\n- Safety Discrepancies: 8\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 4\n\n## Subjects Requiring Attention\n- Subject 4444: High risk, 12 issues\n- Subject 4445: High risk, 7 issues\n- Subject 4449: High risk, 6 issues\n"}
{"id": "site_Study 16_Site 702", "study": "Study 16", "site": "Site 702", "type": "site_summary", "total_subjects": 8, "total_issues": 2, "document": "# Site Report: Site 702\n\n## Site Information\n- **Site ID**: Site 702\n- **Study**: Study 16\n- **Country**: AUS\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.25\n- **Clean Subjects**: 6 (75.0%)\n\n## Risk Profile\n- Low Risk: 6 (75.0%)\n- Medium Risk: 2 (25.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 12\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 703", "study": "Study 16", "site": "Site 703", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 703\n\n## Site Information\n- **Site ID**: Site 703\n- **Study**: Study 16\n- **Country**: JPN\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 704", "study": "Study 16", "site": "Site 704", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 704\n\n## Site Information\n- **Site ID**: Site 704\n- **Study**: Study 16\n- **Country**: JPN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 705", "study": "Study 16", "site": "Site 705", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 705\n\n## Site Information\n- **Site ID**: Site 705\n- **Study**: Study 16\n- **Country**: JPN\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 706", "study": "Study 16", "site": "Site 706", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 706\n\n## Site Information\n- **Site ID**: Site 706\n- **Study**: Study 16\n- **Country**: JPN\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 707", "study": "Study 16", "site": "Site 707", "type": "site_summary", "total_subjects": 2, "total_issues": 6, "document": "# Site Report: Site 707\n\n## Site Information\n- **Site ID**: Site 707\n- **Study**: Study 16\n- **Country**: JPN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 6\n- **Average Issues per Subject**: 3.00\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (50.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 3\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 3\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 4471: High risk, 6 issues\n"}
{"id": "site_Study 16_Site 708", "study": "Study 16", "site": "Site 708", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 708\n\n## Site Information\n- **Site ID**: Site 708\n- **Study**: Study 16\n- **Country**: JPN\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 6\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 709", "study": "Study 16", "site": "Site 709", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 709\n\n## Site Information\n- **Site ID**: Site 709\n- **Study**: Study 16\n- **Country**: JPN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 710", "study": "Study 16", "site": "Site 710", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 710\n\n## Site Information\n- **Site ID**: Site 710\n- **Study**: Study 16\n- **Country**: JPN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 711", "study": "Study 16", "site": "Site 711", "type": "site_summary", "total_subjects": 14, "total_issues": 2, "document": "# Site Report: Site 711\n\n## Site Information\n- **Site ID**: Site 711\n- **Study**: Study 16\n- **Country**: JPN\n- **Total Subjects**: 14\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.14\n- **Clean Subjects**: 12 (85.7%)\n\n## Risk Profile\n- Low Risk: 12 (85.7%)\n- Medium Risk: 2 (14.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 712", "study": "Study 16", "site": "Site 712", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 712\n\n## Site Information\n- **Site ID**: Site 712\n- **Study**: Study 16\n- **Country**: JPN\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 713", "study": "Study 16", "site": "Site 713", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 713\n\n## Site Information\n- **Site ID**: Site 713\n- **Study**: Study 16\n- **Country**: JPN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 714", "study": "Study 16", "site": "Site 714", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 714\n\n## Site Information\n- **Site ID**: Site 714\n- **Study**: Study 16\n- **Country**: JPN\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 715", "study": "Study 16", "site": "Site 715", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 715\n\n## Site Information\n- **Site ID**: Site 715\n- **Study**: Study 16\n- **Country**: JPN\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 716", "study": "Study 16", "site": "Site 716", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 716\n\n## Site Information\n- **Site ID**: Site 716\n- **Study**: Study 16\n- **Country**: JPN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 717", "study": "Study 16", "site": "Site 717", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 717\n\n## Site Information\n- **Site ID**: Site 717\n- **Study**: Study 16\n- **Country**: JPN\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 718", "study": "Study 16", "site": "Site 718", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 718\n\n## Site Information\n- **Site ID**: Site 718\n- **Study**: Study 16\n- **Country**: JPN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 719", "study": "Study 16", "site": "Site 719", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 719\n\n## Site Information\n- **Site ID**: Site 719\n- **Study**: Study 16\n- **Country**: KOR\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 720", "study": "Study 16", "site": "Site 720", "type": "site_summary", "total_subjects": 3, "total_issues": 2, "document": "# Site Report: Site 720\n\n## Site Information\n- **Site ID**: Site 720\n- **Study**: Study 16\n- **Country**: KOR\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.67\n- **Clean Subjects**: 2 (66.7%)\n\n## Risk Profile\n- Low Risk: 2 (66.7%)\n- Medium Risk: 1 (33.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 2\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 3\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 721", "study": "Study 16", "site": "Site 721", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 721\n\n## Site Information\n- **Site ID**: Site 721\n- **Study**: Study 16\n- **Country**: KOR\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 722", "study": "Study 16", "site": "Site 722", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 722\n\n## Site Information\n- **Site ID**: Site 722\n- **Study**: Study 16\n- **Country**: KOR\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 723", "study": "Study 16", "site": "Site 723", "type": "site_summary", "total_subjects": 10, "total_issues": 0, "document": "# Site Report: Site 723\n\n## Site Information\n- **Site ID**: Site 723\n- **Study**: Study 16\n- **Country**: KOR\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 10 (100.0%)\n\n## Risk Profile\n- Low Risk: 10 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 724", "study": "Study 16", "site": "Site 724", "type": "site_summary", "total_subjects": 3, "total_issues": 6, "document": "# Site Report: Site 724\n\n## Site Information\n- **Site ID**: Site 724\n- **Study**: Study 16\n- **Country**: KOR\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 6\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 1 (33.3%)\n\n## Risk Profile\n- Low Risk: 1 (33.3%)\n- Medium Risk: 2 (66.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 5\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 725", "study": "Study 16", "site": "Site 725", "type": "site_summary", "total_subjects": 11, "total_issues": 2, "document": "# Site Report: Site 725\n\n## Site Information\n- **Site ID**: Site 725\n- **Study**: Study 16\n- **Country**: KOR\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.18\n- **Clean Subjects**: 10 (90.9%)\n\n## Risk Profile\n- Low Risk: 10 (90.9%)\n- Medium Risk: 1 (9.1%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 24\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 726", "study": "Study 16", "site": "Site 726", "type": "site_summary", "total_subjects": 5, "total_issues": 2, "document": "# Site Report: Site 726\n\n## Site Information\n- **Site ID**: Site 726\n- **Study**: Study 16\n- **Country**: KOR\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.40\n- **Clean Subjects**: 4 (80.0%)\n\n## Risk Profile\n- Low Risk: 4 (80.0%)\n- Medium Risk: 1 (20.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 727", "study": "Study 16", "site": "Site 727", "type": "site_summary", "total_subjects": 5, "total_issues": 6, "document": "# Site Report: Site 727\n\n## Site Information\n- **Site ID**: Site 727\n- **Study**: Study 16\n- **Country**: TWN\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 6\n- **Average Issues per Subject**: 1.20\n- **Clean Subjects**: 4 (80.0%)\n\n## Risk Profile\n- Low Risk: 4 (80.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (20.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 6\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\n- Subject 4556: High risk, 6 issues\n"}
{"id": "site_Study 16_Site 728", "study": "Study 16", "site": "Site 728", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 728\n\n## Site Information\n- **Site ID**: Site 728\n- **Study**: Study 16\n- **Country**: TWN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 729", "study": "Study 16", "site": "Site 729", "type": "site_summary", "total_subjects": 5, "total_issues": 6, "document": "# Site Report: Site 729\n\n## Site Information\n- **Site ID**: Site 729\n- **Study**: Study 16\n- **Country**: TWN\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 6\n- **Average Issues per Subject**: 1.20\n- **Clean Subjects**: 2 (40.0%)\n\n## Risk Profile\n- Low Risk: 2 (40.0%)\n- Medium Risk: 3 (60.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 4\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 730", "study": "Study 16", "site": "Site 730", "type": "site_summary", "total_subjects": 2, "total_issues": 7, "document": "# Site Report: Site 730\n\n## Site Information\n- **Site ID**: Site 730\n- **Study**: Study 16\n- **Country**: TWN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 7\n- **Average Issues per Subject**: 3.50\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (50.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 7\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 4566: High risk, 7 issues\n"}
{"id": "site_Study 16_Site 731", "study": "Study 16", "site": "Site 731", "type": "site_summary", "total_subjects": 4, "total_issues": 13, "document": "# Site Report: Site 731\n\n## Site Information\n- **Site ID**: Site 731\n- **Study**: Study 16\n- **Country**: TWN\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 13\n- **Average Issues per Subject**: 3.25\n- **Clean Subjects**: 2 (50.0%)\n\n## Risk Profile\n- Low Risk: 2 (50.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 2 (50.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 6\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 4570: High risk, 6 issues\n- Subject 4571: High risk, 7 issues\n"}
{"id": "site_Study 16_Site 732", "study": "Study 16", "site": "Site 732", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 732\n\n## Site Information\n- **Site ID**: Site 732\n- **Study**: Study 16\n- **Country**: TWN\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 733", "study": "Study 16", "site": "Site 733", "type": "site_summary", "total_subjects": 5, "total_issues": 15, "document": "# Site Report: Site 733\n\n## Site Information\n- **Site ID**: Site 733\n- **Study**: Study 16\n- **Country**: TWN\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 15\n- **Average Issues per Subject**: 3.00\n- **Clean Subjects**: 3 (60.0%)\n\n## Risk Profile\n- Low Risk: 3 (60.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 2 (40.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 14\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 4579: High risk, 7 issues\n- Subject 4580: High risk, 8 issues\n"}
{"id": "site_Study 16_Site 734", "study": "Study 16", "site": "Site 734", "type": "site_summary", "total_subjects": 3, "total_issues": 3, "document": "# Site Report: Site 734\n\n## Site Information\n- **Site ID**: Site 734\n- **Study**: Study 16\n- **Country**: CHN\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 1 (33.3%)\n\n## Risk Profile\n- Low Risk: 1 (33.3%)\n- Medium Risk: 2 (66.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 735", "study": "Study 16", "site": "Site 735", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 735\n\n## Site Information\n- **Site ID**: Site 735\n- **Study**: Study 16\n- **Country**: CHN\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 7\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 736", "study": "Study 16", "site": "Site 736", "type": "site_summary", "total_subjects": 7, "total_issues": 2, "document": "# Site Report: Site 736\n\n## Site Information\n- **Site ID**: Site 736\n- **Study**: Study 16\n- **Country**: CHN\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.29\n- **Clean Subjects**: 5 (71.4%)\n\n## Risk Profile\n- Low Risk: 5 (71.4%)\n- Medium Risk: 2 (28.6%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 3\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 737", "study": "Study 16", "site": "Site 737", "type": "site_summary", "total_subjects": 7, "total_issues": 7, "document": "# Site Report: Site 737\n\n## Site Information\n- **Site ID**: Site 737\n- **Study**: Study 16\n- **Country**: CHN\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 7\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 3 (42.9%)\n\n## Risk Profile\n- Low Risk: 3 (42.9%)\n- Medium Risk: 4 (57.1%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 6\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 738", "study": "Study 16", "site": "Site 738", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 738\n\n## Site Information\n- **Site ID**: Site 738\n- **Study**: Study 16\n- **Country**: CHN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 739", "study": "Study 16", "site": "Site 739", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 739\n\n## Site Information\n- **Site ID**: Site 739\n- **Study**: Study 16\n- **Country**: CHN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 740", "study": "Study 16", "site": "Site 740", "type": "site_summary", "total_subjects": 7, "total_issues": 3, "document": "# Site Report: Site 740\n\n## Site Information\n- **Site ID**: Site 740\n- **Study**: Study 16\n- **Country**: CHN\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 0.43\n- **Clean Subjects**: 5 (71.4%)\n\n## Risk Profile\n- Low Risk: 5 (71.4%)\n- Medium Risk: 2 (28.6%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 3\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 7\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 741", "study": "Study 16", "site": "Site 741", "type": "site_summary", "total_subjects": 2, "total_issues": 4, "document": "# Site Report: Site 741\n\n## Site Information\n- **Site ID**: Site 741\n- **Study**: Study 16\n- **Country**: CHN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 4\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 742", "study": "Study 16", "site": "Site 742", "type": "site_summary", "total_subjects": 8, "total_issues": 3, "document": "# Site Report: Site 742\n\n## Site Information\n- **Site ID**: Site 742\n- **Study**: Study 16\n- **Country**: CHN\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 0.38\n- **Clean Subjects**: 6 (75.0%)\n\n## Risk Profile\n- Low Risk: 6 (75.0%)\n- Medium Risk: 2 (25.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 3\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 7\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 743", "study": "Study 16", "site": "Site 743", "type": "site_summary", "total_subjects": 5, "total_issues": 3, "document": "# Site Report: Site 743\n\n## Site Information\n- **Site ID**: Site 743\n- **Study**: Study 16\n- **Country**: CHN\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 0.60\n- **Clean Subjects**: 4 (80.0%)\n\n## Risk Profile\n- Low Risk: 4 (80.0%)\n- Medium Risk: 1 (20.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 744", "study": "Study 16", "site": "Site 744", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 744\n\n## Site Information\n- **Site ID**: Site 744\n- **Study**: Study 16\n- **Country**: CHN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 745", "study": "Study 16", "site": "Site 745", "type": "site_summary", "total_subjects": 7, "total_issues": 14, "document": "# Site Report: Site 745\n\n## Site Information\n- **Site ID**: Site 745\n- **Study**: Study 16\n- **Country**: CHN\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 14\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 4 (57.1%)\n\n## Risk Profile\n- Low Risk: 4 (57.1%)\n- Medium Risk: 2 (28.6%)\n- High Risk: 1 (14.3%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 10\n- Safety Discrepancies: 4\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 7\n\n## Subjects Requiring Attention\n- Subject 4631: High risk, 10 issues\n"}
{"id": "site_Study 16_Site 746", "study": "Study 16", "site": "Site 746", "type": "site_summary", "total_subjects": 3, "total_issues": 4, "document": "# Site Report: Site 746\n\n## Site Information\n- **Site ID**: Site 746\n- **Study**: Study 16\n- **Country**: CHN\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 1.33\n- **Clean Subjects**: 1 (33.3%)\n\n## Risk Profile\n- Low Risk: 1 (33.3%)\n- Medium Risk: 2 (66.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 2\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 747", "study": "Study 16", "site": "Site 747", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 747\n\n## Site Information\n- **Site ID**: Site 747\n- **Study**: Study 16\n- **Country**: CHN\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 748", "study": "Study 16", "site": "Site 748", "type": "site_summary", "total_subjects": 5, "total_issues": 1, "document": "# Site Report: Site 748\n\n## Site Information\n- **Site ID**: Site 748\n- **Study**: Study 16\n- **Country**: CHN\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.20\n- **Clean Subjects**: 4 (80.0%)\n\n## Risk Profile\n- Low Risk: 4 (80.0%)\n- Medium Risk: 1 (20.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 749", "study": "Study 16", "site": "Site 749", "type": "site_summary", "total_subjects": 1, "total_issues": 4, "document": "# Site Report: Site 749\n\n## Site Information\n- **Site ID**: Site 749\n- **Study**: Study 16\n- **Country**: CHN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 4.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 4\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 750", "study": "Study 16", "site": "Site 750", "type": "site_summary", "total_subjects": 4, "total_issues": 2, "document": "# Site Report: Site 750\n\n## Site Information\n- **Site ID**: Site 750\n- **Study**: Study 16\n- **Country**: CHN\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.50\n- **Clean Subjects**: 2 (50.0%)\n\n## Risk Profile\n- Low Risk: 2 (50.0%)\n- Medium Risk: 2 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 751", "study": "Study 16", "site": "Site 751", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 751\n\n## Site Information\n- **Site ID**: Site 751\n- **Study**: Study 16\n- **Country**: CHN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 752", "study": "Study 16", "site": "Site 752", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 752\n\n## Site Information\n- **Site ID**: Site 752\n- **Study**: Study 16\n- **Country**: CHN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 753", "study": "Study 16", "site": "Site 753", "type": "site_summary", "total_subjects": 4, "total_issues": 4, "document": "# Site Report: Site 753\n\n## Site Information\n- **Site ID**: Site 753\n- **Study**: Study 16\n- **Country**: CHN\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 3 (75.0%)\n\n## Risk Profile\n- Low Risk: 3 (75.0%)\n- Medium Risk: 1 (25.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 2\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 754", "study": "Study 16", "site": "Site 754", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 754\n\n## Site Information\n- **Site ID**: Site 754\n- **Study**: Study 16\n- **Country**: CHN\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 755", "study": "Study 16", "site": "Site 755", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 755\n\n## Site Information\n- **Site ID**: Site 755\n- **Study**: Study 16\n- **Country**: CHN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 756", "study": "Study 16", "site": "Site 756", "type": "site_summary", "total_subjects": 3, "total_issues": 1, "document": "# Site Report: Site 756\n\n## Site Information\n- **Site ID**: Site 756\n- **Study**: Study 16\n- **Country**: CHN\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.33\n- **Clean Subjects**: 2 (66.7%)\n\n## Risk Profile\n- Low Risk: 2 (66.7%)\n- Medium Risk: 1 (33.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 757", "study": "Study 16", "site": "Site 757", "type": "site_summary", "total_subjects": 11, "total_issues": 68, "document": "# Site Report: Site 757\n\n## Site Information\n- **Site ID**: Site 757\n- **Study**: Study 16\n- **Country**: TUR\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 68\n- **Average Issues per Subject**: 6.18\n- **Clean Subjects**: 3 (27.3%)\n\n## Risk Profile\n- Low Risk: 3 (27.3%)\n- Medium Risk: 4 (36.4%)\n- High Risk: 4 (36.4%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 64\n- Safety Discrepancies: 4\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 4672: High risk, 15 issues\n- Subject 4673: High risk, 14 issues\n- Subject 4674: High risk, 14 issues\n- Subject 4675: High risk, 8 issues\n"}
{"id": "site_Study 16_Site 758", "study": "Study 16", "site": "Site 758", "type": "site_summary", "total_subjects": 2, "total_issues": 12, "document": "# Site Report: Site 758\n\n## Site Information\n- **Site ID**: Site 758\n- **Study**: Study 16\n- **Country**: TUR\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 12\n- **Average Issues per Subject**: 6.00\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (50.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 10\n- Safety Discrepancies: 2\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\n- Subject 4683: High risk, 12 issues\n"}
{"id": "site_Study 16_Site 759", "study": "Study 16", "site": "Site 759", "type": "site_summary", "total_subjects": 1, "total_issues": 51, "document": "# Site Report: Site 759\n\n## Site Information\n- **Site ID**: Site 759\n- **Study**: Study 16\n- **Country**: TUR\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 51\n- **Average Issues per Subject**: 51.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 8\n- Safety Discrepancies: 2\n- Missing Pages: 0\n- Missing Labs: 41\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 4685: Critical risk, 51 issues\n"}
{"id": "site_Study 16_Site 760", "study": "Study 16", "site": "Site 760", "type": "site_summary", "total_subjects": 5, "total_issues": 12, "document": "# Site Report: Site 760\n\n## Site Information\n- **Site ID**: Site 760\n- **Study**: Study 16\n- **Country**: TUR\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 12\n- **Average Issues per Subject**: 2.40\n- **Clean Subjects**: 4 (80.0%)\n\n## Risk Profile\n- Low Risk: 4 (80.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (20.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 4\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 8\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 4688: High risk, 12 issues\n"}
{"id": "site_Study 16_Site 761", "study": "Study 16", "site": "Site 761", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 761\n\n## Site Information\n- **Site ID**: Site 761\n- **Study**: Study 16\n- **Country**: IND\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 762", "study": "Study 16", "site": "Site 762", "type": "site_summary", "total_subjects": 3, "total_issues": 20, "document": "# Site Report: Site 762\n\n## Site Information\n- **Site ID**: Site 762\n- **Study**: Study 16\n- **Country**: IND\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 20\n- **Average Issues per Subject**: 6.67\n- **Clean Subjects**: 1 (33.3%)\n\n## Risk Profile\n- Low Risk: 1 (33.3%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 2 (66.7%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 15\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 4692: High risk, 9 issues\n- Subject 4693: High risk, 11 issues\n"}
{"id": "site_Study 16_Site 763", "study": "Study 16", "site": "Site 763", "type": "site_summary", "total_subjects": 2, "total_issues": 25, "document": "# Site Report: Site 763\n\n## Site Information\n- **Site ID**: Site 763\n- **Study**: Study 16\n- **Country**: IND\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 25\n- **Average Issues per Subject**: 12.50\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (50.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 6\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 19\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 4696: Critical risk, 25 issues\n"}
{"id": "site_Study 16_Site 764", "study": "Study 16", "site": "Site 764", "type": "site_summary", "total_subjects": 4, "total_issues": 10, "document": "# Site Report: Site 764\n\n## Site Information\n- **Site ID**: Site 764\n- **Study**: Study 16\n- **Country**: IND\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 10\n- **Average Issues per Subject**: 2.50\n- **Clean Subjects**: 3 (75.0%)\n\n## Risk Profile\n- Low Risk: 3 (75.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (25.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 10\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 4698: High risk, 10 issues\n"}
{"id": "site_Study 16_Site 765", "study": "Study 16", "site": "Site 765", "type": "site_summary", "total_subjects": 9, "total_issues": 56, "document": "# Site Report: Site 765\n\n## Site Information\n- **Site ID**: Site 765\n- **Study**: Study 16\n- **Country**: IND\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 56\n- **Average Issues per Subject**: 6.22\n- **Clean Subjects**: 1 (11.1%)\n\n## Risk Profile\n- Low Risk: 1 (11.1%)\n- Medium Risk: 3 (33.3%)\n- High Risk: 5 (55.6%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 50\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 5\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 4701: High risk, 10 issues\n- Subject 4703: High risk, 10 issues\n- Subject 4704: High risk, 11 issues\n- Subject 4705: High risk, 6 issues\n- Subject 4706: High risk, 6 issues\n"}
{"id": "site_Study 16_Site 766", "study": "Study 16", "site": "Site 766", "type": "site_summary", "total_subjects": 4, "total_issues": 36, "document": "# Site Report: Site 766\n\n## Site Information\n- **Site ID**: Site 766\n- **Study**: Study 16\n- **Country**: IND\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 36\n- **Average Issues per Subject**: 9.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 4 (100.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 36\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 4710: High risk, 10 issues\n- Subject 4711: High risk, 10 issues\n- Subject 4712: High risk, 8 issues\n- Subject 4713: High risk, 8 issues\n"}
{"id": "site_Study 16_Site 767", "study": "Study 16", "site": "Site 767", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 767\n\n## Site Information\n- **Site ID**: Site 767\n- **Study**: Study 16\n- **Country**: IND\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 768", "study": "Study 16", "site": "Site 768", "type": "site_summary", "total_subjects": 7, "total_issues": 28, "document": "# Site Report: Site 768\n\n## Site Information\n- **Site ID**: Site 768\n- **Study**: Study 16\n- **Country**: IND\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 28\n- **Average Issues per Subject**: 4.00\n- **Clean Subjects**: 3 (42.9%)\n\n## Risk Profile\n- Low Risk: 3 (42.9%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 4 (57.1%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 28\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\n- Subject 4718: High risk, 8 issues\n- Subject 4720: High risk, 8 issues\n- Subject 4721: High risk, 6 issues\n- Subject 4722: High risk, 6 issues\n"}
{"id": "site_Study 16_Site 769", "study": "Study 16", "site": "Site 769", "type": "site_summary", "total_subjects": 4, "total_issues": 12, "document": "# Site Report: Site 769\n\n## Site Information\n- **Site ID**: Site 769\n- **Study**: Study 16\n- **Country**: IND\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 12\n- **Average Issues per Subject**: 3.00\n- **Clean Subjects**: 3 (75.0%)\n\n## Risk Profile\n- Low Risk: 3 (75.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (25.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 12\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 4724: High risk, 12 issues\n"}
{"id": "site_Study 16_Site 770", "study": "Study 16", "site": "Site 770", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 770\n\n## Site Information\n- **Site ID**: Site 770\n- **Study**: Study 16\n- **Country**: ISR\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 771", "study": "Study 16", "site": "Site 771", "type": "site_summary", "total_subjects": 5, "total_issues": 2, "document": "# Site Report: Site 771\n\n## Site Information\n- **Site ID**: Site 771\n- **Study**: Study 16\n- **Country**: ISR\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.40\n- **Clean Subjects**: 4 (80.0%)\n\n## Risk Profile\n- Low Risk: 4 (80.0%)\n- Medium Risk: 1 (20.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 7\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 772", "study": "Study 16", "site": "Site 772", "type": "site_summary", "total_subjects": 2, "total_issues": 1, "document": "# Site Report: Site 772\n\n## Site Information\n- **Site ID**: Site 772\n- **Study**: Study 16\n- **Country**: ISR\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.50\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 7\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 16_Site 773", "study": "Study 16", "site": "Site 773", "type": "site_summary", "total_subjects": 5, "total_issues": 22, "document": "# Site Report: Site 773\n\n## Site Information\n- **Site ID**: Site 773\n- **Study**: Study 16\n- **Country**: ISR\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 22\n- **Average Issues per Subject**: 4.40\n- **Clean Subjects**: 4 (80.0%)\n\n## Risk Profile\n- Low Risk: 4 (80.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (20.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 22\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\n- Subject 4740: Critical risk, 22 issues\n"}
{"id": "site_Study 16_Site 774", "study": "Study 16", "site": "Site 774", "type": "site_summary", "total_subjects": 3, "total_issues": 1, "document": "# Site Report: Site 774\n\n## Site Information\n- **Site ID**: Site 774\n- **Study**: Study 16\n- **Country**: ISR\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.33\n- **Clean Subjects**: 2 (66.7%)\n\n## Risk Profile\n- Low Risk: 2 (66.7%)\n- Medium Risk: 1 (33.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 17_Site 14", "study": "Study 17", "site": "Site 14", "type": "site_summary", "total_subjects": 2, "total_issues": 8, "document": "# Site Report: Site 14\n\n## Site Information\n- **Site ID**: Site 14\n- **Study**: Study 17\n- **Country**: CAN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 8\n- **Average Issues per Subject**: 4.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 1 (50.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 7\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 25: High risk, 6 issues\n"}
{"id": "site_Study 17_Site 15", "study": "Study 17", "site": "Site 15", "type": "site_summary", "total_subjects": 2, "total_issues": 4, "document": "# Site Report: Site 15\n\n## Site Information\n- **Site ID**: Site 15\n- **Study**: Study 17\n- **Country**: CAN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 4\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 17_Site 16", "study": "Study 17", "site": "Site 16", "type": "site_summary", "total_subjects": 2, "total_issues": 14, "document": "# Site Report: Site 16\n\n## Site Information\n- **Site ID**: Site 16\n- **Study**: Study 17\n- **Country**: CAN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 14\n- **Average Issues per Subject**: 7.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 1 (50.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 14\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 55: High risk, 11 issues\n"}
{"id": "site_Study 17_Site 177", "study": "Study 17", "site": "Site 177", "type": "site_summary", "total_subjects": 3, "total_issues": 87, "document": "# Site Report: Site 177\n\n## Site Information\n- **Site ID**: Site 177\n- **Study**: Study 17\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 87\n- **Average Issues per Subject**: 29.00\n- **Clean Subjects**: 1 (33.3%)\n\n## Risk Profile\n- Low Risk: 1 (33.3%)\n- Medium Risk: 1 (33.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (33.3%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 83\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\n- Subject 1595: Critical risk, 86 issues\n"}
{"id": "site_Study 17_Site 18", "study": "Study 17", "site": "Site 18", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 18\n\n## Site Information\n- **Site ID**: Site 18\n- **Study**: Study 17\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 17_Site 19", "study": "Study 17", "site": "Site 19", "type": "site_summary", "total_subjects": 7, "total_issues": 14, "document": "# Site Report: Site 19\n\n## Site Information\n- **Site ID**: Site 19\n- **Study**: Study 17\n- **Country**: USA\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 14\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 1 (14.3%)\n\n## Risk Profile\n- Low Risk: 1 (14.3%)\n- Medium Risk: 5 (71.4%)\n- High Risk: 1 (14.3%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 5\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 9\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\n- Subject 4756: High risk, 6 issues\n"}
{"id": "site_Study 17_Site 325", "study": "Study 17", "site": "Site 325", "type": "site_summary", "total_subjects": 2, "total_issues": 98, "document": "# Site Report: Site 325\n\n## Site Information\n- **Site ID**: Site 325\n- **Study**: Study 17\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 98\n- **Average Issues per Subject**: 49.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (50.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 80\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2649: Critical risk, 97 issues\n"}
{"id": "site_Study 17_Site 327", "study": "Study 17", "site": "Site 327", "type": "site_summary", "total_subjects": 8, "total_issues": 13, "document": "# Site Report: Site 327\n\n## Site Information\n- **Site ID**: Site 327\n- **Study**: Study 17\n- **Country**: USA\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 13\n- **Average Issues per Subject**: 1.62\n- **Clean Subjects**: 4 (50.0%)\n\n## Risk Profile\n- Low Risk: 4 (50.0%)\n- Medium Risk: 3 (37.5%)\n- High Risk: 1 (12.5%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 4\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 9\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\n- Subject 4759: High risk, 6 issues\n"}
{"id": "site_Study 17_Site 466", "study": "Study 17", "site": "Site 466", "type": "site_summary", "total_subjects": 3, "total_issues": 29, "document": "# Site Report: Site 466\n\n## Site Information\n- **Site ID**: Site 466\n- **Study**: Study 17\n- **Country**: FRA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 29\n- **Average Issues per Subject**: 9.67\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (66.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (33.3%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 27\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\n- Subject 3546: Critical risk, 23 issues\n"}
{"id": "site_Study 17_Site 469", "study": "Study 17", "site": "Site 469", "type": "site_summary", "total_subjects": 9, "total_issues": 10, "document": "# Site Report: Site 469\n\n## Site Information\n- **Site ID**: Site 469\n- **Study**: Study 17\n- **Country**: ISR\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 10\n- **Average Issues per Subject**: 1.11\n- **Clean Subjects**: 5 (55.6%)\n\n## Risk Profile\n- Low Risk: 5 (55.6%)\n- Medium Risk: 4 (44.4%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 9\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 1\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 17_Site 7", "study": "Study 17", "site": "Site 7", "type": "site_summary", "total_subjects": 2, "total_issues": 7, "document": "# Site Report: Site 7\n\n## Site Information\n- **Site ID**: Site 7\n- **Study**: Study 17\n- **Country**: ESP\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 7\n- **Average Issues per Subject**: 3.50\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (50.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 7\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 594: High risk, 7 issues\n"}
{"id": "site_Study 17_Site 775", "study": "Study 17", "site": "Site 775", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 775\n\n## Site Information\n- **Site ID**: Site 775\n- **Study**: Study 17\n- **Country**: ESP\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 1\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 17_Site 776", "study": "Study 17", "site": "Site 776", "type": "site_summary", "total_subjects": 3, "total_issues": 6, "document": "# Site Report: Site 776\n\n## Site Information\n- **Site ID**: Site 776\n- **Study**: Study 17\n- **Country**: CHE\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 6\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 1 (33.3%)\n\n## Risk Profile\n- Low Risk: 1 (33.3%)\n- Medium Risk: 2 (66.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 6\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 18_Site 2", "study": "Study 18", "site": "Site 2", "type": "site_summary", "total_subjects": 51, "total_issues": 5, "document": "# Site Report: Site 2\n\n## Site Information\n- **Site ID**: Site 2\n- **Study**: Study 18\n- **Country**: USA\n- **Total Subjects**: 51\n\n## Performance Metrics\n- **Total Issues**: 5\n- **Average Issues per Subject**: 0.10\n- **Clean Subjects**: 47 (92.2%)\n\n## Risk Profile\n- Low Risk: 47 (92.2%)\n- Medium Risk: 4 (7.8%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 18_Site 3", "study": "Study 18", "site": "Site 3", "type": "site_summary", "total_subjects": 112, "total_issues": 7, "document": "# Site Report: Site 3\n\n## Site Information\n- **Site ID**: Site 3\n- **Study**: Study 18\n- **Country**: USA\n- **Total Subjects**: 112\n\n## Performance Metrics\n- **Total Issues**: 7\n- **Average Issues per Subject**: 0.06\n- **Clean Subjects**: 107 (95.5%)\n\n## Risk Profile\n- Low Risk: 107 (95.5%)\n- Medium Risk: 5 (4.5%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 19_Site 109", "study": "Study 19", "site": "Site 109", "type": "site_summary", "total_subjects": 4, "total_issues": 5, "document": "# Site Report: Site 109\n\n## Site Information\n- **Site ID**: Site 109\n- **Study**: Study 19\n- **Country**: AUS\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 5\n- **Average Issues per Subject**: 1.25\n- **Clean Subjects**: 1 (25.0%)\n\n## Risk Profile\n- Low Risk: 1 (25.0%)\n- Medium Risk: 3 (75.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 19_Site 113", "study": "Study 19", "site": "Site 113", "type": "site_summary", "total_subjects": 4, "total_issues": 18, "document": "# Site Report: Site 113\n\n## Site Information\n- **Site ID**: Site 113\n- **Study**: Study 19\n- **Country**: PRK\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 18\n- **Average Issues per Subject**: 4.50\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 3 (75.0%)\n- High Risk: 1 (25.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 13\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\n- Subject 912: High risk, 11 issues\n"}
{"id": "site_Study 19_Site 155", "study": "Study 19", "site": "Site 155", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 155\n\n## Site Information\n- **Site ID**: Site 155\n- **Study**: Study 19\n- **Country**: TWN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 19_Site 417", "study": "Study 19", "site": "Site 417", "type": "site_summary", "total_subjects": 3, "total_issues": 1, "document": "# Site Report: Site 417\n\n## Site Information\n- **Site ID**: Site 417\n- **Study**: Study 19\n- **Country**: KOR\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.33\n- **Clean Subjects**: 2 (66.7%)\n\n## Risk Profile\n- Low Risk: 2 (66.7%)\n- Medium Risk: 1 (33.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 19_Site 467", "study": "Study 19", "site": "Site 467", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 467\n\n## Site Information\n- **Site ID**: Site 467\n- **Study**: Study 19\n- **Country**: AUS\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 19_Site 468", "study": "Study 19", "site": "Site 468", "type": "site_summary", "total_subjects": 6, "total_issues": 5, "document": "# Site Report: Site 468\n\n## Site Information\n- **Site ID**: Site 468\n- **Study**: Study 19\n- **Country**: AUS\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 5\n- **Average Issues per Subject**: 0.83\n- **Clean Subjects**: 2 (33.3%)\n\n## Risk Profile\n- Low Risk: 2 (33.3%)\n- Medium Risk: 4 (66.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 19_Site 493", "study": "Study 19", "site": "Site 493", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 493\n\n## Site Information\n- **Site ID**: Site 493\n- **Study**: Study 19\n- **Country**: ISR\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 3\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 19_Site 778", "study": "Study 19", "site": "Site 778", "type": "site_summary", "total_subjects": 3, "total_issues": 1, "document": "# Site Report: Site 778\n\n## Site Information\n- **Site ID**: Site 778\n- **Study**: Study 19\n- **Country**: ISR\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.33\n- **Clean Subjects**: 2 (66.7%)\n\n## Risk Profile\n- Low Risk: 2 (66.7%)\n- Medium Risk: 1 (33.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 19_Site 779", "study": "Study 19", "site": "Site 779", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 779\n\n## Site Information\n- **Site ID**: Site 779\n- **Study**: Study 19\n- **Country**: ISR\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 19_Site 780", "study": "Study 19", "site": "Site 780", "type": "site_summary", "total_subjects": 10, "total_issues": 155, "document": "# Site Report: Site 780\n\n## Site Information\n- **Site ID**: Site 780\n- **Study**: Study 19\n- **Country**: SGP\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 155\n- **Average Issues per Subject**: 15.50\n- **Clean Subjects**: 6 (60.0%)\n\n## Risk Profile\n- Low Risk: 6 (60.0%)\n- Medium Risk: 2 (20.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 2 (20.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 152\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\n- Subject 4890: Critical risk, 42 issues\n- Subject 4895: Critical risk, 111 issues\n"}
{"id": "site_Study 19_Site 781", "study": "Study 19", "site": "Site 781", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 781\n\n## Site Information\n- **Site ID**: Site 781\n- **Study**: Study 19\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 19_Site 782", "study": "Study 19", "site": "Site 782", "type": "site_summary", "total_subjects": 4, "total_issues": 10, "document": "# Site Report: Site 782\n\n## Site Information\n- **Site ID**: Site 782\n- **Study**: Study 19\n- **Country**: USA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 10\n- **Average Issues per Subject**: 2.50\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 4 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 6\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 19_Site 9", "study": "Study 19", "site": "Site 9", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 9\n\n## Site Information\n- **Site ID**: Site 9\n- **Study**: Study 19\n- **Country**: FRA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 2_Site 2", "study": "Study 2", "site": "Site 2", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 2\n\n## Site Information\n- **Site ID**: Site 2\n- **Study**: Study 2\n- **Country**: CHN\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 2_Site 28", "study": "Study 2", "site": "Site 28", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 28\n\n## Site Information\n- **Site ID**: Site 28\n- **Study**: Study 2\n- **Country**: CHN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 2_Site 29", "study": "Study 2", "site": "Site 29", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 29\n\n## Site Information\n- **Site ID**: Site 29\n- **Study**: Study 2\n- **Country**: CHN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 2_Site 3", "study": "Study 2", "site": "Site 3", "type": "site_summary", "total_subjects": 6, "total_issues": 27, "document": "# Site Report: Site 3\n\n## Site Information\n- **Site ID**: Site 3\n- **Study**: Study 2\n- **Country**: CHN\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 27\n- **Average Issues per Subject**: 4.50\n- **Clean Subjects**: 5 (83.3%)\n\n## Risk Profile\n- Low Risk: 5 (83.3%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (16.7%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 27\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 102: Critical risk, 27 issues\n"}
{"id": "site_Study 2_Site 30", "study": "Study 2", "site": "Site 30", "type": "site_summary", "total_subjects": 8, "total_issues": 0, "document": "# Site Report: Site 30\n\n## Site Information\n- **Site ID**: Site 30\n- **Study**: Study 2\n- **Country**: CHN\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 8 (100.0%)\n\n## Risk Profile\n- Low Risk: 8 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 2_Site 31", "study": "Study 2", "site": "Site 31", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 31\n\n## Site Information\n- **Site ID**: Site 31\n- **Study**: Study 2\n- **Country**: CHN\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 2_Site 32", "study": "Study 2", "site": "Site 32", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 32\n\n## Site Information\n- **Site ID**: Site 32\n- **Study**: Study 2\n- **Country**: CHN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 2_Site 33", "study": "Study 2", "site": "Site 33", "type": "site_summary", "total_subjects": 11, "total_issues": 10, "document": "# Site Report: Site 33\n\n## Site Information\n- **Site ID**: Site 33\n- **Study**: Study 2\n- **Country**: CHN\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 10\n- **Average Issues per Subject**: 0.91\n- **Clean Subjects**: 10 (90.9%)\n\n## Risk Profile\n- Low Risk: 10 (90.9%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (9.1%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 10\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 130: High risk, 10 issues\n"}
{"id": "site_Study 2_Site 34", "study": "Study 2", "site": "Site 34", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 34\n\n## Site Information\n- **Site ID**: Site 34\n- **Study**: Study 2\n- **Country**: CHN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 2_Site 35", "study": "Study 2", "site": "Site 35", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 35\n\n## Site Information\n- **Site ID**: Site 35\n- **Study**: Study 2\n- **Country**: CHN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 2_Site 36", "study": "Study 2", "site": "Site 36", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 36\n\n## Site Information\n- **Site ID**: Site 36\n- **Study**: Study 2\n- **Country**: CHN\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 2_Site 37", "study": "Study 2", "site": "Site 37", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 37\n\n## Site Information\n- **Site ID**: Site 37\n- **Study**: Study 2\n- **Country**: CHN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 2_Site 38", "study": "Study 2", "site": "Site 38", "type": "site_summary", "total_subjects": 13, "total_issues": 5, "document": "# Site Report: Site 38\n\n## Site Information\n- **Site ID**: Site 38\n- **Study**: Study 2\n- **Country**: CHN\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 5\n- **Average Issues per Subject**: 0.38\n- **Clean Subjects**: 12 (92.3%)\n\n## Risk Profile\n- Low Risk: 12 (92.3%)\n- Medium Risk: 1 (7.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 5\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 2_Site 39", "study": "Study 2", "site": "Site 39", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 39\n\n## Site Information\n- **Site ID**: Site 39\n- **Study**: Study 2\n- **Country**: CHN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 2_Site 4", "study": "Study 2", "site": "Site 4", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 4\n\n## Site Information\n- **Site ID**: Site 4\n- **Study**: Study 2\n- **Country**: CHN\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 2_Site 40", "study": "Study 2", "site": "Site 40", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 40\n\n## Site Information\n- **Site ID**: Site 40\n- **Study**: Study 2\n- **Country**: CHN\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 2_Site 41", "study": "Study 2", "site": "Site 41", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 41\n\n## Site Information\n- **Site ID**: Site 41\n- **Study**: Study 2\n- **Country**: CHN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 2_Site 42", "study": "Study 2", "site": "Site 42", "type": "site_summary", "total_subjects": 5, "total_issues": 1, "document": "# Site Report: Site 42\n\n## Site Information\n- **Site ID**: Site 42\n- **Study**: Study 2\n- **Country**: CHN\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.20\n- **Clean Subjects**: 4 (80.0%)\n\n## Risk Profile\n- Low Risk: 4 (80.0%)\n- Medium Risk: 1 (20.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 20_Site 124", "study": "Study 20", "site": "Site 124", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 124\n\n## Site Information\n- **Site ID**: Site 124\n- **Study**: Study 20\n- **Country**: NLD\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 20_Site 353", "study": "Study 20", "site": "Site 353", "type": "site_summary", "total_subjects": 5, "total_issues": 14, "document": "# Site Report: Site 353\n\n## Site Information\n- **Site ID**: Site 353\n- **Study**: Study 20\n- **Country**: SGP\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 14\n- **Average Issues per Subject**: 2.80\n- **Clean Subjects**: 4 (80.0%)\n\n## Risk Profile\n- Low Risk: 4 (80.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (20.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2844: High risk, 14 issues\n"}
{"id": "site_Study 20_Site 417", "study": "Study 20", "site": "Site 417", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 417\n\n## Site Information\n- **Site ID**: Site 417\n- **Study**: Study 20\n- **Country**: KOR\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 20_Site 466", "study": "Study 20", "site": "Site 466", "type": "site_summary", "total_subjects": 2, "total_issues": 8, "document": "# Site Report: Site 466\n\n## Site Information\n- **Site ID**: Site 466\n- **Study**: Study 20\n- **Country**: AUS\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 8\n- **Average Issues per Subject**: 4.00\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (50.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 8\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 3544: High risk, 8 issues\n"}
{"id": "site_Study 20_Site 575", "study": "Study 20", "site": "Site 575", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 575\n\n## Site Information\n- **Site ID**: Site 575\n- **Study**: Study 20\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 20_Site 783", "study": "Study 20", "site": "Site 783", "type": "site_summary", "total_subjects": 2, "total_issues": 42, "document": "# Site Report: Site 783\n\n## Site Information\n- **Site ID**: Site 783\n- **Study**: Study 20\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 42\n- **Average Issues per Subject**: 21.00\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (50.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 42\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 4904: Critical risk, 42 issues\n"}
{"id": "site_Study 20_Site 785", "study": "Study 20", "site": "Site 785", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 785\n\n## Site Information\n- **Site ID**: Site 785\n- **Study**: Study 20\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 20_Site 87", "study": "Study 20", "site": "Site 87", "type": "site_summary", "total_subjects": 1, "total_issues": 32, "document": "# Site Report: Site 87\n\n## Site Information\n- **Site ID**: Site 87\n- **Study**: Study 20\n- **Country**: ITA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 32\n- **Average Issues per Subject**: 32.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 32\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 627: Critical risk, 32 issues\n"}
{"id": "site_Study 20_Site 9", "study": "Study 20", "site": "Site 9", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 9\n\n## Site Information\n- **Site ID**: Site 9\n- **Study**: Study 20\n- **Country**: FRA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1", "study": "Study 21", "site": "Site 1", "type": "site_summary", "total_subjects": 82, "total_issues": 0, "document": "# Site Report: Site 1\n\n## Site Information\n- **Site ID**: Site 1\n- **Study**: Study 21\n- **Country**: IND\n- **Total Subjects**: 82\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 82 (100.0%)\n\n## Risk Profile\n- Low Risk: 82 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1000", "study": "Study 21", "site": "Site 1000", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 1000\n\n## Site Information\n- **Site ID**: Site 1000\n- **Study**: Study 21\n- **Country**: NOR\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1001", "study": "Study 21", "site": "Site 1001", "type": "site_summary", "total_subjects": 12, "total_issues": 0, "document": "# Site Report: Site 1001\n\n## Site Information\n- **Site ID**: Site 1001\n- **Study**: Study 21\n- **Country**: NOR\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 12 (100.0%)\n\n## Risk Profile\n- Low Risk: 12 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1002", "study": "Study 21", "site": "Site 1002", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 1002\n\n## Site Information\n- **Site ID**: Site 1002\n- **Study**: Study 21\n- **Country**: NOR\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1003", "study": "Study 21", "site": "Site 1003", "type": "site_summary", "total_subjects": 22, "total_issues": 0, "document": "# Site Report: Site 1003\n\n## Site Information\n- **Site ID**: Site 1003\n- **Study**: Study 21\n- **Country**: FIN\n- **Total Subjects**: 22\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 22 (100.0%)\n\n## Risk Profile\n- Low Risk: 22 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1004", "study": "Study 21", "site": "Site 1004", "type": "site_summary", "total_subjects": 17, "total_issues": 0, "document": "# Site Report: Site 1004\n\n## Site Information\n- **Site ID**: Site 1004\n- **Study**: Study 21\n- **Country**: FIN\n- **Total Subjects**: 17\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 17 (100.0%)\n\n## Risk Profile\n- Low Risk: 17 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1005", "study": "Study 21", "site": "Site 1005", "type": "site_summary", "total_subjects": 10, "total_issues": 0, "document": "# Site Report: Site 1005\n\n## Site Information\n- **Site ID**: Site 1005\n- **Study**: Study 21\n- **Country**: FIN\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 10 (100.0%)\n\n## Risk Profile\n- Low Risk: 10 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1006", "study": "Study 21", "site": "Site 1006", "type": "site_summary", "total_subjects": 12, "total_issues": 0, "document": "# Site Report: Site 1006\n\n## Site Information\n- **Site ID**: Site 1006\n- **Study**: Study 21\n- **Country**: FIN\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 12 (100.0%)\n\n## Risk Profile\n- Low Risk: 12 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1007", "study": "Study 21", "site": "Site 1007", "type": "site_summary", "total_subjects": 20, "total_issues": 0, "document": "# Site Report: Site 1007\n\n## Site Information\n- **Site ID**: Site 1007\n- **Study**: Study 21\n- **Country**: FIN\n- **Total Subjects**: 20\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 20 (100.0%)\n\n## Risk Profile\n- Low Risk: 20 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1008", "study": "Study 21", "site": "Site 1008", "type": "site_summary", "total_subjects": 32, "total_issues": 0, "document": "# Site Report: Site 1008\n\n## Site Information\n- **Site ID**: Site 1008\n- **Study**: Study 21\n- **Country**: ISL\n- **Total Subjects**: 32\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 32 (100.0%)\n\n## Risk Profile\n- Low Risk: 32 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1009", "study": "Study 21", "site": "Site 1009", "type": "site_summary", "total_subjects": 22, "total_issues": 0, "document": "# Site Report: Site 1009\n\n## Site Information\n- **Site ID**: Site 1009\n- **Study**: Study 21\n- **Country**: ISL\n- **Total Subjects**: 22\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 22 (100.0%)\n\n## Risk Profile\n- Low Risk: 22 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 101", "study": "Study 21", "site": "Site 101", "type": "site_summary", "total_subjects": 13, "total_issues": 0, "document": "# Site Report: Site 101\n\n## Site Information\n- **Site ID**: Site 101\n- **Study**: Study 21\n- **Country**: SVK\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 13 (100.0%)\n\n## Risk Profile\n- Low Risk: 13 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1010", "study": "Study 21", "site": "Site 1010", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 1010\n\n## Site Information\n- **Site ID**: Site 1010\n- **Study**: Study 21\n- **Country**: GRC\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1011", "study": "Study 21", "site": "Site 1011", "type": "site_summary", "total_subjects": 30, "total_issues": 0, "document": "# Site Report: Site 1011\n\n## Site Information\n- **Site ID**: Site 1011\n- **Study**: Study 21\n- **Country**: GRC\n- **Total Subjects**: 30\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 30 (100.0%)\n\n## Risk Profile\n- Low Risk: 30 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1012", "study": "Study 21", "site": "Site 1012", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 1012\n\n## Site Information\n- **Site ID**: Site 1012\n- **Study**: Study 21\n- **Country**: GRC\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1013", "study": "Study 21", "site": "Site 1013", "type": "site_summary", "total_subjects": 26, "total_issues": 0, "document": "# Site Report: Site 1013\n\n## Site Information\n- **Site ID**: Site 1013\n- **Study**: Study 21\n- **Country**: GRC\n- **Total Subjects**: 26\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 26 (100.0%)\n\n## Risk Profile\n- Low Risk: 26 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1014", "study": "Study 21", "site": "Site 1014", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1014\n\n## Site Information\n- **Site ID**: Site 1014\n- **Study**: Study 21\n- **Country**: GRC\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1015", "study": "Study 21", "site": "Site 1015", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1015\n\n## Site Information\n- **Site ID**: Site 1015\n- **Study**: Study 21\n- **Country**: GRC\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1016", "study": "Study 21", "site": "Site 1016", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 1016\n\n## Site Information\n- **Site ID**: Site 1016\n- **Study**: Study 21\n- **Country**: GRC\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1017", "study": "Study 21", "site": "Site 1017", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 1017\n\n## Site Information\n- **Site ID**: Site 1017\n- **Study**: Study 21\n- **Country**: GRC\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1019", "study": "Study 21", "site": "Site 1019", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 1019\n\n## Site Information\n- **Site ID**: Site 1019\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 102", "study": "Study 21", "site": "Site 102", "type": "site_summary", "total_subjects": 22, "total_issues": 0, "document": "# Site Report: Site 102\n\n## Site Information\n- **Site ID**: Site 102\n- **Study**: Study 21\n- **Country**: SVK\n- **Total Subjects**: 22\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 22 (100.0%)\n\n## Risk Profile\n- Low Risk: 22 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1020", "study": "Study 21", "site": "Site 1020", "type": "site_summary", "total_subjects": 52, "total_issues": 0, "document": "# Site Report: Site 1020\n\n## Site Information\n- **Site ID**: Site 1020\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 52\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 52 (100.0%)\n\n## Risk Profile\n- Low Risk: 52 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1021", "study": "Study 21", "site": "Site 1021", "type": "site_summary", "total_subjects": 8, "total_issues": 0, "document": "# Site Report: Site 1021\n\n## Site Information\n- **Site ID**: Site 1021\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 8 (100.0%)\n\n## Risk Profile\n- Low Risk: 8 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1022", "study": "Study 21", "site": "Site 1022", "type": "site_summary", "total_subjects": 34, "total_issues": 0, "document": "# Site Report: Site 1022\n\n## Site Information\n- **Site ID**: Site 1022\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 34\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 34 (100.0%)\n\n## Risk Profile\n- Low Risk: 34 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1023", "study": "Study 21", "site": "Site 1023", "type": "site_summary", "total_subjects": 11, "total_issues": 0, "document": "# Site Report: Site 1023\n\n## Site Information\n- **Site ID**: Site 1023\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 11 (100.0%)\n\n## Risk Profile\n- Low Risk: 11 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1024", "study": "Study 21", "site": "Site 1024", "type": "site_summary", "total_subjects": 28, "total_issues": 0, "document": "# Site Report: Site 1024\n\n## Site Information\n- **Site ID**: Site 1024\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 28\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 28 (100.0%)\n\n## Risk Profile\n- Low Risk: 28 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1025", "study": "Study 21", "site": "Site 1025", "type": "site_summary", "total_subjects": 38, "total_issues": 0, "document": "# Site Report: Site 1025\n\n## Site Information\n- **Site ID**: Site 1025\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 38\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 38 (100.0%)\n\n## Risk Profile\n- Low Risk: 38 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1026", "study": "Study 21", "site": "Site 1026", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 1026\n\n## Site Information\n- **Site ID**: Site 1026\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1028", "study": "Study 21", "site": "Site 1028", "type": "site_summary", "total_subjects": 9, "total_issues": 0, "document": "# Site Report: Site 1028\n\n## Site Information\n- **Site ID**: Site 1028\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 9 (100.0%)\n\n## Risk Profile\n- Low Risk: 9 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1029", "study": "Study 21", "site": "Site 1029", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1029\n\n## Site Information\n- **Site ID**: Site 1029\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1030", "study": "Study 21", "site": "Site 1030", "type": "site_summary", "total_subjects": 11, "total_issues": 0, "document": "# Site Report: Site 1030\n\n## Site Information\n- **Site ID**: Site 1030\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 11 (100.0%)\n\n## Risk Profile\n- Low Risk: 11 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1031", "study": "Study 21", "site": "Site 1031", "type": "site_summary", "total_subjects": 24, "total_issues": 0, "document": "# Site Report: Site 1031\n\n## Site Information\n- **Site ID**: Site 1031\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 24\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 24 (100.0%)\n\n## Risk Profile\n- Low Risk: 24 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1032", "study": "Study 21", "site": "Site 1032", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 1032\n\n## Site Information\n- **Site ID**: Site 1032\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1033", "study": "Study 21", "site": "Site 1033", "type": "site_summary", "total_subjects": 8, "total_issues": 0, "document": "# Site Report: Site 1033\n\n## Site Information\n- **Site ID**: Site 1033\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 8 (100.0%)\n\n## Risk Profile\n- Low Risk: 8 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1034", "study": "Study 21", "site": "Site 1034", "type": "site_summary", "total_subjects": 12, "total_issues": 0, "document": "# Site Report: Site 1034\n\n## Site Information\n- **Site ID**: Site 1034\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 12 (100.0%)\n\n## Risk Profile\n- Low Risk: 12 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1035", "study": "Study 21", "site": "Site 1035", "type": "site_summary", "total_subjects": 8, "total_issues": 0, "document": "# Site Report: Site 1035\n\n## Site Information\n- **Site ID**: Site 1035\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 8 (100.0%)\n\n## Risk Profile\n- Low Risk: 8 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1036", "study": "Study 21", "site": "Site 1036", "type": "site_summary", "total_subjects": 12, "total_issues": 0, "document": "# Site Report: Site 1036\n\n## Site Information\n- **Site ID**: Site 1036\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 12 (100.0%)\n\n## Risk Profile\n- Low Risk: 12 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1037", "study": "Study 21", "site": "Site 1037", "type": "site_summary", "total_subjects": 17, "total_issues": 0, "document": "# Site Report: Site 1037\n\n## Site Information\n- **Site ID**: Site 1037\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 17\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 17 (100.0%)\n\n## Risk Profile\n- Low Risk: 17 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1038", "study": "Study 21", "site": "Site 1038", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1038\n\n## Site Information\n- **Site ID**: Site 1038\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1039", "study": "Study 21", "site": "Site 1039", "type": "site_summary", "total_subjects": 18, "total_issues": 0, "document": "# Site Report: Site 1039\n\n## Site Information\n- **Site ID**: Site 1039\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 18\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 18 (100.0%)\n\n## Risk Profile\n- Low Risk: 18 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1040", "study": "Study 21", "site": "Site 1040", "type": "site_summary", "total_subjects": 17, "total_issues": 2, "document": "# Site Report: Site 1040\n\n## Site Information\n- **Site ID**: Site 1040\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 17\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.12\n- **Clean Subjects**: 15 (88.2%)\n\n## Risk Profile\n- Low Risk: 15 (88.2%)\n- Medium Risk: 2 (11.8%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1041", "study": "Study 21", "site": "Site 1041", "type": "site_summary", "total_subjects": 15, "total_issues": 0, "document": "# Site Report: Site 1041\n\n## Site Information\n- **Site ID**: Site 1041\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 15\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 15 (100.0%)\n\n## Risk Profile\n- Low Risk: 15 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1042", "study": "Study 21", "site": "Site 1042", "type": "site_summary", "total_subjects": 41, "total_issues": 2, "document": "# Site Report: Site 1042\n\n## Site Information\n- **Site ID**: Site 1042\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 41\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.05\n- **Clean Subjects**: 39 (95.1%)\n\n## Risk Profile\n- Low Risk: 39 (95.1%)\n- Medium Risk: 2 (4.9%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1043", "study": "Study 21", "site": "Site 1043", "type": "site_summary", "total_subjects": 9, "total_issues": 0, "document": "# Site Report: Site 1043\n\n## Site Information\n- **Site ID**: Site 1043\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 9 (100.0%)\n\n## Risk Profile\n- Low Risk: 9 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1044", "study": "Study 21", "site": "Site 1044", "type": "site_summary", "total_subjects": 19, "total_issues": 6, "document": "# Site Report: Site 1044\n\n## Site Information\n- **Site ID**: Site 1044\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 19\n\n## Performance Metrics\n- **Total Issues**: 6\n- **Average Issues per Subject**: 0.32\n- **Clean Subjects**: 13 (68.4%)\n\n## Risk Profile\n- Low Risk: 13 (68.4%)\n- Medium Risk: 6 (31.6%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 6\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1045", "study": "Study 21", "site": "Site 1045", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 1045\n\n## Site Information\n- **Site ID**: Site 1045\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1046", "study": "Study 21", "site": "Site 1046", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 1046\n\n## Site Information\n- **Site ID**: Site 1046\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1047", "study": "Study 21", "site": "Site 1047", "type": "site_summary", "total_subjects": 11, "total_issues": 0, "document": "# Site Report: Site 1047\n\n## Site Information\n- **Site ID**: Site 1047\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 11 (100.0%)\n\n## Risk Profile\n- Low Risk: 11 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1048", "study": "Study 21", "site": "Site 1048", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 1048\n\n## Site Information\n- **Site ID**: Site 1048\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1049", "study": "Study 21", "site": "Site 1049", "type": "site_summary", "total_subjects": 11, "total_issues": 0, "document": "# Site Report: Site 1049\n\n## Site Information\n- **Site ID**: Site 1049\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 11 (100.0%)\n\n## Risk Profile\n- Low Risk: 11 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1050", "study": "Study 21", "site": "Site 1050", "type": "site_summary", "total_subjects": 15, "total_issues": 0, "document": "# Site Report: Site 1050\n\n## Site Information\n- **Site ID**: Site 1050\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 15\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 15 (100.0%)\n\n## Risk Profile\n- Low Risk: 15 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1051", "study": "Study 21", "site": "Site 1051", "type": "site_summary", "total_subjects": 12, "total_issues": 2, "document": "# Site Report: Site 1051\n\n## Site Information\n- **Site ID**: Site 1051\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.17\n- **Clean Subjects**: 10 (83.3%)\n\n## Risk Profile\n- Low Risk: 10 (83.3%)\n- Medium Risk: 2 (16.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1052", "study": "Study 21", "site": "Site 1052", "type": "site_summary", "total_subjects": 16, "total_issues": 7, "document": "# Site Report: Site 1052\n\n## Site Information\n- **Site ID**: Site 1052\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 16\n\n## Performance Metrics\n- **Total Issues**: 7\n- **Average Issues per Subject**: 0.44\n- **Clean Subjects**: 9 (56.2%)\n\n## Risk Profile\n- Low Risk: 9 (56.2%)\n- Medium Risk: 7 (43.8%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 7\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1053", "study": "Study 21", "site": "Site 1053", "type": "site_summary", "total_subjects": 19, "total_issues": 0, "document": "# Site Report: Site 1053\n\n## Site Information\n- **Site ID**: Site 1053\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 19\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 19 (100.0%)\n\n## Risk Profile\n- Low Risk: 19 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1055", "study": "Study 21", "site": "Site 1055", "type": "site_summary", "total_subjects": 9, "total_issues": 0, "document": "# Site Report: Site 1055\n\n## Site Information\n- **Site ID**: Site 1055\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 9 (100.0%)\n\n## Risk Profile\n- Low Risk: 9 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1056", "study": "Study 21", "site": "Site 1056", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1056\n\n## Site Information\n- **Site ID**: Site 1056\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1057", "study": "Study 21", "site": "Site 1057", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 1057\n\n## Site Information\n- **Site ID**: Site 1057\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1058", "study": "Study 21", "site": "Site 1058", "type": "site_summary", "total_subjects": 25, "total_issues": 0, "document": "# Site Report: Site 1058\n\n## Site Information\n- **Site ID**: Site 1058\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 25\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 25 (100.0%)\n\n## Risk Profile\n- Low Risk: 25 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1059", "study": "Study 21", "site": "Site 1059", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 1059\n\n## Site Information\n- **Site ID**: Site 1059\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1060", "study": "Study 21", "site": "Site 1060", "type": "site_summary", "total_subjects": 19, "total_issues": 0, "document": "# Site Report: Site 1060\n\n## Site Information\n- **Site ID**: Site 1060\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 19\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 19 (100.0%)\n\n## Risk Profile\n- Low Risk: 19 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1061", "study": "Study 21", "site": "Site 1061", "type": "site_summary", "total_subjects": 20, "total_issues": 0, "document": "# Site Report: Site 1061\n\n## Site Information\n- **Site ID**: Site 1061\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 20\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 20 (100.0%)\n\n## Risk Profile\n- Low Risk: 20 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1062", "study": "Study 21", "site": "Site 1062", "type": "site_summary", "total_subjects": 20, "total_issues": 0, "document": "# Site Report: Site 1062\n\n## Site Information\n- **Site ID**: Site 1062\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 20\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 20 (100.0%)\n\n## Risk Profile\n- Low Risk: 20 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1063", "study": "Study 21", "site": "Site 1063", "type": "site_summary", "total_subjects": 16, "total_issues": 0, "document": "# Site Report: Site 1063\n\n## Site Information\n- **Site ID**: Site 1063\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 16\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 16 (100.0%)\n\n## Risk Profile\n- Low Risk: 16 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1064", "study": "Study 21", "site": "Site 1064", "type": "site_summary", "total_subjects": 10, "total_issues": 0, "document": "# Site Report: Site 1064\n\n## Site Information\n- **Site ID**: Site 1064\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 10 (100.0%)\n\n## Risk Profile\n- Low Risk: 10 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1065", "study": "Study 21", "site": "Site 1065", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 1065\n\n## Site Information\n- **Site ID**: Site 1065\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1066", "study": "Study 21", "site": "Site 1066", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 1066\n\n## Site Information\n- **Site ID**: Site 1066\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1067", "study": "Study 21", "site": "Site 1067", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 1067\n\n## Site Information\n- **Site ID**: Site 1067\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1068", "study": "Study 21", "site": "Site 1068", "type": "site_summary", "total_subjects": 12, "total_issues": 0, "document": "# Site Report: Site 1068\n\n## Site Information\n- **Site ID**: Site 1068\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 12 (100.0%)\n\n## Risk Profile\n- Low Risk: 12 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1069", "study": "Study 21", "site": "Site 1069", "type": "site_summary", "total_subjects": 23, "total_issues": 0, "document": "# Site Report: Site 1069\n\n## Site Information\n- **Site ID**: Site 1069\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 23\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 23 (100.0%)\n\n## Risk Profile\n- Low Risk: 23 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1070", "study": "Study 21", "site": "Site 1070", "type": "site_summary", "total_subjects": 16, "total_issues": 0, "document": "# Site Report: Site 1070\n\n## Site Information\n- **Site ID**: Site 1070\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 16\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 16 (100.0%)\n\n## Risk Profile\n- Low Risk: 16 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 7\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1071", "study": "Study 21", "site": "Site 1071", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 1071\n\n## Site Information\n- **Site ID**: Site 1071\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1072", "study": "Study 21", "site": "Site 1072", "type": "site_summary", "total_subjects": 16, "total_issues": 1, "document": "# Site Report: Site 1072\n\n## Site Information\n- **Site ID**: Site 1072\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 16\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.06\n- **Clean Subjects**: 15 (93.8%)\n\n## Risk Profile\n- Low Risk: 15 (93.8%)\n- Medium Risk: 1 (6.2%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1073", "study": "Study 21", "site": "Site 1073", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 1073\n\n## Site Information\n- **Site ID**: Site 1073\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1074", "study": "Study 21", "site": "Site 1074", "type": "site_summary", "total_subjects": 17, "total_issues": 0, "document": "# Site Report: Site 1074\n\n## Site Information\n- **Site ID**: Site 1074\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 17\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 17 (100.0%)\n\n## Risk Profile\n- Low Risk: 17 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1075", "study": "Study 21", "site": "Site 1075", "type": "site_summary", "total_subjects": 8, "total_issues": 0, "document": "# Site Report: Site 1075\n\n## Site Information\n- **Site ID**: Site 1075\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 8 (100.0%)\n\n## Risk Profile\n- Low Risk: 8 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1076", "study": "Study 21", "site": "Site 1076", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 1076\n\n## Site Information\n- **Site ID**: Site 1076\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1077", "study": "Study 21", "site": "Site 1077", "type": "site_summary", "total_subjects": 19, "total_issues": 0, "document": "# Site Report: Site 1077\n\n## Site Information\n- **Site ID**: Site 1077\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 19\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 19 (100.0%)\n\n## Risk Profile\n- Low Risk: 19 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1078", "study": "Study 21", "site": "Site 1078", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 1078\n\n## Site Information\n- **Site ID**: Site 1078\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1079", "study": "Study 21", "site": "Site 1079", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1079\n\n## Site Information\n- **Site ID**: Site 1079\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 108", "study": "Study 21", "site": "Site 108", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 108\n\n## Site Information\n- **Site ID**: Site 108\n- **Study**: Study 21\n- **Country**: IND\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1080", "study": "Study 21", "site": "Site 1080", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1080\n\n## Site Information\n- **Site ID**: Site 1080\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1081", "study": "Study 21", "site": "Site 1081", "type": "site_summary", "total_subjects": 10, "total_issues": 0, "document": "# Site Report: Site 1081\n\n## Site Information\n- **Site ID**: Site 1081\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 10 (100.0%)\n\n## Risk Profile\n- Low Risk: 10 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1082", "study": "Study 21", "site": "Site 1082", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 1082\n\n## Site Information\n- **Site ID**: Site 1082\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1083", "study": "Study 21", "site": "Site 1083", "type": "site_summary", "total_subjects": 19, "total_issues": 0, "document": "# Site Report: Site 1083\n\n## Site Information\n- **Site ID**: Site 1083\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 19\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 19 (100.0%)\n\n## Risk Profile\n- Low Risk: 19 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1084", "study": "Study 21", "site": "Site 1084", "type": "site_summary", "total_subjects": 11, "total_issues": 0, "document": "# Site Report: Site 1084\n\n## Site Information\n- **Site ID**: Site 1084\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 11 (100.0%)\n\n## Risk Profile\n- Low Risk: 11 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1085", "study": "Study 21", "site": "Site 1085", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 1085\n\n## Site Information\n- **Site ID**: Site 1085\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1086", "study": "Study 21", "site": "Site 1086", "type": "site_summary", "total_subjects": 17, "total_issues": 0, "document": "# Site Report: Site 1086\n\n## Site Information\n- **Site ID**: Site 1086\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 17\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 17 (100.0%)\n\n## Risk Profile\n- Low Risk: 17 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1087", "study": "Study 21", "site": "Site 1087", "type": "site_summary", "total_subjects": 9, "total_issues": 0, "document": "# Site Report: Site 1087\n\n## Site Information\n- **Site ID**: Site 1087\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 9 (100.0%)\n\n## Risk Profile\n- Low Risk: 9 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1088", "study": "Study 21", "site": "Site 1088", "type": "site_summary", "total_subjects": 10, "total_issues": 0, "document": "# Site Report: Site 1088\n\n## Site Information\n- **Site ID**: Site 1088\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 10 (100.0%)\n\n## Risk Profile\n- Low Risk: 10 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1089", "study": "Study 21", "site": "Site 1089", "type": "site_summary", "total_subjects": 15, "total_issues": 0, "document": "# Site Report: Site 1089\n\n## Site Information\n- **Site ID**: Site 1089\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 15\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 15 (100.0%)\n\n## Risk Profile\n- Low Risk: 15 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1090", "study": "Study 21", "site": "Site 1090", "type": "site_summary", "total_subjects": 12, "total_issues": 2, "document": "# Site Report: Site 1090\n\n## Site Information\n- **Site ID**: Site 1090\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.17\n- **Clean Subjects**: 11 (91.7%)\n\n## Risk Profile\n- Low Risk: 11 (91.7%)\n- Medium Risk: 1 (8.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1091", "study": "Study 21", "site": "Site 1091", "type": "site_summary", "total_subjects": 18, "total_issues": 0, "document": "# Site Report: Site 1091\n\n## Site Information\n- **Site ID**: Site 1091\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 18\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 18 (100.0%)\n\n## Risk Profile\n- Low Risk: 18 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1092", "study": "Study 21", "site": "Site 1092", "type": "site_summary", "total_subjects": 24, "total_issues": 0, "document": "# Site Report: Site 1092\n\n## Site Information\n- **Site ID**: Site 1092\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 24\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 24 (100.0%)\n\n## Risk Profile\n- Low Risk: 24 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1093", "study": "Study 21", "site": "Site 1093", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 1093\n\n## Site Information\n- **Site ID**: Site 1093\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1094", "study": "Study 21", "site": "Site 1094", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 1094\n\n## Site Information\n- **Site ID**: Site 1094\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1095", "study": "Study 21", "site": "Site 1095", "type": "site_summary", "total_subjects": 22, "total_issues": 0, "document": "# Site Report: Site 1095\n\n## Site Information\n- **Site ID**: Site 1095\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 22\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 22 (100.0%)\n\n## Risk Profile\n- Low Risk: 22 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1096", "study": "Study 21", "site": "Site 1096", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 1096\n\n## Site Information\n- **Site ID**: Site 1096\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1097", "study": "Study 21", "site": "Site 1097", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 1097\n\n## Site Information\n- **Site ID**: Site 1097\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1098", "study": "Study 21", "site": "Site 1098", "type": "site_summary", "total_subjects": 9, "total_issues": 1, "document": "# Site Report: Site 1098\n\n## Site Information\n- **Site ID**: Site 1098\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.11\n- **Clean Subjects**: 8 (88.9%)\n\n## Risk Profile\n- Low Risk: 8 (88.9%)\n- Medium Risk: 1 (11.1%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1099", "study": "Study 21", "site": "Site 1099", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 1099\n\n## Site Information\n- **Site ID**: Site 1099\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 11", "study": "Study 21", "site": "Site 11", "type": "site_summary", "total_subjects": 27, "total_issues": 4, "document": "# Site Report: Site 11\n\n## Site Information\n- **Site ID**: Site 11\n- **Study**: Study 21\n- **Country**: FRA\n- **Total Subjects**: 27\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 0.15\n- **Clean Subjects**: 24 (88.9%)\n\n## Risk Profile\n- Low Risk: 24 (88.9%)\n- Medium Risk: 3 (11.1%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 4\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1100", "study": "Study 21", "site": "Site 1100", "type": "site_summary", "total_subjects": 21, "total_issues": 0, "document": "# Site Report: Site 1100\n\n## Site Information\n- **Site ID**: Site 1100\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 21\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 21 (100.0%)\n\n## Risk Profile\n- Low Risk: 21 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1101", "study": "Study 21", "site": "Site 1101", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1101\n\n## Site Information\n- **Site ID**: Site 1101\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1102", "study": "Study 21", "site": "Site 1102", "type": "site_summary", "total_subjects": 11, "total_issues": 0, "document": "# Site Report: Site 1102\n\n## Site Information\n- **Site ID**: Site 1102\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 11 (100.0%)\n\n## Risk Profile\n- Low Risk: 11 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1103", "study": "Study 21", "site": "Site 1103", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 1103\n\n## Site Information\n- **Site ID**: Site 1103\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1104", "study": "Study 21", "site": "Site 1104", "type": "site_summary", "total_subjects": 13, "total_issues": 0, "document": "# Site Report: Site 1104\n\n## Site Information\n- **Site ID**: Site 1104\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 13 (100.0%)\n\n## Risk Profile\n- Low Risk: 13 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1105", "study": "Study 21", "site": "Site 1105", "type": "site_summary", "total_subjects": 21, "total_issues": 0, "document": "# Site Report: Site 1105\n\n## Site Information\n- **Site ID**: Site 1105\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 21\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 21 (100.0%)\n\n## Risk Profile\n- Low Risk: 21 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1106", "study": "Study 21", "site": "Site 1106", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 1106\n\n## Site Information\n- **Site ID**: Site 1106\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1107", "study": "Study 21", "site": "Site 1107", "type": "site_summary", "total_subjects": 12, "total_issues": 1, "document": "# Site Report: Site 1107\n\n## Site Information\n- **Site ID**: Site 1107\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.08\n- **Clean Subjects**: 11 (91.7%)\n\n## Risk Profile\n- Low Risk: 11 (91.7%)\n- Medium Risk: 1 (8.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1108", "study": "Study 21", "site": "Site 1108", "type": "site_summary", "total_subjects": 12, "total_issues": 0, "document": "# Site Report: Site 1108\n\n## Site Information\n- **Site ID**: Site 1108\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 12 (100.0%)\n\n## Risk Profile\n- Low Risk: 12 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1109", "study": "Study 21", "site": "Site 1109", "type": "site_summary", "total_subjects": 10, "total_issues": 0, "document": "# Site Report: Site 1109\n\n## Site Information\n- **Site ID**: Site 1109\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 10 (100.0%)\n\n## Risk Profile\n- Low Risk: 10 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1110", "study": "Study 21", "site": "Site 1110", "type": "site_summary", "total_subjects": 152, "total_issues": 1, "document": "# Site Report: Site 1110\n\n## Site Information\n- **Site ID**: Site 1110\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 152\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.01\n- **Clean Subjects**: 151 (99.3%)\n\n## Risk Profile\n- Low Risk: 151 (99.3%)\n- Medium Risk: 1 (0.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 3\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1111", "study": "Study 21", "site": "Site 1111", "type": "site_summary", "total_subjects": 6, "total_issues": 1, "document": "# Site Report: Site 1111\n\n## Site Information\n- **Site ID**: Site 1111\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.17\n- **Clean Subjects**: 5 (83.3%)\n\n## Risk Profile\n- Low Risk: 5 (83.3%)\n- Medium Risk: 1 (16.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1112", "study": "Study 21", "site": "Site 1112", "type": "site_summary", "total_subjects": 9, "total_issues": 0, "document": "# Site Report: Site 1112\n\n## Site Information\n- **Site ID**: Site 1112\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 9 (100.0%)\n\n## Risk Profile\n- Low Risk: 9 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1113", "study": "Study 21", "site": "Site 1113", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1113\n\n## Site Information\n- **Site ID**: Site 1113\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1114", "study": "Study 21", "site": "Site 1114", "type": "site_summary", "total_subjects": 26, "total_issues": 1, "document": "# Site Report: Site 1114\n\n## Site Information\n- **Site ID**: Site 1114\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 26\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.04\n- **Clean Subjects**: 25 (96.2%)\n\n## Risk Profile\n- Low Risk: 25 (96.2%)\n- Medium Risk: 1 (3.8%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1115", "study": "Study 21", "site": "Site 1115", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 1115\n\n## Site Information\n- **Site ID**: Site 1115\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1116", "study": "Study 21", "site": "Site 1116", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 1116\n\n## Site Information\n- **Site ID**: Site 1116\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1117", "study": "Study 21", "site": "Site 1117", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 1117\n\n## Site Information\n- **Site ID**: Site 1117\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1118", "study": "Study 21", "site": "Site 1118", "type": "site_summary", "total_subjects": 9, "total_issues": 0, "document": "# Site Report: Site 1118\n\n## Site Information\n- **Site ID**: Site 1118\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 9 (100.0%)\n\n## Risk Profile\n- Low Risk: 9 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1119", "study": "Study 21", "site": "Site 1119", "type": "site_summary", "total_subjects": 8, "total_issues": 0, "document": "# Site Report: Site 1119\n\n## Site Information\n- **Site ID**: Site 1119\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 8 (100.0%)\n\n## Risk Profile\n- Low Risk: 8 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1120", "study": "Study 21", "site": "Site 1120", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 1120\n\n## Site Information\n- **Site ID**: Site 1120\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1121", "study": "Study 21", "site": "Site 1121", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1121\n\n## Site Information\n- **Site ID**: Site 1121\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1122", "study": "Study 21", "site": "Site 1122", "type": "site_summary", "total_subjects": 9, "total_issues": 0, "document": "# Site Report: Site 1122\n\n## Site Information\n- **Site ID**: Site 1122\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 9 (100.0%)\n\n## Risk Profile\n- Low Risk: 9 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1123", "study": "Study 21", "site": "Site 1123", "type": "site_summary", "total_subjects": 11, "total_issues": 0, "document": "# Site Report: Site 1123\n\n## Site Information\n- **Site ID**: Site 1123\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 11 (100.0%)\n\n## Risk Profile\n- Low Risk: 11 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1124", "study": "Study 21", "site": "Site 1124", "type": "site_summary", "total_subjects": 12, "total_issues": 0, "document": "# Site Report: Site 1124\n\n## Site Information\n- **Site ID**: Site 1124\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 12 (100.0%)\n\n## Risk Profile\n- Low Risk: 12 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1125", "study": "Study 21", "site": "Site 1125", "type": "site_summary", "total_subjects": 21, "total_issues": 0, "document": "# Site Report: Site 1125\n\n## Site Information\n- **Site ID**: Site 1125\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 21\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 21 (100.0%)\n\n## Risk Profile\n- Low Risk: 21 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1126", "study": "Study 21", "site": "Site 1126", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 1126\n\n## Site Information\n- **Site ID**: Site 1126\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1127", "study": "Study 21", "site": "Site 1127", "type": "site_summary", "total_subjects": 17, "total_issues": 0, "document": "# Site Report: Site 1127\n\n## Site Information\n- **Site ID**: Site 1127\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 17\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 17 (100.0%)\n\n## Risk Profile\n- Low Risk: 17 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1128", "study": "Study 21", "site": "Site 1128", "type": "site_summary", "total_subjects": 12, "total_issues": 0, "document": "# Site Report: Site 1128\n\n## Site Information\n- **Site ID**: Site 1128\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 12 (100.0%)\n\n## Risk Profile\n- Low Risk: 12 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1129", "study": "Study 21", "site": "Site 1129", "type": "site_summary", "total_subjects": 10, "total_issues": 1, "document": "# Site Report: Site 1129\n\n## Site Information\n- **Site ID**: Site 1129\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.10\n- **Clean Subjects**: 9 (90.0%)\n\n## Risk Profile\n- Low Risk: 9 (90.0%)\n- Medium Risk: 1 (10.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 113", "study": "Study 21", "site": "Site 113", "type": "site_summary", "total_subjects": 26, "total_issues": 0, "document": "# Site Report: Site 113\n\n## Site Information\n- **Site ID**: Site 113\n- **Study**: Study 21\n- **Country**: HRV\n- **Total Subjects**: 26\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 26 (100.0%)\n\n## Risk Profile\n- Low Risk: 26 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 4\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1130", "study": "Study 21", "site": "Site 1130", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1130\n\n## Site Information\n- **Site ID**: Site 1130\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1131", "study": "Study 21", "site": "Site 1131", "type": "site_summary", "total_subjects": 13, "total_issues": 0, "document": "# Site Report: Site 1131\n\n## Site Information\n- **Site ID**: Site 1131\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 13 (100.0%)\n\n## Risk Profile\n- Low Risk: 13 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1132", "study": "Study 21", "site": "Site 1132", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 1132\n\n## Site Information\n- **Site ID**: Site 1132\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1133", "study": "Study 21", "site": "Site 1133", "type": "site_summary", "total_subjects": 8, "total_issues": 0, "document": "# Site Report: Site 1133\n\n## Site Information\n- **Site ID**: Site 1133\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 8 (100.0%)\n\n## Risk Profile\n- Low Risk: 8 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1134", "study": "Study 21", "site": "Site 1134", "type": "site_summary", "total_subjects": 25, "total_issues": 0, "document": "# Site Report: Site 1134\n\n## Site Information\n- **Site ID**: Site 1134\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 25\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 25 (100.0%)\n\n## Risk Profile\n- Low Risk: 25 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1135", "study": "Study 21", "site": "Site 1135", "type": "site_summary", "total_subjects": 22, "total_issues": 0, "document": "# Site Report: Site 1135\n\n## Site Information\n- **Site ID**: Site 1135\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 22\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 22 (100.0%)\n\n## Risk Profile\n- Low Risk: 22 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1136", "study": "Study 21", "site": "Site 1136", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 1136\n\n## Site Information\n- **Site ID**: Site 1136\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1137", "study": "Study 21", "site": "Site 1137", "type": "site_summary", "total_subjects": 10, "total_issues": 0, "document": "# Site Report: Site 1137\n\n## Site Information\n- **Site ID**: Site 1137\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 10 (100.0%)\n\n## Risk Profile\n- Low Risk: 10 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1138", "study": "Study 21", "site": "Site 1138", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 1138\n\n## Site Information\n- **Site ID**: Site 1138\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1139", "study": "Study 21", "site": "Site 1139", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1139\n\n## Site Information\n- **Site ID**: Site 1139\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1140", "study": "Study 21", "site": "Site 1140", "type": "site_summary", "total_subjects": 12, "total_issues": 0, "document": "# Site Report: Site 1140\n\n## Site Information\n- **Site ID**: Site 1140\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 12 (100.0%)\n\n## Risk Profile\n- Low Risk: 12 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1141", "study": "Study 21", "site": "Site 1141", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 1141\n\n## Site Information\n- **Site ID**: Site 1141\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1142", "study": "Study 21", "site": "Site 1142", "type": "site_summary", "total_subjects": 10, "total_issues": 0, "document": "# Site Report: Site 1142\n\n## Site Information\n- **Site ID**: Site 1142\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 10 (100.0%)\n\n## Risk Profile\n- Low Risk: 10 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1143", "study": "Study 21", "site": "Site 1143", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 1143\n\n## Site Information\n- **Site ID**: Site 1143\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1144", "study": "Study 21", "site": "Site 1144", "type": "site_summary", "total_subjects": 30, "total_issues": 0, "document": "# Site Report: Site 1144\n\n## Site Information\n- **Site ID**: Site 1144\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 30\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 30 (100.0%)\n\n## Risk Profile\n- Low Risk: 30 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1145", "study": "Study 21", "site": "Site 1145", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1145\n\n## Site Information\n- **Site ID**: Site 1145\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1146", "study": "Study 21", "site": "Site 1146", "type": "site_summary", "total_subjects": 14, "total_issues": 3, "document": "# Site Report: Site 1146\n\n## Site Information\n- **Site ID**: Site 1146\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 14\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 0.21\n- **Clean Subjects**: 12 (85.7%)\n\n## Risk Profile\n- Low Risk: 12 (85.7%)\n- Medium Risk: 2 (14.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1147", "study": "Study 21", "site": "Site 1147", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 1147\n\n## Site Information\n- **Site ID**: Site 1147\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1148", "study": "Study 21", "site": "Site 1148", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 1148\n\n## Site Information\n- **Site ID**: Site 1148\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1149", "study": "Study 21", "site": "Site 1149", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 1149\n\n## Site Information\n- **Site ID**: Site 1149\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1150", "study": "Study 21", "site": "Site 1150", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1150\n\n## Site Information\n- **Site ID**: Site 1150\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1151", "study": "Study 21", "site": "Site 1151", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1151\n\n## Site Information\n- **Site ID**: Site 1151\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1152", "study": "Study 21", "site": "Site 1152", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1152\n\n## Site Information\n- **Site ID**: Site 1152\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1153", "study": "Study 21", "site": "Site 1153", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 1153\n\n## Site Information\n- **Site ID**: Site 1153\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1154", "study": "Study 21", "site": "Site 1154", "type": "site_summary", "total_subjects": 12, "total_issues": 0, "document": "# Site Report: Site 1154\n\n## Site Information\n- **Site ID**: Site 1154\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 12 (100.0%)\n\n## Risk Profile\n- Low Risk: 12 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1155", "study": "Study 21", "site": "Site 1155", "type": "site_summary", "total_subjects": 8, "total_issues": 1, "document": "# Site Report: Site 1155\n\n## Site Information\n- **Site ID**: Site 1155\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.12\n- **Clean Subjects**: 7 (87.5%)\n\n## Risk Profile\n- Low Risk: 7 (87.5%)\n- Medium Risk: 1 (12.5%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1156", "study": "Study 21", "site": "Site 1156", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 1156\n\n## Site Information\n- **Site ID**: Site 1156\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1157", "study": "Study 21", "site": "Site 1157", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 1157\n\n## Site Information\n- **Site ID**: Site 1157\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1158", "study": "Study 21", "site": "Site 1158", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 1158\n\n## Site Information\n- **Site ID**: Site 1158\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1159", "study": "Study 21", "site": "Site 1159", "type": "site_summary", "total_subjects": 23, "total_issues": 0, "document": "# Site Report: Site 1159\n\n## Site Information\n- **Site ID**: Site 1159\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 23\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 23 (100.0%)\n\n## Risk Profile\n- Low Risk: 23 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1160", "study": "Study 21", "site": "Site 1160", "type": "site_summary", "total_subjects": 11, "total_issues": 0, "document": "# Site Report: Site 1160\n\n## Site Information\n- **Site ID**: Site 1160\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 11 (100.0%)\n\n## Risk Profile\n- Low Risk: 11 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1161", "study": "Study 21", "site": "Site 1161", "type": "site_summary", "total_subjects": 56, "total_issues": 0, "document": "# Site Report: Site 1161\n\n## Site Information\n- **Site ID**: Site 1161\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 56\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 56 (100.0%)\n\n## Risk Profile\n- Low Risk: 56 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1162", "study": "Study 21", "site": "Site 1162", "type": "site_summary", "total_subjects": 8, "total_issues": 0, "document": "# Site Report: Site 1162\n\n## Site Information\n- **Site ID**: Site 1162\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 8 (100.0%)\n\n## Risk Profile\n- Low Risk: 8 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1163", "study": "Study 21", "site": "Site 1163", "type": "site_summary", "total_subjects": 10, "total_issues": 0, "document": "# Site Report: Site 1163\n\n## Site Information\n- **Site ID**: Site 1163\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 10 (100.0%)\n\n## Risk Profile\n- Low Risk: 10 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1164", "study": "Study 21", "site": "Site 1164", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 1164\n\n## Site Information\n- **Site ID**: Site 1164\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1165", "study": "Study 21", "site": "Site 1165", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1165\n\n## Site Information\n- **Site ID**: Site 1165\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1166", "study": "Study 21", "site": "Site 1166", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 1166\n\n## Site Information\n- **Site ID**: Site 1166\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1167", "study": "Study 21", "site": "Site 1167", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 1167\n\n## Site Information\n- **Site ID**: Site 1167\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1168", "study": "Study 21", "site": "Site 1168", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 1168\n\n## Site Information\n- **Site ID**: Site 1168\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1169", "study": "Study 21", "site": "Site 1169", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 1169\n\n## Site Information\n- **Site ID**: Site 1169\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1170", "study": "Study 21", "site": "Site 1170", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 1170\n\n## Site Information\n- **Site ID**: Site 1170\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1171", "study": "Study 21", "site": "Site 1171", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 1171\n\n## Site Information\n- **Site ID**: Site 1171\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1172", "study": "Study 21", "site": "Site 1172", "type": "site_summary", "total_subjects": 3, "total_issues": 1, "document": "# Site Report: Site 1172\n\n## Site Information\n- **Site ID**: Site 1172\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.33\n- **Clean Subjects**: 2 (66.7%)\n\n## Risk Profile\n- Low Risk: 2 (66.7%)\n- Medium Risk: 1 (33.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1173", "study": "Study 21", "site": "Site 1173", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 1173\n\n## Site Information\n- **Site ID**: Site 1173\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1174", "study": "Study 21", "site": "Site 1174", "type": "site_summary", "total_subjects": 10, "total_issues": 0, "document": "# Site Report: Site 1174\n\n## Site Information\n- **Site ID**: Site 1174\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 10 (100.0%)\n\n## Risk Profile\n- Low Risk: 10 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1175", "study": "Study 21", "site": "Site 1175", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 1175\n\n## Site Information\n- **Site ID**: Site 1175\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1177", "study": "Study 21", "site": "Site 1177", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 1177\n\n## Site Information\n- **Site ID**: Site 1177\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1178", "study": "Study 21", "site": "Site 1178", "type": "site_summary", "total_subjects": 8, "total_issues": 1, "document": "# Site Report: Site 1178\n\n## Site Information\n- **Site ID**: Site 1178\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.12\n- **Clean Subjects**: 7 (87.5%)\n\n## Risk Profile\n- Low Risk: 7 (87.5%)\n- Medium Risk: 1 (12.5%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1179", "study": "Study 21", "site": "Site 1179", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1179\n\n## Site Information\n- **Site ID**: Site 1179\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1180", "study": "Study 21", "site": "Site 1180", "type": "site_summary", "total_subjects": 21, "total_issues": 4, "document": "# Site Report: Site 1180\n\n## Site Information\n- **Site ID**: Site 1180\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 21\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 0.19\n- **Clean Subjects**: 20 (95.2%)\n\n## Risk Profile\n- Low Risk: 20 (95.2%)\n- Medium Risk: 1 (4.8%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1181", "study": "Study 21", "site": "Site 1181", "type": "site_summary", "total_subjects": 13, "total_issues": 0, "document": "# Site Report: Site 1181\n\n## Site Information\n- **Site ID**: Site 1181\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 13 (100.0%)\n\n## Risk Profile\n- Low Risk: 13 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1182", "study": "Study 21", "site": "Site 1182", "type": "site_summary", "total_subjects": 16, "total_issues": 0, "document": "# Site Report: Site 1182\n\n## Site Information\n- **Site ID**: Site 1182\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 16\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 16 (100.0%)\n\n## Risk Profile\n- Low Risk: 16 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1183", "study": "Study 21", "site": "Site 1183", "type": "site_summary", "total_subjects": 11, "total_issues": 0, "document": "# Site Report: Site 1183\n\n## Site Information\n- **Site ID**: Site 1183\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 11 (100.0%)\n\n## Risk Profile\n- Low Risk: 11 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1184", "study": "Study 21", "site": "Site 1184", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 1184\n\n## Site Information\n- **Site ID**: Site 1184\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1185", "study": "Study 21", "site": "Site 1185", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 1185\n\n## Site Information\n- **Site ID**: Site 1185\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1186", "study": "Study 21", "site": "Site 1186", "type": "site_summary", "total_subjects": 9, "total_issues": 0, "document": "# Site Report: Site 1186\n\n## Site Information\n- **Site ID**: Site 1186\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 9 (100.0%)\n\n## Risk Profile\n- Low Risk: 9 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1187", "study": "Study 21", "site": "Site 1187", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 1187\n\n## Site Information\n- **Site ID**: Site 1187\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1188", "study": "Study 21", "site": "Site 1188", "type": "site_summary", "total_subjects": 9, "total_issues": 0, "document": "# Site Report: Site 1188\n\n## Site Information\n- **Site ID**: Site 1188\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 9 (100.0%)\n\n## Risk Profile\n- Low Risk: 9 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1189", "study": "Study 21", "site": "Site 1189", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 1189\n\n## Site Information\n- **Site ID**: Site 1189\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1190", "study": "Study 21", "site": "Site 1190", "type": "site_summary", "total_subjects": 16, "total_issues": 0, "document": "# Site Report: Site 1190\n\n## Site Information\n- **Site ID**: Site 1190\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 16\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 16 (100.0%)\n\n## Risk Profile\n- Low Risk: 16 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1191", "study": "Study 21", "site": "Site 1191", "type": "site_summary", "total_subjects": 13, "total_issues": 0, "document": "# Site Report: Site 1191\n\n## Site Information\n- **Site ID**: Site 1191\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 13 (100.0%)\n\n## Risk Profile\n- Low Risk: 13 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1192", "study": "Study 21", "site": "Site 1192", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 1192\n\n## Site Information\n- **Site ID**: Site 1192\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1193", "study": "Study 21", "site": "Site 1193", "type": "site_summary", "total_subjects": 18, "total_issues": 0, "document": "# Site Report: Site 1193\n\n## Site Information\n- **Site ID**: Site 1193\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 18\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 18 (100.0%)\n\n## Risk Profile\n- Low Risk: 18 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1194", "study": "Study 21", "site": "Site 1194", "type": "site_summary", "total_subjects": 40, "total_issues": 0, "document": "# Site Report: Site 1194\n\n## Site Information\n- **Site ID**: Site 1194\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 40\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 40 (100.0%)\n\n## Risk Profile\n- Low Risk: 40 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1195", "study": "Study 21", "site": "Site 1195", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1195\n\n## Site Information\n- **Site ID**: Site 1195\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1196", "study": "Study 21", "site": "Site 1196", "type": "site_summary", "total_subjects": 12, "total_issues": 0, "document": "# Site Report: Site 1196\n\n## Site Information\n- **Site ID**: Site 1196\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 12 (100.0%)\n\n## Risk Profile\n- Low Risk: 12 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1197", "study": "Study 21", "site": "Site 1197", "type": "site_summary", "total_subjects": 19, "total_issues": 0, "document": "# Site Report: Site 1197\n\n## Site Information\n- **Site ID**: Site 1197\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 19\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 19 (100.0%)\n\n## Risk Profile\n- Low Risk: 19 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1198", "study": "Study 21", "site": "Site 1198", "type": "site_summary", "total_subjects": 20, "total_issues": 0, "document": "# Site Report: Site 1198\n\n## Site Information\n- **Site ID**: Site 1198\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 20\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 20 (100.0%)\n\n## Risk Profile\n- Low Risk: 20 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1199", "study": "Study 21", "site": "Site 1199", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 1199\n\n## Site Information\n- **Site ID**: Site 1199\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1200", "study": "Study 21", "site": "Site 1200", "type": "site_summary", "total_subjects": 23, "total_issues": 0, "document": "# Site Report: Site 1200\n\n## Site Information\n- **Site ID**: Site 1200\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 23\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 23 (100.0%)\n\n## Risk Profile\n- Low Risk: 23 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1201", "study": "Study 21", "site": "Site 1201", "type": "site_summary", "total_subjects": 5, "total_issues": 2, "document": "# Site Report: Site 1201\n\n## Site Information\n- **Site ID**: Site 1201\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.40\n- **Clean Subjects**: 3 (60.0%)\n\n## Risk Profile\n- Low Risk: 3 (60.0%)\n- Medium Risk: 2 (40.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1202", "study": "Study 21", "site": "Site 1202", "type": "site_summary", "total_subjects": 18, "total_issues": 0, "document": "# Site Report: Site 1202\n\n## Site Information\n- **Site ID**: Site 1202\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 18\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 18 (100.0%)\n\n## Risk Profile\n- Low Risk: 18 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1203", "study": "Study 21", "site": "Site 1203", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 1203\n\n## Site Information\n- **Site ID**: Site 1203\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1204", "study": "Study 21", "site": "Site 1204", "type": "site_summary", "total_subjects": 19, "total_issues": 0, "document": "# Site Report: Site 1204\n\n## Site Information\n- **Site ID**: Site 1204\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 19\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 19 (100.0%)\n\n## Risk Profile\n- Low Risk: 19 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1205", "study": "Study 21", "site": "Site 1205", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 1205\n\n## Site Information\n- **Site ID**: Site 1205\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1206", "study": "Study 21", "site": "Site 1206", "type": "site_summary", "total_subjects": 29, "total_issues": 0, "document": "# Site Report: Site 1206\n\n## Site Information\n- **Site ID**: Site 1206\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 29\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 29 (100.0%)\n\n## Risk Profile\n- Low Risk: 29 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 4\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1207", "study": "Study 21", "site": "Site 1207", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1207\n\n## Site Information\n- **Site ID**: Site 1207\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1208", "study": "Study 21", "site": "Site 1208", "type": "site_summary", "total_subjects": 14, "total_issues": 0, "document": "# Site Report: Site 1208\n\n## Site Information\n- **Site ID**: Site 1208\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 14\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 14 (100.0%)\n\n## Risk Profile\n- Low Risk: 14 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1209", "study": "Study 21", "site": "Site 1209", "type": "site_summary", "total_subjects": 16, "total_issues": 1, "document": "# Site Report: Site 1209\n\n## Site Information\n- **Site ID**: Site 1209\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 16\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.06\n- **Clean Subjects**: 15 (93.8%)\n\n## Risk Profile\n- Low Risk: 15 (93.8%)\n- Medium Risk: 1 (6.2%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1210", "study": "Study 21", "site": "Site 1210", "type": "site_summary", "total_subjects": 8, "total_issues": 0, "document": "# Site Report: Site 1210\n\n## Site Information\n- **Site ID**: Site 1210\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 8 (100.0%)\n\n## Risk Profile\n- Low Risk: 8 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1211", "study": "Study 21", "site": "Site 1211", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 1211\n\n## Site Information\n- **Site ID**: Site 1211\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1212", "study": "Study 21", "site": "Site 1212", "type": "site_summary", "total_subjects": 18, "total_issues": 0, "document": "# Site Report: Site 1212\n\n## Site Information\n- **Site ID**: Site 1212\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 18\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 18 (100.0%)\n\n## Risk Profile\n- Low Risk: 18 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1213", "study": "Study 21", "site": "Site 1213", "type": "site_summary", "total_subjects": 18, "total_issues": 0, "document": "# Site Report: Site 1213\n\n## Site Information\n- **Site ID**: Site 1213\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 18\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 18 (100.0%)\n\n## Risk Profile\n- Low Risk: 18 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1214", "study": "Study 21", "site": "Site 1214", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 1214\n\n## Site Information\n- **Site ID**: Site 1214\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1215", "study": "Study 21", "site": "Site 1215", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 1215\n\n## Site Information\n- **Site ID**: Site 1215\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1216", "study": "Study 21", "site": "Site 1216", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 1216\n\n## Site Information\n- **Site ID**: Site 1216\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1217", "study": "Study 21", "site": "Site 1217", "type": "site_summary", "total_subjects": 7, "total_issues": 1, "document": "# Site Report: Site 1217\n\n## Site Information\n- **Site ID**: Site 1217\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.14\n- **Clean Subjects**: 6 (85.7%)\n\n## Risk Profile\n- Low Risk: 6 (85.7%)\n- Medium Risk: 1 (14.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1218", "study": "Study 21", "site": "Site 1218", "type": "site_summary", "total_subjects": 21, "total_issues": 0, "document": "# Site Report: Site 1218\n\n## Site Information\n- **Site ID**: Site 1218\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 21\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 21 (100.0%)\n\n## Risk Profile\n- Low Risk: 21 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 3\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1219", "study": "Study 21", "site": "Site 1219", "type": "site_summary", "total_subjects": 12, "total_issues": 0, "document": "# Site Report: Site 1219\n\n## Site Information\n- **Site ID**: Site 1219\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 12 (100.0%)\n\n## Risk Profile\n- Low Risk: 12 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1220", "study": "Study 21", "site": "Site 1220", "type": "site_summary", "total_subjects": 24, "total_issues": 0, "document": "# Site Report: Site 1220\n\n## Site Information\n- **Site ID**: Site 1220\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 24\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 24 (100.0%)\n\n## Risk Profile\n- Low Risk: 24 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1221", "study": "Study 21", "site": "Site 1221", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 1221\n\n## Site Information\n- **Site ID**: Site 1221\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1222", "study": "Study 21", "site": "Site 1222", "type": "site_summary", "total_subjects": 27, "total_issues": 0, "document": "# Site Report: Site 1222\n\n## Site Information\n- **Site ID**: Site 1222\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 27\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 27 (100.0%)\n\n## Risk Profile\n- Low Risk: 27 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1223", "study": "Study 21", "site": "Site 1223", "type": "site_summary", "total_subjects": 11, "total_issues": 0, "document": "# Site Report: Site 1223\n\n## Site Information\n- **Site ID**: Site 1223\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 11 (100.0%)\n\n## Risk Profile\n- Low Risk: 11 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1224", "study": "Study 21", "site": "Site 1224", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 1224\n\n## Site Information\n- **Site ID**: Site 1224\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1225", "study": "Study 21", "site": "Site 1225", "type": "site_summary", "total_subjects": 8, "total_issues": 0, "document": "# Site Report: Site 1225\n\n## Site Information\n- **Site ID**: Site 1225\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 8 (100.0%)\n\n## Risk Profile\n- Low Risk: 8 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1226", "study": "Study 21", "site": "Site 1226", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1226\n\n## Site Information\n- **Site ID**: Site 1226\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1227", "study": "Study 21", "site": "Site 1227", "type": "site_summary", "total_subjects": 8, "total_issues": 0, "document": "# Site Report: Site 1227\n\n## Site Information\n- **Site ID**: Site 1227\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 8 (100.0%)\n\n## Risk Profile\n- Low Risk: 8 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1228", "study": "Study 21", "site": "Site 1228", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 1228\n\n## Site Information\n- **Site ID**: Site 1228\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1229", "study": "Study 21", "site": "Site 1229", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 1229\n\n## Site Information\n- **Site ID**: Site 1229\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1230", "study": "Study 21", "site": "Site 1230", "type": "site_summary", "total_subjects": 15, "total_issues": 0, "document": "# Site Report: Site 1230\n\n## Site Information\n- **Site ID**: Site 1230\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 15\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 15 (100.0%)\n\n## Risk Profile\n- Low Risk: 15 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1231", "study": "Study 21", "site": "Site 1231", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 1231\n\n## Site Information\n- **Site ID**: Site 1231\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1232", "study": "Study 21", "site": "Site 1232", "type": "site_summary", "total_subjects": 13, "total_issues": 0, "document": "# Site Report: Site 1232\n\n## Site Information\n- **Site ID**: Site 1232\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 13 (100.0%)\n\n## Risk Profile\n- Low Risk: 13 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1233", "study": "Study 21", "site": "Site 1233", "type": "site_summary", "total_subjects": 17, "total_issues": 0, "document": "# Site Report: Site 1233\n\n## Site Information\n- **Site ID**: Site 1233\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 17\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 17 (100.0%)\n\n## Risk Profile\n- Low Risk: 17 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1234", "study": "Study 21", "site": "Site 1234", "type": "site_summary", "total_subjects": 25, "total_issues": 1, "document": "# Site Report: Site 1234\n\n## Site Information\n- **Site ID**: Site 1234\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 25\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.04\n- **Clean Subjects**: 24 (96.0%)\n\n## Risk Profile\n- Low Risk: 24 (96.0%)\n- Medium Risk: 1 (4.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 6\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1235", "study": "Study 21", "site": "Site 1235", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 1235\n\n## Site Information\n- **Site ID**: Site 1235\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1236", "study": "Study 21", "site": "Site 1236", "type": "site_summary", "total_subjects": 11, "total_issues": 3, "document": "# Site Report: Site 1236\n\n## Site Information\n- **Site ID**: Site 1236\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 0.27\n- **Clean Subjects**: 8 (72.7%)\n\n## Risk Profile\n- Low Risk: 8 (72.7%)\n- Medium Risk: 3 (27.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 3\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1237", "study": "Study 21", "site": "Site 1237", "type": "site_summary", "total_subjects": 9, "total_issues": 0, "document": "# Site Report: Site 1237\n\n## Site Information\n- **Site ID**: Site 1237\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 9 (100.0%)\n\n## Risk Profile\n- Low Risk: 9 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1238", "study": "Study 21", "site": "Site 1238", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 1238\n\n## Site Information\n- **Site ID**: Site 1238\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1239", "study": "Study 21", "site": "Site 1239", "type": "site_summary", "total_subjects": 15, "total_issues": 0, "document": "# Site Report: Site 1239\n\n## Site Information\n- **Site ID**: Site 1239\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 15\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 15 (100.0%)\n\n## Risk Profile\n- Low Risk: 15 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 124", "study": "Study 21", "site": "Site 124", "type": "site_summary", "total_subjects": 13, "total_issues": 0, "document": "# Site Report: Site 124\n\n## Site Information\n- **Site ID**: Site 124\n- **Study**: Study 21\n- **Country**: EST\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 13 (100.0%)\n\n## Risk Profile\n- Low Risk: 13 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1240", "study": "Study 21", "site": "Site 1240", "type": "site_summary", "total_subjects": 9, "total_issues": 0, "document": "# Site Report: Site 1240\n\n## Site Information\n- **Site ID**: Site 1240\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 9 (100.0%)\n\n## Risk Profile\n- Low Risk: 9 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1241", "study": "Study 21", "site": "Site 1241", "type": "site_summary", "total_subjects": 9, "total_issues": 0, "document": "# Site Report: Site 1241\n\n## Site Information\n- **Site ID**: Site 1241\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 9 (100.0%)\n\n## Risk Profile\n- Low Risk: 9 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1242", "study": "Study 21", "site": "Site 1242", "type": "site_summary", "total_subjects": 4, "total_issues": 1, "document": "# Site Report: Site 1242\n\n## Site Information\n- **Site ID**: Site 1242\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.25\n- **Clean Subjects**: 3 (75.0%)\n\n## Risk Profile\n- Low Risk: 3 (75.0%)\n- Medium Risk: 1 (25.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1243", "study": "Study 21", "site": "Site 1243", "type": "site_summary", "total_subjects": 22, "total_issues": 4, "document": "# Site Report: Site 1243\n\n## Site Information\n- **Site ID**: Site 1243\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 22\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 0.18\n- **Clean Subjects**: 20 (90.9%)\n\n## Risk Profile\n- Low Risk: 20 (90.9%)\n- Medium Risk: 2 (9.1%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 4\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1244", "study": "Study 21", "site": "Site 1244", "type": "site_summary", "total_subjects": 72, "total_issues": 0, "document": "# Site Report: Site 1244\n\n## Site Information\n- **Site ID**: Site 1244\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 72\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 72 (100.0%)\n\n## Risk Profile\n- Low Risk: 72 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1245", "study": "Study 21", "site": "Site 1245", "type": "site_summary", "total_subjects": 14, "total_issues": 0, "document": "# Site Report: Site 1245\n\n## Site Information\n- **Site ID**: Site 1245\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 14\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 14 (100.0%)\n\n## Risk Profile\n- Low Risk: 14 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1246", "study": "Study 21", "site": "Site 1246", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 1246\n\n## Site Information\n- **Site ID**: Site 1246\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1247", "study": "Study 21", "site": "Site 1247", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 1247\n\n## Site Information\n- **Site ID**: Site 1247\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1248", "study": "Study 21", "site": "Site 1248", "type": "site_summary", "total_subjects": 3, "total_issues": 2, "document": "# Site Report: Site 1248\n\n## Site Information\n- **Site ID**: Site 1248\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.67\n- **Clean Subjects**: 1 (33.3%)\n\n## Risk Profile\n- Low Risk: 1 (33.3%)\n- Medium Risk: 2 (66.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1249", "study": "Study 21", "site": "Site 1249", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1249\n\n## Site Information\n- **Site ID**: Site 1249\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 125", "study": "Study 21", "site": "Site 125", "type": "site_summary", "total_subjects": 17, "total_issues": 0, "document": "# Site Report: Site 125\n\n## Site Information\n- **Site ID**: Site 125\n- **Study**: Study 21\n- **Country**: EST\n- **Total Subjects**: 17\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 17 (100.0%)\n\n## Risk Profile\n- Low Risk: 17 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1250", "study": "Study 21", "site": "Site 1250", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 1250\n\n## Site Information\n- **Site ID**: Site 1250\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1251", "study": "Study 21", "site": "Site 1251", "type": "site_summary", "total_subjects": 17, "total_issues": 0, "document": "# Site Report: Site 1251\n\n## Site Information\n- **Site ID**: Site 1251\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 17\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 17 (100.0%)\n\n## Risk Profile\n- Low Risk: 17 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1252", "study": "Study 21", "site": "Site 1252", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 1252\n\n## Site Information\n- **Site ID**: Site 1252\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1254", "study": "Study 21", "site": "Site 1254", "type": "site_summary", "total_subjects": 75, "total_issues": 1, "document": "# Site Report: Site 1254\n\n## Site Information\n- **Site ID**: Site 1254\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 75\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.01\n- **Clean Subjects**: 74 (98.7%)\n\n## Risk Profile\n- Low Risk: 74 (98.7%)\n- Medium Risk: 1 (1.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1255", "study": "Study 21", "site": "Site 1255", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 1255\n\n## Site Information\n- **Site ID**: Site 1255\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1256", "study": "Study 21", "site": "Site 1256", "type": "site_summary", "total_subjects": 8, "total_issues": 0, "document": "# Site Report: Site 1256\n\n## Site Information\n- **Site ID**: Site 1256\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 8 (100.0%)\n\n## Risk Profile\n- Low Risk: 8 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1257", "study": "Study 21", "site": "Site 1257", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 1257\n\n## Site Information\n- **Site ID**: Site 1257\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1258", "study": "Study 21", "site": "Site 1258", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 1258\n\n## Site Information\n- **Site ID**: Site 1258\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 126", "study": "Study 21", "site": "Site 126", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 126\n\n## Site Information\n- **Site ID**: Site 126\n- **Study**: Study 21\n- **Country**: EST\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1260", "study": "Study 21", "site": "Site 1260", "type": "site_summary", "total_subjects": 8, "total_issues": 0, "document": "# Site Report: Site 1260\n\n## Site Information\n- **Site ID**: Site 1260\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 8 (100.0%)\n\n## Risk Profile\n- Low Risk: 8 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1261", "study": "Study 21", "site": "Site 1261", "type": "site_summary", "total_subjects": 8, "total_issues": 2, "document": "# Site Report: Site 1261\n\n## Site Information\n- **Site ID**: Site 1261\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.25\n- **Clean Subjects**: 7 (87.5%)\n\n## Risk Profile\n- Low Risk: 7 (87.5%)\n- Medium Risk: 1 (12.5%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1262", "study": "Study 21", "site": "Site 1262", "type": "site_summary", "total_subjects": 19, "total_issues": 1, "document": "# Site Report: Site 1262\n\n## Site Information\n- **Site ID**: Site 1262\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 19\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.05\n- **Clean Subjects**: 18 (94.7%)\n\n## Risk Profile\n- Low Risk: 18 (94.7%)\n- Medium Risk: 1 (5.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1263", "study": "Study 21", "site": "Site 1263", "type": "site_summary", "total_subjects": 17, "total_issues": 0, "document": "# Site Report: Site 1263\n\n## Site Information\n- **Site ID**: Site 1263\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 17\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 17 (100.0%)\n\n## Risk Profile\n- Low Risk: 17 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1264", "study": "Study 21", "site": "Site 1264", "type": "site_summary", "total_subjects": 6, "total_issues": 1, "document": "# Site Report: Site 1264\n\n## Site Information\n- **Site ID**: Site 1264\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.17\n- **Clean Subjects**: 5 (83.3%)\n\n## Risk Profile\n- Low Risk: 5 (83.3%)\n- Medium Risk: 1 (16.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1265", "study": "Study 21", "site": "Site 1265", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 1265\n\n## Site Information\n- **Site ID**: Site 1265\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1266", "study": "Study 21", "site": "Site 1266", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 1266\n\n## Site Information\n- **Site ID**: Site 1266\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1267", "study": "Study 21", "site": "Site 1267", "type": "site_summary", "total_subjects": 17, "total_issues": 1, "document": "# Site Report: Site 1267\n\n## Site Information\n- **Site ID**: Site 1267\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 17\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.06\n- **Clean Subjects**: 16 (94.1%)\n\n## Risk Profile\n- Low Risk: 16 (94.1%)\n- Medium Risk: 1 (5.9%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1268", "study": "Study 21", "site": "Site 1268", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 1268\n\n## Site Information\n- **Site ID**: Site 1268\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1269", "study": "Study 21", "site": "Site 1269", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 1269\n\n## Site Information\n- **Site ID**: Site 1269\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 127", "study": "Study 21", "site": "Site 127", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 127\n\n## Site Information\n- **Site ID**: Site 127\n- **Study**: Study 21\n- **Country**: EST\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1270", "study": "Study 21", "site": "Site 1270", "type": "site_summary", "total_subjects": 20, "total_issues": 1, "document": "# Site Report: Site 1270\n\n## Site Information\n- **Site ID**: Site 1270\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 20\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.05\n- **Clean Subjects**: 19 (95.0%)\n\n## Risk Profile\n- Low Risk: 19 (95.0%)\n- Medium Risk: 1 (5.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1271", "study": "Study 21", "site": "Site 1271", "type": "site_summary", "total_subjects": 13, "total_issues": 0, "document": "# Site Report: Site 1271\n\n## Site Information\n- **Site ID**: Site 1271\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 13 (100.0%)\n\n## Risk Profile\n- Low Risk: 13 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1272", "study": "Study 21", "site": "Site 1272", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 1272\n\n## Site Information\n- **Site ID**: Site 1272\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1273", "study": "Study 21", "site": "Site 1273", "type": "site_summary", "total_subjects": 10, "total_issues": 0, "document": "# Site Report: Site 1273\n\n## Site Information\n- **Site ID**: Site 1273\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 10 (100.0%)\n\n## Risk Profile\n- Low Risk: 10 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1274", "study": "Study 21", "site": "Site 1274", "type": "site_summary", "total_subjects": 22, "total_issues": 0, "document": "# Site Report: Site 1274\n\n## Site Information\n- **Site ID**: Site 1274\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 22\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 22 (100.0%)\n\n## Risk Profile\n- Low Risk: 22 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1275", "study": "Study 21", "site": "Site 1275", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 1275\n\n## Site Information\n- **Site ID**: Site 1275\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1276", "study": "Study 21", "site": "Site 1276", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 1276\n\n## Site Information\n- **Site ID**: Site 1276\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1277", "study": "Study 21", "site": "Site 1277", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 1277\n\n## Site Information\n- **Site ID**: Site 1277\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1278", "study": "Study 21", "site": "Site 1278", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 1278\n\n## Site Information\n- **Site ID**: Site 1278\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1279", "study": "Study 21", "site": "Site 1279", "type": "site_summary", "total_subjects": 6, "total_issues": 1, "document": "# Site Report: Site 1279\n\n## Site Information\n- **Site ID**: Site 1279\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.17\n- **Clean Subjects**: 5 (83.3%)\n\n## Risk Profile\n- Low Risk: 5 (83.3%)\n- Medium Risk: 1 (16.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1280", "study": "Study 21", "site": "Site 1280", "type": "site_summary", "total_subjects": 9, "total_issues": 0, "document": "# Site Report: Site 1280\n\n## Site Information\n- **Site ID**: Site 1280\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 9 (100.0%)\n\n## Risk Profile\n- Low Risk: 9 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1281", "study": "Study 21", "site": "Site 1281", "type": "site_summary", "total_subjects": 9, "total_issues": 0, "document": "# Site Report: Site 1281\n\n## Site Information\n- **Site ID**: Site 1281\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 9 (100.0%)\n\n## Risk Profile\n- Low Risk: 9 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1282", "study": "Study 21", "site": "Site 1282", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 1282\n\n## Site Information\n- **Site ID**: Site 1282\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1283", "study": "Study 21", "site": "Site 1283", "type": "site_summary", "total_subjects": 14, "total_issues": 0, "document": "# Site Report: Site 1283\n\n## Site Information\n- **Site ID**: Site 1283\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 14\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 14 (100.0%)\n\n## Risk Profile\n- Low Risk: 14 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1284", "study": "Study 21", "site": "Site 1284", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 1284\n\n## Site Information\n- **Site ID**: Site 1284\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1285", "study": "Study 21", "site": "Site 1285", "type": "site_summary", "total_subjects": 8, "total_issues": 0, "document": "# Site Report: Site 1285\n\n## Site Information\n- **Site ID**: Site 1285\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 8 (100.0%)\n\n## Risk Profile\n- Low Risk: 8 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1286", "study": "Study 21", "site": "Site 1286", "type": "site_summary", "total_subjects": 13, "total_issues": 0, "document": "# Site Report: Site 1286\n\n## Site Information\n- **Site ID**: Site 1286\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 13 (100.0%)\n\n## Risk Profile\n- Low Risk: 13 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1287", "study": "Study 21", "site": "Site 1287", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 1287\n\n## Site Information\n- **Site ID**: Site 1287\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1288", "study": "Study 21", "site": "Site 1288", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1288\n\n## Site Information\n- **Site ID**: Site 1288\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1289", "study": "Study 21", "site": "Site 1289", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 1289\n\n## Site Information\n- **Site ID**: Site 1289\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 129", "study": "Study 21", "site": "Site 129", "type": "site_summary", "total_subjects": 11, "total_issues": 0, "document": "# Site Report: Site 129\n\n## Site Information\n- **Site ID**: Site 129\n- **Study**: Study 21\n- **Country**: EST\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 11 (100.0%)\n\n## Risk Profile\n- Low Risk: 11 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1290", "study": "Study 21", "site": "Site 1290", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1290\n\n## Site Information\n- **Site ID**: Site 1290\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1293", "study": "Study 21", "site": "Site 1293", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 1293\n\n## Site Information\n- **Site ID**: Site 1293\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1294", "study": "Study 21", "site": "Site 1294", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 1294\n\n## Site Information\n- **Site ID**: Site 1294\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1295", "study": "Study 21", "site": "Site 1295", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 1295\n\n## Site Information\n- **Site ID**: Site 1295\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1296", "study": "Study 21", "site": "Site 1296", "type": "site_summary", "total_subjects": 11, "total_issues": 0, "document": "# Site Report: Site 1296\n\n## Site Information\n- **Site ID**: Site 1296\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 11 (100.0%)\n\n## Risk Profile\n- Low Risk: 11 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1297", "study": "Study 21", "site": "Site 1297", "type": "site_summary", "total_subjects": 13, "total_issues": 0, "document": "# Site Report: Site 1297\n\n## Site Information\n- **Site ID**: Site 1297\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 13 (100.0%)\n\n## Risk Profile\n- Low Risk: 13 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1298", "study": "Study 21", "site": "Site 1298", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 1298\n\n## Site Information\n- **Site ID**: Site 1298\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1299", "study": "Study 21", "site": "Site 1299", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 1299\n\n## Site Information\n- **Site ID**: Site 1299\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 130", "study": "Study 21", "site": "Site 130", "type": "site_summary", "total_subjects": 9, "total_issues": 0, "document": "# Site Report: Site 130\n\n## Site Information\n- **Site ID**: Site 130\n- **Study**: Study 21\n- **Country**: FRA\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 9 (100.0%)\n\n## Risk Profile\n- Low Risk: 9 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1300", "study": "Study 21", "site": "Site 1300", "type": "site_summary", "total_subjects": 10, "total_issues": 0, "document": "# Site Report: Site 1300\n\n## Site Information\n- **Site ID**: Site 1300\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 10 (100.0%)\n\n## Risk Profile\n- Low Risk: 10 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1301", "study": "Study 21", "site": "Site 1301", "type": "site_summary", "total_subjects": 9, "total_issues": 0, "document": "# Site Report: Site 1301\n\n## Site Information\n- **Site ID**: Site 1301\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 9 (100.0%)\n\n## Risk Profile\n- Low Risk: 9 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1302", "study": "Study 21", "site": "Site 1302", "type": "site_summary", "total_subjects": 17, "total_issues": 0, "document": "# Site Report: Site 1302\n\n## Site Information\n- **Site ID**: Site 1302\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 17\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 17 (100.0%)\n\n## Risk Profile\n- Low Risk: 17 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1303", "study": "Study 21", "site": "Site 1303", "type": "site_summary", "total_subjects": 22, "total_issues": 0, "document": "# Site Report: Site 1303\n\n## Site Information\n- **Site ID**: Site 1303\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 22\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 22 (100.0%)\n\n## Risk Profile\n- Low Risk: 22 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1304", "study": "Study 21", "site": "Site 1304", "type": "site_summary", "total_subjects": 21, "total_issues": 0, "document": "# Site Report: Site 1304\n\n## Site Information\n- **Site ID**: Site 1304\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 21\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 21 (100.0%)\n\n## Risk Profile\n- Low Risk: 21 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1305", "study": "Study 21", "site": "Site 1305", "type": "site_summary", "total_subjects": 18, "total_issues": 0, "document": "# Site Report: Site 1305\n\n## Site Information\n- **Site ID**: Site 1305\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 18\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 18 (100.0%)\n\n## Risk Profile\n- Low Risk: 18 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1306", "study": "Study 21", "site": "Site 1306", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 1306\n\n## Site Information\n- **Site ID**: Site 1306\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1307", "study": "Study 21", "site": "Site 1307", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 1307\n\n## Site Information\n- **Site ID**: Site 1307\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1308", "study": "Study 21", "site": "Site 1308", "type": "site_summary", "total_subjects": 13, "total_issues": 0, "document": "# Site Report: Site 1308\n\n## Site Information\n- **Site ID**: Site 1308\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 13 (100.0%)\n\n## Risk Profile\n- Low Risk: 13 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1309", "study": "Study 21", "site": "Site 1309", "type": "site_summary", "total_subjects": 9, "total_issues": 0, "document": "# Site Report: Site 1309\n\n## Site Information\n- **Site ID**: Site 1309\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 9 (100.0%)\n\n## Risk Profile\n- Low Risk: 9 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 131", "study": "Study 21", "site": "Site 131", "type": "site_summary", "total_subjects": 16, "total_issues": 0, "document": "# Site Report: Site 131\n\n## Site Information\n- **Site ID**: Site 131\n- **Study**: Study 21\n- **Country**: FRA\n- **Total Subjects**: 16\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 16 (100.0%)\n\n## Risk Profile\n- Low Risk: 16 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1310", "study": "Study 21", "site": "Site 1310", "type": "site_summary", "total_subjects": 9, "total_issues": 0, "document": "# Site Report: Site 1310\n\n## Site Information\n- **Site ID**: Site 1310\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 9 (100.0%)\n\n## Risk Profile\n- Low Risk: 9 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1311", "study": "Study 21", "site": "Site 1311", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 1311\n\n## Site Information\n- **Site ID**: Site 1311\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1312", "study": "Study 21", "site": "Site 1312", "type": "site_summary", "total_subjects": 10, "total_issues": 0, "document": "# Site Report: Site 1312\n\n## Site Information\n- **Site ID**: Site 1312\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 10 (100.0%)\n\n## Risk Profile\n- Low Risk: 10 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1313", "study": "Study 21", "site": "Site 1313", "type": "site_summary", "total_subjects": 13, "total_issues": 0, "document": "# Site Report: Site 1313\n\n## Site Information\n- **Site ID**: Site 1313\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 13 (100.0%)\n\n## Risk Profile\n- Low Risk: 13 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1314", "study": "Study 21", "site": "Site 1314", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 1314\n\n## Site Information\n- **Site ID**: Site 1314\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1315", "study": "Study 21", "site": "Site 1315", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 1315\n\n## Site Information\n- **Site ID**: Site 1315\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1316", "study": "Study 21", "site": "Site 1316", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 1316\n\n## Site Information\n- **Site ID**: Site 1316\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1317", "study": "Study 21", "site": "Site 1317", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 1317\n\n## Site Information\n- **Site ID**: Site 1317\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1318", "study": "Study 21", "site": "Site 1318", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 1318\n\n## Site Information\n- **Site ID**: Site 1318\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1319", "study": "Study 21", "site": "Site 1319", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1319\n\n## Site Information\n- **Site ID**: Site 1319\n- **Study**: Study 21\n- **Country**: JPN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 132", "study": "Study 21", "site": "Site 132", "type": "site_summary", "total_subjects": 12, "total_issues": 0, "document": "# Site Report: Site 132\n\n## Site Information\n- **Site ID**: Site 132\n- **Study**: Study 21\n- **Country**: FRA\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 12 (100.0%)\n\n## Risk Profile\n- Low Risk: 12 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1320", "study": "Study 21", "site": "Site 1320", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1320\n\n## Site Information\n- **Site ID**: Site 1320\n- **Study**: Study 21\n- **Country**: JPN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1321", "study": "Study 21", "site": "Site 1321", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 1321\n\n## Site Information\n- **Site ID**: Site 1321\n- **Study**: Study 21\n- **Country**: JPN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1322", "study": "Study 21", "site": "Site 1322", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 1322\n\n## Site Information\n- **Site ID**: Site 1322\n- **Study**: Study 21\n- **Country**: JPN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1323", "study": "Study 21", "site": "Site 1323", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 1323\n\n## Site Information\n- **Site ID**: Site 1323\n- **Study**: Study 21\n- **Country**: JPN\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1324", "study": "Study 21", "site": "Site 1324", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 1324\n\n## Site Information\n- **Site ID**: Site 1324\n- **Study**: Study 21\n- **Country**: JPN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1325", "study": "Study 21", "site": "Site 1325", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 1325\n\n## Site Information\n- **Site ID**: Site 1325\n- **Study**: Study 21\n- **Country**: JPN\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1326", "study": "Study 21", "site": "Site 1326", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 1326\n\n## Site Information\n- **Site ID**: Site 1326\n- **Study**: Study 21\n- **Country**: JPN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1327", "study": "Study 21", "site": "Site 1327", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 1327\n\n## Site Information\n- **Site ID**: Site 1327\n- **Study**: Study 21\n- **Country**: JPN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1328", "study": "Study 21", "site": "Site 1328", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 1328\n\n## Site Information\n- **Site ID**: Site 1328\n- **Study**: Study 21\n- **Country**: JPN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1329", "study": "Study 21", "site": "Site 1329", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 1329\n\n## Site Information\n- **Site ID**: Site 1329\n- **Study**: Study 21\n- **Country**: JPN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1330", "study": "Study 21", "site": "Site 1330", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 1330\n\n## Site Information\n- **Site ID**: Site 1330\n- **Study**: Study 21\n- **Country**: AUS\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1331", "study": "Study 21", "site": "Site 1331", "type": "site_summary", "total_subjects": 22, "total_issues": 0, "document": "# Site Report: Site 1331\n\n## Site Information\n- **Site ID**: Site 1331\n- **Study**: Study 21\n- **Country**: AUS\n- **Total Subjects**: 22\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 22 (100.0%)\n\n## Risk Profile\n- Low Risk: 22 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1332", "study": "Study 21", "site": "Site 1332", "type": "site_summary", "total_subjects": 20, "total_issues": 0, "document": "# Site Report: Site 1332\n\n## Site Information\n- **Site ID**: Site 1332\n- **Study**: Study 21\n- **Country**: AUS\n- **Total Subjects**: 20\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 20 (100.0%)\n\n## Risk Profile\n- Low Risk: 20 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1333", "study": "Study 21", "site": "Site 1333", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 1333\n\n## Site Information\n- **Site ID**: Site 1333\n- **Study**: Study 21\n- **Country**: AUS\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1334", "study": "Study 21", "site": "Site 1334", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 1334\n\n## Site Information\n- **Site ID**: Site 1334\n- **Study**: Study 21\n- **Country**: AUS\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1335", "study": "Study 21", "site": "Site 1335", "type": "site_summary", "total_subjects": 14, "total_issues": 0, "document": "# Site Report: Site 1335\n\n## Site Information\n- **Site ID**: Site 1335\n- **Study**: Study 21\n- **Country**: AUS\n- **Total Subjects**: 14\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 14 (100.0%)\n\n## Risk Profile\n- Low Risk: 14 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1336", "study": "Study 21", "site": "Site 1336", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 1336\n\n## Site Information\n- **Site ID**: Site 1336\n- **Study**: Study 21\n- **Country**: AUS\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1337", "study": "Study 21", "site": "Site 1337", "type": "site_summary", "total_subjects": 14, "total_issues": 0, "document": "# Site Report: Site 1337\n\n## Site Information\n- **Site ID**: Site 1337\n- **Study**: Study 21\n- **Country**: AUS\n- **Total Subjects**: 14\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 14 (100.0%)\n\n## Risk Profile\n- Low Risk: 14 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1338", "study": "Study 21", "site": "Site 1338", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 1338\n\n## Site Information\n- **Site ID**: Site 1338\n- **Study**: Study 21\n- **Country**: AUS\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1339", "study": "Study 21", "site": "Site 1339", "type": "site_summary", "total_subjects": 25, "total_issues": 0, "document": "# Site Report: Site 1339\n\n## Site Information\n- **Site ID**: Site 1339\n- **Study**: Study 21\n- **Country**: AUS\n- **Total Subjects**: 25\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 25 (100.0%)\n\n## Risk Profile\n- Low Risk: 25 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1340", "study": "Study 21", "site": "Site 1340", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 1340\n\n## Site Information\n- **Site ID**: Site 1340\n- **Study**: Study 21\n- **Country**: AUS\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1341", "study": "Study 21", "site": "Site 1341", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1341\n\n## Site Information\n- **Site ID**: Site 1341\n- **Study**: Study 21\n- **Country**: AUS\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1342", "study": "Study 21", "site": "Site 1342", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 1342\n\n## Site Information\n- **Site ID**: Site 1342\n- **Study**: Study 21\n- **Country**: AUS\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1343", "study": "Study 21", "site": "Site 1343", "type": "site_summary", "total_subjects": 25, "total_issues": 0, "document": "# Site Report: Site 1343\n\n## Site Information\n- **Site ID**: Site 1343\n- **Study**: Study 21\n- **Country**: AUS\n- **Total Subjects**: 25\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 25 (100.0%)\n\n## Risk Profile\n- Low Risk: 25 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1344", "study": "Study 21", "site": "Site 1344", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1344\n\n## Site Information\n- **Site ID**: Site 1344\n- **Study**: Study 21\n- **Country**: AUS\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1345", "study": "Study 21", "site": "Site 1345", "type": "site_summary", "total_subjects": 11, "total_issues": 0, "document": "# Site Report: Site 1345\n\n## Site Information\n- **Site ID**: Site 1345\n- **Study**: Study 21\n- **Country**: BEL\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 11 (100.0%)\n\n## Risk Profile\n- Low Risk: 11 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1346", "study": "Study 21", "site": "Site 1346", "type": "site_summary", "total_subjects": 10, "total_issues": 1, "document": "# Site Report: Site 1346\n\n## Site Information\n- **Site ID**: Site 1346\n- **Study**: Study 21\n- **Country**: BEL\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.10\n- **Clean Subjects**: 9 (90.0%)\n\n## Risk Profile\n- Low Risk: 9 (90.0%)\n- Medium Risk: 1 (10.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1347", "study": "Study 21", "site": "Site 1347", "type": "site_summary", "total_subjects": 14, "total_issues": 0, "document": "# Site Report: Site 1347\n\n## Site Information\n- **Site ID**: Site 1347\n- **Study**: Study 21\n- **Country**: BEL\n- **Total Subjects**: 14\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 14 (100.0%)\n\n## Risk Profile\n- Low Risk: 14 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1348", "study": "Study 21", "site": "Site 1348", "type": "site_summary", "total_subjects": 9, "total_issues": 1, "document": "# Site Report: Site 1348\n\n## Site Information\n- **Site ID**: Site 1348\n- **Study**: Study 21\n- **Country**: BEL\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.11\n- **Clean Subjects**: 8 (88.9%)\n\n## Risk Profile\n- Low Risk: 8 (88.9%)\n- Medium Risk: 1 (11.1%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1349", "study": "Study 21", "site": "Site 1349", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 1349\n\n## Site Information\n- **Site ID**: Site 1349\n- **Study**: Study 21\n- **Country**: BEL\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1350", "study": "Study 21", "site": "Site 1350", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 1350\n\n## Site Information\n- **Site ID**: Site 1350\n- **Study**: Study 21\n- **Country**: BEL\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1351", "study": "Study 21", "site": "Site 1351", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 1351\n\n## Site Information\n- **Site ID**: Site 1351\n- **Study**: Study 21\n- **Country**: BEL\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1352", "study": "Study 21", "site": "Site 1352", "type": "site_summary", "total_subjects": 22, "total_issues": 0, "document": "# Site Report: Site 1352\n\n## Site Information\n- **Site ID**: Site 1352\n- **Study**: Study 21\n- **Country**: BEL\n- **Total Subjects**: 22\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 22 (100.0%)\n\n## Risk Profile\n- Low Risk: 22 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1353", "study": "Study 21", "site": "Site 1353", "type": "site_summary", "total_subjects": 21, "total_issues": 0, "document": "# Site Report: Site 1353\n\n## Site Information\n- **Site ID**: Site 1353\n- **Study**: Study 21\n- **Country**: BEL\n- **Total Subjects**: 21\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 21 (100.0%)\n\n## Risk Profile\n- Low Risk: 21 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1354", "study": "Study 21", "site": "Site 1354", "type": "site_summary", "total_subjects": 8, "total_issues": 0, "document": "# Site Report: Site 1354\n\n## Site Information\n- **Site ID**: Site 1354\n- **Study**: Study 21\n- **Country**: BEL\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 8 (100.0%)\n\n## Risk Profile\n- Low Risk: 8 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1355", "study": "Study 21", "site": "Site 1355", "type": "site_summary", "total_subjects": 17, "total_issues": 5, "document": "# Site Report: Site 1355\n\n## Site Information\n- **Site ID**: Site 1355\n- **Study**: Study 21\n- **Country**: BEL\n- **Total Subjects**: 17\n\n## Performance Metrics\n- **Total Issues**: 5\n- **Average Issues per Subject**: 0.29\n- **Clean Subjects**: 16 (94.1%)\n\n## Risk Profile\n- Low Risk: 16 (94.1%)\n- Medium Risk: 1 (5.9%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1356", "study": "Study 21", "site": "Site 1356", "type": "site_summary", "total_subjects": 17, "total_issues": 0, "document": "# Site Report: Site 1356\n\n## Site Information\n- **Site ID**: Site 1356\n- **Study**: Study 21\n- **Country**: BEL\n- **Total Subjects**: 17\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 17 (100.0%)\n\n## Risk Profile\n- Low Risk: 17 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1357", "study": "Study 21", "site": "Site 1357", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 1357\n\n## Site Information\n- **Site ID**: Site 1357\n- **Study**: Study 21\n- **Country**: BEL\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1358", "study": "Study 21", "site": "Site 1358", "type": "site_summary", "total_subjects": 22, "total_issues": 0, "document": "# Site Report: Site 1358\n\n## Site Information\n- **Site ID**: Site 1358\n- **Study**: Study 21\n- **Country**: BEL\n- **Total Subjects**: 22\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 22 (100.0%)\n\n## Risk Profile\n- Low Risk: 22 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1359", "study": "Study 21", "site": "Site 1359", "type": "site_summary", "total_subjects": 45, "total_issues": 0, "document": "# Site Report: Site 1359\n\n## Site Information\n- **Site ID**: Site 1359\n- **Study**: Study 21\n- **Country**: BGR\n- **Total Subjects**: 45\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 45 (100.0%)\n\n## Risk Profile\n- Low Risk: 45 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1360", "study": "Study 21", "site": "Site 1360", "type": "site_summary", "total_subjects": 25, "total_issues": 0, "document": "# Site Report: Site 1360\n\n## Site Information\n- **Site ID**: Site 1360\n- **Study**: Study 21\n- **Country**: BGR\n- **Total Subjects**: 25\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 25 (100.0%)\n\n## Risk Profile\n- Low Risk: 25 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1361", "study": "Study 21", "site": "Site 1361", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 1361\n\n## Site Information\n- **Site ID**: Site 1361\n- **Study**: Study 21\n- **Country**: BGR\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1362", "study": "Study 21", "site": "Site 1362", "type": "site_summary", "total_subjects": 64, "total_issues": 1, "document": "# Site Report: Site 1362\n\n## Site Information\n- **Site ID**: Site 1362\n- **Study**: Study 21\n- **Country**: BGR\n- **Total Subjects**: 64\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.02\n- **Clean Subjects**: 63 (98.4%)\n\n## Risk Profile\n- Low Risk: 63 (98.4%)\n- Medium Risk: 1 (1.6%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1363", "study": "Study 21", "site": "Site 1363", "type": "site_summary", "total_subjects": 15, "total_issues": 0, "document": "# Site Report: Site 1363\n\n## Site Information\n- **Site ID**: Site 1363\n- **Study**: Study 21\n- **Country**: BGR\n- **Total Subjects**: 15\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 15 (100.0%)\n\n## Risk Profile\n- Low Risk: 15 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1364", "study": "Study 21", "site": "Site 1364", "type": "site_summary", "total_subjects": 63, "total_issues": 0, "document": "# Site Report: Site 1364\n\n## Site Information\n- **Site ID**: Site 1364\n- **Study**: Study 21\n- **Country**: BGR\n- **Total Subjects**: 63\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 63 (100.0%)\n\n## Risk Profile\n- Low Risk: 63 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1365", "study": "Study 21", "site": "Site 1365", "type": "site_summary", "total_subjects": 16, "total_issues": 0, "document": "# Site Report: Site 1365\n\n## Site Information\n- **Site ID**: Site 1365\n- **Study**: Study 21\n- **Country**: BGR\n- **Total Subjects**: 16\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 16 (100.0%)\n\n## Risk Profile\n- Low Risk: 16 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1366", "study": "Study 21", "site": "Site 1366", "type": "site_summary", "total_subjects": 21, "total_issues": 0, "document": "# Site Report: Site 1366\n\n## Site Information\n- **Site ID**: Site 1366\n- **Study**: Study 21\n- **Country**: BGR\n- **Total Subjects**: 21\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 21 (100.0%)\n\n## Risk Profile\n- Low Risk: 21 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1367", "study": "Study 21", "site": "Site 1367", "type": "site_summary", "total_subjects": 9, "total_issues": 1, "document": "# Site Report: Site 1367\n\n## Site Information\n- **Site ID**: Site 1367\n- **Study**: Study 21\n- **Country**: BGR\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.11\n- **Clean Subjects**: 8 (88.9%)\n\n## Risk Profile\n- Low Risk: 8 (88.9%)\n- Medium Risk: 1 (11.1%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1368", "study": "Study 21", "site": "Site 1368", "type": "site_summary", "total_subjects": 17, "total_issues": 0, "document": "# Site Report: Site 1368\n\n## Site Information\n- **Site ID**: Site 1368\n- **Study**: Study 21\n- **Country**: BGR\n- **Total Subjects**: 17\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 17 (100.0%)\n\n## Risk Profile\n- Low Risk: 17 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1369", "study": "Study 21", "site": "Site 1369", "type": "site_summary", "total_subjects": 44, "total_issues": 0, "document": "# Site Report: Site 1369\n\n## Site Information\n- **Site ID**: Site 1369\n- **Study**: Study 21\n- **Country**: BGR\n- **Total Subjects**: 44\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 44 (100.0%)\n\n## Risk Profile\n- Low Risk: 44 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1370", "study": "Study 21", "site": "Site 1370", "type": "site_summary", "total_subjects": 41, "total_issues": 4, "document": "# Site Report: Site 1370\n\n## Site Information\n- **Site ID**: Site 1370\n- **Study**: Study 21\n- **Country**: BGR\n- **Total Subjects**: 41\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 0.10\n- **Clean Subjects**: 40 (97.6%)\n\n## Risk Profile\n- Low Risk: 40 (97.6%)\n- Medium Risk: 1 (2.4%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1371", "study": "Study 21", "site": "Site 1371", "type": "site_summary", "total_subjects": 45, "total_issues": 0, "document": "# Site Report: Site 1371\n\n## Site Information\n- **Site ID**: Site 1371\n- **Study**: Study 21\n- **Country**: BGR\n- **Total Subjects**: 45\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 45 (100.0%)\n\n## Risk Profile\n- Low Risk: 45 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1372", "study": "Study 21", "site": "Site 1372", "type": "site_summary", "total_subjects": 53, "total_issues": 0, "document": "# Site Report: Site 1372\n\n## Site Information\n- **Site ID**: Site 1372\n- **Study**: Study 21\n- **Country**: BGR\n- **Total Subjects**: 53\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 53 (100.0%)\n\n## Risk Profile\n- Low Risk: 53 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1373", "study": "Study 21", "site": "Site 1373", "type": "site_summary", "total_subjects": 20, "total_issues": 0, "document": "# Site Report: Site 1373\n\n## Site Information\n- **Site ID**: Site 1373\n- **Study**: Study 21\n- **Country**: BGR\n- **Total Subjects**: 20\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 20 (100.0%)\n\n## Risk Profile\n- Low Risk: 20 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1374", "study": "Study 21", "site": "Site 1374", "type": "site_summary", "total_subjects": 26, "total_issues": 0, "document": "# Site Report: Site 1374\n\n## Site Information\n- **Site ID**: Site 1374\n- **Study**: Study 21\n- **Country**: BGR\n- **Total Subjects**: 26\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 26 (100.0%)\n\n## Risk Profile\n- Low Risk: 26 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1375", "study": "Study 21", "site": "Site 1375", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 1375\n\n## Site Information\n- **Site ID**: Site 1375\n- **Study**: Study 21\n- **Country**: BGR\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1376", "study": "Study 21", "site": "Site 1376", "type": "site_summary", "total_subjects": 24, "total_issues": 0, "document": "# Site Report: Site 1376\n\n## Site Information\n- **Site ID**: Site 1376\n- **Study**: Study 21\n- **Country**: BGR\n- **Total Subjects**: 24\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 24 (100.0%)\n\n## Risk Profile\n- Low Risk: 24 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1377", "study": "Study 21", "site": "Site 1377", "type": "site_summary", "total_subjects": 31, "total_issues": 0, "document": "# Site Report: Site 1377\n\n## Site Information\n- **Site ID**: Site 1377\n- **Study**: Study 21\n- **Country**: BGR\n- **Total Subjects**: 31\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 31 (100.0%)\n\n## Risk Profile\n- Low Risk: 31 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1378", "study": "Study 21", "site": "Site 1378", "type": "site_summary", "total_subjects": 8, "total_issues": 0, "document": "# Site Report: Site 1378\n\n## Site Information\n- **Site ID**: Site 1378\n- **Study**: Study 21\n- **Country**: BGR\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 8 (100.0%)\n\n## Risk Profile\n- Low Risk: 8 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1379", "study": "Study 21", "site": "Site 1379", "type": "site_summary", "total_subjects": 28, "total_issues": 0, "document": "# Site Report: Site 1379\n\n## Site Information\n- **Site ID**: Site 1379\n- **Study**: Study 21\n- **Country**: BGR\n- **Total Subjects**: 28\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 28 (100.0%)\n\n## Risk Profile\n- Low Risk: 28 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1380", "study": "Study 21", "site": "Site 1380", "type": "site_summary", "total_subjects": 18, "total_issues": 0, "document": "# Site Report: Site 1380\n\n## Site Information\n- **Site ID**: Site 1380\n- **Study**: Study 21\n- **Country**: BGR\n- **Total Subjects**: 18\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 18 (100.0%)\n\n## Risk Profile\n- Low Risk: 18 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1381", "study": "Study 21", "site": "Site 1381", "type": "site_summary", "total_subjects": 40, "total_issues": 1, "document": "# Site Report: Site 1381\n\n## Site Information\n- **Site ID**: Site 1381\n- **Study**: Study 21\n- **Country**: BGR\n- **Total Subjects**: 40\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.03\n- **Clean Subjects**: 39 (97.5%)\n\n## Risk Profile\n- Low Risk: 39 (97.5%)\n- Medium Risk: 1 (2.5%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 5\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1382", "study": "Study 21", "site": "Site 1382", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 1382\n\n## Site Information\n- **Site ID**: Site 1382\n- **Study**: Study 21\n- **Country**: BGR\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1383", "study": "Study 21", "site": "Site 1383", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 1383\n\n## Site Information\n- **Site ID**: Site 1383\n- **Study**: Study 21\n- **Country**: BGR\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1384", "study": "Study 21", "site": "Site 1384", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 1384\n\n## Site Information\n- **Site ID**: Site 1384\n- **Study**: Study 21\n- **Country**: BGR\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1385", "study": "Study 21", "site": "Site 1385", "type": "site_summary", "total_subjects": 21, "total_issues": 0, "document": "# Site Report: Site 1385\n\n## Site Information\n- **Site ID**: Site 1385\n- **Study**: Study 21\n- **Country**: BGR\n- **Total Subjects**: 21\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 21 (100.0%)\n\n## Risk Profile\n- Low Risk: 21 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1386", "study": "Study 21", "site": "Site 1386", "type": "site_summary", "total_subjects": 11, "total_issues": 0, "document": "# Site Report: Site 1386\n\n## Site Information\n- **Site ID**: Site 1386\n- **Study**: Study 21\n- **Country**: BGR\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 11 (100.0%)\n\n## Risk Profile\n- Low Risk: 11 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1387", "study": "Study 21", "site": "Site 1387", "type": "site_summary", "total_subjects": 10, "total_issues": 0, "document": "# Site Report: Site 1387\n\n## Site Information\n- **Site ID**: Site 1387\n- **Study**: Study 21\n- **Country**: BGR\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 10 (100.0%)\n\n## Risk Profile\n- Low Risk: 10 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1388", "study": "Study 21", "site": "Site 1388", "type": "site_summary", "total_subjects": 33, "total_issues": 0, "document": "# Site Report: Site 1388\n\n## Site Information\n- **Site ID**: Site 1388\n- **Study**: Study 21\n- **Country**: COL\n- **Total Subjects**: 33\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 33 (100.0%)\n\n## Risk Profile\n- Low Risk: 33 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1389", "study": "Study 21", "site": "Site 1389", "type": "site_summary", "total_subjects": 111, "total_issues": 0, "document": "# Site Report: Site 1389\n\n## Site Information\n- **Site ID**: Site 1389\n- **Study**: Study 21\n- **Country**: COL\n- **Total Subjects**: 111\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 111 (100.0%)\n\n## Risk Profile\n- Low Risk: 111 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 3\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1390", "study": "Study 21", "site": "Site 1390", "type": "site_summary", "total_subjects": 88, "total_issues": 0, "document": "# Site Report: Site 1390\n\n## Site Information\n- **Site ID**: Site 1390\n- **Study**: Study 21\n- **Country**: COL\n- **Total Subjects**: 88\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 88 (100.0%)\n\n## Risk Profile\n- Low Risk: 88 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1391", "study": "Study 21", "site": "Site 1391", "type": "site_summary", "total_subjects": 9, "total_issues": 1, "document": "# Site Report: Site 1391\n\n## Site Information\n- **Site ID**: Site 1391\n- **Study**: Study 21\n- **Country**: COL\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.11\n- **Clean Subjects**: 8 (88.9%)\n\n## Risk Profile\n- Low Risk: 8 (88.9%)\n- Medium Risk: 1 (11.1%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1392", "study": "Study 21", "site": "Site 1392", "type": "site_summary", "total_subjects": 23, "total_issues": 0, "document": "# Site Report: Site 1392\n\n## Site Information\n- **Site ID**: Site 1392\n- **Study**: Study 21\n- **Country**: COL\n- **Total Subjects**: 23\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 23 (100.0%)\n\n## Risk Profile\n- Low Risk: 23 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1393", "study": "Study 21", "site": "Site 1393", "type": "site_summary", "total_subjects": 11, "total_issues": 0, "document": "# Site Report: Site 1393\n\n## Site Information\n- **Site ID**: Site 1393\n- **Study**: Study 21\n- **Country**: COL\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 11 (100.0%)\n\n## Risk Profile\n- Low Risk: 11 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1394", "study": "Study 21", "site": "Site 1394", "type": "site_summary", "total_subjects": 28, "total_issues": 0, "document": "# Site Report: Site 1394\n\n## Site Information\n- **Site ID**: Site 1394\n- **Study**: Study 21\n- **Country**: CZE\n- **Total Subjects**: 28\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 28 (100.0%)\n\n## Risk Profile\n- Low Risk: 28 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1395", "study": "Study 21", "site": "Site 1395", "type": "site_summary", "total_subjects": 8, "total_issues": 0, "document": "# Site Report: Site 1395\n\n## Site Information\n- **Site ID**: Site 1395\n- **Study**: Study 21\n- **Country**: CZE\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 8 (100.0%)\n\n## Risk Profile\n- Low Risk: 8 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1396", "study": "Study 21", "site": "Site 1396", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 1396\n\n## Site Information\n- **Site ID**: Site 1396\n- **Study**: Study 21\n- **Country**: CZE\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1397", "study": "Study 21", "site": "Site 1397", "type": "site_summary", "total_subjects": 42, "total_issues": 0, "document": "# Site Report: Site 1397\n\n## Site Information\n- **Site ID**: Site 1397\n- **Study**: Study 21\n- **Country**: CZE\n- **Total Subjects**: 42\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 42 (100.0%)\n\n## Risk Profile\n- Low Risk: 42 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1398", "study": "Study 21", "site": "Site 1398", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 1398\n\n## Site Information\n- **Site ID**: Site 1398\n- **Study**: Study 21\n- **Country**: CZE\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1399", "study": "Study 21", "site": "Site 1399", "type": "site_summary", "total_subjects": 47, "total_issues": 1, "document": "# Site Report: Site 1399\n\n## Site Information\n- **Site ID**: Site 1399\n- **Study**: Study 21\n- **Country**: CZE\n- **Total Subjects**: 47\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.02\n- **Clean Subjects**: 46 (97.9%)\n\n## Risk Profile\n- Low Risk: 46 (97.9%)\n- Medium Risk: 1 (2.1%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 14", "study": "Study 21", "site": "Site 14", "type": "site_summary", "total_subjects": 53, "total_issues": 0, "document": "# Site Report: Site 14\n\n## Site Information\n- **Site ID**: Site 14\n- **Study**: Study 21\n- **Country**: SVK\n- **Total Subjects**: 53\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 53 (100.0%)\n\n## Risk Profile\n- Low Risk: 53 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1400", "study": "Study 21", "site": "Site 1400", "type": "site_summary", "total_subjects": 86, "total_issues": 2, "document": "# Site Report: Site 1400\n\n## Site Information\n- **Site ID**: Site 1400\n- **Study**: Study 21\n- **Country**: CZE\n- **Total Subjects**: 86\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.02\n- **Clean Subjects**: 85 (98.8%)\n\n## Risk Profile\n- Low Risk: 85 (98.8%)\n- Medium Risk: 1 (1.2%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1401", "study": "Study 21", "site": "Site 1401", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 1401\n\n## Site Information\n- **Site ID**: Site 1401\n- **Study**: Study 21\n- **Country**: CZE\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1402", "study": "Study 21", "site": "Site 1402", "type": "site_summary", "total_subjects": 22, "total_issues": 0, "document": "# Site Report: Site 1402\n\n## Site Information\n- **Site ID**: Site 1402\n- **Study**: Study 21\n- **Country**: CZE\n- **Total Subjects**: 22\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 22 (100.0%)\n\n## Risk Profile\n- Low Risk: 22 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 3\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1403", "study": "Study 21", "site": "Site 1403", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 1403\n\n## Site Information\n- **Site ID**: Site 1403\n- **Study**: Study 21\n- **Country**: CZE\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1404", "study": "Study 21", "site": "Site 1404", "type": "site_summary", "total_subjects": 11, "total_issues": 0, "document": "# Site Report: Site 1404\n\n## Site Information\n- **Site ID**: Site 1404\n- **Study**: Study 21\n- **Country**: CZE\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 11 (100.0%)\n\n## Risk Profile\n- Low Risk: 11 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1405", "study": "Study 21", "site": "Site 1405", "type": "site_summary", "total_subjects": 24, "total_issues": 0, "document": "# Site Report: Site 1405\n\n## Site Information\n- **Site ID**: Site 1405\n- **Study**: Study 21\n- **Country**: CZE\n- **Total Subjects**: 24\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 24 (100.0%)\n\n## Risk Profile\n- Low Risk: 24 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1406", "study": "Study 21", "site": "Site 1406", "type": "site_summary", "total_subjects": 9, "total_issues": 0, "document": "# Site Report: Site 1406\n\n## Site Information\n- **Site ID**: Site 1406\n- **Study**: Study 21\n- **Country**: CZE\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 9 (100.0%)\n\n## Risk Profile\n- Low Risk: 9 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1407", "study": "Study 21", "site": "Site 1407", "type": "site_summary", "total_subjects": 22, "total_issues": 0, "document": "# Site Report: Site 1407\n\n## Site Information\n- **Site ID**: Site 1407\n- **Study**: Study 21\n- **Country**: CZE\n- **Total Subjects**: 22\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 22 (100.0%)\n\n## Risk Profile\n- Low Risk: 22 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1408", "study": "Study 21", "site": "Site 1408", "type": "site_summary", "total_subjects": 13, "total_issues": 0, "document": "# Site Report: Site 1408\n\n## Site Information\n- **Site ID**: Site 1408\n- **Study**: Study 21\n- **Country**: CZE\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 13 (100.0%)\n\n## Risk Profile\n- Low Risk: 13 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1409", "study": "Study 21", "site": "Site 1409", "type": "site_summary", "total_subjects": 16, "total_issues": 0, "document": "# Site Report: Site 1409\n\n## Site Information\n- **Site ID**: Site 1409\n- **Study**: Study 21\n- **Country**: CZE\n- **Total Subjects**: 16\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 16 (100.0%)\n\n## Risk Profile\n- Low Risk: 16 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1410", "study": "Study 21", "site": "Site 1410", "type": "site_summary", "total_subjects": 17, "total_issues": 0, "document": "# Site Report: Site 1410\n\n## Site Information\n- **Site ID**: Site 1410\n- **Study**: Study 21\n- **Country**: CZE\n- **Total Subjects**: 17\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 17 (100.0%)\n\n## Risk Profile\n- Low Risk: 17 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1411", "study": "Study 21", "site": "Site 1411", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 1411\n\n## Site Information\n- **Site ID**: Site 1411\n- **Study**: Study 21\n- **Country**: CZE\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1412", "study": "Study 21", "site": "Site 1412", "type": "site_summary", "total_subjects": 40, "total_issues": 0, "document": "# Site Report: Site 1412\n\n## Site Information\n- **Site ID**: Site 1412\n- **Study**: Study 21\n- **Country**: CZE\n- **Total Subjects**: 40\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 40 (100.0%)\n\n## Risk Profile\n- Low Risk: 40 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1413", "study": "Study 21", "site": "Site 1413", "type": "site_summary", "total_subjects": 39, "total_issues": 0, "document": "# Site Report: Site 1413\n\n## Site Information\n- **Site ID**: Site 1413\n- **Study**: Study 21\n- **Country**: CZE\n- **Total Subjects**: 39\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 39 (100.0%)\n\n## Risk Profile\n- Low Risk: 39 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1414", "study": "Study 21", "site": "Site 1414", "type": "site_summary", "total_subjects": 15, "total_issues": 0, "document": "# Site Report: Site 1414\n\n## Site Information\n- **Site ID**: Site 1414\n- **Study**: Study 21\n- **Country**: CZE\n- **Total Subjects**: 15\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 15 (100.0%)\n\n## Risk Profile\n- Low Risk: 15 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1415", "study": "Study 21", "site": "Site 1415", "type": "site_summary", "total_subjects": 56, "total_issues": 0, "document": "# Site Report: Site 1415\n\n## Site Information\n- **Site ID**: Site 1415\n- **Study**: Study 21\n- **Country**: CZE\n- **Total Subjects**: 56\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 56 (100.0%)\n\n## Risk Profile\n- Low Risk: 56 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1416", "study": "Study 21", "site": "Site 1416", "type": "site_summary", "total_subjects": 13, "total_issues": 0, "document": "# Site Report: Site 1416\n\n## Site Information\n- **Site ID**: Site 1416\n- **Study**: Study 21\n- **Country**: CZE\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 13 (100.0%)\n\n## Risk Profile\n- Low Risk: 13 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1417", "study": "Study 21", "site": "Site 1417", "type": "site_summary", "total_subjects": 47, "total_issues": 0, "document": "# Site Report: Site 1417\n\n## Site Information\n- **Site ID**: Site 1417\n- **Study**: Study 21\n- **Country**: CZE\n- **Total Subjects**: 47\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 47 (100.0%)\n\n## Risk Profile\n- Low Risk: 47 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1418", "study": "Study 21", "site": "Site 1418", "type": "site_summary", "total_subjects": 13, "total_issues": 0, "document": "# Site Report: Site 1418\n\n## Site Information\n- **Site ID**: Site 1418\n- **Study**: Study 21\n- **Country**: CZE\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 13 (100.0%)\n\n## Risk Profile\n- Low Risk: 13 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1419", "study": "Study 21", "site": "Site 1419", "type": "site_summary", "total_subjects": 10, "total_issues": 0, "document": "# Site Report: Site 1419\n\n## Site Information\n- **Site ID**: Site 1419\n- **Study**: Study 21\n- **Country**: CZE\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 10 (100.0%)\n\n## Risk Profile\n- Low Risk: 10 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1420", "study": "Study 21", "site": "Site 1420", "type": "site_summary", "total_subjects": 17, "total_issues": 5, "document": "# Site Report: Site 1420\n\n## Site Information\n- **Site ID**: Site 1420\n- **Study**: Study 21\n- **Country**: CZE\n- **Total Subjects**: 17\n\n## Performance Metrics\n- **Total Issues**: 5\n- **Average Issues per Subject**: 0.29\n- **Clean Subjects**: 16 (94.1%)\n\n## Risk Profile\n- Low Risk: 16 (94.1%)\n- Medium Risk: 1 (5.9%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1421", "study": "Study 21", "site": "Site 1421", "type": "site_summary", "total_subjects": 29, "total_issues": 0, "document": "# Site Report: Site 1421\n\n## Site Information\n- **Site ID**: Site 1421\n- **Study**: Study 21\n- **Country**: DNK\n- **Total Subjects**: 29\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 29 (100.0%)\n\n## Risk Profile\n- Low Risk: 29 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1422", "study": "Study 21", "site": "Site 1422", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 1422\n\n## Site Information\n- **Site ID**: Site 1422\n- **Study**: Study 21\n- **Country**: DNK\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1423", "study": "Study 21", "site": "Site 1423", "type": "site_summary", "total_subjects": 13, "total_issues": 0, "document": "# Site Report: Site 1423\n\n## Site Information\n- **Site ID**: Site 1423\n- **Study**: Study 21\n- **Country**: DNK\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 13 (100.0%)\n\n## Risk Profile\n- Low Risk: 13 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1424", "study": "Study 21", "site": "Site 1424", "type": "site_summary", "total_subjects": 15, "total_issues": 0, "document": "# Site Report: Site 1424\n\n## Site Information\n- **Site ID**: Site 1424\n- **Study**: Study 21\n- **Country**: DNK\n- **Total Subjects**: 15\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 15 (100.0%)\n\n## Risk Profile\n- Low Risk: 15 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1425", "study": "Study 21", "site": "Site 1425", "type": "site_summary", "total_subjects": 11, "total_issues": 0, "document": "# Site Report: Site 1425\n\n## Site Information\n- **Site ID**: Site 1425\n- **Study**: Study 21\n- **Country**: DNK\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 11 (100.0%)\n\n## Risk Profile\n- Low Risk: 11 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1426", "study": "Study 21", "site": "Site 1426", "type": "site_summary", "total_subjects": 26, "total_issues": 1, "document": "# Site Report: Site 1426\n\n## Site Information\n- **Site ID**: Site 1426\n- **Study**: Study 21\n- **Country**: DNK\n- **Total Subjects**: 26\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.04\n- **Clean Subjects**: 25 (96.2%)\n\n## Risk Profile\n- Low Risk: 25 (96.2%)\n- Medium Risk: 1 (3.8%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1427", "study": "Study 21", "site": "Site 1427", "type": "site_summary", "total_subjects": 12, "total_issues": 0, "document": "# Site Report: Site 1427\n\n## Site Information\n- **Site ID**: Site 1427\n- **Study**: Study 21\n- **Country**: DNK\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 12 (100.0%)\n\n## Risk Profile\n- Low Risk: 12 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1428", "study": "Study 21", "site": "Site 1428", "type": "site_summary", "total_subjects": 15, "total_issues": 1, "document": "# Site Report: Site 1428\n\n## Site Information\n- **Site ID**: Site 1428\n- **Study**: Study 21\n- **Country**: DNK\n- **Total Subjects**: 15\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.07\n- **Clean Subjects**: 14 (93.3%)\n\n## Risk Profile\n- Low Risk: 14 (93.3%)\n- Medium Risk: 1 (6.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1429", "study": "Study 21", "site": "Site 1429", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 1429\n\n## Site Information\n- **Site ID**: Site 1429\n- **Study**: Study 21\n- **Country**: DNK\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1430", "study": "Study 21", "site": "Site 1430", "type": "site_summary", "total_subjects": 9, "total_issues": 0, "document": "# Site Report: Site 1430\n\n## Site Information\n- **Site ID**: Site 1430\n- **Study**: Study 21\n- **Country**: HUN\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 9 (100.0%)\n\n## Risk Profile\n- Low Risk: 9 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1431", "study": "Study 21", "site": "Site 1431", "type": "site_summary", "total_subjects": 47, "total_issues": 0, "document": "# Site Report: Site 1431\n\n## Site Information\n- **Site ID**: Site 1431\n- **Study**: Study 21\n- **Country**: HUN\n- **Total Subjects**: 47\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 47 (100.0%)\n\n## Risk Profile\n- Low Risk: 47 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1432", "study": "Study 21", "site": "Site 1432", "type": "site_summary", "total_subjects": 44, "total_issues": 0, "document": "# Site Report: Site 1432\n\n## Site Information\n- **Site ID**: Site 1432\n- **Study**: Study 21\n- **Country**: HUN\n- **Total Subjects**: 44\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 44 (100.0%)\n\n## Risk Profile\n- Low Risk: 44 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1433", "study": "Study 21", "site": "Site 1433", "type": "site_summary", "total_subjects": 24, "total_issues": 0, "document": "# Site Report: Site 1433\n\n## Site Information\n- **Site ID**: Site 1433\n- **Study**: Study 21\n- **Country**: HUN\n- **Total Subjects**: 24\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 24 (100.0%)\n\n## Risk Profile\n- Low Risk: 24 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1434", "study": "Study 21", "site": "Site 1434", "type": "site_summary", "total_subjects": 11, "total_issues": 0, "document": "# Site Report: Site 1434\n\n## Site Information\n- **Site ID**: Site 1434\n- **Study**: Study 21\n- **Country**: HUN\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 11 (100.0%)\n\n## Risk Profile\n- Low Risk: 11 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1435", "study": "Study 21", "site": "Site 1435", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 1435\n\n## Site Information\n- **Site ID**: Site 1435\n- **Study**: Study 21\n- **Country**: HUN\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1436", "study": "Study 21", "site": "Site 1436", "type": "site_summary", "total_subjects": 49, "total_issues": 0, "document": "# Site Report: Site 1436\n\n## Site Information\n- **Site ID**: Site 1436\n- **Study**: Study 21\n- **Country**: HUN\n- **Total Subjects**: 49\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 49 (100.0%)\n\n## Risk Profile\n- Low Risk: 49 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1437", "study": "Study 21", "site": "Site 1437", "type": "site_summary", "total_subjects": 47, "total_issues": 1, "document": "# Site Report: Site 1437\n\n## Site Information\n- **Site ID**: Site 1437\n- **Study**: Study 21\n- **Country**: HUN\n- **Total Subjects**: 47\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.02\n- **Clean Subjects**: 46 (97.9%)\n\n## Risk Profile\n- Low Risk: 46 (97.9%)\n- Medium Risk: 1 (2.1%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1438", "study": "Study 21", "site": "Site 1438", "type": "site_summary", "total_subjects": 61, "total_issues": 0, "document": "# Site Report: Site 1438\n\n## Site Information\n- **Site ID**: Site 1438\n- **Study**: Study 21\n- **Country**: HUN\n- **Total Subjects**: 61\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 61 (100.0%)\n\n## Risk Profile\n- Low Risk: 61 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1439", "study": "Study 21", "site": "Site 1439", "type": "site_summary", "total_subjects": 21, "total_issues": 0, "document": "# Site Report: Site 1439\n\n## Site Information\n- **Site ID**: Site 1439\n- **Study**: Study 21\n- **Country**: HUN\n- **Total Subjects**: 21\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 21 (100.0%)\n\n## Risk Profile\n- Low Risk: 21 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1440", "study": "Study 21", "site": "Site 1440", "type": "site_summary", "total_subjects": 13, "total_issues": 0, "document": "# Site Report: Site 1440\n\n## Site Information\n- **Site ID**: Site 1440\n- **Study**: Study 21\n- **Country**: HUN\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 13 (100.0%)\n\n## Risk Profile\n- Low Risk: 13 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1441", "study": "Study 21", "site": "Site 1441", "type": "site_summary", "total_subjects": 12, "total_issues": 0, "document": "# Site Report: Site 1441\n\n## Site Information\n- **Site ID**: Site 1441\n- **Study**: Study 21\n- **Country**: HUN\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 12 (100.0%)\n\n## Risk Profile\n- Low Risk: 12 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1442", "study": "Study 21", "site": "Site 1442", "type": "site_summary", "total_subjects": 19, "total_issues": 0, "document": "# Site Report: Site 1442\n\n## Site Information\n- **Site ID**: Site 1442\n- **Study**: Study 21\n- **Country**: HUN\n- **Total Subjects**: 19\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 19 (100.0%)\n\n## Risk Profile\n- Low Risk: 19 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1443", "study": "Study 21", "site": "Site 1443", "type": "site_summary", "total_subjects": 18, "total_issues": 1, "document": "# Site Report: Site 1443\n\n## Site Information\n- **Site ID**: Site 1443\n- **Study**: Study 21\n- **Country**: HUN\n- **Total Subjects**: 18\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.06\n- **Clean Subjects**: 17 (94.4%)\n\n## Risk Profile\n- Low Risk: 17 (94.4%)\n- Medium Risk: 1 (5.6%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1444", "study": "Study 21", "site": "Site 1444", "type": "site_summary", "total_subjects": 24, "total_issues": 0, "document": "# Site Report: Site 1444\n\n## Site Information\n- **Site ID**: Site 1444\n- **Study**: Study 21\n- **Country**: HUN\n- **Total Subjects**: 24\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 24 (100.0%)\n\n## Risk Profile\n- Low Risk: 24 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1445", "study": "Study 21", "site": "Site 1445", "type": "site_summary", "total_subjects": 16, "total_issues": 0, "document": "# Site Report: Site 1445\n\n## Site Information\n- **Site ID**: Site 1445\n- **Study**: Study 21\n- **Country**: HUN\n- **Total Subjects**: 16\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 16 (100.0%)\n\n## Risk Profile\n- Low Risk: 16 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1446", "study": "Study 21", "site": "Site 1446", "type": "site_summary", "total_subjects": 51, "total_issues": 0, "document": "# Site Report: Site 1446\n\n## Site Information\n- **Site ID**: Site 1446\n- **Study**: Study 21\n- **Country**: HUN\n- **Total Subjects**: 51\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 51 (100.0%)\n\n## Risk Profile\n- Low Risk: 51 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 4\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1447", "study": "Study 21", "site": "Site 1447", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 1447\n\n## Site Information\n- **Site ID**: Site 1447\n- **Study**: Study 21\n- **Country**: HUN\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1448", "study": "Study 21", "site": "Site 1448", "type": "site_summary", "total_subjects": 12, "total_issues": 0, "document": "# Site Report: Site 1448\n\n## Site Information\n- **Site ID**: Site 1448\n- **Study**: Study 21\n- **Country**: HUN\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 12 (100.0%)\n\n## Risk Profile\n- Low Risk: 12 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1449", "study": "Study 21", "site": "Site 1449", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 1449\n\n## Site Information\n- **Site ID**: Site 1449\n- **Study**: Study 21\n- **Country**: HUN\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1450", "study": "Study 21", "site": "Site 1450", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 1450\n\n## Site Information\n- **Site ID**: Site 1450\n- **Study**: Study 21\n- **Country**: HUN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1451", "study": "Study 21", "site": "Site 1451", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 1451\n\n## Site Information\n- **Site ID**: Site 1451\n- **Study**: Study 21\n- **Country**: ISR\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1452", "study": "Study 21", "site": "Site 1452", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 1452\n\n## Site Information\n- **Site ID**: Site 1452\n- **Study**: Study 21\n- **Country**: ISR\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1453", "study": "Study 21", "site": "Site 1453", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 1453\n\n## Site Information\n- **Site ID**: Site 1453\n- **Study**: Study 21\n- **Country**: ISR\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1454", "study": "Study 21", "site": "Site 1454", "type": "site_summary", "total_subjects": 9, "total_issues": 0, "document": "# Site Report: Site 1454\n\n## Site Information\n- **Site ID**: Site 1454\n- **Study**: Study 21\n- **Country**: ISR\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 9 (100.0%)\n\n## Risk Profile\n- Low Risk: 9 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1455", "study": "Study 21", "site": "Site 1455", "type": "site_summary", "total_subjects": 15, "total_issues": 0, "document": "# Site Report: Site 1455\n\n## Site Information\n- **Site ID**: Site 1455\n- **Study**: Study 21\n- **Country**: ISR\n- **Total Subjects**: 15\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 15 (100.0%)\n\n## Risk Profile\n- Low Risk: 15 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1456", "study": "Study 21", "site": "Site 1456", "type": "site_summary", "total_subjects": 51, "total_issues": 0, "document": "# Site Report: Site 1456\n\n## Site Information\n- **Site ID**: Site 1456\n- **Study**: Study 21\n- **Country**: ISR\n- **Total Subjects**: 51\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 51 (100.0%)\n\n## Risk Profile\n- Low Risk: 51 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1457", "study": "Study 21", "site": "Site 1457", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 1457\n\n## Site Information\n- **Site ID**: Site 1457\n- **Study**: Study 21\n- **Country**: ISR\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1458", "study": "Study 21", "site": "Site 1458", "type": "site_summary", "total_subjects": 52, "total_issues": 0, "document": "# Site Report: Site 1458\n\n## Site Information\n- **Site ID**: Site 1458\n- **Study**: Study 21\n- **Country**: ISR\n- **Total Subjects**: 52\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 52 (100.0%)\n\n## Risk Profile\n- Low Risk: 52 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1459", "study": "Study 21", "site": "Site 1459", "type": "site_summary", "total_subjects": 21, "total_issues": 0, "document": "# Site Report: Site 1459\n\n## Site Information\n- **Site ID**: Site 1459\n- **Study**: Study 21\n- **Country**: LVA\n- **Total Subjects**: 21\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 21 (100.0%)\n\n## Risk Profile\n- Low Risk: 21 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1460", "study": "Study 21", "site": "Site 1460", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 1460\n\n## Site Information\n- **Site ID**: Site 1460\n- **Study**: Study 21\n- **Country**: LVA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1461", "study": "Study 21", "site": "Site 1461", "type": "site_summary", "total_subjects": 19, "total_issues": 0, "document": "# Site Report: Site 1461\n\n## Site Information\n- **Site ID**: Site 1461\n- **Study**: Study 21\n- **Country**: LVA\n- **Total Subjects**: 19\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 19 (100.0%)\n\n## Risk Profile\n- Low Risk: 19 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1462", "study": "Study 21", "site": "Site 1462", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 1462\n\n## Site Information\n- **Site ID**: Site 1462\n- **Study**: Study 21\n- **Country**: LVA\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1463", "study": "Study 21", "site": "Site 1463", "type": "site_summary", "total_subjects": 19, "total_issues": 0, "document": "# Site Report: Site 1463\n\n## Site Information\n- **Site ID**: Site 1463\n- **Study**: Study 21\n- **Country**: LVA\n- **Total Subjects**: 19\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 19 (100.0%)\n\n## Risk Profile\n- Low Risk: 19 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1464", "study": "Study 21", "site": "Site 1464", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 1464\n\n## Site Information\n- **Site ID**: Site 1464\n- **Study**: Study 21\n- **Country**: LVA\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1465", "study": "Study 21", "site": "Site 1465", "type": "site_summary", "total_subjects": 8, "total_issues": 0, "document": "# Site Report: Site 1465\n\n## Site Information\n- **Site ID**: Site 1465\n- **Study**: Study 21\n- **Country**: LVA\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 8 (100.0%)\n\n## Risk Profile\n- Low Risk: 8 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1466", "study": "Study 21", "site": "Site 1466", "type": "site_summary", "total_subjects": 30, "total_issues": 0, "document": "# Site Report: Site 1466\n\n## Site Information\n- **Site ID**: Site 1466\n- **Study**: Study 21\n- **Country**: LTU\n- **Total Subjects**: 30\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 30 (100.0%)\n\n## Risk Profile\n- Low Risk: 30 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1467", "study": "Study 21", "site": "Site 1467", "type": "site_summary", "total_subjects": 81, "total_issues": 2, "document": "# Site Report: Site 1467\n\n## Site Information\n- **Site ID**: Site 1467\n- **Study**: Study 21\n- **Country**: LTU\n- **Total Subjects**: 81\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.02\n- **Clean Subjects**: 79 (97.5%)\n\n## Risk Profile\n- Low Risk: 79 (97.5%)\n- Medium Risk: 2 (2.5%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 6\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1468", "study": "Study 21", "site": "Site 1468", "type": "site_summary", "total_subjects": 68, "total_issues": 8, "document": "# Site Report: Site 1468\n\n## Site Information\n- **Site ID**: Site 1468\n- **Study**: Study 21\n- **Country**: LTU\n- **Total Subjects**: 68\n\n## Performance Metrics\n- **Total Issues**: 8\n- **Average Issues per Subject**: 0.12\n- **Clean Subjects**: 65 (95.6%)\n\n## Risk Profile\n- Low Risk: 65 (95.6%)\n- Medium Risk: 3 (4.4%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1469", "study": "Study 21", "site": "Site 1469", "type": "site_summary", "total_subjects": 34, "total_issues": 0, "document": "# Site Report: Site 1469\n\n## Site Information\n- **Site ID**: Site 1469\n- **Study**: Study 21\n- **Country**: LTU\n- **Total Subjects**: 34\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 34 (100.0%)\n\n## Risk Profile\n- Low Risk: 34 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1470", "study": "Study 21", "site": "Site 1470", "type": "site_summary", "total_subjects": 33, "total_issues": 0, "document": "# Site Report: Site 1470\n\n## Site Information\n- **Site ID**: Site 1470\n- **Study**: Study 21\n- **Country**: LTU\n- **Total Subjects**: 33\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 33 (100.0%)\n\n## Risk Profile\n- Low Risk: 33 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1471", "study": "Study 21", "site": "Site 1471", "type": "site_summary", "total_subjects": 67, "total_issues": 1, "document": "# Site Report: Site 1471\n\n## Site Information\n- **Site ID**: Site 1471\n- **Study**: Study 21\n- **Country**: LTU\n- **Total Subjects**: 67\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.01\n- **Clean Subjects**: 66 (98.5%)\n\n## Risk Profile\n- Low Risk: 66 (98.5%)\n- Medium Risk: 1 (1.5%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1472", "study": "Study 21", "site": "Site 1472", "type": "site_summary", "total_subjects": 21, "total_issues": 0, "document": "# Site Report: Site 1472\n\n## Site Information\n- **Site ID**: Site 1472\n- **Study**: Study 21\n- **Country**: LTU\n- **Total Subjects**: 21\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 21 (100.0%)\n\n## Risk Profile\n- Low Risk: 21 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1473", "study": "Study 21", "site": "Site 1473", "type": "site_summary", "total_subjects": 18, "total_issues": 0, "document": "# Site Report: Site 1473\n\n## Site Information\n- **Site ID**: Site 1473\n- **Study**: Study 21\n- **Country**: LTU\n- **Total Subjects**: 18\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 18 (100.0%)\n\n## Risk Profile\n- Low Risk: 18 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1474", "study": "Study 21", "site": "Site 1474", "type": "site_summary", "total_subjects": 23, "total_issues": 0, "document": "# Site Report: Site 1474\n\n## Site Information\n- **Site ID**: Site 1474\n- **Study**: Study 21\n- **Country**: LTU\n- **Total Subjects**: 23\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 23 (100.0%)\n\n## Risk Profile\n- Low Risk: 23 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1475", "study": "Study 21", "site": "Site 1475", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 1475\n\n## Site Information\n- **Site ID**: Site 1475\n- **Study**: Study 21\n- **Country**: LTU\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1476", "study": "Study 21", "site": "Site 1476", "type": "site_summary", "total_subjects": 17, "total_issues": 1, "document": "# Site Report: Site 1476\n\n## Site Information\n- **Site ID**: Site 1476\n- **Study**: Study 21\n- **Country**: LTU\n- **Total Subjects**: 17\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.06\n- **Clean Subjects**: 16 (94.1%)\n\n## Risk Profile\n- Low Risk: 16 (94.1%)\n- Medium Risk: 1 (5.9%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1477", "study": "Study 21", "site": "Site 1477", "type": "site_summary", "total_subjects": 22, "total_issues": 0, "document": "# Site Report: Site 1477\n\n## Site Information\n- **Site ID**: Site 1477\n- **Study**: Study 21\n- **Country**: MYS\n- **Total Subjects**: 22\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 22 (100.0%)\n\n## Risk Profile\n- Low Risk: 22 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 3\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1478", "study": "Study 21", "site": "Site 1478", "type": "site_summary", "total_subjects": 19, "total_issues": 0, "document": "# Site Report: Site 1478\n\n## Site Information\n- **Site ID**: Site 1478\n- **Study**: Study 21\n- **Country**: MYS\n- **Total Subjects**: 19\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 19 (100.0%)\n\n## Risk Profile\n- Low Risk: 19 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1479", "study": "Study 21", "site": "Site 1479", "type": "site_summary", "total_subjects": 38, "total_issues": 1, "document": "# Site Report: Site 1479\n\n## Site Information\n- **Site ID**: Site 1479\n- **Study**: Study 21\n- **Country**: MYS\n- **Total Subjects**: 38\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.03\n- **Clean Subjects**: 37 (97.4%)\n\n## Risk Profile\n- Low Risk: 37 (97.4%)\n- Medium Risk: 1 (2.6%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 148", "study": "Study 21", "site": "Site 148", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 148\n\n## Site Information\n- **Site ID**: Site 148\n- **Study**: Study 21\n- **Country**: ITA\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1480", "study": "Study 21", "site": "Site 1480", "type": "site_summary", "total_subjects": 19, "total_issues": 1, "document": "# Site Report: Site 1480\n\n## Site Information\n- **Site ID**: Site 1480\n- **Study**: Study 21\n- **Country**: MYS\n- **Total Subjects**: 19\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.05\n- **Clean Subjects**: 18 (94.7%)\n\n## Risk Profile\n- Low Risk: 18 (94.7%)\n- Medium Risk: 1 (5.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1481", "study": "Study 21", "site": "Site 1481", "type": "site_summary", "total_subjects": 21, "total_issues": 0, "document": "# Site Report: Site 1481\n\n## Site Information\n- **Site ID**: Site 1481\n- **Study**: Study 21\n- **Country**: MYS\n- **Total Subjects**: 21\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 21 (100.0%)\n\n## Risk Profile\n- Low Risk: 21 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1482", "study": "Study 21", "site": "Site 1482", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 1482\n\n## Site Information\n- **Site ID**: Site 1482\n- **Study**: Study 21\n- **Country**: MYS\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1483", "study": "Study 21", "site": "Site 1483", "type": "site_summary", "total_subjects": 10, "total_issues": 1, "document": "# Site Report: Site 1483\n\n## Site Information\n- **Site ID**: Site 1483\n- **Study**: Study 21\n- **Country**: MEX\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.10\n- **Clean Subjects**: 9 (90.0%)\n\n## Risk Profile\n- Low Risk: 9 (90.0%)\n- Medium Risk: 1 (10.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1484", "study": "Study 21", "site": "Site 1484", "type": "site_summary", "total_subjects": 29, "total_issues": 0, "document": "# Site Report: Site 1484\n\n## Site Information\n- **Site ID**: Site 1484\n- **Study**: Study 21\n- **Country**: MEX\n- **Total Subjects**: 29\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 29 (100.0%)\n\n## Risk Profile\n- Low Risk: 29 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1485", "study": "Study 21", "site": "Site 1485", "type": "site_summary", "total_subjects": 11, "total_issues": 0, "document": "# Site Report: Site 1485\n\n## Site Information\n- **Site ID**: Site 1485\n- **Study**: Study 21\n- **Country**: MEX\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 11 (100.0%)\n\n## Risk Profile\n- Low Risk: 11 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1486", "study": "Study 21", "site": "Site 1486", "type": "site_summary", "total_subjects": 24, "total_issues": 0, "document": "# Site Report: Site 1486\n\n## Site Information\n- **Site ID**: Site 1486\n- **Study**: Study 21\n- **Country**: MEX\n- **Total Subjects**: 24\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 24 (100.0%)\n\n## Risk Profile\n- Low Risk: 24 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1487", "study": "Study 21", "site": "Site 1487", "type": "site_summary", "total_subjects": 17, "total_issues": 0, "document": "# Site Report: Site 1487\n\n## Site Information\n- **Site ID**: Site 1487\n- **Study**: Study 21\n- **Country**: MEX\n- **Total Subjects**: 17\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 17 (100.0%)\n\n## Risk Profile\n- Low Risk: 17 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1488", "study": "Study 21", "site": "Site 1488", "type": "site_summary", "total_subjects": 12, "total_issues": 0, "document": "# Site Report: Site 1488\n\n## Site Information\n- **Site ID**: Site 1488\n- **Study**: Study 21\n- **Country**: MEX\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 12 (100.0%)\n\n## Risk Profile\n- Low Risk: 12 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1489", "study": "Study 21", "site": "Site 1489", "type": "site_summary", "total_subjects": 17, "total_issues": 0, "document": "# Site Report: Site 1489\n\n## Site Information\n- **Site ID**: Site 1489\n- **Study**: Study 21\n- **Country**: MEX\n- **Total Subjects**: 17\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 17 (100.0%)\n\n## Risk Profile\n- Low Risk: 17 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 149", "study": "Study 21", "site": "Site 149", "type": "site_summary", "total_subjects": 8, "total_issues": 0, "document": "# Site Report: Site 149\n\n## Site Information\n- **Site ID**: Site 149\n- **Study**: Study 21\n- **Country**: ITA\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 8 (100.0%)\n\n## Risk Profile\n- Low Risk: 8 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1490", "study": "Study 21", "site": "Site 1490", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 1490\n\n## Site Information\n- **Site ID**: Site 1490\n- **Study**: Study 21\n- **Country**: MEX\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1491", "study": "Study 21", "site": "Site 1491", "type": "site_summary", "total_subjects": 25, "total_issues": 0, "document": "# Site Report: Site 1491\n\n## Site Information\n- **Site ID**: Site 1491\n- **Study**: Study 21\n- **Country**: MEX\n- **Total Subjects**: 25\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 25 (100.0%)\n\n## Risk Profile\n- Low Risk: 25 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1492", "study": "Study 21", "site": "Site 1492", "type": "site_summary", "total_subjects": 21, "total_issues": 0, "document": "# Site Report: Site 1492\n\n## Site Information\n- **Site ID**: Site 1492\n- **Study**: Study 21\n- **Country**: MEX\n- **Total Subjects**: 21\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 21 (100.0%)\n\n## Risk Profile\n- Low Risk: 21 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1493", "study": "Study 21", "site": "Site 1493", "type": "site_summary", "total_subjects": 12, "total_issues": 0, "document": "# Site Report: Site 1493\n\n## Site Information\n- **Site ID**: Site 1493\n- **Study**: Study 21\n- **Country**: MEX\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 12 (100.0%)\n\n## Risk Profile\n- Low Risk: 12 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1494", "study": "Study 21", "site": "Site 1494", "type": "site_summary", "total_subjects": 24, "total_issues": 0, "document": "# Site Report: Site 1494\n\n## Site Information\n- **Site ID**: Site 1494\n- **Study**: Study 21\n- **Country**: MEX\n- **Total Subjects**: 24\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 24 (100.0%)\n\n## Risk Profile\n- Low Risk: 24 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1495", "study": "Study 21", "site": "Site 1495", "type": "site_summary", "total_subjects": 12, "total_issues": 0, "document": "# Site Report: Site 1495\n\n## Site Information\n- **Site ID**: Site 1495\n- **Study**: Study 21\n- **Country**: MEX\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 12 (100.0%)\n\n## Risk Profile\n- Low Risk: 12 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1496", "study": "Study 21", "site": "Site 1496", "type": "site_summary", "total_subjects": 12, "total_issues": 0, "document": "# Site Report: Site 1496\n\n## Site Information\n- **Site ID**: Site 1496\n- **Study**: Study 21\n- **Country**: MEX\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 12 (100.0%)\n\n## Risk Profile\n- Low Risk: 12 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1497", "study": "Study 21", "site": "Site 1497", "type": "site_summary", "total_subjects": 5, "total_issues": 1, "document": "# Site Report: Site 1497\n\n## Site Information\n- **Site ID**: Site 1497\n- **Study**: Study 21\n- **Country**: MEX\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.20\n- **Clean Subjects**: 4 (80.0%)\n\n## Risk Profile\n- Low Risk: 4 (80.0%)\n- Medium Risk: 1 (20.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1498", "study": "Study 21", "site": "Site 1498", "type": "site_summary", "total_subjects": 31, "total_issues": 0, "document": "# Site Report: Site 1498\n\n## Site Information\n- **Site ID**: Site 1498\n- **Study**: Study 21\n- **Country**: MEX\n- **Total Subjects**: 31\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 31 (100.0%)\n\n## Risk Profile\n- Low Risk: 31 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1499", "study": "Study 21", "site": "Site 1499", "type": "site_summary", "total_subjects": 17, "total_issues": 0, "document": "# Site Report: Site 1499\n\n## Site Information\n- **Site ID**: Site 1499\n- **Study**: Study 21\n- **Country**: MEX\n- **Total Subjects**: 17\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 17 (100.0%)\n\n## Risk Profile\n- Low Risk: 17 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 15", "study": "Study 21", "site": "Site 15", "type": "site_summary", "total_subjects": 39, "total_issues": 1, "document": "# Site Report: Site 15\n\n## Site Information\n- **Site ID**: Site 15\n- **Study**: Study 21\n- **Country**: SVK\n- **Total Subjects**: 39\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.03\n- **Clean Subjects**: 38 (97.4%)\n\n## Risk Profile\n- Low Risk: 38 (97.4%)\n- Medium Risk: 1 (2.6%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1500", "study": "Study 21", "site": "Site 1500", "type": "site_summary", "total_subjects": 14, "total_issues": 0, "document": "# Site Report: Site 1500\n\n## Site Information\n- **Site ID**: Site 1500\n- **Study**: Study 21\n- **Country**: NZL\n- **Total Subjects**: 14\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 14 (100.0%)\n\n## Risk Profile\n- Low Risk: 14 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1501", "study": "Study 21", "site": "Site 1501", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 1501\n\n## Site Information\n- **Site ID**: Site 1501\n- **Study**: Study 21\n- **Country**: NZL\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1502", "study": "Study 21", "site": "Site 1502", "type": "site_summary", "total_subjects": 22, "total_issues": 0, "document": "# Site Report: Site 1502\n\n## Site Information\n- **Site ID**: Site 1502\n- **Study**: Study 21\n- **Country**: NZL\n- **Total Subjects**: 22\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 22 (100.0%)\n\n## Risk Profile\n- Low Risk: 22 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1503", "study": "Study 21", "site": "Site 1503", "type": "site_summary", "total_subjects": 35, "total_issues": 0, "document": "# Site Report: Site 1503\n\n## Site Information\n- **Site ID**: Site 1503\n- **Study**: Study 21\n- **Country**: NZL\n- **Total Subjects**: 35\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 35 (100.0%)\n\n## Risk Profile\n- Low Risk: 35 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1504", "study": "Study 21", "site": "Site 1504", "type": "site_summary", "total_subjects": 52, "total_issues": 0, "document": "# Site Report: Site 1504\n\n## Site Information\n- **Site ID**: Site 1504\n- **Study**: Study 21\n- **Country**: NZL\n- **Total Subjects**: 52\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 52 (100.0%)\n\n## Risk Profile\n- Low Risk: 52 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1505", "study": "Study 21", "site": "Site 1505", "type": "site_summary", "total_subjects": 24, "total_issues": 0, "document": "# Site Report: Site 1505\n\n## Site Information\n- **Site ID**: Site 1505\n- **Study**: Study 21\n- **Country**: NZL\n- **Total Subjects**: 24\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 24 (100.0%)\n\n## Risk Profile\n- Low Risk: 24 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1506", "study": "Study 21", "site": "Site 1506", "type": "site_summary", "total_subjects": 12, "total_issues": 0, "document": "# Site Report: Site 1506\n\n## Site Information\n- **Site ID**: Site 1506\n- **Study**: Study 21\n- **Country**: NZL\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 12 (100.0%)\n\n## Risk Profile\n- Low Risk: 12 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1507", "study": "Study 21", "site": "Site 1507", "type": "site_summary", "total_subjects": 17, "total_issues": 0, "document": "# Site Report: Site 1507\n\n## Site Information\n- **Site ID**: Site 1507\n- **Study**: Study 21\n- **Country**: POL\n- **Total Subjects**: 17\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 17 (100.0%)\n\n## Risk Profile\n- Low Risk: 17 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1508", "study": "Study 21", "site": "Site 1508", "type": "site_summary", "total_subjects": 20, "total_issues": 0, "document": "# Site Report: Site 1508\n\n## Site Information\n- **Site ID**: Site 1508\n- **Study**: Study 21\n- **Country**: POL\n- **Total Subjects**: 20\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 20 (100.0%)\n\n## Risk Profile\n- Low Risk: 20 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1509", "study": "Study 21", "site": "Site 1509", "type": "site_summary", "total_subjects": 9, "total_issues": 0, "document": "# Site Report: Site 1509\n\n## Site Information\n- **Site ID**: Site 1509\n- **Study**: Study 21\n- **Country**: POL\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 9 (100.0%)\n\n## Risk Profile\n- Low Risk: 9 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1510", "study": "Study 21", "site": "Site 1510", "type": "site_summary", "total_subjects": 31, "total_issues": 0, "document": "# Site Report: Site 1510\n\n## Site Information\n- **Site ID**: Site 1510\n- **Study**: Study 21\n- **Country**: POL\n- **Total Subjects**: 31\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 31 (100.0%)\n\n## Risk Profile\n- Low Risk: 31 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1511", "study": "Study 21", "site": "Site 1511", "type": "site_summary", "total_subjects": 8, "total_issues": 0, "document": "# Site Report: Site 1511\n\n## Site Information\n- **Site ID**: Site 1511\n- **Study**: Study 21\n- **Country**: POL\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 8 (100.0%)\n\n## Risk Profile\n- Low Risk: 8 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1512", "study": "Study 21", "site": "Site 1512", "type": "site_summary", "total_subjects": 10, "total_issues": 0, "document": "# Site Report: Site 1512\n\n## Site Information\n- **Site ID**: Site 1512\n- **Study**: Study 21\n- **Country**: POL\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 10 (100.0%)\n\n## Risk Profile\n- Low Risk: 10 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1513", "study": "Study 21", "site": "Site 1513", "type": "site_summary", "total_subjects": 173, "total_issues": 2, "document": "# Site Report: Site 1513\n\n## Site Information\n- **Site ID**: Site 1513\n- **Study**: Study 21\n- **Country**: POL\n- **Total Subjects**: 173\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.01\n- **Clean Subjects**: 171 (98.8%)\n\n## Risk Profile\n- Low Risk: 171 (98.8%)\n- Medium Risk: 2 (1.2%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 5\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1514", "study": "Study 21", "site": "Site 1514", "type": "site_summary", "total_subjects": 78, "total_issues": 0, "document": "# Site Report: Site 1514\n\n## Site Information\n- **Site ID**: Site 1514\n- **Study**: Study 21\n- **Country**: POL\n- **Total Subjects**: 78\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 78 (100.0%)\n\n## Risk Profile\n- Low Risk: 78 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1515", "study": "Study 21", "site": "Site 1515", "type": "site_summary", "total_subjects": 20, "total_issues": 0, "document": "# Site Report: Site 1515\n\n## Site Information\n- **Site ID**: Site 1515\n- **Study**: Study 21\n- **Country**: POL\n- **Total Subjects**: 20\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 20 (100.0%)\n\n## Risk Profile\n- Low Risk: 20 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1516", "study": "Study 21", "site": "Site 1516", "type": "site_summary", "total_subjects": 46, "total_issues": 0, "document": "# Site Report: Site 1516\n\n## Site Information\n- **Site ID**: Site 1516\n- **Study**: Study 21\n- **Country**: POL\n- **Total Subjects**: 46\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 46 (100.0%)\n\n## Risk Profile\n- Low Risk: 46 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1517", "study": "Study 21", "site": "Site 1517", "type": "site_summary", "total_subjects": 20, "total_issues": 0, "document": "# Site Report: Site 1517\n\n## Site Information\n- **Site ID**: Site 1517\n- **Study**: Study 21\n- **Country**: POL\n- **Total Subjects**: 20\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 20 (100.0%)\n\n## Risk Profile\n- Low Risk: 20 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1518", "study": "Study 21", "site": "Site 1518", "type": "site_summary", "total_subjects": 13, "total_issues": 0, "document": "# Site Report: Site 1518\n\n## Site Information\n- **Site ID**: Site 1518\n- **Study**: Study 21\n- **Country**: POL\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 13 (100.0%)\n\n## Risk Profile\n- Low Risk: 13 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1519", "study": "Study 21", "site": "Site 1519", "type": "site_summary", "total_subjects": 92, "total_issues": 0, "document": "# Site Report: Site 1519\n\n## Site Information\n- **Site ID**: Site 1519\n- **Study**: Study 21\n- **Country**: POL\n- **Total Subjects**: 92\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 92 (100.0%)\n\n## Risk Profile\n- Low Risk: 92 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1520", "study": "Study 21", "site": "Site 1520", "type": "site_summary", "total_subjects": 104, "total_issues": 2, "document": "# Site Report: Site 1520\n\n## Site Information\n- **Site ID**: Site 1520\n- **Study**: Study 21\n- **Country**: POL\n- **Total Subjects**: 104\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.02\n- **Clean Subjects**: 102 (98.1%)\n\n## Risk Profile\n- Low Risk: 102 (98.1%)\n- Medium Risk: 2 (1.9%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 8\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1521", "study": "Study 21", "site": "Site 1521", "type": "site_summary", "total_subjects": 8, "total_issues": 0, "document": "# Site Report: Site 1521\n\n## Site Information\n- **Site ID**: Site 1521\n- **Study**: Study 21\n- **Country**: POL\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 8 (100.0%)\n\n## Risk Profile\n- Low Risk: 8 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1522", "study": "Study 21", "site": "Site 1522", "type": "site_summary", "total_subjects": 33, "total_issues": 0, "document": "# Site Report: Site 1522\n\n## Site Information\n- **Site ID**: Site 1522\n- **Study**: Study 21\n- **Country**: POL\n- **Total Subjects**: 33\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 33 (100.0%)\n\n## Risk Profile\n- Low Risk: 33 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1523", "study": "Study 21", "site": "Site 1523", "type": "site_summary", "total_subjects": 20, "total_issues": 0, "document": "# Site Report: Site 1523\n\n## Site Information\n- **Site ID**: Site 1523\n- **Study**: Study 21\n- **Country**: POL\n- **Total Subjects**: 20\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 20 (100.0%)\n\n## Risk Profile\n- Low Risk: 20 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1524", "study": "Study 21", "site": "Site 1524", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 1524\n\n## Site Information\n- **Site ID**: Site 1524\n- **Study**: Study 21\n- **Country**: POL\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1526", "study": "Study 21", "site": "Site 1526", "type": "site_summary", "total_subjects": 27, "total_issues": 0, "document": "# Site Report: Site 1526\n\n## Site Information\n- **Site ID**: Site 1526\n- **Study**: Study 21\n- **Country**: POL\n- **Total Subjects**: 27\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 27 (100.0%)\n\n## Risk Profile\n- Low Risk: 27 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1527", "study": "Study 21", "site": "Site 1527", "type": "site_summary", "total_subjects": 54, "total_issues": 0, "document": "# Site Report: Site 1527\n\n## Site Information\n- **Site ID**: Site 1527\n- **Study**: Study 21\n- **Country**: POL\n- **Total Subjects**: 54\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 54 (100.0%)\n\n## Risk Profile\n- Low Risk: 54 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1528", "study": "Study 21", "site": "Site 1528", "type": "site_summary", "total_subjects": 68, "total_issues": 0, "document": "# Site Report: Site 1528\n\n## Site Information\n- **Site ID**: Site 1528\n- **Study**: Study 21\n- **Country**: POL\n- **Total Subjects**: 68\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 68 (100.0%)\n\n## Risk Profile\n- Low Risk: 68 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1529", "study": "Study 21", "site": "Site 1529", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 1529\n\n## Site Information\n- **Site ID**: Site 1529\n- **Study**: Study 21\n- **Country**: POL\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 153", "study": "Study 21", "site": "Site 153", "type": "site_summary", "total_subjects": 46, "total_issues": 0, "document": "# Site Report: Site 153\n\n## Site Information\n- **Site ID**: Site 153\n- **Study**: Study 21\n- **Country**: NLD\n- **Total Subjects**: 46\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 46 (100.0%)\n\n## Risk Profile\n- Low Risk: 46 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1530", "study": "Study 21", "site": "Site 1530", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 1530\n\n## Site Information\n- **Site ID**: Site 1530\n- **Study**: Study 21\n- **Country**: POL\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1531", "study": "Study 21", "site": "Site 1531", "type": "site_summary", "total_subjects": 23, "total_issues": 0, "document": "# Site Report: Site 1531\n\n## Site Information\n- **Site ID**: Site 1531\n- **Study**: Study 21\n- **Country**: POL\n- **Total Subjects**: 23\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 23 (100.0%)\n\n## Risk Profile\n- Low Risk: 23 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1532", "study": "Study 21", "site": "Site 1532", "type": "site_summary", "total_subjects": 15, "total_issues": 0, "document": "# Site Report: Site 1532\n\n## Site Information\n- **Site ID**: Site 1532\n- **Study**: Study 21\n- **Country**: POL\n- **Total Subjects**: 15\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 15 (100.0%)\n\n## Risk Profile\n- Low Risk: 15 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1533", "study": "Study 21", "site": "Site 1533", "type": "site_summary", "total_subjects": 30, "total_issues": 1, "document": "# Site Report: Site 1533\n\n## Site Information\n- **Site ID**: Site 1533\n- **Study**: Study 21\n- **Country**: POL\n- **Total Subjects**: 30\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.03\n- **Clean Subjects**: 29 (96.7%)\n\n## Risk Profile\n- Low Risk: 29 (96.7%)\n- Medium Risk: 1 (3.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1534", "study": "Study 21", "site": "Site 1534", "type": "site_summary", "total_subjects": 27, "total_issues": 0, "document": "# Site Report: Site 1534\n\n## Site Information\n- **Site ID**: Site 1534\n- **Study**: Study 21\n- **Country**: ROU\n- **Total Subjects**: 27\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 27 (100.0%)\n\n## Risk Profile\n- Low Risk: 27 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1535", "study": "Study 21", "site": "Site 1535", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 1535\n\n## Site Information\n- **Site ID**: Site 1535\n- **Study**: Study 21\n- **Country**: ROU\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1536", "study": "Study 21", "site": "Site 1536", "type": "site_summary", "total_subjects": 8, "total_issues": 0, "document": "# Site Report: Site 1536\n\n## Site Information\n- **Site ID**: Site 1536\n- **Study**: Study 21\n- **Country**: ROU\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 8 (100.0%)\n\n## Risk Profile\n- Low Risk: 8 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1537", "study": "Study 21", "site": "Site 1537", "type": "site_summary", "total_subjects": 21, "total_issues": 0, "document": "# Site Report: Site 1537\n\n## Site Information\n- **Site ID**: Site 1537\n- **Study**: Study 21\n- **Country**: ROU\n- **Total Subjects**: 21\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 21 (100.0%)\n\n## Risk Profile\n- Low Risk: 21 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1538", "study": "Study 21", "site": "Site 1538", "type": "site_summary", "total_subjects": 36, "total_issues": 0, "document": "# Site Report: Site 1538\n\n## Site Information\n- **Site ID**: Site 1538\n- **Study**: Study 21\n- **Country**: ROU\n- **Total Subjects**: 36\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 36 (100.0%)\n\n## Risk Profile\n- Low Risk: 36 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1539", "study": "Study 21", "site": "Site 1539", "type": "site_summary", "total_subjects": 29, "total_issues": 0, "document": "# Site Report: Site 1539\n\n## Site Information\n- **Site ID**: Site 1539\n- **Study**: Study 21\n- **Country**: ROU\n- **Total Subjects**: 29\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 29 (100.0%)\n\n## Risk Profile\n- Low Risk: 29 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 154", "study": "Study 21", "site": "Site 154", "type": "site_summary", "total_subjects": 38, "total_issues": 0, "document": "# Site Report: Site 154\n\n## Site Information\n- **Site ID**: Site 154\n- **Study**: Study 21\n- **Country**: NLD\n- **Total Subjects**: 38\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 38 (100.0%)\n\n## Risk Profile\n- Low Risk: 38 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1540", "study": "Study 21", "site": "Site 1540", "type": "site_summary", "total_subjects": 18, "total_issues": 0, "document": "# Site Report: Site 1540\n\n## Site Information\n- **Site ID**: Site 1540\n- **Study**: Study 21\n- **Country**: ROU\n- **Total Subjects**: 18\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 18 (100.0%)\n\n## Risk Profile\n- Low Risk: 18 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1541", "study": "Study 21", "site": "Site 1541", "type": "site_summary", "total_subjects": 41, "total_issues": 0, "document": "# Site Report: Site 1541\n\n## Site Information\n- **Site ID**: Site 1541\n- **Study**: Study 21\n- **Country**: ROU\n- **Total Subjects**: 41\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 41 (100.0%)\n\n## Risk Profile\n- Low Risk: 41 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 12\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1542", "study": "Study 21", "site": "Site 1542", "type": "site_summary", "total_subjects": 23, "total_issues": 0, "document": "# Site Report: Site 1542\n\n## Site Information\n- **Site ID**: Site 1542\n- **Study**: Study 21\n- **Country**: ROU\n- **Total Subjects**: 23\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 23 (100.0%)\n\n## Risk Profile\n- Low Risk: 23 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1543", "study": "Study 21", "site": "Site 1543", "type": "site_summary", "total_subjects": 25, "total_issues": 0, "document": "# Site Report: Site 1543\n\n## Site Information\n- **Site ID**: Site 1543\n- **Study**: Study 21\n- **Country**: ROU\n- **Total Subjects**: 25\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 25 (100.0%)\n\n## Risk Profile\n- Low Risk: 25 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1544", "study": "Study 21", "site": "Site 1544", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1544\n\n## Site Information\n- **Site ID**: Site 1544\n- **Study**: Study 21\n- **Country**: ROU\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1545", "study": "Study 21", "site": "Site 1545", "type": "site_summary", "total_subjects": 28, "total_issues": 0, "document": "# Site Report: Site 1545\n\n## Site Information\n- **Site ID**: Site 1545\n- **Study**: Study 21\n- **Country**: ROU\n- **Total Subjects**: 28\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 28 (100.0%)\n\n## Risk Profile\n- Low Risk: 28 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1546", "study": "Study 21", "site": "Site 1546", "type": "site_summary", "total_subjects": 40, "total_issues": 2, "document": "# Site Report: Site 1546\n\n## Site Information\n- **Site ID**: Site 1546\n- **Study**: Study 21\n- **Country**: ROU\n- **Total Subjects**: 40\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.05\n- **Clean Subjects**: 38 (95.0%)\n\n## Risk Profile\n- Low Risk: 38 (95.0%)\n- Medium Risk: 2 (5.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1547", "study": "Study 21", "site": "Site 1547", "type": "site_summary", "total_subjects": 60, "total_issues": 1, "document": "# Site Report: Site 1547\n\n## Site Information\n- **Site ID**: Site 1547\n- **Study**: Study 21\n- **Country**: ROU\n- **Total Subjects**: 60\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.02\n- **Clean Subjects**: 59 (98.3%)\n\n## Risk Profile\n- Low Risk: 59 (98.3%)\n- Medium Risk: 1 (1.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1548", "study": "Study 21", "site": "Site 1548", "type": "site_summary", "total_subjects": 13, "total_issues": 0, "document": "# Site Report: Site 1548\n\n## Site Information\n- **Site ID**: Site 1548\n- **Study**: Study 21\n- **Country**: ROU\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 13 (100.0%)\n\n## Risk Profile\n- Low Risk: 13 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1549", "study": "Study 21", "site": "Site 1549", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 1549\n\n## Site Information\n- **Site ID**: Site 1549\n- **Study**: Study 21\n- **Country**: ROU\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 155", "study": "Study 21", "site": "Site 155", "type": "site_summary", "total_subjects": 32, "total_issues": 0, "document": "# Site Report: Site 155\n\n## Site Information\n- **Site ID**: Site 155\n- **Study**: Study 21\n- **Country**: NLD\n- **Total Subjects**: 32\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 32 (100.0%)\n\n## Risk Profile\n- Low Risk: 32 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1550", "study": "Study 21", "site": "Site 1550", "type": "site_summary", "total_subjects": 10, "total_issues": 0, "document": "# Site Report: Site 1550\n\n## Site Information\n- **Site ID**: Site 1550\n- **Study**: Study 21\n- **Country**: ROU\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 10 (100.0%)\n\n## Risk Profile\n- Low Risk: 10 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1551", "study": "Study 21", "site": "Site 1551", "type": "site_summary", "total_subjects": 8, "total_issues": 0, "document": "# Site Report: Site 1551\n\n## Site Information\n- **Site ID**: Site 1551\n- **Study**: Study 21\n- **Country**: ROU\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 8 (100.0%)\n\n## Risk Profile\n- Low Risk: 8 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1552", "study": "Study 21", "site": "Site 1552", "type": "site_summary", "total_subjects": 21, "total_issues": 0, "document": "# Site Report: Site 1552\n\n## Site Information\n- **Site ID**: Site 1552\n- **Study**: Study 21\n- **Country**: ROU\n- **Total Subjects**: 21\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 21 (100.0%)\n\n## Risk Profile\n- Low Risk: 21 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1553", "study": "Study 21", "site": "Site 1553", "type": "site_summary", "total_subjects": 16, "total_issues": 1, "document": "# Site Report: Site 1553\n\n## Site Information\n- **Site ID**: Site 1553\n- **Study**: Study 21\n- **Country**: SVN\n- **Total Subjects**: 16\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.06\n- **Clean Subjects**: 15 (93.8%)\n\n## Risk Profile\n- Low Risk: 15 (93.8%)\n- Medium Risk: 1 (6.2%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1555", "study": "Study 21", "site": "Site 1555", "type": "site_summary", "total_subjects": 11, "total_issues": 0, "document": "# Site Report: Site 1555\n\n## Site Information\n- **Site ID**: Site 1555\n- **Study**: Study 21\n- **Country**: SVN\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 11 (100.0%)\n\n## Risk Profile\n- Low Risk: 11 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 7\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1556", "study": "Study 21", "site": "Site 1556", "type": "site_summary", "total_subjects": 14, "total_issues": 0, "document": "# Site Report: Site 1556\n\n## Site Information\n- **Site ID**: Site 1556\n- **Study**: Study 21\n- **Country**: SVN\n- **Total Subjects**: 14\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 14 (100.0%)\n\n## Risk Profile\n- Low Risk: 14 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1557", "study": "Study 21", "site": "Site 1557", "type": "site_summary", "total_subjects": 12, "total_issues": 2, "document": "# Site Report: Site 1557\n\n## Site Information\n- **Site ID**: Site 1557\n- **Study**: Study 21\n- **Country**: SVN\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.17\n- **Clean Subjects**: 10 (83.3%)\n\n## Risk Profile\n- Low Risk: 10 (83.3%)\n- Medium Risk: 2 (16.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1558", "study": "Study 21", "site": "Site 1558", "type": "site_summary", "total_subjects": 16, "total_issues": 0, "document": "# Site Report: Site 1558\n\n## Site Information\n- **Site ID**: Site 1558\n- **Study**: Study 21\n- **Country**: ZAF\n- **Total Subjects**: 16\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 16 (100.0%)\n\n## Risk Profile\n- Low Risk: 16 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1559", "study": "Study 21", "site": "Site 1559", "type": "site_summary", "total_subjects": 52, "total_issues": 0, "document": "# Site Report: Site 1559\n\n## Site Information\n- **Site ID**: Site 1559\n- **Study**: Study 21\n- **Country**: ZAF\n- **Total Subjects**: 52\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 52 (100.0%)\n\n## Risk Profile\n- Low Risk: 52 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 156", "study": "Study 21", "site": "Site 156", "type": "site_summary", "total_subjects": 28, "total_issues": 0, "document": "# Site Report: Site 156\n\n## Site Information\n- **Site ID**: Site 156\n- **Study**: Study 21\n- **Country**: NLD\n- **Total Subjects**: 28\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 28 (100.0%)\n\n## Risk Profile\n- Low Risk: 28 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1560", "study": "Study 21", "site": "Site 1560", "type": "site_summary", "total_subjects": 30, "total_issues": 0, "document": "# Site Report: Site 1560\n\n## Site Information\n- **Site ID**: Site 1560\n- **Study**: Study 21\n- **Country**: ZAF\n- **Total Subjects**: 30\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 30 (100.0%)\n\n## Risk Profile\n- Low Risk: 30 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1561", "study": "Study 21", "site": "Site 1561", "type": "site_summary", "total_subjects": 35, "total_issues": 0, "document": "# Site Report: Site 1561\n\n## Site Information\n- **Site ID**: Site 1561\n- **Study**: Study 21\n- **Country**: ZAF\n- **Total Subjects**: 35\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 35 (100.0%)\n\n## Risk Profile\n- Low Risk: 35 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1562", "study": "Study 21", "site": "Site 1562", "type": "site_summary", "total_subjects": 29, "total_issues": 0, "document": "# Site Report: Site 1562\n\n## Site Information\n- **Site ID**: Site 1562\n- **Study**: Study 21\n- **Country**: ZAF\n- **Total Subjects**: 29\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 29 (100.0%)\n\n## Risk Profile\n- Low Risk: 29 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1563", "study": "Study 21", "site": "Site 1563", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 1563\n\n## Site Information\n- **Site ID**: Site 1563\n- **Study**: Study 21\n- **Country**: ZAF\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1564", "study": "Study 21", "site": "Site 1564", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 1564\n\n## Site Information\n- **Site ID**: Site 1564\n- **Study**: Study 21\n- **Country**: ZAF\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1565", "study": "Study 21", "site": "Site 1565", "type": "site_summary", "total_subjects": 19, "total_issues": 0, "document": "# Site Report: Site 1565\n\n## Site Information\n- **Site ID**: Site 1565\n- **Study**: Study 21\n- **Country**: ZAF\n- **Total Subjects**: 19\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 19 (100.0%)\n\n## Risk Profile\n- Low Risk: 19 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1566", "study": "Study 21", "site": "Site 1566", "type": "site_summary", "total_subjects": 9, "total_issues": 0, "document": "# Site Report: Site 1566\n\n## Site Information\n- **Site ID**: Site 1566\n- **Study**: Study 21\n- **Country**: ZAF\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 9 (100.0%)\n\n## Risk Profile\n- Low Risk: 9 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1567", "study": "Study 21", "site": "Site 1567", "type": "site_summary", "total_subjects": 24, "total_issues": 0, "document": "# Site Report: Site 1567\n\n## Site Information\n- **Site ID**: Site 1567\n- **Study**: Study 21\n- **Country**: ZAF\n- **Total Subjects**: 24\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 24 (100.0%)\n\n## Risk Profile\n- Low Risk: 24 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1568", "study": "Study 21", "site": "Site 1568", "type": "site_summary", "total_subjects": 27, "total_issues": 0, "document": "# Site Report: Site 1568\n\n## Site Information\n- **Site ID**: Site 1568\n- **Study**: Study 21\n- **Country**: ZAF\n- **Total Subjects**: 27\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 27 (100.0%)\n\n## Risk Profile\n- Low Risk: 27 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1569", "study": "Study 21", "site": "Site 1569", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 1569\n\n## Site Information\n- **Site ID**: Site 1569\n- **Study**: Study 21\n- **Country**: ZAF\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 157", "study": "Study 21", "site": "Site 157", "type": "site_summary", "total_subjects": 64, "total_issues": 0, "document": "# Site Report: Site 157\n\n## Site Information\n- **Site ID**: Site 157\n- **Study**: Study 21\n- **Country**: NLD\n- **Total Subjects**: 64\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 64 (100.0%)\n\n## Risk Profile\n- Low Risk: 64 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1570", "study": "Study 21", "site": "Site 1570", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 1570\n\n## Site Information\n- **Site ID**: Site 1570\n- **Study**: Study 21\n- **Country**: ZAF\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1571", "study": "Study 21", "site": "Site 1571", "type": "site_summary", "total_subjects": 22, "total_issues": 0, "document": "# Site Report: Site 1571\n\n## Site Information\n- **Site ID**: Site 1571\n- **Study**: Study 21\n- **Country**: ZAF\n- **Total Subjects**: 22\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 22 (100.0%)\n\n## Risk Profile\n- Low Risk: 22 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1572", "study": "Study 21", "site": "Site 1572", "type": "site_summary", "total_subjects": 41, "total_issues": 1, "document": "# Site Report: Site 1572\n\n## Site Information\n- **Site ID**: Site 1572\n- **Study**: Study 21\n- **Country**: ZAF\n- **Total Subjects**: 41\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.02\n- **Clean Subjects**: 40 (97.6%)\n\n## Risk Profile\n- Low Risk: 40 (97.6%)\n- Medium Risk: 1 (2.4%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1573", "study": "Study 21", "site": "Site 1573", "type": "site_summary", "total_subjects": 36, "total_issues": 2, "document": "# Site Report: Site 1573\n\n## Site Information\n- **Site ID**: Site 1573\n- **Study**: Study 21\n- **Country**: ZAF\n- **Total Subjects**: 36\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.06\n- **Clean Subjects**: 35 (97.2%)\n\n## Risk Profile\n- Low Risk: 35 (97.2%)\n- Medium Risk: 1 (2.8%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1574", "study": "Study 21", "site": "Site 1574", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 1574\n\n## Site Information\n- **Site ID**: Site 1574\n- **Study**: Study 21\n- **Country**: ZAF\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1575", "study": "Study 21", "site": "Site 1575", "type": "site_summary", "total_subjects": 12, "total_issues": 0, "document": "# Site Report: Site 1575\n\n## Site Information\n- **Site ID**: Site 1575\n- **Study**: Study 21\n- **Country**: KOR\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 12 (100.0%)\n\n## Risk Profile\n- Low Risk: 12 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1576", "study": "Study 21", "site": "Site 1576", "type": "site_summary", "total_subjects": 8, "total_issues": 0, "document": "# Site Report: Site 1576\n\n## Site Information\n- **Site ID**: Site 1576\n- **Study**: Study 21\n- **Country**: KOR\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 8 (100.0%)\n\n## Risk Profile\n- Low Risk: 8 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1577", "study": "Study 21", "site": "Site 1577", "type": "site_summary", "total_subjects": 12, "total_issues": 0, "document": "# Site Report: Site 1577\n\n## Site Information\n- **Site ID**: Site 1577\n- **Study**: Study 21\n- **Country**: KOR\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 12 (100.0%)\n\n## Risk Profile\n- Low Risk: 12 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1578", "study": "Study 21", "site": "Site 1578", "type": "site_summary", "total_subjects": 15, "total_issues": 0, "document": "# Site Report: Site 1578\n\n## Site Information\n- **Site ID**: Site 1578\n- **Study**: Study 21\n- **Country**: KOR\n- **Total Subjects**: 15\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 15 (100.0%)\n\n## Risk Profile\n- Low Risk: 15 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1579", "study": "Study 21", "site": "Site 1579", "type": "site_summary", "total_subjects": 26, "total_issues": 4, "document": "# Site Report: Site 1579\n\n## Site Information\n- **Site ID**: Site 1579\n- **Study**: Study 21\n- **Country**: KOR\n- **Total Subjects**: 26\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 0.15\n- **Clean Subjects**: 25 (96.2%)\n\n## Risk Profile\n- Low Risk: 25 (96.2%)\n- Medium Risk: 1 (3.8%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 158", "study": "Study 21", "site": "Site 158", "type": "site_summary", "total_subjects": 35, "total_issues": 0, "document": "# Site Report: Site 158\n\n## Site Information\n- **Site ID**: Site 158\n- **Study**: Study 21\n- **Country**: NLD\n- **Total Subjects**: 35\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 35 (100.0%)\n\n## Risk Profile\n- Low Risk: 35 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1580", "study": "Study 21", "site": "Site 1580", "type": "site_summary", "total_subjects": 32, "total_issues": 0, "document": "# Site Report: Site 1580\n\n## Site Information\n- **Site ID**: Site 1580\n- **Study**: Study 21\n- **Country**: KOR\n- **Total Subjects**: 32\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 32 (100.0%)\n\n## Risk Profile\n- Low Risk: 32 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1581", "study": "Study 21", "site": "Site 1581", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 1581\n\n## Site Information\n- **Site ID**: Site 1581\n- **Study**: Study 21\n- **Country**: KOR\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1582", "study": "Study 21", "site": "Site 1582", "type": "site_summary", "total_subjects": 28, "total_issues": 1, "document": "# Site Report: Site 1582\n\n## Site Information\n- **Site ID**: Site 1582\n- **Study**: Study 21\n- **Country**: KOR\n- **Total Subjects**: 28\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.04\n- **Clean Subjects**: 27 (96.4%)\n\n## Risk Profile\n- Low Risk: 27 (96.4%)\n- Medium Risk: 1 (3.6%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1583", "study": "Study 21", "site": "Site 1583", "type": "site_summary", "total_subjects": 12, "total_issues": 4, "document": "# Site Report: Site 1583\n\n## Site Information\n- **Site ID**: Site 1583\n- **Study**: Study 21\n- **Country**: KOR\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 0.33\n- **Clean Subjects**: 10 (83.3%)\n\n## Risk Profile\n- Low Risk: 10 (83.3%)\n- Medium Risk: 2 (16.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1584", "study": "Study 21", "site": "Site 1584", "type": "site_summary", "total_subjects": 10, "total_issues": 0, "document": "# Site Report: Site 1584\n\n## Site Information\n- **Site ID**: Site 1584\n- **Study**: Study 21\n- **Country**: KOR\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 10 (100.0%)\n\n## Risk Profile\n- Low Risk: 10 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1585", "study": "Study 21", "site": "Site 1585", "type": "site_summary", "total_subjects": 24, "total_issues": 0, "document": "# Site Report: Site 1585\n\n## Site Information\n- **Site ID**: Site 1585\n- **Study**: Study 21\n- **Country**: KOR\n- **Total Subjects**: 24\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 24 (100.0%)\n\n## Risk Profile\n- Low Risk: 24 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1586", "study": "Study 21", "site": "Site 1586", "type": "site_summary", "total_subjects": 12, "total_issues": 0, "document": "# Site Report: Site 1586\n\n## Site Information\n- **Site ID**: Site 1586\n- **Study**: Study 21\n- **Country**: KOR\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 12 (100.0%)\n\n## Risk Profile\n- Low Risk: 12 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1587", "study": "Study 21", "site": "Site 1587", "type": "site_summary", "total_subjects": 11, "total_issues": 0, "document": "# Site Report: Site 1587\n\n## Site Information\n- **Site ID**: Site 1587\n- **Study**: Study 21\n- **Country**: KOR\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 11 (100.0%)\n\n## Risk Profile\n- Low Risk: 11 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1588", "study": "Study 21", "site": "Site 1588", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 1588\n\n## Site Information\n- **Site ID**: Site 1588\n- **Study**: Study 21\n- **Country**: KOR\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1589", "study": "Study 21", "site": "Site 1589", "type": "site_summary", "total_subjects": 24, "total_issues": 1, "document": "# Site Report: Site 1589\n\n## Site Information\n- **Site ID**: Site 1589\n- **Study**: Study 21\n- **Country**: KOR\n- **Total Subjects**: 24\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.04\n- **Clean Subjects**: 23 (95.8%)\n\n## Risk Profile\n- Low Risk: 23 (95.8%)\n- Medium Risk: 1 (4.2%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 159", "study": "Study 21", "site": "Site 159", "type": "site_summary", "total_subjects": 25, "total_issues": 0, "document": "# Site Report: Site 159\n\n## Site Information\n- **Site ID**: Site 159\n- **Study**: Study 21\n- **Country**: NLD\n- **Total Subjects**: 25\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 25 (100.0%)\n\n## Risk Profile\n- Low Risk: 25 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1590", "study": "Study 21", "site": "Site 1590", "type": "site_summary", "total_subjects": 10, "total_issues": 0, "document": "# Site Report: Site 1590\n\n## Site Information\n- **Site ID**: Site 1590\n- **Study**: Study 21\n- **Country**: KOR\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 10 (100.0%)\n\n## Risk Profile\n- Low Risk: 10 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1591", "study": "Study 21", "site": "Site 1591", "type": "site_summary", "total_subjects": 9, "total_issues": 0, "document": "# Site Report: Site 1591\n\n## Site Information\n- **Site ID**: Site 1591\n- **Study**: Study 21\n- **Country**: KOR\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 9 (100.0%)\n\n## Risk Profile\n- Low Risk: 9 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1592", "study": "Study 21", "site": "Site 1592", "type": "site_summary", "total_subjects": 19, "total_issues": 0, "document": "# Site Report: Site 1592\n\n## Site Information\n- **Site ID**: Site 1592\n- **Study**: Study 21\n- **Country**: SWE\n- **Total Subjects**: 19\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 19 (100.0%)\n\n## Risk Profile\n- Low Risk: 19 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1593", "study": "Study 21", "site": "Site 1593", "type": "site_summary", "total_subjects": 23, "total_issues": 1, "document": "# Site Report: Site 1593\n\n## Site Information\n- **Site ID**: Site 1593\n- **Study**: Study 21\n- **Country**: SWE\n- **Total Subjects**: 23\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.04\n- **Clean Subjects**: 22 (95.7%)\n\n## Risk Profile\n- Low Risk: 22 (95.7%)\n- Medium Risk: 1 (4.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1594", "study": "Study 21", "site": "Site 1594", "type": "site_summary", "total_subjects": 17, "total_issues": 0, "document": "# Site Report: Site 1594\n\n## Site Information\n- **Site ID**: Site 1594\n- **Study**: Study 21\n- **Country**: SWE\n- **Total Subjects**: 17\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 17 (100.0%)\n\n## Risk Profile\n- Low Risk: 17 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1595", "study": "Study 21", "site": "Site 1595", "type": "site_summary", "total_subjects": 22, "total_issues": 0, "document": "# Site Report: Site 1595\n\n## Site Information\n- **Site ID**: Site 1595\n- **Study**: Study 21\n- **Country**: SWE\n- **Total Subjects**: 22\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 22 (100.0%)\n\n## Risk Profile\n- Low Risk: 22 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1596", "study": "Study 21", "site": "Site 1596", "type": "site_summary", "total_subjects": 13, "total_issues": 0, "document": "# Site Report: Site 1596\n\n## Site Information\n- **Site ID**: Site 1596\n- **Study**: Study 21\n- **Country**: SWE\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 13 (100.0%)\n\n## Risk Profile\n- Low Risk: 13 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1597", "study": "Study 21", "site": "Site 1597", "type": "site_summary", "total_subjects": 10, "total_issues": 0, "document": "# Site Report: Site 1597\n\n## Site Information\n- **Site ID**: Site 1597\n- **Study**: Study 21\n- **Country**: SWE\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 10 (100.0%)\n\n## Risk Profile\n- Low Risk: 10 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1598", "study": "Study 21", "site": "Site 1598", "type": "site_summary", "total_subjects": 15, "total_issues": 0, "document": "# Site Report: Site 1598\n\n## Site Information\n- **Site ID**: Site 1598\n- **Study**: Study 21\n- **Country**: SWE\n- **Total Subjects**: 15\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 15 (100.0%)\n\n## Risk Profile\n- Low Risk: 15 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1599", "study": "Study 21", "site": "Site 1599", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 1599\n\n## Site Information\n- **Site ID**: Site 1599\n- **Study**: Study 21\n- **Country**: SWE\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 16", "study": "Study 21", "site": "Site 16", "type": "site_summary", "total_subjects": 19, "total_issues": 0, "document": "# Site Report: Site 16\n\n## Site Information\n- **Site ID**: Site 16\n- **Study**: Study 21\n- **Country**: SVK\n- **Total Subjects**: 19\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 19 (100.0%)\n\n## Risk Profile\n- Low Risk: 19 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 160", "study": "Study 21", "site": "Site 160", "type": "site_summary", "total_subjects": 38, "total_issues": 0, "document": "# Site Report: Site 160\n\n## Site Information\n- **Site ID**: Site 160\n- **Study**: Study 21\n- **Country**: NLD\n- **Total Subjects**: 38\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 38 (100.0%)\n\n## Risk Profile\n- Low Risk: 38 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1600", "study": "Study 21", "site": "Site 1600", "type": "site_summary", "total_subjects": 35, "total_issues": 0, "document": "# Site Report: Site 1600\n\n## Site Information\n- **Site ID**: Site 1600\n- **Study**: Study 21\n- **Country**: SWE\n- **Total Subjects**: 35\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 35 (100.0%)\n\n## Risk Profile\n- Low Risk: 35 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1601", "study": "Study 21", "site": "Site 1601", "type": "site_summary", "total_subjects": 12, "total_issues": 0, "document": "# Site Report: Site 1601\n\n## Site Information\n- **Site ID**: Site 1601\n- **Study**: Study 21\n- **Country**: TWN\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 12 (100.0%)\n\n## Risk Profile\n- Low Risk: 12 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1602", "study": "Study 21", "site": "Site 1602", "type": "site_summary", "total_subjects": 22, "total_issues": 10, "document": "# Site Report: Site 1602\n\n## Site Information\n- **Site ID**: Site 1602\n- **Study**: Study 21\n- **Country**: TWN\n- **Total Subjects**: 22\n\n## Performance Metrics\n- **Total Issues**: 10\n- **Average Issues per Subject**: 0.45\n- **Clean Subjects**: 19 (86.4%)\n\n## Risk Profile\n- Low Risk: 19 (86.4%)\n- Medium Risk: 2 (9.1%)\n- High Risk: 1 (4.5%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 28392: High risk, 8 issues\n"}
{"id": "site_Study 21_Site 1603", "study": "Study 21", "site": "Site 1603", "type": "site_summary", "total_subjects": 14, "total_issues": 0, "document": "# Site Report: Site 1603\n\n## Site Information\n- **Site ID**: Site 1603\n- **Study**: Study 21\n- **Country**: TWN\n- **Total Subjects**: 14\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 14 (100.0%)\n\n## Risk Profile\n- Low Risk: 14 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1604", "study": "Study 21", "site": "Site 1604", "type": "site_summary", "total_subjects": 26, "total_issues": 0, "document": "# Site Report: Site 1604\n\n## Site Information\n- **Site ID**: Site 1604\n- **Study**: Study 21\n- **Country**: TWN\n- **Total Subjects**: 26\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 26 (100.0%)\n\n## Risk Profile\n- Low Risk: 26 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1605", "study": "Study 21", "site": "Site 1605", "type": "site_summary", "total_subjects": 20, "total_issues": 0, "document": "# Site Report: Site 1605\n\n## Site Information\n- **Site ID**: Site 1605\n- **Study**: Study 21\n- **Country**: TWN\n- **Total Subjects**: 20\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 20 (100.0%)\n\n## Risk Profile\n- Low Risk: 20 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1606", "study": "Study 21", "site": "Site 1606", "type": "site_summary", "total_subjects": 18, "total_issues": 0, "document": "# Site Report: Site 1606\n\n## Site Information\n- **Site ID**: Site 1606\n- **Study**: Study 21\n- **Country**: TWN\n- **Total Subjects**: 18\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 18 (100.0%)\n\n## Risk Profile\n- Low Risk: 18 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1607", "study": "Study 21", "site": "Site 1607", "type": "site_summary", "total_subjects": 9, "total_issues": 0, "document": "# Site Report: Site 1607\n\n## Site Information\n- **Site ID**: Site 1607\n- **Study**: Study 21\n- **Country**: TWN\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 9 (100.0%)\n\n## Risk Profile\n- Low Risk: 9 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1608", "study": "Study 21", "site": "Site 1608", "type": "site_summary", "total_subjects": 18, "total_issues": 0, "document": "# Site Report: Site 1608\n\n## Site Information\n- **Site ID**: Site 1608\n- **Study**: Study 21\n- **Country**: THA\n- **Total Subjects**: 18\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 18 (100.0%)\n\n## Risk Profile\n- Low Risk: 18 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1609", "study": "Study 21", "site": "Site 1609", "type": "site_summary", "total_subjects": 20, "total_issues": 0, "document": "# Site Report: Site 1609\n\n## Site Information\n- **Site ID**: Site 1609\n- **Study**: Study 21\n- **Country**: THA\n- **Total Subjects**: 20\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 20 (100.0%)\n\n## Risk Profile\n- Low Risk: 20 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 161", "study": "Study 21", "site": "Site 161", "type": "site_summary", "total_subjects": 19, "total_issues": 0, "document": "# Site Report: Site 161\n\n## Site Information\n- **Site ID**: Site 161\n- **Study**: Study 21\n- **Country**: PRT\n- **Total Subjects**: 19\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 19 (100.0%)\n\n## Risk Profile\n- Low Risk: 19 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1610", "study": "Study 21", "site": "Site 1610", "type": "site_summary", "total_subjects": 21, "total_issues": 0, "document": "# Site Report: Site 1610\n\n## Site Information\n- **Site ID**: Site 1610\n- **Study**: Study 21\n- **Country**: THA\n- **Total Subjects**: 21\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 21 (100.0%)\n\n## Risk Profile\n- Low Risk: 21 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1611", "study": "Study 21", "site": "Site 1611", "type": "site_summary", "total_subjects": 34, "total_issues": 0, "document": "# Site Report: Site 1611\n\n## Site Information\n- **Site ID**: Site 1611\n- **Study**: Study 21\n- **Country**: THA\n- **Total Subjects**: 34\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 34 (100.0%)\n\n## Risk Profile\n- Low Risk: 34 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1612", "study": "Study 21", "site": "Site 1612", "type": "site_summary", "total_subjects": 22, "total_issues": 0, "document": "# Site Report: Site 1612\n\n## Site Information\n- **Site ID**: Site 1612\n- **Study**: Study 21\n- **Country**: THA\n- **Total Subjects**: 22\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 22 (100.0%)\n\n## Risk Profile\n- Low Risk: 22 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1613", "study": "Study 21", "site": "Site 1613", "type": "site_summary", "total_subjects": 27, "total_issues": 0, "document": "# Site Report: Site 1613\n\n## Site Information\n- **Site ID**: Site 1613\n- **Study**: Study 21\n- **Country**: THA\n- **Total Subjects**: 27\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 27 (100.0%)\n\n## Risk Profile\n- Low Risk: 27 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1614", "study": "Study 21", "site": "Site 1614", "type": "site_summary", "total_subjects": 8, "total_issues": 0, "document": "# Site Report: Site 1614\n\n## Site Information\n- **Site ID**: Site 1614\n- **Study**: Study 21\n- **Country**: THA\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 8 (100.0%)\n\n## Risk Profile\n- Low Risk: 8 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1615", "study": "Study 21", "site": "Site 1615", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 1615\n\n## Site Information\n- **Site ID**: Site 1615\n- **Study**: Study 21\n- **Country**: TUR\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1616", "study": "Study 21", "site": "Site 1616", "type": "site_summary", "total_subjects": 18, "total_issues": 0, "document": "# Site Report: Site 1616\n\n## Site Information\n- **Site ID**: Site 1616\n- **Study**: Study 21\n- **Country**: TUR\n- **Total Subjects**: 18\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 18 (100.0%)\n\n## Risk Profile\n- Low Risk: 18 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1617", "study": "Study 21", "site": "Site 1617", "type": "site_summary", "total_subjects": 11, "total_issues": 0, "document": "# Site Report: Site 1617\n\n## Site Information\n- **Site ID**: Site 1617\n- **Study**: Study 21\n- **Country**: TUR\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 11 (100.0%)\n\n## Risk Profile\n- Low Risk: 11 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1618", "study": "Study 21", "site": "Site 1618", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 1618\n\n## Site Information\n- **Site ID**: Site 1618\n- **Study**: Study 21\n- **Country**: TUR\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1619", "study": "Study 21", "site": "Site 1619", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 1619\n\n## Site Information\n- **Site ID**: Site 1619\n- **Study**: Study 21\n- **Country**: TUR\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 162", "study": "Study 21", "site": "Site 162", "type": "site_summary", "total_subjects": 87, "total_issues": 0, "document": "# Site Report: Site 162\n\n## Site Information\n- **Site ID**: Site 162\n- **Study**: Study 21\n- **Country**: PRT\n- **Total Subjects**: 87\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 87 (100.0%)\n\n## Risk Profile\n- Low Risk: 87 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1620", "study": "Study 21", "site": "Site 1620", "type": "site_summary", "total_subjects": 51, "total_issues": 0, "document": "# Site Report: Site 1620\n\n## Site Information\n- **Site ID**: Site 1620\n- **Study**: Study 21\n- **Country**: TUR\n- **Total Subjects**: 51\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 51 (100.0%)\n\n## Risk Profile\n- Low Risk: 51 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1621", "study": "Study 21", "site": "Site 1621", "type": "site_summary", "total_subjects": 23, "total_issues": 0, "document": "# Site Report: Site 1621\n\n## Site Information\n- **Site ID**: Site 1621\n- **Study**: Study 21\n- **Country**: TUR\n- **Total Subjects**: 23\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 23 (100.0%)\n\n## Risk Profile\n- Low Risk: 23 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1622", "study": "Study 21", "site": "Site 1622", "type": "site_summary", "total_subjects": 18, "total_issues": 0, "document": "# Site Report: Site 1622\n\n## Site Information\n- **Site ID**: Site 1622\n- **Study**: Study 21\n- **Country**: TUR\n- **Total Subjects**: 18\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 18 (100.0%)\n\n## Risk Profile\n- Low Risk: 18 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1623", "study": "Study 21", "site": "Site 1623", "type": "site_summary", "total_subjects": 30, "total_issues": 0, "document": "# Site Report: Site 1623\n\n## Site Information\n- **Site ID**: Site 1623\n- **Study**: Study 21\n- **Country**: TUR\n- **Total Subjects**: 30\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 30 (100.0%)\n\n## Risk Profile\n- Low Risk: 30 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1624", "study": "Study 21", "site": "Site 1624", "type": "site_summary", "total_subjects": 44, "total_issues": 0, "document": "# Site Report: Site 1624\n\n## Site Information\n- **Site ID**: Site 1624\n- **Study**: Study 21\n- **Country**: TUR\n- **Total Subjects**: 44\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 44 (100.0%)\n\n## Risk Profile\n- Low Risk: 44 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1625", "study": "Study 21", "site": "Site 1625", "type": "site_summary", "total_subjects": 29, "total_issues": 0, "document": "# Site Report: Site 1625\n\n## Site Information\n- **Site ID**: Site 1625\n- **Study**: Study 21\n- **Country**: SRB\n- **Total Subjects**: 29\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 29 (100.0%)\n\n## Risk Profile\n- Low Risk: 29 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1626", "study": "Study 21", "site": "Site 1626", "type": "site_summary", "total_subjects": 20, "total_issues": 0, "document": "# Site Report: Site 1626\n\n## Site Information\n- **Site ID**: Site 1626\n- **Study**: Study 21\n- **Country**: SRB\n- **Total Subjects**: 20\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 20 (100.0%)\n\n## Risk Profile\n- Low Risk: 20 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1627", "study": "Study 21", "site": "Site 1627", "type": "site_summary", "total_subjects": 166, "total_issues": 2, "document": "# Site Report: Site 1627\n\n## Site Information\n- **Site ID**: Site 1627\n- **Study**: Study 21\n- **Country**: SRB\n- **Total Subjects**: 166\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.01\n- **Clean Subjects**: 164 (98.8%)\n\n## Risk Profile\n- Low Risk: 164 (98.8%)\n- Medium Risk: 2 (1.2%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1628", "study": "Study 21", "site": "Site 1628", "type": "site_summary", "total_subjects": 19, "total_issues": 0, "document": "# Site Report: Site 1628\n\n## Site Information\n- **Site ID**: Site 1628\n- **Study**: Study 21\n- **Country**: SRB\n- **Total Subjects**: 19\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 19 (100.0%)\n\n## Risk Profile\n- Low Risk: 19 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1629", "study": "Study 21", "site": "Site 1629", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1629\n\n## Site Information\n- **Site ID**: Site 1629\n- **Study**: Study 21\n- **Country**: SRB\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 163", "study": "Study 21", "site": "Site 163", "type": "site_summary", "total_subjects": 25, "total_issues": 0, "document": "# Site Report: Site 163\n\n## Site Information\n- **Site ID**: Site 163\n- **Study**: Study 21\n- **Country**: SVK\n- **Total Subjects**: 25\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 25 (100.0%)\n\n## Risk Profile\n- Low Risk: 25 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1630", "study": "Study 21", "site": "Site 1630", "type": "site_summary", "total_subjects": 34, "total_issues": 0, "document": "# Site Report: Site 1630\n\n## Site Information\n- **Site ID**: Site 1630\n- **Study**: Study 21\n- **Country**: SRB\n- **Total Subjects**: 34\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 34 (100.0%)\n\n## Risk Profile\n- Low Risk: 34 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1631", "study": "Study 21", "site": "Site 1631", "type": "site_summary", "total_subjects": 25, "total_issues": 0, "document": "# Site Report: Site 1631\n\n## Site Information\n- **Site ID**: Site 1631\n- **Study**: Study 21\n- **Country**: SRB\n- **Total Subjects**: 25\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 25 (100.0%)\n\n## Risk Profile\n- Low Risk: 25 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1632", "study": "Study 21", "site": "Site 1632", "type": "site_summary", "total_subjects": 85, "total_issues": 0, "document": "# Site Report: Site 1632\n\n## Site Information\n- **Site ID**: Site 1632\n- **Study**: Study 21\n- **Country**: SRB\n- **Total Subjects**: 85\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 85 (100.0%)\n\n## Risk Profile\n- Low Risk: 85 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 6\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1633", "study": "Study 21", "site": "Site 1633", "type": "site_summary", "total_subjects": 62, "total_issues": 0, "document": "# Site Report: Site 1633\n\n## Site Information\n- **Site ID**: Site 1633\n- **Study**: Study 21\n- **Country**: SRB\n- **Total Subjects**: 62\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 62 (100.0%)\n\n## Risk Profile\n- Low Risk: 62 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1634", "study": "Study 21", "site": "Site 1634", "type": "site_summary", "total_subjects": 8, "total_issues": 0, "document": "# Site Report: Site 1634\n\n## Site Information\n- **Site ID**: Site 1634\n- **Study**: Study 21\n- **Country**: SRB\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 8 (100.0%)\n\n## Risk Profile\n- Low Risk: 8 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1635", "study": "Study 21", "site": "Site 1635", "type": "site_summary", "total_subjects": 8, "total_issues": 0, "document": "# Site Report: Site 1635\n\n## Site Information\n- **Site ID**: Site 1635\n- **Study**: Study 21\n- **Country**: SRB\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 8 (100.0%)\n\n## Risk Profile\n- Low Risk: 8 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1636", "study": "Study 21", "site": "Site 1636", "type": "site_summary", "total_subjects": 22, "total_issues": 1, "document": "# Site Report: Site 1636\n\n## Site Information\n- **Site ID**: Site 1636\n- **Study**: Study 21\n- **Country**: SRB\n- **Total Subjects**: 22\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.05\n- **Clean Subjects**: 21 (95.5%)\n\n## Risk Profile\n- Low Risk: 21 (95.5%)\n- Medium Risk: 1 (4.5%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 8\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1637", "study": "Study 21", "site": "Site 1637", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 1637\n\n## Site Information\n- **Site ID**: Site 1637\n- **Study**: Study 21\n- **Country**: SRB\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1638", "study": "Study 21", "site": "Site 1638", "type": "site_summary", "total_subjects": 50, "total_issues": 0, "document": "# Site Report: Site 1638\n\n## Site Information\n- **Site ID**: Site 1638\n- **Study**: Study 21\n- **Country**: SRB\n- **Total Subjects**: 50\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 50 (100.0%)\n\n## Risk Profile\n- Low Risk: 50 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 5\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1639", "study": "Study 21", "site": "Site 1639", "type": "site_summary", "total_subjects": 15, "total_issues": 0, "document": "# Site Report: Site 1639\n\n## Site Information\n- **Site ID**: Site 1639\n- **Study**: Study 21\n- **Country**: SRB\n- **Total Subjects**: 15\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 15 (100.0%)\n\n## Risk Profile\n- Low Risk: 15 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 164", "study": "Study 21", "site": "Site 164", "type": "site_summary", "total_subjects": 22, "total_issues": 0, "document": "# Site Report: Site 164\n\n## Site Information\n- **Site ID**: Site 164\n- **Study**: Study 21\n- **Country**: SVK\n- **Total Subjects**: 22\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 22 (100.0%)\n\n## Risk Profile\n- Low Risk: 22 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1640", "study": "Study 21", "site": "Site 1640", "type": "site_summary", "total_subjects": 198, "total_issues": 0, "document": "# Site Report: Site 1640\n\n## Site Information\n- **Site ID**: Site 1640\n- **Study**: Study 21\n- **Country**: SRB\n- **Total Subjects**: 198\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 198 (100.0%)\n\n## Risk Profile\n- Low Risk: 198 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 27\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1641", "study": "Study 21", "site": "Site 1641", "type": "site_summary", "total_subjects": 12, "total_issues": 0, "document": "# Site Report: Site 1641\n\n## Site Information\n- **Site ID**: Site 1641\n- **Study**: Study 21\n- **Country**: SRB\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 12 (100.0%)\n\n## Risk Profile\n- Low Risk: 12 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1642", "study": "Study 21", "site": "Site 1642", "type": "site_summary", "total_subjects": 61, "total_issues": 0, "document": "# Site Report: Site 1642\n\n## Site Information\n- **Site ID**: Site 1642\n- **Study**: Study 21\n- **Country**: SRB\n- **Total Subjects**: 61\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 61 (100.0%)\n\n## Risk Profile\n- Low Risk: 61 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1643", "study": "Study 21", "site": "Site 1643", "type": "site_summary", "total_subjects": 19, "total_issues": 0, "document": "# Site Report: Site 1643\n\n## Site Information\n- **Site ID**: Site 1643\n- **Study**: Study 21\n- **Country**: SRB\n- **Total Subjects**: 19\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 19 (100.0%)\n\n## Risk Profile\n- Low Risk: 19 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 1644", "study": "Study 21", "site": "Site 1644", "type": "site_summary", "total_subjects": 15, "total_issues": 0, "document": "# Site Report: Site 1644\n\n## Site Information\n- **Site ID**: Site 1644\n- **Study**: Study 21\n- **Country**: SRB\n- **Total Subjects**: 15\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 15 (100.0%)\n\n## Risk Profile\n- Low Risk: 15 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 165", "study": "Study 21", "site": "Site 165", "type": "site_summary", "total_subjects": 57, "total_issues": 2, "document": "# Site Report: Site 165\n\n## Site Information\n- **Site ID**: Site 165\n- **Study**: Study 21\n- **Country**: ARG\n- **Total Subjects**: 57\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.04\n- **Clean Subjects**: 56 (98.2%)\n\n## Risk Profile\n- Low Risk: 56 (98.2%)\n- Medium Risk: 1 (1.8%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 166", "study": "Study 21", "site": "Site 166", "type": "site_summary", "total_subjects": 18, "total_issues": 0, "document": "# Site Report: Site 166\n\n## Site Information\n- **Site ID**: Site 166\n- **Study**: Study 21\n- **Country**: ARG\n- **Total Subjects**: 18\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 18 (100.0%)\n\n## Risk Profile\n- Low Risk: 18 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 168", "study": "Study 21", "site": "Site 168", "type": "site_summary", "total_subjects": 10, "total_issues": 0, "document": "# Site Report: Site 168\n\n## Site Information\n- **Site ID**: Site 168\n- **Study**: Study 21\n- **Country**: ARG\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 10 (100.0%)\n\n## Risk Profile\n- Low Risk: 10 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 169", "study": "Study 21", "site": "Site 169", "type": "site_summary", "total_subjects": 17, "total_issues": 0, "document": "# Site Report: Site 169\n\n## Site Information\n- **Site ID**: Site 169\n- **Study**: Study 21\n- **Country**: ARG\n- **Total Subjects**: 17\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 17 (100.0%)\n\n## Risk Profile\n- Low Risk: 17 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 17", "study": "Study 21", "site": "Site 17", "type": "site_summary", "total_subjects": 9, "total_issues": 0, "document": "# Site Report: Site 17\n\n## Site Information\n- **Site ID**: Site 17\n- **Study**: Study 21\n- **Country**: SVK\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 9 (100.0%)\n\n## Risk Profile\n- Low Risk: 9 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 171", "study": "Study 21", "site": "Site 171", "type": "site_summary", "total_subjects": 14, "total_issues": 0, "document": "# Site Report: Site 171\n\n## Site Information\n- **Site ID**: Site 171\n- **Study**: Study 21\n- **Country**: ARG\n- **Total Subjects**: 14\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 14 (100.0%)\n\n## Risk Profile\n- Low Risk: 14 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 172", "study": "Study 21", "site": "Site 172", "type": "site_summary", "total_subjects": 106, "total_issues": 0, "document": "# Site Report: Site 172\n\n## Site Information\n- **Site ID**: Site 172\n- **Study**: Study 21\n- **Country**: ARG\n- **Total Subjects**: 106\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 106 (100.0%)\n\n## Risk Profile\n- Low Risk: 106 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 174", "study": "Study 21", "site": "Site 174", "type": "site_summary", "total_subjects": 49, "total_issues": 0, "document": "# Site Report: Site 174\n\n## Site Information\n- **Site ID**: Site 174\n- **Study**: Study 21\n- **Country**: ARG\n- **Total Subjects**: 49\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 49 (100.0%)\n\n## Risk Profile\n- Low Risk: 49 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 175", "study": "Study 21", "site": "Site 175", "type": "site_summary", "total_subjects": 99, "total_issues": 1, "document": "# Site Report: Site 175\n\n## Site Information\n- **Site ID**: Site 175\n- **Study**: Study 21\n- **Country**: ARG\n- **Total Subjects**: 99\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.01\n- **Clean Subjects**: 98 (99.0%)\n\n## Risk Profile\n- Low Risk: 98 (99.0%)\n- Medium Risk: 1 (1.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 180", "study": "Study 21", "site": "Site 180", "type": "site_summary", "total_subjects": 46, "total_issues": 0, "document": "# Site Report: Site 180\n\n## Site Information\n- **Site ID**: Site 180\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 46\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 46 (100.0%)\n\n## Risk Profile\n- Low Risk: 46 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 181", "study": "Study 21", "site": "Site 181", "type": "site_summary", "total_subjects": 11, "total_issues": 0, "document": "# Site Report: Site 181\n\n## Site Information\n- **Site ID**: Site 181\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 11 (100.0%)\n\n## Risk Profile\n- Low Risk: 11 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 183", "study": "Study 21", "site": "Site 183", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 183\n\n## Site Information\n- **Site ID**: Site 183\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 184", "study": "Study 21", "site": "Site 184", "type": "site_summary", "total_subjects": 27, "total_issues": 0, "document": "# Site Report: Site 184\n\n## Site Information\n- **Site ID**: Site 184\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 27\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 27 (100.0%)\n\n## Risk Profile\n- Low Risk: 27 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 185", "study": "Study 21", "site": "Site 185", "type": "site_summary", "total_subjects": 30, "total_issues": 0, "document": "# Site Report: Site 185\n\n## Site Information\n- **Site ID**: Site 185\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 30\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 30 (100.0%)\n\n## Risk Profile\n- Low Risk: 30 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 186", "study": "Study 21", "site": "Site 186", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 186\n\n## Site Information\n- **Site ID**: Site 186\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 187", "study": "Study 21", "site": "Site 187", "type": "site_summary", "total_subjects": 20, "total_issues": 0, "document": "# Site Report: Site 187\n\n## Site Information\n- **Site ID**: Site 187\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 20\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 20 (100.0%)\n\n## Risk Profile\n- Low Risk: 20 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 189", "study": "Study 21", "site": "Site 189", "type": "site_summary", "total_subjects": 2, "total_issues": 4, "document": "# Site Report: Site 189\n\n## Site Information\n- **Site ID**: Site 189\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 19", "study": "Study 21", "site": "Site 19", "type": "site_summary", "total_subjects": 14, "total_issues": 1, "document": "# Site Report: Site 19\n\n## Site Information\n- **Site ID**: Site 19\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 14\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.07\n- **Clean Subjects**: 13 (92.9%)\n\n## Risk Profile\n- Low Risk: 13 (92.9%)\n- Medium Risk: 1 (7.1%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 191", "study": "Study 21", "site": "Site 191", "type": "site_summary", "total_subjects": 11, "total_issues": 0, "document": "# Site Report: Site 191\n\n## Site Information\n- **Site ID**: Site 191\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 11 (100.0%)\n\n## Risk Profile\n- Low Risk: 11 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 192", "study": "Study 21", "site": "Site 192", "type": "site_summary", "total_subjects": 9, "total_issues": 0, "document": "# Site Report: Site 192\n\n## Site Information\n- **Site ID**: Site 192\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 9 (100.0%)\n\n## Risk Profile\n- Low Risk: 9 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 193", "study": "Study 21", "site": "Site 193", "type": "site_summary", "total_subjects": 8, "total_issues": 0, "document": "# Site Report: Site 193\n\n## Site Information\n- **Site ID**: Site 193\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 8 (100.0%)\n\n## Risk Profile\n- Low Risk: 8 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 194", "study": "Study 21", "site": "Site 194", "type": "site_summary", "total_subjects": 19, "total_issues": 0, "document": "# Site Report: Site 194\n\n## Site Information\n- **Site ID**: Site 194\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 19\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 19 (100.0%)\n\n## Risk Profile\n- Low Risk: 19 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 195", "study": "Study 21", "site": "Site 195", "type": "site_summary", "total_subjects": 44, "total_issues": 0, "document": "# Site Report: Site 195\n\n## Site Information\n- **Site ID**: Site 195\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 44\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 44 (100.0%)\n\n## Risk Profile\n- Low Risk: 44 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 4\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 196", "study": "Study 21", "site": "Site 196", "type": "site_summary", "total_subjects": 10, "total_issues": 0, "document": "# Site Report: Site 196\n\n## Site Information\n- **Site ID**: Site 196\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 10 (100.0%)\n\n## Risk Profile\n- Low Risk: 10 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 197", "study": "Study 21", "site": "Site 197", "type": "site_summary", "total_subjects": 16, "total_issues": 1, "document": "# Site Report: Site 197\n\n## Site Information\n- **Site ID**: Site 197\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 16\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.06\n- **Clean Subjects**: 15 (93.8%)\n\n## Risk Profile\n- Low Risk: 15 (93.8%)\n- Medium Risk: 1 (6.2%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 198", "study": "Study 21", "site": "Site 198", "type": "site_summary", "total_subjects": 17, "total_issues": 0, "document": "# Site Report: Site 198\n\n## Site Information\n- **Site ID**: Site 198\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 17\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 17 (100.0%)\n\n## Risk Profile\n- Low Risk: 17 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 2", "study": "Study 21", "site": "Site 2", "type": "site_summary", "total_subjects": 20, "total_issues": 0, "document": "# Site Report: Site 2\n\n## Site Information\n- **Site ID**: Site 2\n- **Study**: Study 21\n- **Country**: IND\n- **Total Subjects**: 20\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 20 (100.0%)\n\n## Risk Profile\n- Low Risk: 20 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 200", "study": "Study 21", "site": "Site 200", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 200\n\n## Site Information\n- **Site ID**: Site 200\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 201", "study": "Study 21", "site": "Site 201", "type": "site_summary", "total_subjects": 85, "total_issues": 0, "document": "# Site Report: Site 201\n\n## Site Information\n- **Site ID**: Site 201\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 85\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 85 (100.0%)\n\n## Risk Profile\n- Low Risk: 85 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 202", "study": "Study 21", "site": "Site 202", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 202\n\n## Site Information\n- **Site ID**: Site 202\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 203", "study": "Study 21", "site": "Site 203", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 203\n\n## Site Information\n- **Site ID**: Site 203\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 205", "study": "Study 21", "site": "Site 205", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 205\n\n## Site Information\n- **Site ID**: Site 205\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 206", "study": "Study 21", "site": "Site 206", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 206\n\n## Site Information\n- **Site ID**: Site 206\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 207", "study": "Study 21", "site": "Site 207", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 207\n\n## Site Information\n- **Site ID**: Site 207\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 208", "study": "Study 21", "site": "Site 208", "type": "site_summary", "total_subjects": 37, "total_issues": 0, "document": "# Site Report: Site 208\n\n## Site Information\n- **Site ID**: Site 208\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 37\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 37 (100.0%)\n\n## Risk Profile\n- Low Risk: 37 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 209", "study": "Study 21", "site": "Site 209", "type": "site_summary", "total_subjects": 13, "total_issues": 0, "document": "# Site Report: Site 209\n\n## Site Information\n- **Site ID**: Site 209\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 13 (100.0%)\n\n## Risk Profile\n- Low Risk: 13 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 21", "study": "Study 21", "site": "Site 21", "type": "site_summary", "total_subjects": 14, "total_issues": 0, "document": "# Site Report: Site 21\n\n## Site Information\n- **Site ID**: Site 21\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 14\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 14 (100.0%)\n\n## Risk Profile\n- Low Risk: 14 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 211", "study": "Study 21", "site": "Site 211", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 211\n\n## Site Information\n- **Site ID**: Site 211\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 212", "study": "Study 21", "site": "Site 212", "type": "site_summary", "total_subjects": 20, "total_issues": 0, "document": "# Site Report: Site 212\n\n## Site Information\n- **Site ID**: Site 212\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 20\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 20 (100.0%)\n\n## Risk Profile\n- Low Risk: 20 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 214", "study": "Study 21", "site": "Site 214", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 214\n\n## Site Information\n- **Site ID**: Site 214\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 215", "study": "Study 21", "site": "Site 215", "type": "site_summary", "total_subjects": 27, "total_issues": 8, "document": "# Site Report: Site 215\n\n## Site Information\n- **Site ID**: Site 215\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 27\n\n## Performance Metrics\n- **Total Issues**: 8\n- **Average Issues per Subject**: 0.30\n- **Clean Subjects**: 22 (81.5%)\n\n## Risk Profile\n- Low Risk: 22 (81.5%)\n- Medium Risk: 5 (18.5%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 216", "study": "Study 21", "site": "Site 216", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 216\n\n## Site Information\n- **Site ID**: Site 216\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 217", "study": "Study 21", "site": "Site 217", "type": "site_summary", "total_subjects": 18, "total_issues": 1, "document": "# Site Report: Site 217\n\n## Site Information\n- **Site ID**: Site 217\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 18\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.06\n- **Clean Subjects**: 17 (94.4%)\n\n## Risk Profile\n- Low Risk: 17 (94.4%)\n- Medium Risk: 1 (5.6%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 219", "study": "Study 21", "site": "Site 219", "type": "site_summary", "total_subjects": 4, "total_issues": 1, "document": "# Site Report: Site 219\n\n## Site Information\n- **Site ID**: Site 219\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.25\n- **Clean Subjects**: 3 (75.0%)\n\n## Risk Profile\n- Low Risk: 3 (75.0%)\n- Medium Risk: 1 (25.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 22", "study": "Study 21", "site": "Site 22", "type": "site_summary", "total_subjects": 93, "total_issues": 0, "document": "# Site Report: Site 22\n\n## Site Information\n- **Site ID**: Site 22\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 93\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 93 (100.0%)\n\n## Risk Profile\n- Low Risk: 93 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 23", "study": "Study 21", "site": "Site 23", "type": "site_summary", "total_subjects": 12, "total_issues": 0, "document": "# Site Report: Site 23\n\n## Site Information\n- **Site ID**: Site 23\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 12 (100.0%)\n\n## Risk Profile\n- Low Risk: 12 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 24", "study": "Study 21", "site": "Site 24", "type": "site_summary", "total_subjects": 9, "total_issues": 0, "document": "# Site Report: Site 24\n\n## Site Information\n- **Site ID**: Site 24\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 9 (100.0%)\n\n## Risk Profile\n- Low Risk: 9 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 25", "study": "Study 21", "site": "Site 25", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 25\n\n## Site Information\n- **Site ID**: Site 25\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 259", "study": "Study 21", "site": "Site 259", "type": "site_summary", "total_subjects": 29, "total_issues": 0, "document": "# Site Report: Site 259\n\n## Site Information\n- **Site ID**: Site 259\n- **Study**: Study 21\n- **Country**: IND\n- **Total Subjects**: 29\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 29 (100.0%)\n\n## Risk Profile\n- Low Risk: 29 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 4\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 260", "study": "Study 21", "site": "Site 260", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 260\n\n## Site Information\n- **Site ID**: Site 260\n- **Study**: Study 21\n- **Country**: IND\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 261", "study": "Study 21", "site": "Site 261", "type": "site_summary", "total_subjects": 20, "total_issues": 0, "document": "# Site Report: Site 261\n\n## Site Information\n- **Site ID**: Site 261\n- **Study**: Study 21\n- **Country**: IND\n- **Total Subjects**: 20\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 20 (100.0%)\n\n## Risk Profile\n- Low Risk: 20 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 268", "study": "Study 21", "site": "Site 268", "type": "site_summary", "total_subjects": 17, "total_issues": 0, "document": "# Site Report: Site 268\n\n## Site Information\n- **Site ID**: Site 268\n- **Study**: Study 21\n- **Country**: SVK\n- **Total Subjects**: 17\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 17 (100.0%)\n\n## Risk Profile\n- Low Risk: 17 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 269", "study": "Study 21", "site": "Site 269", "type": "site_summary", "total_subjects": 9, "total_issues": 0, "document": "# Site Report: Site 269\n\n## Site Information\n- **Site ID**: Site 269\n- **Study**: Study 21\n- **Country**: SVK\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 9 (100.0%)\n\n## Risk Profile\n- Low Risk: 9 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 27", "study": "Study 21", "site": "Site 27", "type": "site_summary", "total_subjects": 24, "total_issues": 0, "document": "# Site Report: Site 27\n\n## Site Information\n- **Site ID**: Site 27\n- **Study**: Study 21\n- **Country**: LVA\n- **Total Subjects**: 24\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 24 (100.0%)\n\n## Risk Profile\n- Low Risk: 24 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 279", "study": "Study 21", "site": "Site 279", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 279\n\n## Site Information\n- **Site ID**: Site 279\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 28", "study": "Study 21", "site": "Site 28", "type": "site_summary", "total_subjects": 21, "total_issues": 0, "document": "# Site Report: Site 28\n\n## Site Information\n- **Site ID**: Site 28\n- **Study**: Study 21\n- **Country**: IND\n- **Total Subjects**: 21\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 21 (100.0%)\n\n## Risk Profile\n- Low Risk: 21 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 280", "study": "Study 21", "site": "Site 280", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 280\n\n## Site Information\n- **Site ID**: Site 280\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 281", "study": "Study 21", "site": "Site 281", "type": "site_summary", "total_subjects": 10, "total_issues": 0, "document": "# Site Report: Site 281\n\n## Site Information\n- **Site ID**: Site 281\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 10 (100.0%)\n\n## Risk Profile\n- Low Risk: 10 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 282", "study": "Study 21", "site": "Site 282", "type": "site_summary", "total_subjects": 11, "total_issues": 0, "document": "# Site Report: Site 282\n\n## Site Information\n- **Site ID**: Site 282\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 11 (100.0%)\n\n## Risk Profile\n- Low Risk: 11 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 283", "study": "Study 21", "site": "Site 283", "type": "site_summary", "total_subjects": 21, "total_issues": 0, "document": "# Site Report: Site 283\n\n## Site Information\n- **Site ID**: Site 283\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 21\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 21 (100.0%)\n\n## Risk Profile\n- Low Risk: 21 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 284", "study": "Study 21", "site": "Site 284", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 284\n\n## Site Information\n- **Site ID**: Site 284\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 285", "study": "Study 21", "site": "Site 285", "type": "site_summary", "total_subjects": 10, "total_issues": 0, "document": "# Site Report: Site 285\n\n## Site Information\n- **Site ID**: Site 285\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 10 (100.0%)\n\n## Risk Profile\n- Low Risk: 10 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 286", "study": "Study 21", "site": "Site 286", "type": "site_summary", "total_subjects": 10, "total_issues": 2, "document": "# Site Report: Site 286\n\n## Site Information\n- **Site ID**: Site 286\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.20\n- **Clean Subjects**: 8 (80.0%)\n\n## Risk Profile\n- Low Risk: 8 (80.0%)\n- Medium Risk: 2 (20.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 3", "study": "Study 21", "site": "Site 3", "type": "site_summary", "total_subjects": 26, "total_issues": 0, "document": "# Site Report: Site 3\n\n## Site Information\n- **Site ID**: Site 3\n- **Study**: Study 21\n- **Country**: IND\n- **Total Subjects**: 26\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 26 (100.0%)\n\n## Risk Profile\n- Low Risk: 26 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 30", "study": "Study 21", "site": "Site 30", "type": "site_summary", "total_subjects": 56, "total_issues": 0, "document": "# Site Report: Site 30\n\n## Site Information\n- **Site ID**: Site 30\n- **Study**: Study 21\n- **Country**: IND\n- **Total Subjects**: 56\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 56 (100.0%)\n\n## Risk Profile\n- Low Risk: 56 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 315", "study": "Study 21", "site": "Site 315", "type": "site_summary", "total_subjects": 21, "total_issues": 0, "document": "# Site Report: Site 315\n\n## Site Information\n- **Site ID**: Site 315\n- **Study**: Study 21\n- **Country**: ARG\n- **Total Subjects**: 21\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 21 (100.0%)\n\n## Risk Profile\n- Low Risk: 21 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 316", "study": "Study 21", "site": "Site 316", "type": "site_summary", "total_subjects": 99, "total_issues": 0, "document": "# Site Report: Site 316\n\n## Site Information\n- **Site ID**: Site 316\n- **Study**: Study 21\n- **Country**: ARG\n- **Total Subjects**: 99\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 99 (100.0%)\n\n## Risk Profile\n- Low Risk: 99 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 318", "study": "Study 21", "site": "Site 318", "type": "site_summary", "total_subjects": 109, "total_issues": 2, "document": "# Site Report: Site 318\n\n## Site Information\n- **Site ID**: Site 318\n- **Study**: Study 21\n- **Country**: ARG\n- **Total Subjects**: 109\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.02\n- **Clean Subjects**: 107 (98.2%)\n\n## Risk Profile\n- Low Risk: 107 (98.2%)\n- Medium Risk: 2 (1.8%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 319", "study": "Study 21", "site": "Site 319", "type": "site_summary", "total_subjects": 41, "total_issues": 0, "document": "# Site Report: Site 319\n\n## Site Information\n- **Site ID**: Site 319\n- **Study**: Study 21\n- **Country**: ARG\n- **Total Subjects**: 41\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 41 (100.0%)\n\n## Risk Profile\n- Low Risk: 41 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 325", "study": "Study 21", "site": "Site 325", "type": "site_summary", "total_subjects": 15, "total_issues": 0, "document": "# Site Report: Site 325\n\n## Site Information\n- **Site ID**: Site 325\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 15\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 15 (100.0%)\n\n## Risk Profile\n- Low Risk: 15 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 327", "study": "Study 21", "site": "Site 327", "type": "site_summary", "total_subjects": 12, "total_issues": 0, "document": "# Site Report: Site 327\n\n## Site Information\n- **Site ID**: Site 327\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 12 (100.0%)\n\n## Risk Profile\n- Low Risk: 12 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 330", "study": "Study 21", "site": "Site 330", "type": "site_summary", "total_subjects": 73, "total_issues": 0, "document": "# Site Report: Site 330\n\n## Site Information\n- **Site ID**: Site 330\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 73\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 73 (100.0%)\n\n## Risk Profile\n- Low Risk: 73 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 332", "study": "Study 21", "site": "Site 332", "type": "site_summary", "total_subjects": 10, "total_issues": 0, "document": "# Site Report: Site 332\n\n## Site Information\n- **Site ID**: Site 332\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 10 (100.0%)\n\n## Risk Profile\n- Low Risk: 10 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 333", "study": "Study 21", "site": "Site 333", "type": "site_summary", "total_subjects": 15, "total_issues": 0, "document": "# Site Report: Site 333\n\n## Site Information\n- **Site ID**: Site 333\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 15\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 15 (100.0%)\n\n## Risk Profile\n- Low Risk: 15 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 34", "study": "Study 21", "site": "Site 34", "type": "site_summary", "total_subjects": 23, "total_issues": 0, "document": "# Site Report: Site 34\n\n## Site Information\n- **Site ID**: Site 34\n- **Study**: Study 21\n- **Country**: IND\n- **Total Subjects**: 23\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 23 (100.0%)\n\n## Risk Profile\n- Low Risk: 23 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 341", "study": "Study 21", "site": "Site 341", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 341\n\n## Site Information\n- **Site ID**: Site 341\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 342", "study": "Study 21", "site": "Site 342", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 342\n\n## Site Information\n- **Site ID**: Site 342\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 344", "study": "Study 21", "site": "Site 344", "type": "site_summary", "total_subjects": 18, "total_issues": 0, "document": "# Site Report: Site 344\n\n## Site Information\n- **Site ID**: Site 344\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 18\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 18 (100.0%)\n\n## Risk Profile\n- Low Risk: 18 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 345", "study": "Study 21", "site": "Site 345", "type": "site_summary", "total_subjects": 12, "total_issues": 0, "document": "# Site Report: Site 345\n\n## Site Information\n- **Site ID**: Site 345\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 12 (100.0%)\n\n## Risk Profile\n- Low Risk: 12 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 346", "study": "Study 21", "site": "Site 346", "type": "site_summary", "total_subjects": 8, "total_issues": 0, "document": "# Site Report: Site 346\n\n## Site Information\n- **Site ID**: Site 346\n- **Study**: Study 21\n- **Country**: AUS\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 8 (100.0%)\n\n## Risk Profile\n- Low Risk: 8 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 347", "study": "Study 21", "site": "Site 347", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 347\n\n## Site Information\n- **Site ID**: Site 347\n- **Study**: Study 21\n- **Country**: AUS\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 35", "study": "Study 21", "site": "Site 35", "type": "site_summary", "total_subjects": 110, "total_issues": 0, "document": "# Site Report: Site 35\n\n## Site Information\n- **Site ID**: Site 35\n- **Study**: Study 21\n- **Country**: IND\n- **Total Subjects**: 110\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 110 (100.0%)\n\n## Risk Profile\n- Low Risk: 110 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 352", "study": "Study 21", "site": "Site 352", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 352\n\n## Site Information\n- **Site ID**: Site 352\n- **Study**: Study 21\n- **Country**: CHN\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 354", "study": "Study 21", "site": "Site 354", "type": "site_summary", "total_subjects": 13, "total_issues": 0, "document": "# Site Report: Site 354\n\n## Site Information\n- **Site ID**: Site 354\n- **Study**: Study 21\n- **Country**: SVK\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 13 (100.0%)\n\n## Risk Profile\n- Low Risk: 13 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 356", "study": "Study 21", "site": "Site 356", "type": "site_summary", "total_subjects": 131, "total_issues": 0, "document": "# Site Report: Site 356\n\n## Site Information\n- **Site ID**: Site 356\n- **Study**: Study 21\n- **Country**: ARG\n- **Total Subjects**: 131\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 131 (100.0%)\n\n## Risk Profile\n- Low Risk: 131 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 357", "study": "Study 21", "site": "Site 357", "type": "site_summary", "total_subjects": 23, "total_issues": 0, "document": "# Site Report: Site 357\n\n## Site Information\n- **Site ID**: Site 357\n- **Study**: Study 21\n- **Country**: IND\n- **Total Subjects**: 23\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 23 (100.0%)\n\n## Risk Profile\n- Low Risk: 23 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 37", "study": "Study 21", "site": "Site 37", "type": "site_summary", "total_subjects": 11, "total_issues": 0, "document": "# Site Report: Site 37\n\n## Site Information\n- **Site ID**: Site 37\n- **Study**: Study 21\n- **Country**: IND\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 11 (100.0%)\n\n## Risk Profile\n- Low Risk: 11 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 38", "study": "Study 21", "site": "Site 38", "type": "site_summary", "total_subjects": 42, "total_issues": 0, "document": "# Site Report: Site 38\n\n## Site Information\n- **Site ID**: Site 38\n- **Study**: Study 21\n- **Country**: IND\n- **Total Subjects**: 42\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 42 (100.0%)\n\n## Risk Profile\n- Low Risk: 42 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 3\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 39", "study": "Study 21", "site": "Site 39", "type": "site_summary", "total_subjects": 16, "total_issues": 0, "document": "# Site Report: Site 39\n\n## Site Information\n- **Site ID**: Site 39\n- **Study**: Study 21\n- **Country**: IND\n- **Total Subjects**: 16\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 16 (100.0%)\n\n## Risk Profile\n- Low Risk: 16 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 4", "study": "Study 21", "site": "Site 4", "type": "site_summary", "total_subjects": 14, "total_issues": 0, "document": "# Site Report: Site 4\n\n## Site Information\n- **Site ID**: Site 4\n- **Study**: Study 21\n- **Country**: IND\n- **Total Subjects**: 14\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 14 (100.0%)\n\n## Risk Profile\n- Low Risk: 14 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 40", "study": "Study 21", "site": "Site 40", "type": "site_summary", "total_subjects": 17, "total_issues": 0, "document": "# Site Report: Site 40\n\n## Site Information\n- **Site ID**: Site 40\n- **Study**: Study 21\n- **Country**: IND\n- **Total Subjects**: 17\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 17 (100.0%)\n\n## Risk Profile\n- Low Risk: 17 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 41", "study": "Study 21", "site": "Site 41", "type": "site_summary", "total_subjects": 33, "total_issues": 1, "document": "# Site Report: Site 41\n\n## Site Information\n- **Site ID**: Site 41\n- **Study**: Study 21\n- **Country**: IND\n- **Total Subjects**: 33\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.03\n- **Clean Subjects**: 32 (97.0%)\n\n## Risk Profile\n- Low Risk: 32 (97.0%)\n- Medium Risk: 1 (3.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 418", "study": "Study 21", "site": "Site 418", "type": "site_summary", "total_subjects": 10, "total_issues": 0, "document": "# Site Report: Site 418\n\n## Site Information\n- **Site ID**: Site 418\n- **Study**: Study 21\n- **Country**: HRV\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 10 (100.0%)\n\n## Risk Profile\n- Low Risk: 10 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 419", "study": "Study 21", "site": "Site 419", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 419\n\n## Site Information\n- **Site ID**: Site 419\n- **Study**: Study 21\n- **Country**: HRV\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 42", "study": "Study 21", "site": "Site 42", "type": "site_summary", "total_subjects": 69, "total_issues": 1, "document": "# Site Report: Site 42\n\n## Site Information\n- **Site ID**: Site 42\n- **Study**: Study 21\n- **Country**: IND\n- **Total Subjects**: 69\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.01\n- **Clean Subjects**: 68 (98.6%)\n\n## Risk Profile\n- Low Risk: 68 (98.6%)\n- Medium Risk: 1 (1.4%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 420", "study": "Study 21", "site": "Site 420", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 420\n\n## Site Information\n- **Site ID**: Site 420\n- **Study**: Study 21\n- **Country**: HRV\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 421", "study": "Study 21", "site": "Site 421", "type": "site_summary", "total_subjects": 14, "total_issues": 0, "document": "# Site Report: Site 421\n\n## Site Information\n- **Site ID**: Site 421\n- **Study**: Study 21\n- **Country**: HRV\n- **Total Subjects**: 14\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 14 (100.0%)\n\n## Risk Profile\n- Low Risk: 14 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 422", "study": "Study 21", "site": "Site 422", "type": "site_summary", "total_subjects": 14, "total_issues": 0, "document": "# Site Report: Site 422\n\n## Site Information\n- **Site ID**: Site 422\n- **Study**: Study 21\n- **Country**: HRV\n- **Total Subjects**: 14\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 14 (100.0%)\n\n## Risk Profile\n- Low Risk: 14 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 423", "study": "Study 21", "site": "Site 423", "type": "site_summary", "total_subjects": 48, "total_issues": 0, "document": "# Site Report: Site 423\n\n## Site Information\n- **Site ID**: Site 423\n- **Study**: Study 21\n- **Country**: HRV\n- **Total Subjects**: 48\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 48 (100.0%)\n\n## Risk Profile\n- Low Risk: 48 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 435", "study": "Study 21", "site": "Site 435", "type": "site_summary", "total_subjects": 91, "total_issues": 0, "document": "# Site Report: Site 435\n\n## Site Information\n- **Site ID**: Site 435\n- **Study**: Study 21\n- **Country**: ARG\n- **Total Subjects**: 91\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 91 (100.0%)\n\n## Risk Profile\n- Low Risk: 91 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 436", "study": "Study 21", "site": "Site 436", "type": "site_summary", "total_subjects": 39, "total_issues": 0, "document": "# Site Report: Site 436\n\n## Site Information\n- **Site ID**: Site 436\n- **Study**: Study 21\n- **Country**: ARG\n- **Total Subjects**: 39\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 39 (100.0%)\n\n## Risk Profile\n- Low Risk: 39 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 437", "study": "Study 21", "site": "Site 437", "type": "site_summary", "total_subjects": 96, "total_issues": 0, "document": "# Site Report: Site 437\n\n## Site Information\n- **Site ID**: Site 437\n- **Study**: Study 21\n- **Country**: ARG\n- **Total Subjects**: 96\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 96 (100.0%)\n\n## Risk Profile\n- Low Risk: 96 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 438", "study": "Study 21", "site": "Site 438", "type": "site_summary", "total_subjects": 18, "total_issues": 0, "document": "# Site Report: Site 438\n\n## Site Information\n- **Site ID**: Site 438\n- **Study**: Study 21\n- **Country**: ARG\n- **Total Subjects**: 18\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 18 (100.0%)\n\n## Risk Profile\n- Low Risk: 18 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 441", "study": "Study 21", "site": "Site 441", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 441\n\n## Site Information\n- **Site ID**: Site 441\n- **Study**: Study 21\n- **Country**: ARG\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 450", "study": "Study 21", "site": "Site 450", "type": "site_summary", "total_subjects": 11, "total_issues": 0, "document": "# Site Report: Site 450\n\n## Site Information\n- **Site ID**: Site 450\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 11 (100.0%)\n\n## Risk Profile\n- Low Risk: 11 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 451", "study": "Study 21", "site": "Site 451", "type": "site_summary", "total_subjects": 59, "total_issues": 0, "document": "# Site Report: Site 451\n\n## Site Information\n- **Site ID**: Site 451\n- **Study**: Study 21\n- **Country**: IND\n- **Total Subjects**: 59\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 59 (100.0%)\n\n## Risk Profile\n- Low Risk: 59 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 452", "study": "Study 21", "site": "Site 452", "type": "site_summary", "total_subjects": 48, "total_issues": 1, "document": "# Site Report: Site 452\n\n## Site Information\n- **Site ID**: Site 452\n- **Study**: Study 21\n- **Country**: IND\n- **Total Subjects**: 48\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.02\n- **Clean Subjects**: 47 (97.9%)\n\n## Risk Profile\n- Low Risk: 47 (97.9%)\n- Medium Risk: 1 (2.1%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 453", "study": "Study 21", "site": "Site 453", "type": "site_summary", "total_subjects": 44, "total_issues": 0, "document": "# Site Report: Site 453\n\n## Site Information\n- **Site ID**: Site 453\n- **Study**: Study 21\n- **Country**: IND\n- **Total Subjects**: 44\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 44 (100.0%)\n\n## Risk Profile\n- Low Risk: 44 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 3\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 454", "study": "Study 21", "site": "Site 454", "type": "site_summary", "total_subjects": 15, "total_issues": 0, "document": "# Site Report: Site 454\n\n## Site Information\n- **Site ID**: Site 454\n- **Study**: Study 21\n- **Country**: IND\n- **Total Subjects**: 15\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 15 (100.0%)\n\n## Risk Profile\n- Low Risk: 15 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 455", "study": "Study 21", "site": "Site 455", "type": "site_summary", "total_subjects": 8, "total_issues": 0, "document": "# Site Report: Site 455\n\n## Site Information\n- **Site ID**: Site 455\n- **Study**: Study 21\n- **Country**: IND\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 8 (100.0%)\n\n## Risk Profile\n- Low Risk: 8 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 456", "study": "Study 21", "site": "Site 456", "type": "site_summary", "total_subjects": 13, "total_issues": 0, "document": "# Site Report: Site 456\n\n## Site Information\n- **Site ID**: Site 456\n- **Study**: Study 21\n- **Country**: IND\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 13 (100.0%)\n\n## Risk Profile\n- Low Risk: 13 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 458", "study": "Study 21", "site": "Site 458", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 458\n\n## Site Information\n- **Site ID**: Site 458\n- **Study**: Study 21\n- **Country**: IND\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 464", "study": "Study 21", "site": "Site 464", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 464\n\n## Site Information\n- **Site ID**: Site 464\n- **Study**: Study 21\n- **Country**: ITA\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 465", "study": "Study 21", "site": "Site 465", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 465\n\n## Site Information\n- **Site ID**: Site 465\n- **Study**: Study 21\n- **Country**: RUS\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 48", "study": "Study 21", "site": "Site 48", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 48\n\n## Site Information\n- **Site ID**: Site 48\n- **Study**: Study 21\n- **Country**: KEN\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 49", "study": "Study 21", "site": "Site 49", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 49\n\n## Site Information\n- **Site ID**: Site 49\n- **Study**: Study 21\n- **Country**: KEN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 5", "study": "Study 21", "site": "Site 5", "type": "site_summary", "total_subjects": 25, "total_issues": 0, "document": "# Site Report: Site 5\n\n## Site Information\n- **Site ID**: Site 5\n- **Study**: Study 21\n- **Country**: MUS\n- **Total Subjects**: 25\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 25 (100.0%)\n\n## Risk Profile\n- Low Risk: 25 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 502", "study": "Study 21", "site": "Site 502", "type": "site_summary", "total_subjects": 11, "total_issues": 0, "document": "# Site Report: Site 502\n\n## Site Information\n- **Site ID**: Site 502\n- **Study**: Study 21\n- **Country**: HRV\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 11 (100.0%)\n\n## Risk Profile\n- Low Risk: 11 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 503", "study": "Study 21", "site": "Site 503", "type": "site_summary", "total_subjects": 31, "total_issues": 0, "document": "# Site Report: Site 503\n\n## Site Information\n- **Site ID**: Site 503\n- **Study**: Study 21\n- **Country**: HRV\n- **Total Subjects**: 31\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 31 (100.0%)\n\n## Risk Profile\n- Low Risk: 31 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 504", "study": "Study 21", "site": "Site 504", "type": "site_summary", "total_subjects": 20, "total_issues": 2, "document": "# Site Report: Site 504\n\n## Site Information\n- **Site ID**: Site 504\n- **Study**: Study 21\n- **Country**: HRV\n- **Total Subjects**: 20\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.10\n- **Clean Subjects**: 18 (90.0%)\n\n## Risk Profile\n- Low Risk: 18 (90.0%)\n- Medium Risk: 2 (10.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 505", "study": "Study 21", "site": "Site 505", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 505\n\n## Site Information\n- **Site ID**: Site 505\n- **Study**: Study 21\n- **Country**: HRV\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 506", "study": "Study 21", "site": "Site 506", "type": "site_summary", "total_subjects": 16, "total_issues": 0, "document": "# Site Report: Site 506\n\n## Site Information\n- **Site ID**: Site 506\n- **Study**: Study 21\n- **Country**: HRV\n- **Total Subjects**: 16\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 16 (100.0%)\n\n## Risk Profile\n- Low Risk: 16 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 507", "study": "Study 21", "site": "Site 507", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 507\n\n## Site Information\n- **Site ID**: Site 507\n- **Study**: Study 21\n- **Country**: HRV\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 508", "study": "Study 21", "site": "Site 508", "type": "site_summary", "total_subjects": 15, "total_issues": 0, "document": "# Site Report: Site 508\n\n## Site Information\n- **Site ID**: Site 508\n- **Study**: Study 21\n- **Country**: HRV\n- **Total Subjects**: 15\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 15 (100.0%)\n\n## Risk Profile\n- Low Risk: 15 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 509", "study": "Study 21", "site": "Site 509", "type": "site_summary", "total_subjects": 8, "total_issues": 0, "document": "# Site Report: Site 509\n\n## Site Information\n- **Site ID**: Site 509\n- **Study**: Study 21\n- **Country**: FRA\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 8 (100.0%)\n\n## Risk Profile\n- Low Risk: 8 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 510", "study": "Study 21", "site": "Site 510", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 510\n\n## Site Information\n- **Site ID**: Site 510\n- **Study**: Study 21\n- **Country**: FRA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 511", "study": "Study 21", "site": "Site 511", "type": "site_summary", "total_subjects": 7, "total_issues": 1, "document": "# Site Report: Site 511\n\n## Site Information\n- **Site ID**: Site 511\n- **Study**: Study 21\n- **Country**: FRA\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.14\n- **Clean Subjects**: 6 (85.7%)\n\n## Risk Profile\n- Low Risk: 6 (85.7%)\n- Medium Risk: 1 (14.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 517", "study": "Study 21", "site": "Site 517", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 517\n\n## Site Information\n- **Site ID**: Site 517\n- **Study**: Study 21\n- **Country**: ITA\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 520", "study": "Study 21", "site": "Site 520", "type": "site_summary", "total_subjects": 25, "total_issues": 0, "document": "# Site Report: Site 520\n\n## Site Information\n- **Site ID**: Site 520\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 25\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 25 (100.0%)\n\n## Risk Profile\n- Low Risk: 25 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 521", "study": "Study 21", "site": "Site 521", "type": "site_summary", "total_subjects": 11, "total_issues": 0, "document": "# Site Report: Site 521\n\n## Site Information\n- **Site ID**: Site 521\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 11 (100.0%)\n\n## Risk Profile\n- Low Risk: 11 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 522", "study": "Study 21", "site": "Site 522", "type": "site_summary", "total_subjects": 36, "total_issues": 0, "document": "# Site Report: Site 522\n\n## Site Information\n- **Site ID**: Site 522\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 36\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 36 (100.0%)\n\n## Risk Profile\n- Low Risk: 36 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 523", "study": "Study 21", "site": "Site 523", "type": "site_summary", "total_subjects": 19, "total_issues": 1, "document": "# Site Report: Site 523\n\n## Site Information\n- **Site ID**: Site 523\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 19\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.05\n- **Clean Subjects**: 18 (94.7%)\n\n## Risk Profile\n- Low Risk: 18 (94.7%)\n- Medium Risk: 1 (5.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 535", "study": "Study 21", "site": "Site 535", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 535\n\n## Site Information\n- **Site ID**: Site 535\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 537", "study": "Study 21", "site": "Site 537", "type": "site_summary", "total_subjects": 12, "total_issues": 2, "document": "# Site Report: Site 537\n\n## Site Information\n- **Site ID**: Site 537\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.17\n- **Clean Subjects**: 11 (91.7%)\n\n## Risk Profile\n- Low Risk: 11 (91.7%)\n- Medium Risk: 1 (8.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 538", "study": "Study 21", "site": "Site 538", "type": "site_summary", "total_subjects": 9, "total_issues": 0, "document": "# Site Report: Site 538\n\n## Site Information\n- **Site ID**: Site 538\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 9 (100.0%)\n\n## Risk Profile\n- Low Risk: 9 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 539", "study": "Study 21", "site": "Site 539", "type": "site_summary", "total_subjects": 10, "total_issues": 0, "document": "# Site Report: Site 539\n\n## Site Information\n- **Site ID**: Site 539\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 10 (100.0%)\n\n## Risk Profile\n- Low Risk: 10 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 540", "study": "Study 21", "site": "Site 540", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 540\n\n## Site Information\n- **Site ID**: Site 540\n- **Study**: Study 21\n- **Country**: JPN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 544", "study": "Study 21", "site": "Site 544", "type": "site_summary", "total_subjects": 81, "total_issues": 0, "document": "# Site Report: Site 544\n\n## Site Information\n- **Site ID**: Site 544\n- **Study**: Study 21\n- **Country**: COL\n- **Total Subjects**: 81\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 81 (100.0%)\n\n## Risk Profile\n- Low Risk: 81 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 545", "study": "Study 21", "site": "Site 545", "type": "site_summary", "total_subjects": 50, "total_issues": 0, "document": "# Site Report: Site 545\n\n## Site Information\n- **Site ID**: Site 545\n- **Study**: Study 21\n- **Country**: COL\n- **Total Subjects**: 50\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 50 (100.0%)\n\n## Risk Profile\n- Low Risk: 50 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 546", "study": "Study 21", "site": "Site 546", "type": "site_summary", "total_subjects": 39, "total_issues": 0, "document": "# Site Report: Site 546\n\n## Site Information\n- **Site ID**: Site 546\n- **Study**: Study 21\n- **Country**: COL\n- **Total Subjects**: 39\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 39 (100.0%)\n\n## Risk Profile\n- Low Risk: 39 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 547", "study": "Study 21", "site": "Site 547", "type": "site_summary", "total_subjects": 28, "total_issues": 0, "document": "# Site Report: Site 547\n\n## Site Information\n- **Site ID**: Site 547\n- **Study**: Study 21\n- **Country**: COL\n- **Total Subjects**: 28\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 28 (100.0%)\n\n## Risk Profile\n- Low Risk: 28 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 548", "study": "Study 21", "site": "Site 548", "type": "site_summary", "total_subjects": 61, "total_issues": 0, "document": "# Site Report: Site 548\n\n## Site Information\n- **Site ID**: Site 548\n- **Study**: Study 21\n- **Country**: COL\n- **Total Subjects**: 61\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 61 (100.0%)\n\n## Risk Profile\n- Low Risk: 61 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 550", "study": "Study 21", "site": "Site 550", "type": "site_summary", "total_subjects": 15, "total_issues": 0, "document": "# Site Report: Site 550\n\n## Site Information\n- **Site ID**: Site 550\n- **Study**: Study 21\n- **Country**: COL\n- **Total Subjects**: 15\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 15 (100.0%)\n\n## Risk Profile\n- Low Risk: 15 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 552", "study": "Study 21", "site": "Site 552", "type": "site_summary", "total_subjects": 12, "total_issues": 0, "document": "# Site Report: Site 552\n\n## Site Information\n- **Site ID**: Site 552\n- **Study**: Study 21\n- **Country**: COL\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 12 (100.0%)\n\n## Risk Profile\n- Low Risk: 12 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 571", "study": "Study 21", "site": "Site 571", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 571\n\n## Site Information\n- **Site ID**: Site 571\n- **Study**: Study 21\n- **Country**: FRA\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 575", "study": "Study 21", "site": "Site 575", "type": "site_summary", "total_subjects": 14, "total_issues": 0, "document": "# Site Report: Site 575\n\n## Site Information\n- **Site ID**: Site 575\n- **Study**: Study 21\n- **Country**: PRT\n- **Total Subjects**: 14\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 14 (100.0%)\n\n## Risk Profile\n- Low Risk: 14 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 578", "study": "Study 21", "site": "Site 578", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 578\n\n## Site Information\n- **Site ID**: Site 578\n- **Study**: Study 21\n- **Country**: RUS\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 580", "study": "Study 21", "site": "Site 580", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 580\n\n## Site Information\n- **Site ID**: Site 580\n- **Study**: Study 21\n- **Country**: RUS\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 6\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 584", "study": "Study 21", "site": "Site 584", "type": "site_summary", "total_subjects": 12, "total_issues": 2, "document": "# Site Report: Site 584\n\n## Site Information\n- **Site ID**: Site 584\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.17\n- **Clean Subjects**: 11 (91.7%)\n\n## Risk Profile\n- Low Risk: 11 (91.7%)\n- Medium Risk: 1 (8.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 59", "study": "Study 21", "site": "Site 59", "type": "site_summary", "total_subjects": 20, "total_issues": 0, "document": "# Site Report: Site 59\n\n## Site Information\n- **Site ID**: Site 59\n- **Study**: Study 21\n- **Country**: MUS\n- **Total Subjects**: 20\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 20 (100.0%)\n\n## Risk Profile\n- Low Risk: 20 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 593", "study": "Study 21", "site": "Site 593", "type": "site_summary", "total_subjects": 10, "total_issues": 0, "document": "# Site Report: Site 593\n\n## Site Information\n- **Site ID**: Site 593\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 10 (100.0%)\n\n## Risk Profile\n- Low Risk: 10 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 594", "study": "Study 21", "site": "Site 594", "type": "site_summary", "total_subjects": 10, "total_issues": 0, "document": "# Site Report: Site 594\n\n## Site Information\n- **Site ID**: Site 594\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 10 (100.0%)\n\n## Risk Profile\n- Low Risk: 10 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 596", "study": "Study 21", "site": "Site 596", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 596\n\n## Site Information\n- **Site ID**: Site 596\n- **Study**: Study 21\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 62", "study": "Study 21", "site": "Site 62", "type": "site_summary", "total_subjects": 27, "total_issues": 0, "document": "# Site Report: Site 62\n\n## Site Information\n- **Site ID**: Site 62\n- **Study**: Study 21\n- **Country**: PHL\n- **Total Subjects**: 27\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 27 (100.0%)\n\n## Risk Profile\n- Low Risk: 27 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 63", "study": "Study 21", "site": "Site 63", "type": "site_summary", "total_subjects": 20, "total_issues": 0, "document": "# Site Report: Site 63\n\n## Site Information\n- **Site ID**: Site 63\n- **Study**: Study 21\n- **Country**: PHL\n- **Total Subjects**: 20\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 20 (100.0%)\n\n## Risk Profile\n- Low Risk: 20 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 64", "study": "Study 21", "site": "Site 64", "type": "site_summary", "total_subjects": 20, "total_issues": 0, "document": "# Site Report: Site 64\n\n## Site Information\n- **Site ID**: Site 64\n- **Study**: Study 21\n- **Country**: PHL\n- **Total Subjects**: 20\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 20 (100.0%)\n\n## Risk Profile\n- Low Risk: 20 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 65", "study": "Study 21", "site": "Site 65", "type": "site_summary", "total_subjects": 17, "total_issues": 0, "document": "# Site Report: Site 65\n\n## Site Information\n- **Site ID**: Site 65\n- **Study**: Study 21\n- **Country**: PHL\n- **Total Subjects**: 17\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 17 (100.0%)\n\n## Risk Profile\n- Low Risk: 17 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 7", "study": "Study 21", "site": "Site 7", "type": "site_summary", "total_subjects": 47, "total_issues": 0, "document": "# Site Report: Site 7\n\n## Site Information\n- **Site ID**: Site 7\n- **Study**: Study 21\n- **Country**: SGP\n- **Total Subjects**: 47\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 47 (100.0%)\n\n## Risk Profile\n- Low Risk: 47 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 4\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 775", "study": "Study 21", "site": "Site 775", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 775\n\n## Site Information\n- **Site ID**: Site 775\n- **Study**: Study 21\n- **Country**: SGP\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 781", "study": "Study 21", "site": "Site 781", "type": "site_summary", "total_subjects": 13, "total_issues": 0, "document": "# Site Report: Site 781\n\n## Site Information\n- **Site ID**: Site 781\n- **Study**: Study 21\n- **Country**: PRT\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 13 (100.0%)\n\n## Risk Profile\n- Low Risk: 13 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 783", "study": "Study 21", "site": "Site 783", "type": "site_summary", "total_subjects": 12, "total_issues": 0, "document": "# Site Report: Site 783\n\n## Site Information\n- **Site ID**: Site 783\n- **Study**: Study 21\n- **Country**: PRT\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 12 (100.0%)\n\n## Risk Profile\n- Low Risk: 12 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 784", "study": "Study 21", "site": "Site 784", "type": "site_summary", "total_subjects": 22, "total_issues": 0, "document": "# Site Report: Site 784\n\n## Site Information\n- **Site ID**: Site 784\n- **Study**: Study 21\n- **Country**: PRT\n- **Total Subjects**: 22\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 22 (100.0%)\n\n## Risk Profile\n- Low Risk: 22 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 785", "study": "Study 21", "site": "Site 785", "type": "site_summary", "total_subjects": 17, "total_issues": 0, "document": "# Site Report: Site 785\n\n## Site Information\n- **Site ID**: Site 785\n- **Study**: Study 21\n- **Country**: PRT\n- **Total Subjects**: 17\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 17 (100.0%)\n\n## Risk Profile\n- Low Risk: 17 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 786", "study": "Study 21", "site": "Site 786", "type": "site_summary", "total_subjects": 6, "total_issues": 5, "document": "# Site Report: Site 786\n\n## Site Information\n- **Site ID**: Site 786\n- **Study**: Study 21\n- **Country**: IND\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 5\n- **Average Issues per Subject**: 0.83\n- **Clean Subjects**: 5 (83.3%)\n\n## Risk Profile\n- Low Risk: 5 (83.3%)\n- Medium Risk: 1 (16.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 787", "study": "Study 21", "site": "Site 787", "type": "site_summary", "total_subjects": 12, "total_issues": 0, "document": "# Site Report: Site 787\n\n## Site Information\n- **Site ID**: Site 787\n- **Study**: Study 21\n- **Country**: IND\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 12 (100.0%)\n\n## Risk Profile\n- Low Risk: 12 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 788", "study": "Study 21", "site": "Site 788", "type": "site_summary", "total_subjects": 65, "total_issues": 0, "document": "# Site Report: Site 788\n\n## Site Information\n- **Site ID**: Site 788\n- **Study**: Study 21\n- **Country**: IND\n- **Total Subjects**: 65\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 65 (100.0%)\n\n## Risk Profile\n- Low Risk: 65 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 789", "study": "Study 21", "site": "Site 789", "type": "site_summary", "total_subjects": 22, "total_issues": 0, "document": "# Site Report: Site 789\n\n## Site Information\n- **Site ID**: Site 789\n- **Study**: Study 21\n- **Country**: IND\n- **Total Subjects**: 22\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 22 (100.0%)\n\n## Risk Profile\n- Low Risk: 22 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 4\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 79", "study": "Study 21", "site": "Site 79", "type": "site_summary", "total_subjects": 23, "total_issues": 0, "document": "# Site Report: Site 79\n\n## Site Information\n- **Site ID**: Site 79\n- **Study**: Study 21\n- **Country**: SGP\n- **Total Subjects**: 23\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 23 (100.0%)\n\n## Risk Profile\n- Low Risk: 23 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 790", "study": "Study 21", "site": "Site 790", "type": "site_summary", "total_subjects": 18, "total_issues": 1, "document": "# Site Report: Site 790\n\n## Site Information\n- **Site ID**: Site 790\n- **Study**: Study 21\n- **Country**: IND\n- **Total Subjects**: 18\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.06\n- **Clean Subjects**: 17 (94.4%)\n\n## Risk Profile\n- Low Risk: 17 (94.4%)\n- Medium Risk: 1 (5.6%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 791", "study": "Study 21", "site": "Site 791", "type": "site_summary", "total_subjects": 14, "total_issues": 0, "document": "# Site Report: Site 791\n\n## Site Information\n- **Site ID**: Site 791\n- **Study**: Study 21\n- **Country**: IND\n- **Total Subjects**: 14\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 14 (100.0%)\n\n## Risk Profile\n- Low Risk: 14 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 792", "study": "Study 21", "site": "Site 792", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 792\n\n## Site Information\n- **Site ID**: Site 792\n- **Study**: Study 21\n- **Country**: IND\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 793", "study": "Study 21", "site": "Site 793", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 793\n\n## Site Information\n- **Site ID**: Site 793\n- **Study**: Study 21\n- **Country**: IND\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 794", "study": "Study 21", "site": "Site 794", "type": "site_summary", "total_subjects": 11, "total_issues": 1, "document": "# Site Report: Site 794\n\n## Site Information\n- **Site ID**: Site 794\n- **Study**: Study 21\n- **Country**: IND\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.09\n- **Clean Subjects**: 10 (90.9%)\n\n## Risk Profile\n- Low Risk: 10 (90.9%)\n- Medium Risk: 1 (9.1%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 795", "study": "Study 21", "site": "Site 795", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 795\n\n## Site Information\n- **Site ID**: Site 795\n- **Study**: Study 21\n- **Country**: IND\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 796", "study": "Study 21", "site": "Site 796", "type": "site_summary", "total_subjects": 8, "total_issues": 0, "document": "# Site Report: Site 796\n\n## Site Information\n- **Site ID**: Site 796\n- **Study**: Study 21\n- **Country**: IND\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 8 (100.0%)\n\n## Risk Profile\n- Low Risk: 8 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 797", "study": "Study 21", "site": "Site 797", "type": "site_summary", "total_subjects": 11, "total_issues": 0, "document": "# Site Report: Site 797\n\n## Site Information\n- **Site ID**: Site 797\n- **Study**: Study 21\n- **Country**: IND\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 11 (100.0%)\n\n## Risk Profile\n- Low Risk: 11 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 798", "study": "Study 21", "site": "Site 798", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 798\n\n## Site Information\n- **Site ID**: Site 798\n- **Study**: Study 21\n- **Country**: IND\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 799", "study": "Study 21", "site": "Site 799", "type": "site_summary", "total_subjects": 16, "total_issues": 0, "document": "# Site Report: Site 799\n\n## Site Information\n- **Site ID**: Site 799\n- **Study**: Study 21\n- **Country**: IND\n- **Total Subjects**: 16\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 16 (100.0%)\n\n## Risk Profile\n- Low Risk: 16 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 8", "study": "Study 21", "site": "Site 8", "type": "site_summary", "total_subjects": 13, "total_issues": 0, "document": "# Site Report: Site 8\n\n## Site Information\n- **Site ID**: Site 8\n- **Study**: Study 21\n- **Country**: SGP\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 13 (100.0%)\n\n## Risk Profile\n- Low Risk: 13 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 800", "study": "Study 21", "site": "Site 800", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 800\n\n## Site Information\n- **Site ID**: Site 800\n- **Study**: Study 21\n- **Country**: IND\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 801", "study": "Study 21", "site": "Site 801", "type": "site_summary", "total_subjects": 18, "total_issues": 0, "document": "# Site Report: Site 801\n\n## Site Information\n- **Site ID**: Site 801\n- **Study**: Study 21\n- **Country**: HRV\n- **Total Subjects**: 18\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 18 (100.0%)\n\n## Risk Profile\n- Low Risk: 18 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 802", "study": "Study 21", "site": "Site 802", "type": "site_summary", "total_subjects": 8, "total_issues": 0, "document": "# Site Report: Site 802\n\n## Site Information\n- **Site ID**: Site 802\n- **Study**: Study 21\n- **Country**: HRV\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 8 (100.0%)\n\n## Risk Profile\n- Low Risk: 8 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 803", "study": "Study 21", "site": "Site 803", "type": "site_summary", "total_subjects": 8, "total_issues": 0, "document": "# Site Report: Site 803\n\n## Site Information\n- **Site ID**: Site 803\n- **Study**: Study 21\n- **Country**: EST\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 8 (100.0%)\n\n## Risk Profile\n- Low Risk: 8 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 804", "study": "Study 21", "site": "Site 804", "type": "site_summary", "total_subjects": 9, "total_issues": 0, "document": "# Site Report: Site 804\n\n## Site Information\n- **Site ID**: Site 804\n- **Study**: Study 21\n- **Country**: EST\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 9 (100.0%)\n\n## Risk Profile\n- Low Risk: 9 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 805", "study": "Study 21", "site": "Site 805", "type": "site_summary", "total_subjects": 17, "total_issues": 0, "document": "# Site Report: Site 805\n\n## Site Information\n- **Site ID**: Site 805\n- **Study**: Study 21\n- **Country**: EST\n- **Total Subjects**: 17\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 17 (100.0%)\n\n## Risk Profile\n- Low Risk: 17 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 806", "study": "Study 21", "site": "Site 806", "type": "site_summary", "total_subjects": 27, "total_issues": 0, "document": "# Site Report: Site 806\n\n## Site Information\n- **Site ID**: Site 806\n- **Study**: Study 21\n- **Country**: FRA\n- **Total Subjects**: 27\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 27 (100.0%)\n\n## Risk Profile\n- Low Risk: 27 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 807", "study": "Study 21", "site": "Site 807", "type": "site_summary", "total_subjects": 9, "total_issues": 0, "document": "# Site Report: Site 807\n\n## Site Information\n- **Site ID**: Site 807\n- **Study**: Study 21\n- **Country**: FRA\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 9 (100.0%)\n\n## Risk Profile\n- Low Risk: 9 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 808", "study": "Study 21", "site": "Site 808", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 808\n\n## Site Information\n- **Site ID**: Site 808\n- **Study**: Study 21\n- **Country**: FRA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 809", "study": "Study 21", "site": "Site 809", "type": "site_summary", "total_subjects": 20, "total_issues": 0, "document": "# Site Report: Site 809\n\n## Site Information\n- **Site ID**: Site 809\n- **Study**: Study 21\n- **Country**: FRA\n- **Total Subjects**: 20\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 20 (100.0%)\n\n## Risk Profile\n- Low Risk: 20 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 4\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 810", "study": "Study 21", "site": "Site 810", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 810\n\n## Site Information\n- **Site ID**: Site 810\n- **Study**: Study 21\n- **Country**: FRA\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 811", "study": "Study 21", "site": "Site 811", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 811\n\n## Site Information\n- **Site ID**: Site 811\n- **Study**: Study 21\n- **Country**: FRA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 812", "study": "Study 21", "site": "Site 812", "type": "site_summary", "total_subjects": 6, "total_issues": 1, "document": "# Site Report: Site 812\n\n## Site Information\n- **Site ID**: Site 812\n- **Study**: Study 21\n- **Country**: FRA\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.17\n- **Clean Subjects**: 5 (83.3%)\n\n## Risk Profile\n- Low Risk: 5 (83.3%)\n- Medium Risk: 1 (16.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 813", "study": "Study 21", "site": "Site 813", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 813\n\n## Site Information\n- **Site ID**: Site 813\n- **Study**: Study 21\n- **Country**: FRA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 814", "study": "Study 21", "site": "Site 814", "type": "site_summary", "total_subjects": 17, "total_issues": 0, "document": "# Site Report: Site 814\n\n## Site Information\n- **Site ID**: Site 814\n- **Study**: Study 21\n- **Country**: FRA\n- **Total Subjects**: 17\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 17 (100.0%)\n\n## Risk Profile\n- Low Risk: 17 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 815", "study": "Study 21", "site": "Site 815", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 815\n\n## Site Information\n- **Site ID**: Site 815\n- **Study**: Study 21\n- **Country**: FRA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 816", "study": "Study 21", "site": "Site 816", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 816\n\n## Site Information\n- **Site ID**: Site 816\n- **Study**: Study 21\n- **Country**: FRA\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 817", "study": "Study 21", "site": "Site 817", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 817\n\n## Site Information\n- **Site ID**: Site 817\n- **Study**: Study 21\n- **Country**: FRA\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 818", "study": "Study 21", "site": "Site 818", "type": "site_summary", "total_subjects": 22, "total_issues": 0, "document": "# Site Report: Site 818\n\n## Site Information\n- **Site ID**: Site 818\n- **Study**: Study 21\n- **Country**: FRA\n- **Total Subjects**: 22\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 22 (100.0%)\n\n## Risk Profile\n- Low Risk: 22 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 819", "study": "Study 21", "site": "Site 819", "type": "site_summary", "total_subjects": 8, "total_issues": 0, "document": "# Site Report: Site 819\n\n## Site Information\n- **Site ID**: Site 819\n- **Study**: Study 21\n- **Country**: FRA\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 8 (100.0%)\n\n## Risk Profile\n- Low Risk: 8 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 820", "study": "Study 21", "site": "Site 820", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 820\n\n## Site Information\n- **Site ID**: Site 820\n- **Study**: Study 21\n- **Country**: FRA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 821", "study": "Study 21", "site": "Site 821", "type": "site_summary", "total_subjects": 8, "total_issues": 0, "document": "# Site Report: Site 821\n\n## Site Information\n- **Site ID**: Site 821\n- **Study**: Study 21\n- **Country**: FRA\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 8 (100.0%)\n\n## Risk Profile\n- Low Risk: 8 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 822", "study": "Study 21", "site": "Site 822", "type": "site_summary", "total_subjects": 10, "total_issues": 0, "document": "# Site Report: Site 822\n\n## Site Information\n- **Site ID**: Site 822\n- **Study**: Study 21\n- **Country**: FRA\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 10 (100.0%)\n\n## Risk Profile\n- Low Risk: 10 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 823", "study": "Study 21", "site": "Site 823", "type": "site_summary", "total_subjects": 13, "total_issues": 0, "document": "# Site Report: Site 823\n\n## Site Information\n- **Site ID**: Site 823\n- **Study**: Study 21\n- **Country**: FRA\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 13 (100.0%)\n\n## Risk Profile\n- Low Risk: 13 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 824", "study": "Study 21", "site": "Site 824", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 824\n\n## Site Information\n- **Site ID**: Site 824\n- **Study**: Study 21\n- **Country**: FRA\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 825", "study": "Study 21", "site": "Site 825", "type": "site_summary", "total_subjects": 36, "total_issues": 1, "document": "# Site Report: Site 825\n\n## Site Information\n- **Site ID**: Site 825\n- **Study**: Study 21\n- **Country**: FRA\n- **Total Subjects**: 36\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.03\n- **Clean Subjects**: 35 (97.2%)\n\n## Risk Profile\n- Low Risk: 35 (97.2%)\n- Medium Risk: 1 (2.8%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 826", "study": "Study 21", "site": "Site 826", "type": "site_summary", "total_subjects": 16, "total_issues": 0, "document": "# Site Report: Site 826\n\n## Site Information\n- **Site ID**: Site 826\n- **Study**: Study 21\n- **Country**: FRA\n- **Total Subjects**: 16\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 16 (100.0%)\n\n## Risk Profile\n- Low Risk: 16 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 827", "study": "Study 21", "site": "Site 827", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 827\n\n## Site Information\n- **Site ID**: Site 827\n- **Study**: Study 21\n- **Country**: FRA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 828", "study": "Study 21", "site": "Site 828", "type": "site_summary", "total_subjects": 9, "total_issues": 0, "document": "# Site Report: Site 828\n\n## Site Information\n- **Site ID**: Site 828\n- **Study**: Study 21\n- **Country**: FRA\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 9 (100.0%)\n\n## Risk Profile\n- Low Risk: 9 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 829", "study": "Study 21", "site": "Site 829", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 829\n\n## Site Information\n- **Site ID**: Site 829\n- **Study**: Study 21\n- **Country**: FRA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 830", "study": "Study 21", "site": "Site 830", "type": "site_summary", "total_subjects": 8, "total_issues": 0, "document": "# Site Report: Site 830\n\n## Site Information\n- **Site ID**: Site 830\n- **Study**: Study 21\n- **Country**: FRA\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 8 (100.0%)\n\n## Risk Profile\n- Low Risk: 8 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 831", "study": "Study 21", "site": "Site 831", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 831\n\n## Site Information\n- **Site ID**: Site 831\n- **Study**: Study 21\n- **Country**: FRA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 832", "study": "Study 21", "site": "Site 832", "type": "site_summary", "total_subjects": 19, "total_issues": 0, "document": "# Site Report: Site 832\n\n## Site Information\n- **Site ID**: Site 832\n- **Study**: Study 21\n- **Country**: ITA\n- **Total Subjects**: 19\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 19 (100.0%)\n\n## Risk Profile\n- Low Risk: 19 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 833", "study": "Study 21", "site": "Site 833", "type": "site_summary", "total_subjects": 16, "total_issues": 0, "document": "# Site Report: Site 833\n\n## Site Information\n- **Site ID**: Site 833\n- **Study**: Study 21\n- **Country**: ITA\n- **Total Subjects**: 16\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 16 (100.0%)\n\n## Risk Profile\n- Low Risk: 16 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 834", "study": "Study 21", "site": "Site 834", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 834\n\n## Site Information\n- **Site ID**: Site 834\n- **Study**: Study 21\n- **Country**: ITA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 835", "study": "Study 21", "site": "Site 835", "type": "site_summary", "total_subjects": 32, "total_issues": 0, "document": "# Site Report: Site 835\n\n## Site Information\n- **Site ID**: Site 835\n- **Study**: Study 21\n- **Country**: ITA\n- **Total Subjects**: 32\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 32 (100.0%)\n\n## Risk Profile\n- Low Risk: 32 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 836", "study": "Study 21", "site": "Site 836", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 836\n\n## Site Information\n- **Site ID**: Site 836\n- **Study**: Study 21\n- **Country**: ITA\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 837", "study": "Study 21", "site": "Site 837", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 837\n\n## Site Information\n- **Site ID**: Site 837\n- **Study**: Study 21\n- **Country**: ITA\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 838", "study": "Study 21", "site": "Site 838", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 838\n\n## Site Information\n- **Site ID**: Site 838\n- **Study**: Study 21\n- **Country**: ITA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 839", "study": "Study 21", "site": "Site 839", "type": "site_summary", "total_subjects": 47, "total_issues": 3, "document": "# Site Report: Site 839\n\n## Site Information\n- **Site ID**: Site 839\n- **Study**: Study 21\n- **Country**: ITA\n- **Total Subjects**: 47\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 0.06\n- **Clean Subjects**: 46 (97.9%)\n\n## Risk Profile\n- Low Risk: 46 (97.9%)\n- Medium Risk: 1 (2.1%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 840", "study": "Study 21", "site": "Site 840", "type": "site_summary", "total_subjects": 8, "total_issues": 0, "document": "# Site Report: Site 840\n\n## Site Information\n- **Site ID**: Site 840\n- **Study**: Study 21\n- **Country**: ITA\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 8 (100.0%)\n\n## Risk Profile\n- Low Risk: 8 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 841", "study": "Study 21", "site": "Site 841", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 841\n\n## Site Information\n- **Site ID**: Site 841\n- **Study**: Study 21\n- **Country**: ITA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 842", "study": "Study 21", "site": "Site 842", "type": "site_summary", "total_subjects": 15, "total_issues": 0, "document": "# Site Report: Site 842\n\n## Site Information\n- **Site ID**: Site 842\n- **Study**: Study 21\n- **Country**: ITA\n- **Total Subjects**: 15\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 15 (100.0%)\n\n## Risk Profile\n- Low Risk: 15 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 843", "study": "Study 21", "site": "Site 843", "type": "site_summary", "total_subjects": 12, "total_issues": 0, "document": "# Site Report: Site 843\n\n## Site Information\n- **Site ID**: Site 843\n- **Study**: Study 21\n- **Country**: ITA\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 12 (100.0%)\n\n## Risk Profile\n- Low Risk: 12 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 844", "study": "Study 21", "site": "Site 844", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 844\n\n## Site Information\n- **Site ID**: Site 844\n- **Study**: Study 21\n- **Country**: ITA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 845", "study": "Study 21", "site": "Site 845", "type": "site_summary", "total_subjects": 25, "total_issues": 1, "document": "# Site Report: Site 845\n\n## Site Information\n- **Site ID**: Site 845\n- **Study**: Study 21\n- **Country**: NLD\n- **Total Subjects**: 25\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.04\n- **Clean Subjects**: 24 (96.0%)\n\n## Risk Profile\n- Low Risk: 24 (96.0%)\n- Medium Risk: 1 (4.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 846", "study": "Study 21", "site": "Site 846", "type": "site_summary", "total_subjects": 28, "total_issues": 0, "document": "# Site Report: Site 846\n\n## Site Information\n- **Site ID**: Site 846\n- **Study**: Study 21\n- **Country**: NLD\n- **Total Subjects**: 28\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 28 (100.0%)\n\n## Risk Profile\n- Low Risk: 28 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 847", "study": "Study 21", "site": "Site 847", "type": "site_summary", "total_subjects": 47, "total_issues": 0, "document": "# Site Report: Site 847\n\n## Site Information\n- **Site ID**: Site 847\n- **Study**: Study 21\n- **Country**: NLD\n- **Total Subjects**: 47\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 47 (100.0%)\n\n## Risk Profile\n- Low Risk: 47 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 848", "study": "Study 21", "site": "Site 848", "type": "site_summary", "total_subjects": 40, "total_issues": 0, "document": "# Site Report: Site 848\n\n## Site Information\n- **Site ID**: Site 848\n- **Study**: Study 21\n- **Country**: NLD\n- **Total Subjects**: 40\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 40 (100.0%)\n\n## Risk Profile\n- Low Risk: 40 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 849", "study": "Study 21", "site": "Site 849", "type": "site_summary", "total_subjects": 41, "total_issues": 0, "document": "# Site Report: Site 849\n\n## Site Information\n- **Site ID**: Site 849\n- **Study**: Study 21\n- **Country**: NLD\n- **Total Subjects**: 41\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 41 (100.0%)\n\n## Risk Profile\n- Low Risk: 41 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 850", "study": "Study 21", "site": "Site 850", "type": "site_summary", "total_subjects": 27, "total_issues": 0, "document": "# Site Report: Site 850\n\n## Site Information\n- **Site ID**: Site 850\n- **Study**: Study 21\n- **Country**: NLD\n- **Total Subjects**: 27\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 27 (100.0%)\n\n## Risk Profile\n- Low Risk: 27 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 851", "study": "Study 21", "site": "Site 851", "type": "site_summary", "total_subjects": 27, "total_issues": 0, "document": "# Site Report: Site 851\n\n## Site Information\n- **Site ID**: Site 851\n- **Study**: Study 21\n- **Country**: NLD\n- **Total Subjects**: 27\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 27 (100.0%)\n\n## Risk Profile\n- Low Risk: 27 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 852", "study": "Study 21", "site": "Site 852", "type": "site_summary", "total_subjects": 24, "total_issues": 0, "document": "# Site Report: Site 852\n\n## Site Information\n- **Site ID**: Site 852\n- **Study**: Study 21\n- **Country**: NLD\n- **Total Subjects**: 24\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 24 (100.0%)\n\n## Risk Profile\n- Low Risk: 24 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 853", "study": "Study 21", "site": "Site 853", "type": "site_summary", "total_subjects": 11, "total_issues": 0, "document": "# Site Report: Site 853\n\n## Site Information\n- **Site ID**: Site 853\n- **Study**: Study 21\n- **Country**: NLD\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 11 (100.0%)\n\n## Risk Profile\n- Low Risk: 11 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 854", "study": "Study 21", "site": "Site 854", "type": "site_summary", "total_subjects": 64, "total_issues": 0, "document": "# Site Report: Site 854\n\n## Site Information\n- **Site ID**: Site 854\n- **Study**: Study 21\n- **Country**: NLD\n- **Total Subjects**: 64\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 64 (100.0%)\n\n## Risk Profile\n- Low Risk: 64 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 855", "study": "Study 21", "site": "Site 855", "type": "site_summary", "total_subjects": 21, "total_issues": 1, "document": "# Site Report: Site 855\n\n## Site Information\n- **Site ID**: Site 855\n- **Study**: Study 21\n- **Country**: NLD\n- **Total Subjects**: 21\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.05\n- **Clean Subjects**: 20 (95.2%)\n\n## Risk Profile\n- Low Risk: 20 (95.2%)\n- Medium Risk: 1 (4.8%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 856", "study": "Study 21", "site": "Site 856", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 856\n\n## Site Information\n- **Site ID**: Site 856\n- **Study**: Study 21\n- **Country**: NLD\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 857", "study": "Study 21", "site": "Site 857", "type": "site_summary", "total_subjects": 19, "total_issues": 0, "document": "# Site Report: Site 857\n\n## Site Information\n- **Site ID**: Site 857\n- **Study**: Study 21\n- **Country**: NLD\n- **Total Subjects**: 19\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 19 (100.0%)\n\n## Risk Profile\n- Low Risk: 19 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 858", "study": "Study 21", "site": "Site 858", "type": "site_summary", "total_subjects": 9, "total_issues": 0, "document": "# Site Report: Site 858\n\n## Site Information\n- **Site ID**: Site 858\n- **Study**: Study 21\n- **Country**: NLD\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 9 (100.0%)\n\n## Risk Profile\n- Low Risk: 9 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 859", "study": "Study 21", "site": "Site 859", "type": "site_summary", "total_subjects": 29, "total_issues": 6, "document": "# Site Report: Site 859\n\n## Site Information\n- **Site ID**: Site 859\n- **Study**: Study 21\n- **Country**: PRT\n- **Total Subjects**: 29\n\n## Performance Metrics\n- **Total Issues**: 6\n- **Average Issues per Subject**: 0.21\n- **Clean Subjects**: 27 (93.1%)\n\n## Risk Profile\n- Low Risk: 27 (93.1%)\n- Medium Risk: 2 (6.9%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 860", "study": "Study 21", "site": "Site 860", "type": "site_summary", "total_subjects": 8, "total_issues": 1, "document": "# Site Report: Site 860\n\n## Site Information\n- **Site ID**: Site 860\n- **Study**: Study 21\n- **Country**: PRT\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.12\n- **Clean Subjects**: 7 (87.5%)\n\n## Risk Profile\n- Low Risk: 7 (87.5%)\n- Medium Risk: 1 (12.5%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 861", "study": "Study 21", "site": "Site 861", "type": "site_summary", "total_subjects": 16, "total_issues": 0, "document": "# Site Report: Site 861\n\n## Site Information\n- **Site ID**: Site 861\n- **Study**: Study 21\n- **Country**: PRT\n- **Total Subjects**: 16\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 16 (100.0%)\n\n## Risk Profile\n- Low Risk: 16 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 862", "study": "Study 21", "site": "Site 862", "type": "site_summary", "total_subjects": 23, "total_issues": 0, "document": "# Site Report: Site 862\n\n## Site Information\n- **Site ID**: Site 862\n- **Study**: Study 21\n- **Country**: PRT\n- **Total Subjects**: 23\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 23 (100.0%)\n\n## Risk Profile\n- Low Risk: 23 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 863", "study": "Study 21", "site": "Site 863", "type": "site_summary", "total_subjects": 12, "total_issues": 0, "document": "# Site Report: Site 863\n\n## Site Information\n- **Site ID**: Site 863\n- **Study**: Study 21\n- **Country**: PRT\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 12 (100.0%)\n\n## Risk Profile\n- Low Risk: 12 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 864", "study": "Study 21", "site": "Site 864", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 864\n\n## Site Information\n- **Site ID**: Site 864\n- **Study**: Study 21\n- **Country**: RUS\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 865", "study": "Study 21", "site": "Site 865", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 865\n\n## Site Information\n- **Site ID**: Site 865\n- **Study**: Study 21\n- **Country**: RUS\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 866", "study": "Study 21", "site": "Site 866", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 866\n\n## Site Information\n- **Site ID**: Site 866\n- **Study**: Study 21\n- **Country**: RUS\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 867", "study": "Study 21", "site": "Site 867", "type": "site_summary", "total_subjects": 40, "total_issues": 0, "document": "# Site Report: Site 867\n\n## Site Information\n- **Site ID**: Site 867\n- **Study**: Study 21\n- **Country**: SVK\n- **Total Subjects**: 40\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 40 (100.0%)\n\n## Risk Profile\n- Low Risk: 40 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 868", "study": "Study 21", "site": "Site 868", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 868\n\n## Site Information\n- **Site ID**: Site 868\n- **Study**: Study 21\n- **Country**: SVK\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 869", "study": "Study 21", "site": "Site 869", "type": "site_summary", "total_subjects": 32, "total_issues": 0, "document": "# Site Report: Site 869\n\n## Site Information\n- **Site ID**: Site 869\n- **Study**: Study 21\n- **Country**: SVK\n- **Total Subjects**: 32\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 32 (100.0%)\n\n## Risk Profile\n- Low Risk: 32 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 87", "study": "Study 21", "site": "Site 87", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 87\n\n## Site Information\n- **Site ID**: Site 87\n- **Study**: Study 21\n- **Country**: AUT\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 870", "study": "Study 21", "site": "Site 870", "type": "site_summary", "total_subjects": 22, "total_issues": 0, "document": "# Site Report: Site 870\n\n## Site Information\n- **Site ID**: Site 870\n- **Study**: Study 21\n- **Country**: SVK\n- **Total Subjects**: 22\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 22 (100.0%)\n\n## Risk Profile\n- Low Risk: 22 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 871", "study": "Study 21", "site": "Site 871", "type": "site_summary", "total_subjects": 38, "total_issues": 0, "document": "# Site Report: Site 871\n\n## Site Information\n- **Site ID**: Site 871\n- **Study**: Study 21\n- **Country**: SVK\n- **Total Subjects**: 38\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 38 (100.0%)\n\n## Risk Profile\n- Low Risk: 38 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 872", "study": "Study 21", "site": "Site 872", "type": "site_summary", "total_subjects": 40, "total_issues": 0, "document": "# Site Report: Site 872\n\n## Site Information\n- **Site ID**: Site 872\n- **Study**: Study 21\n- **Country**: SVK\n- **Total Subjects**: 40\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 40 (100.0%)\n\n## Risk Profile\n- Low Risk: 40 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 873", "study": "Study 21", "site": "Site 873", "type": "site_summary", "total_subjects": 29, "total_issues": 0, "document": "# Site Report: Site 873\n\n## Site Information\n- **Site ID**: Site 873\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 29\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 29 (100.0%)\n\n## Risk Profile\n- Low Risk: 29 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 874", "study": "Study 21", "site": "Site 874", "type": "site_summary", "total_subjects": 14, "total_issues": 0, "document": "# Site Report: Site 874\n\n## Site Information\n- **Site ID**: Site 874\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 14\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 14 (100.0%)\n\n## Risk Profile\n- Low Risk: 14 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 875", "study": "Study 21", "site": "Site 875", "type": "site_summary", "total_subjects": 16, "total_issues": 0, "document": "# Site Report: Site 875\n\n## Site Information\n- **Site ID**: Site 875\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 16\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 16 (100.0%)\n\n## Risk Profile\n- Low Risk: 16 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 876", "study": "Study 21", "site": "Site 876", "type": "site_summary", "total_subjects": 25, "total_issues": 0, "document": "# Site Report: Site 876\n\n## Site Information\n- **Site ID**: Site 876\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 25\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 25 (100.0%)\n\n## Risk Profile\n- Low Risk: 25 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 877", "study": "Study 21", "site": "Site 877", "type": "site_summary", "total_subjects": 25, "total_issues": 0, "document": "# Site Report: Site 877\n\n## Site Information\n- **Site ID**: Site 877\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 25\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 25 (100.0%)\n\n## Risk Profile\n- Low Risk: 25 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 878", "study": "Study 21", "site": "Site 878", "type": "site_summary", "total_subjects": 15, "total_issues": 3, "document": "# Site Report: Site 878\n\n## Site Information\n- **Site ID**: Site 878\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 15\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 0.20\n- **Clean Subjects**: 14 (93.3%)\n\n## Risk Profile\n- Low Risk: 14 (93.3%)\n- Medium Risk: 1 (6.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 879", "study": "Study 21", "site": "Site 879", "type": "site_summary", "total_subjects": 5, "total_issues": 1, "document": "# Site Report: Site 879\n\n## Site Information\n- **Site ID**: Site 879\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.20\n- **Clean Subjects**: 4 (80.0%)\n\n## Risk Profile\n- Low Risk: 4 (80.0%)\n- Medium Risk: 1 (20.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 88", "study": "Study 21", "site": "Site 88", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 88\n\n## Site Information\n- **Site ID**: Site 88\n- **Study**: Study 21\n- **Country**: AUT\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 880", "study": "Study 21", "site": "Site 880", "type": "site_summary", "total_subjects": 19, "total_issues": 0, "document": "# Site Report: Site 880\n\n## Site Information\n- **Site ID**: Site 880\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 19\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 19 (100.0%)\n\n## Risk Profile\n- Low Risk: 19 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 881", "study": "Study 21", "site": "Site 881", "type": "site_summary", "total_subjects": 15, "total_issues": 0, "document": "# Site Report: Site 881\n\n## Site Information\n- **Site ID**: Site 881\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 15\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 15 (100.0%)\n\n## Risk Profile\n- Low Risk: 15 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 882", "study": "Study 21", "site": "Site 882", "type": "site_summary", "total_subjects": 29, "total_issues": 0, "document": "# Site Report: Site 882\n\n## Site Information\n- **Site ID**: Site 882\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 29\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 29 (100.0%)\n\n## Risk Profile\n- Low Risk: 29 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 883", "study": "Study 21", "site": "Site 883", "type": "site_summary", "total_subjects": 23, "total_issues": 0, "document": "# Site Report: Site 883\n\n## Site Information\n- **Site ID**: Site 883\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 23\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 23 (100.0%)\n\n## Risk Profile\n- Low Risk: 23 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 4\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 884", "study": "Study 21", "site": "Site 884", "type": "site_summary", "total_subjects": 17, "total_issues": 0, "document": "# Site Report: Site 884\n\n## Site Information\n- **Site ID**: Site 884\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 17\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 17 (100.0%)\n\n## Risk Profile\n- Low Risk: 17 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 885", "study": "Study 21", "site": "Site 885", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 885\n\n## Site Information\n- **Site ID**: Site 885\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 886", "study": "Study 21", "site": "Site 886", "type": "site_summary", "total_subjects": 43, "total_issues": 0, "document": "# Site Report: Site 886\n\n## Site Information\n- **Site ID**: Site 886\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 43\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 43 (100.0%)\n\n## Risk Profile\n- Low Risk: 43 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 887", "study": "Study 21", "site": "Site 887", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 887\n\n## Site Information\n- **Site ID**: Site 887\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 888", "study": "Study 21", "site": "Site 888", "type": "site_summary", "total_subjects": 23, "total_issues": 0, "document": "# Site Report: Site 888\n\n## Site Information\n- **Site ID**: Site 888\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 23\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 23 (100.0%)\n\n## Risk Profile\n- Low Risk: 23 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 889", "study": "Study 21", "site": "Site 889", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 889\n\n## Site Information\n- **Site ID**: Site 889\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 89", "study": "Study 21", "site": "Site 89", "type": "site_summary", "total_subjects": 15, "total_issues": 0, "document": "# Site Report: Site 89\n\n## Site Information\n- **Site ID**: Site 89\n- **Study**: Study 21\n- **Country**: SVK\n- **Total Subjects**: 15\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 15 (100.0%)\n\n## Risk Profile\n- Low Risk: 15 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 890", "study": "Study 21", "site": "Site 890", "type": "site_summary", "total_subjects": 20, "total_issues": 0, "document": "# Site Report: Site 890\n\n## Site Information\n- **Site ID**: Site 890\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 20\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 20 (100.0%)\n\n## Risk Profile\n- Low Risk: 20 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 891", "study": "Study 21", "site": "Site 891", "type": "site_summary", "total_subjects": 15, "total_issues": 0, "document": "# Site Report: Site 891\n\n## Site Information\n- **Site ID**: Site 891\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 15\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 15 (100.0%)\n\n## Risk Profile\n- Low Risk: 15 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 892", "study": "Study 21", "site": "Site 892", "type": "site_summary", "total_subjects": 17, "total_issues": 0, "document": "# Site Report: Site 892\n\n## Site Information\n- **Site ID**: Site 892\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 17\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 17 (100.0%)\n\n## Risk Profile\n- Low Risk: 17 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 893", "study": "Study 21", "site": "Site 893", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 893\n\n## Site Information\n- **Site ID**: Site 893\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 894", "study": "Study 21", "site": "Site 894", "type": "site_summary", "total_subjects": 18, "total_issues": 0, "document": "# Site Report: Site 894\n\n## Site Information\n- **Site ID**: Site 894\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 18\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 18 (100.0%)\n\n## Risk Profile\n- Low Risk: 18 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 895", "study": "Study 21", "site": "Site 895", "type": "site_summary", "total_subjects": 14, "total_issues": 1, "document": "# Site Report: Site 895\n\n## Site Information\n- **Site ID**: Site 895\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 14\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.07\n- **Clean Subjects**: 13 (92.9%)\n\n## Risk Profile\n- Low Risk: 13 (92.9%)\n- Medium Risk: 1 (7.1%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 896", "study": "Study 21", "site": "Site 896", "type": "site_summary", "total_subjects": 13, "total_issues": 0, "document": "# Site Report: Site 896\n\n## Site Information\n- **Site ID**: Site 896\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 13 (100.0%)\n\n## Risk Profile\n- Low Risk: 13 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 897", "study": "Study 21", "site": "Site 897", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 897\n\n## Site Information\n- **Site ID**: Site 897\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 898", "study": "Study 21", "site": "Site 898", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 898\n\n## Site Information\n- **Site ID**: Site 898\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 899", "study": "Study 21", "site": "Site 899", "type": "site_summary", "total_subjects": 20, "total_issues": 0, "document": "# Site Report: Site 899\n\n## Site Information\n- **Site ID**: Site 899\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 20\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 20 (100.0%)\n\n## Risk Profile\n- Low Risk: 20 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 90", "study": "Study 21", "site": "Site 90", "type": "site_summary", "total_subjects": 14, "total_issues": 0, "document": "# Site Report: Site 90\n\n## Site Information\n- **Site ID**: Site 90\n- **Study**: Study 21\n- **Country**: SVK\n- **Total Subjects**: 14\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 14 (100.0%)\n\n## Risk Profile\n- Low Risk: 14 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 900", "study": "Study 21", "site": "Site 900", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 900\n\n## Site Information\n- **Site ID**: Site 900\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 901", "study": "Study 21", "site": "Site 901", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 901\n\n## Site Information\n- **Site ID**: Site 901\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 902", "study": "Study 21", "site": "Site 902", "type": "site_summary", "total_subjects": 7, "total_issues": 1, "document": "# Site Report: Site 902\n\n## Site Information\n- **Site ID**: Site 902\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.14\n- **Clean Subjects**: 6 (85.7%)\n\n## Risk Profile\n- Low Risk: 6 (85.7%)\n- Medium Risk: 1 (14.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 903", "study": "Study 21", "site": "Site 903", "type": "site_summary", "total_subjects": 25, "total_issues": 0, "document": "# Site Report: Site 903\n\n## Site Information\n- **Site ID**: Site 903\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 25\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 25 (100.0%)\n\n## Risk Profile\n- Low Risk: 25 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 904", "study": "Study 21", "site": "Site 904", "type": "site_summary", "total_subjects": 12, "total_issues": 0, "document": "# Site Report: Site 904\n\n## Site Information\n- **Site ID**: Site 904\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 12 (100.0%)\n\n## Risk Profile\n- Low Risk: 12 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 905", "study": "Study 21", "site": "Site 905", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 905\n\n## Site Information\n- **Site ID**: Site 905\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 906", "study": "Study 21", "site": "Site 906", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 906\n\n## Site Information\n- **Site ID**: Site 906\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 907", "study": "Study 21", "site": "Site 907", "type": "site_summary", "total_subjects": 13, "total_issues": 0, "document": "# Site Report: Site 907\n\n## Site Information\n- **Site ID**: Site 907\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 13 (100.0%)\n\n## Risk Profile\n- Low Risk: 13 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 908", "study": "Study 21", "site": "Site 908", "type": "site_summary", "total_subjects": 17, "total_issues": 0, "document": "# Site Report: Site 908\n\n## Site Information\n- **Site ID**: Site 908\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 17\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 17 (100.0%)\n\n## Risk Profile\n- Low Risk: 17 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 909", "study": "Study 21", "site": "Site 909", "type": "site_summary", "total_subjects": 64, "total_issues": 0, "document": "# Site Report: Site 909\n\n## Site Information\n- **Site ID**: Site 909\n- **Study**: Study 21\n- **Country**: ESP\n- **Total Subjects**: 64\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 64 (100.0%)\n\n## Risk Profile\n- Low Risk: 64 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 5\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 91", "study": "Study 21", "site": "Site 91", "type": "site_summary", "total_subjects": 35, "total_issues": 0, "document": "# Site Report: Site 91\n\n## Site Information\n- **Site ID**: Site 91\n- **Study**: Study 21\n- **Country**: SVK\n- **Total Subjects**: 35\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 35 (100.0%)\n\n## Risk Profile\n- Low Risk: 35 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 910", "study": "Study 21", "site": "Site 910", "type": "site_summary", "total_subjects": 59, "total_issues": 1, "document": "# Site Report: Site 910\n\n## Site Information\n- **Site ID**: Site 910\n- **Study**: Study 21\n- **Country**: ARG\n- **Total Subjects**: 59\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.02\n- **Clean Subjects**: 58 (98.3%)\n\n## Risk Profile\n- Low Risk: 58 (98.3%)\n- Medium Risk: 1 (1.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 911", "study": "Study 21", "site": "Site 911", "type": "site_summary", "total_subjects": 72, "total_issues": 0, "document": "# Site Report: Site 911\n\n## Site Information\n- **Site ID**: Site 911\n- **Study**: Study 21\n- **Country**: ARG\n- **Total Subjects**: 72\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 72 (100.0%)\n\n## Risk Profile\n- Low Risk: 72 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 912", "study": "Study 21", "site": "Site 912", "type": "site_summary", "total_subjects": 16, "total_issues": 0, "document": "# Site Report: Site 912\n\n## Site Information\n- **Site ID**: Site 912\n- **Study**: Study 21\n- **Country**: ARG\n- **Total Subjects**: 16\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 16 (100.0%)\n\n## Risk Profile\n- Low Risk: 16 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 913", "study": "Study 21", "site": "Site 913", "type": "site_summary", "total_subjects": 21, "total_issues": 0, "document": "# Site Report: Site 913\n\n## Site Information\n- **Site ID**: Site 913\n- **Study**: Study 21\n- **Country**: ARG\n- **Total Subjects**: 21\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 21 (100.0%)\n\n## Risk Profile\n- Low Risk: 21 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 3\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 914", "study": "Study 21", "site": "Site 914", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 914\n\n## Site Information\n- **Site ID**: Site 914\n- **Study**: Study 21\n- **Country**: ARG\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 915", "study": "Study 21", "site": "Site 915", "type": "site_summary", "total_subjects": 44, "total_issues": 0, "document": "# Site Report: Site 915\n\n## Site Information\n- **Site ID**: Site 915\n- **Study**: Study 21\n- **Country**: ARG\n- **Total Subjects**: 44\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 44 (100.0%)\n\n## Risk Profile\n- Low Risk: 44 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 916", "study": "Study 21", "site": "Site 916", "type": "site_summary", "total_subjects": 133, "total_issues": 1, "document": "# Site Report: Site 916\n\n## Site Information\n- **Site ID**: Site 916\n- **Study**: Study 21\n- **Country**: ARG\n- **Total Subjects**: 133\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.01\n- **Clean Subjects**: 132 (99.2%)\n\n## Risk Profile\n- Low Risk: 132 (99.2%)\n- Medium Risk: 1 (0.8%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 917", "study": "Study 21", "site": "Site 917", "type": "site_summary", "total_subjects": 15, "total_issues": 0, "document": "# Site Report: Site 917\n\n## Site Information\n- **Site ID**: Site 917\n- **Study**: Study 21\n- **Country**: ARG\n- **Total Subjects**: 15\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 15 (100.0%)\n\n## Risk Profile\n- Low Risk: 15 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 918", "study": "Study 21", "site": "Site 918", "type": "site_summary", "total_subjects": 22, "total_issues": 1, "document": "# Site Report: Site 918\n\n## Site Information\n- **Site ID**: Site 918\n- **Study**: Study 21\n- **Country**: ARG\n- **Total Subjects**: 22\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.05\n- **Clean Subjects**: 21 (95.5%)\n\n## Risk Profile\n- Low Risk: 21 (95.5%)\n- Medium Risk: 1 (4.5%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 919", "study": "Study 21", "site": "Site 919", "type": "site_summary", "total_subjects": 41, "total_issues": 3, "document": "# Site Report: Site 919\n\n## Site Information\n- **Site ID**: Site 919\n- **Study**: Study 21\n- **Country**: ARG\n- **Total Subjects**: 41\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 0.07\n- **Clean Subjects**: 39 (95.1%)\n\n## Risk Profile\n- Low Risk: 39 (95.1%)\n- Medium Risk: 2 (4.9%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 3\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 92", "study": "Study 21", "site": "Site 92", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 92\n\n## Site Information\n- **Site ID**: Site 92\n- **Study**: Study 21\n- **Country**: SVK\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 920", "study": "Study 21", "site": "Site 920", "type": "site_summary", "total_subjects": 27, "total_issues": 0, "document": "# Site Report: Site 920\n\n## Site Information\n- **Site ID**: Site 920\n- **Study**: Study 21\n- **Country**: ARG\n- **Total Subjects**: 27\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 27 (100.0%)\n\n## Risk Profile\n- Low Risk: 27 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 921", "study": "Study 21", "site": "Site 921", "type": "site_summary", "total_subjects": 106, "total_issues": 0, "document": "# Site Report: Site 921\n\n## Site Information\n- **Site ID**: Site 921\n- **Study**: Study 21\n- **Country**: BRA\n- **Total Subjects**: 106\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 106 (100.0%)\n\n## Risk Profile\n- Low Risk: 106 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 922", "study": "Study 21", "site": "Site 922", "type": "site_summary", "total_subjects": 35, "total_issues": 1, "document": "# Site Report: Site 922\n\n## Site Information\n- **Site ID**: Site 922\n- **Study**: Study 21\n- **Country**: BRA\n- **Total Subjects**: 35\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.03\n- **Clean Subjects**: 34 (97.1%)\n\n## Risk Profile\n- Low Risk: 34 (97.1%)\n- Medium Risk: 1 (2.9%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 923", "study": "Study 21", "site": "Site 923", "type": "site_summary", "total_subjects": 104, "total_issues": 0, "document": "# Site Report: Site 923\n\n## Site Information\n- **Site ID**: Site 923\n- **Study**: Study 21\n- **Country**: BRA\n- **Total Subjects**: 104\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 104 (100.0%)\n\n## Risk Profile\n- Low Risk: 104 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 924", "study": "Study 21", "site": "Site 924", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 924\n\n## Site Information\n- **Site ID**: Site 924\n- **Study**: Study 21\n- **Country**: BRA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 925", "study": "Study 21", "site": "Site 925", "type": "site_summary", "total_subjects": 242, "total_issues": 2, "document": "# Site Report: Site 925\n\n## Site Information\n- **Site ID**: Site 925\n- **Study**: Study 21\n- **Country**: BRA\n- **Total Subjects**: 242\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.01\n- **Clean Subjects**: 240 (99.2%)\n\n## Risk Profile\n- Low Risk: 240 (99.2%)\n- Medium Risk: 2 (0.8%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 926", "study": "Study 21", "site": "Site 926", "type": "site_summary", "total_subjects": 57, "total_issues": 0, "document": "# Site Report: Site 926\n\n## Site Information\n- **Site ID**: Site 926\n- **Study**: Study 21\n- **Country**: BRA\n- **Total Subjects**: 57\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 57 (100.0%)\n\n## Risk Profile\n- Low Risk: 57 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 927", "study": "Study 21", "site": "Site 927", "type": "site_summary", "total_subjects": 101, "total_issues": 1, "document": "# Site Report: Site 927\n\n## Site Information\n- **Site ID**: Site 927\n- **Study**: Study 21\n- **Country**: BRA\n- **Total Subjects**: 101\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.01\n- **Clean Subjects**: 100 (99.0%)\n\n## Risk Profile\n- Low Risk: 100 (99.0%)\n- Medium Risk: 1 (1.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 928", "study": "Study 21", "site": "Site 928", "type": "site_summary", "total_subjects": 46, "total_issues": 0, "document": "# Site Report: Site 928\n\n## Site Information\n- **Site ID**: Site 928\n- **Study**: Study 21\n- **Country**: BRA\n- **Total Subjects**: 46\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 46 (100.0%)\n\n## Risk Profile\n- Low Risk: 46 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 929", "study": "Study 21", "site": "Site 929", "type": "site_summary", "total_subjects": 54, "total_issues": 0, "document": "# Site Report: Site 929\n\n## Site Information\n- **Site ID**: Site 929\n- **Study**: Study 21\n- **Country**: BRA\n- **Total Subjects**: 54\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 54 (100.0%)\n\n## Risk Profile\n- Low Risk: 54 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 930", "study": "Study 21", "site": "Site 930", "type": "site_summary", "total_subjects": 144, "total_issues": 0, "document": "# Site Report: Site 930\n\n## Site Information\n- **Site ID**: Site 930\n- **Study**: Study 21\n- **Country**: BRA\n- **Total Subjects**: 144\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 144 (100.0%)\n\n## Risk Profile\n- Low Risk: 144 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 931", "study": "Study 21", "site": "Site 931", "type": "site_summary", "total_subjects": 135, "total_issues": 0, "document": "# Site Report: Site 931\n\n## Site Information\n- **Site ID**: Site 931\n- **Study**: Study 21\n- **Country**: BRA\n- **Total Subjects**: 135\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 135 (100.0%)\n\n## Risk Profile\n- Low Risk: 135 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 932", "study": "Study 21", "site": "Site 932", "type": "site_summary", "total_subjects": 61, "total_issues": 1, "document": "# Site Report: Site 932\n\n## Site Information\n- **Site ID**: Site 932\n- **Study**: Study 21\n- **Country**: BRA\n- **Total Subjects**: 61\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.02\n- **Clean Subjects**: 60 (98.4%)\n\n## Risk Profile\n- Low Risk: 60 (98.4%)\n- Medium Risk: 1 (1.6%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 933", "study": "Study 21", "site": "Site 933", "type": "site_summary", "total_subjects": 53, "total_issues": 0, "document": "# Site Report: Site 933\n\n## Site Information\n- **Site ID**: Site 933\n- **Study**: Study 21\n- **Country**: BRA\n- **Total Subjects**: 53\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 53 (100.0%)\n\n## Risk Profile\n- Low Risk: 53 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 934", "study": "Study 21", "site": "Site 934", "type": "site_summary", "total_subjects": 56, "total_issues": 0, "document": "# Site Report: Site 934\n\n## Site Information\n- **Site ID**: Site 934\n- **Study**: Study 21\n- **Country**: BRA\n- **Total Subjects**: 56\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 56 (100.0%)\n\n## Risk Profile\n- Low Risk: 56 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 5\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 935", "study": "Study 21", "site": "Site 935", "type": "site_summary", "total_subjects": 32, "total_issues": 0, "document": "# Site Report: Site 935\n\n## Site Information\n- **Site ID**: Site 935\n- **Study**: Study 21\n- **Country**: BRA\n- **Total Subjects**: 32\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 32 (100.0%)\n\n## Risk Profile\n- Low Risk: 32 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 936", "study": "Study 21", "site": "Site 936", "type": "site_summary", "total_subjects": 20, "total_issues": 1, "document": "# Site Report: Site 936\n\n## Site Information\n- **Site ID**: Site 936\n- **Study**: Study 21\n- **Country**: BRA\n- **Total Subjects**: 20\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.05\n- **Clean Subjects**: 19 (95.0%)\n\n## Risk Profile\n- Low Risk: 19 (95.0%)\n- Medium Risk: 1 (5.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 937", "study": "Study 21", "site": "Site 937", "type": "site_summary", "total_subjects": 52, "total_issues": 0, "document": "# Site Report: Site 937\n\n## Site Information\n- **Site ID**: Site 937\n- **Study**: Study 21\n- **Country**: BRA\n- **Total Subjects**: 52\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 52 (100.0%)\n\n## Risk Profile\n- Low Risk: 52 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 938", "study": "Study 21", "site": "Site 938", "type": "site_summary", "total_subjects": 13, "total_issues": 0, "document": "# Site Report: Site 938\n\n## Site Information\n- **Site ID**: Site 938\n- **Study**: Study 21\n- **Country**: BRA\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 13 (100.0%)\n\n## Risk Profile\n- Low Risk: 13 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 939", "study": "Study 21", "site": "Site 939", "type": "site_summary", "total_subjects": 29, "total_issues": 0, "document": "# Site Report: Site 939\n\n## Site Information\n- **Site ID**: Site 939\n- **Study**: Study 21\n- **Country**: BRA\n- **Total Subjects**: 29\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 29 (100.0%)\n\n## Risk Profile\n- Low Risk: 29 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 94", "study": "Study 21", "site": "Site 94", "type": "site_summary", "total_subjects": 20, "total_issues": 0, "document": "# Site Report: Site 94\n\n## Site Information\n- **Site ID**: Site 94\n- **Study**: Study 21\n- **Country**: SVK\n- **Total Subjects**: 20\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 20 (100.0%)\n\n## Risk Profile\n- Low Risk: 20 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 940", "study": "Study 21", "site": "Site 940", "type": "site_summary", "total_subjects": 48, "total_issues": 0, "document": "# Site Report: Site 940\n\n## Site Information\n- **Site ID**: Site 940\n- **Study**: Study 21\n- **Country**: BRA\n- **Total Subjects**: 48\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 48 (100.0%)\n\n## Risk Profile\n- Low Risk: 48 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 941", "study": "Study 21", "site": "Site 941", "type": "site_summary", "total_subjects": 38, "total_issues": 1, "document": "# Site Report: Site 941\n\n## Site Information\n- **Site ID**: Site 941\n- **Study**: Study 21\n- **Country**: BRA\n- **Total Subjects**: 38\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.03\n- **Clean Subjects**: 37 (97.4%)\n\n## Risk Profile\n- Low Risk: 37 (97.4%)\n- Medium Risk: 1 (2.6%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 942", "study": "Study 21", "site": "Site 942", "type": "site_summary", "total_subjects": 38, "total_issues": 0, "document": "# Site Report: Site 942\n\n## Site Information\n- **Site ID**: Site 942\n- **Study**: Study 21\n- **Country**: BRA\n- **Total Subjects**: 38\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 38 (100.0%)\n\n## Risk Profile\n- Low Risk: 38 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 5\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 943", "study": "Study 21", "site": "Site 943", "type": "site_summary", "total_subjects": 44, "total_issues": 0, "document": "# Site Report: Site 943\n\n## Site Information\n- **Site ID**: Site 943\n- **Study**: Study 21\n- **Country**: BRA\n- **Total Subjects**: 44\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 44 (100.0%)\n\n## Risk Profile\n- Low Risk: 44 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 944", "study": "Study 21", "site": "Site 944", "type": "site_summary", "total_subjects": 15, "total_issues": 0, "document": "# Site Report: Site 944\n\n## Site Information\n- **Site ID**: Site 944\n- **Study**: Study 21\n- **Country**: BRA\n- **Total Subjects**: 15\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 15 (100.0%)\n\n## Risk Profile\n- Low Risk: 15 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 945", "study": "Study 21", "site": "Site 945", "type": "site_summary", "total_subjects": 19, "total_issues": 0, "document": "# Site Report: Site 945\n\n## Site Information\n- **Site ID**: Site 945\n- **Study**: Study 21\n- **Country**: BRA\n- **Total Subjects**: 19\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 19 (100.0%)\n\n## Risk Profile\n- Low Risk: 19 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 946", "study": "Study 21", "site": "Site 946", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 946\n\n## Site Information\n- **Site ID**: Site 946\n- **Study**: Study 21\n- **Country**: BRA\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 947", "study": "Study 21", "site": "Site 947", "type": "site_summary", "total_subjects": 37, "total_issues": 0, "document": "# Site Report: Site 947\n\n## Site Information\n- **Site ID**: Site 947\n- **Study**: Study 21\n- **Country**: BRA\n- **Total Subjects**: 37\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 37 (100.0%)\n\n## Risk Profile\n- Low Risk: 37 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 948", "study": "Study 21", "site": "Site 948", "type": "site_summary", "total_subjects": 13, "total_issues": 0, "document": "# Site Report: Site 948\n\n## Site Information\n- **Site ID**: Site 948\n- **Study**: Study 21\n- **Country**: BRA\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 13 (100.0%)\n\n## Risk Profile\n- Low Risk: 13 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 949", "study": "Study 21", "site": "Site 949", "type": "site_summary", "total_subjects": 41, "total_issues": 0, "document": "# Site Report: Site 949\n\n## Site Information\n- **Site ID**: Site 949\n- **Study**: Study 21\n- **Country**: BRA\n- **Total Subjects**: 41\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 41 (100.0%)\n\n## Risk Profile\n- Low Risk: 41 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 95", "study": "Study 21", "site": "Site 95", "type": "site_summary", "total_subjects": 17, "total_issues": 0, "document": "# Site Report: Site 95\n\n## Site Information\n- **Site ID**: Site 95\n- **Study**: Study 21\n- **Country**: SVK\n- **Total Subjects**: 17\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 17 (100.0%)\n\n## Risk Profile\n- Low Risk: 17 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 950", "study": "Study 21", "site": "Site 950", "type": "site_summary", "total_subjects": 124, "total_issues": 0, "document": "# Site Report: Site 950\n\n## Site Information\n- **Site ID**: Site 950\n- **Study**: Study 21\n- **Country**: BRA\n- **Total Subjects**: 124\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 124 (100.0%)\n\n## Risk Profile\n- Low Risk: 124 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 951", "study": "Study 21", "site": "Site 951", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 951\n\n## Site Information\n- **Site ID**: Site 951\n- **Study**: Study 21\n- **Country**: CAN\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 952", "study": "Study 21", "site": "Site 952", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 952\n\n## Site Information\n- **Site ID**: Site 952\n- **Study**: Study 21\n- **Country**: CAN\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 953", "study": "Study 21", "site": "Site 953", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 953\n\n## Site Information\n- **Site ID**: Site 953\n- **Study**: Study 21\n- **Country**: CAN\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 954", "study": "Study 21", "site": "Site 954", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 954\n\n## Site Information\n- **Site ID**: Site 954\n- **Study**: Study 21\n- **Country**: CAN\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 955", "study": "Study 21", "site": "Site 955", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 955\n\n## Site Information\n- **Site ID**: Site 955\n- **Study**: Study 21\n- **Country**: CAN\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 956", "study": "Study 21", "site": "Site 956", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 956\n\n## Site Information\n- **Site ID**: Site 956\n- **Study**: Study 21\n- **Country**: CAN\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 957", "study": "Study 21", "site": "Site 957", "type": "site_summary", "total_subjects": 16, "total_issues": 0, "document": "# Site Report: Site 957\n\n## Site Information\n- **Site ID**: Site 957\n- **Study**: Study 21\n- **Country**: CAN\n- **Total Subjects**: 16\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 16 (100.0%)\n\n## Risk Profile\n- Low Risk: 16 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 958", "study": "Study 21", "site": "Site 958", "type": "site_summary", "total_subjects": 18, "total_issues": 2, "document": "# Site Report: Site 958\n\n## Site Information\n- **Site ID**: Site 958\n- **Study**: Study 21\n- **Country**: CAN\n- **Total Subjects**: 18\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.11\n- **Clean Subjects**: 17 (94.4%)\n\n## Risk Profile\n- Low Risk: 17 (94.4%)\n- Medium Risk: 1 (5.6%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 959", "study": "Study 21", "site": "Site 959", "type": "site_summary", "total_subjects": 10, "total_issues": 0, "document": "# Site Report: Site 959\n\n## Site Information\n- **Site ID**: Site 959\n- **Study**: Study 21\n- **Country**: CAN\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 10 (100.0%)\n\n## Risk Profile\n- Low Risk: 10 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 96", "study": "Study 21", "site": "Site 96", "type": "site_summary", "total_subjects": 9, "total_issues": 0, "document": "# Site Report: Site 96\n\n## Site Information\n- **Site ID**: Site 96\n- **Study**: Study 21\n- **Country**: SVK\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 9 (100.0%)\n\n## Risk Profile\n- Low Risk: 9 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 960", "study": "Study 21", "site": "Site 960", "type": "site_summary", "total_subjects": 17, "total_issues": 0, "document": "# Site Report: Site 960\n\n## Site Information\n- **Site ID**: Site 960\n- **Study**: Study 21\n- **Country**: CAN\n- **Total Subjects**: 17\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 17 (100.0%)\n\n## Risk Profile\n- Low Risk: 17 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 961", "study": "Study 21", "site": "Site 961", "type": "site_summary", "total_subjects": 13, "total_issues": 0, "document": "# Site Report: Site 961\n\n## Site Information\n- **Site ID**: Site 961\n- **Study**: Study 21\n- **Country**: CAN\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 13 (100.0%)\n\n## Risk Profile\n- Low Risk: 13 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 962", "study": "Study 21", "site": "Site 962", "type": "site_summary", "total_subjects": 16, "total_issues": 0, "document": "# Site Report: Site 962\n\n## Site Information\n- **Site ID**: Site 962\n- **Study**: Study 21\n- **Country**: CAN\n- **Total Subjects**: 16\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 16 (100.0%)\n\n## Risk Profile\n- Low Risk: 16 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 963", "study": "Study 21", "site": "Site 963", "type": "site_summary", "total_subjects": 8, "total_issues": 0, "document": "# Site Report: Site 963\n\n## Site Information\n- **Site ID**: Site 963\n- **Study**: Study 21\n- **Country**: CAN\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 8 (100.0%)\n\n## Risk Profile\n- Low Risk: 8 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 964", "study": "Study 21", "site": "Site 964", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 964\n\n## Site Information\n- **Site ID**: Site 964\n- **Study**: Study 21\n- **Country**: CAN\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 965", "study": "Study 21", "site": "Site 965", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 965\n\n## Site Information\n- **Site ID**: Site 965\n- **Study**: Study 21\n- **Country**: CAN\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 966", "study": "Study 21", "site": "Site 966", "type": "site_summary", "total_subjects": 11, "total_issues": 1, "document": "# Site Report: Site 966\n\n## Site Information\n- **Site ID**: Site 966\n- **Study**: Study 21\n- **Country**: CAN\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.09\n- **Clean Subjects**: 10 (90.9%)\n\n## Risk Profile\n- Low Risk: 10 (90.9%)\n- Medium Risk: 1 (9.1%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 967", "study": "Study 21", "site": "Site 967", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 967\n\n## Site Information\n- **Site ID**: Site 967\n- **Study**: Study 21\n- **Country**: CAN\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 968", "study": "Study 21", "site": "Site 968", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 968\n\n## Site Information\n- **Site ID**: Site 968\n- **Study**: Study 21\n- **Country**: CAN\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 969", "study": "Study 21", "site": "Site 969", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 969\n\n## Site Information\n- **Site ID**: Site 969\n- **Study**: Study 21\n- **Country**: CAN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 97", "study": "Study 21", "site": "Site 97", "type": "site_summary", "total_subjects": 22, "total_issues": 0, "document": "# Site Report: Site 97\n\n## Site Information\n- **Site ID**: Site 97\n- **Study**: Study 21\n- **Country**: SVK\n- **Total Subjects**: 22\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 22 (100.0%)\n\n## Risk Profile\n- Low Risk: 22 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 970", "study": "Study 21", "site": "Site 970", "type": "site_summary", "total_subjects": 11, "total_issues": 0, "document": "# Site Report: Site 970\n\n## Site Information\n- **Site ID**: Site 970\n- **Study**: Study 21\n- **Country**: CAN\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 11 (100.0%)\n\n## Risk Profile\n- Low Risk: 11 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 971", "study": "Study 21", "site": "Site 971", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 971\n\n## Site Information\n- **Site ID**: Site 971\n- **Study**: Study 21\n- **Country**: CAN\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 972", "study": "Study 21", "site": "Site 972", "type": "site_summary", "total_subjects": 14, "total_issues": 0, "document": "# Site Report: Site 972\n\n## Site Information\n- **Site ID**: Site 972\n- **Study**: Study 21\n- **Country**: CAN\n- **Total Subjects**: 14\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 14 (100.0%)\n\n## Risk Profile\n- Low Risk: 14 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 973", "study": "Study 21", "site": "Site 973", "type": "site_summary", "total_subjects": 10, "total_issues": 0, "document": "# Site Report: Site 973\n\n## Site Information\n- **Site ID**: Site 973\n- **Study**: Study 21\n- **Country**: CAN\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 10 (100.0%)\n\n## Risk Profile\n- Low Risk: 10 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 974", "study": "Study 21", "site": "Site 974", "type": "site_summary", "total_subjects": 25, "total_issues": 0, "document": "# Site Report: Site 974\n\n## Site Information\n- **Site ID**: Site 974\n- **Study**: Study 21\n- **Country**: CAN\n- **Total Subjects**: 25\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 25 (100.0%)\n\n## Risk Profile\n- Low Risk: 25 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 3\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 975", "study": "Study 21", "site": "Site 975", "type": "site_summary", "total_subjects": 15, "total_issues": 0, "document": "# Site Report: Site 975\n\n## Site Information\n- **Site ID**: Site 975\n- **Study**: Study 21\n- **Country**: CAN\n- **Total Subjects**: 15\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 15 (100.0%)\n\n## Risk Profile\n- Low Risk: 15 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 976", "study": "Study 21", "site": "Site 976", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 976\n\n## Site Information\n- **Site ID**: Site 976\n- **Study**: Study 21\n- **Country**: CAN\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 977", "study": "Study 21", "site": "Site 977", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 977\n\n## Site Information\n- **Site ID**: Site 977\n- **Study**: Study 21\n- **Country**: CAN\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 978", "study": "Study 21", "site": "Site 978", "type": "site_summary", "total_subjects": 8, "total_issues": 0, "document": "# Site Report: Site 978\n\n## Site Information\n- **Site ID**: Site 978\n- **Study**: Study 21\n- **Country**: CAN\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 8 (100.0%)\n\n## Risk Profile\n- Low Risk: 8 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 979", "study": "Study 21", "site": "Site 979", "type": "site_summary", "total_subjects": 66, "total_issues": 0, "document": "# Site Report: Site 979\n\n## Site Information\n- **Site ID**: Site 979\n- **Study**: Study 21\n- **Country**: CAN\n- **Total Subjects**: 66\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 66 (100.0%)\n\n## Risk Profile\n- Low Risk: 66 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 98", "study": "Study 21", "site": "Site 98", "type": "site_summary", "total_subjects": 11, "total_issues": 0, "document": "# Site Report: Site 98\n\n## Site Information\n- **Site ID**: Site 98\n- **Study**: Study 21\n- **Country**: SVK\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 11 (100.0%)\n\n## Risk Profile\n- Low Risk: 11 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 980", "study": "Study 21", "site": "Site 980", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 980\n\n## Site Information\n- **Site ID**: Site 980\n- **Study**: Study 21\n- **Country**: CAN\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 981", "study": "Study 21", "site": "Site 981", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 981\n\n## Site Information\n- **Site ID**: Site 981\n- **Study**: Study 21\n- **Country**: CAN\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 982", "study": "Study 21", "site": "Site 982", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 982\n\n## Site Information\n- **Site ID**: Site 982\n- **Study**: Study 21\n- **Country**: CAN\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 983", "study": "Study 21", "site": "Site 983", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 983\n\n## Site Information\n- **Site ID**: Site 983\n- **Study**: Study 21\n- **Country**: CAN\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 984", "study": "Study 21", "site": "Site 984", "type": "site_summary", "total_subjects": 22, "total_issues": 0, "document": "# Site Report: Site 984\n\n## Site Information\n- **Site ID**: Site 984\n- **Study**: Study 21\n- **Country**: CAN\n- **Total Subjects**: 22\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 22 (100.0%)\n\n## Risk Profile\n- Low Risk: 22 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 985", "study": "Study 21", "site": "Site 985", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 985\n\n## Site Information\n- **Site ID**: Site 985\n- **Study**: Study 21\n- **Country**: CAN\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 986", "study": "Study 21", "site": "Site 986", "type": "site_summary", "total_subjects": 23, "total_issues": 0, "document": "# Site Report: Site 986\n\n## Site Information\n- **Site ID**: Site 986\n- **Study**: Study 21\n- **Country**: CHL\n- **Total Subjects**: 23\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 23 (100.0%)\n\n## Risk Profile\n- Low Risk: 23 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 987", "study": "Study 21", "site": "Site 987", "type": "site_summary", "total_subjects": 44, "total_issues": 0, "document": "# Site Report: Site 987\n\n## Site Information\n- **Site ID**: Site 987\n- **Study**: Study 21\n- **Country**: CHL\n- **Total Subjects**: 44\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 44 (100.0%)\n\n## Risk Profile\n- Low Risk: 44 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 988", "study": "Study 21", "site": "Site 988", "type": "site_summary", "total_subjects": 25, "total_issues": 2, "document": "# Site Report: Site 988\n\n## Site Information\n- **Site ID**: Site 988\n- **Study**: Study 21\n- **Country**: CHL\n- **Total Subjects**: 25\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.08\n- **Clean Subjects**: 24 (96.0%)\n\n## Risk Profile\n- Low Risk: 24 (96.0%)\n- Medium Risk: 1 (4.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 989", "study": "Study 21", "site": "Site 989", "type": "site_summary", "total_subjects": 33, "total_issues": 2, "document": "# Site Report: Site 989\n\n## Site Information\n- **Site ID**: Site 989\n- **Study**: Study 21\n- **Country**: CHL\n- **Total Subjects**: 33\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.06\n- **Clean Subjects**: 31 (93.9%)\n\n## Risk Profile\n- Low Risk: 31 (93.9%)\n- Medium Risk: 2 (6.1%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 990", "study": "Study 21", "site": "Site 990", "type": "site_summary", "total_subjects": 36, "total_issues": 0, "document": "# Site Report: Site 990\n\n## Site Information\n- **Site ID**: Site 990\n- **Study**: Study 21\n- **Country**: CHL\n- **Total Subjects**: 36\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 36 (100.0%)\n\n## Risk Profile\n- Low Risk: 36 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 991", "study": "Study 21", "site": "Site 991", "type": "site_summary", "total_subjects": 19, "total_issues": 0, "document": "# Site Report: Site 991\n\n## Site Information\n- **Site ID**: Site 991\n- **Study**: Study 21\n- **Country**: CHL\n- **Total Subjects**: 19\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 19 (100.0%)\n\n## Risk Profile\n- Low Risk: 19 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 992", "study": "Study 21", "site": "Site 992", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 992\n\n## Site Information\n- **Site ID**: Site 992\n- **Study**: Study 21\n- **Country**: CHL\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 993", "study": "Study 21", "site": "Site 993", "type": "site_summary", "total_subjects": 34, "total_issues": 1, "document": "# Site Report: Site 993\n\n## Site Information\n- **Site ID**: Site 993\n- **Study**: Study 21\n- **Country**: CHL\n- **Total Subjects**: 34\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.03\n- **Clean Subjects**: 33 (97.1%)\n\n## Risk Profile\n- Low Risk: 33 (97.1%)\n- Medium Risk: 1 (2.9%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 994", "study": "Study 21", "site": "Site 994", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 994\n\n## Site Information\n- **Site ID**: Site 994\n- **Study**: Study 21\n- **Country**: CHL\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 995", "study": "Study 21", "site": "Site 995", "type": "site_summary", "total_subjects": 13, "total_issues": 0, "document": "# Site Report: Site 995\n\n## Site Information\n- **Site ID**: Site 995\n- **Study**: Study 21\n- **Country**: NOR\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 13 (100.0%)\n\n## Risk Profile\n- Low Risk: 13 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 996", "study": "Study 21", "site": "Site 996", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 996\n\n## Site Information\n- **Site ID**: Site 996\n- **Study**: Study 21\n- **Country**: NOR\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 997", "study": "Study 21", "site": "Site 997", "type": "site_summary", "total_subjects": 32, "total_issues": 0, "document": "# Site Report: Site 997\n\n## Site Information\n- **Site ID**: Site 997\n- **Study**: Study 21\n- **Country**: NOR\n- **Total Subjects**: 32\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 32 (100.0%)\n\n## Risk Profile\n- Low Risk: 32 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 998", "study": "Study 21", "site": "Site 998", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 998\n\n## Site Information\n- **Site ID**: Site 998\n- **Study**: Study 21\n- **Country**: NOR\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 21_Site 999", "study": "Study 21", "site": "Site 999", "type": "site_summary", "total_subjects": 32, "total_issues": 0, "document": "# Site Report: Site 999\n\n## Site Information\n- **Site ID**: Site 999\n- **Study**: Study 21\n- **Country**: NOR\n- **Total Subjects**: 32\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 32 (100.0%)\n\n## Risk Profile\n- Low Risk: 32 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 100", "study": "Study 22", "site": "Site 100", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 100\n\n## Site Information\n- **Site ID**: Site 100\n- **Study**: Study 22\n- **Country**: POL\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1009", "study": "Study 22", "site": "Site 1009", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1009\n\n## Site Information\n- **Site ID**: Site 1009\n- **Study**: Study 22\n- **Country**: MEX\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 101", "study": "Study 22", "site": "Site 101", "type": "site_summary", "total_subjects": 2, "total_issues": 3, "document": "# Site Report: Site 101\n\n## Site Information\n- **Site ID**: Site 101\n- **Study**: Study 22\n- **Country**: POL\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 1.50\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 2\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1020", "study": "Study 22", "site": "Site 1020", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 1020\n\n## Site Information\n- **Site ID**: Site 1020\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1049", "study": "Study 22", "site": "Site 1049", "type": "site_summary", "total_subjects": 1, "total_issues": 5, "document": "# Site Report: Site 1049\n\n## Site Information\n- **Site ID**: Site 1049\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 5\n- **Average Issues per Subject**: 5.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1052", "study": "Study 22", "site": "Site 1052", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1052\n\n## Site Information\n- **Site ID**: Site 1052\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1057", "study": "Study 22", "site": "Site 1057", "type": "site_summary", "total_subjects": 1, "total_issues": 4, "document": "# Site Report: Site 1057\n\n## Site Information\n- **Site ID**: Site 1057\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 4.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 3\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1074", "study": "Study 22", "site": "Site 1074", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1074\n\n## Site Information\n- **Site ID**: Site 1074\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1083", "study": "Study 22", "site": "Site 1083", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1083\n\n## Site Information\n- **Site ID**: Site 1083\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1084", "study": "Study 22", "site": "Site 1084", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1084\n\n## Site Information\n- **Site ID**: Site 1084\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1093", "study": "Study 22", "site": "Site 1093", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1093\n\n## Site Information\n- **Site ID**: Site 1093\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1106", "study": "Study 22", "site": "Site 1106", "type": "site_summary", "total_subjects": 4, "total_issues": 1, "document": "# Site Report: Site 1106\n\n## Site Information\n- **Site ID**: Site 1106\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.25\n- **Clean Subjects**: 3 (75.0%)\n\n## Risk Profile\n- Low Risk: 3 (75.0%)\n- Medium Risk: 1 (25.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1108", "study": "Study 22", "site": "Site 1108", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1108\n\n## Site Information\n- **Site ID**: Site 1108\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1112", "study": "Study 22", "site": "Site 1112", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1112\n\n## Site Information\n- **Site ID**: Site 1112\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1113", "study": "Study 22", "site": "Site 1113", "type": "site_summary", "total_subjects": 3, "total_issues": 1, "document": "# Site Report: Site 1113\n\n## Site Information\n- **Site ID**: Site 1113\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.33\n- **Clean Subjects**: 2 (66.7%)\n\n## Risk Profile\n- Low Risk: 2 (66.7%)\n- Medium Risk: 1 (33.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1121", "study": "Study 22", "site": "Site 1121", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1121\n\n## Site Information\n- **Site ID**: Site 1121\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1123", "study": "Study 22", "site": "Site 1123", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1123\n\n## Site Information\n- **Site ID**: Site 1123\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1129", "study": "Study 22", "site": "Site 1129", "type": "site_summary", "total_subjects": 3, "total_issues": 4, "document": "# Site Report: Site 1129\n\n## Site Information\n- **Site ID**: Site 1129\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 1.33\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 3 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1155", "study": "Study 22", "site": "Site 1155", "type": "site_summary", "total_subjects": 2, "total_issues": 1, "document": "# Site Report: Site 1155\n\n## Site Information\n- **Site ID**: Site 1155\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.50\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1162", "study": "Study 22", "site": "Site 1162", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1162\n\n## Site Information\n- **Site ID**: Site 1162\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1169", "study": "Study 22", "site": "Site 1169", "type": "site_summary", "total_subjects": 1, "total_issues": 2, "document": "# Site Report: Site 1169\n\n## Site Information\n- **Site ID**: Site 1169\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1172", "study": "Study 22", "site": "Site 1172", "type": "site_summary", "total_subjects": 3, "total_issues": 3, "document": "# Site Report: Site 1172\n\n## Site Information\n- **Site ID**: Site 1172\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 3 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 3\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1174", "study": "Study 22", "site": "Site 1174", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1174\n\n## Site Information\n- **Site ID**: Site 1174\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1175", "study": "Study 22", "site": "Site 1175", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1175\n\n## Site Information\n- **Site ID**: Site 1175\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1179", "study": "Study 22", "site": "Site 1179", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1179\n\n## Site Information\n- **Site ID**: Site 1179\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1180", "study": "Study 22", "site": "Site 1180", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1180\n\n## Site Information\n- **Site ID**: Site 1180\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 125", "study": "Study 22", "site": "Site 125", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 125\n\n## Site Information\n- **Site ID**: Site 125\n- **Study**: Study 22\n- **Country**: BGR\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 126", "study": "Study 22", "site": "Site 126", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 126\n\n## Site Information\n- **Site ID**: Site 126\n- **Study**: Study 22\n- **Country**: BGR\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1295", "study": "Study 22", "site": "Site 1295", "type": "site_summary", "total_subjects": 1, "total_issues": 6, "document": "# Site Report: Site 1295\n\n## Site Information\n- **Site ID**: Site 1295\n- **Study**: Study 22\n- **Country**: CHN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 6\n- **Average Issues per Subject**: 6.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (100.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 2\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 44116: High risk, 6 issues\n"}
{"id": "site_Study 22_Site 1297", "study": "Study 22", "site": "Site 1297", "type": "site_summary", "total_subjects": 2, "total_issues": 1, "document": "# Site Report: Site 1297\n\n## Site Information\n- **Site ID**: Site 1297\n- **Study**: Study 22\n- **Country**: CHN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.50\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1306", "study": "Study 22", "site": "Site 1306", "type": "site_summary", "total_subjects": 1, "total_issues": 2, "document": "# Site Report: Site 1306\n\n## Site Information\n- **Site ID**: Site 1306\n- **Study**: Study 22\n- **Country**: CHN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 2\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1310", "study": "Study 22", "site": "Site 1310", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 1310\n\n## Site Information\n- **Site ID**: Site 1310\n- **Study**: Study 22\n- **Country**: CHN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1336", "study": "Study 22", "site": "Site 1336", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 1336\n\n## Site Information\n- **Site ID**: Site 1336\n- **Study**: Study 22\n- **Country**: HRV\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1342", "study": "Study 22", "site": "Site 1342", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1342\n\n## Site Information\n- **Site ID**: Site 1342\n- **Study**: Study 22\n- **Country**: HRV\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1347", "study": "Study 22", "site": "Site 1347", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1347\n\n## Site Information\n- **Site ID**: Site 1347\n- **Study**: Study 22\n- **Country**: DNK\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1350", "study": "Study 22", "site": "Site 1350", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1350\n\n## Site Information\n- **Site ID**: Site 1350\n- **Study**: Study 22\n- **Country**: DNK\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1355", "study": "Study 22", "site": "Site 1355", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1355\n\n## Site Information\n- **Site ID**: Site 1355\n- **Study**: Study 22\n- **Country**: DNK\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1360", "study": "Study 22", "site": "Site 1360", "type": "site_summary", "total_subjects": 2, "total_issues": 7, "document": "# Site Report: Site 1360\n\n## Site Information\n- **Site ID**: Site 1360\n- **Study**: Study 22\n- **Country**: LVA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 7\n- **Average Issues per Subject**: 3.50\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 1 (50.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 20819: High risk, 6 issues\n"}
{"id": "site_Study 22_Site 1362", "study": "Study 22", "site": "Site 1362", "type": "site_summary", "total_subjects": 3, "total_issues": 3, "document": "# Site Report: Site 1362\n\n## Site Information\n- **Site ID**: Site 1362\n- **Study**: Study 22\n- **Country**: LVA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 3 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 3\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1390", "study": "Study 22", "site": "Site 1390", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1390\n\n## Site Information\n- **Site ID**: Site 1390\n- **Study**: Study 22\n- **Country**: LTU\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 14", "study": "Study 22", "site": "Site 14", "type": "site_summary", "total_subjects": 1, "total_issues": 2, "document": "# Site Report: Site 14\n\n## Site Information\n- **Site ID**: Site 14\n- **Study**: Study 22\n- **Country**: POL\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 153", "study": "Study 22", "site": "Site 153", "type": "site_summary", "total_subjects": 2, "total_issues": 1, "document": "# Site Report: Site 153\n\n## Site Information\n- **Site ID**: Site 153\n- **Study**: Study 22\n- **Country**: HUN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.50\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 154", "study": "Study 22", "site": "Site 154", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 154\n\n## Site Information\n- **Site ID**: Site 154\n- **Study**: Study 22\n- **Country**: HUN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 158", "study": "Study 22", "site": "Site 158", "type": "site_summary", "total_subjects": 3, "total_issues": 3, "document": "# Site Report: Site 158\n\n## Site Information\n- **Site ID**: Site 158\n- **Study**: Study 22\n- **Country**: HUN\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 3 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 16", "study": "Study 22", "site": "Site 16", "type": "site_summary", "total_subjects": 3, "total_issues": 51, "document": "# Site Report: Site 16\n\n## Site Information\n- **Site ID**: Site 16\n- **Study**: Study 22\n- **Country**: POL\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 51\n- **Average Issues per Subject**: 17.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (66.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (33.3%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 4\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 8365: Critical risk, 47 issues\n"}
{"id": "site_Study 22_Site 162", "study": "Study 22", "site": "Site 162", "type": "site_summary", "total_subjects": 1, "total_issues": 2, "document": "# Site Report: Site 162\n\n## Site Information\n- **Site ID**: Site 162\n- **Study**: Study 22\n- **Country**: ISR\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 164", "study": "Study 22", "site": "Site 164", "type": "site_summary", "total_subjects": 3, "total_issues": 7, "document": "# Site Report: Site 164\n\n## Site Information\n- **Site ID**: Site 164\n- **Study**: Study 22\n- **Country**: POL\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 7\n- **Average Issues per Subject**: 2.33\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 3 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1647", "study": "Study 22", "site": "Site 1647", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1647\n\n## Site Information\n- **Site ID**: Site 1647\n- **Study**: Study 22\n- **Country**: IND\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1652", "study": "Study 22", "site": "Site 1652", "type": "site_summary", "total_subjects": 1, "total_issues": 2, "document": "# Site Report: Site 1652\n\n## Site Information\n- **Site ID**: Site 1652\n- **Study**: Study 22\n- **Country**: IND\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1653", "study": "Study 22", "site": "Site 1653", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1653\n\n## Site Information\n- **Site ID**: Site 1653\n- **Study**: Study 22\n- **Country**: IND\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1657", "study": "Study 22", "site": "Site 1657", "type": "site_summary", "total_subjects": 1, "total_issues": 6, "document": "# Site Report: Site 1657\n\n## Site Information\n- **Site ID**: Site 1657\n- **Study**: Study 22\n- **Country**: IND\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 6\n- **Average Issues per Subject**: 6.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (100.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 30507: High risk, 6 issues\n"}
{"id": "site_Study 22_Site 166", "study": "Study 22", "site": "Site 166", "type": "site_summary", "total_subjects": 5, "total_issues": 6, "document": "# Site Report: Site 166\n\n## Site Information\n- **Site ID**: Site 166\n- **Study**: Study 22\n- **Country**: ARG\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 6\n- **Average Issues per Subject**: 1.20\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 5 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 5\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1661", "study": "Study 22", "site": "Site 1661", "type": "site_summary", "total_subjects": 1, "total_issues": 3, "document": "# Site Report: Site 1661\n\n## Site Information\n- **Site ID**: Site 1661\n- **Study**: Study 22\n- **Country**: IND\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 3.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1666", "study": "Study 22", "site": "Site 1666", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1666\n\n## Site Information\n- **Site ID**: Site 1666\n- **Study**: Study 22\n- **Country**: IND\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1669", "study": "Study 22", "site": "Site 1669", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1669\n\n## Site Information\n- **Site ID**: Site 1669\n- **Study**: Study 22\n- **Country**: IND\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1670", "study": "Study 22", "site": "Site 1670", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1670\n\n## Site Information\n- **Site ID**: Site 1670\n- **Study**: Study 22\n- **Country**: IND\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1673", "study": "Study 22", "site": "Site 1673", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 1673\n\n## Site Information\n- **Site ID**: Site 1673\n- **Study**: Study 22\n- **Country**: MYS\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1674", "study": "Study 22", "site": "Site 1674", "type": "site_summary", "total_subjects": 1, "total_issues": 3, "document": "# Site Report: Site 1674\n\n## Site Information\n- **Site ID**: Site 1674\n- **Study**: Study 22\n- **Country**: MYS\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 3.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 3\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 168", "study": "Study 22", "site": "Site 168", "type": "site_summary", "total_subjects": 4, "total_issues": 3, "document": "# Site Report: Site 168\n\n## Site Information\n- **Site ID**: Site 168\n- **Study**: Study 22\n- **Country**: ARG\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 0.75\n- **Clean Subjects**: 1 (25.0%)\n\n## Risk Profile\n- Low Risk: 1 (25.0%)\n- Medium Risk: 3 (75.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 3\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1683", "study": "Study 22", "site": "Site 1683", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1683\n\n## Site Information\n- **Site ID**: Site 1683\n- **Study**: Study 22\n- **Country**: MYS\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1687", "study": "Study 22", "site": "Site 1687", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1687\n\n## Site Information\n- **Site ID**: Site 1687\n- **Study**: Study 22\n- **Country**: THA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1689", "study": "Study 22", "site": "Site 1689", "type": "site_summary", "total_subjects": 1, "total_issues": 11, "document": "# Site Report: Site 1689\n\n## Site Information\n- **Site ID**: Site 1689\n- **Study**: Study 22\n- **Country**: TUR\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 11\n- **Average Issues per Subject**: 11.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (100.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 31555: High risk, 11 issues\n"}
{"id": "site_Study 22_Site 169", "study": "Study 22", "site": "Site 169", "type": "site_summary", "total_subjects": 3, "total_issues": 3, "document": "# Site Report: Site 169\n\n## Site Information\n- **Site ID**: Site 169\n- **Study**: Study 22\n- **Country**: ARG\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 3 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1691", "study": "Study 22", "site": "Site 1691", "type": "site_summary", "total_subjects": 1, "total_issues": 4, "document": "# Site Report: Site 1691\n\n## Site Information\n- **Site ID**: Site 1691\n- **Study**: Study 22\n- **Country**: VNM\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 4.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1692", "study": "Study 22", "site": "Site 1692", "type": "site_summary", "total_subjects": 1, "total_issues": 8, "document": "# Site Report: Site 1692\n\n## Site Information\n- **Site ID**: Site 1692\n- **Study**: Study 22\n- **Country**: VNM\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 8\n- **Average Issues per Subject**: 8.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (100.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 31665: High risk, 8 issues\n"}
{"id": "site_Study 22_Site 1693", "study": "Study 22", "site": "Site 1693", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 1693\n\n## Site Information\n- **Site ID**: Site 1693\n- **Study**: Study 22\n- **Country**: VNM\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1695", "study": "Study 22", "site": "Site 1695", "type": "site_summary", "total_subjects": 3, "total_issues": 3, "document": "# Site Report: Site 1695\n\n## Site Information\n- **Site ID**: Site 1695\n- **Study**: Study 22\n- **Country**: BGR\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 3 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 3\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1696", "study": "Study 22", "site": "Site 1696", "type": "site_summary", "total_subjects": 2, "total_issues": 4, "document": "# Site Report: Site 1696\n\n## Site Information\n- **Site ID**: Site 1696\n- **Study**: Study 22\n- **Country**: BGR\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1699", "study": "Study 22", "site": "Site 1699", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1699\n\n## Site Information\n- **Site ID**: Site 1699\n- **Study**: Study 22\n- **Country**: BGR\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1703", "study": "Study 22", "site": "Site 1703", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 1703\n\n## Site Information\n- **Site ID**: Site 1703\n- **Study**: Study 22\n- **Country**: BGR\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 2\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1704", "study": "Study 22", "site": "Site 1704", "type": "site_summary", "total_subjects": 1, "total_issues": 4, "document": "# Site Report: Site 1704\n\n## Site Information\n- **Site ID**: Site 1704\n- **Study**: Study 22\n- **Country**: BGR\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 4.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 4\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1706", "study": "Study 22", "site": "Site 1706", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1706\n\n## Site Information\n- **Site ID**: Site 1706\n- **Study**: Study 22\n- **Country**: BGR\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1710", "study": "Study 22", "site": "Site 1710", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1710\n\n## Site Information\n- **Site ID**: Site 1710\n- **Study**: Study 22\n- **Country**: CZE\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1712", "study": "Study 22", "site": "Site 1712", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1712\n\n## Site Information\n- **Site ID**: Site 1712\n- **Study**: Study 22\n- **Country**: CZE\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1713", "study": "Study 22", "site": "Site 1713", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1713\n\n## Site Information\n- **Site ID**: Site 1713\n- **Study**: Study 22\n- **Country**: CZE\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1717", "study": "Study 22", "site": "Site 1717", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1717\n\n## Site Information\n- **Site ID**: Site 1717\n- **Study**: Study 22\n- **Country**: FRA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 172", "study": "Study 22", "site": "Site 172", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 172\n\n## Site Information\n- **Site ID**: Site 172\n- **Study**: Study 22\n- **Country**: ARG\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1722", "study": "Study 22", "site": "Site 1722", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 1722\n\n## Site Information\n- **Site ID**: Site 1722\n- **Study**: Study 22\n- **Country**: FRA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1723", "study": "Study 22", "site": "Site 1723", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1723\n\n## Site Information\n- **Site ID**: Site 1723\n- **Study**: Study 22\n- **Country**: FRA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1726", "study": "Study 22", "site": "Site 1726", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1726\n\n## Site Information\n- **Site ID**: Site 1726\n- **Study**: Study 22\n- **Country**: FRA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1728", "study": "Study 22", "site": "Site 1728", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1728\n\n## Site Information\n- **Site ID**: Site 1728\n- **Study**: Study 22\n- **Country**: FRA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1730", "study": "Study 22", "site": "Site 1730", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1730\n\n## Site Information\n- **Site ID**: Site 1730\n- **Study**: Study 22\n- **Country**: FRA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1735", "study": "Study 22", "site": "Site 1735", "type": "site_summary", "total_subjects": 2, "total_issues": 1, "document": "# Site Report: Site 1735\n\n## Site Information\n- **Site ID**: Site 1735\n- **Study**: Study 22\n- **Country**: HUN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.50\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1749", "study": "Study 22", "site": "Site 1749", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 1749\n\n## Site Information\n- **Site ID**: Site 1749\n- **Study**: Study 22\n- **Country**: ITA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1752", "study": "Study 22", "site": "Site 1752", "type": "site_summary", "total_subjects": 2, "total_issues": 7, "document": "# Site Report: Site 1752\n\n## Site Information\n- **Site ID**: Site 1752\n- **Study**: Study 22\n- **Country**: ITA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 7\n- **Average Issues per Subject**: 3.50\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (50.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 33355: High risk, 7 issues\n"}
{"id": "site_Study 22_Site 1753", "study": "Study 22", "site": "Site 1753", "type": "site_summary", "total_subjects": 1, "total_issues": 4, "document": "# Site Report: Site 1753\n\n## Site Information\n- **Site ID**: Site 1753\n- **Study**: Study 22\n- **Country**: ITA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 4.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1756", "study": "Study 22", "site": "Site 1756", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1756\n\n## Site Information\n- **Site ID**: Site 1756\n- **Study**: Study 22\n- **Country**: ITA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1759", "study": "Study 22", "site": "Site 1759", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 1759\n\n## Site Information\n- **Site ID**: Site 1759\n- **Study**: Study 22\n- **Country**: ITA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 176", "study": "Study 22", "site": "Site 176", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 176\n\n## Site Information\n- **Site ID**: Site 176\n- **Study**: Study 22\n- **Country**: ARG\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1762", "study": "Study 22", "site": "Site 1762", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1762\n\n## Site Information\n- **Site ID**: Site 1762\n- **Study**: Study 22\n- **Country**: ITA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1763", "study": "Study 22", "site": "Site 1763", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1763\n\n## Site Information\n- **Site ID**: Site 1763\n- **Study**: Study 22\n- **Country**: ITA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1769", "study": "Study 22", "site": "Site 1769", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1769\n\n## Site Information\n- **Site ID**: Site 1769\n- **Study**: Study 22\n- **Country**: NLD\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 177", "study": "Study 22", "site": "Site 177", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 177\n\n## Site Information\n- **Site ID**: Site 177\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1771", "study": "Study 22", "site": "Site 1771", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1771\n\n## Site Information\n- **Site ID**: Site 1771\n- **Study**: Study 22\n- **Country**: NLD\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1773", "study": "Study 22", "site": "Site 1773", "type": "site_summary", "total_subjects": 2, "total_issues": 3, "document": "# Site Report: Site 1773\n\n## Site Information\n- **Site ID**: Site 1773\n- **Study**: Study 22\n- **Country**: NLD\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 1.50\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 2\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1774", "study": "Study 22", "site": "Site 1774", "type": "site_summary", "total_subjects": 2, "total_issues": 1, "document": "# Site Report: Site 1774\n\n## Site Information\n- **Site ID**: Site 1774\n- **Study**: Study 22\n- **Country**: NLD\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.50\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1775", "study": "Study 22", "site": "Site 1775", "type": "site_summary", "total_subjects": 5, "total_issues": 4, "document": "# Site Report: Site 1775\n\n## Site Information\n- **Site ID**: Site 1775\n- **Study**: Study 22\n- **Country**: NLD\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 0.80\n- **Clean Subjects**: 1 (20.0%)\n\n## Risk Profile\n- Low Risk: 1 (20.0%)\n- Medium Risk: 4 (80.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1776", "study": "Study 22", "site": "Site 1776", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1776\n\n## Site Information\n- **Site ID**: Site 1776\n- **Study**: Study 22\n- **Country**: NLD\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1777", "study": "Study 22", "site": "Site 1777", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1777\n\n## Site Information\n- **Site ID**: Site 1777\n- **Study**: Study 22\n- **Country**: NLD\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1778", "study": "Study 22", "site": "Site 1778", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1778\n\n## Site Information\n- **Site ID**: Site 1778\n- **Study**: Study 22\n- **Country**: NLD\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 178", "study": "Study 22", "site": "Site 178", "type": "site_summary", "total_subjects": 2, "total_issues": 3, "document": "# Site Report: Site 178\n\n## Site Information\n- **Site ID**: Site 178\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 1.50\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1783", "study": "Study 22", "site": "Site 1783", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1783\n\n## Site Information\n- **Site ID**: Site 1783\n- **Study**: Study 22\n- **Country**: NLD\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1785", "study": "Study 22", "site": "Site 1785", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1785\n\n## Site Information\n- **Site ID**: Site 1785\n- **Study**: Study 22\n- **Country**: NLD\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1786", "study": "Study 22", "site": "Site 1786", "type": "site_summary", "total_subjects": 4, "total_issues": 4, "document": "# Site Report: Site 1786\n\n## Site Information\n- **Site ID**: Site 1786\n- **Study**: Study 22\n- **Country**: NLD\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 4 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 4\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1787", "study": "Study 22", "site": "Site 1787", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1787\n\n## Site Information\n- **Site ID**: Site 1787\n- **Study**: Study 22\n- **Country**: NLD\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1790", "study": "Study 22", "site": "Site 1790", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1790\n\n## Site Information\n- **Site ID**: Site 1790\n- **Study**: Study 22\n- **Country**: POL\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1796", "study": "Study 22", "site": "Site 1796", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1796\n\n## Site Information\n- **Site ID**: Site 1796\n- **Study**: Study 22\n- **Country**: ROU\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1798", "study": "Study 22", "site": "Site 1798", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1798\n\n## Site Information\n- **Site ID**: Site 1798\n- **Study**: Study 22\n- **Country**: ROU\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 180", "study": "Study 22", "site": "Site 180", "type": "site_summary", "total_subjects": 2, "total_issues": 16, "document": "# Site Report: Site 180\n\n## Site Information\n- **Site ID**: Site 180\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 16\n- **Average Issues per Subject**: 8.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 1 (50.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 14997: High risk, 14 issues\n"}
{"id": "site_Study 22_Site 1807", "study": "Study 22", "site": "Site 1807", "type": "site_summary", "total_subjects": 24, "total_issues": 27, "document": "# Site Report: Site 1807\n\n## Site Information\n- **Site ID**: Site 1807\n- **Study**: Study 22\n- **Country**: ROU\n- **Total Subjects**: 24\n\n## Performance Metrics\n- **Total Issues**: 27\n- **Average Issues per Subject**: 1.12\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 24 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 26\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1808", "study": "Study 22", "site": "Site 1808", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 1808\n\n## Site Information\n- **Site ID**: Site 1808\n- **Study**: Study 22\n- **Country**: ROU\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 181", "study": "Study 22", "site": "Site 181", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 181\n\n## Site Information\n- **Site ID**: Site 181\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1810", "study": "Study 22", "site": "Site 1810", "type": "site_summary", "total_subjects": 2, "total_issues": 3, "document": "# Site Report: Site 1810\n\n## Site Information\n- **Site ID**: Site 1810\n- **Study**: Study 22\n- **Country**: ROU\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 1.50\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1817", "study": "Study 22", "site": "Site 1817", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1817\n\n## Site Information\n- **Site ID**: Site 1817\n- **Study**: Study 22\n- **Country**: SVK\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 182", "study": "Study 22", "site": "Site 182", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 182\n\n## Site Information\n- **Site ID**: Site 182\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1820", "study": "Study 22", "site": "Site 1820", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1820\n\n## Site Information\n- **Site ID**: Site 1820\n- **Study**: Study 22\n- **Country**: SVK\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1824", "study": "Study 22", "site": "Site 1824", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1824\n\n## Site Information\n- **Site ID**: Site 1824\n- **Study**: Study 22\n- **Country**: SVK\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1826", "study": "Study 22", "site": "Site 1826", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1826\n\n## Site Information\n- **Site ID**: Site 1826\n- **Study**: Study 22\n- **Country**: SVK\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1827", "study": "Study 22", "site": "Site 1827", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1827\n\n## Site Information\n- **Site ID**: Site 1827\n- **Study**: Study 22\n- **Country**: SVK\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1828", "study": "Study 22", "site": "Site 1828", "type": "site_summary", "total_subjects": 4, "total_issues": 6, "document": "# Site Report: Site 1828\n\n## Site Information\n- **Site ID**: Site 1828\n- **Study**: Study 22\n- **Country**: SVK\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 6\n- **Average Issues per Subject**: 1.50\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 4 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1832", "study": "Study 22", "site": "Site 1832", "type": "site_summary", "total_subjects": 2, "total_issues": 1, "document": "# Site Report: Site 1832\n\n## Site Information\n- **Site ID**: Site 1832\n- **Study**: Study 22\n- **Country**: SVK\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.50\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1833", "study": "Study 22", "site": "Site 1833", "type": "site_summary", "total_subjects": 1, "total_issues": 2, "document": "# Site Report: Site 1833\n\n## Site Information\n- **Site ID**: Site 1833\n- **Study**: Study 22\n- **Country**: SVK\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 2\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1836", "study": "Study 22", "site": "Site 1836", "type": "site_summary", "total_subjects": 1, "total_issues": 3, "document": "# Site Report: Site 1836\n\n## Site Information\n- **Site ID**: Site 1836\n- **Study**: Study 22\n- **Country**: SVK\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 3.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1840", "study": "Study 22", "site": "Site 1840", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1840\n\n## Site Information\n- **Site ID**: Site 1840\n- **Study**: Study 22\n- **Country**: SVK\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1842", "study": "Study 22", "site": "Site 1842", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1842\n\n## Site Information\n- **Site ID**: Site 1842\n- **Study**: Study 22\n- **Country**: SVK\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1844", "study": "Study 22", "site": "Site 1844", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1844\n\n## Site Information\n- **Site ID**: Site 1844\n- **Study**: Study 22\n- **Country**: SVK\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1847", "study": "Study 22", "site": "Site 1847", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1847\n\n## Site Information\n- **Site ID**: Site 1847\n- **Study**: Study 22\n- **Country**: ESP\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1848", "study": "Study 22", "site": "Site 1848", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1848\n\n## Site Information\n- **Site ID**: Site 1848\n- **Study**: Study 22\n- **Country**: ESP\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1851", "study": "Study 22", "site": "Site 1851", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1851\n\n## Site Information\n- **Site ID**: Site 1851\n- **Study**: Study 22\n- **Country**: ESP\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1855", "study": "Study 22", "site": "Site 1855", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1855\n\n## Site Information\n- **Site ID**: Site 1855\n- **Study**: Study 22\n- **Country**: ESP\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1856", "study": "Study 22", "site": "Site 1856", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1856\n\n## Site Information\n- **Site ID**: Site 1856\n- **Study**: Study 22\n- **Country**: ESP\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1857", "study": "Study 22", "site": "Site 1857", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1857\n\n## Site Information\n- **Site ID**: Site 1857\n- **Study**: Study 22\n- **Country**: ESP\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1858", "study": "Study 22", "site": "Site 1858", "type": "site_summary", "total_subjects": 1, "total_issues": 20, "document": "# Site Report: Site 1858\n\n## Site Information\n- **Site ID**: Site 1858\n- **Study**: Study 22\n- **Country**: ESP\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 20\n- **Average Issues per Subject**: 20.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 35688: Critical risk, 20 issues\n"}
{"id": "site_Study 22_Site 1859", "study": "Study 22", "site": "Site 1859", "type": "site_summary", "total_subjects": 4, "total_issues": 4, "document": "# Site Report: Site 1859\n\n## Site Information\n- **Site ID**: Site 1859\n- **Study**: Study 22\n- **Country**: ESP\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 4 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1860", "study": "Study 22", "site": "Site 1860", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1860\n\n## Site Information\n- **Site ID**: Site 1860\n- **Study**: Study 22\n- **Country**: ESP\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1861", "study": "Study 22", "site": "Site 1861", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1861\n\n## Site Information\n- **Site ID**: Site 1861\n- **Study**: Study 22\n- **Country**: ESP\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1863", "study": "Study 22", "site": "Site 1863", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1863\n\n## Site Information\n- **Site ID**: Site 1863\n- **Study**: Study 22\n- **Country**: ESP\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1866", "study": "Study 22", "site": "Site 1866", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1866\n\n## Site Information\n- **Site ID**: Site 1866\n- **Study**: Study 22\n- **Country**: ESP\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1867", "study": "Study 22", "site": "Site 1867", "type": "site_summary", "total_subjects": 3, "total_issues": 3, "document": "# Site Report: Site 1867\n\n## Site Information\n- **Site ID**: Site 1867\n- **Study**: Study 22\n- **Country**: ESP\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 3 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1869", "study": "Study 22", "site": "Site 1869", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 1869\n\n## Site Information\n- **Site ID**: Site 1869\n- **Study**: Study 22\n- **Country**: ESP\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 187", "study": "Study 22", "site": "Site 187", "type": "site_summary", "total_subjects": 1, "total_issues": 18, "document": "# Site Report: Site 187\n\n## Site Information\n- **Site ID**: Site 187\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 18\n- **Average Issues per Subject**: 18.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 18\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 15526: Critical risk, 18 issues\n"}
{"id": "site_Study 22_Site 1871", "study": "Study 22", "site": "Site 1871", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1871\n\n## Site Information\n- **Site ID**: Site 1871\n- **Study**: Study 22\n- **Country**: ESP\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1873", "study": "Study 22", "site": "Site 1873", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1873\n\n## Site Information\n- **Site ID**: Site 1873\n- **Study**: Study 22\n- **Country**: ESP\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1877", "study": "Study 22", "site": "Site 1877", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 1877\n\n## Site Information\n- **Site ID**: Site 1877\n- **Study**: Study 22\n- **Country**: ESP\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1878", "study": "Study 22", "site": "Site 1878", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 1878\n\n## Site Information\n- **Site ID**: Site 1878\n- **Study**: Study 22\n- **Country**: ESP\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1879", "study": "Study 22", "site": "Site 1879", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1879\n\n## Site Information\n- **Site ID**: Site 1879\n- **Study**: Study 22\n- **Country**: ESP\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1881", "study": "Study 22", "site": "Site 1881", "type": "site_summary", "total_subjects": 1, "total_issues": 2, "document": "# Site Report: Site 1881\n\n## Site Information\n- **Site ID**: Site 1881\n- **Study**: Study 22\n- **Country**: ESP\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1883", "study": "Study 22", "site": "Site 1883", "type": "site_summary", "total_subjects": 1, "total_issues": 2, "document": "# Site Report: Site 1883\n\n## Site Information\n- **Site ID**: Site 1883\n- **Study**: Study 22\n- **Country**: ESP\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1884", "study": "Study 22", "site": "Site 1884", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1884\n\n## Site Information\n- **Site ID**: Site 1884\n- **Study**: Study 22\n- **Country**: ESP\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1886", "study": "Study 22", "site": "Site 1886", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1886\n\n## Site Information\n- **Site ID**: Site 1886\n- **Study**: Study 22\n- **Country**: ESP\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 189", "study": "Study 22", "site": "Site 189", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 189\n\n## Site Information\n- **Site ID**: Site 189\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1893", "study": "Study 22", "site": "Site 1893", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1893\n\n## Site Information\n- **Site ID**: Site 1893\n- **Study**: Study 22\n- **Country**: ESP\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1895", "study": "Study 22", "site": "Site 1895", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1895\n\n## Site Information\n- **Site ID**: Site 1895\n- **Study**: Study 22\n- **Country**: ESP\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1897", "study": "Study 22", "site": "Site 1897", "type": "site_summary", "total_subjects": 2, "total_issues": 4, "document": "# Site Report: Site 1897\n\n## Site Information\n- **Site ID**: Site 1897\n- **Study**: Study 22\n- **Country**: ESP\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1901", "study": "Study 22", "site": "Site 1901", "type": "site_summary", "total_subjects": 2, "total_issues": 1, "document": "# Site Report: Site 1901\n\n## Site Information\n- **Site ID**: Site 1901\n- **Study**: Study 22\n- **Country**: ESP\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.50\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1902", "study": "Study 22", "site": "Site 1902", "type": "site_summary", "total_subjects": 4, "total_issues": 2, "document": "# Site Report: Site 1902\n\n## Site Information\n- **Site ID**: Site 1902\n- **Study**: Study 22\n- **Country**: ESP\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.50\n- **Clean Subjects**: 2 (50.0%)\n\n## Risk Profile\n- Low Risk: 2 (50.0%)\n- Medium Risk: 2 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1904", "study": "Study 22", "site": "Site 1904", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1904\n\n## Site Information\n- **Site ID**: Site 1904\n- **Study**: Study 22\n- **Country**: ESP\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1906", "study": "Study 22", "site": "Site 1906", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1906\n\n## Site Information\n- **Site ID**: Site 1906\n- **Study**: Study 22\n- **Country**: CHE\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1909", "study": "Study 22", "site": "Site 1909", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1909\n\n## Site Information\n- **Site ID**: Site 1909\n- **Study**: Study 22\n- **Country**: GBR\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1910", "study": "Study 22", "site": "Site 1910", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1910\n\n## Site Information\n- **Site ID**: Site 1910\n- **Study**: Study 22\n- **Country**: GBR\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1911", "study": "Study 22", "site": "Site 1911", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 1911\n\n## Site Information\n- **Site ID**: Site 1911\n- **Study**: Study 22\n- **Country**: GBR\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1914", "study": "Study 22", "site": "Site 1914", "type": "site_summary", "total_subjects": 6, "total_issues": 16, "document": "# Site Report: Site 1914\n\n## Site Information\n- **Site ID**: Site 1914\n- **Study**: Study 22\n- **Country**: GBR\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 16\n- **Average Issues per Subject**: 2.67\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 6 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 12\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1917", "study": "Study 22", "site": "Site 1917", "type": "site_summary", "total_subjects": 5, "total_issues": 8, "document": "# Site Report: Site 1917\n\n## Site Information\n- **Site ID**: Site 1917\n- **Study**: Study 22\n- **Country**: GBR\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 8\n- **Average Issues per Subject**: 1.60\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 5 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 2\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1925", "study": "Study 22", "site": "Site 1925", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1925\n\n## Site Information\n- **Site ID**: Site 1925\n- **Study**: Study 22\n- **Country**: GBR\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1929", "study": "Study 22", "site": "Site 1929", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1929\n\n## Site Information\n- **Site ID**: Site 1929\n- **Study**: Study 22\n- **Country**: GBR\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1930", "study": "Study 22", "site": "Site 1930", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1930\n\n## Site Information\n- **Site ID**: Site 1930\n- **Study**: Study 22\n- **Country**: GBR\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1934", "study": "Study 22", "site": "Site 1934", "type": "site_summary", "total_subjects": 2, "total_issues": 3, "document": "# Site Report: Site 1934\n\n## Site Information\n- **Site ID**: Site 1934\n- **Study**: Study 22\n- **Country**: GBR\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 1.50\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 2\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1935", "study": "Study 22", "site": "Site 1935", "type": "site_summary", "total_subjects": 3, "total_issues": 3, "document": "# Site Report: Site 1935\n\n## Site Information\n- **Site ID**: Site 1935\n- **Study**: Study 22\n- **Country**: GBR\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 3 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1937", "study": "Study 22", "site": "Site 1937", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1937\n\n## Site Information\n- **Site ID**: Site 1937\n- **Study**: Study 22\n- **Country**: GBR\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 194", "study": "Study 22", "site": "Site 194", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 194\n\n## Site Information\n- **Site ID**: Site 194\n- **Study**: Study 22\n- **Country**: CHN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1944", "study": "Study 22", "site": "Site 1944", "type": "site_summary", "total_subjects": 1, "total_issues": 2, "document": "# Site Report: Site 1944\n\n## Site Information\n- **Site ID**: Site 1944\n- **Study**: Study 22\n- **Country**: GBR\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1945", "study": "Study 22", "site": "Site 1945", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1945\n\n## Site Information\n- **Site ID**: Site 1945\n- **Study**: Study 22\n- **Country**: GBR\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1946", "study": "Study 22", "site": "Site 1946", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1946\n\n## Site Information\n- **Site ID**: Site 1946\n- **Study**: Study 22\n- **Country**: GBR\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1948", "study": "Study 22", "site": "Site 1948", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 1948\n\n## Site Information\n- **Site ID**: Site 1948\n- **Study**: Study 22\n- **Country**: GBR\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1949", "study": "Study 22", "site": "Site 1949", "type": "site_summary", "total_subjects": 2, "total_issues": 1, "document": "# Site Report: Site 1949\n\n## Site Information\n- **Site ID**: Site 1949\n- **Study**: Study 22\n- **Country**: GBR\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.50\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 195", "study": "Study 22", "site": "Site 195", "type": "site_summary", "total_subjects": 1, "total_issues": 3, "document": "# Site Report: Site 195\n\n## Site Information\n- **Site ID**: Site 195\n- **Study**: Study 22\n- **Country**: CHN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 3.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1950", "study": "Study 22", "site": "Site 1950", "type": "site_summary", "total_subjects": 1, "total_issues": 4, "document": "# Site Report: Site 1950\n\n## Site Information\n- **Site ID**: Site 1950\n- **Study**: Study 22\n- **Country**: GBR\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 4.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1952", "study": "Study 22", "site": "Site 1952", "type": "site_summary", "total_subjects": 2, "total_issues": 1, "document": "# Site Report: Site 1952\n\n## Site Information\n- **Site ID**: Site 1952\n- **Study**: Study 22\n- **Country**: ARG\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.50\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1956", "study": "Study 22", "site": "Site 1956", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1956\n\n## Site Information\n- **Site ID**: Site 1956\n- **Study**: Study 22\n- **Country**: ARG\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1957", "study": "Study 22", "site": "Site 1957", "type": "site_summary", "total_subjects": 4, "total_issues": 3, "document": "# Site Report: Site 1957\n\n## Site Information\n- **Site ID**: Site 1957\n- **Study**: Study 22\n- **Country**: BRA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 0.75\n- **Clean Subjects**: 1 (25.0%)\n\n## Risk Profile\n- Low Risk: 1 (25.0%)\n- Medium Risk: 3 (75.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 196", "study": "Study 22", "site": "Site 196", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 196\n\n## Site Information\n- **Site ID**: Site 196\n- **Study**: Study 22\n- **Country**: CHN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1960", "study": "Study 22", "site": "Site 1960", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1960\n\n## Site Information\n- **Site ID**: Site 1960\n- **Study**: Study 22\n- **Country**: BRA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1963", "study": "Study 22", "site": "Site 1963", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1963\n\n## Site Information\n- **Site ID**: Site 1963\n- **Study**: Study 22\n- **Country**: CAN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1964", "study": "Study 22", "site": "Site 1964", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1964\n\n## Site Information\n- **Site ID**: Site 1964\n- **Study**: Study 22\n- **Country**: CAN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1970", "study": "Study 22", "site": "Site 1970", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 1970\n\n## Site Information\n- **Site ID**: Site 1970\n- **Study**: Study 22\n- **Country**: COL\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1974", "study": "Study 22", "site": "Site 1974", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 1974\n\n## Site Information\n- **Site ID**: Site 1974\n- **Study**: Study 22\n- **Country**: COL\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1978", "study": "Study 22", "site": "Site 1978", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1978\n\n## Site Information\n- **Site ID**: Site 1978\n- **Study**: Study 22\n- **Country**: COL\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 198", "study": "Study 22", "site": "Site 198", "type": "site_summary", "total_subjects": 2, "total_issues": 3, "document": "# Site Report: Site 198\n\n## Site Information\n- **Site ID**: Site 198\n- **Study**: Study 22\n- **Country**: CHN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 1.50\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1982", "study": "Study 22", "site": "Site 1982", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1982\n\n## Site Information\n- **Site ID**: Site 1982\n- **Study**: Study 22\n- **Country**: MEX\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1983", "study": "Study 22", "site": "Site 1983", "type": "site_summary", "total_subjects": 4, "total_issues": 4, "document": "# Site Report: Site 1983\n\n## Site Information\n- **Site ID**: Site 1983\n- **Study**: Study 22\n- **Country**: MEX\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 4 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1986", "study": "Study 22", "site": "Site 1986", "type": "site_summary", "total_subjects": 14, "total_issues": 14, "document": "# Site Report: Site 1986\n\n## Site Information\n- **Site ID**: Site 1986\n- **Study**: Study 22\n- **Country**: MEX\n- **Total Subjects**: 14\n\n## Performance Metrics\n- **Total Issues**: 14\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 14 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 14\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1989", "study": "Study 22", "site": "Site 1989", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 1989\n\n## Site Information\n- **Site ID**: Site 1989\n- **Study**: Study 22\n- **Country**: MEX\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1990", "study": "Study 22", "site": "Site 1990", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1990\n\n## Site Information\n- **Site ID**: Site 1990\n- **Study**: Study 22\n- **Country**: MEX\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1994", "study": "Study 22", "site": "Site 1994", "type": "site_summary", "total_subjects": 4, "total_issues": 4, "document": "# Site Report: Site 1994\n\n## Site Information\n- **Site ID**: Site 1994\n- **Study**: Study 22\n- **Country**: MEX\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 4 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 3\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 1998", "study": "Study 22", "site": "Site 1998", "type": "site_summary", "total_subjects": 3, "total_issues": 3, "document": "# Site Report: Site 1998\n\n## Site Information\n- **Site ID**: Site 1998\n- **Study**: Study 22\n- **Country**: MEX\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 3 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 20", "study": "Study 22", "site": "Site 20", "type": "site_summary", "total_subjects": 3, "total_issues": 5, "document": "# Site Report: Site 20\n\n## Site Information\n- **Site ID**: Site 20\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 5\n- **Average Issues per Subject**: 1.67\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 3 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 200", "study": "Study 22", "site": "Site 200", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 200\n\n## Site Information\n- **Site ID**: Site 200\n- **Study**: Study 22\n- **Country**: CHN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2002", "study": "Study 22", "site": "Site 2002", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 2002\n\n## Site Information\n- **Site ID**: Site 2002\n- **Study**: Study 22\n- **Country**: MEX\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2005", "study": "Study 22", "site": "Site 2005", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 2005\n\n## Site Information\n- **Site ID**: Site 2005\n- **Study**: Study 22\n- **Country**: MEX\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2007", "study": "Study 22", "site": "Site 2007", "type": "site_summary", "total_subjects": 3, "total_issues": 3, "document": "# Site Report: Site 2007\n\n## Site Information\n- **Site ID**: Site 2007\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 3 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2010", "study": "Study 22", "site": "Site 2010", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 2010\n\n## Site Information\n- **Site ID**: Site 2010\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2012", "study": "Study 22", "site": "Site 2012", "type": "site_summary", "total_subjects": 3, "total_issues": 7, "document": "# Site Report: Site 2012\n\n## Site Information\n- **Site ID**: Site 2012\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 7\n- **Average Issues per Subject**: 2.33\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 3 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2015", "study": "Study 22", "site": "Site 2015", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 2015\n\n## Site Information\n- **Site ID**: Site 2015\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2020", "study": "Study 22", "site": "Site 2020", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 2020\n\n## Site Information\n- **Site ID**: Site 2020\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2023", "study": "Study 22", "site": "Site 2023", "type": "site_summary", "total_subjects": 2, "total_issues": 3, "document": "# Site Report: Site 2023\n\n## Site Information\n- **Site ID**: Site 2023\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 1.50\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2024", "study": "Study 22", "site": "Site 2024", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 2024\n\n## Site Information\n- **Site ID**: Site 2024\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2029", "study": "Study 22", "site": "Site 2029", "type": "site_summary", "total_subjects": 3, "total_issues": 3, "document": "# Site Report: Site 2029\n\n## Site Information\n- **Site ID**: Site 2029\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 3 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 203", "study": "Study 22", "site": "Site 203", "type": "site_summary", "total_subjects": 1, "total_issues": 3, "document": "# Site Report: Site 203\n\n## Site Information\n- **Site ID**: Site 203\n- **Study**: Study 22\n- **Country**: CHN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 3.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2032", "study": "Study 22", "site": "Site 2032", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 2032\n\n## Site Information\n- **Site ID**: Site 2032\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2033", "study": "Study 22", "site": "Site 2033", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 2033\n\n## Site Information\n- **Site ID**: Site 2033\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2035", "study": "Study 22", "site": "Site 2035", "type": "site_summary", "total_subjects": 2, "total_issues": 1, "document": "# Site Report: Site 2035\n\n## Site Information\n- **Site ID**: Site 2035\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.50\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2042", "study": "Study 22", "site": "Site 2042", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 2042\n\n## Site Information\n- **Site ID**: Site 2042\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2044", "study": "Study 22", "site": "Site 2044", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 2044\n\n## Site Information\n- **Site ID**: Site 2044\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2047", "study": "Study 22", "site": "Site 2047", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 2047\n\n## Site Information\n- **Site ID**: Site 2047\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2048", "study": "Study 22", "site": "Site 2048", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 2048\n\n## Site Information\n- **Site ID**: Site 2048\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2052", "study": "Study 22", "site": "Site 2052", "type": "site_summary", "total_subjects": 4, "total_issues": 4, "document": "# Site Report: Site 2052\n\n## Site Information\n- **Site ID**: Site 2052\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 4 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2053", "study": "Study 22", "site": "Site 2053", "type": "site_summary", "total_subjects": 2, "total_issues": 3, "document": "# Site Report: Site 2053\n\n## Site Information\n- **Site ID**: Site 2053\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 1.50\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2056", "study": "Study 22", "site": "Site 2056", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 2056\n\n## Site Information\n- **Site ID**: Site 2056\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2059", "study": "Study 22", "site": "Site 2059", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 2059\n\n## Site Information\n- **Site ID**: Site 2059\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 206", "study": "Study 22", "site": "Site 206", "type": "site_summary", "total_subjects": 3, "total_issues": 3, "document": "# Site Report: Site 206\n\n## Site Information\n- **Site ID**: Site 206\n- **Study**: Study 22\n- **Country**: CHN\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 3 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2061", "study": "Study 22", "site": "Site 2061", "type": "site_summary", "total_subjects": 3, "total_issues": 5, "document": "# Site Report: Site 2061\n\n## Site Information\n- **Site ID**: Site 2061\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 5\n- **Average Issues per Subject**: 1.67\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 3 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 3\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2063", "study": "Study 22", "site": "Site 2063", "type": "site_summary", "total_subjects": 4, "total_issues": 40, "document": "# Site Report: Site 2063\n\n## Site Information\n- **Site ID**: Site 2063\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 40\n- **Average Issues per Subject**: 10.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 3 (75.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (25.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 38\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 42593: Critical risk, 36 issues\n"}
{"id": "site_Study 22_Site 2066", "study": "Study 22", "site": "Site 2066", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 2066\n\n## Site Information\n- **Site ID**: Site 2066\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2072", "study": "Study 22", "site": "Site 2072", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 2072\n\n## Site Information\n- **Site ID**: Site 2072\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2074", "study": "Study 22", "site": "Site 2074", "type": "site_summary", "total_subjects": 1, "total_issues": 2, "document": "# Site Report: Site 2074\n\n## Site Information\n- **Site ID**: Site 2074\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2075", "study": "Study 22", "site": "Site 2075", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 2075\n\n## Site Information\n- **Site ID**: Site 2075\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2076", "study": "Study 22", "site": "Site 2076", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 2076\n\n## Site Information\n- **Site ID**: Site 2076\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2081", "study": "Study 22", "site": "Site 2081", "type": "site_summary", "total_subjects": 2, "total_issues": 8, "document": "# Site Report: Site 2081\n\n## Site Information\n- **Site ID**: Site 2081\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 8\n- **Average Issues per Subject**: 4.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 3\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2085", "study": "Study 22", "site": "Site 2085", "type": "site_summary", "total_subjects": 2, "total_issues": 1, "document": "# Site Report: Site 2085\n\n## Site Information\n- **Site ID**: Site 2085\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.50\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2088", "study": "Study 22", "site": "Site 2088", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 2088\n\n## Site Information\n- **Site ID**: Site 2088\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2089", "study": "Study 22", "site": "Site 2089", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 2089\n\n## Site Information\n- **Site ID**: Site 2089\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 209", "study": "Study 22", "site": "Site 209", "type": "site_summary", "total_subjects": 3, "total_issues": 5, "document": "# Site Report: Site 209\n\n## Site Information\n- **Site ID**: Site 209\n- **Study**: Study 22\n- **Country**: CHN\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 5\n- **Average Issues per Subject**: 1.67\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 3 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 2\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2091", "study": "Study 22", "site": "Site 2091", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 2091\n\n## Site Information\n- **Site ID**: Site 2091\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2094", "study": "Study 22", "site": "Site 2094", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 2094\n\n## Site Information\n- **Site ID**: Site 2094\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2096", "study": "Study 22", "site": "Site 2096", "type": "site_summary", "total_subjects": 1, "total_issues": 3, "document": "# Site Report: Site 2096\n\n## Site Information\n- **Site ID**: Site 2096\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 3.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 3\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2097", "study": "Study 22", "site": "Site 2097", "type": "site_summary", "total_subjects": 2, "total_issues": 1, "document": "# Site Report: Site 2097\n\n## Site Information\n- **Site ID**: Site 2097\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.50\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 210", "study": "Study 22", "site": "Site 210", "type": "site_summary", "total_subjects": 1, "total_issues": 2, "document": "# Site Report: Site 210\n\n## Site Information\n- **Site ID**: Site 210\n- **Study**: Study 22\n- **Country**: CHN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 2\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2100", "study": "Study 22", "site": "Site 2100", "type": "site_summary", "total_subjects": 2, "total_issues": 3, "document": "# Site Report: Site 2100\n\n## Site Information\n- **Site ID**: Site 2100\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 1.50\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2104", "study": "Study 22", "site": "Site 2104", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 2104\n\n## Site Information\n- **Site ID**: Site 2104\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2105", "study": "Study 22", "site": "Site 2105", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 2105\n\n## Site Information\n- **Site ID**: Site 2105\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2110", "study": "Study 22", "site": "Site 2110", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 2110\n\n## Site Information\n- **Site ID**: Site 2110\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2112", "study": "Study 22", "site": "Site 2112", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 2112\n\n## Site Information\n- **Site ID**: Site 2112\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2117", "study": "Study 22", "site": "Site 2117", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 2117\n\n## Site Information\n- **Site ID**: Site 2117\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2119", "study": "Study 22", "site": "Site 2119", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 2119\n\n## Site Information\n- **Site ID**: Site 2119\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2120", "study": "Study 22", "site": "Site 2120", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 2120\n\n## Site Information\n- **Site ID**: Site 2120\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2125", "study": "Study 22", "site": "Site 2125", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 2125\n\n## Site Information\n- **Site ID**: Site 2125\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2131", "study": "Study 22", "site": "Site 2131", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 2131\n\n## Site Information\n- **Site ID**: Site 2131\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2137", "study": "Study 22", "site": "Site 2137", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 2137\n\n## Site Information\n- **Site ID**: Site 2137\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2138", "study": "Study 22", "site": "Site 2138", "type": "site_summary", "total_subjects": 1, "total_issues": 2, "document": "# Site Report: Site 2138\n\n## Site Information\n- **Site ID**: Site 2138\n- **Study**: Study 22\n- **Country**: CHN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 2\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 214", "study": "Study 22", "site": "Site 214", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 214\n\n## Site Information\n- **Site ID**: Site 214\n- **Study**: Study 22\n- **Country**: CHN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2141", "study": "Study 22", "site": "Site 2141", "type": "site_summary", "total_subjects": 4, "total_issues": 4, "document": "# Site Report: Site 2141\n\n## Site Information\n- **Site ID**: Site 2141\n- **Study**: Study 22\n- **Country**: HKG\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 4 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 3\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2150", "study": "Study 22", "site": "Site 2150", "type": "site_summary", "total_subjects": 1, "total_issues": 2, "document": "# Site Report: Site 2150\n\n## Site Information\n- **Site ID**: Site 2150\n- **Study**: Study 22\n- **Country**: DNK\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 2\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2151", "study": "Study 22", "site": "Site 2151", "type": "site_summary", "total_subjects": 3, "total_issues": 4, "document": "# Site Report: Site 2151\n\n## Site Information\n- **Site ID**: Site 2151\n- **Study**: Study 22\n- **Country**: EST\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 1.33\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 3 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2154", "study": "Study 22", "site": "Site 2154", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 2154\n\n## Site Information\n- **Site ID**: Site 2154\n- **Study**: Study 22\n- **Country**: EST\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 2158", "study": "Study 22", "site": "Site 2158", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 2158\n\n## Site Information\n- **Site ID**: Site 2158\n- **Study**: Study 22\n- **Country**: LVA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 219", "study": "Study 22", "site": "Site 219", "type": "site_summary", "total_subjects": 1, "total_issues": 2, "document": "# Site Report: Site 219\n\n## Site Information\n- **Site ID**: Site 219\n- **Study**: Study 22\n- **Country**: CHN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 2\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 22", "study": "Study 22", "site": "Site 22", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 22\n\n## Site Information\n- **Site ID**: Site 22\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 24", "study": "Study 22", "site": "Site 24", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 24\n\n## Site Information\n- **Site ID**: Site 24\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 28", "study": "Study 22", "site": "Site 28", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 28\n\n## Site Information\n- **Site ID**: Site 28\n- **Study**: Study 22\n- **Country**: AUS\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 292", "study": "Study 22", "site": "Site 292", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 292\n\n## Site Information\n- **Site ID**: Site 292\n- **Study**: Study 22\n- **Country**: ROU\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 308", "study": "Study 22", "site": "Site 308", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 308\n\n## Site Information\n- **Site ID**: Site 308\n- **Study**: Study 22\n- **Country**: SVK\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 317", "study": "Study 22", "site": "Site 317", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 317\n\n## Site Information\n- **Site ID**: Site 317\n- **Study**: Study 22\n- **Country**: ARG\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 318", "study": "Study 22", "site": "Site 318", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 318\n\n## Site Information\n- **Site ID**: Site 318\n- **Study**: Study 22\n- **Country**: ARG\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 323", "study": "Study 22", "site": "Site 323", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 323\n\n## Site Information\n- **Site ID**: Site 323\n- **Study**: Study 22\n- **Country**: ARG\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 330", "study": "Study 22", "site": "Site 330", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 330\n\n## Site Information\n- **Site ID**: Site 330\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 332", "study": "Study 22", "site": "Site 332", "type": "site_summary", "total_subjects": 8, "total_issues": 7, "document": "# Site Report: Site 332\n\n## Site Information\n- **Site ID**: Site 332\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 7\n- **Average Issues per Subject**: 0.88\n- **Clean Subjects**: 1 (12.5%)\n\n## Risk Profile\n- Low Risk: 1 (12.5%)\n- Medium Risk: 7 (87.5%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 5\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 333", "study": "Study 22", "site": "Site 333", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 333\n\n## Site Information\n- **Site ID**: Site 333\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 339", "study": "Study 22", "site": "Site 339", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 339\n\n## Site Information\n- **Site ID**: Site 339\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 343", "study": "Study 22", "site": "Site 343", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 343\n\n## Site Information\n- **Site ID**: Site 343\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 345", "study": "Study 22", "site": "Site 345", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 345\n\n## Site Information\n- **Site ID**: Site 345\n- **Study**: Study 22\n- **Country**: CHN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 350", "study": "Study 22", "site": "Site 350", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 350\n\n## Site Information\n- **Site ID**: Site 350\n- **Study**: Study 22\n- **Country**: ESP\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 355", "study": "Study 22", "site": "Site 355", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 355\n\n## Site Information\n- **Site ID**: Site 355\n- **Study**: Study 22\n- **Country**: POL\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 356", "study": "Study 22", "site": "Site 356", "type": "site_summary", "total_subjects": 1, "total_issues": 2, "document": "# Site Report: Site 356\n\n## Site Information\n- **Site ID**: Site 356\n- **Study**: Study 22\n- **Country**: ARG\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 2\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 357", "study": "Study 22", "site": "Site 357", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 357\n\n## Site Information\n- **Site ID**: Site 357\n- **Study**: Study 22\n- **Country**: AUS\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 359", "study": "Study 22", "site": "Site 359", "type": "site_summary", "total_subjects": 2, "total_issues": 1, "document": "# Site Report: Site 359\n\n## Site Information\n- **Site ID**: Site 359\n- **Study**: Study 22\n- **Country**: AUT\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.50\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 435", "study": "Study 22", "site": "Site 435", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 435\n\n## Site Information\n- **Site ID**: Site 435\n- **Study**: Study 22\n- **Country**: ARG\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 436", "study": "Study 22", "site": "Site 436", "type": "site_summary", "total_subjects": 1, "total_issues": 2, "document": "# Site Report: Site 436\n\n## Site Information\n- **Site ID**: Site 436\n- **Study**: Study 22\n- **Country**: ARG\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 438", "study": "Study 22", "site": "Site 438", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 438\n\n## Site Information\n- **Site ID**: Site 438\n- **Study**: Study 22\n- **Country**: ARG\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 441", "study": "Study 22", "site": "Site 441", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 441\n\n## Site Information\n- **Site ID**: Site 441\n- **Study**: Study 22\n- **Country**: ARG\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 442", "study": "Study 22", "site": "Site 442", "type": "site_summary", "total_subjects": 3, "total_issues": 2, "document": "# Site Report: Site 442\n\n## Site Information\n- **Site ID**: Site 442\n- **Study**: Study 22\n- **Country**: ARG\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.67\n- **Clean Subjects**: 1 (33.3%)\n\n## Risk Profile\n- Low Risk: 1 (33.3%)\n- Medium Risk: 2 (66.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 443", "study": "Study 22", "site": "Site 443", "type": "site_summary", "total_subjects": 3, "total_issues": 3, "document": "# Site Report: Site 443\n\n## Site Information\n- **Site ID**: Site 443\n- **Study**: Study 22\n- **Country**: ARG\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 3 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 3\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 445", "study": "Study 22", "site": "Site 445", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 445\n\n## Site Information\n- **Site ID**: Site 445\n- **Study**: Study 22\n- **Country**: ARG\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 448", "study": "Study 22", "site": "Site 448", "type": "site_summary", "total_subjects": 3, "total_issues": 3, "document": "# Site Report: Site 448\n\n## Site Information\n- **Site ID**: Site 448\n- **Study**: Study 22\n- **Country**: ARG\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 3 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 3\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 460", "study": "Study 22", "site": "Site 460", "type": "site_summary", "total_subjects": 5, "total_issues": 17, "document": "# Site Report: Site 460\n\n## Site Information\n- **Site ID**: Site 460\n- **Study**: Study 22\n- **Country**: TWN\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 17\n- **Average Issues per Subject**: 3.40\n- **Clean Subjects**: 1 (20.0%)\n\n## Risk Profile\n- Low Risk: 1 (20.0%)\n- Medium Risk: 2 (40.0%)\n- High Risk: 2 (40.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 31333: High risk, 9 issues\n- Subject 31338: High risk, 6 issues\n"}
{"id": "site_Study 22_Site 461", "study": "Study 22", "site": "Site 461", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 461\n\n## Site Information\n- **Site ID**: Site 461\n- **Study**: Study 22\n- **Country**: THA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 465", "study": "Study 22", "site": "Site 465", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 465\n\n## Site Information\n- **Site ID**: Site 465\n- **Study**: Study 22\n- **Country**: ITA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 467", "study": "Study 22", "site": "Site 467", "type": "site_summary", "total_subjects": 3, "total_issues": 3, "document": "# Site Report: Site 467\n\n## Site Information\n- **Site ID**: Site 467\n- **Study**: Study 22\n- **Country**: IND\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 3 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 3\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 469", "study": "Study 22", "site": "Site 469", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 469\n\n## Site Information\n- **Site ID**: Site 469\n- **Study**: Study 22\n- **Country**: MYS\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 473", "study": "Study 22", "site": "Site 473", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 473\n\n## Site Information\n- **Site ID**: Site 473\n- **Study**: Study 22\n- **Country**: TWN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 474", "study": "Study 22", "site": "Site 474", "type": "site_summary", "total_subjects": 2, "total_issues": 1, "document": "# Site Report: Site 474\n\n## Site Information\n- **Site ID**: Site 474\n- **Study**: Study 22\n- **Country**: TWN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.50\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 475", "study": "Study 22", "site": "Site 475", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 475\n\n## Site Information\n- **Site ID**: Site 475\n- **Study**: Study 22\n- **Country**: THA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 476", "study": "Study 22", "site": "Site 476", "type": "site_summary", "total_subjects": 1, "total_issues": 2, "document": "# Site Report: Site 476\n\n## Site Information\n- **Site ID**: Site 476\n- **Study**: Study 22\n- **Country**: THA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 478", "study": "Study 22", "site": "Site 478", "type": "site_summary", "total_subjects": 5, "total_issues": 13, "document": "# Site Report: Site 478\n\n## Site Information\n- **Site ID**: Site 478\n- **Study**: Study 22\n- **Country**: THA\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 13\n- **Average Issues per Subject**: 2.60\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 4 (80.0%)\n- High Risk: 1 (20.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 31445: High risk, 6 issues\n"}
{"id": "site_Study 22_Site 480", "study": "Study 22", "site": "Site 480", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 480\n\n## Site Information\n- **Site ID**: Site 480\n- **Study**: Study 22\n- **Country**: TUR\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 481", "study": "Study 22", "site": "Site 481", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 481\n\n## Site Information\n- **Site ID**: Site 481\n- **Study**: Study 22\n- **Country**: TUR\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 483", "study": "Study 22", "site": "Site 483", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 483\n\n## Site Information\n- **Site ID**: Site 483\n- **Study**: Study 22\n- **Country**: TUR\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 484", "study": "Study 22", "site": "Site 484", "type": "site_summary", "total_subjects": 2, "total_issues": 3, "document": "# Site Report: Site 484\n\n## Site Information\n- **Site ID**: Site 484\n- **Study**: Study 22\n- **Country**: TUR\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 1.50\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 3\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 487", "study": "Study 22", "site": "Site 487", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 487\n\n## Site Information\n- **Site ID**: Site 487\n- **Study**: Study 22\n- **Country**: TUR\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 489", "study": "Study 22", "site": "Site 489", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 489\n\n## Site Information\n- **Site ID**: Site 489\n- **Study**: Study 22\n- **Country**: TUR\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 503", "study": "Study 22", "site": "Site 503", "type": "site_summary", "total_subjects": 2, "total_issues": 4, "document": "# Site Report: Site 503\n\n## Site Information\n- **Site ID**: Site 503\n- **Study**: Study 22\n- **Country**: BEL\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 504", "study": "Study 22", "site": "Site 504", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 504\n\n## Site Information\n- **Site ID**: Site 504\n- **Study**: Study 22\n- **Country**: BEL\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 511", "study": "Study 22", "site": "Site 511", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 511\n\n## Site Information\n- **Site ID**: Site 511\n- **Study**: Study 22\n- **Country**: CZE\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 513", "study": "Study 22", "site": "Site 513", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 513\n\n## Site Information\n- **Site ID**: Site 513\n- **Study**: Study 22\n- **Country**: FRA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 518", "study": "Study 22", "site": "Site 518", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 518\n\n## Site Information\n- **Site ID**: Site 518\n- **Study**: Study 22\n- **Country**: ITA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 521", "study": "Study 22", "site": "Site 521", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 521\n\n## Site Information\n- **Site ID**: Site 521\n- **Study**: Study 22\n- **Country**: PRT\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 526", "study": "Study 22", "site": "Site 526", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 526\n\n## Site Information\n- **Site ID**: Site 526\n- **Study**: Study 22\n- **Country**: ROU\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 527", "study": "Study 22", "site": "Site 527", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 527\n\n## Site Information\n- **Site ID**: Site 527\n- **Study**: Study 22\n- **Country**: ROU\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 529", "study": "Study 22", "site": "Site 529", "type": "site_summary", "total_subjects": 4, "total_issues": 9, "document": "# Site Report: Site 529\n\n## Site Information\n- **Site ID**: Site 529\n- **Study**: Study 22\n- **Country**: ESP\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 9\n- **Average Issues per Subject**: 2.25\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 4 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 3\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 535", "study": "Study 22", "site": "Site 535", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 535\n\n## Site Information\n- **Site ID**: Site 535\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 543", "study": "Study 22", "site": "Site 543", "type": "site_summary", "total_subjects": 3, "total_issues": 8, "document": "# Site Report: Site 543\n\n## Site Information\n- **Site ID**: Site 543\n- **Study**: Study 22\n- **Country**: LTU\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 8\n- **Average Issues per Subject**: 2.67\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 3 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 546", "study": "Study 22", "site": "Site 546", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 546\n\n## Site Information\n- **Site ID**: Site 546\n- **Study**: Study 22\n- **Country**: LTU\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 547", "study": "Study 22", "site": "Site 547", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 547\n\n## Site Information\n- **Site ID**: Site 547\n- **Study**: Study 22\n- **Country**: LTU\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 548", "study": "Study 22", "site": "Site 548", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 548\n\n## Site Information\n- **Site ID**: Site 548\n- **Study**: Study 22\n- **Country**: LTU\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 554", "study": "Study 22", "site": "Site 554", "type": "site_summary", "total_subjects": 1, "total_issues": 3, "document": "# Site Report: Site 554\n\n## Site Information\n- **Site ID**: Site 554\n- **Study**: Study 22\n- **Country**: IND\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 3.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 2\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 572", "study": "Study 22", "site": "Site 572", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 572\n\n## Site Information\n- **Site ID**: Site 572\n- **Study**: Study 22\n- **Country**: FRA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 573", "study": "Study 22", "site": "Site 573", "type": "site_summary", "total_subjects": 1, "total_issues": 3, "document": "# Site Report: Site 573\n\n## Site Information\n- **Site ID**: Site 573\n- **Study**: Study 22\n- **Country**: FRA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 3.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 58", "study": "Study 22", "site": "Site 58", "type": "site_summary", "total_subjects": 2, "total_issues": 10, "document": "# Site Report: Site 58\n\n## Site Information\n- **Site ID**: Site 58\n- **Study**: Study 22\n- **Country**: PHL\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 10\n- **Average Issues per Subject**: 5.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 1 (50.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 9\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 31000: High risk, 9 issues\n"}
{"id": "site_Study 22_Site 583", "study": "Study 22", "site": "Site 583", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 583\n\n## Site Information\n- **Site ID**: Site 583\n- **Study**: Study 22\n- **Country**: NLD\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 587", "study": "Study 22", "site": "Site 587", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 587\n\n## Site Information\n- **Site ID**: Site 587\n- **Study**: Study 22\n- **Country**: CHE\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 589", "study": "Study 22", "site": "Site 589", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 589\n\n## Site Information\n- **Site ID**: Site 589\n- **Study**: Study 22\n- **Country**: GBR\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 59", "study": "Study 22", "site": "Site 59", "type": "site_summary", "total_subjects": 3, "total_issues": 4, "document": "# Site Report: Site 59\n\n## Site Information\n- **Site ID**: Site 59\n- **Study**: Study 22\n- **Country**: SGP\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 1.33\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 3 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 3\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 590", "study": "Study 22", "site": "Site 590", "type": "site_summary", "total_subjects": 1, "total_issues": 3, "document": "# Site Report: Site 590\n\n## Site Information\n- **Site ID**: Site 590\n- **Study**: Study 22\n- **Country**: GBR\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 3.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 591", "study": "Study 22", "site": "Site 591", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 591\n\n## Site Information\n- **Site ID**: Site 591\n- **Study**: Study 22\n- **Country**: GBR\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 592", "study": "Study 22", "site": "Site 592", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 592\n\n## Site Information\n- **Site ID**: Site 592\n- **Study**: Study 22\n- **Country**: GBR\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 593", "study": "Study 22", "site": "Site 593", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 593\n\n## Site Information\n- **Site ID**: Site 593\n- **Study**: Study 22\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 597", "study": "Study 22", "site": "Site 597", "type": "site_summary", "total_subjects": 3, "total_issues": 3, "document": "# Site Report: Site 597\n\n## Site Information\n- **Site ID**: Site 597\n- **Study**: Study 22\n- **Country**: IND\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 3 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 3\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 6", "study": "Study 22", "site": "Site 6", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 6\n\n## Site Information\n- **Site ID**: Site 6\n- **Study**: Study 22\n- **Country**: SGP\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 62", "study": "Study 22", "site": "Site 62", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 62\n\n## Site Information\n- **Site ID**: Site 62\n- **Study**: Study 22\n- **Country**: ZAF\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 64", "study": "Study 22", "site": "Site 64", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 64\n\n## Site Information\n- **Site ID**: Site 64\n- **Study**: Study 22\n- **Country**: ZAF\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 65", "study": "Study 22", "site": "Site 65", "type": "site_summary", "total_subjects": 4, "total_issues": 4, "document": "# Site Report: Site 65\n\n## Site Information\n- **Site ID**: Site 65\n- **Study**: Study 22\n- **Country**: ZAF\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 1 (25.0%)\n\n## Risk Profile\n- Low Risk: 1 (25.0%)\n- Medium Risk: 3 (75.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 2\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 67", "study": "Study 22", "site": "Site 67", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 67\n\n## Site Information\n- **Site ID**: Site 67\n- **Study**: Study 22\n- **Country**: ZAF\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 70", "study": "Study 22", "site": "Site 70", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 70\n\n## Site Information\n- **Site ID**: Site 70\n- **Study**: Study 22\n- **Country**: ZAF\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 73", "study": "Study 22", "site": "Site 73", "type": "site_summary", "total_subjects": 1, "total_issues": 4, "document": "# Site Report: Site 73\n\n## Site Information\n- **Site ID**: Site 73\n- **Study**: Study 22\n- **Country**: ZAF\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 4.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 4\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 777", "study": "Study 22", "site": "Site 777", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 777\n\n## Site Information\n- **Site ID**: Site 777\n- **Study**: Study 22\n- **Country**: TUR\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 781", "study": "Study 22", "site": "Site 781", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 781\n\n## Site Information\n- **Site ID**: Site 781\n- **Study**: Study 22\n- **Country**: ISR\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 813", "study": "Study 22", "site": "Site 813", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 813\n\n## Site Information\n- **Site ID**: Site 813\n- **Study**: Study 22\n- **Country**: CZE\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 815", "study": "Study 22", "site": "Site 815", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 815\n\n## Site Information\n- **Site ID**: Site 815\n- **Study**: Study 22\n- **Country**: CZE\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 817", "study": "Study 22", "site": "Site 817", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 817\n\n## Site Information\n- **Site ID**: Site 817\n- **Study**: Study 22\n- **Country**: CZE\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 824", "study": "Study 22", "site": "Site 824", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 824\n\n## Site Information\n- **Site ID**: Site 824\n- **Study**: Study 22\n- **Country**: CZE\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 859", "study": "Study 22", "site": "Site 859", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 859\n\n## Site Information\n- **Site ID**: Site 859\n- **Study**: Study 22\n- **Country**: ISR\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 861", "study": "Study 22", "site": "Site 861", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 861\n\n## Site Information\n- **Site ID**: Site 861\n- **Study**: Study 22\n- **Country**: ISR\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 865", "study": "Study 22", "site": "Site 865", "type": "site_summary", "total_subjects": 2, "total_issues": 6, "document": "# Site Report: Site 865\n\n## Site Information\n- **Site ID**: Site 865\n- **Study**: Study 22\n- **Country**: ITA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 6\n- **Average Issues per Subject**: 3.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 868", "study": "Study 22", "site": "Site 868", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 868\n\n## Site Information\n- **Site ID**: Site 868\n- **Study**: Study 22\n- **Country**: POL\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 876", "study": "Study 22", "site": "Site 876", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 876\n\n## Site Information\n- **Site ID**: Site 876\n- **Study**: Study 22\n- **Country**: PRT\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 879", "study": "Study 22", "site": "Site 879", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 879\n\n## Site Information\n- **Site ID**: Site 879\n- **Study**: Study 22\n- **Country**: PRT\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 89", "study": "Study 22", "site": "Site 89", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 89\n\n## Site Information\n- **Site ID**: Site 89\n- **Study**: Study 22\n- **Country**: POL\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 910", "study": "Study 22", "site": "Site 910", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 910\n\n## Site Information\n- **Site ID**: Site 910\n- **Study**: Study 22\n- **Country**: ARG\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 913", "study": "Study 22", "site": "Site 913", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 913\n\n## Site Information\n- **Site ID**: Site 913\n- **Study**: Study 22\n- **Country**: ARG\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 918", "study": "Study 22", "site": "Site 918", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 918\n\n## Site Information\n- **Site ID**: Site 918\n- **Study**: Study 22\n- **Country**: ARG\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 919", "study": "Study 22", "site": "Site 919", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 919\n\n## Site Information\n- **Site ID**: Site 919\n- **Study**: Study 22\n- **Country**: ARG\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 921", "study": "Study 22", "site": "Site 921", "type": "site_summary", "total_subjects": 3, "total_issues": 3, "document": "# Site Report: Site 921\n\n## Site Information\n- **Site ID**: Site 921\n- **Study**: Study 22\n- **Country**: BRA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 3 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 927", "study": "Study 22", "site": "Site 927", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 927\n\n## Site Information\n- **Site ID**: Site 927\n- **Study**: Study 22\n- **Country**: BRA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 928", "study": "Study 22", "site": "Site 928", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 928\n\n## Site Information\n- **Site ID**: Site 928\n- **Study**: Study 22\n- **Country**: BRA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 929", "study": "Study 22", "site": "Site 929", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 929\n\n## Site Information\n- **Site ID**: Site 929\n- **Study**: Study 22\n- **Country**: BRA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 931", "study": "Study 22", "site": "Site 931", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 931\n\n## Site Information\n- **Site ID**: Site 931\n- **Study**: Study 22\n- **Country**: BRA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 935", "study": "Study 22", "site": "Site 935", "type": "site_summary", "total_subjects": 2, "total_issues": 3, "document": "# Site Report: Site 935\n\n## Site Information\n- **Site ID**: Site 935\n- **Study**: Study 22\n- **Country**: BRA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 1.50\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 3\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 939", "study": "Study 22", "site": "Site 939", "type": "site_summary", "total_subjects": 3, "total_issues": 1, "document": "# Site Report: Site 939\n\n## Site Information\n- **Site ID**: Site 939\n- **Study**: Study 22\n- **Country**: BRA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.33\n- **Clean Subjects**: 2 (66.7%)\n\n## Risk Profile\n- Low Risk: 2 (66.7%)\n- Medium Risk: 1 (33.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 940", "study": "Study 22", "site": "Site 940", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 940\n\n## Site Information\n- **Site ID**: Site 940\n- **Study**: Study 22\n- **Country**: BRA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 942", "study": "Study 22", "site": "Site 942", "type": "site_summary", "total_subjects": 5, "total_issues": 7, "document": "# Site Report: Site 942\n\n## Site Information\n- **Site ID**: Site 942\n- **Study**: Study 22\n- **Country**: BRA\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 7\n- **Average Issues per Subject**: 1.40\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 5 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 3\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 944", "study": "Study 22", "site": "Site 944", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 944\n\n## Site Information\n- **Site ID**: Site 944\n- **Study**: Study 22\n- **Country**: BRA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 945", "study": "Study 22", "site": "Site 945", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 945\n\n## Site Information\n- **Site ID**: Site 945\n- **Study**: Study 22\n- **Country**: BRA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 946", "study": "Study 22", "site": "Site 946", "type": "site_summary", "total_subjects": 3, "total_issues": 2, "document": "# Site Report: Site 946\n\n## Site Information\n- **Site ID**: Site 946\n- **Study**: Study 22\n- **Country**: BRA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.67\n- **Clean Subjects**: 1 (33.3%)\n\n## Risk Profile\n- Low Risk: 1 (33.3%)\n- Medium Risk: 2 (66.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 950", "study": "Study 22", "site": "Site 950", "type": "site_summary", "total_subjects": 3, "total_issues": 3, "document": "# Site Report: Site 950\n\n## Site Information\n- **Site ID**: Site 950\n- **Study**: Study 22\n- **Country**: BRA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 3 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 3\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 951", "study": "Study 22", "site": "Site 951", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 951\n\n## Site Information\n- **Site ID**: Site 951\n- **Study**: Study 22\n- **Country**: CAN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 952", "study": "Study 22", "site": "Site 952", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 952\n\n## Site Information\n- **Site ID**: Site 952\n- **Study**: Study 22\n- **Country**: CAN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 959", "study": "Study 22", "site": "Site 959", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 959\n\n## Site Information\n- **Site ID**: Site 959\n- **Study**: Study 22\n- **Country**: CAN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 96", "study": "Study 22", "site": "Site 96", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 96\n\n## Site Information\n- **Site ID**: Site 96\n- **Study**: Study 22\n- **Country**: POL\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 2\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 960", "study": "Study 22", "site": "Site 960", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 960\n\n## Site Information\n- **Site ID**: Site 960\n- **Study**: Study 22\n- **Country**: CAN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 961", "study": "Study 22", "site": "Site 961", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 961\n\n## Site Information\n- **Site ID**: Site 961\n- **Study**: Study 22\n- **Country**: CAN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 963", "study": "Study 22", "site": "Site 963", "type": "site_summary", "total_subjects": 4, "total_issues": 4, "document": "# Site Report: Site 963\n\n## Site Information\n- **Site ID**: Site 963\n- **Study**: Study 22\n- **Country**: CAN\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 4 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 965", "study": "Study 22", "site": "Site 965", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 965\n\n## Site Information\n- **Site ID**: Site 965\n- **Study**: Study 22\n- **Country**: CAN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 966", "study": "Study 22", "site": "Site 966", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 966\n\n## Site Information\n- **Site ID**: Site 966\n- **Study**: Study 22\n- **Country**: CAN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 967", "study": "Study 22", "site": "Site 967", "type": "site_summary", "total_subjects": 3, "total_issues": 4, "document": "# Site Report: Site 967\n\n## Site Information\n- **Site ID**: Site 967\n- **Study**: Study 22\n- **Country**: CAN\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 1.33\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 3 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 4\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 970", "study": "Study 22", "site": "Site 970", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 970\n\n## Site Information\n- **Site ID**: Site 970\n- **Study**: Study 22\n- **Country**: CAN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 973", "study": "Study 22", "site": "Site 973", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 973\n\n## Site Information\n- **Site ID**: Site 973\n- **Study**: Study 22\n- **Country**: CAN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 977", "study": "Study 22", "site": "Site 977", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 977\n\n## Site Information\n- **Site ID**: Site 977\n- **Study**: Study 22\n- **Country**: CAN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 978", "study": "Study 22", "site": "Site 978", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 978\n\n## Site Information\n- **Site ID**: Site 978\n- **Study**: Study 22\n- **Country**: CAN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 98", "study": "Study 22", "site": "Site 98", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 98\n\n## Site Information\n- **Site ID**: Site 98\n- **Study**: Study 22\n- **Country**: POL\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 22_Site 997", "study": "Study 22", "site": "Site 997", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 997\n\n## Site Information\n- **Site ID**: Site 997\n- **Study**: Study 22\n- **Country**: COL\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 23_Site 109", "study": "Study 23", "site": "Site 109", "type": "site_summary", "total_subjects": 56, "total_issues": 1, "document": "# Site Report: Site 109\n\n## Site Information\n- **Site ID**: Site 109\n- **Study**: Study 23\n- **Country**: COD\n- **Total Subjects**: 56\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.02\n- **Clean Subjects**: 55 (98.2%)\n\n## Risk Profile\n- Low Risk: 55 (98.2%)\n- Medium Risk: 1 (1.8%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 23_Site 11", "study": "Study 23", "site": "Site 11", "type": "site_summary", "total_subjects": 89, "total_issues": 3, "document": "# Site Report: Site 11\n\n## Site Information\n- **Site ID**: Site 11\n- **Study**: Study 23\n- **Country**: UGA\n- **Total Subjects**: 89\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 0.03\n- **Clean Subjects**: 88 (98.9%)\n\n## Risk Profile\n- Low Risk: 88 (98.9%)\n- Medium Risk: 1 (1.1%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 3\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 23_Site 113", "study": "Study 23", "site": "Site 113", "type": "site_summary", "total_subjects": 39, "total_issues": 1, "document": "# Site Report: Site 113\n\n## Site Information\n- **Site ID**: Site 113\n- **Study**: Study 23\n- **Country**: RWA\n- **Total Subjects**: 39\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.03\n- **Clean Subjects**: 38 (97.4%)\n\n## Risk Profile\n- Low Risk: 38 (97.4%)\n- Medium Risk: 1 (2.6%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 23_Site 124", "study": "Study 23", "site": "Site 124", "type": "site_summary", "total_subjects": 10, "total_issues": 0, "document": "# Site Report: Site 124\n\n## Site Information\n- **Site ID**: Site 124\n- **Study**: Study 23\n- **Country**: TZA\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 10 (100.0%)\n\n## Risk Profile\n- Low Risk: 10 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 23_Site 125", "study": "Study 23", "site": "Site 125", "type": "site_summary", "total_subjects": 37, "total_issues": 6, "document": "# Site Report: Site 125\n\n## Site Information\n- **Site ID**: Site 125\n- **Study**: Study 23\n- **Country**: TZA\n- **Total Subjects**: 37\n\n## Performance Metrics\n- **Total Issues**: 6\n- **Average Issues per Subject**: 0.16\n- **Clean Subjects**: 36 (97.3%)\n\n## Risk Profile\n- Low Risk: 36 (97.3%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (2.7%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 6\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1081: High risk, 6 issues\n"}
{"id": "site_Study 23_Site 126", "study": "Study 23", "site": "Site 126", "type": "site_summary", "total_subjects": 14, "total_issues": 0, "document": "# Site Report: Site 126\n\n## Site Information\n- **Site ID**: Site 126\n- **Study**: Study 23\n- **Country**: TZA\n- **Total Subjects**: 14\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 14 (100.0%)\n\n## Risk Profile\n- Low Risk: 14 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 23_Site 1673", "study": "Study 23", "site": "Site 1673", "type": "site_summary", "total_subjects": 56, "total_issues": 0, "document": "# Site Report: Site 1673\n\n## Site Information\n- **Site ID**: Site 1673\n- **Study**: Study 23\n- **Country**: GHA\n- **Total Subjects**: 56\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 56 (100.0%)\n\n## Risk Profile\n- Low Risk: 56 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 23_Site 2", "study": "Study 23", "site": "Site 2", "type": "site_summary", "total_subjects": 133, "total_issues": 27, "document": "# Site Report: Site 2\n\n## Site Information\n- **Site ID**: Site 2\n- **Study**: Study 23\n- **Country**: BFA\n- **Total Subjects**: 133\n\n## Performance Metrics\n- **Total Issues**: 27\n- **Average Issues per Subject**: 0.20\n- **Clean Subjects**: 125 (94.0%)\n\n## Risk Profile\n- Low Risk: 125 (94.0%)\n- Medium Risk: 7 (5.3%)\n- High Risk: 1 (0.8%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 27\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 99: High risk, 6 issues\n"}
{"id": "site_Study 23_Site 2161", "study": "Study 23", "site": "Site 2161", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 2161\n\n## Site Information\n- **Site ID**: Site 2161\n- **Study**: Study 23\n- **Country**: IND\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 23_Site 2162", "study": "Study 23", "site": "Site 2162", "type": "site_summary", "total_subjects": 8, "total_issues": 0, "document": "# Site Report: Site 2162\n\n## Site Information\n- **Site ID**: Site 2162\n- **Study**: Study 23\n- **Country**: NER\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 8 (100.0%)\n\n## Risk Profile\n- Low Risk: 8 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 23_Site 259", "study": "Study 23", "site": "Site 259", "type": "site_summary", "total_subjects": 22, "total_issues": 0, "document": "# Site Report: Site 259\n\n## Site Information\n- **Site ID**: Site 259\n- **Study**: Study 23\n- **Country**: BFA\n- **Total Subjects**: 22\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 22 (100.0%)\n\n## Risk Profile\n- Low Risk: 22 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 23_Site 28", "study": "Study 23", "site": "Site 28", "type": "site_summary", "total_subjects": 19, "total_issues": 0, "document": "# Site Report: Site 28\n\n## Site Information\n- **Site ID**: Site 28\n- **Study**: Study 23\n- **Country**: BFA\n- **Total Subjects**: 19\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 19 (100.0%)\n\n## Risk Profile\n- Low Risk: 19 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 23_Site 3", "study": "Study 23", "site": "Site 3", "type": "site_summary", "total_subjects": 137, "total_issues": 187, "document": "# Site Report: Site 3\n\n## Site Information\n- **Site ID**: Site 3\n- **Study**: Study 23\n- **Country**: BFA\n- **Total Subjects**: 137\n\n## Performance Metrics\n- **Total Issues**: 187\n- **Average Issues per Subject**: 1.36\n- **Clean Subjects**: 76 (55.5%)\n\n## Risk Profile\n- Low Risk: 76 (55.5%)\n- Medium Risk: 57 (41.6%)\n- High Risk: 4 (2.9%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 187\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 4029: High risk, 6 issues\n- Subject 46051: High risk, 8 issues\n- Subject 4834: High risk, 6 issues\n- Subject 778: High risk, 6 issues\n"}
{"id": "site_Study 23_Site 353", "study": "Study 23", "site": "Site 353", "type": "site_summary", "total_subjects": 17, "total_issues": 0, "document": "# Site Report: Site 353\n\n## Site Information\n- **Site ID**: Site 353\n- **Study**: Study 23\n- **Country**: ZMB\n- **Total Subjects**: 17\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 17 (100.0%)\n\n## Risk Profile\n- Low Risk: 17 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 23_Site 4", "study": "Study 23", "site": "Site 4", "type": "site_summary", "total_subjects": 99, "total_issues": 13, "document": "# Site Report: Site 4\n\n## Site Information\n- **Site ID**: Site 4\n- **Study**: Study 23\n- **Country**: BFA\n- **Total Subjects**: 99\n\n## Performance Metrics\n- **Total Issues**: 13\n- **Average Issues per Subject**: 0.13\n- **Clean Subjects**: 90 (90.9%)\n\n## Risk Profile\n- Low Risk: 90 (90.9%)\n- Medium Risk: 9 (9.1%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 13\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 23_Site 417", "study": "Study 23", "site": "Site 417", "type": "site_summary", "total_subjects": 30, "total_issues": 0, "document": "# Site Report: Site 417\n\n## Site Information\n- **Site ID**: Site 417\n- **Study**: Study 23\n- **Country**: RWA\n- **Total Subjects**: 30\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 30 (100.0%)\n\n## Risk Profile\n- Low Risk: 30 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 23_Site 466", "study": "Study 23", "site": "Site 466", "type": "site_summary", "total_subjects": 22, "total_issues": 0, "document": "# Site Report: Site 466\n\n## Site Information\n- **Site ID**: Site 466\n- **Study**: Study 23\n- **Country**: COD\n- **Total Subjects**: 22\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 22 (100.0%)\n\n## Risk Profile\n- Low Risk: 22 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 23_Site 467", "study": "Study 23", "site": "Site 467", "type": "site_summary", "total_subjects": 75, "total_issues": 0, "document": "# Site Report: Site 467\n\n## Site Information\n- **Site ID**: Site 467\n- **Study**: Study 23\n- **Country**: COD\n- **Total Subjects**: 75\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 75 (100.0%)\n\n## Risk Profile\n- Low Risk: 75 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 23_Site 468", "study": "Study 23", "site": "Site 468", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 468\n\n## Site Information\n- **Site ID**: Site 468\n- **Study**: Study 23\n- **Country**: COD\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 23_Site 469", "study": "Study 23", "site": "Site 469", "type": "site_summary", "total_subjects": 114, "total_issues": 18, "document": "# Site Report: Site 469\n\n## Site Information\n- **Site ID**: Site 469\n- **Study**: Study 23\n- **Country**: GHA\n- **Total Subjects**: 114\n\n## Performance Metrics\n- **Total Issues**: 18\n- **Average Issues per Subject**: 0.16\n- **Clean Subjects**: 109 (95.6%)\n\n## Risk Profile\n- Low Risk: 109 (95.6%)\n- Medium Risk: 4 (3.5%)\n- High Risk: 1 (0.9%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 18\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 46642: High risk, 6 issues\n"}
{"id": "site_Study 23_Site 47", "study": "Study 23", "site": "Site 47", "type": "site_summary", "total_subjects": 57, "total_issues": 1, "document": "# Site Report: Site 47\n\n## Site Information\n- **Site ID**: Site 47\n- **Study**: Study 23\n- **Country**: COD\n- **Total Subjects**: 57\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.02\n- **Clean Subjects**: 56 (98.2%)\n\n## Risk Profile\n- Low Risk: 56 (98.2%)\n- Medium Risk: 1 (1.8%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 1\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 23_Site 48", "study": "Study 23", "site": "Site 48", "type": "site_summary", "total_subjects": 26, "total_issues": 0, "document": "# Site Report: Site 48\n\n## Site Information\n- **Site ID**: Site 48\n- **Study**: Study 23\n- **Country**: GAB\n- **Total Subjects**: 26\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 26 (100.0%)\n\n## Risk Profile\n- Low Risk: 26 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 23_Site 50", "study": "Study 23", "site": "Site 50", "type": "site_summary", "total_subjects": 61, "total_issues": 0, "document": "# Site Report: Site 50\n\n## Site Information\n- **Site ID**: Site 50\n- **Study**: Study 23\n- **Country**: GAB\n- **Total Subjects**: 61\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 61 (100.0%)\n\n## Risk Profile\n- Low Risk: 61 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 23_Site 502", "study": "Study 23", "site": "Site 502", "type": "site_summary", "total_subjects": 44, "total_issues": 9, "document": "# Site Report: Site 502\n\n## Site Information\n- **Site ID**: Site 502\n- **Study**: Study 23\n- **Country**: RWA\n- **Total Subjects**: 44\n\n## Performance Metrics\n- **Total Issues**: 9\n- **Average Issues per Subject**: 0.20\n- **Clean Subjects**: 40 (90.9%)\n\n## Risk Profile\n- Low Risk: 40 (90.9%)\n- Medium Risk: 4 (9.1%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 9\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 23_Site 504", "study": "Study 23", "site": "Site 504", "type": "site_summary", "total_subjects": 40, "total_issues": 0, "document": "# Site Report: Site 504\n\n## Site Information\n- **Site ID**: Site 504\n- **Study**: Study 23\n- **Country**: RWA\n- **Total Subjects**: 40\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 40 (100.0%)\n\n## Risk Profile\n- Low Risk: 40 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 23_Site 506", "study": "Study 23", "site": "Site 506", "type": "site_summary", "total_subjects": 44, "total_issues": 7, "document": "# Site Report: Site 506\n\n## Site Information\n- **Site ID**: Site 506\n- **Study**: Study 23\n- **Country**: RWA\n- **Total Subjects**: 44\n\n## Performance Metrics\n- **Total Issues**: 7\n- **Average Issues per Subject**: 0.16\n- **Clean Subjects**: 41 (93.2%)\n\n## Risk Profile\n- Low Risk: 41 (93.2%)\n- Medium Risk: 3 (6.8%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 7\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 23_Site 61", "study": "Study 23", "site": "Site 61", "type": "site_summary", "total_subjects": 42, "total_issues": 0, "document": "# Site Report: Site 61\n\n## Site Information\n- **Site ID**: Site 61\n- **Study**: Study 23\n- **Country**: CIV\n- **Total Subjects**: 42\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 42 (100.0%)\n\n## Risk Profile\n- Low Risk: 42 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 23_Site 62", "study": "Study 23", "site": "Site 62", "type": "site_summary", "total_subjects": 38, "total_issues": 1, "document": "# Site Report: Site 62\n\n## Site Information\n- **Site ID**: Site 62\n- **Study**: Study 23\n- **Country**: CIV\n- **Total Subjects**: 38\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.03\n- **Clean Subjects**: 37 (97.4%)\n\n## Risk Profile\n- Low Risk: 37 (97.4%)\n- Medium Risk: 1 (2.6%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 23_Site 63", "study": "Study 23", "site": "Site 63", "type": "site_summary", "total_subjects": 96, "total_issues": 0, "document": "# Site Report: Site 63\n\n## Site Information\n- **Site ID**: Site 63\n- **Study**: Study 23\n- **Country**: CIV\n- **Total Subjects**: 96\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 96 (100.0%)\n\n## Risk Profile\n- Low Risk: 96 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 5\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 23_Site 64", "study": "Study 23", "site": "Site 64", "type": "site_summary", "total_subjects": 80, "total_issues": 0, "document": "# Site Report: Site 64\n\n## Site Information\n- **Site ID**: Site 64\n- **Study**: Study 23\n- **Country**: CIV\n- **Total Subjects**: 80\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 80 (100.0%)\n\n## Risk Profile\n- Low Risk: 80 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 23_Site 7", "study": "Study 23", "site": "Site 7", "type": "site_summary", "total_subjects": 53, "total_issues": 60, "document": "# Site Report: Site 7\n\n## Site Information\n- **Site ID**: Site 7\n- **Study**: Study 23\n- **Country**: KEN\n- **Total Subjects**: 53\n\n## Performance Metrics\n- **Total Issues**: 60\n- **Average Issues per Subject**: 1.13\n- **Clean Subjects**: 38 (71.7%)\n\n## Risk Profile\n- Low Risk: 38 (71.7%)\n- Medium Risk: 11 (20.8%)\n- High Risk: 4 (7.5%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 60\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 47045: High risk, 6 issues\n- Subject 47055: High risk, 6 issues\n- Subject 47056: High risk, 9 issues\n- Subject 6213: High risk, 6 issues\n"}
{"id": "site_Study 23_Site 780", "study": "Study 23", "site": "Site 780", "type": "site_summary", "total_subjects": 45, "total_issues": 12, "document": "# Site Report: Site 780\n\n## Site Information\n- **Site ID**: Site 780\n- **Study**: Study 23\n- **Country**: ZMB\n- **Total Subjects**: 45\n\n## Performance Metrics\n- **Total Issues**: 12\n- **Average Issues per Subject**: 0.27\n- **Clean Subjects**: 42 (93.3%)\n\n## Risk Profile\n- Low Risk: 42 (93.3%)\n- Medium Risk: 2 (4.4%)\n- High Risk: 1 (2.2%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 12\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 47518: High risk, 6 issues\n"}
{"id": "site_Study 23_Site 79", "study": "Study 23", "site": "Site 79", "type": "site_summary", "total_subjects": 71, "total_issues": 89, "document": "# Site Report: Site 79\n\n## Site Information\n- **Site ID**: Site 79\n- **Study**: Study 23\n- **Country**: KEN\n- **Total Subjects**: 71\n\n## Performance Metrics\n- **Total Issues**: 89\n- **Average Issues per Subject**: 1.25\n- **Clean Subjects**: 55 (77.5%)\n\n## Risk Profile\n- Low Risk: 55 (77.5%)\n- Medium Risk: 7 (9.9%)\n- High Risk: 9 (12.7%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 88\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 46912: High risk, 6 issues\n- Subject 46922: High risk, 6 issues\n- Subject 46935: High risk, 6 issues\n- Subject 46937: High risk, 9 issues\n- Subject 46949: High risk, 11 issues\n- Subject 46951: High risk, 6 issues\n- Subject 46969: High risk, 12 issues\n- Subject 46993: High risk, 6 issues\n- Subject 6175: High risk, 6 issues\n"}
{"id": "site_Study 23_Site 8", "study": "Study 23", "site": "Site 8", "type": "site_summary", "total_subjects": 60, "total_issues": 13, "document": "# Site Report: Site 8\n\n## Site Information\n- **Site ID**: Site 8\n- **Study**: Study 23\n- **Country**: KEN\n- **Total Subjects**: 60\n\n## Performance Metrics\n- **Total Issues**: 13\n- **Average Issues per Subject**: 0.22\n- **Clean Subjects**: 56 (93.3%)\n\n## Risk Profile\n- Low Risk: 56 (93.3%)\n- Medium Risk: 3 (5.0%)\n- High Risk: 1 (1.7%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 12\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 6227: High risk, 6 issues\n"}
{"id": "site_Study 23_Site 9", "study": "Study 23", "site": "Site 9", "type": "site_summary", "total_subjects": 112, "total_issues": 9, "document": "# Site Report: Site 9\n\n## Site Information\n- **Site ID**: Site 9\n- **Study**: Study 23\n- **Country**: MLI\n- **Total Subjects**: 112\n\n## Performance Metrics\n- **Total Issues**: 9\n- **Average Issues per Subject**: 0.08\n- **Clean Subjects**: 110 (98.2%)\n\n## Risk Profile\n- Low Risk: 110 (98.2%)\n- Medium Risk: 1 (0.9%)\n- High Risk: 1 (0.9%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 9\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 47204: High risk, 6 issues\n"}
{"id": "site_Study 24_Site 1", "study": "Study 24", "site": "Site 1", "type": "site_summary", "total_subjects": 2, "total_issues": 62, "document": "# Site Report: Site 1\n\n## Site Information\n- **Site ID**: Site 1\n- **Study**: Study 24\n- **Country**: AUS\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 62\n- **Average Issues per Subject**: 31.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 2 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 59\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 169: Critical risk, 20 issues\n- Subject 752: Critical risk, 42 issues\n"}
{"id": "site_Study 24_Site 10", "study": "Study 24", "site": "Site 10", "type": "site_summary", "total_subjects": 7, "total_issues": 130, "document": "# Site Report: Site 10\n\n## Site Information\n- **Site ID**: Site 10\n- **Study**: Study 24\n- **Country**: HKG\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 130\n- **Average Issues per Subject**: 18.57\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 4 (57.1%)\n- High Risk: 1 (14.3%)\n- Critical Risk: 2 (28.6%)\n\n## Issue Breakdown\n- Open EDRR Issues: 3\n- Safety Discrepancies: 4\n- Missing Pages: 0\n- Missing Labs: 120\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\n- Subject 17: Critical risk, 92 issues\n- Subject 18: Critical risk, 21 issues\n- Subject 854: High risk, 7 issues\n"}
{"id": "site_Study 24_Site 1018", "study": "Study 24", "site": "Site 1018", "type": "site_summary", "total_subjects": 3, "total_issues": 141, "document": "# Site Report: Site 1018\n\n## Site Information\n- **Site ID**: Site 1018\n- **Study**: Study 24\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 141\n- **Average Issues per Subject**: 47.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 3 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 135\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 14934: Critical risk, 47 issues\n- Subject 14935: Critical risk, 44 issues\n- Subject 14936: Critical risk, 50 issues\n"}
{"id": "site_Study 24_Site 1034", "study": "Study 24", "site": "Site 1034", "type": "site_summary", "total_subjects": 6, "total_issues": 95, "document": "# Site Report: Site 1034\n\n## Site Information\n- **Site ID**: Site 1034\n- **Study**: Study 24\n- **Country**: USA\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 95\n- **Average Issues per Subject**: 15.83\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (33.3%)\n- High Risk: 1 (16.7%)\n- Critical Risk: 3 (50.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 88\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\n- Subject 15654: Critical risk, 32 issues\n- Subject 15656: High risk, 6 issues\n- Subject 15657: Critical risk, 16 issues\n- Subject 15658: Critical risk, 34 issues\n"}
{"id": "site_Study 24_Site 1037", "study": "Study 24", "site": "Site 1037", "type": "site_summary", "total_subjects": 1, "total_issues": 72, "document": "# Site Report: Site 1037\n\n## Site Information\n- **Site ID**: Site 1037\n- **Study**: Study 24\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 72\n- **Average Issues per Subject**: 72.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 68\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 15713: Critical risk, 72 issues\n"}
{"id": "site_Study 24_Site 1042", "study": "Study 24", "site": "Site 1042", "type": "site_summary", "total_subjects": 1, "total_issues": 5, "document": "# Site Report: Site 1042\n\n## Site Information\n- **Site ID**: Site 1042\n- **Study**: Study 24\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 5\n- **Average Issues per Subject**: 5.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 1\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 24_Site 110", "study": "Study 24", "site": "Site 110", "type": "site_summary", "total_subjects": 1, "total_issues": 48, "document": "# Site Report: Site 110\n\n## Site Information\n- **Site ID**: Site 110\n- **Study**: Study 24\n- **Country**: HKG\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 48\n- **Average Issues per Subject**: 48.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 47\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 893: Critical risk, 48 issues\n"}
{"id": "site_Study 24_Site 113", "study": "Study 24", "site": "Site 113", "type": "site_summary", "total_subjects": 18, "total_issues": 685, "document": "# Site Report: Site 113\n\n## Site Information\n- **Site ID**: Site 113\n- **Study**: Study 24\n- **Country**: CHN\n- **Total Subjects**: 18\n\n## Performance Metrics\n- **Total Issues**: 685\n- **Average Issues per Subject**: 38.06\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (5.6%)\n- High Risk: 1 (5.6%)\n- Critical Risk: 16 (88.9%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 33\n- Missing Pages: 0\n- Missing Labs: 643\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 6238: Critical risk, 35 issues\n- Subject 6239: Critical risk, 37 issues\n- Subject 6241: High risk, 6 issues\n- Subject 6242: Critical risk, 35 issues\n- Subject 6243: Critical risk, 38 issues\n- Subject 6244: Critical risk, 18 issues\n- Subject 6245: Critical risk, 36 issues\n- Subject 6246: Critical risk, 35 issues\n- Subject 6247: Critical risk, 40 issues\n- Subject 6248: Critical risk, 36 issues\n"}
{"id": "site_Study 24_Site 1645", "study": "Study 24", "site": "Site 1645", "type": "site_summary", "total_subjects": 2, "total_issues": 41, "document": "# Site Report: Site 1645\n\n## Site Information\n- **Site ID**: Site 1645\n- **Study**: Study 24\n- **Country**: IND\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 41\n- **Average Issues per Subject**: 20.50\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (50.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 39\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 30314: Critical risk, 36 issues\n"}
{"id": "site_Study 24_Site 1646", "study": "Study 24", "site": "Site 1646", "type": "site_summary", "total_subjects": 3, "total_issues": 116, "document": "# Site Report: Site 1646\n\n## Site Information\n- **Site ID**: Site 1646\n- **Study**: Study 24\n- **Country**: IND\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 116\n- **Average Issues per Subject**: 38.67\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 3 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 116\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 30346: Critical risk, 47 issues\n- Subject 30347: Critical risk, 34 issues\n- Subject 30348: Critical risk, 35 issues\n"}
{"id": "site_Study 24_Site 1648", "study": "Study 24", "site": "Site 1648", "type": "site_summary", "total_subjects": 5, "total_issues": 29, "document": "# Site Report: Site 1648\n\n## Site Information\n- **Site ID**: Site 1648\n- **Study**: Study 24\n- **Country**: IND\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 29\n- **Average Issues per Subject**: 5.80\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (40.0%)\n- High Risk: 3 (60.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 24\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\n- Subject 30393: High risk, 7 issues\n- Subject 30394: High risk, 7 issues\n- Subject 30399: High risk, 10 issues\n"}
{"id": "site_Study 24_Site 1673", "study": "Study 24", "site": "Site 1673", "type": "site_summary", "total_subjects": 2, "total_issues": 10, "document": "# Site Report: Site 1673\n\n## Site Information\n- **Site ID**: Site 1673\n- **Study**: Study 24\n- **Country**: TWN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 10\n- **Average Issues per Subject**: 5.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 6\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 24_Site 1674", "study": "Study 24", "site": "Site 1674", "type": "site_summary", "total_subjects": 9, "total_issues": 77, "document": "# Site Report: Site 1674\n\n## Site Information\n- **Site ID**: Site 1674\n- **Study**: Study 24\n- **Country**: TWN\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 77\n- **Average Issues per Subject**: 8.56\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 4 (44.4%)\n- High Risk: 4 (44.4%)\n- Critical Risk: 1 (11.1%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 72\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\n- Subject 30856: High risk, 12 issues\n- Subject 30857: High risk, 6 issues\n- Subject 30860: High risk, 7 issues\n- Subject 30862: Critical risk, 31 issues\n- Subject 30863: High risk, 7 issues\n"}
{"id": "site_Study 24_Site 1675", "study": "Study 24", "site": "Site 1675", "type": "site_summary", "total_subjects": 5, "total_issues": 53, "document": "# Site Report: Site 1675\n\n## Site Information\n- **Site ID**: Site 1675\n- **Study**: Study 24\n- **Country**: TWN\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 53\n- **Average Issues per Subject**: 10.60\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 5 (100.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 20\n- Missing Pages: 0\n- Missing Labs: 29\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 30870: High risk, 13 issues\n- Subject 30871: High risk, 14 issues\n- Subject 30873: High risk, 9 issues\n- Subject 30874: High risk, 11 issues\n- Subject 30875: High risk, 6 issues\n"}
{"id": "site_Study 24_Site 1676", "study": "Study 24", "site": "Site 1676", "type": "site_summary", "total_subjects": 5, "total_issues": 19, "document": "# Site Report: Site 1676\n\n## Site Information\n- **Site ID**: Site 1676\n- **Study**: Study 24\n- **Country**: TWN\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 19\n- **Average Issues per Subject**: 3.80\n- **Clean Subjects**: 1 (20.0%)\n\n## Risk Profile\n- Low Risk: 1 (20.0%)\n- Medium Risk: 2 (40.0%)\n- High Risk: 2 (40.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 16\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 30884: High risk, 6 issues\n- Subject 30886: High risk, 7 issues\n"}
{"id": "site_Study 24_Site 178", "study": "Study 24", "site": "Site 178", "type": "site_summary", "total_subjects": 5, "total_issues": 133, "document": "# Site Report: Site 178\n\n## Site Information\n- **Site ID**: Site 178\n- **Study**: Study 24\n- **Country**: USA\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 133\n- **Average Issues per Subject**: 26.60\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (20.0%)\n- High Risk: 1 (20.0%)\n- Critical Risk: 3 (60.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 133\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1600: Critical risk, 39 issues\n- Subject 3393: Critical risk, 51 issues\n- Subject 3394: High risk, 12 issues\n- Subject 40403: Critical risk, 26 issues\n"}
{"id": "site_Study 24_Site 1791", "study": "Study 24", "site": "Site 1791", "type": "site_summary", "total_subjects": 3, "total_issues": 5, "document": "# Site Report: Site 1791\n\n## Site Information\n- **Site ID**: Site 1791\n- **Study**: Study 24\n- **Country**: ISR\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 5\n- **Average Issues per Subject**: 1.67\n- **Clean Subjects**: 1 (33.3%)\n\n## Risk Profile\n- Low Risk: 1 (33.3%)\n- Medium Risk: 2 (66.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 4\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 24_Site 1962", "study": "Study 24", "site": "Site 1962", "type": "site_summary", "total_subjects": 1, "total_issues": 27, "document": "# Site Report: Site 1962\n\n## Site Information\n- **Site ID**: Site 1962\n- **Study**: Study 24\n- **Country**: CAN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 27\n- **Average Issues per Subject**: 27.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 25\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 38937: Critical risk, 27 issues\n"}
{"id": "site_Study 24_Site 2013", "study": "Study 24", "site": "Site 2013", "type": "site_summary", "total_subjects": 4, "total_issues": 396, "document": "# Site Report: Site 2013\n\n## Site Information\n- **Site ID**: Site 2013\n- **Study**: Study 24\n- **Country**: USA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 396\n- **Average Issues per Subject**: 99.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 4 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 392\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\n- Subject 41288: Critical risk, 249 issues\n- Subject 41289: Critical risk, 62 issues\n- Subject 41291: Critical risk, 26 issues\n- Subject 41293: Critical risk, 59 issues\n"}
{"id": "site_Study 24_Site 2014", "study": "Study 24", "site": "Site 2014", "type": "site_summary", "total_subjects": 1, "total_issues": 26, "document": "# Site Report: Site 2014\n\n## Site Information\n- **Site ID**: Site 2014\n- **Study**: Study 24\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 26\n- **Average Issues per Subject**: 26.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 26\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 41295: Critical risk, 26 issues\n"}
{"id": "site_Study 24_Site 2015", "study": "Study 24", "site": "Site 2015", "type": "site_summary", "total_subjects": 7, "total_issues": 416, "document": "# Site Report: Site 2015\n\n## Site Information\n- **Site ID**: Site 2015\n- **Study**: Study 24\n- **Country**: USA\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 416\n- **Average Issues per Subject**: 59.43\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (14.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 6 (85.7%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 411\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 41299: Critical risk, 210 issues\n- Subject 41301: Critical risk, 76 issues\n- Subject 41302: Critical risk, 27 issues\n- Subject 41303: Critical risk, 33 issues\n- Subject 41304: Critical risk, 34 issues\n- Subject 41305: Critical risk, 34 issues\n"}
{"id": "site_Study 24_Site 2030", "study": "Study 24", "site": "Site 2030", "type": "site_summary", "total_subjects": 6, "total_issues": 290, "document": "# Site Report: Site 2030\n\n## Site Information\n- **Site ID**: Site 2030\n- **Study**: Study 24\n- **Country**: USA\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 290\n- **Average Issues per Subject**: 48.33\n- **Clean Subjects**: 1 (16.7%)\n\n## Risk Profile\n- Low Risk: 1 (16.7%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 5 (83.3%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 283\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 41801: Critical risk, 33 issues\n- Subject 41802: Critical risk, 94 issues\n- Subject 41803: Critical risk, 44 issues\n- Subject 41804: Critical risk, 85 issues\n- Subject 41805: Critical risk, 34 issues\n"}
{"id": "site_Study 24_Site 2043", "study": "Study 24", "site": "Site 2043", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 2043\n\n## Site Information\n- **Site ID**: Site 2043\n- **Study**: Study 24\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 24_Site 2161", "study": "Study 24", "site": "Site 2161", "type": "site_summary", "total_subjects": 4, "total_issues": 687, "document": "# Site Report: Site 2161\n\n## Site Information\n- **Site ID**: Site 2161\n- **Study**: Study 24\n- **Country**: TUR\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 687\n- **Average Issues per Subject**: 171.75\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (25.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 3 (75.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 684\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 47661: Critical risk, 214 issues\n- Subject 47662: Critical risk, 213 issues\n- Subject 47663: Critical risk, 258 issues\n"}
{"id": "site_Study 24_Site 2163", "study": "Study 24", "site": "Site 2163", "type": "site_summary", "total_subjects": 2, "total_issues": 13, "document": "# Site Report: Site 2163\n\n## Site Information\n- **Site ID**: Site 2163\n- **Study**: Study 24\n- **Country**: IND\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 13\n- **Average Issues per Subject**: 6.50\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 1 (50.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 6\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 47572: High risk, 8 issues\n"}
{"id": "site_Study 24_Site 2164", "study": "Study 24", "site": "Site 2164", "type": "site_summary", "total_subjects": 5, "total_issues": 282, "document": "# Site Report: Site 2164\n\n## Site Information\n- **Site ID**: Site 2164\n- **Study**: Study 24\n- **Country**: KOR\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 282\n- **Average Issues per Subject**: 56.40\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 5 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 279\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 47603: Critical risk, 40 issues\n- Subject 47604: Critical risk, 114 issues\n- Subject 47605: Critical risk, 50 issues\n- Subject 47606: Critical risk, 48 issues\n- Subject 47607: Critical risk, 30 issues\n"}
{"id": "site_Study 24_Site 2165", "study": "Study 24", "site": "Site 2165", "type": "site_summary", "total_subjects": 8, "total_issues": 207, "document": "# Site Report: Site 2165\n\n## Site Information\n- **Site ID**: Site 2165\n- **Study**: Study 24\n- **Country**: KOR\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 207\n- **Average Issues per Subject**: 25.88\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 3 (37.5%)\n- Critical Risk: 5 (62.5%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 14\n- Missing Pages: 0\n- Missing Labs: 184\n- Outstanding Visits: 3\n\n## Subjects Requiring Attention\n- Subject 47608: High risk, 9 issues\n- Subject 47609: Critical risk, 56 issues\n- Subject 47610: Critical risk, 16 issues\n- Subject 47611: Critical risk, 31 issues\n- Subject 47612: Critical risk, 38 issues\n- Subject 47613: High risk, 8 issues\n- Subject 47614: Critical risk, 41 issues\n- Subject 47615: High risk, 8 issues\n"}
{"id": "site_Study 24_Site 2166", "study": "Study 24", "site": "Site 2166", "type": "site_summary", "total_subjects": 4, "total_issues": 51, "document": "# Site Report: Site 2166\n\n## Site Information\n- **Site ID**: Site 2166\n- **Study**: Study 24\n- **Country**: KOR\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 51\n- **Average Issues per Subject**: 12.75\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (25.0%)\n- High Risk: 1 (25.0%)\n- Critical Risk: 2 (50.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 50\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 47616: Critical risk, 17 issues\n- Subject 47617: Critical risk, 26 issues\n- Subject 47618: High risk, 6 issues\n"}
{"id": "site_Study 24_Site 2167", "study": "Study 24", "site": "Site 2167", "type": "site_summary", "total_subjects": 8, "total_issues": 495, "document": "# Site Report: Site 2167\n\n## Site Information\n- **Site ID**: Site 2167\n- **Study**: Study 24\n- **Country**: KOR\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 495\n- **Average Issues per Subject**: 61.88\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (12.5%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 7 (87.5%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 495\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 47620: Critical risk, 66 issues\n- Subject 47621: Critical risk, 70 issues\n- Subject 47622: Critical risk, 61 issues\n- Subject 47624: Critical risk, 66 issues\n- Subject 47625: Critical risk, 99 issues\n- Subject 47626: Critical risk, 61 issues\n- Subject 47627: Critical risk, 70 issues\n"}
{"id": "site_Study 24_Site 2168", "study": "Study 24", "site": "Site 2168", "type": "site_summary", "total_subjects": 8, "total_issues": 585, "document": "# Site Report: Site 2168\n\n## Site Information\n- **Site ID**: Site 2168\n- **Study**: Study 24\n- **Country**: KOR\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 585\n- **Average Issues per Subject**: 73.12\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 8 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 4\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 581\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 47628: Critical risk, 33 issues\n- Subject 47630: Critical risk, 55 issues\n- Subject 47632: Critical risk, 77 issues\n- Subject 47633: Critical risk, 149 issues\n- Subject 47634: Critical risk, 102 issues\n- Subject 47635: Critical risk, 44 issues\n- Subject 47636: Critical risk, 72 issues\n- Subject 47637: Critical risk, 53 issues\n"}
{"id": "site_Study 24_Site 2169", "study": "Study 24", "site": "Site 2169", "type": "site_summary", "total_subjects": 8, "total_issues": 50, "document": "# Site Report: Site 2169\n\n## Site Information\n- **Site ID**: Site 2169\n- **Study**: Study 24\n- **Country**: KOR\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 50\n- **Average Issues per Subject**: 6.25\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 3 (37.5%)\n- High Risk: 5 (62.5%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 3\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 41\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\n- Subject 47642: High risk, 9 issues\n- Subject 47643: High risk, 8 issues\n- Subject 47644: High risk, 8 issues\n- Subject 47645: High risk, 7 issues\n- Subject 47647: High risk, 7 issues\n"}
{"id": "site_Study 24_Site 2170", "study": "Study 24", "site": "Site 2170", "type": "site_summary", "total_subjects": 4, "total_issues": 771, "document": "# Site Report: Site 2170\n\n## Site Information\n- **Site ID**: Site 2170\n- **Study**: Study 24\n- **Country**: TUR\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 771\n- **Average Issues per Subject**: 192.75\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 4 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 3\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 767\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 47651: Critical risk, 209 issues\n- Subject 47652: Critical risk, 267 issues\n- Subject 47653: Critical risk, 213 issues\n- Subject 47654: Critical risk, 82 issues\n"}
{"id": "site_Study 24_Site 2171", "study": "Study 24", "site": "Site 2171", "type": "site_summary", "total_subjects": 3, "total_issues": 220, "document": "# Site Report: Site 2171\n\n## Site Information\n- **Site ID**: Site 2171\n- **Study**: Study 24\n- **Country**: TUR\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 220\n- **Average Issues per Subject**: 73.33\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 3 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 218\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 47655: Critical risk, 64 issues\n- Subject 47656: Critical risk, 93 issues\n- Subject 47657: Critical risk, 63 issues\n"}
{"id": "site_Study 24_Site 2172", "study": "Study 24", "site": "Site 2172", "type": "site_summary", "total_subjects": 3, "total_issues": 551, "document": "# Site Report: Site 2172\n\n## Site Information\n- **Site ID**: Site 2172\n- **Study**: Study 24\n- **Country**: TUR\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 551\n- **Average Issues per Subject**: 183.67\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 3 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 550\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 47658: Critical risk, 241 issues\n- Subject 47659: Critical risk, 145 issues\n- Subject 47660: Critical risk, 165 issues\n"}
{"id": "site_Study 24_Site 2173", "study": "Study 24", "site": "Site 2173", "type": "site_summary", "total_subjects": 4, "total_issues": 236, "document": "# Site Report: Site 2173\n\n## Site Information\n- **Site ID**: Site 2173\n- **Study**: Study 24\n- **Country**: TUR\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 236\n- **Average Issues per Subject**: 59.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 4 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 233\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 47664: Critical risk, 63 issues\n- Subject 47665: Critical risk, 78 issues\n- Subject 47666: Critical risk, 47 issues\n- Subject 47667: Critical risk, 48 issues\n"}
{"id": "site_Study 24_Site 2174", "study": "Study 24", "site": "Site 2174", "type": "site_summary", "total_subjects": 2, "total_issues": 40, "document": "# Site Report: Site 2174\n\n## Site Information\n- **Site ID**: Site 2174\n- **Study**: Study 24\n- **Country**: TUR\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 40\n- **Average Issues per Subject**: 20.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (50.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 40\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 47668: Critical risk, 36 issues\n"}
{"id": "site_Study 24_Site 2175", "study": "Study 24", "site": "Site 2175", "type": "site_summary", "total_subjects": 1, "total_issues": 36, "document": "# Site Report: Site 2175\n\n## Site Information\n- **Site ID**: Site 2175\n- **Study**: Study 24\n- **Country**: TUR\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 36\n- **Average Issues per Subject**: 36.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 36\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 47670: Critical risk, 36 issues\n"}
{"id": "site_Study 24_Site 2176", "study": "Study 24", "site": "Site 2176", "type": "site_summary", "total_subjects": 4, "total_issues": 236, "document": "# Site Report: Site 2176\n\n## Site Information\n- **Site ID**: Site 2176\n- **Study**: Study 24\n- **Country**: TUR\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 236\n- **Average Issues per Subject**: 59.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (25.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 3 (75.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 233\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\n- Subject 47673: Critical risk, 87 issues\n- Subject 47674: Critical risk, 86 issues\n- Subject 47675: Critical risk, 61 issues\n"}
{"id": "site_Study 24_Site 2177", "study": "Study 24", "site": "Site 2177", "type": "site_summary", "total_subjects": 3, "total_issues": 215, "document": "# Site Report: Site 2177\n\n## Site Information\n- **Site ID**: Site 2177\n- **Study**: Study 24\n- **Country**: TUR\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 215\n- **Average Issues per Subject**: 71.67\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 3 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 213\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\n- Subject 47677: Critical risk, 92 issues\n- Subject 47678: Critical risk, 62 issues\n- Subject 47679: Critical risk, 61 issues\n"}
{"id": "site_Study 24_Site 2178", "study": "Study 24", "site": "Site 2178", "type": "site_summary", "total_subjects": 3, "total_issues": 211, "document": "# Site Report: Site 2178\n\n## Site Information\n- **Site ID**: Site 2178\n- **Study**: Study 24\n- **Country**: TUR\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 211\n- **Average Issues per Subject**: 70.33\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 3 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 210\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 47681: Critical risk, 105 issues\n- Subject 47682: Critical risk, 70 issues\n- Subject 47683: Critical risk, 36 issues\n"}
{"id": "site_Study 24_Site 2179", "study": "Study 24", "site": "Site 2179", "type": "site_summary", "total_subjects": 2, "total_issues": 57, "document": "# Site Report: Site 2179\n\n## Site Information\n- **Site ID**: Site 2179\n- **Study**: Study 24\n- **Country**: TUR\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 57\n- **Average Issues per Subject**: 28.50\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 2 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 57\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 47684: Critical risk, 27 issues\n- Subject 47685: Critical risk, 30 issues\n"}
{"id": "site_Study 24_Site 2180", "study": "Study 24", "site": "Site 2180", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 2180\n\n## Site Information\n- **Site ID**: Site 2180\n- **Study**: Study 24\n- **Country**: TUR\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 24_Site 2181", "study": "Study 24", "site": "Site 2181", "type": "site_summary", "total_subjects": 3, "total_issues": 60, "document": "# Site Report: Site 2181\n\n## Site Information\n- **Site ID**: Site 2181\n- **Study**: Study 24\n- **Country**: TUR\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 60\n- **Average Issues per Subject**: 20.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (33.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 2 (66.7%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 58\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 47690: Critical risk, 39 issues\n- Subject 47691: Critical risk, 20 issues\n"}
{"id": "site_Study 24_Site 2182", "study": "Study 24", "site": "Site 2182", "type": "site_summary", "total_subjects": 3, "total_issues": 36, "document": "# Site Report: Site 2182\n\n## Site Information\n- **Site ID**: Site 2182\n- **Study**: Study 24\n- **Country**: TUR\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 36\n- **Average Issues per Subject**: 12.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (66.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (33.3%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 36\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 47693: Critical risk, 29 issues\n"}
{"id": "site_Study 24_Site 2183", "study": "Study 24", "site": "Site 2183", "type": "site_summary", "total_subjects": 5, "total_issues": 93, "document": "# Site Report: Site 2183\n\n## Site Information\n- **Site ID**: Site 2183\n- **Study**: Study 24\n- **Country**: CHN\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 93\n- **Average Issues per Subject**: 18.60\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 3 (60.0%)\n- Critical Risk: 2 (40.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 66\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\n- Subject 47698: High risk, 11 issues\n- Subject 47699: Critical risk, 37 issues\n- Subject 47700: High risk, 10 issues\n- Subject 47701: High risk, 9 issues\n- Subject 47702: Critical risk, 26 issues\n"}
{"id": "site_Study 24_Site 2184", "study": "Study 24", "site": "Site 2184", "type": "site_summary", "total_subjects": 7, "total_issues": 124, "document": "# Site Report: Site 2184\n\n## Site Information\n- **Site ID**: Site 2184\n- **Study**: Study 24\n- **Country**: CHN\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 124\n- **Average Issues per Subject**: 17.71\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 4 (57.1%)\n- Critical Risk: 3 (42.9%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 92\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 47703: High risk, 11 issues\n- Subject 47704: High risk, 9 issues\n- Subject 47705: High risk, 13 issues\n- Subject 47707: Critical risk, 41 issues\n- Subject 47708: High risk, 15 issues\n- Subject 47709: Critical risk, 17 issues\n- Subject 47711: Critical risk, 18 issues\n"}
{"id": "site_Study 24_Site 2185", "study": "Study 24", "site": "Site 2185", "type": "site_summary", "total_subjects": 5, "total_issues": 36, "document": "# Site Report: Site 2185\n\n## Site Information\n- **Site ID**: Site 2185\n- **Study**: Study 24\n- **Country**: CHN\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 36\n- **Average Issues per Subject**: 7.20\n- **Clean Subjects**: 1 (20.0%)\n\n## Risk Profile\n- Low Risk: 1 (20.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 4 (80.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 34\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\n- Subject 47717: High risk, 9 issues\n- Subject 47718: High risk, 10 issues\n- Subject 47720: High risk, 8 issues\n- Subject 47721: High risk, 9 issues\n"}
{"id": "site_Study 24_Site 2186", "study": "Study 24", "site": "Site 2186", "type": "site_summary", "total_subjects": 5, "total_issues": 66, "document": "# Site Report: Site 2186\n\n## Site Information\n- **Site ID**: Site 2186\n- **Study**: Study 24\n- **Country**: CHN\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 66\n- **Average Issues per Subject**: 13.20\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (20.0%)\n- High Risk: 3 (60.0%)\n- Critical Risk: 1 (20.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 57\n- Outstanding Visits: 3\n\n## Subjects Requiring Attention\n- Subject 47724: Critical risk, 35 issues\n- Subject 47725: High risk, 7 issues\n- Subject 47726: High risk, 11 issues\n- Subject 47728: High risk, 9 issues\n"}
{"id": "site_Study 24_Site 2187", "study": "Study 24", "site": "Site 2187", "type": "site_summary", "total_subjects": 6, "total_issues": 271, "document": "# Site Report: Site 2187\n\n## Site Information\n- **Site ID**: Site 2187\n- **Study**: Study 24\n- **Country**: DEU\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 271\n- **Average Issues per Subject**: 45.17\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 6 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 271\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\n- Subject 47737: Critical risk, 45 issues\n- Subject 47739: Critical risk, 59 issues\n- Subject 47740: Critical risk, 53 issues\n- Subject 47741: Critical risk, 30 issues\n- Subject 47742: Critical risk, 54 issues\n- Subject 47743: Critical risk, 30 issues\n"}
{"id": "site_Study 24_Site 2188", "study": "Study 24", "site": "Site 2188", "type": "site_summary", "total_subjects": 3, "total_issues": 208, "document": "# Site Report: Site 2188\n\n## Site Information\n- **Site ID**: Site 2188\n- **Study**: Study 24\n- **Country**: ISR\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 208\n- **Average Issues per Subject**: 69.33\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 3 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 208\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\n- Subject 47744: Critical risk, 154 issues\n- Subject 47745: Critical risk, 24 issues\n- Subject 47746: Critical risk, 30 issues\n"}
{"id": "site_Study 24_Site 2189", "study": "Study 24", "site": "Site 2189", "type": "site_summary", "total_subjects": 1, "total_issues": 19, "document": "# Site Report: Site 2189\n\n## Site Information\n- **Site ID**: Site 2189\n- **Study**: Study 24\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 19\n- **Average Issues per Subject**: 19.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 18\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 47763: Critical risk, 19 issues\n"}
{"id": "site_Study 24_Site 2191", "study": "Study 24", "site": "Site 2191", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 2191\n\n## Site Information\n- **Site ID**: Site 2191\n- **Study**: Study 24\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 24_Site 259", "study": "Study 24", "site": "Site 259", "type": "site_summary", "total_subjects": 3, "total_issues": 174, "document": "# Site Report: Site 259\n\n## Site Information\n- **Site ID**: Site 259\n- **Study**: Study 24\n- **Country**: AUS\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 174\n- **Average Issues per Subject**: 58.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 3 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 170\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2236: Critical risk, 62 issues\n- Subject 4990: Critical risk, 58 issues\n- Subject 4991: Critical risk, 54 issues\n"}
{"id": "site_Study 24_Site 28", "study": "Study 24", "site": "Site 28", "type": "site_summary", "total_subjects": 4, "total_issues": 143, "document": "# Site Report: Site 28\n\n## Site Information\n- **Site ID**: Site 28\n- **Study**: Study 24\n- **Country**: AUS\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 143\n- **Average Issues per Subject**: 35.75\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 4 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 142\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\n- Subject 107: Critical risk, 26 issues\n- Subject 108: Critical risk, 27 issues\n- Subject 2233: Critical risk, 31 issues\n- Subject 2234: Critical risk, 59 issues\n"}
{"id": "site_Study 24_Site 281", "study": "Study 24", "site": "Site 281", "type": "site_summary", "total_subjects": 19, "total_issues": 345, "document": "# Site Report: Site 281\n\n## Site Information\n- **Site ID**: Site 281\n- **Study**: Study 24\n- **Country**: DEU\n- **Total Subjects**: 19\n\n## Performance Metrics\n- **Total Issues**: 345\n- **Average Issues per Subject**: 18.16\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (10.5%)\n- High Risk: 10 (52.6%)\n- Critical Risk: 7 (36.8%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 329\n- Outstanding Visits: 6\n\n## Subjects Requiring Attention\n- Subject 2364: High risk, 13 issues\n- Subject 2365: High risk, 12 issues\n- Subject 2366: Critical risk, 16 issues\n- Subject 47729: Critical risk, 33 issues\n- Subject 47730: Critical risk, 36 issues\n- Subject 47731: High risk, 6 issues\n- Subject 47734: High risk, 7 issues\n- Subject 9328: Critical risk, 22 issues\n- Subject 9329: High risk, 13 issues\n- Subject 9330: Critical risk, 35 issues\n"}
{"id": "site_Study 24_Site 286", "study": "Study 24", "site": "Site 286", "type": "site_summary", "total_subjects": 7, "total_issues": 192, "document": "# Site Report: Site 286\n\n## Site Information\n- **Site ID**: Site 286\n- **Study**: Study 24\n- **Country**: DEU\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 192\n- **Average Issues per Subject**: 27.43\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 7 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 191\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2386: Critical risk, 25 issues\n- Subject 2388: Critical risk, 20 issues\n- Subject 2389: Critical risk, 32 issues\n- Subject 2390: Critical risk, 32 issues\n- Subject 9776: Critical risk, 27 issues\n- Subject 9777: Critical risk, 27 issues\n- Subject 9778: Critical risk, 29 issues\n"}
{"id": "site_Study 24_Site 3", "study": "Study 24", "site": "Site 3", "type": "site_summary", "total_subjects": 3, "total_issues": 13, "document": "# Site Report: Site 3\n\n## Site Information\n- **Site ID**: Site 3\n- **Study**: Study 24\n- **Country**: AUS\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 13\n- **Average Issues per Subject**: 4.33\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 3 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 10\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 24_Site 326", "study": "Study 24", "site": "Site 326", "type": "site_summary", "total_subjects": 3, "total_issues": 49, "document": "# Site Report: Site 326\n\n## Site Information\n- **Site ID**: Site 326\n- **Study**: Study 24\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 49\n- **Average Issues per Subject**: 16.33\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (33.3%)\n- Critical Risk: 2 (66.7%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 46\n- Outstanding Visits: 3\n\n## Subjects Requiring Attention\n- Subject 2652: Critical risk, 18 issues\n- Subject 2653: Critical risk, 17 issues\n- Subject 2654: High risk, 14 issues\n"}
{"id": "site_Study 24_Site 327", "study": "Study 24", "site": "Site 327", "type": "site_summary", "total_subjects": 2, "total_issues": 74, "document": "# Site Report: Site 327\n\n## Site Information\n- **Site ID**: Site 327\n- **Study**: Study 24\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 74\n- **Average Issues per Subject**: 37.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 2 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 70\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\n- Subject 2664: Critical risk, 45 issues\n- Subject 2665: Critical risk, 29 issues\n"}
{"id": "site_Study 24_Site 338", "study": "Study 24", "site": "Site 338", "type": "site_summary", "total_subjects": 1, "total_issues": 10, "document": "# Site Report: Site 338\n\n## Site Information\n- **Site ID**: Site 338\n- **Study**: Study 24\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 10\n- **Average Issues per Subject**: 10.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (100.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 6\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2749: High risk, 10 issues\n"}
{"id": "site_Study 24_Site 349", "study": "Study 24", "site": "Site 349", "type": "site_summary", "total_subjects": 1, "total_issues": 29, "document": "# Site Report: Site 349\n\n## Site Information\n- **Site ID**: Site 349\n- **Study**: Study 24\n- **Country**: PRT\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 29\n- **Average Issues per Subject**: 29.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 28\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2829: Critical risk, 29 issues\n"}
{"id": "site_Study 24_Site 420", "study": "Study 24", "site": "Site 420", "type": "site_summary", "total_subjects": 5, "total_issues": 69, "document": "# Site Report: Site 420\n\n## Site Information\n- **Site ID**: Site 420\n- **Study**: Study 24\n- **Country**: CHN\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 69\n- **Average Issues per Subject**: 13.80\n- **Clean Subjects**: 1 (20.0%)\n\n## Risk Profile\n- Low Risk: 1 (20.0%)\n- Medium Risk: 2 (40.0%)\n- High Risk: 1 (20.0%)\n- Critical Risk: 1 (20.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 52\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 3234: High risk, 11 issues\n- Subject 6458: Critical risk, 53 issues\n"}
{"id": "site_Study 24_Site 423", "study": "Study 24", "site": "Site 423", "type": "site_summary", "total_subjects": 5, "total_issues": 41, "document": "# Site Report: Site 423\n\n## Site Information\n- **Site ID**: Site 423\n- **Study**: Study 24\n- **Country**: CHN\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 41\n- **Average Issues per Subject**: 8.20\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 5 (100.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 35\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\n- Subject 3245: High risk, 8 issues\n- Subject 3247: High risk, 8 issues\n- Subject 6489: High risk, 8 issues\n- Subject 6490: High risk, 8 issues\n- Subject 6491: High risk, 9 issues\n"}
{"id": "site_Study 24_Site 425", "study": "Study 24", "site": "Site 425", "type": "site_summary", "total_subjects": 1, "total_issues": 33, "document": "# Site Report: Site 425\n\n## Site Information\n- **Site ID**: Site 425\n- **Study**: Study 24\n- **Country**: CHN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 33\n- **Average Issues per Subject**: 33.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 33\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 3256: Critical risk, 33 issues\n"}
{"id": "site_Study 24_Site 426", "study": "Study 24", "site": "Site 426", "type": "site_summary", "total_subjects": 5, "total_issues": 75, "document": "# Site Report: Site 426\n\n## Site Information\n- **Site ID**: Site 426\n- **Study**: Study 24\n- **Country**: CHN\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 75\n- **Average Issues per Subject**: 15.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 4 (80.0%)\n- Critical Risk: 1 (20.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 71\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 3257: High risk, 10 issues\n- Subject 3258: High risk, 9 issues\n- Subject 3260: High risk, 9 issues\n- Subject 47713: High risk, 12 issues\n- Subject 47714: Critical risk, 35 issues\n"}
{"id": "site_Study 24_Site 469", "study": "Study 24", "site": "Site 469", "type": "site_summary", "total_subjects": 2, "total_issues": 54, "document": "# Site Report: Site 469\n\n## Site Information\n- **Site ID**: Site 469\n- **Study**: Study 24\n- **Country**: TWN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 54\n- **Average Issues per Subject**: 27.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 2 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 54\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 3565: Critical risk, 28 issues\n- Subject 4744: Critical risk, 26 issues\n"}
{"id": "site_Study 24_Site 48", "study": "Study 24", "site": "Site 48", "type": "site_summary", "total_subjects": 15, "total_issues": 160, "document": "# Site Report: Site 48\n\n## Site Information\n- **Site ID**: Site 48\n- **Study**: Study 24\n- **Country**: KOR\n- **Total Subjects**: 15\n\n## Performance Metrics\n- **Total Issues**: 160\n- **Average Issues per Subject**: 10.67\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 3 (20.0%)\n- High Risk: 10 (66.7%)\n- Critical Risk: 2 (13.3%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 158\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\n- Subject 208: High risk, 9 issues\n- Subject 209: High risk, 8 issues\n- Subject 211: Critical risk, 30 issues\n- Subject 212: High risk, 6 issues\n- Subject 213: Critical risk, 38 issues\n- Subject 214: High risk, 7 issues\n- Subject 216: High risk, 10 issues\n- Subject 218: High risk, 6 issues\n- Subject 219: High risk, 6 issues\n- Subject 220: High risk, 11 issues\n"}
{"id": "site_Study 24_Site 49", "study": "Study 24", "site": "Site 49", "type": "site_summary", "total_subjects": 10, "total_issues": 193, "document": "# Site Report: Site 49\n\n## Site Information\n- **Site ID**: Site 49\n- **Study**: Study 24\n- **Country**: KOR\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 193\n- **Average Issues per Subject**: 19.30\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 6 (60.0%)\n- Critical Risk: 4 (40.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 185\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\n- Subject 233: Critical risk, 22 issues\n- Subject 234: Critical risk, 48 issues\n- Subject 235: Critical risk, 19 issues\n- Subject 236: High risk, 15 issues\n- Subject 238: High risk, 11 issues\n- Subject 241: High risk, 14 issues\n- Subject 242: High risk, 14 issues\n- Subject 243: Critical risk, 28 issues\n- Subject 244: High risk, 14 issues\n- Subject 245: High risk, 8 issues\n"}
{"id": "site_Study 24_Site 5", "study": "Study 24", "site": "Site 5", "type": "site_summary", "total_subjects": 3, "total_issues": 71, "document": "# Site Report: Site 5\n\n## Site Information\n- **Site ID**: Site 5\n- **Study**: Study 24\n- **Country**: TUR\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 71\n- **Average Issues per Subject**: 23.67\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (66.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (33.3%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 14\n- Missing Pages: 0\n- Missing Labs: 57\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\n- Subject 11: Critical risk, 65 issues\n"}
{"id": "site_Study 24_Site 50", "study": "Study 24", "site": "Site 50", "type": "site_summary", "total_subjects": 19, "total_issues": 1158, "document": "# Site Report: Site 50\n\n## Site Information\n- **Site ID**: Site 50\n- **Study**: Study 24\n- **Country**: KOR\n- **Total Subjects**: 19\n\n## Performance Metrics\n- **Total Issues**: 1158\n- **Average Issues per Subject**: 60.95\n- **Clean Subjects**: 1 (5.3%)\n\n## Risk Profile\n- Low Risk: 1 (5.3%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (5.3%)\n- Critical Risk: 17 (89.5%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 2\n- Missing Pages: 0\n- Missing Labs: 1142\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\n- Subject 271: Critical risk, 36 issues\n- Subject 272: Critical risk, 96 issues\n- Subject 273: Critical risk, 64 issues\n- Subject 274: Critical risk, 64 issues\n- Subject 275: Critical risk, 58 issues\n- Subject 276: Critical risk, 58 issues\n- Subject 277: Critical risk, 85 issues\n- Subject 278: Critical risk, 58 issues\n- Subject 279: Critical risk, 174 issues\n- Subject 280: Critical risk, 67 issues\n"}
{"id": "site_Study 24_Site 506", "study": "Study 24", "site": "Site 506", "type": "site_summary", "total_subjects": 5, "total_issues": 16, "document": "# Site Report: Site 506\n\n## Site Information\n- **Site ID**: Site 506\n- **Study**: Study 24\n- **Country**: CHN\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 16\n- **Average Issues per Subject**: 3.20\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 5 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 10\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 24_Site 507", "study": "Study 24", "site": "Site 507", "type": "site_summary", "total_subjects": 2, "total_issues": 42, "document": "# Site Report: Site 507\n\n## Site Information\n- **Site ID**: Site 507\n- **Study**: Study 24\n- **Country**: CHN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 42\n- **Average Issues per Subject**: 21.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (50.0%)\n- Critical Risk: 1 (50.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 41\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\n- Subject 3727: High risk, 9 issues\n- Subject 3728: Critical risk, 33 issues\n"}
{"id": "site_Study 24_Site 51", "study": "Study 24", "site": "Site 51", "type": "site_summary", "total_subjects": 11, "total_issues": 101, "document": "# Site Report: Site 51\n\n## Site Information\n- **Site ID**: Site 51\n- **Study**: Study 24\n- **Country**: KOR\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 101\n- **Average Issues per Subject**: 9.18\n- **Clean Subjects**: 2 (18.2%)\n\n## Risk Profile\n- Low Risk: 2 (18.2%)\n- Medium Risk: 3 (27.3%)\n- High Risk: 4 (36.4%)\n- Critical Risk: 2 (18.2%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 26\n- Missing Pages: 0\n- Missing Labs: 72\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\n- Subject 292: High risk, 12 issues\n- Subject 293: Critical risk, 25 issues\n- Subject 294: High risk, 7 issues\n- Subject 295: High risk, 8 issues\n- Subject 299: High risk, 11 issues\n- Subject 304: Critical risk, 34 issues\n"}
{"id": "site_Study 24_Site 52", "study": "Study 24", "site": "Site 52", "type": "site_summary", "total_subjects": 31, "total_issues": 2371, "document": "# Site Report: Site 52\n\n## Site Information\n- **Site ID**: Site 52\n- **Study**: Study 24\n- **Country**: KOR\n- **Total Subjects**: 31\n\n## Performance Metrics\n- **Total Issues**: 2371\n- **Average Issues per Subject**: 76.48\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 31 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 2368\n- Outstanding Visits: 4\n\n## Subjects Requiring Attention\n- Subject 309: Critical risk, 62 issues\n- Subject 311: Critical risk, 118 issues\n- Subject 312: Critical risk, 69 issues\n- Subject 313: Critical risk, 120 issues\n- Subject 314: Critical risk, 90 issues\n- Subject 47573: Critical risk, 82 issues\n- Subject 47574: Critical risk, 69 issues\n- Subject 47575: Critical risk, 116 issues\n- Subject 47576: Critical risk, 71 issues\n- Subject 47578: Critical risk, 91 issues\n"}
{"id": "site_Study 24_Site 520", "study": "Study 24", "site": "Site 520", "type": "site_summary", "total_subjects": 3, "total_issues": 11, "document": "# Site Report: Site 520\n\n## Site Information\n- **Site ID**: Site 520\n- **Study**: Study 24\n- **Country**: DEU\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 11\n- **Average Issues per Subject**: 3.67\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 3 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 6\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 24_Site 521", "study": "Study 24", "site": "Site 521", "type": "site_summary", "total_subjects": 5, "total_issues": 122, "document": "# Site Report: Site 521\n\n## Site Information\n- **Site ID**: Site 521\n- **Study**: Study 24\n- **Country**: DEU\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 122\n- **Average Issues per Subject**: 24.40\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (20.0%)\n- Critical Risk: 4 (80.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 122\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\n- Subject 3771: Critical risk, 28 issues\n- Subject 3772: Critical risk, 26 issues\n- Subject 3773: High risk, 13 issues\n- Subject 8892: Critical risk, 33 issues\n- Subject 8893: Critical risk, 22 issues\n"}
{"id": "site_Study 24_Site 522", "study": "Study 24", "site": "Site 522", "type": "site_summary", "total_subjects": 3, "total_issues": 121, "document": "# Site Report: Site 522\n\n## Site Information\n- **Site ID**: Site 522\n- **Study**: Study 24\n- **Country**: DEU\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 121\n- **Average Issues per Subject**: 40.33\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 3 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 121\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\n- Subject 3774: Critical risk, 58 issues\n- Subject 8927: Critical risk, 31 issues\n- Subject 8928: Critical risk, 32 issues\n"}
{"id": "site_Study 24_Site 524", "study": "Study 24", "site": "Site 524", "type": "site_summary", "total_subjects": 1, "total_issues": 69, "document": "# Site Report: Site 524\n\n## Site Information\n- **Site ID**: Site 524\n- **Study**: Study 24\n- **Country**: ISR\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 69\n- **Average Issues per Subject**: 69.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 66\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\n- Subject 3778: Critical risk, 69 issues\n"}
{"id": "site_Study 24_Site 525", "study": "Study 24", "site": "Site 525", "type": "site_summary", "total_subjects": 4, "total_issues": 183, "document": "# Site Report: Site 525\n\n## Site Information\n- **Site ID**: Site 525\n- **Study**: Study 24\n- **Country**: ISR\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 183\n- **Average Issues per Subject**: 45.75\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 4 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 183\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 3782: Critical risk, 51 issues\n- Subject 47747: Critical risk, 26 issues\n- Subject 47748: Critical risk, 52 issues\n- Subject 47749: Critical risk, 54 issues\n"}
{"id": "site_Study 24_Site 53", "study": "Study 24", "site": "Site 53", "type": "site_summary", "total_subjects": 8, "total_issues": 34, "document": "# Site Report: Site 53\n\n## Site Information\n- **Site ID**: Site 53\n- **Study**: Study 24\n- **Country**: KOR\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 34\n- **Average Issues per Subject**: 4.25\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 7 (87.5%)\n- High Risk: 1 (12.5%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 33\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 322: High risk, 6 issues\n"}
{"id": "site_Study 24_Site 530", "study": "Study 24", "site": "Site 530", "type": "site_summary", "total_subjects": 3, "total_issues": 73, "document": "# Site Report: Site 530\n\n## Site Information\n- **Site ID**: Site 530\n- **Study**: Study 24\n- **Country**: PRT\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 73\n- **Average Issues per Subject**: 24.33\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 3 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 73\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\n- Subject 35413: Critical risk, 26 issues\n- Subject 35415: Critical risk, 25 issues\n- Subject 3799: Critical risk, 22 issues\n"}
{"id": "site_Study 24_Site 536", "study": "Study 24", "site": "Site 536", "type": "site_summary", "total_subjects": 3, "total_issues": 140, "document": "# Site Report: Site 536\n\n## Site Information\n- **Site ID**: Site 536\n- **Study**: Study 24\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 140\n- **Average Issues per Subject**: 46.67\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 3 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 139\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\n- Subject 3821: Critical risk, 27 issues\n- Subject 3822: Critical risk, 55 issues\n- Subject 3823: Critical risk, 58 issues\n"}
{"id": "site_Study 24_Site 558", "study": "Study 24", "site": "Site 558", "type": "site_summary", "total_subjects": 1, "total_issues": 72, "document": "# Site Report: Site 558\n\n## Site Information\n- **Site ID**: Site 558\n- **Study**: Study 24\n- **Country**: TUR\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 72\n- **Average Issues per Subject**: 72.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 70\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\n- Subject 3890: Critical risk, 72 issues\n"}
{"id": "site_Study 24_Site 594", "study": "Study 24", "site": "Site 594", "type": "site_summary", "total_subjects": 2, "total_issues": 85, "document": "# Site Report: Site 594\n\n## Site Information\n- **Site ID**: Site 594\n- **Study**: Study 24\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 85\n- **Average Issues per Subject**: 42.50\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 2 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 79\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 4014: Critical risk, 48 issues\n- Subject 4015: Critical risk, 37 issues\n"}
{"id": "site_Study 24_Site 597", "study": "Study 24", "site": "Site 597", "type": "site_summary", "total_subjects": 3, "total_issues": 32, "document": "# Site Report: Site 597\n\n## Site Information\n- **Site ID**: Site 597\n- **Study**: Study 24\n- **Country**: IND\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 32\n- **Average Issues per Subject**: 10.67\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (66.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (33.3%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 32\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 30317: Critical risk, 28 issues\n"}
{"id": "site_Study 24_Site 6", "study": "Study 24", "site": "Site 6", "type": "site_summary", "total_subjects": 3, "total_issues": 715, "document": "# Site Report: Site 6\n\n## Site Information\n- **Site ID**: Site 6\n- **Study**: Study 24\n- **Country**: TUR\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 715\n- **Average Issues per Subject**: 238.33\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 3 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 715\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 12: Critical risk, 339 issues\n- Subject 13: Critical risk, 211 issues\n- Subject 31074: Critical risk, 165 issues\n"}
{"id": "site_Study 24_Site 875", "study": "Study 24", "site": "Site 875", "type": "site_summary", "total_subjects": 23, "total_issues": 681, "document": "# Site Report: Site 875\n\n## Site Information\n- **Site ID**: Site 875\n- **Study**: Study 24\n- **Country**: DEU\n- **Total Subjects**: 23\n\n## Performance Metrics\n- **Total Issues**: 681\n- **Average Issues per Subject**: 29.61\n- **Clean Subjects**: 1 (4.3%)\n\n## Risk Profile\n- Low Risk: 1 (4.3%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 22 (95.7%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 667\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\n- Subject 8964: Critical risk, 42 issues\n- Subject 8965: Critical risk, 32 issues\n- Subject 8966: Critical risk, 18 issues\n- Subject 8967: Critical risk, 33 issues\n- Subject 8968: Critical risk, 33 issues\n- Subject 8969: Critical risk, 33 issues\n- Subject 8970: Critical risk, 35 issues\n- Subject 8971: Critical risk, 37 issues\n- Subject 8972: Critical risk, 37 issues\n- Subject 8973: Critical risk, 41 issues\n"}
{"id": "site_Study 24_Site 876", "study": "Study 24", "site": "Site 876", "type": "site_summary", "total_subjects": 6, "total_issues": 36, "document": "# Site Report: Site 876\n\n## Site Information\n- **Site ID**: Site 876\n- **Study**: Study 24\n- **Country**: DEU\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 36\n- **Average Issues per Subject**: 6.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 5 (83.3%)\n- High Risk: 1 (16.7%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 35\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 8991: High risk, 11 issues\n"}
{"id": "site_Study 24_Site 877", "study": "Study 24", "site": "Site 877", "type": "site_summary", "total_subjects": 2, "total_issues": 3, "document": "# Site Report: Site 877\n\n## Site Information\n- **Site ID**: Site 877\n- **Study**: Study 24\n- **Country**: DEU\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 1.50\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 24_Site 879", "study": "Study 24", "site": "Site 879", "type": "site_summary", "total_subjects": 4, "total_issues": 12, "document": "# Site Report: Site 879\n\n## Site Information\n- **Site ID**: Site 879\n- **Study**: Study 24\n- **Country**: DEU\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 12\n- **Average Issues per Subject**: 3.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 4 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 12\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 24_Site 88", "study": "Study 24", "site": "Site 88", "type": "site_summary", "total_subjects": 2, "total_issues": 60, "document": "# Site Report: Site 88\n\n## Site Information\n- **Site ID**: Site 88\n- **Study**: Study 24\n- **Country**: HKG\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 60\n- **Average Issues per Subject**: 30.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 2 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 2\n- Missing Pages: 0\n- Missing Labs: 58\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 633: Critical risk, 30 issues\n- Subject 634: Critical risk, 30 issues\n"}
{"id": "site_Study 24_Site 880", "study": "Study 24", "site": "Site 880", "type": "site_summary", "total_subjects": 8, "total_issues": 335, "document": "# Site Report: Site 880\n\n## Site Information\n- **Site ID**: Site 880\n- **Study**: Study 24\n- **Country**: DEU\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 335\n- **Average Issues per Subject**: 41.88\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (12.5%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 7 (87.5%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 328\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\n- Subject 9115: Critical risk, 23 issues\n- Subject 9116: Critical risk, 31 issues\n- Subject 9117: Critical risk, 63 issues\n- Subject 9118: Critical risk, 30 issues\n- Subject 9119: Critical risk, 93 issues\n- Subject 9120: Critical risk, 62 issues\n- Subject 9122: Critical risk, 32 issues\n"}
{"id": "site_Study 24_Site 883", "study": "Study 24", "site": "Site 883", "type": "site_summary", "total_subjects": 3, "total_issues": 82, "document": "# Site Report: Site 883\n\n## Site Information\n- **Site ID**: Site 883\n- **Study**: Study 24\n- **Country**: DEU\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 82\n- **Average Issues per Subject**: 27.33\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 3 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 82\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\n- Subject 9190: Critical risk, 29 issues\n- Subject 9191: Critical risk, 28 issues\n- Subject 9192: Critical risk, 25 issues\n"}
{"id": "site_Study 24_Site 884", "study": "Study 24", "site": "Site 884", "type": "site_summary", "total_subjects": 4, "total_issues": 38, "document": "# Site Report: Site 884\n\n## Site Information\n- **Site ID**: Site 884\n- **Study**: Study 24\n- **Country**: DEU\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 38\n- **Average Issues per Subject**: 9.50\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (25.0%)\n- High Risk: 2 (50.0%)\n- Critical Risk: 1 (25.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 14\n- Missing Pages: 0\n- Missing Labs: 21\n- Outstanding Visits: 4\n\n## Subjects Requiring Attention\n- Subject 9217: Critical risk, 19 issues\n- Subject 9218: High risk, 8 issues\n- Subject 9220: High risk, 6 issues\n"}
{"id": "site_Study 24_Site 887", "study": "Study 24", "site": "Site 887", "type": "site_summary", "total_subjects": 2, "total_issues": 14, "document": "# Site Report: Site 887\n\n## Site Information\n- **Site ID**: Site 887\n- **Study**: Study 24\n- **Country**: DEU\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 14\n- **Average Issues per Subject**: 7.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 2 (100.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 10\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 9280: High risk, 8 issues\n- Subject 9281: High risk, 6 issues\n"}
{"id": "site_Study 24_Site 888", "study": "Study 24", "site": "Site 888", "type": "site_summary", "total_subjects": 23, "total_issues": 546, "document": "# Site Report: Site 888\n\n## Site Information\n- **Site ID**: Site 888\n- **Study**: Study 24\n- **Country**: DEU\n- **Total Subjects**: 23\n\n## Performance Metrics\n- **Total Issues**: 546\n- **Average Issues per Subject**: 23.74\n- **Clean Subjects**: 2 (8.7%)\n\n## Risk Profile\n- Low Risk: 2 (8.7%)\n- Medium Risk: 7 (30.4%)\n- High Risk: 3 (13.0%)\n- Critical Risk: 11 (47.8%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 512\n- Outstanding Visits: 10\n\n## Subjects Requiring Attention\n- Subject 9286: Critical risk, 24 issues\n- Subject 9287: Critical risk, 71 issues\n- Subject 9288: Critical risk, 76 issues\n- Subject 9289: Critical risk, 60 issues\n- Subject 9291: Critical risk, 78 issues\n- Subject 9292: Critical risk, 29 issues\n- Subject 9293: Critical risk, 32 issues\n- Subject 9294: Critical risk, 30 issues\n- Subject 9296: High risk, 6 issues\n- Subject 9297: Critical risk, 34 issues\n"}
{"id": "site_Study 24_Site 904", "study": "Study 24", "site": "Site 904", "type": "site_summary", "total_subjects": 2, "total_issues": 10, "document": "# Site Report: Site 904\n\n## Site Information\n- **Site ID**: Site 904\n- **Study**: Study 24\n- **Country**: DEU\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 10\n- **Average Issues per Subject**: 5.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 1 (50.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 10\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\n- Subject 9600: High risk, 8 issues\n"}
{"id": "site_Study 24_Site 952", "study": "Study 24", "site": "Site 952", "type": "site_summary", "total_subjects": 3, "total_issues": 17, "document": "# Site Report: Site 952\n\n## Site Information\n- **Site ID**: Site 952\n- **Study**: Study 24\n- **Country**: CAN\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 17\n- **Average Issues per Subject**: 5.67\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (66.7%)\n- High Risk: 1 (33.3%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 4\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 13635: High risk, 10 issues\n"}
{"id": "site_Study 24_Site 953", "study": "Study 24", "site": "Site 953", "type": "site_summary", "total_subjects": 9, "total_issues": 215, "document": "# Site Report: Site 953\n\n## Site Information\n- **Site ID**: Site 953\n- **Study**: Study 24\n- **Country**: CAN\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 215\n- **Average Issues per Subject**: 23.89\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (22.2%)\n- High Risk: 1 (11.1%)\n- Critical Risk: 6 (66.7%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 201\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 13651: High risk, 10 issues\n- Subject 13652: Critical risk, 36 issues\n- Subject 13655: Critical risk, 34 issues\n- Subject 13656: Critical risk, 29 issues\n- Subject 47750: Critical risk, 34 issues\n- Subject 47752: Critical risk, 33 issues\n- Subject 47753: Critical risk, 31 issues\n"}
{"id": "site_Study 24_Site 954", "study": "Study 24", "site": "Site 954", "type": "site_summary", "total_subjects": 1, "total_issues": 32, "document": "# Site Report: Site 954\n\n## Site Information\n- **Site ID**: Site 954\n- **Study**: Study 24\n- **Country**: CAN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 32\n- **Average Issues per Subject**: 32.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 29\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 13658: Critical risk, 32 issues\n"}
{"id": "site_Study 24_Site 955", "study": "Study 24", "site": "Site 955", "type": "site_summary", "total_subjects": 12, "total_issues": 282, "document": "# Site Report: Site 955\n\n## Site Information\n- **Site ID**: Site 955\n- **Study**: Study 24\n- **Country**: CAN\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 282\n- **Average Issues per Subject**: 23.50\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (8.3%)\n- High Risk: 4 (33.3%)\n- Critical Risk: 7 (58.3%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 255\n- Outstanding Visits: 3\n\n## Subjects Requiring Attention\n- Subject 13667: Critical risk, 54 issues\n- Subject 13668: Critical risk, 33 issues\n- Subject 13670: Critical risk, 34 issues\n- Subject 13671: Critical risk, 33 issues\n- Subject 38951: Critical risk, 16 issues\n- Subject 38952: Critical risk, 36 issues\n- Subject 47755: High risk, 7 issues\n- Subject 47756: High risk, 9 issues\n- Subject 47757: High risk, 9 issues\n- Subject 47759: Critical risk, 40 issues\n"}
{"id": "site_Study 24_Site 963", "study": "Study 24", "site": "Site 963", "type": "site_summary", "total_subjects": 13, "total_issues": 460, "document": "# Site Report: Site 963\n\n## Site Information\n- **Site ID**: Site 963\n- **Study**: Study 24\n- **Country**: CAN\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 460\n- **Average Issues per Subject**: 35.38\n- **Clean Subjects**: 2 (15.4%)\n\n## Risk Profile\n- Low Risk: 2 (15.4%)\n- Medium Risk: 1 (7.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 10 (76.9%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 444\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\n- Subject 13826: Critical risk, 31 issues\n- Subject 13827: Critical risk, 57 issues\n- Subject 13829: Critical risk, 59 issues\n- Subject 13832: Critical risk, 41 issues\n- Subject 13833: Critical risk, 62 issues\n- Subject 13834: Critical risk, 34 issues\n- Subject 13836: Critical risk, 39 issues\n- Subject 13837: Critical risk, 36 issues\n- Subject 13839: Critical risk, 29 issues\n- Subject 39017: Critical risk, 70 issues\n"}
{"id": "site_Study 24_Site 986", "study": "Study 24", "site": "Site 986", "type": "site_summary", "total_subjects": 1, "total_issues": 33, "document": "# Site Report: Site 986\n\n## Site Information\n- **Site ID**: Site 986\n- **Study**: Study 24\n- **Country**: MEX\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 33\n- **Average Issues per Subject**: 33.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 33\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 14214: Critical risk, 33 issues\n"}
{"id": "site_Study 25_Site 1003", "study": "Study 25", "site": "Site 1003", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1003\n\n## Site Information\n- **Site ID**: Site 1003\n- **Study**: Study 25\n- **Country**: SVK\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 1004", "study": "Study 25", "site": "Site 1004", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 1004\n\n## Site Information\n- **Site ID**: Site 1004\n- **Study**: Study 25\n- **Country**: SVK\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 2\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 1008", "study": "Study 25", "site": "Site 1008", "type": "site_summary", "total_subjects": 3, "total_issues": 3, "document": "# Site Report: Site 1008\n\n## Site Information\n- **Site ID**: Site 1008\n- **Study**: Study 25\n- **Country**: SVN\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 1 (33.3%)\n\n## Risk Profile\n- Low Risk: 1 (33.3%)\n- Medium Risk: 2 (66.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 3\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 1010", "study": "Study 25", "site": "Site 1010", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 1010\n\n## Site Information\n- **Site ID**: Site 1010\n- **Study**: Study 25\n- **Country**: ZAF\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 109", "study": "Study 25", "site": "Site 109", "type": "site_summary", "total_subjects": 8, "total_issues": 1, "document": "# Site Report: Site 109\n\n## Site Information\n- **Site ID**: Site 109\n- **Study**: Study 25\n- **Country**: AUS\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.12\n- **Clean Subjects**: 7 (87.5%)\n\n## Risk Profile\n- Low Risk: 7 (87.5%)\n- Medium Risk: 1 (12.5%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 11", "study": "Study 25", "site": "Site 11", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 11\n\n## Site Information\n- **Site ID**: Site 11\n- **Study**: Study 25\n- **Country**: IND\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 12", "study": "Study 25", "site": "Site 12", "type": "site_summary", "total_subjects": 1, "total_issues": 2, "document": "# Site Report: Site 12\n\n## Site Information\n- **Site ID**: Site 12\n- **Study**: Study 25\n- **Country**: ISR\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 2\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 125", "study": "Study 25", "site": "Site 125", "type": "site_summary", "total_subjects": 4, "total_issues": 6, "document": "# Site Report: Site 125\n\n## Site Information\n- **Site ID**: Site 125\n- **Study**: Study 25\n- **Country**: HUN\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 6\n- **Average Issues per Subject**: 1.50\n- **Clean Subjects**: 2 (50.0%)\n\n## Risk Profile\n- Low Risk: 2 (50.0%)\n- Medium Risk: 2 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 6\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 126", "study": "Study 25", "site": "Site 126", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 126\n\n## Site Information\n- **Site ID**: Site 126\n- **Study**: Study 25\n- **Country**: HUN\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 127", "study": "Study 25", "site": "Site 127", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 127\n\n## Site Information\n- **Site ID**: Site 127\n- **Study**: Study 25\n- **Country**: HUN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 13", "study": "Study 25", "site": "Site 13", "type": "site_summary", "total_subjects": 11, "total_issues": 8, "document": "# Site Report: Site 13\n\n## Site Information\n- **Site ID**: Site 13\n- **Study**: Study 25\n- **Country**: NLD\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 8\n- **Average Issues per Subject**: 0.73\n- **Clean Subjects**: 9 (81.8%)\n\n## Risk Profile\n- Low Risk: 9 (81.8%)\n- Medium Risk: 1 (9.1%)\n- High Risk: 1 (9.1%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 7\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1478: High risk, 7 issues\n"}
{"id": "site_Study 25_Site 130", "study": "Study 25", "site": "Site 130", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 130\n\n## Site Information\n- **Site ID**: Site 130\n- **Study**: Study 25\n- **Country**: IND\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 131", "study": "Study 25", "site": "Site 131", "type": "site_summary", "total_subjects": 7, "total_issues": 2, "document": "# Site Report: Site 131\n\n## Site Information\n- **Site ID**: Site 131\n- **Study**: Study 25\n- **Country**: IND\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.29\n- **Clean Subjects**: 5 (71.4%)\n\n## Risk Profile\n- Low Risk: 5 (71.4%)\n- Medium Risk: 2 (28.6%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 148", "study": "Study 25", "site": "Site 148", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 148\n\n## Site Information\n- **Site ID**: Site 148\n- **Study**: Study 25\n- **Country**: ITA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 149", "study": "Study 25", "site": "Site 149", "type": "site_summary", "total_subjects": 21, "total_issues": 1, "document": "# Site Report: Site 149\n\n## Site Information\n- **Site ID**: Site 149\n- **Study**: Study 25\n- **Country**: ITA\n- **Total Subjects**: 21\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.05\n- **Clean Subjects**: 20 (95.2%)\n\n## Risk Profile\n- Low Risk: 20 (95.2%)\n- Medium Risk: 1 (4.8%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 154", "study": "Study 25", "site": "Site 154", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 154\n\n## Site Information\n- **Site ID**: Site 154\n- **Study**: Study 25\n- **Country**: JPN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 155", "study": "Study 25", "site": "Site 155", "type": "site_summary", "total_subjects": 9, "total_issues": 0, "document": "# Site Report: Site 155\n\n## Site Information\n- **Site ID**: Site 155\n- **Study**: Study 25\n- **Country**: JPN\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 9 (100.0%)\n\n## Risk Profile\n- Low Risk: 9 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 158", "study": "Study 25", "site": "Site 158", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 158\n\n## Site Information\n- **Site ID**: Site 158\n- **Study**: Study 25\n- **Country**: JPN\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 160", "study": "Study 25", "site": "Site 160", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 160\n\n## Site Information\n- **Site ID**: Site 160\n- **Study**: Study 25\n- **Country**: JPN\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 162", "study": "Study 25", "site": "Site 162", "type": "site_summary", "total_subjects": 10, "total_issues": 0, "document": "# Site Report: Site 162\n\n## Site Information\n- **Site ID**: Site 162\n- **Study**: Study 25\n- **Country**: KOR\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 10 (100.0%)\n\n## Risk Profile\n- Low Risk: 10 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 1673", "study": "Study 25", "site": "Site 1673", "type": "site_summary", "total_subjects": 5, "total_issues": 1, "document": "# Site Report: Site 1673\n\n## Site Information\n- **Site ID**: Site 1673\n- **Study**: Study 25\n- **Country**: BRA\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.20\n- **Clean Subjects**: 4 (80.0%)\n\n## Risk Profile\n- Low Risk: 4 (80.0%)\n- Medium Risk: 1 (20.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 1674", "study": "Study 25", "site": "Site 1674", "type": "site_summary", "total_subjects": 5, "total_issues": 1, "document": "# Site Report: Site 1674\n\n## Site Information\n- **Site ID**: Site 1674\n- **Study**: Study 25\n- **Country**: BRA\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.20\n- **Clean Subjects**: 4 (80.0%)\n\n## Risk Profile\n- Low Risk: 4 (80.0%)\n- Medium Risk: 1 (20.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 1676", "study": "Study 25", "site": "Site 1676", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 1676\n\n## Site Information\n- **Site ID**: Site 1676\n- **Study**: Study 25\n- **Country**: BRA\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 1677", "study": "Study 25", "site": "Site 1677", "type": "site_summary", "total_subjects": 9, "total_issues": 4, "document": "# Site Report: Site 1677\n\n## Site Information\n- **Site ID**: Site 1677\n- **Study**: Study 25\n- **Country**: BRA\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 0.44\n- **Clean Subjects**: 8 (88.9%)\n\n## Risk Profile\n- Low Risk: 8 (88.9%)\n- Medium Risk: 1 (11.1%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 4\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 1678", "study": "Study 25", "site": "Site 1678", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 1678\n\n## Site Information\n- **Site ID**: Site 1678\n- **Study**: Study 25\n- **Country**: BRA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 1716", "study": "Study 25", "site": "Site 1716", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 1716\n\n## Site Information\n- **Site ID**: Site 1716\n- **Study**: Study 25\n- **Country**: ISR\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 1734", "study": "Study 25", "site": "Site 1734", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 1734\n\n## Site Information\n- **Site ID**: Site 1734\n- **Study**: Study 25\n- **Country**: JPN\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 1735", "study": "Study 25", "site": "Site 1735", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 1735\n\n## Site Information\n- **Site ID**: Site 1735\n- **Study**: Study 25\n- **Country**: JPN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 1736", "study": "Study 25", "site": "Site 1736", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 1736\n\n## Site Information\n- **Site ID**: Site 1736\n- **Study**: Study 25\n- **Country**: JPN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 1737", "study": "Study 25", "site": "Site 1737", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1737\n\n## Site Information\n- **Site ID**: Site 1737\n- **Study**: Study 25\n- **Country**: JPN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 1738", "study": "Study 25", "site": "Site 1738", "type": "site_summary", "total_subjects": 15, "total_issues": 7, "document": "# Site Report: Site 1738\n\n## Site Information\n- **Site ID**: Site 1738\n- **Study**: Study 25\n- **Country**: JPN\n- **Total Subjects**: 15\n\n## Performance Metrics\n- **Total Issues**: 7\n- **Average Issues per Subject**: 0.47\n- **Clean Subjects**: 14 (93.3%)\n\n## Risk Profile\n- Low Risk: 14 (93.3%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (6.7%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 7\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 33012: High risk, 7 issues\n"}
{"id": "site_Study 25_Site 1739", "study": "Study 25", "site": "Site 1739", "type": "site_summary", "total_subjects": 10, "total_issues": 0, "document": "# Site Report: Site 1739\n\n## Site Information\n- **Site ID**: Site 1739\n- **Study**: Study 25\n- **Country**: JPN\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 10 (100.0%)\n\n## Risk Profile\n- Low Risk: 10 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 1740", "study": "Study 25", "site": "Site 1740", "type": "site_summary", "total_subjects": 10, "total_issues": 1, "document": "# Site Report: Site 1740\n\n## Site Information\n- **Site ID**: Site 1740\n- **Study**: Study 25\n- **Country**: JPN\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.10\n- **Clean Subjects**: 9 (90.0%)\n\n## Risk Profile\n- Low Risk: 9 (90.0%)\n- Medium Risk: 1 (10.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 1743", "study": "Study 25", "site": "Site 1743", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 1743\n\n## Site Information\n- **Site ID**: Site 1743\n- **Study**: Study 25\n- **Country**: JPN\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 1744", "study": "Study 25", "site": "Site 1744", "type": "site_summary", "total_subjects": 6, "total_issues": 2, "document": "# Site Report: Site 1744\n\n## Site Information\n- **Site ID**: Site 1744\n- **Study**: Study 25\n- **Country**: JPN\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.33\n- **Clean Subjects**: 5 (83.3%)\n\n## Risk Profile\n- Low Risk: 5 (83.3%)\n- Medium Risk: 1 (16.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 2\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 1745", "study": "Study 25", "site": "Site 1745", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 1745\n\n## Site Information\n- **Site ID**: Site 1745\n- **Study**: Study 25\n- **Country**: JPN\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 1747", "study": "Study 25", "site": "Site 1747", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 1747\n\n## Site Information\n- **Site ID**: Site 1747\n- **Study**: Study 25\n- **Country**: MYS\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 1770", "study": "Study 25", "site": "Site 1770", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 1770\n\n## Site Information\n- **Site ID**: Site 1770\n- **Study**: Study 25\n- **Country**: MEX\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 1771", "study": "Study 25", "site": "Site 1771", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 1771\n\n## Site Information\n- **Site ID**: Site 1771\n- **Study**: Study 25\n- **Country**: MEX\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 1772", "study": "Study 25", "site": "Site 1772", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 1772\n\n## Site Information\n- **Site ID**: Site 1772\n- **Study**: Study 25\n- **Country**: MEX\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 1791", "study": "Study 25", "site": "Site 1791", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 1791\n\n## Site Information\n- **Site ID**: Site 1791\n- **Study**: Study 25\n- **Country**: RUS\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 1795", "study": "Study 25", "site": "Site 1795", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 1795\n\n## Site Information\n- **Site ID**: Site 1795\n- **Study**: Study 25\n- **Country**: RUS\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 1816", "study": "Study 25", "site": "Site 1816", "type": "site_summary", "total_subjects": 8, "total_issues": 0, "document": "# Site Report: Site 1816\n\n## Site Information\n- **Site ID**: Site 1816\n- **Study**: Study 25\n- **Country**: SGP\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 8 (100.0%)\n\n## Risk Profile\n- Low Risk: 8 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 1845", "study": "Study 25", "site": "Site 1845", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 1845\n\n## Site Information\n- **Site ID**: Site 1845\n- **Study**: Study 25\n- **Country**: ESP\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 1846", "study": "Study 25", "site": "Site 1846", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 1846\n\n## Site Information\n- **Site ID**: Site 1846\n- **Study**: Study 25\n- **Country**: ESP\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 1847", "study": "Study 25", "site": "Site 1847", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1847\n\n## Site Information\n- **Site ID**: Site 1847\n- **Study**: Study 25\n- **Country**: ESP\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 1848", "study": "Study 25", "site": "Site 1848", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1848\n\n## Site Information\n- **Site ID**: Site 1848\n- **Study**: Study 25\n- **Country**: ESP\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 1849", "study": "Study 25", "site": "Site 1849", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 1849\n\n## Site Information\n- **Site ID**: Site 1849\n- **Study**: Study 25\n- **Country**: ESP\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 1850", "study": "Study 25", "site": "Site 1850", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 1850\n\n## Site Information\n- **Site ID**: Site 1850\n- **Study**: Study 25\n- **Country**: ESP\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 1906", "study": "Study 25", "site": "Site 1906", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 1906\n\n## Site Information\n- **Site ID**: Site 1906\n- **Study**: Study 25\n- **Country**: SWE\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 1909", "study": "Study 25", "site": "Site 1909", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 1909\n\n## Site Information\n- **Site ID**: Site 1909\n- **Study**: Study 25\n- **Country**: TWN\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 1951", "study": "Study 25", "site": "Site 1951", "type": "site_summary", "total_subjects": 9, "total_issues": 0, "document": "# Site Report: Site 1951\n\n## Site Information\n- **Site ID**: Site 1951\n- **Study**: Study 25\n- **Country**: VNM\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 9 (100.0%)\n\n## Risk Profile\n- Low Risk: 9 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 1957", "study": "Study 25", "site": "Site 1957", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1957\n\n## Site Information\n- **Site ID**: Site 1957\n- **Study**: Study 25\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 1958", "study": "Study 25", "site": "Site 1958", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 1958\n\n## Site Information\n- **Site ID**: Site 1958\n- **Study**: Study 25\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 1960", "study": "Study 25", "site": "Site 1960", "type": "site_summary", "total_subjects": 6, "total_issues": 2, "document": "# Site Report: Site 1960\n\n## Site Information\n- **Site ID**: Site 1960\n- **Study**: Study 25\n- **Country**: USA\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.33\n- **Clean Subjects**: 4 (66.7%)\n\n## Risk Profile\n- Low Risk: 4 (66.7%)\n- Medium Risk: 2 (33.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 2\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 1981", "study": "Study 25", "site": "Site 1981", "type": "site_summary", "total_subjects": 13, "total_issues": 3, "document": "# Site Report: Site 1981\n\n## Site Information\n- **Site ID**: Site 1981\n- **Study**: Study 25\n- **Country**: SVN\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 0.23\n- **Clean Subjects**: 10 (76.9%)\n\n## Risk Profile\n- Low Risk: 10 (76.9%)\n- Medium Risk: 3 (23.1%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2", "study": "Study 25", "site": "Site 2", "type": "site_summary", "total_subjects": 5, "total_issues": 1, "document": "# Site Report: Site 2\n\n## Site Information\n- **Site ID**: Site 2\n- **Study**: Study 25\n- **Country**: ARG\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.20\n- **Clean Subjects**: 4 (80.0%)\n\n## Risk Profile\n- Low Risk: 4 (80.0%)\n- Medium Risk: 1 (20.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2184", "study": "Study 25", "site": "Site 2184", "type": "site_summary", "total_subjects": 2, "total_issues": 1, "document": "# Site Report: Site 2184\n\n## Site Information\n- **Site ID**: Site 2184\n- **Study**: Study 25\n- **Country**: DEU\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.50\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2188", "study": "Study 25", "site": "Site 2188", "type": "site_summary", "total_subjects": 14, "total_issues": 0, "document": "# Site Report: Site 2188\n\n## Site Information\n- **Site ID**: Site 2188\n- **Study**: Study 25\n- **Country**: RUS\n- **Total Subjects**: 14\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 14 (100.0%)\n\n## Risk Profile\n- Low Risk: 14 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2192", "study": "Study 25", "site": "Site 2192", "type": "site_summary", "total_subjects": 6, "total_issues": 1, "document": "# Site Report: Site 2192\n\n## Site Information\n- **Site ID**: Site 2192\n- **Study**: Study 25\n- **Country**: CHN\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.17\n- **Clean Subjects**: 5 (83.3%)\n\n## Risk Profile\n- Low Risk: 5 (83.3%)\n- Medium Risk: 1 (16.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2193", "study": "Study 25", "site": "Site 2193", "type": "site_summary", "total_subjects": 32, "total_issues": 1, "document": "# Site Report: Site 2193\n\n## Site Information\n- **Site ID**: Site 2193\n- **Study**: Study 25\n- **Country**: CHN\n- **Total Subjects**: 32\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.03\n- **Clean Subjects**: 31 (96.9%)\n\n## Risk Profile\n- Low Risk: 31 (96.9%)\n- Medium Risk: 1 (3.1%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2194", "study": "Study 25", "site": "Site 2194", "type": "site_summary", "total_subjects": 20, "total_issues": 3, "document": "# Site Report: Site 2194\n\n## Site Information\n- **Site ID**: Site 2194\n- **Study**: Study 25\n- **Country**: CHN\n- **Total Subjects**: 20\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 0.15\n- **Clean Subjects**: 18 (90.0%)\n\n## Risk Profile\n- Low Risk: 18 (90.0%)\n- Medium Risk: 2 (10.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 3\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2195", "study": "Study 25", "site": "Site 2195", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 2195\n\n## Site Information\n- **Site ID**: Site 2195\n- **Study**: Study 25\n- **Country**: CHN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2196", "study": "Study 25", "site": "Site 2196", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 2196\n\n## Site Information\n- **Site ID**: Site 2196\n- **Study**: Study 25\n- **Country**: CHN\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2197", "study": "Study 25", "site": "Site 2197", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 2197\n\n## Site Information\n- **Site ID**: Site 2197\n- **Study**: Study 25\n- **Country**: CHN\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2198", "study": "Study 25", "site": "Site 2198", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 2198\n\n## Site Information\n- **Site ID**: Site 2198\n- **Study**: Study 25\n- **Country**: CHN\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2199", "study": "Study 25", "site": "Site 2199", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 2199\n\n## Site Information\n- **Site ID**: Site 2199\n- **Study**: Study 25\n- **Country**: CHN\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2200", "study": "Study 25", "site": "Site 2200", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 2200\n\n## Site Information\n- **Site ID**: Site 2200\n- **Study**: Study 25\n- **Country**: CHN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2201", "study": "Study 25", "site": "Site 2201", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 2201\n\n## Site Information\n- **Site ID**: Site 2201\n- **Study**: Study 25\n- **Country**: CHN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2202", "study": "Study 25", "site": "Site 2202", "type": "site_summary", "total_subjects": 8, "total_issues": 7, "document": "# Site Report: Site 2202\n\n## Site Information\n- **Site ID**: Site 2202\n- **Study**: Study 25\n- **Country**: CHN\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 7\n- **Average Issues per Subject**: 0.88\n- **Clean Subjects**: 7 (87.5%)\n\n## Risk Profile\n- Low Risk: 7 (87.5%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (12.5%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 7\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 47872: High risk, 7 issues\n"}
{"id": "site_Study 25_Site 2203", "study": "Study 25", "site": "Site 2203", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 2203\n\n## Site Information\n- **Site ID**: Site 2203\n- **Study**: Study 25\n- **Country**: CHN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2204", "study": "Study 25", "site": "Site 2204", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 2204\n\n## Site Information\n- **Site ID**: Site 2204\n- **Study**: Study 25\n- **Country**: CHN\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2205", "study": "Study 25", "site": "Site 2205", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 2205\n\n## Site Information\n- **Site ID**: Site 2205\n- **Study**: Study 25\n- **Country**: CHN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2206", "study": "Study 25", "site": "Site 2206", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 2206\n\n## Site Information\n- **Site ID**: Site 2206\n- **Study**: Study 25\n- **Country**: DEU\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2207", "study": "Study 25", "site": "Site 2207", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 2207\n\n## Site Information\n- **Site ID**: Site 2207\n- **Study**: Study 25\n- **Country**: DEU\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2208", "study": "Study 25", "site": "Site 2208", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 2208\n\n## Site Information\n- **Site ID**: Site 2208\n- **Study**: Study 25\n- **Country**: JPN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2209", "study": "Study 25", "site": "Site 2209", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 2209\n\n## Site Information\n- **Site ID**: Site 2209\n- **Study**: Study 25\n- **Country**: JPN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2210", "study": "Study 25", "site": "Site 2210", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 2210\n\n## Site Information\n- **Site ID**: Site 2210\n- **Study**: Study 25\n- **Country**: JPN\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2211", "study": "Study 25", "site": "Site 2211", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 2211\n\n## Site Information\n- **Site ID**: Site 2211\n- **Study**: Study 25\n- **Country**: MEX\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2212", "study": "Study 25", "site": "Site 2212", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 2212\n\n## Site Information\n- **Site ID**: Site 2212\n- **Study**: Study 25\n- **Country**: TWN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2213", "study": "Study 25", "site": "Site 2213", "type": "site_summary", "total_subjects": 9, "total_issues": 1, "document": "# Site Report: Site 2213\n\n## Site Information\n- **Site ID**: Site 2213\n- **Study**: Study 25\n- **Country**: THA\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.11\n- **Clean Subjects**: 8 (88.9%)\n\n## Risk Profile\n- Low Risk: 8 (88.9%)\n- Medium Risk: 1 (11.1%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2214", "study": "Study 25", "site": "Site 2214", "type": "site_summary", "total_subjects": 13, "total_issues": 0, "document": "# Site Report: Site 2214\n\n## Site Information\n- **Site ID**: Site 2214\n- **Study**: Study 25\n- **Country**: THA\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 13 (100.0%)\n\n## Risk Profile\n- Low Risk: 13 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2215", "study": "Study 25", "site": "Site 2215", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 2215\n\n## Site Information\n- **Site ID**: Site 2215\n- **Study**: Study 25\n- **Country**: THA\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2216", "study": "Study 25", "site": "Site 2216", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 2216\n\n## Site Information\n- **Site ID**: Site 2216\n- **Study**: Study 25\n- **Country**: THA\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2217", "study": "Study 25", "site": "Site 2217", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 2217\n\n## Site Information\n- **Site ID**: Site 2217\n- **Study**: Study 25\n- **Country**: THA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2218", "study": "Study 25", "site": "Site 2218", "type": "site_summary", "total_subjects": 5, "total_issues": 3, "document": "# Site Report: Site 2218\n\n## Site Information\n- **Site ID**: Site 2218\n- **Study**: Study 25\n- **Country**: TUR\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 0.60\n- **Clean Subjects**: 3 (60.0%)\n\n## Risk Profile\n- Low Risk: 3 (60.0%)\n- Medium Risk: 2 (40.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2219", "study": "Study 25", "site": "Site 2219", "type": "site_summary", "total_subjects": 26, "total_issues": 7, "document": "# Site Report: Site 2219\n\n## Site Information\n- **Site ID**: Site 2219\n- **Study**: Study 25\n- **Country**: TUR\n- **Total Subjects**: 26\n\n## Performance Metrics\n- **Total Issues**: 7\n- **Average Issues per Subject**: 0.27\n- **Clean Subjects**: 22 (84.6%)\n\n## Risk Profile\n- Low Risk: 22 (84.6%)\n- Medium Risk: 4 (15.4%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 6\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2220", "study": "Study 25", "site": "Site 2220", "type": "site_summary", "total_subjects": 14, "total_issues": 2, "document": "# Site Report: Site 2220\n\n## Site Information\n- **Site ID**: Site 2220\n- **Study**: Study 25\n- **Country**: TUR\n- **Total Subjects**: 14\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.14\n- **Clean Subjects**: 12 (85.7%)\n\n## Risk Profile\n- Low Risk: 12 (85.7%)\n- Medium Risk: 2 (14.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 2\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2221", "study": "Study 25", "site": "Site 2221", "type": "site_summary", "total_subjects": 30, "total_issues": 3, "document": "# Site Report: Site 2221\n\n## Site Information\n- **Site ID**: Site 2221\n- **Study**: Study 25\n- **Country**: TUR\n- **Total Subjects**: 30\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 0.10\n- **Clean Subjects**: 27 (90.0%)\n\n## Risk Profile\n- Low Risk: 27 (90.0%)\n- Medium Risk: 3 (10.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 3\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2222", "study": "Study 25", "site": "Site 2222", "type": "site_summary", "total_subjects": 9, "total_issues": 1, "document": "# Site Report: Site 2222\n\n## Site Information\n- **Site ID**: Site 2222\n- **Study**: Study 25\n- **Country**: TUR\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.11\n- **Clean Subjects**: 8 (88.9%)\n\n## Risk Profile\n- Low Risk: 8 (88.9%)\n- Medium Risk: 1 (11.1%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2223", "study": "Study 25", "site": "Site 2223", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 2223\n\n## Site Information\n- **Site ID**: Site 2223\n- **Study**: Study 25\n- **Country**: TUR\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2224", "study": "Study 25", "site": "Site 2224", "type": "site_summary", "total_subjects": 18, "total_issues": 3, "document": "# Site Report: Site 2224\n\n## Site Information\n- **Site ID**: Site 2224\n- **Study**: Study 25\n- **Country**: TUR\n- **Total Subjects**: 18\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 0.17\n- **Clean Subjects**: 15 (83.3%)\n\n## Risk Profile\n- Low Risk: 15 (83.3%)\n- Medium Risk: 3 (16.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 3\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2225", "study": "Study 25", "site": "Site 2225", "type": "site_summary", "total_subjects": 8, "total_issues": 4, "document": "# Site Report: Site 2225\n\n## Site Information\n- **Site ID**: Site 2225\n- **Study**: Study 25\n- **Country**: TUR\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 0.50\n- **Clean Subjects**: 6 (75.0%)\n\n## Risk Profile\n- Low Risk: 6 (75.0%)\n- Medium Risk: 2 (25.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 1\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2226", "study": "Study 25", "site": "Site 2226", "type": "site_summary", "total_subjects": 2, "total_issues": 1, "document": "# Site Report: Site 2226\n\n## Site Information\n- **Site ID**: Site 2226\n- **Study**: Study 25\n- **Country**: TUR\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.50\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2227", "study": "Study 25", "site": "Site 2227", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 2227\n\n## Site Information\n- **Site ID**: Site 2227\n- **Study**: Study 25\n- **Country**: GBR\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2228", "study": "Study 25", "site": "Site 2228", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 2228\n\n## Site Information\n- **Site ID**: Site 2228\n- **Study**: Study 25\n- **Country**: GBR\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2229", "study": "Study 25", "site": "Site 2229", "type": "site_summary", "total_subjects": 3, "total_issues": 1, "document": "# Site Report: Site 2229\n\n## Site Information\n- **Site ID**: Site 2229\n- **Study**: Study 25\n- **Country**: GBR\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.33\n- **Clean Subjects**: 2 (66.7%)\n\n## Risk Profile\n- Low Risk: 2 (66.7%)\n- Medium Risk: 1 (33.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2230", "study": "Study 25", "site": "Site 2230", "type": "site_summary", "total_subjects": 6, "total_issues": 4, "document": "# Site Report: Site 2230\n\n## Site Information\n- **Site ID**: Site 2230\n- **Study**: Study 25\n- **Country**: GBR\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 0.67\n- **Clean Subjects**: 5 (83.3%)\n\n## Risk Profile\n- Low Risk: 5 (83.3%)\n- Medium Risk: 1 (16.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 4\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2231", "study": "Study 25", "site": "Site 2231", "type": "site_summary", "total_subjects": 5, "total_issues": 1, "document": "# Site Report: Site 2231\n\n## Site Information\n- **Site ID**: Site 2231\n- **Study**: Study 25\n- **Country**: GBR\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.20\n- **Clean Subjects**: 4 (80.0%)\n\n## Risk Profile\n- Low Risk: 4 (80.0%)\n- Medium Risk: 1 (20.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2232", "study": "Study 25", "site": "Site 2232", "type": "site_summary", "total_subjects": 17, "total_issues": 1, "document": "# Site Report: Site 2232\n\n## Site Information\n- **Site ID**: Site 2232\n- **Study**: Study 25\n- **Country**: USA\n- **Total Subjects**: 17\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.06\n- **Clean Subjects**: 16 (94.1%)\n\n## Risk Profile\n- Low Risk: 16 (94.1%)\n- Medium Risk: 1 (5.9%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2233", "study": "Study 25", "site": "Site 2233", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 2233\n\n## Site Information\n- **Site ID**: Site 2233\n- **Study**: Study 25\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2234", "study": "Study 25", "site": "Site 2234", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 2234\n\n## Site Information\n- **Site ID**: Site 2234\n- **Study**: Study 25\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2235", "study": "Study 25", "site": "Site 2235", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 2235\n\n## Site Information\n- **Site ID**: Site 2235\n- **Study**: Study 25\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2236", "study": "Study 25", "site": "Site 2236", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 2236\n\n## Site Information\n- **Site ID**: Site 2236\n- **Study**: Study 25\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2237", "study": "Study 25", "site": "Site 2237", "type": "site_summary", "total_subjects": 5, "total_issues": 1, "document": "# Site Report: Site 2237\n\n## Site Information\n- **Site ID**: Site 2237\n- **Study**: Study 25\n- **Country**: USA\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.20\n- **Clean Subjects**: 4 (80.0%)\n\n## Risk Profile\n- Low Risk: 4 (80.0%)\n- Medium Risk: 1 (20.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2238", "study": "Study 25", "site": "Site 2238", "type": "site_summary", "total_subjects": 8, "total_issues": 0, "document": "# Site Report: Site 2238\n\n## Site Information\n- **Site ID**: Site 2238\n- **Study**: Study 25\n- **Country**: USA\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 8 (100.0%)\n\n## Risk Profile\n- Low Risk: 8 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2239", "study": "Study 25", "site": "Site 2239", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 2239\n\n## Site Information\n- **Site ID**: Site 2239\n- **Study**: Study 25\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2240", "study": "Study 25", "site": "Site 2240", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 2240\n\n## Site Information\n- **Site ID**: Site 2240\n- **Study**: Study 25\n- **Country**: USA\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2241", "study": "Study 25", "site": "Site 2241", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 2241\n\n## Site Information\n- **Site ID**: Site 2241\n- **Study**: Study 25\n- **Country**: USA\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2242", "study": "Study 25", "site": "Site 2242", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 2242\n\n## Site Information\n- **Site ID**: Site 2242\n- **Study**: Study 25\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2243", "study": "Study 25", "site": "Site 2243", "type": "site_summary", "total_subjects": 9, "total_issues": 0, "document": "# Site Report: Site 2243\n\n## Site Information\n- **Site ID**: Site 2243\n- **Study**: Study 25\n- **Country**: USA\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 9 (100.0%)\n\n## Risk Profile\n- Low Risk: 9 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2244", "study": "Study 25", "site": "Site 2244", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 2244\n\n## Site Information\n- **Site ID**: Site 2244\n- **Study**: Study 25\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2245", "study": "Study 25", "site": "Site 2245", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 2245\n\n## Site Information\n- **Site ID**: Site 2245\n- **Study**: Study 25\n- **Country**: USA\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2246", "study": "Study 25", "site": "Site 2246", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 2246\n\n## Site Information\n- **Site ID**: Site 2246\n- **Study**: Study 25\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2247", "study": "Study 25", "site": "Site 2247", "type": "site_summary", "total_subjects": 10, "total_issues": 2, "document": "# Site Report: Site 2247\n\n## Site Information\n- **Site ID**: Site 2247\n- **Study**: Study 25\n- **Country**: USA\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.20\n- **Clean Subjects**: 9 (90.0%)\n\n## Risk Profile\n- Low Risk: 9 (90.0%)\n- Medium Risk: 1 (10.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 2\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2248", "study": "Study 25", "site": "Site 2248", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 2248\n\n## Site Information\n- **Site ID**: Site 2248\n- **Study**: Study 25\n- **Country**: USA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2249", "study": "Study 25", "site": "Site 2249", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 2249\n\n## Site Information\n- **Site ID**: Site 2249\n- **Study**: Study 25\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2250", "study": "Study 25", "site": "Site 2250", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 2250\n\n## Site Information\n- **Site ID**: Site 2250\n- **Study**: Study 25\n- **Country**: USA\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2251", "study": "Study 25", "site": "Site 2251", "type": "site_summary", "total_subjects": 2, "total_issues": 8, "document": "# Site Report: Site 2251\n\n## Site Information\n- **Site ID**: Site 2251\n- **Study**: Study 25\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 8\n- **Average Issues per Subject**: 4.00\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (50.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 8\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 48196: High risk, 8 issues\n"}
{"id": "site_Study 25_Site 2252", "study": "Study 25", "site": "Site 2252", "type": "site_summary", "total_subjects": 8, "total_issues": 3, "document": "# Site Report: Site 2252\n\n## Site Information\n- **Site ID**: Site 2252\n- **Study**: Study 25\n- **Country**: USA\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 0.38\n- **Clean Subjects**: 6 (75.0%)\n\n## Risk Profile\n- Low Risk: 6 (75.0%)\n- Medium Risk: 2 (25.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 2\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2253", "study": "Study 25", "site": "Site 2253", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 2253\n\n## Site Information\n- **Site ID**: Site 2253\n- **Study**: Study 25\n- **Country**: USA\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 2254", "study": "Study 25", "site": "Site 2254", "type": "site_summary", "total_subjects": 5, "total_issues": 2, "document": "# Site Report: Site 2254\n\n## Site Information\n- **Site ID**: Site 2254\n- **Study**: Study 25\n- **Country**: ZAF\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.40\n- **Clean Subjects**: 4 (80.0%)\n\n## Risk Profile\n- Low Risk: 4 (80.0%)\n- Medium Risk: 1 (20.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 29", "study": "Study 25", "site": "Site 29", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 29\n\n## Site Information\n- **Site ID**: Site 29\n- **Study**: Study 25\n- **Country**: ARG\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 3", "study": "Study 25", "site": "Site 3", "type": "site_summary", "total_subjects": 7, "total_issues": 1, "document": "# Site Report: Site 3\n\n## Site Information\n- **Site ID**: Site 3\n- **Study**: Study 25\n- **Country**: ARG\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.14\n- **Clean Subjects**: 6 (85.7%)\n\n## Risk Profile\n- Low Risk: 6 (85.7%)\n- Medium Risk: 1 (14.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 30", "study": "Study 25", "site": "Site 30", "type": "site_summary", "total_subjects": 7, "total_issues": 1, "document": "# Site Report: Site 30\n\n## Site Information\n- **Site ID**: Site 30\n- **Study**: Study 25\n- **Country**: ARG\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.14\n- **Clean Subjects**: 6 (85.7%)\n\n## Risk Profile\n- Low Risk: 6 (85.7%)\n- Medium Risk: 1 (14.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 31", "study": "Study 25", "site": "Site 31", "type": "site_summary", "total_subjects": 1, "total_issues": 5, "document": "# Site Report: Site 31\n\n## Site Information\n- **Site ID**: Site 31\n- **Study**: Study 25\n- **Country**: ARG\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 5\n- **Average Issues per Subject**: 5.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 4\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 323", "study": "Study 25", "site": "Site 323", "type": "site_summary", "total_subjects": 6, "total_issues": 1, "document": "# Site Report: Site 323\n\n## Site Information\n- **Site ID**: Site 323\n- **Study**: Study 25\n- **Country**: VNM\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.17\n- **Clean Subjects**: 5 (83.3%)\n\n## Risk Profile\n- Low Risk: 5 (83.3%)\n- Medium Risk: 1 (16.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 351", "study": "Study 25", "site": "Site 351", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 351\n\n## Site Information\n- **Site ID**: Site 351\n- **Study**: Study 25\n- **Country**: SWE\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 353", "study": "Study 25", "site": "Site 353", "type": "site_summary", "total_subjects": 4, "total_issues": 2, "document": "# Site Report: Site 353\n\n## Site Information\n- **Site ID**: Site 353\n- **Study**: Study 25\n- **Country**: ISR\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.50\n- **Clean Subjects**: 2 (50.0%)\n\n## Risk Profile\n- Low Risk: 2 (50.0%)\n- Medium Risk: 2 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 2\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 360", "study": "Study 25", "site": "Site 360", "type": "site_summary", "total_subjects": 3, "total_issues": 1, "document": "# Site Report: Site 360\n\n## Site Information\n- **Site ID**: Site 360\n- **Study**: Study 25\n- **Country**: FRA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.33\n- **Clean Subjects**: 2 (66.7%)\n\n## Risk Profile\n- Low Risk: 2 (66.7%)\n- Medium Risk: 1 (33.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 361", "study": "Study 25", "site": "Site 361", "type": "site_summary", "total_subjects": 3, "total_issues": 3, "document": "# Site Report: Site 361\n\n## Site Information\n- **Site ID**: Site 361\n- **Study**: Study 25\n- **Country**: FRA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 2 (66.7%)\n\n## Risk Profile\n- Low Risk: 2 (66.7%)\n- Medium Risk: 1 (33.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 3\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 362", "study": "Study 25", "site": "Site 362", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 362\n\n## Site Information\n- **Site ID**: Site 362\n- **Study**: Study 25\n- **Country**: FRA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 417", "study": "Study 25", "site": "Site 417", "type": "site_summary", "total_subjects": 8, "total_issues": 2, "document": "# Site Report: Site 417\n\n## Site Information\n- **Site ID**: Site 417\n- **Study**: Study 25\n- **Country**: DEU\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.25\n- **Clean Subjects**: 7 (87.5%)\n\n## Risk Profile\n- Low Risk: 7 (87.5%)\n- Medium Risk: 1 (12.5%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 419", "study": "Study 25", "site": "Site 419", "type": "site_summary", "total_subjects": 13, "total_issues": 5, "document": "# Site Report: Site 419\n\n## Site Information\n- **Site ID**: Site 419\n- **Study**: Study 25\n- **Country**: DEU\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 5\n- **Average Issues per Subject**: 0.38\n- **Clean Subjects**: 10 (76.9%)\n\n## Risk Profile\n- Low Risk: 10 (76.9%)\n- Medium Risk: 3 (23.1%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 4\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 420", "study": "Study 25", "site": "Site 420", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 420\n\n## Site Information\n- **Site ID**: Site 420\n- **Study**: Study 25\n- **Country**: DEU\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 422", "study": "Study 25", "site": "Site 422", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 422\n\n## Site Information\n- **Site ID**: Site 422\n- **Study**: Study 25\n- **Country**: DEU\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 423", "study": "Study 25", "site": "Site 423", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 423\n\n## Site Information\n- **Site ID**: Site 423\n- **Study**: Study 25\n- **Country**: DEU\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 424", "study": "Study 25", "site": "Site 424", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 424\n\n## Site Information\n- **Site ID**: Site 424\n- **Study**: Study 25\n- **Country**: DEU\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 464", "study": "Study 25", "site": "Site 464", "type": "site_summary", "total_subjects": 5, "total_issues": 1, "document": "# Site Report: Site 464\n\n## Site Information\n- **Site ID**: Site 464\n- **Study**: Study 25\n- **Country**: ITA\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.20\n- **Clean Subjects**: 4 (80.0%)\n\n## Risk Profile\n- Low Risk: 4 (80.0%)\n- Medium Risk: 1 (20.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 466", "study": "Study 25", "site": "Site 466", "type": "site_summary", "total_subjects": 6, "total_issues": 2, "document": "# Site Report: Site 466\n\n## Site Information\n- **Site ID**: Site 466\n- **Study**: Study 25\n- **Country**: AUS\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.33\n- **Clean Subjects**: 4 (66.7%)\n\n## Risk Profile\n- Low Risk: 4 (66.7%)\n- Medium Risk: 2 (33.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 2\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 467", "study": "Study 25", "site": "Site 467", "type": "site_summary", "total_subjects": 4, "total_issues": 1, "document": "# Site Report: Site 467\n\n## Site Information\n- **Site ID**: Site 467\n- **Study**: Study 25\n- **Country**: AUS\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.25\n- **Clean Subjects**: 3 (75.0%)\n\n## Risk Profile\n- Low Risk: 3 (75.0%)\n- Medium Risk: 1 (25.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 468", "study": "Study 25", "site": "Site 468", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 468\n\n## Site Information\n- **Site ID**: Site 468\n- **Study**: Study 25\n- **Country**: AUS\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 469", "study": "Study 25", "site": "Site 469", "type": "site_summary", "total_subjects": 13, "total_issues": 1, "document": "# Site Report: Site 469\n\n## Site Information\n- **Site ID**: Site 469\n- **Study**: Study 25\n- **Country**: BRA\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.08\n- **Clean Subjects**: 12 (92.3%)\n\n## Risk Profile\n- Low Risk: 12 (92.3%)\n- Medium Risk: 1 (7.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 47", "study": "Study 25", "site": "Site 47", "type": "site_summary", "total_subjects": 8, "total_issues": 1, "document": "# Site Report: Site 47\n\n## Site Information\n- **Site ID**: Site 47\n- **Study**: Study 25\n- **Country**: AUS\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.12\n- **Clean Subjects**: 7 (87.5%)\n\n## Risk Profile\n- Low Risk: 7 (87.5%)\n- Medium Risk: 1 (12.5%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 475", "study": "Study 25", "site": "Site 475", "type": "site_summary", "total_subjects": 15, "total_issues": 2, "document": "# Site Report: Site 475\n\n## Site Information\n- **Site ID**: Site 475\n- **Study**: Study 25\n- **Country**: CZE\n- **Total Subjects**: 15\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.13\n- **Clean Subjects**: 14 (93.3%)\n\n## Risk Profile\n- Low Risk: 14 (93.3%)\n- Medium Risk: 1 (6.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 479", "study": "Study 25", "site": "Site 479", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 479\n\n## Site Information\n- **Site ID**: Site 479\n- **Study**: Study 25\n- **Country**: DNK\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 48", "study": "Study 25", "site": "Site 48", "type": "site_summary", "total_subjects": 11, "total_issues": 2, "document": "# Site Report: Site 48\n\n## Site Information\n- **Site ID**: Site 48\n- **Study**: Study 25\n- **Country**: BEL\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.18\n- **Clean Subjects**: 9 (81.8%)\n\n## Risk Profile\n- Low Risk: 9 (81.8%)\n- Medium Risk: 2 (18.2%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 2\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 480", "study": "Study 25", "site": "Site 480", "type": "site_summary", "total_subjects": 8, "total_issues": 2, "document": "# Site Report: Site 480\n\n## Site Information\n- **Site ID**: Site 480\n- **Study**: Study 25\n- **Country**: DNK\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.25\n- **Clean Subjects**: 6 (75.0%)\n\n## Risk Profile\n- Low Risk: 6 (75.0%)\n- Medium Risk: 2 (25.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 2\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 49", "study": "Study 25", "site": "Site 49", "type": "site_summary", "total_subjects": 6, "total_issues": 2, "document": "# Site Report: Site 49\n\n## Site Information\n- **Site ID**: Site 49\n- **Study**: Study 25\n- **Country**: BEL\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.33\n- **Clean Subjects**: 4 (66.7%)\n\n## Risk Profile\n- Low Risk: 4 (66.7%)\n- Medium Risk: 2 (33.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 5", "study": "Study 25", "site": "Site 5", "type": "site_summary", "total_subjects": 2, "total_issues": 2, "document": "# Site Report: Site 5\n\n## Site Information\n- **Site ID**: Site 5\n- **Study**: Study 25\n- **Country**: CAN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 2\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 50", "study": "Study 25", "site": "Site 50", "type": "site_summary", "total_subjects": 10, "total_issues": 7, "document": "# Site Report: Site 50\n\n## Site Information\n- **Site ID**: Site 50\n- **Study**: Study 25\n- **Country**: BEL\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 7\n- **Average Issues per Subject**: 0.70\n- **Clean Subjects**: 9 (90.0%)\n\n## Risk Profile\n- Low Risk: 9 (90.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (10.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 7\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 279: High risk, 7 issues\n"}
{"id": "site_Study 25_Site 504", "study": "Study 25", "site": "Site 504", "type": "site_summary", "total_subjects": 8, "total_issues": 4, "document": "# Site Report: Site 504\n\n## Site Information\n- **Site ID**: Site 504\n- **Study**: Study 25\n- **Country**: DEU\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 0.50\n- **Clean Subjects**: 6 (75.0%)\n\n## Risk Profile\n- Low Risk: 6 (75.0%)\n- Medium Risk: 2 (25.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 4\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 507", "study": "Study 25", "site": "Site 507", "type": "site_summary", "total_subjects": 8, "total_issues": 0, "document": "# Site Report: Site 507\n\n## Site Information\n- **Site ID**: Site 507\n- **Study**: Study 25\n- **Country**: DEU\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 8 (100.0%)\n\n## Risk Profile\n- Low Risk: 8 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 508", "study": "Study 25", "site": "Site 508", "type": "site_summary", "total_subjects": 7, "total_issues": 3, "document": "# Site Report: Site 508\n\n## Site Information\n- **Site ID**: Site 508\n- **Study**: Study 25\n- **Country**: DEU\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 0.43\n- **Clean Subjects**: 4 (57.1%)\n\n## Risk Profile\n- Low Risk: 4 (57.1%)\n- Medium Risk: 3 (42.9%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 2\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 509", "study": "Study 25", "site": "Site 509", "type": "site_summary", "total_subjects": 8, "total_issues": 1, "document": "# Site Report: Site 509\n\n## Site Information\n- **Site ID**: Site 509\n- **Study**: Study 25\n- **Country**: IND\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.12\n- **Clean Subjects**: 7 (87.5%)\n\n## Risk Profile\n- Low Risk: 7 (87.5%)\n- Medium Risk: 1 (12.5%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 510", "study": "Study 25", "site": "Site 510", "type": "site_summary", "total_subjects": 8, "total_issues": 2, "document": "# Site Report: Site 510\n\n## Site Information\n- **Site ID**: Site 510\n- **Study**: Study 25\n- **Country**: IND\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.25\n- **Clean Subjects**: 6 (75.0%)\n\n## Risk Profile\n- Low Risk: 6 (75.0%)\n- Medium Risk: 2 (25.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 2\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 512", "study": "Study 25", "site": "Site 512", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 512\n\n## Site Information\n- **Site ID**: Site 512\n- **Study**: Study 25\n- **Country**: ISR\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 518", "study": "Study 25", "site": "Site 518", "type": "site_summary", "total_subjects": 12, "total_issues": 2, "document": "# Site Report: Site 518\n\n## Site Information\n- **Site ID**: Site 518\n- **Study**: Study 25\n- **Country**: MYS\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.17\n- **Clean Subjects**: 10 (83.3%)\n\n## Risk Profile\n- Low Risk: 10 (83.3%)\n- Medium Risk: 2 (16.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 521", "study": "Study 25", "site": "Site 521", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 521\n\n## Site Information\n- **Site ID**: Site 521\n- **Study**: Study 25\n- **Country**: NOR\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 525", "study": "Study 25", "site": "Site 525", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 525\n\n## Site Information\n- **Site ID**: Site 525\n- **Study**: Study 25\n- **Country**: RUS\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 526", "study": "Study 25", "site": "Site 526", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 526\n\n## Site Information\n- **Site ID**: Site 526\n- **Study**: Study 25\n- **Country**: RUS\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 529", "study": "Study 25", "site": "Site 529", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 529\n\n## Site Information\n- **Site ID**: Site 529\n- **Study**: Study 25\n- **Country**: ESP\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 530", "study": "Study 25", "site": "Site 530", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 530\n\n## Site Information\n- **Site ID**: Site 530\n- **Study**: Study 25\n- **Country**: ESP\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 567", "study": "Study 25", "site": "Site 567", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 567\n\n## Site Information\n- **Site ID**: Site 567\n- **Study**: Study 25\n- **Country**: DEU\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 575", "study": "Study 25", "site": "Site 575", "type": "site_summary", "total_subjects": 9, "total_issues": 0, "document": "# Site Report: Site 575\n\n## Site Information\n- **Site ID**: Site 575\n- **Study**: Study 25\n- **Country**: KOR\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 9 (100.0%)\n\n## Risk Profile\n- Low Risk: 9 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 586", "study": "Study 25", "site": "Site 586", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 586\n\n## Site Information\n- **Site ID**: Site 586\n- **Study**: Study 25\n- **Country**: SWE\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 588", "study": "Study 25", "site": "Site 588", "type": "site_summary", "total_subjects": 10, "total_issues": 0, "document": "# Site Report: Site 588\n\n## Site Information\n- **Site ID**: Site 588\n- **Study**: Study 25\n- **Country**: TWN\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 10 (100.0%)\n\n## Risk Profile\n- Low Risk: 10 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 589", "study": "Study 25", "site": "Site 589", "type": "site_summary", "total_subjects": 19, "total_issues": 0, "document": "# Site Report: Site 589\n\n## Site Information\n- **Site ID**: Site 589\n- **Study**: Study 25\n- **Country**: TWN\n- **Total Subjects**: 19\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 19 (100.0%)\n\n## Risk Profile\n- Low Risk: 19 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 590", "study": "Study 25", "site": "Site 590", "type": "site_summary", "total_subjects": 4, "total_issues": 1, "document": "# Site Report: Site 590\n\n## Site Information\n- **Site ID**: Site 590\n- **Study**: Study 25\n- **Country**: TWN\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.25\n- **Clean Subjects**: 3 (75.0%)\n\n## Risk Profile\n- Low Risk: 3 (75.0%)\n- Medium Risk: 1 (25.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 592", "study": "Study 25", "site": "Site 592", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 592\n\n## Site Information\n- **Site ID**: Site 592\n- **Study**: Study 25\n- **Country**: TWN\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 598", "study": "Study 25", "site": "Site 598", "type": "site_summary", "total_subjects": 5, "total_issues": 1, "document": "# Site Report: Site 598\n\n## Site Information\n- **Site ID**: Site 598\n- **Study**: Study 25\n- **Country**: SGP\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.20\n- **Clean Subjects**: 4 (80.0%)\n\n## Risk Profile\n- Low Risk: 4 (80.0%)\n- Medium Risk: 1 (20.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 6", "study": "Study 25", "site": "Site 6", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 6\n\n## Site Information\n- **Site ID**: Site 6\n- **Study**: Study 25\n- **Country**: CAN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 61", "study": "Study 25", "site": "Site 61", "type": "site_summary", "total_subjects": 21, "total_issues": 8, "document": "# Site Report: Site 61\n\n## Site Information\n- **Site ID**: Site 61\n- **Study**: Study 25\n- **Country**: CHN\n- **Total Subjects**: 21\n\n## Performance Metrics\n- **Total Issues**: 8\n- **Average Issues per Subject**: 0.38\n- **Clean Subjects**: 19 (90.5%)\n\n## Risk Profile\n- Low Risk: 19 (90.5%)\n- Medium Risk: 1 (4.8%)\n- High Risk: 1 (4.8%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 7\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 31086: High risk, 7 issues\n"}
{"id": "site_Study 25_Site 62", "study": "Study 25", "site": "Site 62", "type": "site_summary", "total_subjects": 10, "total_issues": 1, "document": "# Site Report: Site 62\n\n## Site Information\n- **Site ID**: Site 62\n- **Study**: Study 25\n- **Country**: CHN\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.10\n- **Clean Subjects**: 9 (90.0%)\n\n## Risk Profile\n- Low Risk: 9 (90.0%)\n- Medium Risk: 1 (10.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 63", "study": "Study 25", "site": "Site 63", "type": "site_summary", "total_subjects": 23, "total_issues": 0, "document": "# Site Report: Site 63\n\n## Site Information\n- **Site ID**: Site 63\n- **Study**: Study 25\n- **Country**: CHN\n- **Total Subjects**: 23\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 23 (100.0%)\n\n## Risk Profile\n- Low Risk: 23 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 65", "study": "Study 25", "site": "Site 65", "type": "site_summary", "total_subjects": 8, "total_issues": 22, "document": "# Site Report: Site 65\n\n## Site Information\n- **Site ID**: Site 65\n- **Study**: Study 25\n- **Country**: CHN\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 22\n- **Average Issues per Subject**: 2.75\n- **Clean Subjects**: 7 (87.5%)\n\n## Risk Profile\n- Low Risk: 7 (87.5%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (12.5%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 22\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 448: Critical risk, 22 issues\n"}
{"id": "site_Study 25_Site 66", "study": "Study 25", "site": "Site 66", "type": "site_summary", "total_subjects": 10, "total_issues": 0, "document": "# Site Report: Site 66\n\n## Site Information\n- **Site ID**: Site 66\n- **Study**: Study 25\n- **Country**: CHN\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 10 (100.0%)\n\n## Risk Profile\n- Low Risk: 10 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 67", "study": "Study 25", "site": "Site 67", "type": "site_summary", "total_subjects": 17, "total_issues": 7, "document": "# Site Report: Site 67\n\n## Site Information\n- **Site ID**: Site 67\n- **Study**: Study 25\n- **Country**: CHN\n- **Total Subjects**: 17\n\n## Performance Metrics\n- **Total Issues**: 7\n- **Average Issues per Subject**: 0.41\n- **Clean Subjects**: 16 (94.1%)\n\n## Risk Profile\n- Low Risk: 16 (94.1%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (5.9%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 7\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 31114: High risk, 7 issues\n"}
{"id": "site_Study 25_Site 68", "study": "Study 25", "site": "Site 68", "type": "site_summary", "total_subjects": 8, "total_issues": 0, "document": "# Site Report: Site 68\n\n## Site Information\n- **Site ID**: Site 68\n- **Study**: Study 25\n- **Country**: CHN\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 8 (100.0%)\n\n## Risk Profile\n- Low Risk: 8 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 69", "study": "Study 25", "site": "Site 69", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 69\n\n## Site Information\n- **Site ID**: Site 69\n- **Study**: Study 25\n- **Country**: CHN\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 7", "study": "Study 25", "site": "Site 7", "type": "site_summary", "total_subjects": 16, "total_issues": 0, "document": "# Site Report: Site 7\n\n## Site Information\n- **Site ID**: Site 7\n- **Study**: Study 25\n- **Country**: COL\n- **Total Subjects**: 16\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 16 (100.0%)\n\n## Risk Profile\n- Low Risk: 16 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 70", "study": "Study 25", "site": "Site 70", "type": "site_summary", "total_subjects": 18, "total_issues": 1, "document": "# Site Report: Site 70\n\n## Site Information\n- **Site ID**: Site 70\n- **Study**: Study 25\n- **Country**: CHN\n- **Total Subjects**: 18\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.06\n- **Clean Subjects**: 17 (94.4%)\n\n## Risk Profile\n- Low Risk: 17 (94.4%)\n- Medium Risk: 1 (5.6%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 71", "study": "Study 25", "site": "Site 71", "type": "site_summary", "total_subjects": 12, "total_issues": 7, "document": "# Site Report: Site 71\n\n## Site Information\n- **Site ID**: Site 71\n- **Study**: Study 25\n- **Country**: CHN\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 7\n- **Average Issues per Subject**: 0.58\n- **Clean Subjects**: 11 (91.7%)\n\n## Risk Profile\n- Low Risk: 11 (91.7%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (8.3%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 7\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 524: High risk, 7 issues\n"}
{"id": "site_Study 25_Site 72", "study": "Study 25", "site": "Site 72", "type": "site_summary", "total_subjects": 10, "total_issues": 15, "document": "# Site Report: Site 72\n\n## Site Information\n- **Site ID**: Site 72\n- **Study**: Study 25\n- **Country**: CHN\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 15\n- **Average Issues per Subject**: 1.50\n- **Clean Subjects**: 9 (90.0%)\n\n## Risk Profile\n- Low Risk: 9 (90.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (10.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 15\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 537: High risk, 15 issues\n"}
{"id": "site_Study 25_Site 73", "study": "Study 25", "site": "Site 73", "type": "site_summary", "total_subjects": 6, "total_issues": 8, "document": "# Site Report: Site 73\n\n## Site Information\n- **Site ID**: Site 73\n- **Study**: Study 25\n- **Country**: CHN\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 8\n- **Average Issues per Subject**: 1.33\n- **Clean Subjects**: 4 (66.7%)\n\n## Risk Profile\n- Low Risk: 4 (66.7%)\n- Medium Risk: 1 (16.7%)\n- High Risk: 1 (16.7%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 8\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 545: High risk, 7 issues\n"}
{"id": "site_Study 25_Site 75", "study": "Study 25", "site": "Site 75", "type": "site_summary", "total_subjects": 12, "total_issues": 0, "document": "# Site Report: Site 75\n\n## Site Information\n- **Site ID**: Site 75\n- **Study**: Study 25\n- **Country**: CHN\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 12 (100.0%)\n\n## Risk Profile\n- Low Risk: 12 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 776", "study": "Study 25", "site": "Site 776", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 776\n\n## Site Information\n- **Site ID**: Site 776\n- **Study**: Study 25\n- **Country**: DNK\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 777", "study": "Study 25", "site": "Site 777", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 777\n\n## Site Information\n- **Site ID**: Site 777\n- **Study**: Study 25\n- **Country**: DNK\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 778", "study": "Study 25", "site": "Site 778", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 778\n\n## Site Information\n- **Site ID**: Site 778\n- **Study**: Study 25\n- **Country**: FIN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 780", "study": "Study 25", "site": "Site 780", "type": "site_summary", "total_subjects": 10, "total_issues": 7, "document": "# Site Report: Site 780\n\n## Site Information\n- **Site ID**: Site 780\n- **Study**: Study 25\n- **Country**: ISR\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 7\n- **Average Issues per Subject**: 0.70\n- **Clean Subjects**: 9 (90.0%)\n\n## Risk Profile\n- Low Risk: 9 (90.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (10.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 7\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 4897: High risk, 7 issues\n"}
{"id": "site_Study 25_Site 781", "study": "Study 25", "site": "Site 781", "type": "site_summary", "total_subjects": 4, "total_issues": 1, "document": "# Site Report: Site 781\n\n## Site Information\n- **Site ID**: Site 781\n- **Study**: Study 25\n- **Country**: KOR\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.25\n- **Clean Subjects**: 3 (75.0%)\n\n## Risk Profile\n- Low Risk: 3 (75.0%)\n- Medium Risk: 1 (25.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 783", "study": "Study 25", "site": "Site 783", "type": "site_summary", "total_subjects": 9, "total_issues": 0, "document": "# Site Report: Site 783\n\n## Site Information\n- **Site ID**: Site 783\n- **Study**: Study 25\n- **Country**: KOR\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 9 (100.0%)\n\n## Risk Profile\n- Low Risk: 9 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 784", "study": "Study 25", "site": "Site 784", "type": "site_summary", "total_subjects": 8, "total_issues": 2, "document": "# Site Report: Site 784\n\n## Site Information\n- **Site ID**: Site 784\n- **Study**: Study 25\n- **Country**: KOR\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.25\n- **Clean Subjects**: 7 (87.5%)\n\n## Risk Profile\n- Low Risk: 7 (87.5%)\n- Medium Risk: 1 (12.5%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 2\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 785", "study": "Study 25", "site": "Site 785", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 785\n\n## Site Information\n- **Site ID**: Site 785\n- **Study**: Study 25\n- **Country**: KOR\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 79", "study": "Study 25", "site": "Site 79", "type": "site_summary", "total_subjects": 20, "total_issues": 1, "document": "# Site Report: Site 79\n\n## Site Information\n- **Site ID**: Site 79\n- **Study**: Study 25\n- **Country**: COL\n- **Total Subjects**: 20\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.05\n- **Clean Subjects**: 19 (95.0%)\n\n## Risk Profile\n- Low Risk: 19 (95.0%)\n- Medium Risk: 1 (5.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 801", "study": "Study 25", "site": "Site 801", "type": "site_summary", "total_subjects": 5, "total_issues": 1, "document": "# Site Report: Site 801\n\n## Site Information\n- **Site ID**: Site 801\n- **Study**: Study 25\n- **Country**: DEU\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.20\n- **Clean Subjects**: 4 (80.0%)\n\n## Risk Profile\n- Low Risk: 4 (80.0%)\n- Medium Risk: 1 (20.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 806", "study": "Study 25", "site": "Site 806", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 806\n\n## Site Information\n- **Site ID**: Site 806\n- **Study**: Study 25\n- **Country**: IND\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 846", "study": "Study 25", "site": "Site 846", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 846\n\n## Site Information\n- **Site ID**: Site 846\n- **Study**: Study 25\n- **Country**: JPN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 847", "study": "Study 25", "site": "Site 847", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 847\n\n## Site Information\n- **Site ID**: Site 847\n- **Study**: Study 25\n- **Country**: JPN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 848", "study": "Study 25", "site": "Site 848", "type": "site_summary", "total_subjects": 5, "total_issues": 8, "document": "# Site Report: Site 848\n\n## Site Information\n- **Site ID**: Site 848\n- **Study**: Study 25\n- **Country**: JPN\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 8\n- **Average Issues per Subject**: 1.60\n- **Clean Subjects**: 4 (80.0%)\n\n## Risk Profile\n- Low Risk: 4 (80.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (20.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 8\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 7552: High risk, 8 issues\n"}
{"id": "site_Study 25_Site 852", "study": "Study 25", "site": "Site 852", "type": "site_summary", "total_subjects": 10, "total_issues": 0, "document": "# Site Report: Site 852\n\n## Site Information\n- **Site ID**: Site 852\n- **Study**: Study 25\n- **Country**: JPN\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 10 (100.0%)\n\n## Risk Profile\n- Low Risk: 10 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 854", "study": "Study 25", "site": "Site 854", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 854\n\n## Site Information\n- **Site ID**: Site 854\n- **Study**: Study 25\n- **Country**: JPN\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 857", "study": "Study 25", "site": "Site 857", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 857\n\n## Site Information\n- **Site ID**: Site 857\n- **Study**: Study 25\n- **Country**: JPN\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 859", "study": "Study 25", "site": "Site 859", "type": "site_summary", "total_subjects": 9, "total_issues": 0, "document": "# Site Report: Site 859\n\n## Site Information\n- **Site ID**: Site 859\n- **Study**: Study 25\n- **Country**: KOR\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 9 (100.0%)\n\n## Risk Profile\n- Low Risk: 9 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 860", "study": "Study 25", "site": "Site 860", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 860\n\n## Site Information\n- **Site ID**: Site 860\n- **Study**: Study 25\n- **Country**: KOR\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 861", "study": "Study 25", "site": "Site 861", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 861\n\n## Site Information\n- **Site ID**: Site 861\n- **Study**: Study 25\n- **Country**: KOR\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 862", "study": "Study 25", "site": "Site 862", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 862\n\n## Site Information\n- **Site ID**: Site 862\n- **Study**: Study 25\n- **Country**: KOR\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 863", "study": "Study 25", "site": "Site 863", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 863\n\n## Site Information\n- **Site ID**: Site 863\n- **Study**: Study 25\n- **Country**: KOR\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 873", "study": "Study 25", "site": "Site 873", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 873\n\n## Site Information\n- **Site ID**: Site 873\n- **Study**: Study 25\n- **Country**: NOR\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 923", "study": "Study 25", "site": "Site 923", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 923\n\n## Site Information\n- **Site ID**: Site 923\n- **Study**: Study 25\n- **Country**: USA\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 924", "study": "Study 25", "site": "Site 924", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 924\n\n## Site Information\n- **Site ID**: Site 924\n- **Study**: Study 25\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 926", "study": "Study 25", "site": "Site 926", "type": "site_summary", "total_subjects": 9, "total_issues": 0, "document": "# Site Report: Site 926\n\n## Site Information\n- **Site ID**: Site 926\n- **Study**: Study 25\n- **Country**: USA\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 9 (100.0%)\n\n## Risk Profile\n- Low Risk: 9 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 929", "study": "Study 25", "site": "Site 929", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 929\n\n## Site Information\n- **Site ID**: Site 929\n- **Study**: Study 25\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 932", "study": "Study 25", "site": "Site 932", "type": "site_summary", "total_subjects": 5, "total_issues": 1, "document": "# Site Report: Site 932\n\n## Site Information\n- **Site ID**: Site 932\n- **Study**: Study 25\n- **Country**: USA\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.20\n- **Clean Subjects**: 4 (80.0%)\n\n## Risk Profile\n- Low Risk: 4 (80.0%)\n- Medium Risk: 1 (20.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 933", "study": "Study 25", "site": "Site 933", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 933\n\n## Site Information\n- **Site ID**: Site 933\n- **Study**: Study 25\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 937", "study": "Study 25", "site": "Site 937", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 937\n\n## Site Information\n- **Site ID**: Site 937\n- **Study**: Study 25\n- **Country**: USA\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 939", "study": "Study 25", "site": "Site 939", "type": "site_summary", "total_subjects": 4, "total_issues": 1, "document": "# Site Report: Site 939\n\n## Site Information\n- **Site ID**: Site 939\n- **Study**: Study 25\n- **Country**: USA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.25\n- **Clean Subjects**: 3 (75.0%)\n\n## Risk Profile\n- Low Risk: 3 (75.0%)\n- Medium Risk: 1 (25.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 941", "study": "Study 25", "site": "Site 941", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 941\n\n## Site Information\n- **Site ID**: Site 941\n- **Study**: Study 25\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 942", "study": "Study 25", "site": "Site 942", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 942\n\n## Site Information\n- **Site ID**: Site 942\n- **Study**: Study 25\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 943", "study": "Study 25", "site": "Site 943", "type": "site_summary", "total_subjects": 10, "total_issues": 0, "document": "# Site Report: Site 943\n\n## Site Information\n- **Site ID**: Site 943\n- **Study**: Study 25\n- **Country**: USA\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 10 (100.0%)\n\n## Risk Profile\n- Low Risk: 10 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 945", "study": "Study 25", "site": "Site 945", "type": "site_summary", "total_subjects": 8, "total_issues": 0, "document": "# Site Report: Site 945\n\n## Site Information\n- **Site ID**: Site 945\n- **Study**: Study 25\n- **Country**: USA\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 8 (100.0%)\n\n## Risk Profile\n- Low Risk: 8 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 954", "study": "Study 25", "site": "Site 954", "type": "site_summary", "total_subjects": 5, "total_issues": 9, "document": "# Site Report: Site 954\n\n## Site Information\n- **Site ID**: Site 954\n- **Study**: Study 25\n- **Country**: USA\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 9\n- **Average Issues per Subject**: 1.80\n- **Clean Subjects**: 4 (80.0%)\n\n## Risk Profile\n- Low Risk: 4 (80.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (20.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 8\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 13659: High risk, 9 issues\n"}
{"id": "site_Study 25_Site 955", "study": "Study 25", "site": "Site 955", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 955\n\n## Site Information\n- **Site ID**: Site 955\n- **Study**: Study 25\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 958", "study": "Study 25", "site": "Site 958", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 958\n\n## Site Information\n- **Site ID**: Site 958\n- **Study**: Study 25\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 25_Site 995", "study": "Study 25", "site": "Site 995", "type": "site_summary", "total_subjects": 5, "total_issues": 2, "document": "# Site Report: Site 995\n\n## Site Information\n- **Site ID**: Site 995\n- **Study**: Study 25\n- **Country**: CHL\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.40\n- **Clean Subjects**: 4 (80.0%)\n\n## Risk Profile\n- Low Risk: 4 (80.0%)\n- Medium Risk: 1 (20.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 4_Site 1", "study": "Study 4", "site": "Site 1", "type": "site_summary", "total_subjects": 21, "total_issues": 9, "document": "# Site Report: Site 1\n\n## Site Information\n- **Site ID**: Site 1\n- **Study**: Study 4\n- **Country**: KOR\n- **Total Subjects**: 21\n\n## Performance Metrics\n- **Total Issues**: 9\n- **Average Issues per Subject**: 0.43\n- **Clean Subjects**: 18 (85.7%)\n\n## Risk Profile\n- Low Risk: 18 (85.7%)\n- Medium Risk: 2 (9.5%)\n- High Risk: 1 (4.8%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 9\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 767: High risk, 6 issues\n"}
{"id": "site_Study 4_Site 10", "study": "Study 4", "site": "Site 10", "type": "site_summary", "total_subjects": 11, "total_issues": 111, "document": "# Site Report: Site 10\n\n## Site Information\n- **Site ID**: Site 10\n- **Study**: Study 4\n- **Country**: AUT\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 111\n- **Average Issues per Subject**: 10.09\n- **Clean Subjects**: 1 (9.1%)\n\n## Risk Profile\n- Low Risk: 1 (9.1%)\n- Medium Risk: 3 (27.3%)\n- High Risk: 5 (45.5%)\n- Critical Risk: 2 (18.2%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 110\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 19: High risk, 9 issues\n- Subject 851: Critical risk, 19 issues\n- Subject 852: High risk, 15 issues\n- Subject 854: Critical risk, 23 issues\n- Subject 855: High risk, 12 issues\n- Subject 856: High risk, 10 issues\n- Subject 860: High risk, 13 issues\n"}
{"id": "site_Study 4_Site 108", "study": "Study 4", "site": "Site 108", "type": "site_summary", "total_subjects": 20, "total_issues": 114, "document": "# Site Report: Site 108\n\n## Site Information\n- **Site ID**: Site 108\n- **Study**: Study 4\n- **Country**: TWN\n- **Total Subjects**: 20\n\n## Performance Metrics\n- **Total Issues**: 114\n- **Average Issues per Subject**: 5.70\n- **Clean Subjects**: 8 (40.0%)\n\n## Risk Profile\n- Low Risk: 8 (40.0%)\n- Medium Risk: 4 (20.0%)\n- High Risk: 6 (30.0%)\n- Critical Risk: 2 (10.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 112\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 809: High risk, 9 issues\n- Subject 814: Critical risk, 24 issues\n- Subject 816: High risk, 6 issues\n- Subject 818: High risk, 13 issues\n- Subject 823: High risk, 7 issues\n- Subject 825: Critical risk, 30 issues\n- Subject 828: High risk, 12 issues\n- Subject 832: High risk, 7 issues\n"}
{"id": "site_Study 4_Site 109", "study": "Study 4", "site": "Site 109", "type": "site_summary", "total_subjects": 11, "total_issues": 36, "document": "# Site Report: Site 109\n\n## Site Information\n- **Site ID**: Site 109\n- **Study**: Study 4\n- **Country**: SGP\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 36\n- **Average Issues per Subject**: 3.27\n- **Clean Subjects**: 6 (54.5%)\n\n## Risk Profile\n- Low Risk: 6 (54.5%)\n- Medium Risk: 2 (18.2%)\n- High Risk: 3 (27.3%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 36\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 835: High risk, 9 issues\n- Subject 838: High risk, 9 issues\n- Subject 843: High risk, 14 issues\n"}
{"id": "site_Study 4_Site 11", "study": "Study 4", "site": "Site 11", "type": "site_summary", "total_subjects": 13, "total_issues": 136, "document": "# Site Report: Site 11\n\n## Site Information\n- **Site ID**: Site 11\n- **Study**: Study 4\n- **Country**: NLD\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 136\n- **Average Issues per Subject**: 10.46\n- **Clean Subjects**: 2 (15.4%)\n\n## Risk Profile\n- Low Risk: 2 (15.4%)\n- Medium Risk: 3 (23.1%)\n- High Risk: 5 (38.5%)\n- Critical Risk: 3 (23.1%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 134\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1125: High risk, 14 issues\n- Subject 1129: High risk, 10 issues\n- Subject 1130: Critical risk, 19 issues\n- Subject 1131: Critical risk, 24 issues\n- Subject 1132: High risk, 7 issues\n- Subject 1136: High risk, 12 issues\n- Subject 20: High risk, 9 issues\n- Subject 21: Critical risk, 29 issues\n"}
{"id": "site_Study 4_Site 110", "study": "Study 4", "site": "Site 110", "type": "site_summary", "total_subjects": 3, "total_issues": 4, "document": "# Site Report: Site 110\n\n## Site Information\n- **Site ID**: Site 110\n- **Study**: Study 4\n- **Country**: AUT\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 1.33\n- **Clean Subjects**: 1 (33.3%)\n\n## Risk Profile\n- Low Risk: 1 (33.3%)\n- Medium Risk: 2 (66.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 4\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 4_Site 111", "study": "Study 4", "site": "Site 111", "type": "site_summary", "total_subjects": 1, "total_issues": 2, "document": "# Site Report: Site 111\n\n## Site Information\n- **Site ID**: Site 111\n- **Study**: Study 4\n- **Country**: BEL\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 2\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 4_Site 112", "study": "Study 4", "site": "Site 112", "type": "site_summary", "total_subjects": 11, "total_issues": 102, "document": "# Site Report: Site 112\n\n## Site Information\n- **Site ID**: Site 112\n- **Study**: Study 4\n- **Country**: BEL\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 102\n- **Average Issues per Subject**: 9.27\n- **Clean Subjects**: 2 (18.2%)\n\n## Risk Profile\n- Low Risk: 2 (18.2%)\n- Medium Risk: 2 (18.2%)\n- High Risk: 5 (45.5%)\n- Critical Risk: 2 (18.2%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 101\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 898: High risk, 9 issues\n- Subject 899: Critical risk, 27 issues\n- Subject 901: High risk, 15 issues\n- Subject 904: High risk, 13 issues\n- Subject 907: High risk, 9 issues\n- Subject 908: High risk, 6 issues\n- Subject 910: Critical risk, 16 issues\n"}
{"id": "site_Study 4_Site 113", "study": "Study 4", "site": "Site 113", "type": "site_summary", "total_subjects": 6, "total_issues": 50, "document": "# Site Report: Site 113\n\n## Site Information\n- **Site ID**: Site 113\n- **Study**: Study 4\n- **Country**: DNK\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 50\n- **Average Issues per Subject**: 8.33\n- **Clean Subjects**: 2 (33.3%)\n\n## Risk Profile\n- Low Risk: 2 (33.3%)\n- Medium Risk: 2 (33.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 2 (33.3%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 50\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 915: Critical risk, 26 issues\n- Subject 916: Critical risk, 17 issues\n"}
{"id": "site_Study 4_Site 114", "study": "Study 4", "site": "Site 114", "type": "site_summary", "total_subjects": 12, "total_issues": 138, "document": "# Site Report: Site 114\n\n## Site Information\n- **Site ID**: Site 114\n- **Study**: Study 4\n- **Country**: FRA\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 138\n- **Average Issues per Subject**: 11.50\n- **Clean Subjects**: 4 (33.3%)\n\n## Risk Profile\n- Low Risk: 4 (33.3%)\n- Medium Risk: 2 (16.7%)\n- High Risk: 2 (16.7%)\n- Critical Risk: 4 (33.3%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 137\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 918: Critical risk, 41 issues\n- Subject 922: High risk, 8 issues\n- Subject 924: Critical risk, 21 issues\n- Subject 925: Critical risk, 28 issues\n- Subject 929: High risk, 12 issues\n- Subject 933: Critical risk, 22 issues\n"}
{"id": "site_Study 4_Site 115", "study": "Study 4", "site": "Site 115", "type": "site_summary", "total_subjects": 16, "total_issues": 107, "document": "# Site Report: Site 115\n\n## Site Information\n- **Site ID**: Site 115\n- **Study**: Study 4\n- **Country**: FRA\n- **Total Subjects**: 16\n\n## Performance Metrics\n- **Total Issues**: 107\n- **Average Issues per Subject**: 6.69\n- **Clean Subjects**: 8 (50.0%)\n\n## Risk Profile\n- Low Risk: 8 (50.0%)\n- Medium Risk: 1 (6.2%)\n- High Risk: 5 (31.2%)\n- Critical Risk: 2 (12.5%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 105\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 936: Critical risk, 17 issues\n- Subject 937: High risk, 12 issues\n- Subject 940: High risk, 6 issues\n- Subject 944: High risk, 11 issues\n- Subject 947: High risk, 9 issues\n- Subject 948: High risk, 9 issues\n- Subject 949: Critical risk, 39 issues\n"}
{"id": "site_Study 4_Site 116", "study": "Study 4", "site": "Site 116", "type": "site_summary", "total_subjects": 33, "total_issues": 163, "document": "# Site Report: Site 116\n\n## Site Information\n- **Site ID**: Site 116\n- **Study**: Study 4\n- **Country**: FRA\n- **Total Subjects**: 33\n\n## Performance Metrics\n- **Total Issues**: 163\n- **Average Issues per Subject**: 4.94\n- **Clean Subjects**: 12 (36.4%)\n\n## Risk Profile\n- Low Risk: 12 (36.4%)\n- Medium Risk: 11 (33.3%)\n- High Risk: 8 (24.2%)\n- Critical Risk: 2 (6.1%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 163\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 962: High risk, 7 issues\n- Subject 964: High risk, 7 issues\n- Subject 972: High risk, 8 issues\n- Subject 973: High risk, 8 issues\n- Subject 976: Critical risk, 36 issues\n- Subject 979: Critical risk, 20 issues\n- Subject 980: High risk, 15 issues\n- Subject 987: High risk, 6 issues\n- Subject 988: High risk, 14 issues\n- Subject 990: High risk, 11 issues\n"}
{"id": "site_Study 4_Site 117", "study": "Study 4", "site": "Site 117", "type": "site_summary", "total_subjects": 7, "total_issues": 18, "document": "# Site Report: Site 117\n\n## Site Information\n- **Site ID**: Site 117\n- **Study**: Study 4\n- **Country**: FRA\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 18\n- **Average Issues per Subject**: 2.57\n- **Clean Subjects**: 3 (42.9%)\n\n## Risk Profile\n- Low Risk: 3 (42.9%)\n- Medium Risk: 3 (42.9%)\n- High Risk: 1 (14.3%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 16\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 994: High risk, 13 issues\n"}
{"id": "site_Study 4_Site 118", "study": "Study 4", "site": "Site 118", "type": "site_summary", "total_subjects": 18, "total_issues": 163, "document": "# Site Report: Site 118\n\n## Site Information\n- **Site ID**: Site 118\n- **Study**: Study 4\n- **Country**: FRA\n- **Total Subjects**: 18\n\n## Performance Metrics\n- **Total Issues**: 163\n- **Average Issues per Subject**: 9.06\n- **Clean Subjects**: 4 (22.2%)\n\n## Risk Profile\n- Low Risk: 4 (22.2%)\n- Medium Risk: 5 (27.8%)\n- High Risk: 4 (22.2%)\n- Critical Risk: 5 (27.8%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 161\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1002: Critical risk, 26 issues\n- Subject 1005: High risk, 10 issues\n- Subject 1006: Critical risk, 18 issues\n- Subject 1008: High risk, 9 issues\n- Subject 1009: Critical risk, 29 issues\n- Subject 1010: High risk, 8 issues\n- Subject 1014: Critical risk, 25 issues\n- Subject 1016: Critical risk, 18 issues\n- Subject 1018: High risk, 8 issues\n"}
{"id": "site_Study 4_Site 119", "study": "Study 4", "site": "Site 119", "type": "site_summary", "total_subjects": 10, "total_issues": 169, "document": "# Site Report: Site 119\n\n## Site Information\n- **Site ID**: Site 119\n- **Study**: Study 4\n- **Country**: FRA\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 169\n- **Average Issues per Subject**: 16.90\n- **Clean Subjects**: 3 (30.0%)\n\n## Risk Profile\n- Low Risk: 3 (30.0%)\n- Medium Risk: 2 (20.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 5 (50.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 168\n- Missing Pages: 0\n- Missing Labs: 1\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1019: Critical risk, 25 issues\n- Subject 1020: Critical risk, 23 issues\n- Subject 1021: Critical risk, 21 issues\n- Subject 1023: Critical risk, 47 issues\n- Subject 1025: Critical risk, 50 issues\n"}
{"id": "site_Study 4_Site 120", "study": "Study 4", "site": "Site 120", "type": "site_summary", "total_subjects": 14, "total_issues": 226, "document": "# Site Report: Site 120\n\n## Site Information\n- **Site ID**: Site 120\n- **Study**: Study 4\n- **Country**: FRA\n- **Total Subjects**: 14\n\n## Performance Metrics\n- **Total Issues**: 226\n- **Average Issues per Subject**: 16.14\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (14.3%)\n- High Risk: 5 (35.7%)\n- Critical Risk: 7 (50.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 226\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1030: High risk, 15 issues\n- Subject 1031: High risk, 12 issues\n- Subject 1033: Critical risk, 17 issues\n- Subject 1035: Critical risk, 18 issues\n- Subject 1036: High risk, 8 issues\n- Subject 1037: High risk, 9 issues\n- Subject 1038: High risk, 12 issues\n- Subject 1039: Critical risk, 24 issues\n- Subject 1041: Critical risk, 31 issues\n- Subject 1042: Critical risk, 16 issues\n"}
{"id": "site_Study 4_Site 121", "study": "Study 4", "site": "Site 121", "type": "site_summary", "total_subjects": 5, "total_issues": 2, "document": "# Site Report: Site 121\n\n## Site Information\n- **Site ID**: Site 121\n- **Study**: Study 4\n- **Country**: FRA\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.40\n- **Clean Subjects**: 4 (80.0%)\n\n## Risk Profile\n- Low Risk: 4 (80.0%)\n- Medium Risk: 1 (20.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 2\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 4_Site 122", "study": "Study 4", "site": "Site 122", "type": "site_summary", "total_subjects": 8, "total_issues": 6, "document": "# Site Report: Site 122\n\n## Site Information\n- **Site ID**: Site 122\n- **Study**: Study 4\n- **Country**: FRA\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 6\n- **Average Issues per Subject**: 0.75\n- **Clean Subjects**: 6 (75.0%)\n\n## Risk Profile\n- Low Risk: 6 (75.0%)\n- Medium Risk: 2 (25.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 6\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 4_Site 123", "study": "Study 4", "site": "Site 123", "type": "site_summary", "total_subjects": 1, "total_issues": 7, "document": "# Site Report: Site 123\n\n## Site Information\n- **Site ID**: Site 123\n- **Study**: Study 4\n- **Country**: FRA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 7\n- **Average Issues per Subject**: 7.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (100.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 7\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1066: High risk, 7 issues\n"}
{"id": "site_Study 4_Site 124", "study": "Study 4", "site": "Site 124", "type": "site_summary", "total_subjects": 4, "total_issues": 35, "document": "# Site Report: Site 124\n\n## Site Information\n- **Site ID**: Site 124\n- **Study**: Study 4\n- **Country**: DEU\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 35\n- **Average Issues per Subject**: 8.75\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (25.0%)\n- High Risk: 3 (75.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 35\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1067: High risk, 10 issues\n- Subject 1070: High risk, 11 issues\n- Subject 1071: High risk, 11 issues\n"}
{"id": "site_Study 4_Site 125", "study": "Study 4", "site": "Site 125", "type": "site_summary", "total_subjects": 18, "total_issues": 34, "document": "# Site Report: Site 125\n\n## Site Information\n- **Site ID**: Site 125\n- **Study**: Study 4\n- **Country**: DEU\n- **Total Subjects**: 18\n\n## Performance Metrics\n- **Total Issues**: 34\n- **Average Issues per Subject**: 1.89\n- **Clean Subjects**: 12 (66.7%)\n\n## Risk Profile\n- Low Risk: 12 (66.7%)\n- Medium Risk: 4 (22.2%)\n- High Risk: 2 (11.1%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 33\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1073: High risk, 13 issues\n- Subject 1078: High risk, 12 issues\n"}
{"id": "site_Study 4_Site 126", "study": "Study 4", "site": "Site 126", "type": "site_summary", "total_subjects": 25, "total_issues": 336, "document": "# Site Report: Site 126\n\n## Site Information\n- **Site ID**: Site 126\n- **Study**: Study 4\n- **Country**: DEU\n- **Total Subjects**: 25\n\n## Performance Metrics\n- **Total Issues**: 336\n- **Average Issues per Subject**: 13.44\n- **Clean Subjects**: 1 (4.0%)\n\n## Risk Profile\n- Low Risk: 1 (4.0%)\n- Medium Risk: 8 (32.0%)\n- High Risk: 7 (28.0%)\n- Critical Risk: 9 (36.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 336\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1091: Critical risk, 23 issues\n- Subject 1093: High risk, 9 issues\n- Subject 1095: Critical risk, 17 issues\n- Subject 1096: Critical risk, 17 issues\n- Subject 1097: High risk, 7 issues\n- Subject 1098: High risk, 7 issues\n- Subject 1100: High risk, 12 issues\n- Subject 1101: Critical risk, 46 issues\n- Subject 1103: High risk, 7 issues\n- Subject 1105: Critical risk, 39 issues\n"}
{"id": "site_Study 4_Site 127", "study": "Study 4", "site": "Site 127", "type": "site_summary", "total_subjects": 3, "total_issues": 13, "document": "# Site Report: Site 127\n\n## Site Information\n- **Site ID**: Site 127\n- **Study**: Study 4\n- **Country**: DEU\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 13\n- **Average Issues per Subject**: 4.33\n- **Clean Subjects**: 1 (33.3%)\n\n## Risk Profile\n- Low Risk: 1 (33.3%)\n- Medium Risk: 1 (33.3%)\n- High Risk: 1 (33.3%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 13\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1119: High risk, 8 issues\n"}
{"id": "site_Study 4_Site 128", "study": "Study 4", "site": "Site 128", "type": "site_summary", "total_subjects": 3, "total_issues": 25, "document": "# Site Report: Site 128\n\n## Site Information\n- **Site ID**: Site 128\n- **Study**: Study 4\n- **Country**: DEU\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 25\n- **Average Issues per Subject**: 8.33\n- **Clean Subjects**: 1 (33.3%)\n\n## Risk Profile\n- Low Risk: 1 (33.3%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (33.3%)\n- Critical Risk: 1 (33.3%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 25\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1121: High risk, 8 issues\n- Subject 1123: Critical risk, 17 issues\n"}
{"id": "site_Study 4_Site 129", "study": "Study 4", "site": "Site 129", "type": "site_summary", "total_subjects": 1, "total_issues": 30, "document": "# Site Report: Site 129\n\n## Site Information\n- **Site ID**: Site 129\n- **Study**: Study 4\n- **Country**: DEU\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 30\n- **Average Issues per Subject**: 30.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 30\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1124: Critical risk, 30 issues\n"}
{"id": "site_Study 4_Site 13", "study": "Study 4", "site": "Site 13", "type": "site_summary", "total_subjects": 11, "total_issues": 111, "document": "# Site Report: Site 13\n\n## Site Information\n- **Site ID**: Site 13\n- **Study**: Study 4\n- **Country**: CAN\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 111\n- **Average Issues per Subject**: 10.09\n- **Clean Subjects**: 3 (27.3%)\n\n## Risk Profile\n- Low Risk: 3 (27.3%)\n- Medium Risk: 4 (36.4%)\n- High Risk: 1 (9.1%)\n- Critical Risk: 3 (27.3%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 111\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1480: Critical risk, 41 issues\n- Subject 1482: High risk, 13 issues\n- Subject 1485: Critical risk, 17 issues\n- Subject 24: Critical risk, 25 issues\n"}
{"id": "site_Study 4_Site 130", "study": "Study 4", "site": "Site 130", "type": "site_summary", "total_subjects": 7, "total_issues": 57, "document": "# Site Report: Site 130\n\n## Site Information\n- **Site ID**: Site 130\n- **Study**: Study 4\n- **Country**: NLD\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 57\n- **Average Issues per Subject**: 8.14\n- **Clean Subjects**: 2 (28.6%)\n\n## Risk Profile\n- Low Risk: 2 (28.6%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 4 (57.1%)\n- Critical Risk: 1 (14.3%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 57\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1138: High risk, 14 issues\n- Subject 1139: High risk, 8 issues\n- Subject 1141: High risk, 6 issues\n- Subject 1142: High risk, 9 issues\n- Subject 1144: Critical risk, 20 issues\n"}
{"id": "site_Study 4_Site 131", "study": "Study 4", "site": "Site 131", "type": "site_summary", "total_subjects": 3, "total_issues": 57, "document": "# Site Report: Site 131\n\n## Site Information\n- **Site ID**: Site 131\n- **Study**: Study 4\n- **Country**: NLD\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 57\n- **Average Issues per Subject**: 19.00\n- **Clean Subjects**: 2 (66.7%)\n\n## Risk Profile\n- Low Risk: 2 (66.7%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (33.3%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 57\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1147: Critical risk, 57 issues\n"}
{"id": "site_Study 4_Site 132", "study": "Study 4", "site": "Site 132", "type": "site_summary", "total_subjects": 6, "total_issues": 42, "document": "# Site Report: Site 132\n\n## Site Information\n- **Site ID**: Site 132\n- **Study**: Study 4\n- **Country**: NLD\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 42\n- **Average Issues per Subject**: 7.00\n- **Clean Subjects**: 1 (16.7%)\n\n## Risk Profile\n- Low Risk: 1 (16.7%)\n- Medium Risk: 2 (33.3%)\n- High Risk: 3 (50.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 42\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1148: High risk, 7 issues\n- Subject 1149: High risk, 14 issues\n- Subject 1153: High risk, 13 issues\n"}
{"id": "site_Study 4_Site 133", "study": "Study 4", "site": "Site 133", "type": "site_summary", "total_subjects": 23, "total_issues": 63, "document": "# Site Report: Site 133\n\n## Site Information\n- **Site ID**: Site 133\n- **Study**: Study 4\n- **Country**: POL\n- **Total Subjects**: 23\n\n## Performance Metrics\n- **Total Issues**: 63\n- **Average Issues per Subject**: 2.74\n- **Clean Subjects**: 15 (65.2%)\n\n## Risk Profile\n- Low Risk: 15 (65.2%)\n- Medium Risk: 5 (21.7%)\n- High Risk: 2 (8.7%)\n- Critical Risk: 1 (4.3%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 63\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1156: Critical risk, 32 issues\n- Subject 1158: High risk, 6 issues\n- Subject 1164: High risk, 9 issues\n"}
{"id": "site_Study 4_Site 134", "study": "Study 4", "site": "Site 134", "type": "site_summary", "total_subjects": 5, "total_issues": 28, "document": "# Site Report: Site 134\n\n## Site Information\n- **Site ID**: Site 134\n- **Study**: Study 4\n- **Country**: POL\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 28\n- **Average Issues per Subject**: 5.60\n- **Clean Subjects**: 2 (40.0%)\n\n## Risk Profile\n- Low Risk: 2 (40.0%)\n- Medium Risk: 1 (20.0%)\n- High Risk: 2 (40.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 28\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\n- Subject 1179: High risk, 14 issues\n- Subject 1181: High risk, 10 issues\n"}
{"id": "site_Study 4_Site 135", "study": "Study 4", "site": "Site 135", "type": "site_summary", "total_subjects": 10, "total_issues": 46, "document": "# Site Report: Site 135\n\n## Site Information\n- **Site ID**: Site 135\n- **Study**: Study 4\n- **Country**: POL\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 46\n- **Average Issues per Subject**: 4.60\n- **Clean Subjects**: 8 (80.0%)\n\n## Risk Profile\n- Low Risk: 8 (80.0%)\n- Medium Risk: 1 (10.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (10.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 46\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1186: Critical risk, 44 issues\n"}
{"id": "site_Study 4_Site 136", "study": "Study 4", "site": "Site 136", "type": "site_summary", "total_subjects": 9, "total_issues": 16, "document": "# Site Report: Site 136\n\n## Site Information\n- **Site ID**: Site 136\n- **Study**: Study 4\n- **Country**: ESP\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 16\n- **Average Issues per Subject**: 1.78\n- **Clean Subjects**: 5 (55.6%)\n\n## Risk Profile\n- Low Risk: 5 (55.6%)\n- Medium Risk: 3 (33.3%)\n- High Risk: 1 (11.1%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 4\n- Safety Discrepancies: 12\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1195: High risk, 11 issues\n"}
{"id": "site_Study 4_Site 137", "study": "Study 4", "site": "Site 137", "type": "site_summary", "total_subjects": 12, "total_issues": 87, "document": "# Site Report: Site 137\n\n## Site Information\n- **Site ID**: Site 137\n- **Study**: Study 4\n- **Country**: ESP\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 87\n- **Average Issues per Subject**: 7.25\n- **Clean Subjects**: 6 (50.0%)\n\n## Risk Profile\n- Low Risk: 6 (50.0%)\n- Medium Risk: 1 (8.3%)\n- High Risk: 3 (25.0%)\n- Critical Risk: 2 (16.7%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 86\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1208: High risk, 15 issues\n- Subject 1209: Critical risk, 22 issues\n- Subject 1213: Critical risk, 25 issues\n- Subject 1214: High risk, 8 issues\n- Subject 1216: High risk, 13 issues\n"}
{"id": "site_Study 4_Site 138", "study": "Study 4", "site": "Site 138", "type": "site_summary", "total_subjects": 18, "total_issues": 267, "document": "# Site Report: Site 138\n\n## Site Information\n- **Site ID**: Site 138\n- **Study**: Study 4\n- **Country**: ESP\n- **Total Subjects**: 18\n\n## Performance Metrics\n- **Total Issues**: 267\n- **Average Issues per Subject**: 14.83\n- **Clean Subjects**: 4 (22.2%)\n\n## Risk Profile\n- Low Risk: 4 (22.2%)\n- Medium Risk: 3 (16.7%)\n- High Risk: 6 (33.3%)\n- Critical Risk: 5 (27.8%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 265\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1219: High risk, 12 issues\n- Subject 1221: High risk, 6 issues\n- Subject 1222: Critical risk, 23 issues\n- Subject 1228: Critical risk, 29 issues\n- Subject 1232: Critical risk, 29 issues\n- Subject 1233: High risk, 6 issues\n- Subject 1235: Critical risk, 26 issues\n- Subject 1236: High risk, 15 issues\n- Subject 1237: High risk, 12 issues\n- Subject 1238: Critical risk, 86 issues\n"}
{"id": "site_Study 4_Site 139", "study": "Study 4", "site": "Site 139", "type": "site_summary", "total_subjects": 49, "total_issues": 218, "document": "# Site Report: Site 139\n\n## Site Information\n- **Site ID**: Site 139\n- **Study**: Study 4\n- **Country**: ESP\n- **Total Subjects**: 49\n\n## Performance Metrics\n- **Total Issues**: 218\n- **Average Issues per Subject**: 4.45\n- **Clean Subjects**: 15 (30.6%)\n\n## Risk Profile\n- Low Risk: 15 (30.6%)\n- Medium Risk: 19 (38.8%)\n- High Risk: 12 (24.5%)\n- Critical Risk: 3 (6.1%)\n\n## Issue Breakdown\n- Open EDRR Issues: 8\n- Safety Discrepancies: 209\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1241: High risk, 6 issues\n- Subject 1243: High risk, 8 issues\n- Subject 1244: Critical risk, 43 issues\n- Subject 1251: High risk, 8 issues\n- Subject 1256: High risk, 7 issues\n- Subject 1257: High risk, 6 issues\n- Subject 1258: High risk, 6 issues\n- Subject 1261: High risk, 8 issues\n- Subject 1270: Critical risk, 18 issues\n- Subject 1272: High risk, 13 issues\n"}
{"id": "site_Study 4_Site 14", "study": "Study 4", "site": "Site 14", "type": "site_summary", "total_subjects": 3, "total_issues": 1, "document": "# Site Report: Site 14\n\n## Site Information\n- **Site ID**: Site 14\n- **Study**: Study 4\n- **Country**: CAN\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.33\n- **Clean Subjects**: 2 (66.7%)\n\n## Risk Profile\n- Low Risk: 2 (66.7%)\n- Medium Risk: 1 (33.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 4_Site 140", "study": "Study 4", "site": "Site 140", "type": "site_summary", "total_subjects": 23, "total_issues": 198, "document": "# Site Report: Site 140\n\n## Site Information\n- **Site ID**: Site 140\n- **Study**: Study 4\n- **Country**: ESP\n- **Total Subjects**: 23\n\n## Performance Metrics\n- **Total Issues**: 198\n- **Average Issues per Subject**: 8.61\n- **Clean Subjects**: 7 (30.4%)\n\n## Risk Profile\n- Low Risk: 7 (30.4%)\n- Medium Risk: 7 (30.4%)\n- High Risk: 5 (21.7%)\n- Critical Risk: 4 (17.4%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 197\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1295: Critical risk, 57 issues\n- Subject 1298: High risk, 7 issues\n- Subject 1302: Critical risk, 22 issues\n- Subject 1306: Critical risk, 22 issues\n- Subject 1308: High risk, 12 issues\n- Subject 1311: Critical risk, 37 issues\n- Subject 1312: High risk, 6 issues\n- Subject 1315: High risk, 6 issues\n- Subject 1321: High risk, 9 issues\n"}
{"id": "site_Study 4_Site 141", "study": "Study 4", "site": "Site 141", "type": "site_summary", "total_subjects": 3, "total_issues": 7, "document": "# Site Report: Site 141\n\n## Site Information\n- **Site ID**: Site 141\n- **Study**: Study 4\n- **Country**: ESP\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 7\n- **Average Issues per Subject**: 2.33\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 3 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 6\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 4_Site 142", "study": "Study 4", "site": "Site 142", "type": "site_summary", "total_subjects": 12, "total_issues": 227, "document": "# Site Report: Site 142\n\n## Site Information\n- **Site ID**: Site 142\n- **Study**: Study 4\n- **Country**: ESP\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 227\n- **Average Issues per Subject**: 18.92\n- **Clean Subjects**: 2 (16.7%)\n\n## Risk Profile\n- Low Risk: 2 (16.7%)\n- Medium Risk: 2 (16.7%)\n- High Risk: 2 (16.7%)\n- Critical Risk: 6 (50.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 227\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1322: High risk, 14 issues\n- Subject 1323: Critical risk, 57 issues\n- Subject 1324: Critical risk, 28 issues\n- Subject 1325: Critical risk, 24 issues\n- Subject 1326: Critical risk, 25 issues\n- Subject 1327: Critical risk, 23 issues\n- Subject 1328: Critical risk, 39 issues\n- Subject 1330: High risk, 8 issues\n"}
{"id": "site_Study 4_Site 143", "study": "Study 4", "site": "Site 143", "type": "site_summary", "total_subjects": 11, "total_issues": 67, "document": "# Site Report: Site 143\n\n## Site Information\n- **Site ID**: Site 143\n- **Study**: Study 4\n- **Country**: ESP\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 67\n- **Average Issues per Subject**: 6.09\n- **Clean Subjects**: 6 (54.5%)\n\n## Risk Profile\n- Low Risk: 6 (54.5%)\n- Medium Risk: 3 (27.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 2 (18.2%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 67\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1342: Critical risk, 37 issues\n- Subject 1343: Critical risk, 21 issues\n"}
{"id": "site_Study 4_Site 144", "study": "Study 4", "site": "Site 144", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 144\n\n## Site Information\n- **Site ID**: Site 144\n- **Study**: Study 4\n- **Country**: ESP\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 4_Site 145", "study": "Study 4", "site": "Site 145", "type": "site_summary", "total_subjects": 8, "total_issues": 13, "document": "# Site Report: Site 145\n\n## Site Information\n- **Site ID**: Site 145\n- **Study**: Study 4\n- **Country**: ESP\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 13\n- **Average Issues per Subject**: 1.62\n- **Clean Subjects**: 5 (62.5%)\n\n## Risk Profile\n- Low Risk: 5 (62.5%)\n- Medium Risk: 2 (25.0%)\n- High Risk: 1 (12.5%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 11\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1368: High risk, 7 issues\n"}
{"id": "site_Study 4_Site 146", "study": "Study 4", "site": "Site 146", "type": "site_summary", "total_subjects": 9, "total_issues": 110, "document": "# Site Report: Site 146\n\n## Site Information\n- **Site ID**: Site 146\n- **Study**: Study 4\n- **Country**: ESP\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 110\n- **Average Issues per Subject**: 12.22\n- **Clean Subjects**: 4 (44.4%)\n\n## Risk Profile\n- Low Risk: 4 (44.4%)\n- Medium Risk: 1 (11.1%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 4 (44.4%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 109\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1373: Critical risk, 30 issues\n- Subject 1376: Critical risk, 30 issues\n- Subject 1380: Critical risk, 18 issues\n- Subject 1385: Critical risk, 30 issues\n"}
{"id": "site_Study 4_Site 147", "study": "Study 4", "site": "Site 147", "type": "site_summary", "total_subjects": 4, "total_issues": 9, "document": "# Site Report: Site 147\n\n## Site Information\n- **Site ID**: Site 147\n- **Study**: Study 4\n- **Country**: SWE\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 9\n- **Average Issues per Subject**: 2.25\n- **Clean Subjects**: 2 (50.0%)\n\n## Risk Profile\n- Low Risk: 2 (50.0%)\n- Medium Risk: 1 (25.0%)\n- High Risk: 1 (25.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 9\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1389: High risk, 7 issues\n"}
{"id": "site_Study 4_Site 148", "study": "Study 4", "site": "Site 148", "type": "site_summary", "total_subjects": 7, "total_issues": 103, "document": "# Site Report: Site 148\n\n## Site Information\n- **Site ID**: Site 148\n- **Study**: Study 4\n- **Country**: SWE\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 103\n- **Average Issues per Subject**: 14.71\n- **Clean Subjects**: 2 (28.6%)\n\n## Risk Profile\n- Low Risk: 2 (28.6%)\n- Medium Risk: 1 (14.3%)\n- High Risk: 1 (14.3%)\n- Critical Risk: 3 (42.9%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 103\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1393: Critical risk, 27 issues\n- Subject 1394: Critical risk, 20 issues\n- Subject 1396: High risk, 11 issues\n- Subject 1400: Critical risk, 41 issues\n"}
{"id": "site_Study 4_Site 149", "study": "Study 4", "site": "Site 149", "type": "site_summary", "total_subjects": 7, "total_issues": 78, "document": "# Site Report: Site 149\n\n## Site Information\n- **Site ID**: Site 149\n- **Study**: Study 4\n- **Country**: SWE\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 78\n- **Average Issues per Subject**: 11.14\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 5 (71.4%)\n- Critical Risk: 2 (28.6%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 78\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1401: High risk, 6 issues\n- Subject 1402: High risk, 11 issues\n- Subject 1403: Critical risk, 19 issues\n- Subject 1404: Critical risk, 22 issues\n- Subject 1405: High risk, 7 issues\n- Subject 1406: High risk, 7 issues\n- Subject 1407: High risk, 6 issues\n"}
{"id": "site_Study 4_Site 15", "study": "Study 4", "site": "Site 15", "type": "site_summary", "total_subjects": 2, "total_issues": 16, "document": "# Site Report: Site 15\n\n## Site Information\n- **Site ID**: Site 15\n- **Study**: Study 4\n- **Country**: CAN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 16\n- **Average Issues per Subject**: 8.00\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (50.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 16\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 39: Critical risk, 16 issues\n"}
{"id": "site_Study 4_Site 150", "study": "Study 4", "site": "Site 150", "type": "site_summary", "total_subjects": 4, "total_issues": 184, "document": "# Site Report: Site 150\n\n## Site Information\n- **Site ID**: Site 150\n- **Study**: Study 4\n- **Country**: CHE\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 184\n- **Average Issues per Subject**: 46.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 4 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 184\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1408: Critical risk, 36 issues\n- Subject 1409: Critical risk, 95 issues\n- Subject 1410: Critical risk, 20 issues\n- Subject 1411: Critical risk, 33 issues\n"}
{"id": "site_Study 4_Site 151", "study": "Study 4", "site": "Site 151", "type": "site_summary", "total_subjects": 3, "total_issues": 20, "document": "# Site Report: Site 151\n\n## Site Information\n- **Site ID**: Site 151\n- **Study**: Study 4\n- **Country**: CHE\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 20\n- **Average Issues per Subject**: 6.67\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (33.3%)\n- High Risk: 2 (66.7%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 20\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1413: High risk, 6 issues\n- Subject 1415: High risk, 13 issues\n"}
{"id": "site_Study 4_Site 152", "study": "Study 4", "site": "Site 152", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 152\n\n## Site Information\n- **Site ID**: Site 152\n- **Study**: Study 4\n- **Country**: CHE\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 4_Site 153", "study": "Study 4", "site": "Site 153", "type": "site_summary", "total_subjects": 3, "total_issues": 4, "document": "# Site Report: Site 153\n\n## Site Information\n- **Site ID**: Site 153\n- **Study**: Study 4\n- **Country**: GBR\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 1.33\n- **Clean Subjects**: 2 (66.7%)\n\n## Risk Profile\n- Low Risk: 2 (66.7%)\n- Medium Risk: 1 (33.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 4\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 4_Site 154", "study": "Study 4", "site": "Site 154", "type": "site_summary", "total_subjects": 6, "total_issues": 36, "document": "# Site Report: Site 154\n\n## Site Information\n- **Site ID**: Site 154\n- **Study**: Study 4\n- **Country**: GBR\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 36\n- **Average Issues per Subject**: 6.00\n- **Clean Subjects**: 3 (50.0%)\n\n## Risk Profile\n- Low Risk: 3 (50.0%)\n- Medium Risk: 1 (16.7%)\n- High Risk: 1 (16.7%)\n- Critical Risk: 1 (16.7%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 36\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1423: High risk, 15 issues\n- Subject 1425: Critical risk, 19 issues\n"}
{"id": "site_Study 4_Site 155", "study": "Study 4", "site": "Site 155", "type": "site_summary", "total_subjects": 3, "total_issues": 8, "document": "# Site Report: Site 155\n\n## Site Information\n- **Site ID**: Site 155\n- **Study**: Study 4\n- **Country**: GBR\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 8\n- **Average Issues per Subject**: 2.67\n- **Clean Subjects**: 2 (66.7%)\n\n## Risk Profile\n- Low Risk: 2 (66.7%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (33.3%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 7\n- Missing Pages: 0\n- Missing Labs: 1\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1428: High risk, 8 issues\n"}
{"id": "site_Study 4_Site 156", "study": "Study 4", "site": "Site 156", "type": "site_summary", "total_subjects": 8, "total_issues": 25, "document": "# Site Report: Site 156\n\n## Site Information\n- **Site ID**: Site 156\n- **Study**: Study 4\n- **Country**: GBR\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 25\n- **Average Issues per Subject**: 3.12\n- **Clean Subjects**: 4 (50.0%)\n\n## Risk Profile\n- Low Risk: 4 (50.0%)\n- Medium Risk: 1 (12.5%)\n- High Risk: 3 (37.5%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 3\n- Safety Discrepancies: 22\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1431: High risk, 9 issues\n- Subject 1433: High risk, 8 issues\n- Subject 1436: High risk, 6 issues\n"}
{"id": "site_Study 4_Site 157", "study": "Study 4", "site": "Site 157", "type": "site_summary", "total_subjects": 3, "total_issues": 13, "document": "# Site Report: Site 157\n\n## Site Information\n- **Site ID**: Site 157\n- **Study**: Study 4\n- **Country**: GBR\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 13\n- **Average Issues per Subject**: 4.33\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (66.7%)\n- High Risk: 1 (33.3%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 13\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1440: High risk, 6 issues\n"}
{"id": "site_Study 4_Site 158", "study": "Study 4", "site": "Site 158", "type": "site_summary", "total_subjects": 6, "total_issues": 26, "document": "# Site Report: Site 158\n\n## Site Information\n- **Site ID**: Site 158\n- **Study**: Study 4\n- **Country**: GBR\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 26\n- **Average Issues per Subject**: 4.33\n- **Clean Subjects**: 2 (33.3%)\n\n## Risk Profile\n- Low Risk: 2 (33.3%)\n- Medium Risk: 2 (33.3%)\n- High Risk: 2 (33.3%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 25\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1442: High risk, 10 issues\n- Subject 1445: High risk, 12 issues\n"}
{"id": "site_Study 4_Site 159", "study": "Study 4", "site": "Site 159", "type": "site_summary", "total_subjects": 4, "total_issues": 19, "document": "# Site Report: Site 159\n\n## Site Information\n- **Site ID**: Site 159\n- **Study**: Study 4\n- **Country**: GBR\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 19\n- **Average Issues per Subject**: 4.75\n- **Clean Subjects**: 1 (25.0%)\n\n## Risk Profile\n- Low Risk: 1 (25.0%)\n- Medium Risk: 1 (25.0%)\n- High Risk: 2 (50.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 19\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1449: High risk, 8 issues\n- Subject 1452: High risk, 6 issues\n"}
{"id": "site_Study 4_Site 16", "study": "Study 4", "site": "Site 16", "type": "site_summary", "total_subjects": 4, "total_issues": 11, "document": "# Site Report: Site 16\n\n## Site Information\n- **Site ID**: Site 16\n- **Study**: Study 4\n- **Country**: CAN\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 11\n- **Average Issues per Subject**: 2.75\n- **Clean Subjects**: 1 (25.0%)\n\n## Risk Profile\n- Low Risk: 1 (25.0%)\n- Medium Risk: 2 (50.0%)\n- High Risk: 1 (25.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 11\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 55: High risk, 7 issues\n"}
{"id": "site_Study 4_Site 160", "study": "Study 4", "site": "Site 160", "type": "site_summary", "total_subjects": 3, "total_issues": 1, "document": "# Site Report: Site 160\n\n## Site Information\n- **Site ID**: Site 160\n- **Study**: Study 4\n- **Country**: GBR\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.33\n- **Clean Subjects**: 2 (66.7%)\n\n## Risk Profile\n- Low Risk: 2 (66.7%)\n- Medium Risk: 1 (33.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 1\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 4_Site 161", "study": "Study 4", "site": "Site 161", "type": "site_summary", "total_subjects": 3, "total_issues": 25, "document": "# Site Report: Site 161\n\n## Site Information\n- **Site ID**: Site 161\n- **Study**: Study 4\n- **Country**: CZE\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 25\n- **Average Issues per Subject**: 8.33\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (33.3%)\n- High Risk: 1 (33.3%)\n- Critical Risk: 1 (33.3%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 24\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1457: High risk, 7 issues\n- Subject 1458: Critical risk, 16 issues\n"}
{"id": "site_Study 4_Site 162", "study": "Study 4", "site": "Site 162", "type": "site_summary", "total_subjects": 15, "total_issues": 18, "document": "# Site Report: Site 162\n\n## Site Information\n- **Site ID**: Site 162\n- **Study**: Study 4\n- **Country**: CZE\n- **Total Subjects**: 15\n\n## Performance Metrics\n- **Total Issues**: 18\n- **Average Issues per Subject**: 1.20\n- **Clean Subjects**: 11 (73.3%)\n\n## Risk Profile\n- Low Risk: 11 (73.3%)\n- Medium Risk: 2 (13.3%)\n- High Risk: 2 (13.3%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 18\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1459: High risk, 7 issues\n- Subject 1471: High risk, 9 issues\n"}
{"id": "site_Study 4_Site 163", "study": "Study 4", "site": "Site 163", "type": "site_summary", "total_subjects": 2, "total_issues": 25, "document": "# Site Report: Site 163\n\n## Site Information\n- **Site ID**: Site 163\n- **Study**: Study 4\n- **Country**: CAN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 25\n- **Average Issues per Subject**: 12.50\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (50.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 25\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1497: Critical risk, 24 issues\n"}
{"id": "site_Study 4_Site 164", "study": "Study 4", "site": "Site 164", "type": "site_summary", "total_subjects": 13, "total_issues": 219, "document": "# Site Report: Site 164\n\n## Site Information\n- **Site ID**: Site 164\n- **Study**: Study 4\n- **Country**: CAN\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 219\n- **Average Issues per Subject**: 16.85\n- **Clean Subjects**: 1 (7.7%)\n\n## Risk Profile\n- Low Risk: 1 (7.7%)\n- Medium Risk: 3 (23.1%)\n- High Risk: 3 (23.1%)\n- Critical Risk: 6 (46.2%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 217\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1499: Critical risk, 31 issues\n- Subject 1500: High risk, 9 issues\n- Subject 1502: Critical risk, 16 issues\n- Subject 1503: Critical risk, 63 issues\n- Subject 1504: Critical risk, 16 issues\n- Subject 1505: Critical risk, 20 issues\n- Subject 1507: High risk, 12 issues\n- Subject 1508: Critical risk, 30 issues\n- Subject 1509: High risk, 10 issues\n"}
{"id": "site_Study 4_Site 165", "study": "Study 4", "site": "Site 165", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 165\n\n## Site Information\n- **Site ID**: Site 165\n- **Study**: Study 4\n- **Country**: CHN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 4_Site 166", "study": "Study 4", "site": "Site 166", "type": "site_summary", "total_subjects": 5, "total_issues": 74, "document": "# Site Report: Site 166\n\n## Site Information\n- **Site ID**: Site 166\n- **Study**: Study 4\n- **Country**: CHN\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 74\n- **Average Issues per Subject**: 14.80\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (40.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 3 (60.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 73\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1515: Critical risk, 28 issues\n- Subject 1517: Critical risk, 23 issues\n- Subject 1518: Critical risk, 16 issues\n"}
{"id": "site_Study 4_Site 167", "study": "Study 4", "site": "Site 167", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 167\n\n## Site Information\n- **Site ID**: Site 167\n- **Study**: Study 4\n- **Country**: CHN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 4_Site 168", "study": "Study 4", "site": "Site 168", "type": "site_summary", "total_subjects": 14, "total_issues": 25, "document": "# Site Report: Site 168\n\n## Site Information\n- **Site ID**: Site 168\n- **Study**: Study 4\n- **Country**: CHN\n- **Total Subjects**: 14\n\n## Performance Metrics\n- **Total Issues**: 25\n- **Average Issues per Subject**: 1.79\n- **Clean Subjects**: 9 (64.3%)\n\n## Risk Profile\n- Low Risk: 9 (64.3%)\n- Medium Risk: 3 (21.4%)\n- High Risk: 2 (14.3%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 25\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1530: High risk, 7 issues\n- Subject 1533: High risk, 8 issues\n"}
{"id": "site_Study 4_Site 169", "study": "Study 4", "site": "Site 169", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 169\n\n## Site Information\n- **Site ID**: Site 169\n- **Study**: Study 4\n- **Country**: CHN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 4_Site 170", "study": "Study 4", "site": "Site 170", "type": "site_summary", "total_subjects": 6, "total_issues": 50, "document": "# Site Report: Site 170\n\n## Site Information\n- **Site ID**: Site 170\n- **Study**: Study 4\n- **Country**: CHN\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 50\n- **Average Issues per Subject**: 8.33\n- **Clean Subjects**: 1 (16.7%)\n\n## Risk Profile\n- Low Risk: 1 (16.7%)\n- Medium Risk: 2 (33.3%)\n- High Risk: 1 (16.7%)\n- Critical Risk: 2 (33.3%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 49\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1541: Critical risk, 18 issues\n- Subject 1543: Critical risk, 16 issues\n- Subject 1544: High risk, 8 issues\n"}
{"id": "site_Study 4_Site 171", "study": "Study 4", "site": "Site 171", "type": "site_summary", "total_subjects": 19, "total_issues": 22, "document": "# Site Report: Site 171\n\n## Site Information\n- **Site ID**: Site 171\n- **Study**: Study 4\n- **Country**: CHN\n- **Total Subjects**: 19\n\n## Performance Metrics\n- **Total Issues**: 22\n- **Average Issues per Subject**: 1.16\n- **Clean Subjects**: 14 (73.7%)\n\n## Risk Profile\n- Low Risk: 14 (73.7%)\n- Medium Risk: 4 (21.1%)\n- High Risk: 1 (5.3%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 22\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1547: High risk, 10 issues\n"}
{"id": "site_Study 4_Site 172", "study": "Study 4", "site": "Site 172", "type": "site_summary", "total_subjects": 4, "total_issues": 7, "document": "# Site Report: Site 172\n\n## Site Information\n- **Site ID**: Site 172\n- **Study**: Study 4\n- **Country**: CHN\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 7\n- **Average Issues per Subject**: 1.75\n- **Clean Subjects**: 2 (50.0%)\n\n## Risk Profile\n- Low Risk: 2 (50.0%)\n- Medium Risk: 1 (25.0%)\n- High Risk: 1 (25.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 6\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1568: High risk, 6 issues\n"}
{"id": "site_Study 4_Site 173", "study": "Study 4", "site": "Site 173", "type": "site_summary", "total_subjects": 7, "total_issues": 76, "document": "# Site Report: Site 173\n\n## Site Information\n- **Site ID**: Site 173\n- **Study**: Study 4\n- **Country**: CHN\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 76\n- **Average Issues per Subject**: 10.86\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 3 (42.9%)\n- High Risk: 2 (28.6%)\n- Critical Risk: 2 (28.6%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 76\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1571: High risk, 15 issues\n- Subject 1572: Critical risk, 16 issues\n- Subject 1573: High risk, 15 issues\n- Subject 1576: Critical risk, 22 issues\n"}
{"id": "site_Study 4_Site 174", "study": "Study 4", "site": "Site 174", "type": "site_summary", "total_subjects": 13, "total_issues": 136, "document": "# Site Report: Site 174\n\n## Site Information\n- **Site ID**: Site 174\n- **Study**: Study 4\n- **Country**: CHN\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 136\n- **Average Issues per Subject**: 10.46\n- **Clean Subjects**: 3 (23.1%)\n\n## Risk Profile\n- Low Risk: 3 (23.1%)\n- Medium Risk: 5 (38.5%)\n- High Risk: 1 (7.7%)\n- Critical Risk: 4 (30.8%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 136\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1579: Critical risk, 44 issues\n- Subject 1582: Critical risk, 26 issues\n- Subject 1587: Critical risk, 21 issues\n- Subject 1589: High risk, 7 issues\n- Subject 1590: Critical risk, 18 issues\n"}
{"id": "site_Study 4_Site 175", "study": "Study 4", "site": "Site 175", "type": "site_summary", "total_subjects": 1, "total_issues": 75, "document": "# Site Report: Site 175\n\n## Site Information\n- **Site ID**: Site 175\n- **Study**: Study 4\n- **Country**: CHN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 75\n- **Average Issues per Subject**: 75.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 75\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1591: Critical risk, 75 issues\n"}
{"id": "site_Study 4_Site 177", "study": "Study 4", "site": "Site 177", "type": "site_summary", "total_subjects": 7, "total_issues": 59, "document": "# Site Report: Site 177\n\n## Site Information\n- **Site ID**: Site 177\n- **Study**: Study 4\n- **Country**: JPN\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 59\n- **Average Issues per Subject**: 8.43\n- **Clean Subjects**: 1 (14.3%)\n\n## Risk Profile\n- Low Risk: 1 (14.3%)\n- Medium Risk: 1 (14.3%)\n- High Risk: 3 (42.9%)\n- Critical Risk: 2 (28.6%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 58\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1593: High risk, 6 issues\n- Subject 1594: Critical risk, 17 issues\n- Subject 1595: High risk, 7 issues\n- Subject 1596: High risk, 7 issues\n- Subject 1598: Critical risk, 21 issues\n"}
{"id": "site_Study 4_Site 178", "study": "Study 4", "site": "Site 178", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 178\n\n## Site Information\n- **Site ID**: Site 178\n- **Study**: Study 4\n- **Country**: JPN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 4_Site 179", "study": "Study 4", "site": "Site 179", "type": "site_summary", "total_subjects": 6, "total_issues": 13, "document": "# Site Report: Site 179\n\n## Site Information\n- **Site ID**: Site 179\n- **Study**: Study 4\n- **Country**: JPN\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 13\n- **Average Issues per Subject**: 2.17\n- **Clean Subjects**: 4 (66.7%)\n\n## Risk Profile\n- Low Risk: 4 (66.7%)\n- Medium Risk: 1 (16.7%)\n- High Risk: 1 (16.7%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 13\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1607: High risk, 12 issues\n"}
{"id": "site_Study 4_Site 18", "study": "Study 4", "site": "Site 18", "type": "site_summary", "total_subjects": 2, "total_issues": 21, "document": "# Site Report: Site 18\n\n## Site Information\n- **Site ID**: Site 18\n- **Study**: Study 4\n- **Country**: JPN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 21\n- **Average Issues per Subject**: 10.50\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (50.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 21\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 64: Critical risk, 18 issues\n"}
{"id": "site_Study 4_Site 180", "study": "Study 4", "site": "Site 180", "type": "site_summary", "total_subjects": 4, "total_issues": 29, "document": "# Site Report: Site 180\n\n## Site Information\n- **Site ID**: Site 180\n- **Study**: Study 4\n- **Country**: JPN\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 29\n- **Average Issues per Subject**: 7.25\n- **Clean Subjects**: 2 (50.0%)\n\n## Risk Profile\n- Low Risk: 2 (50.0%)\n- Medium Risk: 1 (25.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (25.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 29\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1611: Critical risk, 25 issues\n"}
{"id": "site_Study 4_Site 181", "study": "Study 4", "site": "Site 181", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 181\n\n## Site Information\n- **Site ID**: Site 181\n- **Study**: Study 4\n- **Country**: JPN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 4_Site 182", "study": "Study 4", "site": "Site 182", "type": "site_summary", "total_subjects": 1, "total_issues": 3, "document": "# Site Report: Site 182\n\n## Site Information\n- **Site ID**: Site 182\n- **Study**: Study 4\n- **Country**: JPN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 3.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 3\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 4_Site 183", "study": "Study 4", "site": "Site 183", "type": "site_summary", "total_subjects": 3, "total_issues": 7, "document": "# Site Report: Site 183\n\n## Site Information\n- **Site ID**: Site 183\n- **Study**: Study 4\n- **Country**: JPN\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 7\n- **Average Issues per Subject**: 2.33\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 3 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 7\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 4_Site 184", "study": "Study 4", "site": "Site 184", "type": "site_summary", "total_subjects": 3, "total_issues": 40, "document": "# Site Report: Site 184\n\n## Site Information\n- **Site ID**: Site 184\n- **Study**: Study 4\n- **Country**: JPN\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 40\n- **Average Issues per Subject**: 13.33\n- **Clean Subjects**: 1 (33.3%)\n\n## Risk Profile\n- Low Risk: 1 (33.3%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (33.3%)\n- Critical Risk: 1 (33.3%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 39\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1624: High risk, 15 issues\n- Subject 1626: Critical risk, 25 issues\n"}
{"id": "site_Study 4_Site 185", "study": "Study 4", "site": "Site 185", "type": "site_summary", "total_subjects": 5, "total_issues": 55, "document": "# Site Report: Site 185\n\n## Site Information\n- **Site ID**: Site 185\n- **Study**: Study 4\n- **Country**: JPN\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 55\n- **Average Issues per Subject**: 11.00\n- **Clean Subjects**: 1 (20.0%)\n\n## Risk Profile\n- Low Risk: 1 (20.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 3 (60.0%)\n- Critical Risk: 1 (20.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 54\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1629: High risk, 13 issues\n- Subject 1631: High risk, 8 issues\n- Subject 1632: Critical risk, 24 issues\n- Subject 1633: High risk, 10 issues\n"}
{"id": "site_Study 4_Site 186", "study": "Study 4", "site": "Site 186", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 186\n\n## Site Information\n- **Site ID**: Site 186\n- **Study**: Study 4\n- **Country**: JPN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 4_Site 187", "study": "Study 4", "site": "Site 187", "type": "site_summary", "total_subjects": 2, "total_issues": 1, "document": "# Site Report: Site 187\n\n## Site Information\n- **Site ID**: Site 187\n- **Study**: Study 4\n- **Country**: JPN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.50\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 4_Site 188", "study": "Study 4", "site": "Site 188", "type": "site_summary", "total_subjects": 2, "total_issues": 37, "document": "# Site Report: Site 188\n\n## Site Information\n- **Site ID**: Site 188\n- **Study**: Study 4\n- **Country**: JPN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 37\n- **Average Issues per Subject**: 18.50\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (50.0%)\n- Critical Risk: 1 (50.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 37\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1637: High risk, 15 issues\n- Subject 1638: Critical risk, 22 issues\n"}
{"id": "site_Study 4_Site 189", "study": "Study 4", "site": "Site 189", "type": "site_summary", "total_subjects": 2, "total_issues": 47, "document": "# Site Report: Site 189\n\n## Site Information\n- **Site ID**: Site 189\n- **Study**: Study 4\n- **Country**: JPN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 47\n- **Average Issues per Subject**: 23.50\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (50.0%)\n- Critical Risk: 1 (50.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 47\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1639: Critical risk, 34 issues\n- Subject 1640: High risk, 13 issues\n"}
{"id": "site_Study 4_Site 190", "study": "Study 4", "site": "Site 190", "type": "site_summary", "total_subjects": 24, "total_issues": 236, "document": "# Site Report: Site 190\n\n## Site Information\n- **Site ID**: Site 190\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 24\n\n## Performance Metrics\n- **Total Issues**: 236\n- **Average Issues per Subject**: 9.83\n- **Clean Subjects**: 5 (20.8%)\n\n## Risk Profile\n- Low Risk: 5 (20.8%)\n- Medium Risk: 7 (29.2%)\n- High Risk: 8 (33.3%)\n- Critical Risk: 4 (16.7%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 235\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1641: High risk, 12 issues\n- Subject 1643: Critical risk, 32 issues\n- Subject 1648: High risk, 8 issues\n- Subject 1649: Critical risk, 38 issues\n- Subject 1651: High risk, 6 issues\n- Subject 1657: High risk, 10 issues\n- Subject 1658: Critical risk, 53 issues\n- Subject 1661: High risk, 8 issues\n- Subject 1662: Critical risk, 20 issues\n- Subject 1665: High risk, 14 issues\n"}
{"id": "site_Study 4_Site 191", "study": "Study 4", "site": "Site 191", "type": "site_summary", "total_subjects": 13, "total_issues": 71, "document": "# Site Report: Site 191\n\n## Site Information\n- **Site ID**: Site 191\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 71\n- **Average Issues per Subject**: 5.46\n- **Clean Subjects**: 7 (53.8%)\n\n## Risk Profile\n- Low Risk: 7 (53.8%)\n- Medium Risk: 1 (7.7%)\n- High Risk: 3 (23.1%)\n- Critical Risk: 2 (15.4%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 70\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1673: Critical risk, 22 issues\n- Subject 1679: High risk, 12 issues\n- Subject 1682: High risk, 14 issues\n- Subject 1683: High risk, 6 issues\n- Subject 1685: Critical risk, 16 issues\n"}
{"id": "site_Study 4_Site 192", "study": "Study 4", "site": "Site 192", "type": "site_summary", "total_subjects": 3, "total_issues": 12, "document": "# Site Report: Site 192\n\n## Site Information\n- **Site ID**: Site 192\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 12\n- **Average Issues per Subject**: 4.00\n- **Clean Subjects**: 1 (33.3%)\n\n## Risk Profile\n- Low Risk: 1 (33.3%)\n- Medium Risk: 1 (33.3%)\n- High Risk: 1 (33.3%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 12\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1689: High risk, 7 issues\n"}
{"id": "site_Study 4_Site 193", "study": "Study 4", "site": "Site 193", "type": "site_summary", "total_subjects": 1, "total_issues": 15, "document": "# Site Report: Site 193\n\n## Site Information\n- **Site ID**: Site 193\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 15\n- **Average Issues per Subject**: 15.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (100.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 15\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1698: High risk, 15 issues\n"}
{"id": "site_Study 4_Site 194", "study": "Study 4", "site": "Site 194", "type": "site_summary", "total_subjects": 11, "total_issues": 87, "document": "# Site Report: Site 194\n\n## Site Information\n- **Site ID**: Site 194\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 87\n- **Average Issues per Subject**: 7.91\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 5 (45.5%)\n- High Risk: 5 (45.5%)\n- Critical Risk: 1 (9.1%)\n\n## Issue Breakdown\n- Open EDRR Issues: 4\n- Safety Discrepancies: 83\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1699: Critical risk, 29 issues\n- Subject 1701: High risk, 11 issues\n- Subject 1702: High risk, 9 issues\n- Subject 1705: High risk, 6 issues\n- Subject 1709: High risk, 6 issues\n- Subject 1711: High risk, 8 issues\n"}
{"id": "site_Study 4_Site 195", "study": "Study 4", "site": "Site 195", "type": "site_summary", "total_subjects": 3, "total_issues": 14, "document": "# Site Report: Site 195\n\n## Site Information\n- **Site ID**: Site 195\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 14\n- **Average Issues per Subject**: 4.67\n- **Clean Subjects**: 1 (33.3%)\n\n## Risk Profile\n- Low Risk: 1 (33.3%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 2 (66.7%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 14\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1712: High risk, 7 issues\n- Subject 1834: High risk, 7 issues\n"}
{"id": "site_Study 4_Site 196", "study": "Study 4", "site": "Site 196", "type": "site_summary", "total_subjects": 4, "total_issues": 77, "document": "# Site Report: Site 196\n\n## Site Information\n- **Site ID**: Site 196\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 77\n- **Average Issues per Subject**: 19.25\n- **Clean Subjects**: 1 (25.0%)\n\n## Risk Profile\n- Low Risk: 1 (25.0%)\n- Medium Risk: 1 (25.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 2 (50.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 76\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1713: Critical risk, 53 issues\n- Subject 1714: Critical risk, 21 issues\n"}
{"id": "site_Study 4_Site 197", "study": "Study 4", "site": "Site 197", "type": "site_summary", "total_subjects": 6, "total_issues": 7, "document": "# Site Report: Site 197\n\n## Site Information\n- **Site ID**: Site 197\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 7\n- **Average Issues per Subject**: 1.17\n- **Clean Subjects**: 4 (66.7%)\n\n## Risk Profile\n- Low Risk: 4 (66.7%)\n- Medium Risk: 2 (33.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 6\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 4_Site 198", "study": "Study 4", "site": "Site 198", "type": "site_summary", "total_subjects": 20, "total_issues": 198, "document": "# Site Report: Site 198\n\n## Site Information\n- **Site ID**: Site 198\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 20\n\n## Performance Metrics\n- **Total Issues**: 198\n- **Average Issues per Subject**: 9.90\n- **Clean Subjects**: 4 (20.0%)\n\n## Risk Profile\n- Low Risk: 4 (20.0%)\n- Medium Risk: 5 (25.0%)\n- High Risk: 7 (35.0%)\n- Critical Risk: 4 (20.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 198\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1723: Critical risk, 35 issues\n- Subject 1724: High risk, 14 issues\n- Subject 1726: Critical risk, 22 issues\n- Subject 1728: High risk, 11 issues\n- Subject 1729: High risk, 8 issues\n- Subject 1730: High risk, 12 issues\n- Subject 1732: High risk, 15 issues\n- Subject 1736: High risk, 6 issues\n- Subject 1737: High risk, 14 issues\n- Subject 1738: Critical risk, 31 issues\n"}
{"id": "site_Study 4_Site 199", "study": "Study 4", "site": "Site 199", "type": "site_summary", "total_subjects": 5, "total_issues": 36, "document": "# Site Report: Site 199\n\n## Site Information\n- **Site ID**: Site 199\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 36\n- **Average Issues per Subject**: 7.20\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 4 (80.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (20.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 35\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2002: Critical risk, 26 issues\n"}
{"id": "site_Study 4_Site 20", "study": "Study 4", "site": "Site 20", "type": "site_summary", "total_subjects": 3, "total_issues": 12, "document": "# Site Report: Site 20\n\n## Site Information\n- **Site ID**: Site 20\n- **Study**: Study 4\n- **Country**: JPN\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 12\n- **Average Issues per Subject**: 4.00\n- **Clean Subjects**: 1 (33.3%)\n\n## Risk Profile\n- Low Risk: 1 (33.3%)\n- Medium Risk: 1 (33.3%)\n- High Risk: 1 (33.3%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 12\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1601: High risk, 10 issues\n"}
{"id": "site_Study 4_Site 200", "study": "Study 4", "site": "Site 200", "type": "site_summary", "total_subjects": 6, "total_issues": 76, "document": "# Site Report: Site 200\n\n## Site Information\n- **Site ID**: Site 200\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 76\n- **Average Issues per Subject**: 12.67\n- **Clean Subjects**: 1 (16.7%)\n\n## Risk Profile\n- Low Risk: 1 (16.7%)\n- Medium Risk: 1 (16.7%)\n- High Risk: 1 (16.7%)\n- Critical Risk: 3 (50.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 76\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1744: Critical risk, 17 issues\n- Subject 1745: Critical risk, 23 issues\n- Subject 1748: Critical risk, 25 issues\n- Subject 1751: High risk, 9 issues\n"}
{"id": "site_Study 4_Site 201", "study": "Study 4", "site": "Site 201", "type": "site_summary", "total_subjects": 6, "total_issues": 9, "document": "# Site Report: Site 201\n\n## Site Information\n- **Site ID**: Site 201\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 9\n- **Average Issues per Subject**: 1.50\n- **Clean Subjects**: 4 (66.7%)\n\n## Risk Profile\n- Low Risk: 4 (66.7%)\n- Medium Risk: 1 (16.7%)\n- High Risk: 1 (16.7%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 9\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1759: High risk, 6 issues\n"}
{"id": "site_Study 4_Site 202", "study": "Study 4", "site": "Site 202", "type": "site_summary", "total_subjects": 13, "total_issues": 62, "document": "# Site Report: Site 202\n\n## Site Information\n- **Site ID**: Site 202\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 62\n- **Average Issues per Subject**: 4.77\n- **Clean Subjects**: 5 (38.5%)\n\n## Risk Profile\n- Low Risk: 5 (38.5%)\n- Medium Risk: 4 (30.8%)\n- High Risk: 4 (30.8%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 62\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1764: High risk, 14 issues\n- Subject 1776: High risk, 9 issues\n- Subject 1777: High risk, 14 issues\n- Subject 1778: High risk, 10 issues\n"}
{"id": "site_Study 4_Site 203", "study": "Study 4", "site": "Site 203", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 203\n\n## Site Information\n- **Site ID**: Site 203\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 4_Site 204", "study": "Study 4", "site": "Site 204", "type": "site_summary", "total_subjects": 6, "total_issues": 67, "document": "# Site Report: Site 204\n\n## Site Information\n- **Site ID**: Site 204\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 67\n- **Average Issues per Subject**: 11.17\n- **Clean Subjects**: 3 (50.0%)\n\n## Risk Profile\n- Low Risk: 3 (50.0%)\n- Medium Risk: 2 (33.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (16.7%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 67\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1783: Critical risk, 57 issues\n"}
{"id": "site_Study 4_Site 205", "study": "Study 4", "site": "Site 205", "type": "site_summary", "total_subjects": 3, "total_issues": 17, "document": "# Site Report: Site 205\n\n## Site Information\n- **Site ID**: Site 205\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 17\n- **Average Issues per Subject**: 5.67\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (33.3%)\n- High Risk: 2 (66.7%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 17\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1787: High risk, 8 issues\n- Subject 1789: High risk, 7 issues\n"}
{"id": "site_Study 4_Site 206", "study": "Study 4", "site": "Site 206", "type": "site_summary", "total_subjects": 14, "total_issues": 104, "document": "# Site Report: Site 206\n\n## Site Information\n- **Site ID**: Site 206\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 14\n\n## Performance Metrics\n- **Total Issues**: 104\n- **Average Issues per Subject**: 7.43\n- **Clean Subjects**: 4 (28.6%)\n\n## Risk Profile\n- Low Risk: 4 (28.6%)\n- Medium Risk: 3 (21.4%)\n- High Risk: 6 (42.9%)\n- Critical Risk: 1 (7.1%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 104\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1790: High risk, 14 issues\n- Subject 1799: High risk, 13 issues\n- Subject 1801: High risk, 15 issues\n- Subject 1802: High risk, 6 issues\n- Subject 1803: High risk, 8 issues\n- Subject 1805: High risk, 10 issues\n- Subject 1809: Critical risk, 28 issues\n"}
{"id": "site_Study 4_Site 207", "study": "Study 4", "site": "Site 207", "type": "site_summary", "total_subjects": 8, "total_issues": 136, "document": "# Site Report: Site 207\n\n## Site Information\n- **Site ID**: Site 207\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 136\n- **Average Issues per Subject**: 17.00\n- **Clean Subjects**: 1 (12.5%)\n\n## Risk Profile\n- Low Risk: 1 (12.5%)\n- Medium Risk: 2 (25.0%)\n- High Risk: 1 (12.5%)\n- Critical Risk: 4 (50.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 136\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1810: High risk, 7 issues\n- Subject 1814: Critical risk, 52 issues\n- Subject 1815: Critical risk, 27 issues\n- Subject 1816: Critical risk, 17 issues\n- Subject 1818: Critical risk, 27 issues\n"}
{"id": "site_Study 4_Site 208", "study": "Study 4", "site": "Site 208", "type": "site_summary", "total_subjects": 3, "total_issues": 44, "document": "# Site Report: Site 208\n\n## Site Information\n- **Site ID**: Site 208\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 44\n- **Average Issues per Subject**: 14.67\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (33.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 2 (66.7%)\n\n## Issue Breakdown\n- Open EDRR Issues: 5\n- Safety Discrepancies: 39\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1820: Critical risk, 18 issues\n- Subject 1823: Critical risk, 22 issues\n"}
{"id": "site_Study 4_Site 209", "study": "Study 4", "site": "Site 209", "type": "site_summary", "total_subjects": 3, "total_issues": 41, "document": "# Site Report: Site 209\n\n## Site Information\n- **Site ID**: Site 209\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 41\n- **Average Issues per Subject**: 13.67\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 2 (66.7%)\n- Critical Risk: 1 (33.3%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 40\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1825: High risk, 11 issues\n- Subject 1826: Critical risk, 19 issues\n- Subject 1827: High risk, 11 issues\n"}
{"id": "site_Study 4_Site 210", "study": "Study 4", "site": "Site 210", "type": "site_summary", "total_subjects": 4, "total_issues": 51, "document": "# Site Report: Site 210\n\n## Site Information\n- **Site ID**: Site 210\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 51\n- **Average Issues per Subject**: 12.75\n- **Clean Subjects**: 1 (25.0%)\n\n## Risk Profile\n- Low Risk: 1 (25.0%)\n- Medium Risk: 1 (25.0%)\n- High Risk: 1 (25.0%)\n- Critical Risk: 1 (25.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 51\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1829: Critical risk, 40 issues\n- Subject 1831: High risk, 7 issues\n"}
{"id": "site_Study 4_Site 211", "study": "Study 4", "site": "Site 211", "type": "site_summary", "total_subjects": 11, "total_issues": 203, "document": "# Site Report: Site 211\n\n## Site Information\n- **Site ID**: Site 211\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 203\n- **Average Issues per Subject**: 18.45\n- **Clean Subjects**: 2 (18.2%)\n\n## Risk Profile\n- Low Risk: 2 (18.2%)\n- Medium Risk: 2 (18.2%)\n- High Risk: 3 (27.3%)\n- Critical Risk: 4 (36.4%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 203\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1837: High risk, 11 issues\n- Subject 1838: High risk, 6 issues\n- Subject 1840: High risk, 14 issues\n- Subject 1841: Critical risk, 28 issues\n- Subject 1843: Critical risk, 44 issues\n- Subject 1846: Critical risk, 29 issues\n- Subject 1847: Critical risk, 66 issues\n"}
{"id": "site_Study 4_Site 212", "study": "Study 4", "site": "Site 212", "type": "site_summary", "total_subjects": 13, "total_issues": 203, "document": "# Site Report: Site 212\n\n## Site Information\n- **Site ID**: Site 212\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 203\n- **Average Issues per Subject**: 15.62\n- **Clean Subjects**: 2 (15.4%)\n\n## Risk Profile\n- Low Risk: 2 (15.4%)\n- Medium Risk: 2 (15.4%)\n- High Risk: 3 (23.1%)\n- Critical Risk: 6 (46.2%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 202\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1852: High risk, 7 issues\n- Subject 1854: High risk, 13 issues\n- Subject 1855: Critical risk, 19 issues\n- Subject 1856: Critical risk, 43 issues\n- Subject 1857: Critical risk, 17 issues\n- Subject 1859: Critical risk, 37 issues\n- Subject 1860: Critical risk, 20 issues\n- Subject 1861: Critical risk, 36 issues\n- Subject 2211: High risk, 8 issues\n"}
{"id": "site_Study 4_Site 213", "study": "Study 4", "site": "Site 213", "type": "site_summary", "total_subjects": 7, "total_issues": 32, "document": "# Site Report: Site 213\n\n## Site Information\n- **Site ID**: Site 213\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 32\n- **Average Issues per Subject**: 4.57\n- **Clean Subjects**: 3 (42.9%)\n\n## Risk Profile\n- Low Risk: 3 (42.9%)\n- Medium Risk: 2 (28.6%)\n- High Risk: 1 (14.3%)\n- Critical Risk: 1 (14.3%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 31\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1863: Critical risk, 16 issues\n- Subject 1864: High risk, 10 issues\n"}
{"id": "site_Study 4_Site 214", "study": "Study 4", "site": "Site 214", "type": "site_summary", "total_subjects": 2, "total_issues": 18, "document": "# Site Report: Site 214\n\n## Site Information\n- **Site ID**: Site 214\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 18\n- **Average Issues per Subject**: 9.00\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (50.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 18\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2074: Critical risk, 18 issues\n"}
{"id": "site_Study 4_Site 215", "study": "Study 4", "site": "Site 215", "type": "site_summary", "total_subjects": 20, "total_issues": 192, "document": "# Site Report: Site 215\n\n## Site Information\n- **Site ID**: Site 215\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 20\n\n## Performance Metrics\n- **Total Issues**: 192\n- **Average Issues per Subject**: 9.60\n- **Clean Subjects**: 6 (30.0%)\n\n## Risk Profile\n- Low Risk: 6 (30.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 11 (55.0%)\n- Critical Risk: 3 (15.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 6\n- Safety Discrepancies: 186\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1871: High risk, 7 issues\n- Subject 1874: High risk, 9 issues\n- Subject 1880: High risk, 10 issues\n- Subject 1881: High risk, 15 issues\n- Subject 1883: High risk, 14 issues\n- Subject 1884: High risk, 12 issues\n- Subject 1885: High risk, 14 issues\n- Subject 1886: High risk, 7 issues\n- Subject 1889: High risk, 6 issues\n- Subject 1891: High risk, 8 issues\n"}
{"id": "site_Study 4_Site 216", "study": "Study 4", "site": "Site 216", "type": "site_summary", "total_subjects": 7, "total_issues": 61, "document": "# Site Report: Site 216\n\n## Site Information\n- **Site ID**: Site 216\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 61\n- **Average Issues per Subject**: 8.71\n- **Clean Subjects**: 2 (28.6%)\n\n## Risk Profile\n- Low Risk: 2 (28.6%)\n- Medium Risk: 1 (14.3%)\n- High Risk: 3 (42.9%)\n- Critical Risk: 1 (14.3%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 60\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1898: High risk, 11 issues\n- Subject 1900: High risk, 14 issues\n- Subject 1907: High risk, 11 issues\n- Subject 1908: Critical risk, 22 issues\n"}
{"id": "site_Study 4_Site 217", "study": "Study 4", "site": "Site 217", "type": "site_summary", "total_subjects": 7, "total_issues": 31, "document": "# Site Report: Site 217\n\n## Site Information\n- **Site ID**: Site 217\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 31\n- **Average Issues per Subject**: 4.43\n- **Clean Subjects**: 2 (28.6%)\n\n## Risk Profile\n- Low Risk: 2 (28.6%)\n- Medium Risk: 4 (57.1%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (14.3%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 31\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1915: Critical risk, 22 issues\n"}
{"id": "site_Study 4_Site 218", "study": "Study 4", "site": "Site 218", "type": "site_summary", "total_subjects": 7, "total_issues": 51, "document": "# Site Report: Site 218\n\n## Site Information\n- **Site ID**: Site 218\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 51\n- **Average Issues per Subject**: 7.29\n- **Clean Subjects**: 3 (42.9%)\n\n## Risk Profile\n- Low Risk: 3 (42.9%)\n- Medium Risk: 1 (14.3%)\n- High Risk: 2 (28.6%)\n- Critical Risk: 1 (14.3%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 51\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1918: High risk, 8 issues\n- Subject 1919: High risk, 8 issues\n- Subject 1921: Critical risk, 31 issues\n"}
{"id": "site_Study 4_Site 219", "study": "Study 4", "site": "Site 219", "type": "site_summary", "total_subjects": 2, "total_issues": 55, "document": "# Site Report: Site 219\n\n## Site Information\n- **Site ID**: Site 219\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 55\n- **Average Issues per Subject**: 27.50\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 2 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 55\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1923: Critical risk, 34 issues\n- Subject 1924: Critical risk, 21 issues\n"}
{"id": "site_Study 4_Site 22", "study": "Study 4", "site": "Site 22", "type": "site_summary", "total_subjects": 5, "total_issues": 9, "document": "# Site Report: Site 22\n\n## Site Information\n- **Site ID**: Site 22\n- **Study**: Study 4\n- **Country**: JPN\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 9\n- **Average Issues per Subject**: 1.80\n- **Clean Subjects**: 2 (40.0%)\n\n## Risk Profile\n- Low Risk: 2 (40.0%)\n- Medium Risk: 3 (60.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 9\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 4_Site 220", "study": "Study 4", "site": "Site 220", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 220\n\n## Site Information\n- **Site ID**: Site 220\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 4_Site 221", "study": "Study 4", "site": "Site 221", "type": "site_summary", "total_subjects": 8, "total_issues": 91, "document": "# Site Report: Site 221\n\n## Site Information\n- **Site ID**: Site 221\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 91\n- **Average Issues per Subject**: 11.38\n- **Clean Subjects**: 1 (12.5%)\n\n## Risk Profile\n- Low Risk: 1 (12.5%)\n- Medium Risk: 2 (25.0%)\n- High Risk: 2 (25.0%)\n- Critical Risk: 3 (37.5%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 91\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1927: High risk, 6 issues\n- Subject 1929: Critical risk, 20 issues\n- Subject 1931: High risk, 6 issues\n- Subject 1934: Critical risk, 17 issues\n- Subject 1935: Critical risk, 34 issues\n"}
{"id": "site_Study 4_Site 222", "study": "Study 4", "site": "Site 222", "type": "site_summary", "total_subjects": 9, "total_issues": 56, "document": "# Site Report: Site 222\n\n## Site Information\n- **Site ID**: Site 222\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 56\n- **Average Issues per Subject**: 6.22\n- **Clean Subjects**: 2 (22.2%)\n\n## Risk Profile\n- Low Risk: 2 (22.2%)\n- Medium Risk: 3 (33.3%)\n- High Risk: 3 (33.3%)\n- Critical Risk: 1 (11.1%)\n\n## Issue Breakdown\n- Open EDRR Issues: 3\n- Safety Discrepancies: 53\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1939: Critical risk, 18 issues\n- Subject 1940: High risk, 9 issues\n- Subject 1941: High risk, 6 issues\n- Subject 1942: High risk, 13 issues\n"}
{"id": "site_Study 4_Site 223", "study": "Study 4", "site": "Site 223", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 223\n\n## Site Information\n- **Site ID**: Site 223\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 4_Site 224", "study": "Study 4", "site": "Site 224", "type": "site_summary", "total_subjects": 8, "total_issues": 168, "document": "# Site Report: Site 224\n\n## Site Information\n- **Site ID**: Site 224\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 168\n- **Average Issues per Subject**: 21.00\n- **Clean Subjects**: 2 (25.0%)\n\n## Risk Profile\n- Low Risk: 2 (25.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (12.5%)\n- Critical Risk: 5 (62.5%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 168\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1948: Critical risk, 33 issues\n- Subject 1950: Critical risk, 18 issues\n- Subject 1952: Critical risk, 28 issues\n- Subject 1954: Critical risk, 30 issues\n- Subject 1955: Critical risk, 48 issues\n- Subject 1956: High risk, 11 issues\n"}
{"id": "site_Study 4_Site 225", "study": "Study 4", "site": "Site 225", "type": "site_summary", "total_subjects": 11, "total_issues": 65, "document": "# Site Report: Site 225\n\n## Site Information\n- **Site ID**: Site 225\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 65\n- **Average Issues per Subject**: 5.91\n- **Clean Subjects**: 3 (27.3%)\n\n## Risk Profile\n- Low Risk: 3 (27.3%)\n- Medium Risk: 3 (27.3%)\n- High Risk: 4 (36.4%)\n- Critical Risk: 1 (9.1%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 64\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1957: High risk, 8 issues\n- Subject 1959: High risk, 9 issues\n- Subject 1960: High risk, 13 issues\n- Subject 1966: High risk, 7 issues\n- Subject 1967: Critical risk, 21 issues\n"}
{"id": "site_Study 4_Site 226", "study": "Study 4", "site": "Site 226", "type": "site_summary", "total_subjects": 4, "total_issues": 13, "document": "# Site Report: Site 226\n\n## Site Information\n- **Site ID**: Site 226\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 13\n- **Average Issues per Subject**: 3.25\n- **Clean Subjects**: 1 (25.0%)\n\n## Risk Profile\n- Low Risk: 1 (25.0%)\n- Medium Risk: 2 (50.0%)\n- High Risk: 1 (25.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 11\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1970: High risk, 9 issues\n"}
{"id": "site_Study 4_Site 227", "study": "Study 4", "site": "Site 227", "type": "site_summary", "total_subjects": 2, "total_issues": 3, "document": "# Site Report: Site 227\n\n## Site Information\n- **Site ID**: Site 227\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 1.50\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 3\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 4_Site 228", "study": "Study 4", "site": "Site 228", "type": "site_summary", "total_subjects": 7, "total_issues": 96, "document": "# Site Report: Site 228\n\n## Site Information\n- **Site ID**: Site 228\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 96\n- **Average Issues per Subject**: 13.71\n- **Clean Subjects**: 1 (14.3%)\n\n## Risk Profile\n- Low Risk: 1 (14.3%)\n- Medium Risk: 1 (14.3%)\n- High Risk: 3 (42.9%)\n- Critical Risk: 2 (28.6%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 95\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1977: Critical risk, 34 issues\n- Subject 1978: High risk, 10 issues\n- Subject 1981: High risk, 9 issues\n- Subject 1982: Critical risk, 32 issues\n- Subject 1983: High risk, 10 issues\n"}
{"id": "site_Study 4_Site 229", "study": "Study 4", "site": "Site 229", "type": "site_summary", "total_subjects": 6, "total_issues": 29, "document": "# Site Report: Site 229\n\n## Site Information\n- **Site ID**: Site 229\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 29\n- **Average Issues per Subject**: 4.83\n- **Clean Subjects**: 4 (66.7%)\n\n## Risk Profile\n- Low Risk: 4 (66.7%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (16.7%)\n- Critical Risk: 1 (16.7%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 29\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1986: High risk, 6 issues\n- Subject 1990: Critical risk, 23 issues\n"}
{"id": "site_Study 4_Site 230", "study": "Study 4", "site": "Site 230", "type": "site_summary", "total_subjects": 2, "total_issues": 31, "document": "# Site Report: Site 230\n\n## Site Information\n- **Site ID**: Site 230\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 31\n- **Average Issues per Subject**: 15.50\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (50.0%)\n- Critical Risk: 1 (50.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 31\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1996: High risk, 14 issues\n- Subject 1997: Critical risk, 17 issues\n"}
{"id": "site_Study 4_Site 231", "study": "Study 4", "site": "Site 231", "type": "site_summary", "total_subjects": 15, "total_issues": 37, "document": "# Site Report: Site 231\n\n## Site Information\n- **Site ID**: Site 231\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 15\n\n## Performance Metrics\n- **Total Issues**: 37\n- **Average Issues per Subject**: 2.47\n- **Clean Subjects**: 7 (46.7%)\n\n## Risk Profile\n- Low Risk: 7 (46.7%)\n- Medium Risk: 5 (33.3%)\n- High Risk: 3 (20.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 37\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2008: High risk, 6 issues\n- Subject 2010: High risk, 7 issues\n- Subject 2085: High risk, 10 issues\n"}
{"id": "site_Study 4_Site 232", "study": "Study 4", "site": "Site 232", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 232\n\n## Site Information\n- **Site ID**: Site 232\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 4_Site 233", "study": "Study 4", "site": "Site 233", "type": "site_summary", "total_subjects": 2, "total_issues": 17, "document": "# Site Report: Site 233\n\n## Site Information\n- **Site ID**: Site 233\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 17\n- **Average Issues per Subject**: 8.50\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (50.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 17\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2022: Critical risk, 17 issues\n"}
{"id": "site_Study 4_Site 234", "study": "Study 4", "site": "Site 234", "type": "site_summary", "total_subjects": 5, "total_issues": 59, "document": "# Site Report: Site 234\n\n## Site Information\n- **Site ID**: Site 234\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 59\n- **Average Issues per Subject**: 11.80\n- **Clean Subjects**: 1 (20.0%)\n\n## Risk Profile\n- Low Risk: 1 (20.0%)\n- Medium Risk: 1 (20.0%)\n- High Risk: 1 (20.0%)\n- Critical Risk: 2 (40.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 59\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2023: Critical risk, 23 issues\n- Subject 2024: High risk, 8 issues\n- Subject 2027: Critical risk, 23 issues\n"}
{"id": "site_Study 4_Site 235", "study": "Study 4", "site": "Site 235", "type": "site_summary", "total_subjects": 5, "total_issues": 28, "document": "# Site Report: Site 235\n\n## Site Information\n- **Site ID**: Site 235\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 28\n- **Average Issues per Subject**: 5.60\n- **Clean Subjects**: 2 (40.0%)\n\n## Risk Profile\n- Low Risk: 2 (40.0%)\n- Medium Risk: 1 (20.0%)\n- High Risk: 2 (40.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 28\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2060: High risk, 9 issues\n- Subject 2063: High risk, 15 issues\n"}
{"id": "site_Study 4_Site 236", "study": "Study 4", "site": "Site 236", "type": "site_summary", "total_subjects": 25, "total_issues": 637, "document": "# Site Report: Site 236\n\n## Site Information\n- **Site ID**: Site 236\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 25\n\n## Performance Metrics\n- **Total Issues**: 637\n- **Average Issues per Subject**: 25.48\n- **Clean Subjects**: 4 (16.0%)\n\n## Risk Profile\n- Low Risk: 4 (16.0%)\n- Medium Risk: 2 (8.0%)\n- High Risk: 3 (12.0%)\n- Critical Risk: 16 (64.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 5\n- Safety Discrepancies: 631\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2029: Critical risk, 22 issues\n- Subject 2030: Critical risk, 40 issues\n- Subject 2031: Critical risk, 58 issues\n- Subject 2032: Critical risk, 20 issues\n- Subject 2033: Critical risk, 61 issues\n- Subject 2034: Critical risk, 85 issues\n- Subject 2036: Critical risk, 17 issues\n- Subject 2037: Critical risk, 54 issues\n- Subject 2039: High risk, 11 issues\n- Subject 2040: Critical risk, 26 issues\n"}
{"id": "site_Study 4_Site 237", "study": "Study 4", "site": "Site 237", "type": "site_summary", "total_subjects": 8, "total_issues": 8, "document": "# Site Report: Site 237\n\n## Site Information\n- **Site ID**: Site 237\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 8\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 7 (87.5%)\n\n## Risk Profile\n- Low Risk: 7 (87.5%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (12.5%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 8\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2070: High risk, 8 issues\n"}
{"id": "site_Study 4_Site 238", "study": "Study 4", "site": "Site 238", "type": "site_summary", "total_subjects": 11, "total_issues": 52, "document": "# Site Report: Site 238\n\n## Site Information\n- **Site ID**: Site 238\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 52\n- **Average Issues per Subject**: 4.73\n- **Clean Subjects**: 2 (18.2%)\n\n## Risk Profile\n- Low Risk: 2 (18.2%)\n- Medium Risk: 6 (54.5%)\n- High Risk: 3 (27.3%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 52\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2081: High risk, 12 issues\n- Subject 2082: High risk, 14 issues\n- Subject 2084: High risk, 9 issues\n"}
{"id": "site_Study 4_Site 239", "study": "Study 4", "site": "Site 239", "type": "site_summary", "total_subjects": 10, "total_issues": 109, "document": "# Site Report: Site 239\n\n## Site Information\n- **Site ID**: Site 239\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 109\n- **Average Issues per Subject**: 10.90\n- **Clean Subjects**: 3 (30.0%)\n\n## Risk Profile\n- Low Risk: 3 (30.0%)\n- Medium Risk: 1 (10.0%)\n- High Risk: 3 (30.0%)\n- Critical Risk: 3 (30.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 109\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2087: Critical risk, 25 issues\n- Subject 2090: High risk, 9 issues\n- Subject 2091: High risk, 12 issues\n- Subject 2093: Critical risk, 24 issues\n- Subject 2096: Critical risk, 25 issues\n- Subject 2097: High risk, 10 issues\n"}
{"id": "site_Study 4_Site 240", "study": "Study 4", "site": "Site 240", "type": "site_summary", "total_subjects": 6, "total_issues": 88, "document": "# Site Report: Site 240\n\n## Site Information\n- **Site ID**: Site 240\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 88\n- **Average Issues per Subject**: 14.67\n- **Clean Subjects**: 2 (33.3%)\n\n## Risk Profile\n- Low Risk: 2 (33.3%)\n- Medium Risk: 3 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (16.7%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 87\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2099: Critical risk, 77 issues\n"}
{"id": "site_Study 4_Site 241", "study": "Study 4", "site": "Site 241", "type": "site_summary", "total_subjects": 4, "total_issues": 55, "document": "# Site Report: Site 241\n\n## Site Information\n- **Site ID**: Site 241\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 55\n- **Average Issues per Subject**: 13.75\n- **Clean Subjects**: 2 (50.0%)\n\n## Risk Profile\n- Low Risk: 2 (50.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 2 (50.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 55\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2108: Critical risk, 31 issues\n- Subject 2111: Critical risk, 24 issues\n"}
{"id": "site_Study 4_Site 242", "study": "Study 4", "site": "Site 242", "type": "site_summary", "total_subjects": 3, "total_issues": 8, "document": "# Site Report: Site 242\n\n## Site Information\n- **Site ID**: Site 242\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 8\n- **Average Issues per Subject**: 2.67\n- **Clean Subjects**: 2 (66.7%)\n\n## Risk Profile\n- Low Risk: 2 (66.7%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (33.3%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 8\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2112: High risk, 8 issues\n"}
{"id": "site_Study 4_Site 243", "study": "Study 4", "site": "Site 243", "type": "site_summary", "total_subjects": 11, "total_issues": 132, "document": "# Site Report: Site 243\n\n## Site Information\n- **Site ID**: Site 243\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 132\n- **Average Issues per Subject**: 12.00\n- **Clean Subjects**: 2 (18.2%)\n\n## Risk Profile\n- Low Risk: 2 (18.2%)\n- Medium Risk: 1 (9.1%)\n- High Risk: 4 (36.4%)\n- Critical Risk: 4 (36.4%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 132\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2115: High risk, 10 issues\n- Subject 2116: Critical risk, 20 issues\n- Subject 2118: Critical risk, 18 issues\n- Subject 2119: High risk, 15 issues\n- Subject 2121: High risk, 8 issues\n- Subject 2122: Critical risk, 24 issues\n- Subject 2124: High risk, 15 issues\n- Subject 2125: Critical risk, 20 issues\n"}
{"id": "site_Study 4_Site 244", "study": "Study 4", "site": "Site 244", "type": "site_summary", "total_subjects": 2, "total_issues": 9, "document": "# Site Report: Site 244\n\n## Site Information\n- **Site ID**: Site 244\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 9\n- **Average Issues per Subject**: 4.50\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (50.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 9\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2128: High risk, 9 issues\n"}
{"id": "site_Study 4_Site 245", "study": "Study 4", "site": "Site 245", "type": "site_summary", "total_subjects": 20, "total_issues": 176, "document": "# Site Report: Site 245\n\n## Site Information\n- **Site ID**: Site 245\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 20\n\n## Performance Metrics\n- **Total Issues**: 176\n- **Average Issues per Subject**: 8.80\n- **Clean Subjects**: 3 (15.0%)\n\n## Risk Profile\n- Low Risk: 3 (15.0%)\n- Medium Risk: 6 (30.0%)\n- High Risk: 8 (40.0%)\n- Critical Risk: 3 (15.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 176\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2130: Critical risk, 19 issues\n- Subject 2133: High risk, 12 issues\n- Subject 2134: High risk, 9 issues\n- Subject 2137: High risk, 6 issues\n- Subject 2140: Critical risk, 36 issues\n- Subject 2142: High risk, 9 issues\n- Subject 2143: High risk, 7 issues\n- Subject 2144: High risk, 10 issues\n- Subject 2145: High risk, 11 issues\n- Subject 2149: Critical risk, 22 issues\n"}
{"id": "site_Study 4_Site 246", "study": "Study 4", "site": "Site 246", "type": "site_summary", "total_subjects": 6, "total_issues": 17, "document": "# Site Report: Site 246\n\n## Site Information\n- **Site ID**: Site 246\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 17\n- **Average Issues per Subject**: 2.83\n- **Clean Subjects**: 2 (33.3%)\n\n## Risk Profile\n- Low Risk: 2 (33.3%)\n- Medium Risk: 2 (33.3%)\n- High Risk: 2 (33.3%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 17\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2152: High risk, 6 issues\n- Subject 2157: High risk, 8 issues\n"}
{"id": "site_Study 4_Site 247", "study": "Study 4", "site": "Site 247", "type": "site_summary", "total_subjects": 2, "total_issues": 6, "document": "# Site Report: Site 247\n\n## Site Information\n- **Site ID**: Site 247\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 6\n- **Average Issues per Subject**: 3.00\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (50.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 6\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2158: High risk, 6 issues\n"}
{"id": "site_Study 4_Site 248", "study": "Study 4", "site": "Site 248", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 248\n\n## Site Information\n- **Site ID**: Site 248\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 4_Site 249", "study": "Study 4", "site": "Site 249", "type": "site_summary", "total_subjects": 2, "total_issues": 88, "document": "# Site Report: Site 249\n\n## Site Information\n- **Site ID**: Site 249\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 88\n- **Average Issues per Subject**: 44.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (50.0%)\n- Critical Risk: 1 (50.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 88\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2164: Critical risk, 75 issues\n- Subject 2165: High risk, 13 issues\n"}
{"id": "site_Study 4_Site 25", "study": "Study 4", "site": "Site 25", "type": "site_summary", "total_subjects": 4, "total_issues": 1, "document": "# Site Report: Site 25\n\n## Site Information\n- **Site ID**: Site 25\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.25\n- **Clean Subjects**: 3 (75.0%)\n\n## Risk Profile\n- Low Risk: 3 (75.0%)\n- Medium Risk: 1 (25.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 4_Site 250", "study": "Study 4", "site": "Site 250", "type": "site_summary", "total_subjects": 7, "total_issues": 45, "document": "# Site Report: Site 250\n\n## Site Information\n- **Site ID**: Site 250\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 45\n- **Average Issues per Subject**: 6.43\n- **Clean Subjects**: 4 (57.1%)\n\n## Risk Profile\n- Low Risk: 4 (57.1%)\n- Medium Risk: 1 (14.3%)\n- High Risk: 1 (14.3%)\n- Critical Risk: 1 (14.3%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 45\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2169: High risk, 15 issues\n- Subject 2171: Critical risk, 25 issues\n"}
{"id": "site_Study 4_Site 251", "study": "Study 4", "site": "Site 251", "type": "site_summary", "total_subjects": 5, "total_issues": 33, "document": "# Site Report: Site 251\n\n## Site Information\n- **Site ID**: Site 251\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 33\n- **Average Issues per Subject**: 6.60\n- **Clean Subjects**: 1 (20.0%)\n\n## Risk Profile\n- Low Risk: 1 (20.0%)\n- Medium Risk: 2 (40.0%)\n- High Risk: 1 (20.0%)\n- Critical Risk: 1 (20.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 4\n- Safety Discrepancies: 29\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2177: High risk, 8 issues\n- Subject 2178: Critical risk, 16 issues\n"}
{"id": "site_Study 4_Site 252", "study": "Study 4", "site": "Site 252", "type": "site_summary", "total_subjects": 6, "total_issues": 142, "document": "# Site Report: Site 252\n\n## Site Information\n- **Site ID**: Site 252\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 142\n- **Average Issues per Subject**: 23.67\n- **Clean Subjects**: 1 (16.7%)\n\n## Risk Profile\n- Low Risk: 1 (16.7%)\n- Medium Risk: 1 (16.7%)\n- High Risk: 1 (16.7%)\n- Critical Risk: 3 (50.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 140\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2183: Critical risk, 49 issues\n- Subject 2185: Critical risk, 45 issues\n- Subject 2186: Critical risk, 38 issues\n- Subject 2187: High risk, 8 issues\n"}
{"id": "site_Study 4_Site 253", "study": "Study 4", "site": "Site 253", "type": "site_summary", "total_subjects": 4, "total_issues": 8, "document": "# Site Report: Site 253\n\n## Site Information\n- **Site ID**: Site 253\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 8\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 2 (50.0%)\n\n## Risk Profile\n- Low Risk: 2 (50.0%)\n- Medium Risk: 2 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 8\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 4_Site 254", "study": "Study 4", "site": "Site 254", "type": "site_summary", "total_subjects": 5, "total_issues": 89, "document": "# Site Report: Site 254\n\n## Site Information\n- **Site ID**: Site 254\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 89\n- **Average Issues per Subject**: 17.80\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (20.0%)\n- High Risk: 3 (60.0%)\n- Critical Risk: 1 (20.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 88\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2195: High risk, 12 issues\n- Subject 2196: High risk, 12 issues\n- Subject 2197: High risk, 11 issues\n- Subject 2198: Critical risk, 50 issues\n"}
{"id": "site_Study 4_Site 255", "study": "Study 4", "site": "Site 255", "type": "site_summary", "total_subjects": 17, "total_issues": 107, "document": "# Site Report: Site 255\n\n## Site Information\n- **Site ID**: Site 255\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 17\n\n## Performance Metrics\n- **Total Issues**: 107\n- **Average Issues per Subject**: 6.29\n- **Clean Subjects**: 4 (23.5%)\n\n## Risk Profile\n- Low Risk: 4 (23.5%)\n- Medium Risk: 1 (5.9%)\n- High Risk: 12 (70.6%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 107\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2202: High risk, 8 issues\n- Subject 2205: High risk, 12 issues\n- Subject 2206: High risk, 6 issues\n- Subject 2208: High risk, 14 issues\n- Subject 2209: High risk, 6 issues\n- Subject 2210: High risk, 10 issues\n- Subject 2212: High risk, 10 issues\n- Subject 2213: High risk, 6 issues\n- Subject 2215: High risk, 8 issues\n- Subject 2216: High risk, 6 issues\n"}
{"id": "site_Study 4_Site 256", "study": "Study 4", "site": "Site 256", "type": "site_summary", "total_subjects": 4, "total_issues": 9, "document": "# Site Report: Site 256\n\n## Site Information\n- **Site ID**: Site 256\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 9\n- **Average Issues per Subject**: 2.25\n- **Clean Subjects**: 3 (75.0%)\n\n## Risk Profile\n- Low Risk: 3 (75.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (25.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 9\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2222: High risk, 9 issues\n"}
{"id": "site_Study 4_Site 257", "study": "Study 4", "site": "Site 257", "type": "site_summary", "total_subjects": 2, "total_issues": 42, "document": "# Site Report: Site 257\n\n## Site Information\n- **Site ID**: Site 257\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 42\n- **Average Issues per Subject**: 21.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (50.0%)\n- Critical Risk: 1 (50.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 42\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2223: Critical risk, 34 issues\n- Subject 2225: High risk, 8 issues\n"}
{"id": "site_Study 4_Site 258", "study": "Study 4", "site": "Site 258", "type": "site_summary", "total_subjects": 6, "total_issues": 199, "document": "# Site Report: Site 258\n\n## Site Information\n- **Site ID**: Site 258\n- **Study**: Study 4\n- **Country**: USA\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 199\n- **Average Issues per Subject**: 33.17\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 3 (50.0%)\n- Critical Risk: 3 (50.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 199\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2226: High risk, 7 issues\n- Subject 2227: High risk, 12 issues\n- Subject 2228: Critical risk, 68 issues\n- Subject 2229: Critical risk, 78 issues\n- Subject 2230: High risk, 12 issues\n- Subject 2232: Critical risk, 22 issues\n"}
{"id": "site_Study 4_Site 3", "study": "Study 4", "site": "Site 3", "type": "site_summary", "total_subjects": 17, "total_issues": 71, "document": "# Site Report: Site 3\n\n## Site Information\n- **Site ID**: Site 3\n- **Study**: Study 4\n- **Country**: KOR\n- **Total Subjects**: 17\n\n## Performance Metrics\n- **Total Issues**: 71\n- **Average Issues per Subject**: 4.18\n- **Clean Subjects**: 5 (29.4%)\n\n## Risk Profile\n- Low Risk: 5 (29.4%)\n- Medium Risk: 8 (47.1%)\n- High Risk: 3 (17.6%)\n- Critical Risk: 1 (5.9%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 71\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 777: Critical risk, 19 issues\n- Subject 778: High risk, 8 issues\n- Subject 780: High risk, 10 issues\n- Subject 781: High risk, 13 issues\n"}
{"id": "site_Study 4_Site 4", "study": "Study 4", "site": "Site 4", "type": "site_summary", "total_subjects": 15, "total_issues": 25, "document": "# Site Report: Site 4\n\n## Site Information\n- **Site ID**: Site 4\n- **Study**: Study 4\n- **Country**: KOR\n- **Total Subjects**: 15\n\n## Performance Metrics\n- **Total Issues**: 25\n- **Average Issues per Subject**: 1.67\n- **Clean Subjects**: 9 (60.0%)\n\n## Risk Profile\n- Low Risk: 9 (60.0%)\n- Medium Risk: 3 (20.0%)\n- High Risk: 3 (20.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 25\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 790: High risk, 7 issues\n- Subject 796: High risk, 7 issues\n- Subject 800: High risk, 6 issues\n"}
{"id": "site_Study 4_Site 43", "study": "Study 4", "site": "Site 43", "type": "site_summary", "total_subjects": 9, "total_issues": 44, "document": "# Site Report: Site 43\n\n## Site Information\n- **Site ID**: Site 43\n- **Study**: Study 4\n- **Country**: TWN\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 44\n- **Average Issues per Subject**: 4.89\n- **Clean Subjects**: 3 (33.3%)\n\n## Risk Profile\n- Low Risk: 3 (33.3%)\n- Medium Risk: 4 (44.4%)\n- High Risk: 1 (11.1%)\n- Critical Risk: 1 (11.1%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 43\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 170: High risk, 12 issues\n- Subject 805: Critical risk, 21 issues\n"}
{"id": "site_Study 4_Site 47", "study": "Study 4", "site": "Site 47", "type": "site_summary", "total_subjects": 10, "total_issues": 91, "document": "# Site Report: Site 47\n\n## Site Information\n- **Site ID**: Site 47\n- **Study**: Study 4\n- **Country**: SGP\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 91\n- **Average Issues per Subject**: 9.10\n- **Clean Subjects**: 1 (10.0%)\n\n## Risk Profile\n- Low Risk: 1 (10.0%)\n- Medium Risk: 4 (40.0%)\n- High Risk: 3 (30.0%)\n- Critical Risk: 2 (20.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 91\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 190: High risk, 13 issues\n- Subject 191: High risk, 12 issues\n- Subject 193: Critical risk, 28 issues\n- Subject 198: High risk, 10 issues\n- Subject 200: Critical risk, 19 issues\n"}
{"id": "site_Study 4_Site 87", "study": "Study 4", "site": "Site 87", "type": "site_summary", "total_subjects": 35, "total_issues": 153, "document": "# Site Report: Site 87\n\n## Site Information\n- **Site ID**: Site 87\n- **Study**: Study 4\n- **Country**: AUT\n- **Total Subjects**: 35\n\n## Performance Metrics\n- **Total Issues**: 153\n- **Average Issues per Subject**: 4.37\n- **Clean Subjects**: 14 (40.0%)\n\n## Risk Profile\n- Low Risk: 14 (40.0%)\n- Medium Risk: 8 (22.9%)\n- High Risk: 11 (31.4%)\n- Critical Risk: 2 (5.7%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 153\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 627: Critical risk, 25 issues\n- Subject 629: High risk, 7 issues\n- Subject 630: High risk, 13 issues\n- Subject 631: High risk, 6 issues\n- Subject 873: High risk, 7 issues\n- Subject 876: High risk, 15 issues\n- Subject 879: Critical risk, 18 issues\n- Subject 880: High risk, 6 issues\n- Subject 883: High risk, 10 issues\n- Subject 885: High risk, 7 issues\n"}
{"id": "site_Study 4_Site 91", "study": "Study 4", "site": "Site 91", "type": "site_summary", "total_subjects": 10, "total_issues": 75, "document": "# Site Report: Site 91\n\n## Site Information\n- **Site ID**: Site 91\n- **Study**: Study 4\n- **Country**: CAN\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 75\n- **Average Issues per Subject**: 7.50\n- **Clean Subjects**: 2 (20.0%)\n\n## Risk Profile\n- Low Risk: 2 (20.0%)\n- Medium Risk: 2 (20.0%)\n- High Risk: 5 (50.0%)\n- Critical Risk: 1 (10.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 75\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1488: Critical risk, 23 issues\n- Subject 1492: High risk, 15 issues\n- Subject 1493: High risk, 8 issues\n- Subject 1495: High risk, 7 issues\n- Subject 647: High risk, 9 issues\n- Subject 648: High risk, 8 issues\n"}
{"id": "site_Study 4_Site 92", "study": "Study 4", "site": "Site 92", "type": "site_summary", "total_subjects": 13, "total_issues": 21, "document": "# Site Report: Site 92\n\n## Site Information\n- **Site ID**: Site 92\n- **Study**: Study 4\n- **Country**: CAN\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 21\n- **Average Issues per Subject**: 1.62\n- **Clean Subjects**: 8 (61.5%)\n\n## Risk Profile\n- Low Risk: 8 (61.5%)\n- Medium Risk: 3 (23.1%)\n- High Risk: 2 (15.4%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 21\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 650: High risk, 7 issues\n- Subject 653: High risk, 6 issues\n"}
{"id": "site_Study 5_Site 14", "study": "Study 5", "site": "Site 14", "type": "site_summary", "total_subjects": 1, "total_issues": 12, "document": "# Site Report: Site 14\n\n## Site Information\n- **Site ID**: Site 14\n- **Study**: Study 5\n- **Country**: AUT\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 12\n- **Average Issues per Subject**: 12.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (100.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 12\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 25: High risk, 12 issues\n"}
{"id": "site_Study 5_Site 15", "study": "Study 5", "site": "Site 15", "type": "site_summary", "total_subjects": 7, "total_issues": 5, "document": "# Site Report: Site 15\n\n## Site Information\n- **Site ID**: Site 15\n- **Study**: Study 5\n- **Country**: AUT\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 5\n- **Average Issues per Subject**: 0.71\n- **Clean Subjects**: 6 (85.7%)\n\n## Risk Profile\n- Low Risk: 6 (85.7%)\n- Medium Risk: 1 (14.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 5\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 165", "study": "Study 5", "site": "Site 165", "type": "site_summary", "total_subjects": 7, "total_issues": 11, "document": "# Site Report: Site 165\n\n## Site Information\n- **Site ID**: Site 165\n- **Study**: Study 5\n- **Country**: ARG\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 11\n- **Average Issues per Subject**: 1.57\n- **Clean Subjects**: 6 (85.7%)\n\n## Risk Profile\n- Low Risk: 6 (85.7%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (14.3%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 10\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2590: High risk, 11 issues\n"}
{"id": "site_Study 5_Site 179", "study": "Study 5", "site": "Site 179", "type": "site_summary", "total_subjects": 4, "total_issues": 3, "document": "# Site Report: Site 179\n\n## Site Information\n- **Site ID**: Site 179\n- **Study**: Study 5\n- **Country**: USA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 0.75\n- **Clean Subjects**: 1 (25.0%)\n\n## Risk Profile\n- Low Risk: 1 (25.0%)\n- Medium Risk: 3 (75.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 3\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 18", "study": "Study 5", "site": "Site 18", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 18\n\n## Site Information\n- **Site ID**: Site 18\n- **Study**: Study 5\n- **Country**: USA\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 180", "study": "Study 5", "site": "Site 180", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 180\n\n## Site Information\n- **Site ID**: Site 180\n- **Study**: Study 5\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 181", "study": "Study 5", "site": "Site 181", "type": "site_summary", "total_subjects": 14, "total_issues": 7, "document": "# Site Report: Site 181\n\n## Site Information\n- **Site ID**: Site 181\n- **Study**: Study 5\n- **Country**: USA\n- **Total Subjects**: 14\n\n## Performance Metrics\n- **Total Issues**: 7\n- **Average Issues per Subject**: 0.50\n- **Clean Subjects**: 12 (85.7%)\n\n## Risk Profile\n- Low Risk: 12 (85.7%)\n- Medium Risk: 1 (7.1%)\n- High Risk: 1 (7.1%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 7\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2674: High risk, 6 issues\n"}
{"id": "site_Study 5_Site 187", "study": "Study 5", "site": "Site 187", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 187\n\n## Site Information\n- **Site ID**: Site 187\n- **Study**: Study 5\n- **Country**: USA\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 189", "study": "Study 5", "site": "Site 189", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 189\n\n## Site Information\n- **Site ID**: Site 189\n- **Study**: Study 5\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 19", "study": "Study 5", "site": "Site 19", "type": "site_summary", "total_subjects": 2, "total_issues": 3, "document": "# Site Report: Site 19\n\n## Site Information\n- **Site ID**: Site 19\n- **Study**: Study 5\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 1.50\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 2\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 191", "study": "Study 5", "site": "Site 191", "type": "site_summary", "total_subjects": 11, "total_issues": 0, "document": "# Site Report: Site 191\n\n## Site Information\n- **Site ID**: Site 191\n- **Study**: Study 5\n- **Country**: JPN\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 11 (100.0%)\n\n## Risk Profile\n- Low Risk: 11 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 192", "study": "Study 5", "site": "Site 192", "type": "site_summary", "total_subjects": 11, "total_issues": 10, "document": "# Site Report: Site 192\n\n## Site Information\n- **Site ID**: Site 192\n- **Study**: Study 5\n- **Country**: JPN\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 10\n- **Average Issues per Subject**: 0.91\n- **Clean Subjects**: 9 (81.8%)\n\n## Risk Profile\n- Low Risk: 9 (81.8%)\n- Medium Risk: 1 (9.1%)\n- High Risk: 1 (9.1%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 10\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1690: High risk, 7 issues\n"}
{"id": "site_Study 5_Site 193", "study": "Study 5", "site": "Site 193", "type": "site_summary", "total_subjects": 15, "total_issues": 2, "document": "# Site Report: Site 193\n\n## Site Information\n- **Site ID**: Site 193\n- **Study**: Study 5\n- **Country**: JPN\n- **Total Subjects**: 15\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.13\n- **Clean Subjects**: 14 (93.3%)\n\n## Risk Profile\n- Low Risk: 14 (93.3%)\n- Medium Risk: 1 (6.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 2\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 196", "study": "Study 5", "site": "Site 196", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 196\n\n## Site Information\n- **Site ID**: Site 196\n- **Study**: Study 5\n- **Country**: JPN\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 197", "study": "Study 5", "site": "Site 197", "type": "site_summary", "total_subjects": 7, "total_issues": 5, "document": "# Site Report: Site 197\n\n## Site Information\n- **Site ID**: Site 197\n- **Study**: Study 5\n- **Country**: JPN\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 5\n- **Average Issues per Subject**: 0.71\n- **Clean Subjects**: 6 (85.7%)\n\n## Risk Profile\n- Low Risk: 6 (85.7%)\n- Medium Risk: 1 (14.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 5\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 198", "study": "Study 5", "site": "Site 198", "type": "site_summary", "total_subjects": 4, "total_issues": 24, "document": "# Site Report: Site 198\n\n## Site Information\n- **Site ID**: Site 198\n- **Study**: Study 5\n- **Country**: JPN\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 24\n- **Average Issues per Subject**: 6.00\n- **Clean Subjects**: 2 (50.0%)\n\n## Risk Profile\n- Low Risk: 2 (50.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 2 (50.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 24\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\n- Subject 1724: High risk, 12 issues\n- Subject 1725: High risk, 12 issues\n"}
{"id": "site_Study 5_Site 2", "study": "Study 5", "site": "Site 2", "type": "site_summary", "total_subjects": 4, "total_issues": 10, "document": "# Site Report: Site 2\n\n## Site Information\n- **Site ID**: Site 2\n- **Study**: Study 5\n- **Country**: AUS\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 10\n- **Average Issues per Subject**: 2.50\n- **Clean Subjects**: 2 (50.0%)\n\n## Risk Profile\n- Low Risk: 2 (50.0%)\n- Medium Risk: 1 (25.0%)\n- High Risk: 1 (25.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 9\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\n- Subject 3: High risk, 7 issues\n"}
{"id": "site_Study 5_Site 200", "study": "Study 5", "site": "Site 200", "type": "site_summary", "total_subjects": 11, "total_issues": 2, "document": "# Site Report: Site 200\n\n## Site Information\n- **Site ID**: Site 200\n- **Study**: Study 5\n- **Country**: JPN\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.18\n- **Clean Subjects**: 10 (90.9%)\n\n## Risk Profile\n- Low Risk: 10 (90.9%)\n- Medium Risk: 1 (9.1%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 2\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 24", "study": "Study 5", "site": "Site 24", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 24\n\n## Site Information\n- **Site ID**: Site 24\n- **Study**: Study 5\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 25", "study": "Study 5", "site": "Site 25", "type": "site_summary", "total_subjects": 7, "total_issues": 11, "document": "# Site Report: Site 25\n\n## Site Information\n- **Site ID**: Site 25\n- **Study**: Study 5\n- **Country**: JPN\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 11\n- **Average Issues per Subject**: 1.57\n- **Clean Subjects**: 5 (71.4%)\n\n## Risk Profile\n- Low Risk: 5 (71.4%)\n- Medium Risk: 1 (14.3%)\n- High Risk: 1 (14.3%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 11\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1694: High risk, 9 issues\n"}
{"id": "site_Study 5_Site 260", "study": "Study 5", "site": "Site 260", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 260\n\n## Site Information\n- **Site ID**: Site 260\n- **Study**: Study 5\n- **Country**: SGP\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 261", "study": "Study 5", "site": "Site 261", "type": "site_summary", "total_subjects": 14, "total_issues": 29, "document": "# Site Report: Site 261\n\n## Site Information\n- **Site ID**: Site 261\n- **Study**: Study 5\n- **Country**: SGP\n- **Total Subjects**: 14\n\n## Performance Metrics\n- **Total Issues**: 29\n- **Average Issues per Subject**: 2.07\n- **Clean Subjects**: 9 (64.3%)\n\n## Risk Profile\n- Low Risk: 9 (64.3%)\n- Medium Risk: 1 (7.1%)\n- High Risk: 4 (28.6%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 29\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2242: High risk, 10 issues\n- Subject 2243: High risk, 6 issues\n- Subject 2245: High risk, 6 issues\n- Subject 2246: High risk, 6 issues\n"}
{"id": "site_Study 5_Site 262", "study": "Study 5", "site": "Site 262", "type": "site_summary", "total_subjects": 9, "total_issues": 1, "document": "# Site Report: Site 262\n\n## Site Information\n- **Site ID**: Site 262\n- **Study**: Study 5\n- **Country**: TWN\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.11\n- **Clean Subjects**: 8 (88.9%)\n\n## Risk Profile\n- Low Risk: 8 (88.9%)\n- Medium Risk: 1 (11.1%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 1\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 263", "study": "Study 5", "site": "Site 263", "type": "site_summary", "total_subjects": 9, "total_issues": 6, "document": "# Site Report: Site 263\n\n## Site Information\n- **Site ID**: Site 263\n- **Study**: Study 5\n- **Country**: TWN\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 6\n- **Average Issues per Subject**: 0.67\n- **Clean Subjects**: 7 (77.8%)\n\n## Risk Profile\n- Low Risk: 7 (77.8%)\n- Medium Risk: 2 (22.2%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 6\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 264", "study": "Study 5", "site": "Site 264", "type": "site_summary", "total_subjects": 9, "total_issues": 0, "document": "# Site Report: Site 264\n\n## Site Information\n- **Site ID**: Site 264\n- **Study**: Study 5\n- **Country**: TWN\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 9 (100.0%)\n\n## Risk Profile\n- Low Risk: 9 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 265", "study": "Study 5", "site": "Site 265", "type": "site_summary", "total_subjects": 7, "total_issues": 1, "document": "# Site Report: Site 265\n\n## Site Information\n- **Site ID**: Site 265\n- **Study**: Study 5\n- **Country**: TWN\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.14\n- **Clean Subjects**: 6 (85.7%)\n\n## Risk Profile\n- Low Risk: 6 (85.7%)\n- Medium Risk: 1 (14.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 1\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 266", "study": "Study 5", "site": "Site 266", "type": "site_summary", "total_subjects": 7, "total_issues": 10, "document": "# Site Report: Site 266\n\n## Site Information\n- **Site ID**: Site 266\n- **Study**: Study 5\n- **Country**: MYS\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 10\n- **Average Issues per Subject**: 1.43\n- **Clean Subjects**: 5 (71.4%)\n\n## Risk Profile\n- Low Risk: 5 (71.4%)\n- Medium Risk: 2 (28.6%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 10\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 267", "study": "Study 5", "site": "Site 267", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 267\n\n## Site Information\n- **Site ID**: Site 267\n- **Study**: Study 5\n- **Country**: MYS\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 268", "study": "Study 5", "site": "Site 268", "type": "site_summary", "total_subjects": 15, "total_issues": 1, "document": "# Site Report: Site 268\n\n## Site Information\n- **Site ID**: Site 268\n- **Study**: Study 5\n- **Country**: BEL\n- **Total Subjects**: 15\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.07\n- **Clean Subjects**: 14 (93.3%)\n\n## Risk Profile\n- Low Risk: 14 (93.3%)\n- Medium Risk: 1 (6.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 1\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 269", "study": "Study 5", "site": "Site 269", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 269\n\n## Site Information\n- **Site ID**: Site 269\n- **Study**: Study 5\n- **Country**: BEL\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 270", "study": "Study 5", "site": "Site 270", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 270\n\n## Site Information\n- **Site ID**: Site 270\n- **Study**: Study 5\n- **Country**: CZE\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 271", "study": "Study 5", "site": "Site 271", "type": "site_summary", "total_subjects": 12, "total_issues": 0, "document": "# Site Report: Site 271\n\n## Site Information\n- **Site ID**: Site 271\n- **Study**: Study 5\n- **Country**: CZE\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 12 (100.0%)\n\n## Risk Profile\n- Low Risk: 12 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 272", "study": "Study 5", "site": "Site 272", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 272\n\n## Site Information\n- **Site ID**: Site 272\n- **Study**: Study 5\n- **Country**: CZE\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 273", "study": "Study 5", "site": "Site 273", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 273\n\n## Site Information\n- **Site ID**: Site 273\n- **Study**: Study 5\n- **Country**: FRA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 274", "study": "Study 5", "site": "Site 274", "type": "site_summary", "total_subjects": 1, "total_issues": 14, "document": "# Site Report: Site 274\n\n## Site Information\n- **Site ID**: Site 274\n- **Study**: Study 5\n- **Country**: FRA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 14\n- **Average Issues per Subject**: 14.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (100.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 14\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2336: High risk, 14 issues\n"}
{"id": "site_Study 5_Site 275", "study": "Study 5", "site": "Site 275", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 275\n\n## Site Information\n- **Site ID**: Site 275\n- **Study**: Study 5\n- **Country**: FRA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 276", "study": "Study 5", "site": "Site 276", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 276\n\n## Site Information\n- **Site ID**: Site 276\n- **Study**: Study 5\n- **Country**: FRA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 277", "study": "Study 5", "site": "Site 277", "type": "site_summary", "total_subjects": 10, "total_issues": 10, "document": "# Site Report: Site 277\n\n## Site Information\n- **Site ID**: Site 277\n- **Study**: Study 5\n- **Country**: FRA\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 10\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 6 (60.0%)\n\n## Risk Profile\n- Low Risk: 6 (60.0%)\n- Medium Risk: 4 (40.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 10\n- Outstanding Visits: 3\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 278", "study": "Study 5", "site": "Site 278", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 278\n\n## Site Information\n- **Site ID**: Site 278\n- **Study**: Study 5\n- **Country**: FRA\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 279", "study": "Study 5", "site": "Site 279", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 279\n\n## Site Information\n- **Site ID**: Site 279\n- **Study**: Study 5\n- **Country**: DEU\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 28", "study": "Study 5", "site": "Site 28", "type": "site_summary", "total_subjects": 5, "total_issues": 6, "document": "# Site Report: Site 28\n\n## Site Information\n- **Site ID**: Site 28\n- **Study**: Study 5\n- **Country**: AUS\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 6\n- **Average Issues per Subject**: 1.20\n- **Clean Subjects**: 3 (60.0%)\n\n## Risk Profile\n- Low Risk: 3 (60.0%)\n- Medium Risk: 2 (40.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 6\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 280", "study": "Study 5", "site": "Site 280", "type": "site_summary", "total_subjects": 5, "total_issues": 11, "document": "# Site Report: Site 280\n\n## Site Information\n- **Site ID**: Site 280\n- **Study**: Study 5\n- **Country**: DEU\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 11\n- **Average Issues per Subject**: 2.20\n- **Clean Subjects**: 4 (80.0%)\n\n## Risk Profile\n- Low Risk: 4 (80.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (20.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 11\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2362: High risk, 11 issues\n"}
{"id": "site_Study 5_Site 281", "study": "Study 5", "site": "Site 281", "type": "site_summary", "total_subjects": 3, "total_issues": 4, "document": "# Site Report: Site 281\n\n## Site Information\n- **Site ID**: Site 281\n- **Study**: Study 5\n- **Country**: DEU\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 1.33\n- **Clean Subjects**: 1 (33.3%)\n\n## Risk Profile\n- Low Risk: 1 (33.3%)\n- Medium Risk: 2 (66.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 4\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 282", "study": "Study 5", "site": "Site 282", "type": "site_summary", "total_subjects": 8, "total_issues": 11, "document": "# Site Report: Site 282\n\n## Site Information\n- **Site ID**: Site 282\n- **Study**: Study 5\n- **Country**: DEU\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 11\n- **Average Issues per Subject**: 1.38\n- **Clean Subjects**: 6 (75.0%)\n\n## Risk Profile\n- Low Risk: 6 (75.0%)\n- Medium Risk: 1 (12.5%)\n- High Risk: 1 (12.5%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 11\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2373: High risk, 7 issues\n"}
{"id": "site_Study 5_Site 284", "study": "Study 5", "site": "Site 284", "type": "site_summary", "total_subjects": 8, "total_issues": 0, "document": "# Site Report: Site 284\n\n## Site Information\n- **Site ID**: Site 284\n- **Study**: Study 5\n- **Country**: HUN\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 8 (100.0%)\n\n## Risk Profile\n- Low Risk: 8 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 285", "study": "Study 5", "site": "Site 285", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 285\n\n## Site Information\n- **Site ID**: Site 285\n- **Study**: Study 5\n- **Country**: HUN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 286", "study": "Study 5", "site": "Site 286", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 286\n\n## Site Information\n- **Site ID**: Site 286\n- **Study**: Study 5\n- **Country**: HUN\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 287", "study": "Study 5", "site": "Site 287", "type": "site_summary", "total_subjects": 7, "total_issues": 6, "document": "# Site Report: Site 287\n\n## Site Information\n- **Site ID**: Site 287\n- **Study**: Study 5\n- **Country**: ISR\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 6\n- **Average Issues per Subject**: 0.86\n- **Clean Subjects**: 6 (85.7%)\n\n## Risk Profile\n- Low Risk: 6 (85.7%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (14.3%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 6\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2397: High risk, 6 issues\n"}
{"id": "site_Study 5_Site 288", "study": "Study 5", "site": "Site 288", "type": "site_summary", "total_subjects": 1, "total_issues": 5, "document": "# Site Report: Site 288\n\n## Site Information\n- **Site ID**: Site 288\n- **Study**: Study 5\n- **Country**: ISR\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 5\n- **Average Issues per Subject**: 5.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 5\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 289", "study": "Study 5", "site": "Site 289", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 289\n\n## Site Information\n- **Site ID**: Site 289\n- **Study**: Study 5\n- **Country**: ISR\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 290", "study": "Study 5", "site": "Site 290", "type": "site_summary", "total_subjects": 8, "total_issues": 2, "document": "# Site Report: Site 290\n\n## Site Information\n- **Site ID**: Site 290\n- **Study**: Study 5\n- **Country**: ISR\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.25\n- **Clean Subjects**: 7 (87.5%)\n\n## Risk Profile\n- Low Risk: 7 (87.5%)\n- Medium Risk: 1 (12.5%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 2\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 291", "study": "Study 5", "site": "Site 291", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 291\n\n## Site Information\n- **Site ID**: Site 291\n- **Study**: Study 5\n- **Country**: ISR\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 292", "study": "Study 5", "site": "Site 292", "type": "site_summary", "total_subjects": 4, "total_issues": 2, "document": "# Site Report: Site 292\n\n## Site Information\n- **Site ID**: Site 292\n- **Study**: Study 5\n- **Country**: ITA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.50\n- **Clean Subjects**: 3 (75.0%)\n\n## Risk Profile\n- Low Risk: 3 (75.0%)\n- Medium Risk: 1 (25.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 2\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 293", "study": "Study 5", "site": "Site 293", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 293\n\n## Site Information\n- **Site ID**: Site 293\n- **Study**: Study 5\n- **Country**: ITA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 294", "study": "Study 5", "site": "Site 294", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 294\n\n## Site Information\n- **Site ID**: Site 294\n- **Study**: Study 5\n- **Country**: ITA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 295", "study": "Study 5", "site": "Site 295", "type": "site_summary", "total_subjects": 9, "total_issues": 0, "document": "# Site Report: Site 295\n\n## Site Information\n- **Site ID**: Site 295\n- **Study**: Study 5\n- **Country**: ITA\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 9 (100.0%)\n\n## Risk Profile\n- Low Risk: 9 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 296", "study": "Study 5", "site": "Site 296", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 296\n\n## Site Information\n- **Site ID**: Site 296\n- **Study**: Study 5\n- **Country**: ITA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 297", "study": "Study 5", "site": "Site 297", "type": "site_summary", "total_subjects": 26, "total_issues": 13, "document": "# Site Report: Site 297\n\n## Site Information\n- **Site ID**: Site 297\n- **Study**: Study 5\n- **Country**: ITA\n- **Total Subjects**: 26\n\n## Performance Metrics\n- **Total Issues**: 13\n- **Average Issues per Subject**: 0.50\n- **Clean Subjects**: 21 (80.8%)\n\n## Risk Profile\n- Low Risk: 21 (80.8%)\n- Medium Risk: 5 (19.2%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 13\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 298", "study": "Study 5", "site": "Site 298", "type": "site_summary", "total_subjects": 1, "total_issues": 4, "document": "# Site Report: Site 298\n\n## Site Information\n- **Site ID**: Site 298\n- **Study**: Study 5\n- **Country**: SVK\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 4.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 4\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 299", "study": "Study 5", "site": "Site 299", "type": "site_summary", "total_subjects": 12, "total_issues": 7, "document": "# Site Report: Site 299\n\n## Site Information\n- **Site ID**: Site 299\n- **Study**: Study 5\n- **Country**: SVK\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 7\n- **Average Issues per Subject**: 0.58\n- **Clean Subjects**: 11 (91.7%)\n\n## Risk Profile\n- Low Risk: 11 (91.7%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (8.3%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 7\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2472: High risk, 7 issues\n"}
{"id": "site_Study 5_Site 3", "study": "Study 5", "site": "Site 3", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 3\n\n## Site Information\n- **Site ID**: Site 3\n- **Study**: Study 5\n- **Country**: AUS\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 300", "study": "Study 5", "site": "Site 300", "type": "site_summary", "total_subjects": 36, "total_issues": 2, "document": "# Site Report: Site 300\n\n## Site Information\n- **Site ID**: Site 300\n- **Study**: Study 5\n- **Country**: ESP\n- **Total Subjects**: 36\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.06\n- **Clean Subjects**: 35 (97.2%)\n\n## Risk Profile\n- Low Risk: 35 (97.2%)\n- Medium Risk: 1 (2.8%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 2\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 301", "study": "Study 5", "site": "Site 301", "type": "site_summary", "total_subjects": 3, "total_issues": 3, "document": "# Site Report: Site 301\n\n## Site Information\n- **Site ID**: Site 301\n- **Study**: Study 5\n- **Country**: ESP\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 2 (66.7%)\n\n## Risk Profile\n- Low Risk: 2 (66.7%)\n- Medium Risk: 1 (33.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 2\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 302", "study": "Study 5", "site": "Site 302", "type": "site_summary", "total_subjects": 9, "total_issues": 10, "document": "# Site Report: Site 302\n\n## Site Information\n- **Site ID**: Site 302\n- **Study**: Study 5\n- **Country**: ESP\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 10\n- **Average Issues per Subject**: 1.11\n- **Clean Subjects**: 8 (88.9%)\n\n## Risk Profile\n- Low Risk: 8 (88.9%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (11.1%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 2\n- Missing Pages: 0\n- Missing Labs: 8\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2518: High risk, 10 issues\n"}
{"id": "site_Study 5_Site 303", "study": "Study 5", "site": "Site 303", "type": "site_summary", "total_subjects": 10, "total_issues": 0, "document": "# Site Report: Site 303\n\n## Site Information\n- **Site ID**: Site 303\n- **Study**: Study 5\n- **Country**: ESP\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 10 (100.0%)\n\n## Risk Profile\n- Low Risk: 10 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 304", "study": "Study 5", "site": "Site 304", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 304\n\n## Site Information\n- **Site ID**: Site 304\n- **Study**: Study 5\n- **Country**: ESP\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 305", "study": "Study 5", "site": "Site 305", "type": "site_summary", "total_subjects": 3, "total_issues": 2, "document": "# Site Report: Site 305\n\n## Site Information\n- **Site ID**: Site 305\n- **Study**: Study 5\n- **Country**: ESP\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.67\n- **Clean Subjects**: 2 (66.7%)\n\n## Risk Profile\n- Low Risk: 2 (66.7%)\n- Medium Risk: 1 (33.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 2\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 306", "study": "Study 5", "site": "Site 306", "type": "site_summary", "total_subjects": 16, "total_issues": 2, "document": "# Site Report: Site 306\n\n## Site Information\n- **Site ID**: Site 306\n- **Study**: Study 5\n- **Country**: ESP\n- **Total Subjects**: 16\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.12\n- **Clean Subjects**: 14 (87.5%)\n\n## Risk Profile\n- Low Risk: 14 (87.5%)\n- Medium Risk: 2 (12.5%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 2\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 307", "study": "Study 5", "site": "Site 307", "type": "site_summary", "total_subjects": 13, "total_issues": 30, "document": "# Site Report: Site 307\n\n## Site Information\n- **Site ID**: Site 307\n- **Study**: Study 5\n- **Country**: ESP\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 30\n- **Average Issues per Subject**: 2.31\n- **Clean Subjects**: 11 (84.6%)\n\n## Risk Profile\n- Low Risk: 11 (84.6%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (7.7%)\n- Critical Risk: 1 (7.7%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 30\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\n- Subject 2569: High risk, 14 issues\n- Subject 2570: Critical risk, 16 issues\n"}
{"id": "site_Study 5_Site 308", "study": "Study 5", "site": "Site 308", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 308\n\n## Site Information\n- **Site ID**: Site 308\n- **Study**: Study 5\n- **Country**: GBR\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 309", "study": "Study 5", "site": "Site 309", "type": "site_summary", "total_subjects": 1, "total_issues": 2, "document": "# Site Report: Site 309\n\n## Site Information\n- **Site ID**: Site 309\n- **Study**: Study 5\n- **Country**: GBR\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 2\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 310", "study": "Study 5", "site": "Site 310", "type": "site_summary", "total_subjects": 1, "total_issues": 36, "document": "# Site Report: Site 310\n\n## Site Information\n- **Site ID**: Site 310\n- **Study**: Study 5\n- **Country**: GBR\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 36\n- **Average Issues per Subject**: 36.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 36\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2580: Critical risk, 36 issues\n"}
{"id": "site_Study 5_Site 311", "study": "Study 5", "site": "Site 311", "type": "site_summary", "total_subjects": 1, "total_issues": 3, "document": "# Site Report: Site 311\n\n## Site Information\n- **Site ID**: Site 311\n- **Study**: Study 5\n- **Country**: CHE\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 3.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 3\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 312", "study": "Study 5", "site": "Site 312", "type": "site_summary", "total_subjects": 2, "total_issues": 4, "document": "# Site Report: Site 312\n\n## Site Information\n- **Site ID**: Site 312\n- **Study**: Study 5\n- **Country**: CHE\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 4\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 313", "study": "Study 5", "site": "Site 313", "type": "site_summary", "total_subjects": 1, "total_issues": 7, "document": "# Site Report: Site 313\n\n## Site Information\n- **Site ID**: Site 313\n- **Study**: Study 5\n- **Country**: CHE\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 7\n- **Average Issues per Subject**: 7.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (100.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 2\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2584: High risk, 7 issues\n"}
{"id": "site_Study 5_Site 314", "study": "Study 5", "site": "Site 314", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 314\n\n## Site Information\n- **Site ID**: Site 314\n- **Study**: Study 5\n- **Country**: NLD\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 316", "study": "Study 5", "site": "Site 316", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 316\n\n## Site Information\n- **Site ID**: Site 316\n- **Study**: Study 5\n- **Country**: ARG\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 317", "study": "Study 5", "site": "Site 317", "type": "site_summary", "total_subjects": 11, "total_issues": 6, "document": "# Site Report: Site 317\n\n## Site Information\n- **Site ID**: Site 317\n- **Study**: Study 5\n- **Country**: CAN\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 6\n- **Average Issues per Subject**: 0.55\n- **Clean Subjects**: 10 (90.9%)\n\n## Risk Profile\n- Low Risk: 10 (90.9%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (9.1%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 6\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2608: High risk, 6 issues\n"}
{"id": "site_Study 5_Site 318", "study": "Study 5", "site": "Site 318", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 318\n\n## Site Information\n- **Site ID**: Site 318\n- **Study**: Study 5\n- **Country**: CAN\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 319", "study": "Study 5", "site": "Site 319", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 319\n\n## Site Information\n- **Site ID**: Site 319\n- **Study**: Study 5\n- **Country**: CAN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 320", "study": "Study 5", "site": "Site 320", "type": "site_summary", "total_subjects": 5, "total_issues": 10, "document": "# Site Report: Site 320\n\n## Site Information\n- **Site ID**: Site 320\n- **Study**: Study 5\n- **Country**: CAN\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 10\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 3 (60.0%)\n\n## Risk Profile\n- Low Risk: 3 (60.0%)\n- Medium Risk: 1 (20.0%)\n- High Risk: 1 (20.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 10\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2618: High risk, 6 issues\n"}
{"id": "site_Study 5_Site 321", "study": "Study 5", "site": "Site 321", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 321\n\n## Site Information\n- **Site ID**: Site 321\n- **Study**: Study 5\n- **Country**: CAN\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 322", "study": "Study 5", "site": "Site 322", "type": "site_summary", "total_subjects": 10, "total_issues": 29, "document": "# Site Report: Site 322\n\n## Site Information\n- **Site ID**: Site 322\n- **Study**: Study 5\n- **Country**: CAN\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 29\n- **Average Issues per Subject**: 2.90\n- **Clean Subjects**: 5 (50.0%)\n\n## Risk Profile\n- Low Risk: 5 (50.0%)\n- Medium Risk: 2 (20.0%)\n- High Risk: 3 (30.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 28\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\n- Subject 2626: High risk, 7 issues\n- Subject 2629: High risk, 6 issues\n- Subject 2630: High risk, 6 issues\n"}
{"id": "site_Study 5_Site 323", "study": "Study 5", "site": "Site 323", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 323\n\n## Site Information\n- **Site ID**: Site 323\n- **Study**: Study 5\n- **Country**: CAN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 324", "study": "Study 5", "site": "Site 324", "type": "site_summary", "total_subjects": 9, "total_issues": 17, "document": "# Site Report: Site 324\n\n## Site Information\n- **Site ID**: Site 324\n- **Study**: Study 5\n- **Country**: BRA\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 17\n- **Average Issues per Subject**: 1.89\n- **Clean Subjects**: 8 (88.9%)\n\n## Risk Profile\n- Low Risk: 8 (88.9%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (11.1%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 17\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2640: Critical risk, 17 issues\n"}
{"id": "site_Study 5_Site 325", "study": "Study 5", "site": "Site 325", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 325\n\n## Site Information\n- **Site ID**: Site 325\n- **Study**: Study 5\n- **Country**: USA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 326", "study": "Study 5", "site": "Site 326", "type": "site_summary", "total_subjects": 12, "total_issues": 26, "document": "# Site Report: Site 326\n\n## Site Information\n- **Site ID**: Site 326\n- **Study**: Study 5\n- **Country**: USA\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 26\n- **Average Issues per Subject**: 2.17\n- **Clean Subjects**: 7 (58.3%)\n\n## Risk Profile\n- Low Risk: 7 (58.3%)\n- Medium Risk: 3 (25.0%)\n- High Risk: 2 (16.7%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 26\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2656: High risk, 7 issues\n- Subject 2657: High risk, 7 issues\n"}
{"id": "site_Study 5_Site 327", "study": "Study 5", "site": "Site 327", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 327\n\n## Site Information\n- **Site ID**: Site 327\n- **Study**: Study 5\n- **Country**: USA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 328", "study": "Study 5", "site": "Site 328", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 328\n\n## Site Information\n- **Site ID**: Site 328\n- **Study**: Study 5\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 329", "study": "Study 5", "site": "Site 329", "type": "site_summary", "total_subjects": 17, "total_issues": 10, "document": "# Site Report: Site 329\n\n## Site Information\n- **Site ID**: Site 329\n- **Study**: Study 5\n- **Country**: USA\n- **Total Subjects**: 17\n\n## Performance Metrics\n- **Total Issues**: 10\n- **Average Issues per Subject**: 0.59\n- **Clean Subjects**: 11 (64.7%)\n\n## Risk Profile\n- Low Risk: 11 (64.7%)\n- Medium Risk: 6 (35.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 9\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 330", "study": "Study 5", "site": "Site 330", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 330\n\n## Site Information\n- **Site ID**: Site 330\n- **Study**: Study 5\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 331", "study": "Study 5", "site": "Site 331", "type": "site_summary", "total_subjects": 6, "total_issues": 41, "document": "# Site Report: Site 331\n\n## Site Information\n- **Site ID**: Site 331\n- **Study**: Study 5\n- **Country**: USA\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 41\n- **Average Issues per Subject**: 6.83\n- **Clean Subjects**: 4 (66.7%)\n\n## Risk Profile\n- Low Risk: 4 (66.7%)\n- Medium Risk: 1 (16.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (16.7%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 40\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2707: Critical risk, 40 issues\n"}
{"id": "site_Study 5_Site 332", "study": "Study 5", "site": "Site 332", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 332\n\n## Site Information\n- **Site ID**: Site 332\n- **Study**: Study 5\n- **Country**: USA\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 333", "study": "Study 5", "site": "Site 333", "type": "site_summary", "total_subjects": 10, "total_issues": 8, "document": "# Site Report: Site 333\n\n## Site Information\n- **Site ID**: Site 333\n- **Study**: Study 5\n- **Country**: USA\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 8\n- **Average Issues per Subject**: 0.80\n- **Clean Subjects**: 8 (80.0%)\n\n## Risk Profile\n- Low Risk: 8 (80.0%)\n- Medium Risk: 1 (10.0%)\n- High Risk: 1 (10.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 8\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\n- Subject 2721: High risk, 7 issues\n"}
{"id": "site_Study 5_Site 334", "study": "Study 5", "site": "Site 334", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 334\n\n## Site Information\n- **Site ID**: Site 334\n- **Study**: Study 5\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 335", "study": "Study 5", "site": "Site 335", "type": "site_summary", "total_subjects": 8, "total_issues": 0, "document": "# Site Report: Site 335\n\n## Site Information\n- **Site ID**: Site 335\n- **Study**: Study 5\n- **Country**: USA\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 8 (100.0%)\n\n## Risk Profile\n- Low Risk: 8 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 336", "study": "Study 5", "site": "Site 336", "type": "site_summary", "total_subjects": 5, "total_issues": 11, "document": "# Site Report: Site 336\n\n## Site Information\n- **Site ID**: Site 336\n- **Study**: Study 5\n- **Country**: USA\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 11\n- **Average Issues per Subject**: 2.20\n- **Clean Subjects**: 4 (80.0%)\n\n## Risk Profile\n- Low Risk: 4 (80.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (20.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 11\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\n- Subject 2740: High risk, 11 issues\n"}
{"id": "site_Study 5_Site 337", "study": "Study 5", "site": "Site 337", "type": "site_summary", "total_subjects": 5, "total_issues": 10, "document": "# Site Report: Site 337\n\n## Site Information\n- **Site ID**: Site 337\n- **Study**: Study 5\n- **Country**: USA\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 10\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 4 (80.0%)\n\n## Risk Profile\n- Low Risk: 4 (80.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (20.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 2\n- Missing Pages: 0\n- Missing Labs: 8\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\n- Subject 2745: High risk, 10 issues\n"}
{"id": "site_Study 5_Site 338", "study": "Study 5", "site": "Site 338", "type": "site_summary", "total_subjects": 8, "total_issues": 28, "document": "# Site Report: Site 338\n\n## Site Information\n- **Site ID**: Site 338\n- **Study**: Study 5\n- **Country**: USA\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 28\n- **Average Issues per Subject**: 3.50\n- **Clean Subjects**: 5 (62.5%)\n\n## Risk Profile\n- Low Risk: 5 (62.5%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 3 (37.5%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 28\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\n- Subject 2751: High risk, 13 issues\n- Subject 2752: High risk, 8 issues\n- Subject 2756: High risk, 7 issues\n"}
{"id": "site_Study 5_Site 339", "study": "Study 5", "site": "Site 339", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 339\n\n## Site Information\n- **Site ID**: Site 339\n- **Study**: Study 5\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 340", "study": "Study 5", "site": "Site 340", "type": "site_summary", "total_subjects": 2, "total_issues": 3, "document": "# Site Report: Site 340\n\n## Site Information\n- **Site ID**: Site 340\n- **Study**: Study 5\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 1.50\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 3\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 341", "study": "Study 5", "site": "Site 341", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 341\n\n## Site Information\n- **Site ID**: Site 341\n- **Study**: Study 5\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 343", "study": "Study 5", "site": "Site 343", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 343\n\n## Site Information\n- **Site ID**: Site 343\n- **Study**: Study 5\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 344", "study": "Study 5", "site": "Site 344", "type": "site_summary", "total_subjects": 9, "total_issues": 0, "document": "# Site Report: Site 344\n\n## Site Information\n- **Site ID**: Site 344\n- **Study**: Study 5\n- **Country**: JPN\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 9 (100.0%)\n\n## Risk Profile\n- Low Risk: 9 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 345", "study": "Study 5", "site": "Site 345", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 345\n\n## Site Information\n- **Site ID**: Site 345\n- **Study**: Study 5\n- **Country**: JPN\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 346", "study": "Study 5", "site": "Site 346", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 346\n\n## Site Information\n- **Site ID**: Site 346\n- **Study**: Study 5\n- **Country**: CHN\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 347", "study": "Study 5", "site": "Site 347", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 347\n\n## Site Information\n- **Site ID**: Site 347\n- **Study**: Study 5\n- **Country**: CHN\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 5_Site 348", "study": "Study 5", "site": "Site 348", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 348\n\n## Site Information\n- **Site ID**: Site 348\n- **Study**: Study 5\n- **Country**: CHN\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 6_Site 14", "study": "Study 6", "site": "Site 14", "type": "site_summary", "total_subjects": 12, "total_issues": 8, "document": "# Site Report: Site 14\n\n## Site Information\n- **Site ID**: Site 14\n- **Study**: Study 6\n- **Country**: AUS\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 8\n- **Average Issues per Subject**: 0.67\n- **Clean Subjects**: 6 (50.0%)\n\n## Risk Profile\n- Low Risk: 6 (50.0%)\n- Medium Risk: 6 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 5\n- Outstanding Visits: 4\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 6_Site 15", "study": "Study 6", "site": "Site 15", "type": "site_summary", "total_subjects": 3, "total_issues": 12, "document": "# Site Report: Site 15\n\n## Site Information\n- **Site ID**: Site 15\n- **Study**: Study 6\n- **Country**: AUS\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 12\n- **Average Issues per Subject**: 4.00\n- **Clean Subjects**: 2 (66.7%)\n\n## Risk Profile\n- Low Risk: 2 (66.7%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (33.3%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 10\n- Outstanding Visits: 4\n\n## Subjects Requiring Attention\n- Subject 39: High risk, 12 issues\n"}
{"id": "site_Study 6_Site 165", "study": "Study 6", "site": "Site 165", "type": "site_summary", "total_subjects": 4, "total_issues": 172, "document": "# Site Report: Site 165\n\n## Site Information\n- **Site ID**: Site 165\n- **Study**: Study 6\n- **Country**: CHN\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 172\n- **Average Issues per Subject**: 43.00\n- **Clean Subjects**: 1 (25.0%)\n\n## Risk Profile\n- Low Risk: 1 (25.0%)\n- Medium Risk: 1 (25.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 2 (50.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 168\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\n- Subject 1513: Critical risk, 39 issues\n- Subject 2586: Critical risk, 131 issues\n"}
{"id": "site_Study 6_Site 168", "study": "Study 6", "site": "Site 168", "type": "site_summary", "total_subjects": 1, "total_issues": 48, "document": "# Site Report: Site 168\n\n## Site Information\n- **Site ID**: Site 168\n- **Study**: Study 6\n- **Country**: CHN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 48\n- **Average Issues per Subject**: 48.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 48\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 1520: Critical risk, 48 issues\n"}
{"id": "site_Study 6_Site 191", "study": "Study 6", "site": "Site 191", "type": "site_summary", "total_subjects": 2, "total_issues": 1, "document": "# Site Report: Site 191\n\n## Site Information\n- **Site ID**: Site 191\n- **Study**: Study 6\n- **Country**: JPN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.50\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 6_Site 193", "study": "Study 6", "site": "Site 193", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 193\n\n## Site Information\n- **Site ID**: Site 193\n- **Study**: Study 6\n- **Country**: JPN\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 6_Site 194", "study": "Study 6", "site": "Site 194", "type": "site_summary", "total_subjects": 2, "total_issues": 4, "document": "# Site Report: Site 194\n\n## Site Information\n- **Site ID**: Site 194\n- **Study**: Study 6\n- **Country**: JPN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 2.00\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 6_Site 20", "study": "Study 6", "site": "Site 20", "type": "site_summary", "total_subjects": 7, "total_issues": 1, "document": "# Site Report: Site 20\n\n## Site Information\n- **Site ID**: Site 20\n- **Study**: Study 6\n- **Country**: USA\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.14\n- **Clean Subjects**: 6 (85.7%)\n\n## Risk Profile\n- Low Risk: 6 (85.7%)\n- Medium Risk: 1 (14.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 1\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 6_Site 345", "study": "Study 6", "site": "Site 345", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 345\n\n## Site Information\n- **Site ID**: Site 345\n- **Study**: Study 6\n- **Country**: JPN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 1\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 6_Site 349", "study": "Study 6", "site": "Site 349", "type": "site_summary", "total_subjects": 7, "total_issues": 1, "document": "# Site Report: Site 349\n\n## Site Information\n- **Site ID**: Site 349\n- **Study**: Study 6\n- **Country**: SGP\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.14\n- **Clean Subjects**: 6 (85.7%)\n\n## Risk Profile\n- Low Risk: 6 (85.7%)\n- Medium Risk: 1 (14.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 6_Site 350", "study": "Study 6", "site": "Site 350", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 350\n\n## Site Information\n- **Site ID**: Site 350\n- **Study**: Study 6\n- **Country**: SGP\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 6_Site 351", "study": "Study 6", "site": "Site 351", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 351\n\n## Site Information\n- **Site ID**: Site 351\n- **Study**: Study 6\n- **Country**: TWN\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 3\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 6_Site 352", "study": "Study 6", "site": "Site 352", "type": "site_summary", "total_subjects": 1, "total_issues": 1, "document": "# Site Report: Site 352\n\n## Site Information\n- **Site ID**: Site 352\n- **Study**: Study 6\n- **Country**: JPN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 6_Site 62", "study": "Study 6", "site": "Site 62", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 62\n\n## Site Information\n- **Site ID**: Site 62\n- **Study**: Study 6\n- **Country**: ISR\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 7_Site 12", "study": "Study 7", "site": "Site 12", "type": "site_summary", "total_subjects": 3, "total_issues": 7, "document": "# Site Report: Site 12\n\n## Site Information\n- **Site ID**: Site 12\n- **Study**: Study 7\n- **Country**: SGP\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 7\n- **Average Issues per Subject**: 2.33\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 3 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 7_Site 14", "study": "Study 7", "site": "Site 14", "type": "site_summary", "total_subjects": 7, "total_issues": 657, "document": "# Site Report: Site 14\n\n## Site Information\n- **Site ID**: Site 14\n- **Study**: Study 7\n- **Country**: CHN\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 657\n- **Average Issues per Subject**: 93.86\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 7 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 5\n- Missing Pages: 0\n- Missing Labs: 648\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 25: Critical risk, 51 issues\n- Subject 26: Critical risk, 136 issues\n- Subject 27: Critical risk, 94 issues\n- Subject 28: Critical risk, 124 issues\n- Subject 29: Critical risk, 97 issues\n- Subject 31: Critical risk, 104 issues\n- Subject 34: Critical risk, 51 issues\n"}
{"id": "site_Study 7_Site 148", "study": "Study 7", "site": "Site 148", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 148\n\n## Site Information\n- **Site ID**: Site 148\n- **Study**: Study 7\n- **Country**: TWN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 7_Site 17", "study": "Study 7", "site": "Site 17", "type": "site_summary", "total_subjects": 1, "total_issues": 36, "document": "# Site Report: Site 17\n\n## Site Information\n- **Site ID**: Site 17\n- **Study**: Study 7\n- **Country**: CHN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 36\n- **Average Issues per Subject**: 36.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 34\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 61: Critical risk, 36 issues\n"}
{"id": "site_Study 7_Site 353", "study": "Study 7", "site": "Site 353", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 353\n\n## Site Information\n- **Site ID**: Site 353\n- **Study**: Study 7\n- **Country**: SGP\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 7_Site 354", "study": "Study 7", "site": "Site 354", "type": "site_summary", "total_subjects": 1, "total_issues": 51, "document": "# Site Report: Site 354\n\n## Site Information\n- **Site ID**: Site 354\n- **Study**: Study 7\n- **Country**: CHN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 51\n- **Average Issues per Subject**: 51.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 1 (100.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 51\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 2850: Critical risk, 51 issues\n"}
{"id": "site_Study 7_Site 356", "study": "Study 7", "site": "Site 356", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 356\n\n## Site Information\n- **Site ID**: Site 356\n- **Study**: Study 7\n- **Country**: JPN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 1", "study": "Study 8", "site": "Site 1", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 1\n\n## Site Information\n- **Site ID**: Site 1\n- **Study**: Study 8\n- **Country**: ARG\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 10", "study": "Study 8", "site": "Site 10", "type": "site_summary", "total_subjects": 13, "total_issues": 0, "document": "# Site Report: Site 10\n\n## Site Information\n- **Site ID**: Site 10\n- **Study**: Study 8\n- **Country**: BGR\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 13 (100.0%)\n\n## Risk Profile\n- Low Risk: 13 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 110", "study": "Study 8", "site": "Site 110", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 110\n\n## Site Information\n- **Site ID**: Site 110\n- **Study**: Study 8\n- **Country**: BGR\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 111", "study": "Study 8", "site": "Site 111", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 111\n\n## Site Information\n- **Site ID**: Site 111\n- **Study**: Study 8\n- **Country**: DEU\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 112", "study": "Study 8", "site": "Site 112", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 112\n\n## Site Information\n- **Site ID**: Site 112\n- **Study**: Study 8\n- **Country**: DEU\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 113", "study": "Study 8", "site": "Site 113", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 113\n\n## Site Information\n- **Site ID**: Site 113\n- **Study**: Study 8\n- **Country**: ITA\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 167", "study": "Study 8", "site": "Site 167", "type": "site_summary", "total_subjects": 13, "total_issues": 1, "document": "# Site Report: Site 167\n\n## Site Information\n- **Site ID**: Site 167\n- **Study**: Study 8\n- **Country**: KOR\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.08\n- **Clean Subjects**: 12 (92.3%)\n\n## Risk Profile\n- Low Risk: 12 (92.3%)\n- Medium Risk: 1 (7.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 174", "study": "Study 8", "site": "Site 174", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 174\n\n## Site Information\n- **Site ID**: Site 174\n- **Study**: Study 8\n- **Country**: MYS\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 175", "study": "Study 8", "site": "Site 175", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 175\n\n## Site Information\n- **Site ID**: Site 175\n- **Study**: Study 8\n- **Country**: MYS\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 176", "study": "Study 8", "site": "Site 176", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 176\n\n## Site Information\n- **Site ID**: Site 176\n- **Study**: Study 8\n- **Country**: IND\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 178", "study": "Study 8", "site": "Site 178", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 178\n\n## Site Information\n- **Site ID**: Site 178\n- **Study**: Study 8\n- **Country**: USA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 180", "study": "Study 8", "site": "Site 180", "type": "site_summary", "total_subjects": 2, "total_issues": 3, "document": "# Site Report: Site 180\n\n## Site Information\n- **Site ID**: Site 180\n- **Study**: Study 8\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 1.50\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 2 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 2\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 181", "study": "Study 8", "site": "Site 181", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 181\n\n## Site Information\n- **Site ID**: Site 181\n- **Study**: Study 8\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 183", "study": "Study 8", "site": "Site 183", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 183\n\n## Site Information\n- **Site ID**: Site 183\n- **Study**: Study 8\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 185", "study": "Study 8", "site": "Site 185", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 185\n\n## Site Information\n- **Site ID**: Site 185\n- **Study**: Study 8\n- **Country**: USA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 2", "study": "Study 8", "site": "Site 2", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 2\n\n## Site Information\n- **Site ID**: Site 2\n- **Study**: Study 8\n- **Country**: ARG\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 28", "study": "Study 8", "site": "Site 28", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 28\n\n## Site Information\n- **Site ID**: Site 28\n- **Study**: Study 8\n- **Country**: ARG\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 3", "study": "Study 8", "site": "Site 3", "type": "site_summary", "total_subjects": 8, "total_issues": 1, "document": "# Site Report: Site 3\n\n## Site Information\n- **Site ID**: Site 3\n- **Study**: Study 8\n- **Country**: ARG\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.12\n- **Clean Subjects**: 7 (87.5%)\n\n## Risk Profile\n- Low Risk: 7 (87.5%)\n- Medium Risk: 1 (12.5%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 31", "study": "Study 8", "site": "Site 31", "type": "site_summary", "total_subjects": 9, "total_issues": 1, "document": "# Site Report: Site 31\n\n## Site Information\n- **Site ID**: Site 31\n- **Study**: Study 8\n- **Country**: CAN\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.11\n- **Clean Subjects**: 8 (88.9%)\n\n## Risk Profile\n- Low Risk: 8 (88.9%)\n- Medium Risk: 1 (11.1%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 316", "study": "Study 8", "site": "Site 316", "type": "site_summary", "total_subjects": 8, "total_issues": 0, "document": "# Site Report: Site 316\n\n## Site Information\n- **Site ID**: Site 316\n- **Study**: Study 8\n- **Country**: KOR\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 8 (100.0%)\n\n## Risk Profile\n- Low Risk: 8 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 317", "study": "Study 8", "site": "Site 317", "type": "site_summary", "total_subjects": 11, "total_issues": 0, "document": "# Site Report: Site 317\n\n## Site Information\n- **Site ID**: Site 317\n- **Study**: Study 8\n- **Country**: ZAF\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 11 (100.0%)\n\n## Risk Profile\n- Low Risk: 11 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 318", "study": "Study 8", "site": "Site 318", "type": "site_summary", "total_subjects": 6, "total_issues": 4, "document": "# Site Report: Site 318\n\n## Site Information\n- **Site ID**: Site 318\n- **Study**: Study 8\n- **Country**: ZAF\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 0.67\n- **Clean Subjects**: 4 (66.7%)\n\n## Risk Profile\n- Low Risk: 4 (66.7%)\n- Medium Risk: 2 (33.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 3\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 323", "study": "Study 8", "site": "Site 323", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 323\n\n## Site Information\n- **Site ID**: Site 323\n- **Study**: Study 8\n- **Country**: ARE\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 326", "study": "Study 8", "site": "Site 326", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 326\n\n## Site Information\n- **Site ID**: Site 326\n- **Study**: Study 8\n- **Country**: USA\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 327", "study": "Study 8", "site": "Site 327", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 327\n\n## Site Information\n- **Site ID**: Site 327\n- **Study**: Study 8\n- **Country**: USA\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 357", "study": "Study 8", "site": "Site 357", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 357\n\n## Site Information\n- **Site ID**: Site 357\n- **Study**: Study 8\n- **Country**: CAN\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 358", "study": "Study 8", "site": "Site 358", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 358\n\n## Site Information\n- **Site ID**: Site 358\n- **Study**: Study 8\n- **Country**: BGR\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 359", "study": "Study 8", "site": "Site 359", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 359\n\n## Site Information\n- **Site ID**: Site 359\n- **Study**: Study 8\n- **Country**: BGR\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 360", "study": "Study 8", "site": "Site 360", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 360\n\n## Site Information\n- **Site ID**: Site 360\n- **Study**: Study 8\n- **Country**: CZE\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 361", "study": "Study 8", "site": "Site 361", "type": "site_summary", "total_subjects": 4, "total_issues": 4, "document": "# Site Report: Site 361\n\n## Site Information\n- **Site ID**: Site 361\n- **Study**: Study 8\n- **Country**: CZE\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 4\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 2 (50.0%)\n\n## Risk Profile\n- Low Risk: 2 (50.0%)\n- Medium Risk: 2 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 3\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 362", "study": "Study 8", "site": "Site 362", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 362\n\n## Site Information\n- **Site ID**: Site 362\n- **Study**: Study 8\n- **Country**: CZE\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 363", "study": "Study 8", "site": "Site 363", "type": "site_summary", "total_subjects": 14, "total_issues": 2, "document": "# Site Report: Site 363\n\n## Site Information\n- **Site ID**: Site 363\n- **Study**: Study 8\n- **Country**: CZE\n- **Total Subjects**: 14\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.14\n- **Clean Subjects**: 12 (85.7%)\n\n## Risk Profile\n- Low Risk: 12 (85.7%)\n- Medium Risk: 2 (14.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 364", "study": "Study 8", "site": "Site 364", "type": "site_summary", "total_subjects": 9, "total_issues": 0, "document": "# Site Report: Site 364\n\n## Site Information\n- **Site ID**: Site 364\n- **Study**: Study 8\n- **Country**: FRA\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 9 (100.0%)\n\n## Risk Profile\n- Low Risk: 9 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 365", "study": "Study 8", "site": "Site 365", "type": "site_summary", "total_subjects": 16, "total_issues": 0, "document": "# Site Report: Site 365\n\n## Site Information\n- **Site ID**: Site 365\n- **Study**: Study 8\n- **Country**: FRA\n- **Total Subjects**: 16\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 16 (100.0%)\n\n## Risk Profile\n- Low Risk: 16 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 3\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 366", "study": "Study 8", "site": "Site 366", "type": "site_summary", "total_subjects": 13, "total_issues": 2, "document": "# Site Report: Site 366\n\n## Site Information\n- **Site ID**: Site 366\n- **Study**: Study 8\n- **Country**: FRA\n- **Total Subjects**: 13\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.15\n- **Clean Subjects**: 11 (84.6%)\n\n## Risk Profile\n- Low Risk: 11 (84.6%)\n- Medium Risk: 2 (15.4%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 367", "study": "Study 8", "site": "Site 367", "type": "site_summary", "total_subjects": 10, "total_issues": 2, "document": "# Site Report: Site 367\n\n## Site Information\n- **Site ID**: Site 367\n- **Study**: Study 8\n- **Country**: FRA\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.20\n- **Clean Subjects**: 9 (90.0%)\n\n## Risk Profile\n- Low Risk: 9 (90.0%)\n- Medium Risk: 1 (10.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 368", "study": "Study 8", "site": "Site 368", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 368\n\n## Site Information\n- **Site ID**: Site 368\n- **Study**: Study 8\n- **Country**: FRA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 369", "study": "Study 8", "site": "Site 369", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 369\n\n## Site Information\n- **Site ID**: Site 369\n- **Study**: Study 8\n- **Country**: FRA\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 370", "study": "Study 8", "site": "Site 370", "type": "site_summary", "total_subjects": 16, "total_issues": 2, "document": "# Site Report: Site 370\n\n## Site Information\n- **Site ID**: Site 370\n- **Study**: Study 8\n- **Country**: FRA\n- **Total Subjects**: 16\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.12\n- **Clean Subjects**: 15 (93.8%)\n\n## Risk Profile\n- Low Risk: 15 (93.8%)\n- Medium Risk: 1 (6.2%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 371", "study": "Study 8", "site": "Site 371", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 371\n\n## Site Information\n- **Site ID**: Site 371\n- **Study**: Study 8\n- **Country**: FRA\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 372", "study": "Study 8", "site": "Site 372", "type": "site_summary", "total_subjects": 7, "total_issues": 1, "document": "# Site Report: Site 372\n\n## Site Information\n- **Site ID**: Site 372\n- **Study**: Study 8\n- **Country**: FRA\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.14\n- **Clean Subjects**: 6 (85.7%)\n\n## Risk Profile\n- Low Risk: 6 (85.7%)\n- Medium Risk: 1 (14.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 373", "study": "Study 8", "site": "Site 373", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 373\n\n## Site Information\n- **Site ID**: Site 373\n- **Study**: Study 8\n- **Country**: FRA\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 374", "study": "Study 8", "site": "Site 374", "type": "site_summary", "total_subjects": 17, "total_issues": 0, "document": "# Site Report: Site 374\n\n## Site Information\n- **Site ID**: Site 374\n- **Study**: Study 8\n- **Country**: FRA\n- **Total Subjects**: 17\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 17 (100.0%)\n\n## Risk Profile\n- Low Risk: 17 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 375", "study": "Study 8", "site": "Site 375", "type": "site_summary", "total_subjects": 14, "total_issues": 0, "document": "# Site Report: Site 375\n\n## Site Information\n- **Site ID**: Site 375\n- **Study**: Study 8\n- **Country**: FRA\n- **Total Subjects**: 14\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 14 (100.0%)\n\n## Risk Profile\n- Low Risk: 14 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 5\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 376", "study": "Study 8", "site": "Site 376", "type": "site_summary", "total_subjects": 11, "total_issues": 1, "document": "# Site Report: Site 376\n\n## Site Information\n- **Site ID**: Site 376\n- **Study**: Study 8\n- **Country**: FRA\n- **Total Subjects**: 11\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.09\n- **Clean Subjects**: 10 (90.9%)\n\n## Risk Profile\n- Low Risk: 10 (90.9%)\n- Medium Risk: 1 (9.1%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 377", "study": "Study 8", "site": "Site 377", "type": "site_summary", "total_subjects": 14, "total_issues": 1, "document": "# Site Report: Site 377\n\n## Site Information\n- **Site ID**: Site 377\n- **Study**: Study 8\n- **Country**: DEU\n- **Total Subjects**: 14\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.07\n- **Clean Subjects**: 13 (92.9%)\n\n## Risk Profile\n- Low Risk: 13 (92.9%)\n- Medium Risk: 1 (7.1%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 378", "study": "Study 8", "site": "Site 378", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 378\n\n## Site Information\n- **Site ID**: Site 378\n- **Study**: Study 8\n- **Country**: DEU\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 379", "study": "Study 8", "site": "Site 379", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 379\n\n## Site Information\n- **Site ID**: Site 379\n- **Study**: Study 8\n- **Country**: DEU\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 380", "study": "Study 8", "site": "Site 380", "type": "site_summary", "total_subjects": 28, "total_issues": 0, "document": "# Site Report: Site 380\n\n## Site Information\n- **Site ID**: Site 380\n- **Study**: Study 8\n- **Country**: DEU\n- **Total Subjects**: 28\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 28 (100.0%)\n\n## Risk Profile\n- Low Risk: 28 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 381", "study": "Study 8", "site": "Site 381", "type": "site_summary", "total_subjects": 5, "total_issues": 2, "document": "# Site Report: Site 381\n\n## Site Information\n- **Site ID**: Site 381\n- **Study**: Study 8\n- **Country**: DEU\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.40\n- **Clean Subjects**: 4 (80.0%)\n\n## Risk Profile\n- Low Risk: 4 (80.0%)\n- Medium Risk: 1 (20.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 382", "study": "Study 8", "site": "Site 382", "type": "site_summary", "total_subjects": 8, "total_issues": 1, "document": "# Site Report: Site 382\n\n## Site Information\n- **Site ID**: Site 382\n- **Study**: Study 8\n- **Country**: DEU\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.12\n- **Clean Subjects**: 7 (87.5%)\n\n## Risk Profile\n- Low Risk: 7 (87.5%)\n- Medium Risk: 1 (12.5%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 383", "study": "Study 8", "site": "Site 383", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 383\n\n## Site Information\n- **Site ID**: Site 383\n- **Study**: Study 8\n- **Country**: DEU\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 384", "study": "Study 8", "site": "Site 384", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 384\n\n## Site Information\n- **Site ID**: Site 384\n- **Study**: Study 8\n- **Country**: DEU\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 385", "study": "Study 8", "site": "Site 385", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 385\n\n## Site Information\n- **Site ID**: Site 385\n- **Study**: Study 8\n- **Country**: DEU\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 386", "study": "Study 8", "site": "Site 386", "type": "site_summary", "total_subjects": 6, "total_issues": 1, "document": "# Site Report: Site 386\n\n## Site Information\n- **Site ID**: Site 386\n- **Study**: Study 8\n- **Country**: DEU\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.17\n- **Clean Subjects**: 5 (83.3%)\n\n## Risk Profile\n- Low Risk: 5 (83.3%)\n- Medium Risk: 1 (16.7%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 387", "study": "Study 8", "site": "Site 387", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 387\n\n## Site Information\n- **Site ID**: Site 387\n- **Study**: Study 8\n- **Country**: DEU\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 388", "study": "Study 8", "site": "Site 388", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 388\n\n## Site Information\n- **Site ID**: Site 388\n- **Study**: Study 8\n- **Country**: DEU\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 389", "study": "Study 8", "site": "Site 389", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 389\n\n## Site Information\n- **Site ID**: Site 389\n- **Study**: Study 8\n- **Country**: DEU\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 390", "study": "Study 8", "site": "Site 390", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 390\n\n## Site Information\n- **Site ID**: Site 390\n- **Study**: Study 8\n- **Country**: DEU\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 391", "study": "Study 8", "site": "Site 391", "type": "site_summary", "total_subjects": 1, "total_issues": 3, "document": "# Site Report: Site 391\n\n## Site Information\n- **Site ID**: Site 391\n- **Study**: Study 8\n- **Country**: DEU\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 3.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 392", "study": "Study 8", "site": "Site 392", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 392\n\n## Site Information\n- **Site ID**: Site 392\n- **Study**: Study 8\n- **Country**: DEU\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 393", "study": "Study 8", "site": "Site 393", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 393\n\n## Site Information\n- **Site ID**: Site 393\n- **Study**: Study 8\n- **Country**: DEU\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 394", "study": "Study 8", "site": "Site 394", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 394\n\n## Site Information\n- **Site ID**: Site 394\n- **Study**: Study 8\n- **Country**: DEU\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 395", "study": "Study 8", "site": "Site 395", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 395\n\n## Site Information\n- **Site ID**: Site 395\n- **Study**: Study 8\n- **Country**: DEU\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 396", "study": "Study 8", "site": "Site 396", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 396\n\n## Site Information\n- **Site ID**: Site 396\n- **Study**: Study 8\n- **Country**: DEU\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 397", "study": "Study 8", "site": "Site 397", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 397\n\n## Site Information\n- **Site ID**: Site 397\n- **Study**: Study 8\n- **Country**: DEU\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 398", "study": "Study 8", "site": "Site 398", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 398\n\n## Site Information\n- **Site ID**: Site 398\n- **Study**: Study 8\n- **Country**: DEU\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 399", "study": "Study 8", "site": "Site 399", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 399\n\n## Site Information\n- **Site ID**: Site 399\n- **Study**: Study 8\n- **Country**: DEU\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 4", "study": "Study 8", "site": "Site 4", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 4\n\n## Site Information\n- **Site ID**: Site 4\n- **Study**: Study 8\n- **Country**: ARG\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 400", "study": "Study 8", "site": "Site 400", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 400\n\n## Site Information\n- **Site ID**: Site 400\n- **Study**: Study 8\n- **Country**: DEU\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 401", "study": "Study 8", "site": "Site 401", "type": "site_summary", "total_subjects": 6, "total_issues": 7, "document": "# Site Report: Site 401\n\n## Site Information\n- **Site ID**: Site 401\n- **Study**: Study 8\n- **Country**: DEU\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 7\n- **Average Issues per Subject**: 1.17\n- **Clean Subjects**: 5 (83.3%)\n\n## Risk Profile\n- Low Risk: 5 (83.3%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (16.7%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 3172: High risk, 7 issues\n"}
{"id": "site_Study 8_Site 402", "study": "Study 8", "site": "Site 402", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 402\n\n## Site Information\n- **Site ID**: Site 402\n- **Study**: Study 8\n- **Country**: DEU\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 403", "study": "Study 8", "site": "Site 403", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 403\n\n## Site Information\n- **Site ID**: Site 403\n- **Study**: Study 8\n- **Country**: DEU\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 404", "study": "Study 8", "site": "Site 404", "type": "site_summary", "total_subjects": 2, "total_issues": 1, "document": "# Site Report: Site 404\n\n## Site Information\n- **Site ID**: Site 404\n- **Study**: Study 8\n- **Country**: DEU\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.50\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 405", "study": "Study 8", "site": "Site 405", "type": "site_summary", "total_subjects": 3, "total_issues": 1, "document": "# Site Report: Site 405\n\n## Site Information\n- **Site ID**: Site 405\n- **Study**: Study 8\n- **Country**: DEU\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.33\n- **Clean Subjects**: 2 (66.7%)\n\n## Risk Profile\n- Low Risk: 2 (66.7%)\n- Medium Risk: 1 (33.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 1\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 406", "study": "Study 8", "site": "Site 406", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 406\n\n## Site Information\n- **Site ID**: Site 406\n- **Study**: Study 8\n- **Country**: GRC\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 407", "study": "Study 8", "site": "Site 407", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 407\n\n## Site Information\n- **Site ID**: Site 407\n- **Study**: Study 8\n- **Country**: GRC\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 408", "study": "Study 8", "site": "Site 408", "type": "site_summary", "total_subjects": 6, "total_issues": 3, "document": "# Site Report: Site 408\n\n## Site Information\n- **Site ID**: Site 408\n- **Study**: Study 8\n- **Country**: GRC\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 0.50\n- **Clean Subjects**: 4 (66.7%)\n\n## Risk Profile\n- Low Risk: 4 (66.7%)\n- Medium Risk: 2 (33.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 3\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 409", "study": "Study 8", "site": "Site 409", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 409\n\n## Site Information\n- **Site ID**: Site 409\n- **Study**: Study 8\n- **Country**: GRC\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 410", "study": "Study 8", "site": "Site 410", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 410\n\n## Site Information\n- **Site ID**: Site 410\n- **Study**: Study 8\n- **Country**: GRC\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 411", "study": "Study 8", "site": "Site 411", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 411\n\n## Site Information\n- **Site ID**: Site 411\n- **Study**: Study 8\n- **Country**: HUN\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 412", "study": "Study 8", "site": "Site 412", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 412\n\n## Site Information\n- **Site ID**: Site 412\n- **Study**: Study 8\n- **Country**: HUN\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 413", "study": "Study 8", "site": "Site 413", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 413\n\n## Site Information\n- **Site ID**: Site 413\n- **Study**: Study 8\n- **Country**: HUN\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 414", "study": "Study 8", "site": "Site 414", "type": "site_summary", "total_subjects": 4, "total_issues": 1, "document": "# Site Report: Site 414\n\n## Site Information\n- **Site ID**: Site 414\n- **Study**: Study 8\n- **Country**: ITA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.25\n- **Clean Subjects**: 3 (75.0%)\n\n## Risk Profile\n- Low Risk: 3 (75.0%)\n- Medium Risk: 1 (25.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 415", "study": "Study 8", "site": "Site 415", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 415\n\n## Site Information\n- **Site ID**: Site 415\n- **Study**: Study 8\n- **Country**: ITA\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 2\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 416", "study": "Study 8", "site": "Site 416", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 416\n\n## Site Information\n- **Site ID**: Site 416\n- **Study**: Study 8\n- **Country**: ITA\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 417", "study": "Study 8", "site": "Site 417", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 417\n\n## Site Information\n- **Site ID**: Site 417\n- **Study**: Study 8\n- **Country**: ITA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 418", "study": "Study 8", "site": "Site 418", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 418\n\n## Site Information\n- **Site ID**: Site 418\n- **Study**: Study 8\n- **Country**: ROU\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 419", "study": "Study 8", "site": "Site 419", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 419\n\n## Site Information\n- **Site ID**: Site 419\n- **Study**: Study 8\n- **Country**: ROU\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 420", "study": "Study 8", "site": "Site 420", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 420\n\n## Site Information\n- **Site ID**: Site 420\n- **Study**: Study 8\n- **Country**: ROU\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 421", "study": "Study 8", "site": "Site 421", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 421\n\n## Site Information\n- **Site ID**: Site 421\n- **Study**: Study 8\n- **Country**: ROU\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 422", "study": "Study 8", "site": "Site 422", "type": "site_summary", "total_subjects": 2, "total_issues": 1, "document": "# Site Report: Site 422\n\n## Site Information\n- **Site ID**: Site 422\n- **Study**: Study 8\n- **Country**: ROU\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.50\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 1 (50.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 423", "study": "Study 8", "site": "Site 423", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 423\n\n## Site Information\n- **Site ID**: Site 423\n- **Study**: Study 8\n- **Country**: ROU\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 424", "study": "Study 8", "site": "Site 424", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 424\n\n## Site Information\n- **Site ID**: Site 424\n- **Study**: Study 8\n- **Country**: ROU\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 425", "study": "Study 8", "site": "Site 425", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 425\n\n## Site Information\n- **Site ID**: Site 425\n- **Study**: Study 8\n- **Country**: ROU\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 426", "study": "Study 8", "site": "Site 426", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 426\n\n## Site Information\n- **Site ID**: Site 426\n- **Study**: Study 8\n- **Country**: SVK\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 427", "study": "Study 8", "site": "Site 427", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 427\n\n## Site Information\n- **Site ID**: Site 427\n- **Study**: Study 8\n- **Country**: SVK\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 428", "study": "Study 8", "site": "Site 428", "type": "site_summary", "total_subjects": 4, "total_issues": 1, "document": "# Site Report: Site 428\n\n## Site Information\n- **Site ID**: Site 428\n- **Study**: Study 8\n- **Country**: CHE\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.25\n- **Clean Subjects**: 3 (75.0%)\n\n## Risk Profile\n- Low Risk: 3 (75.0%)\n- Medium Risk: 1 (25.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 429", "study": "Study 8", "site": "Site 429", "type": "site_summary", "total_subjects": 2, "total_issues": 11, "document": "# Site Report: Site 429\n\n## Site Information\n- **Site ID**: Site 429\n- **Study**: Study 8\n- **Country**: GBR\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 11\n- **Average Issues per Subject**: 5.50\n- **Clean Subjects**: 1 (50.0%)\n\n## Risk Profile\n- Low Risk: 1 (50.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (50.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 5\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 3269: High risk, 11 issues\n"}
{"id": "site_Study 8_Site 430", "study": "Study 8", "site": "Site 430", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 430\n\n## Site Information\n- **Site ID**: Site 430\n- **Study**: Study 8\n- **Country**: GBR\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 431", "study": "Study 8", "site": "Site 431", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 431\n\n## Site Information\n- **Site ID**: Site 431\n- **Study**: Study 8\n- **Country**: GBR\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 432", "study": "Study 8", "site": "Site 432", "type": "site_summary", "total_subjects": 1, "total_issues": 3, "document": "# Site Report: Site 432\n\n## Site Information\n- **Site ID**: Site 432\n- **Study**: Study 8\n- **Country**: GBR\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 3.00\n- **Clean Subjects**: 0 (0.0%)\n\n## Risk Profile\n- Low Risk: 0 (0.0%)\n- Medium Risk: 1 (100.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 3\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 433", "study": "Study 8", "site": "Site 433", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 433\n\n## Site Information\n- **Site ID**: Site 433\n- **Study**: Study 8\n- **Country**: GBR\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 434", "study": "Study 8", "site": "Site 434", "type": "site_summary", "total_subjects": 3, "total_issues": 0, "document": "# Site Report: Site 434\n\n## Site Information\n- **Site ID**: Site 434\n- **Study**: Study 8\n- **Country**: NLD\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 3 (100.0%)\n\n## Risk Profile\n- Low Risk: 3 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 435", "study": "Study 8", "site": "Site 435", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 435\n\n## Site Information\n- **Site ID**: Site 435\n- **Study**: Study 8\n- **Country**: JOR\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 436", "study": "Study 8", "site": "Site 436", "type": "site_summary", "total_subjects": 8, "total_issues": 2, "document": "# Site Report: Site 436\n\n## Site Information\n- **Site ID**: Site 436\n- **Study**: Study 8\n- **Country**: MYS\n- **Total Subjects**: 8\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.25\n- **Clean Subjects**: 7 (87.5%)\n\n## Risk Profile\n- Low Risk: 7 (87.5%)\n- Medium Risk: 1 (12.5%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 1\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 437", "study": "Study 8", "site": "Site 437", "type": "site_summary", "total_subjects": 7, "total_issues": 0, "document": "# Site Report: Site 437\n\n## Site Information\n- **Site ID**: Site 437\n- **Study**: Study 8\n- **Country**: MYS\n- **Total Subjects**: 7\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 7 (100.0%)\n\n## Risk Profile\n- Low Risk: 7 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 438", "study": "Study 8", "site": "Site 438", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 438\n\n## Site Information\n- **Site ID**: Site 438\n- **Study**: Study 8\n- **Country**: MYS\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 439", "study": "Study 8", "site": "Site 439", "type": "site_summary", "total_subjects": 10, "total_issues": 11, "document": "# Site Report: Site 439\n\n## Site Information\n- **Site ID**: Site 439\n- **Study**: Study 8\n- **Country**: SGP\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 11\n- **Average Issues per Subject**: 1.10\n- **Clean Subjects**: 9 (90.0%)\n\n## Risk Profile\n- Low Risk: 9 (90.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 1 (10.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 11\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 3331: High risk, 11 issues\n"}
{"id": "site_Study 8_Site 440", "study": "Study 8", "site": "Site 440", "type": "site_summary", "total_subjects": 6, "total_issues": 0, "document": "# Site Report: Site 440\n\n## Site Information\n- **Site ID**: Site 440\n- **Study**: Study 8\n- **Country**: SGP\n- **Total Subjects**: 6\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 6 (100.0%)\n\n## Risk Profile\n- Low Risk: 6 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 441", "study": "Study 8", "site": "Site 441", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 441\n\n## Site Information\n- **Site ID**: Site 441\n- **Study**: Study 8\n- **Country**: SGP\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 442", "study": "Study 8", "site": "Site 442", "type": "site_summary", "total_subjects": 10, "total_issues": 1, "document": "# Site Report: Site 442\n\n## Site Information\n- **Site ID**: Site 442\n- **Study**: Study 8\n- **Country**: OMN\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 1\n- **Average Issues per Subject**: 0.10\n- **Clean Subjects**: 9 (90.0%)\n\n## Risk Profile\n- Low Risk: 9 (90.0%)\n- Medium Risk: 1 (10.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 443", "study": "Study 8", "site": "Site 443", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 443\n\n## Site Information\n- **Site ID**: Site 443\n- **Study**: Study 8\n- **Country**: TUR\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 444", "study": "Study 8", "site": "Site 444", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 444\n\n## Site Information\n- **Site ID**: Site 444\n- **Study**: Study 8\n- **Country**: TUR\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 445", "study": "Study 8", "site": "Site 445", "type": "site_summary", "total_subjects": 1, "total_issues": 0, "document": "# Site Report: Site 445\n\n## Site Information\n- **Site ID**: Site 445\n- **Study**: Study 8\n- **Country**: TUR\n- **Total Subjects**: 1\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 1 (100.0%)\n\n## Risk Profile\n- Low Risk: 1 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 446", "study": "Study 8", "site": "Site 446", "type": "site_summary", "total_subjects": 2, "total_issues": 0, "document": "# Site Report: Site 446\n\n## Site Information\n- **Site ID**: Site 446\n- **Study**: Study 8\n- **Country**: IND\n- **Total Subjects**: 2\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 2 (100.0%)\n\n## Risk Profile\n- Low Risk: 2 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 447", "study": "Study 8", "site": "Site 447", "type": "site_summary", "total_subjects": 5, "total_issues": 0, "document": "# Site Report: Site 447\n\n## Site Information\n- **Site ID**: Site 447\n- **Study**: Study 8\n- **Country**: IND\n- **Total Subjects**: 5\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 5 (100.0%)\n\n## Risk Profile\n- Low Risk: 5 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 448", "study": "Study 8", "site": "Site 448", "type": "site_summary", "total_subjects": 3, "total_issues": 3, "document": "# Site Report: Site 448\n\n## Site Information\n- **Site ID**: Site 448\n- **Study**: Study 8\n- **Country**: IND\n- **Total Subjects**: 3\n\n## Performance Metrics\n- **Total Issues**: 3\n- **Average Issues per Subject**: 1.00\n- **Clean Subjects**: 2 (66.7%)\n\n## Risk Profile\n- Low Risk: 2 (66.7%)\n- Medium Risk: 1 (33.3%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 449", "study": "Study 8", "site": "Site 449", "type": "site_summary", "total_subjects": 10, "total_issues": 0, "document": "# Site Report: Site 449\n\n## Site Information\n- **Site ID**: Site 449\n- **Study**: Study 8\n- **Country**: IND\n- **Total Subjects**: 10\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 10 (100.0%)\n\n## Risk Profile\n- Low Risk: 10 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 450", "study": "Study 8", "site": "Site 450", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 450\n\n## Site Information\n- **Site ID**: Site 450\n- **Study**: Study 8\n- **Country**: USA\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 8_Site 88", "study": "Study 8", "site": "Site 88", "type": "site_summary", "total_subjects": 4, "total_issues": 0, "document": "# Site Report: Site 88\n\n## Site Information\n- **Site ID**: Site 88\n- **Study**: Study 8\n- **Country**: BGR\n- **Total Subjects**: 4\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 4 (100.0%)\n\n## Risk Profile\n- Low Risk: 4 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 9_Site 110", "study": "Study 9", "site": "Site 110", "type": "site_summary", "total_subjects": 22, "total_issues": 0, "document": "# Site Report: Site 110\n\n## Site Information\n- **Site ID**: Site 110\n- **Study**: Study 9\n- **Country**: CIV\n- **Total Subjects**: 22\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 22 (100.0%)\n\n## Risk Profile\n- Low Risk: 22 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 9_Site 14", "study": "Study 9", "site": "Site 14", "type": "site_summary", "total_subjects": 9, "total_issues": 0, "document": "# Site Report: Site 14\n\n## Site Information\n- **Site ID**: Site 14\n- **Study**: Study 9\n- **Country**: GAB\n- **Total Subjects**: 9\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 9 (100.0%)\n\n## Risk Profile\n- Low Risk: 9 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 9_Site 15", "study": "Study 9", "site": "Site 15", "type": "site_summary", "total_subjects": 14, "total_issues": 0, "document": "# Site Report: Site 15\n\n## Site Information\n- **Site ID**: Site 15\n- **Study**: Study 9\n- **Country**: GAB\n- **Total Subjects**: 14\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 14 (100.0%)\n\n## Risk Profile\n- Low Risk: 14 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 9_Site 165", "study": "Study 9", "site": "Site 165", "type": "site_summary", "total_subjects": 18, "total_issues": 2, "document": "# Site Report: Site 165\n\n## Site Information\n- **Site ID**: Site 165\n- **Study**: Study 9\n- **Country**: GHA\n- **Total Subjects**: 18\n\n## Performance Metrics\n- **Total Issues**: 2\n- **Average Issues per Subject**: 0.11\n- **Clean Subjects**: 17 (94.4%)\n\n## Risk Profile\n- Low Risk: 17 (94.4%)\n- Medium Risk: 1 (5.6%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 2\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 9_Site 177", "study": "Study 9", "site": "Site 177", "type": "site_summary", "total_subjects": 16, "total_issues": 0, "document": "# Site Report: Site 177\n\n## Site Information\n- **Site ID**: Site 177\n- **Study**: Study 9\n- **Country**: KEN\n- **Total Subjects**: 16\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 16 (100.0%)\n\n## Risk Profile\n- Low Risk: 16 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 9_Site 18", "study": "Study 9", "site": "Site 18", "type": "site_summary", "total_subjects": 31, "total_issues": 0, "document": "# Site Report: Site 18\n\n## Site Information\n- **Site ID**: Site 18\n- **Study**: Study 9\n- **Country**: KEN\n- **Total Subjects**: 31\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 31 (100.0%)\n\n## Risk Profile\n- Low Risk: 31 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 9_Site 2", "study": "Study 9", "site": "Site 2", "type": "site_summary", "total_subjects": 20, "total_issues": 31, "document": "# Site Report: Site 2\n\n## Site Information\n- **Site ID**: Site 2\n- **Study**: Study 9\n- **Country**: BFA\n- **Total Subjects**: 20\n\n## Performance Metrics\n- **Total Issues**: 31\n- **Average Issues per Subject**: 1.55\n- **Clean Subjects**: 16 (80.0%)\n\n## Risk Profile\n- Low Risk: 16 (80.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 4 (20.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 31\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\n- Subject 3407: High risk, 8 issues\n- Subject 3408: High risk, 8 issues\n- Subject 3409: High risk, 8 issues\n- Subject 3412: High risk, 7 issues\n"}
{"id": "site_Study 9_Site 347", "study": "Study 9", "site": "Site 347", "type": "site_summary", "total_subjects": 12, "total_issues": 0, "document": "# Site Report: Site 347\n\n## Site Information\n- **Site ID**: Site 347\n- **Study**: Study 9\n- **Country**: UGA\n- **Total Subjects**: 12\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 12 (100.0%)\n\n## Risk Profile\n- Low Risk: 12 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
{"id": "site_Study 9_Site 87", "study": "Study 9", "site": "Site 87", "type": "site_summary", "total_subjects": 26, "total_issues": 0, "document": "# Site Report: Site 87\n\n## Site Information\n- **Site ID**: Site 87\n- **Study**: Study 9\n- **Country**: CIV\n- **Total Subjects**: 26\n\n## Performance Metrics\n- **Total Issues**: 0\n- **Average Issues per Subject**: 0.00\n- **Clean Subjects**: 26 (100.0%)\n\n## Risk Profile\n- Low Risk: 26 (100.0%)\n- Medium Risk: 0 (0.0%)\n- High Risk: 0 (0.0%)\n- Critical Risk: 0 (0.0%)\n\n## Issue Breakdown\n- Open EDRR Issues: 0\n- Safety Discrepancies: 0\n- Missing Pages: 0\n- Missing Labs: 0\n- Outstanding Visits: 0\n\n## Subjects Requiring Attention\nNo high-priority subjects.\n"}
